Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2024-08-16
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| PCLAF | -11.424165 |
| RRM2 | -8.727520 |
| TK1 | -7.883332 |
| HIST1H1C | -7.054759 |
| RCBTB2 | -6.881857 |
| HVCN1 | -6.772249 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10461 |
| num_genes_in_profile | 14592 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 11381 |
| num_profile_genes_not_in_sets | 3211 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets:| Gene sets metrics | |
|---|---|
| num_genesets | 10461 |
| num_genesets_excluded | 4546 |
| num_genesets_included | 5915 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOCC KNL1 SPC105 COMPLEX | 5 | 3.08e-04 | -0.932 | 7.04e-03 |
| GOBP OPSONIZATION | 5 | 8.20e-04 | -0.864 | 1.45e-02 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 5.38e-04 | 0.816 | 1.03e-02 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY | 5 | 1.66e-03 | -0.812 | 2.43e-02 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 5 | 1.68e-03 | -0.811 | 2.44e-02 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 8 | 9.11e-05 | -0.799 | 2.75e-03 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 7 | 3.18e-04 | 0.786 | 7.20e-03 |
| GOCC MCM COMPLEX | 8 | 1.38e-04 | -0.778 | 3.83e-03 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 3.66e-04 | 0.778 | 7.79e-03 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 8 | 1.46e-04 | -0.775 | 4.02e-03 |
| GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS | 5 | 2.71e-03 | -0.774 | 3.48e-02 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 7 | 4.37e-04 | -0.767 | 8.93e-03 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 5 | 3.64e-03 | -0.751 | 4.22e-02 |
| GOMF IGG BINDING | 6 | 1.51e-03 | -0.748 | 2.28e-02 |
| GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 5 | 3.80e-03 | -0.747 | 4.34e-02 |
| GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES | 6 | 1.61e-03 | -0.743 | 2.38e-02 |
| GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION | 5 | 4.06e-03 | -0.742 | 4.51e-02 |
| GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS | 5 | 4.14e-03 | 0.740 | 4.57e-02 |
| GOBP APOPTOTIC CHROMOSOME CONDENSATION | 5 | 4.69e-03 | -0.730 | 4.90e-02 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 7 | 8.67e-04 | -0.727 | 1.51e-02 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 5 | 5.46e-03 | 0.718 | 5.43e-02 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE | 5 | 5.46e-03 | -0.718 | 5.43e-02 |
| GOCC PROTEASOME REGULATORY PARTICLE | 19 | 6.21e-08 | 0.717 | 5.76e-06 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 7 | 1.06e-03 | -0.715 | 1.76e-02 |
| GOCC PROTEASE INHIBITOR COMPLEX | 5 | 6.25e-03 | 0.706 | 5.98e-02 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 5 | 6.43e-03 | -0.704 | 6.09e-02 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 6.48e-03 | 0.703 | 6.13e-02 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 6 | 3.01e-03 | -0.699 | 3.74e-02 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 6.78e-03 | 0.699 | 6.33e-02 |
| GOBP RESPONSE TO VITAMIN A | 6 | 3.16e-03 | -0.696 | 3.84e-02 |
| GOBP RESPONSE TO FUNGICIDE | 6 | 3.32e-03 | -0.692 | 3.97e-02 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 5 | 7.41e-03 | 0.692 | 6.70e-02 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 3.42e-04 | 0.689 | 7.48e-03 |
| GOBP POSITIVE REGULATION OF RECEPTOR BINDING | 5 | 7.63e-03 | -0.689 | 6.86e-02 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 14 | 8.55e-06 | -0.687 | 3.72e-04 |
| GOBP GLOMERULUS MORPHOGENESIS | 5 | 8.11e-03 | -0.684 | 7.12e-02 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 3.77e-03 | 0.683 | 4.34e-02 |
| GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY | 6 | 3.97e-03 | -0.679 | 4.47e-02 |
| GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 5 | 8.71e-03 | -0.677 | 7.50e-02 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 9 | 4.35e-04 | -0.677 | 8.91e-03 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 6 | 4.10e-03 | -0.677 | 4.54e-02 |
| GOBP CATECHOLAMINE UPTAKE | 6 | 4.13e-03 | 0.676 | 4.56e-02 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 13 | 2.56e-05 | -0.674 | 9.42e-04 |
| GOBP ADP METABOLIC PROCESS | 7 | 2.06e-03 | 0.673 | 2.85e-02 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 9.49e-03 | -0.670 | 7.97e-02 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 6 | 4.56e-03 | -0.669 | 4.85e-02 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 7 | 2.28e-03 | -0.666 | 3.08e-02 |
| GOCC CMG COMPLEX | 10 | 2.95e-04 | -0.661 | 6.85e-03 |
| GOCC HEMIDESMOSOME | 6 | 5.15e-03 | -0.659 | 5.25e-02 |
| GOBP MEIOTIC CHROMOSOME SEPARATION | 5 | 1.08e-02 | -0.658 | 8.70e-02 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOCC KNL1 SPC105 COMPLEX | 5 | 3.08e-04 | -9.32e-01 | 7.04e-03 |
| GOBP OPSONIZATION | 5 | 8.20e-04 | -8.64e-01 | 1.45e-02 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 5.38e-04 | 8.16e-01 | 1.03e-02 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY | 5 | 1.66e-03 | -8.12e-01 | 2.43e-02 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 5 | 1.68e-03 | -8.11e-01 | 2.44e-02 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 8 | 9.11e-05 | -7.99e-01 | 2.75e-03 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 7 | 3.18e-04 | 7.86e-01 | 7.20e-03 |
| GOCC MCM COMPLEX | 8 | 1.38e-04 | -7.78e-01 | 3.83e-03 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 3.66e-04 | 7.78e-01 | 7.79e-03 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 8 | 1.46e-04 | -7.75e-01 | 4.02e-03 |
| GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS | 5 | 2.71e-03 | -7.74e-01 | 3.48e-02 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 7 | 4.37e-04 | -7.67e-01 | 8.93e-03 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 5 | 3.64e-03 | -7.51e-01 | 4.22e-02 |
| GOMF IGG BINDING | 6 | 1.51e-03 | -7.48e-01 | 2.28e-02 |
| GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 5 | 3.80e-03 | -7.47e-01 | 4.34e-02 |
| GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES | 6 | 1.61e-03 | -7.43e-01 | 2.38e-02 |
| GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION | 5 | 4.06e-03 | -7.42e-01 | 4.51e-02 |
| GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS | 5 | 4.14e-03 | 7.40e-01 | 4.57e-02 |
| GOBP APOPTOTIC CHROMOSOME CONDENSATION | 5 | 4.69e-03 | -7.30e-01 | 4.90e-02 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 7 | 8.67e-04 | -7.27e-01 | 1.51e-02 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 5 | 5.46e-03 | 7.18e-01 | 5.43e-02 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE | 5 | 5.46e-03 | -7.18e-01 | 5.43e-02 |
| GOCC PROTEASOME REGULATORY PARTICLE | 19 | 6.21e-08 | 7.17e-01 | 5.76e-06 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 7 | 1.06e-03 | -7.15e-01 | 1.76e-02 |
| GOCC PROTEASE INHIBITOR COMPLEX | 5 | 6.25e-03 | 7.06e-01 | 5.98e-02 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 5 | 6.43e-03 | -7.04e-01 | 6.09e-02 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 6.48e-03 | 7.03e-01 | 6.13e-02 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 6 | 3.01e-03 | -6.99e-01 | 3.74e-02 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 6.78e-03 | 6.99e-01 | 6.33e-02 |
| GOBP RESPONSE TO VITAMIN A | 6 | 3.16e-03 | -6.96e-01 | 3.84e-02 |
| GOBP RESPONSE TO FUNGICIDE | 6 | 3.32e-03 | -6.92e-01 | 3.97e-02 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 5 | 7.41e-03 | 6.92e-01 | 6.70e-02 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 3.42e-04 | 6.89e-01 | 7.48e-03 |
| GOBP POSITIVE REGULATION OF RECEPTOR BINDING | 5 | 7.63e-03 | -6.89e-01 | 6.86e-02 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 14 | 8.55e-06 | -6.87e-01 | 3.72e-04 |
| GOBP GLOMERULUS MORPHOGENESIS | 5 | 8.11e-03 | -6.84e-01 | 7.12e-02 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 3.77e-03 | 6.83e-01 | 4.34e-02 |
| GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY | 6 | 3.97e-03 | -6.79e-01 | 4.47e-02 |
| GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 5 | 8.71e-03 | -6.77e-01 | 7.50e-02 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 9 | 4.35e-04 | -6.77e-01 | 8.91e-03 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 6 | 4.10e-03 | -6.77e-01 | 4.54e-02 |
| GOBP CATECHOLAMINE UPTAKE | 6 | 4.13e-03 | 6.76e-01 | 4.56e-02 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 13 | 2.56e-05 | -6.74e-01 | 9.42e-04 |
| GOBP ADP METABOLIC PROCESS | 7 | 2.06e-03 | 6.73e-01 | 2.85e-02 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 9.49e-03 | -6.70e-01 | 7.97e-02 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 6 | 4.56e-03 | -6.69e-01 | 4.85e-02 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 7 | 2.28e-03 | -6.66e-01 | 3.08e-02 |
| GOCC CMG COMPLEX | 10 | 2.95e-04 | -6.61e-01 | 6.85e-03 |
| GOCC HEMIDESMOSOME | 6 | 5.15e-03 | -6.59e-01 | 5.25e-02 |
| GOBP MEIOTIC CHROMOSOME SEPARATION | 5 | 1.08e-02 | -6.58e-01 | 8.70e-02 |
| GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 6 | 5.66e-03 | -6.52e-01 | 5.61e-02 |
| GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 1.17e-02 | -6.51e-01 | 9.13e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 27 | 5.40e-09 | -6.49e-01 | 7.27e-07 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 7 | 3.07e-03 | -6.46e-01 | 3.76e-02 |
| GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 7 | 3.07e-03 | -6.46e-01 | 3.76e-02 |
| GOBP CAMP CATABOLIC PROCESS | 7 | 3.26e-03 | -6.42e-01 | 3.92e-02 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE | 6 | 6.54e-03 | -6.41e-01 | 6.16e-02 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 8 | 1.73e-03 | -6.40e-01 | 2.49e-02 |
| GOBP HISTONE H3 K9 METHYLATION | 5 | 1.34e-02 | -6.39e-01 | 9.99e-02 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 6.76e-03 | 6.38e-01 | 6.32e-02 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 15 | 1.94e-05 | -6.37e-01 | 7.37e-04 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 1.25e-07 | 6.37e-01 | 1.04e-05 |
| GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 7.43e-03 | -6.31e-01 | 6.71e-02 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 7.45e-03 | 6.31e-01 | 6.72e-02 |
| GOBP CELLULAR RESPONSE TO COCAINE | 6 | 7.83e-03 | -6.27e-01 | 6.96e-02 |
| GOCC BLOC 1 COMPLEX | 9 | 1.15e-03 | 6.26e-01 | 1.88e-02 |
| GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 8.07e-03 | 6.25e-01 | 7.10e-02 |
| GOCC DENDRITIC SPINE HEAD | 5 | 1.61e-02 | -6.21e-01 | 1.14e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 8 | 2.34e-03 | 6.21e-01 | 3.13e-02 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 4.58e-03 | -6.19e-01 | 4.85e-02 |
| GOCC TRAMP COMPLEX | 5 | 1.66e-02 | -6.18e-01 | 1.16e-01 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 6 | 8.85e-03 | -6.17e-01 | 7.59e-02 |
| GOMF CXCR CHEMOKINE RECEPTOR BINDING | 5 | 1.69e-02 | -6.17e-01 | 1.17e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 6 | 8.86e-03 | -6.17e-01 | 7.59e-02 |
| GOBP SEX DETERMINATION | 5 | 1.69e-02 | -6.17e-01 | 1.17e-01 |
| GOBP CELLULAR RESPONSE TO IRON ION | 6 | 8.87e-03 | -6.17e-01 | 7.60e-02 |
| GOBP LUTEINIZATION | 6 | 9.02e-03 | -6.16e-01 | 7.70e-02 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 5 | 1.73e-02 | -6.15e-01 | 1.19e-01 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 10 | 7.63e-04 | -6.15e-01 | 1.37e-02 |
| GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 9 | 1.44e-03 | -6.13e-01 | 2.20e-02 |
| GOCC PEPTIDASE INHIBITOR COMPLEX | 7 | 5.12e-03 | 6.11e-01 | 5.23e-02 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 6 | 9.56e-03 | -6.11e-01 | 8.01e-02 |
| GOBP NEUTROPHIL EXTRAVASATION | 10 | 8.47e-04 | -6.09e-01 | 1.49e-02 |
| GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY | 6 | 9.90e-03 | -6.08e-01 | 8.17e-02 |
| GOMF CASPASE BINDING | 8 | 2.95e-03 | 6.07e-01 | 3.68e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 30 | 8.89e-09 | -6.07e-01 | 1.13e-06 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 5.79e-03 | -6.02e-01 | 5.66e-02 |
| GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 6 | 1.07e-02 | 6.02e-01 | 8.65e-02 |
| GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION | 5 | 1.98e-02 | -6.02e-01 | 1.30e-01 |
| GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 1.00e-03 | 6.01e-01 | 1.69e-02 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 6 | 1.09e-02 | -6.00e-01 | 8.73e-02 |
| GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 7 | 6.05e-03 | -5.99e-01 | 5.82e-02 |
| GOBP U4 SNRNA 3 END PROCESSING | 8 | 3.38e-03 | 5.98e-01 | 4.01e-02 |
| GOBP ADP BIOSYNTHETIC PROCESS | 5 | 2.09e-02 | 5.97e-01 | 1.34e-01 |
| GOBP THREONINE METABOLIC PROCESS | 5 | 2.10e-02 | 5.96e-01 | 1.35e-01 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 7 | 6.48e-03 | -5.94e-01 | 6.13e-02 |
| GOMF CERAMIDE 1 PHOSPHATE BINDING | 5 | 2.16e-02 | 5.93e-01 | 1.36e-01 |
| GOBP SKELETAL MUSCLE TISSUE GROWTH | 5 | 2.21e-02 | -5.91e-01 | 1.38e-01 |
| GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY | 5 | 2.26e-02 | 5.89e-01 | 1.40e-01 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 9 | 2.28e-03 | -5.87e-01 | 3.08e-02 |
| GOMF DELTA CATENIN BINDING | 5 | 2.41e-02 | -5.83e-01 | 1.46e-01 |
| GOMF POLY A RNA POLYMERASE ACTIVITY | 8 | 4.40e-03 | -5.81e-01 | 4.77e-02 |
| GOBP BONE TRABECULA MORPHOGENESIS | 6 | 1.37e-02 | -5.81e-01 | 1.01e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 8 | 4.45e-03 | 5.81e-01 | 4.80e-02 |
| GOBP HYPOTONIC RESPONSE | 11 | 8.67e-04 | -5.80e-01 | 1.51e-02 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 1.54e-08 | 5.78e-01 | 1.84e-06 |
| GOBP REGULATION OF MUCUS SECRETION | 5 | 2.54e-02 | 5.77e-01 | 1.51e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 8 | 4.81e-03 | -5.76e-01 | 4.99e-02 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 17 | 4.14e-05 | -5.74e-01 | 1.43e-03 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 1.50e-02 | -5.73e-01 | 1.09e-01 |
| GOMF LIPOPEPTIDE BINDING | 6 | 1.53e-02 | -5.72e-01 | 1.10e-01 |
| GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS | 5 | 2.70e-02 | 5.71e-01 | 1.57e-01 |
| GOBP MAST CELL CYTOKINE PRODUCTION | 5 | 2.75e-02 | -5.69e-01 | 1.60e-01 |
| GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 7 | 9.76e-03 | -5.64e-01 | 8.11e-02 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 12 | 7.22e-04 | 5.64e-01 | 1.31e-02 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 2.91e-02 | -5.63e-01 | 1.65e-01 |
| GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.68e-02 | 5.63e-01 | 1.17e-01 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 11 | 1.23e-03 | -5.63e-01 | 1.98e-02 |
| GOMF AMIDINE LYASE ACTIVITY | 7 | 9.97e-03 | 5.62e-01 | 8.20e-02 |
| GOBP CHOLESTEROL IMPORT | 6 | 1.70e-02 | 5.62e-01 | 1.18e-01 |
| GOMF TRAIL BINDING | 5 | 2.95e-02 | 5.62e-01 | 1.67e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 5 | 2.98e-02 | -5.61e-01 | 1.68e-01 |
| GOBP REGULATION OF RECEPTOR BINDING | 10 | 2.14e-03 | -5.61e-01 | 2.94e-02 |
| GOBP VASCULAR WOUND HEALING | 10 | 2.19e-03 | 5.59e-01 | 2.98e-02 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 7 | 1.04e-02 | -5.59e-01 | 8.53e-02 |
| GOBP SLEEP | 8 | 6.49e-03 | -5.56e-01 | 6.13e-02 |
| GOBP SIALYLATION | 5 | 3.15e-02 | -5.55e-01 | 1.73e-01 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 7 | 1.10e-02 | -5.55e-01 | 8.79e-02 |
| GOBP MYOBLAST PROLIFERATION | 14 | 3.28e-04 | -5.54e-01 | 7.35e-03 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 11 | 1.46e-03 | -5.54e-01 | 2.23e-02 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 12 | 9.12e-04 | 5.53e-01 | 1.58e-02 |
| GOBP RESPONSE TO ZINC ION STARVATION | 7 | 1.13e-02 | -5.53e-01 | 8.91e-02 |
| GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 6.86e-03 | -5.52e-01 | 6.37e-02 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 | 9 | 4.17e-03 | 5.51e-01 | 4.59e-02 |
| GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 3.28e-02 | -5.51e-01 | 1.78e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 6 | 1.94e-02 | 5.51e-01 | 1.29e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 9 | 4.26e-03 | 5.50e-01 | 4.65e-02 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 5 | 3.32e-02 | -5.50e-01 | 1.79e-01 |
| GOCC U7 SNRNP | 7 | 1.20e-02 | 5.48e-01 | 9.28e-02 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 6 | 2.00e-02 | -5.48e-01 | 1.31e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 8 | 7.28e-03 | -5.48e-01 | 6.62e-02 |
| GOCC CONDENSIN COMPLEX | 8 | 7.28e-03 | -5.48e-01 | 6.62e-02 |
| GOBP CELLULAR RESPONSE TO UV A | 6 | 2.01e-02 | -5.48e-01 | 1.31e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 6 | 2.05e-02 | 5.46e-01 | 1.33e-01 |
| GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 5 | 3.45e-02 | -5.46e-01 | 1.83e-01 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 5 | 3.45e-02 | -5.46e-01 | 1.83e-01 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 7 | 1.24e-02 | -5.46e-01 | 9.51e-02 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 3.50e-02 | -5.44e-01 | 1.84e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 5 | 3.51e-02 | -5.44e-01 | 1.84e-01 |
| GOMF OPSONIN RECEPTOR ACTIVITY | 5 | 3.52e-02 | -5.44e-01 | 1.85e-01 |
| GOBP DISACCHARIDE METABOLIC PROCESS | 6 | 2.12e-02 | -5.43e-01 | 1.35e-01 |
| GOBP PROLINE TRANSMEMBRANE TRANSPORT | 7 | 1.30e-02 | -5.42e-01 | 9.83e-02 |
| GOBP DE NOVO NAD BIOSYNTHETIC PROCESS | 6 | 2.16e-02 | -5.41e-01 | 1.36e-01 |
| GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 5 | 3.61e-02 | -5.41e-01 | 1.88e-01 |
| GOCC OUTER KINETOCHORE | 17 | 1.13e-04 | -5.41e-01 | 3.28e-03 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 8.08e-03 | 5.41e-01 | 7.11e-02 |
| GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING | 6 | 2.20e-02 | -5.40e-01 | 1.38e-01 |
| GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 7 | 1.34e-02 | -5.40e-01 | 9.99e-02 |
| GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 3.68e-02 | -5.39e-01 | 1.90e-01 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 10 | 3.17e-03 | -5.39e-01 | 3.84e-02 |
| GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 3.72e-02 | -5.38e-01 | 1.91e-01 |
| GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 10 | 3.21e-03 | -5.38e-01 | 3.88e-02 |
| GOBP PEROXISOME FISSION | 9 | 5.33e-03 | 5.36e-01 | 5.35e-02 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 7 | 1.40e-02 | -5.36e-01 | 1.03e-01 |
| GOMF HISTONE H3K27ME2 H3K27ME3 DEMETHYLASE ACTIVITY | 5 | 3.83e-02 | -5.35e-01 | 1.93e-01 |
| GOMF BMP BINDING | 5 | 3.85e-02 | -5.35e-01 | 1.94e-01 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 3.86e-02 | 5.34e-01 | 1.94e-01 |
| GOBP LEYDIG CELL DIFFERENTIATION | 5 | 3.86e-02 | -5.34e-01 | 1.94e-01 |
| GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION | 6 | 2.38e-02 | -5.33e-01 | 1.45e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 3.92e-02 | 5.33e-01 | 1.96e-01 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 8 | 9.18e-03 | -5.32e-01 | 7.79e-02 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 7 | 1.48e-02 | -5.32e-01 | 1.08e-01 |
| GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 6 | 2.43e-02 | -5.31e-01 | 1.47e-01 |
| GOBP WNT PROTEIN SECRETION | 5 | 4.02e-02 | 5.30e-01 | 1.99e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 11 | 2.35e-03 | -5.30e-01 | 3.13e-02 |
| GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 7 | 1.52e-02 | 5.30e-01 | 1.09e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL PROLIFERATION | 5 | 4.07e-02 | -5.29e-01 | 2.01e-01 |
| GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 6 | 2.51e-02 | 5.28e-01 | 1.50e-01 |
| GOBP TYPE II HYPERSENSITIVITY | 5 | 4.14e-02 | -5.27e-01 | 2.03e-01 |
| GOBP MEIOTIC CELL CYCLE PHASE TRANSITION | 8 | 9.94e-03 | -5.26e-01 | 8.18e-02 |
| GOBP ADRENAL GLAND DEVELOPMENT | 15 | 4.44e-04 | -5.24e-01 | 9.04e-03 |
| GOMF METALLODIPEPTIDASE ACTIVITY | 6 | 2.65e-02 | -5.23e-01 | 1.55e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 8 | 1.06e-02 | 5.22e-01 | 8.58e-02 |
| GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 5 | 4.43e-02 | -5.19e-01 | 2.13e-01 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 17 | 2.09e-04 | 5.19e-01 | 5.37e-03 |
| GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 9 | 7.09e-03 | -5.18e-01 | 6.51e-02 |
| GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 1.12e-02 | 5.18e-01 | 8.83e-02 |
| GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION | 5 | 4.48e-02 | -5.18e-01 | 2.14e-01 |
| GOBP PROTEIN IMPORT | 6 | 2.80e-02 | -5.18e-01 | 1.62e-01 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 7.38e-03 | 5.16e-01 | 6.69e-02 |
| GOBP MITOTIC SPINDLE ELONGATION | 11 | 3.23e-03 | -5.13e-01 | 3.90e-02 |
| GOBP IMMATURE T CELL PROLIFERATION | 7 | 1.90e-02 | 5.12e-01 | 1.27e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 7 | 1.90e-02 | -5.12e-01 | 1.27e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 8 | 1.22e-02 | -5.12e-01 | 9.40e-02 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 6 | 3.03e-02 | -5.11e-01 | 1.69e-01 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 10 | 5.19e-03 | 5.10e-01 | 5.27e-02 |
| GOMF RIBONUCLEASE P RNA BINDING | 10 | 5.19e-03 | 5.10e-01 | 5.27e-02 |
| GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY | 5 | 4.82e-02 | 5.10e-01 | 2.24e-01 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 4.82e-02 | -5.10e-01 | 2.24e-01 |
| GOBP RESPONSE TO INACTIVITY | 6 | 3.05e-02 | -5.10e-01 | 1.70e-01 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 16 | 4.12e-04 | 5.10e-01 | 8.59e-03 |
| GOBP CARNITINE TRANSMEMBRANE TRANSPORT | 5 | 4.84e-02 | 5.10e-01 | 2.24e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 4.85e-02 | -5.09e-01 | 2.24e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 5 | 4.85e-02 | 5.09e-01 | 2.24e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 13 | 1.50e-03 | -5.09e-01 | 2.26e-02 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 8.40e-03 | -5.07e-01 | 7.27e-02 |
| GOBP REGULATION OF MICROVILLUS ASSEMBLY | 6 | 3.15e-02 | -5.07e-01 | 1.73e-01 |
| GOBP GENITALIA MORPHOGENESIS | 5 | 4.96e-02 | -5.07e-01 | 2.26e-01 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 6 | 3.19e-02 | 5.06e-01 | 1.75e-01 |
| GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS | 5 | 5.03e-02 | -5.05e-01 | 2.28e-01 |
| GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS | 12 | 2.45e-03 | 5.05e-01 | 3.22e-02 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 20 | 9.51e-05 | -5.04e-01 | 2.86e-03 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 11 | 3.96e-03 | -5.02e-01 | 4.47e-02 |
| GOCC PROTEASOME COMPLEX | 57 | 5.64e-11 | 5.02e-01 | 1.39e-08 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 12 | 2.67e-03 | -5.01e-01 | 3.45e-02 |
| GOBP HEXOSE PHOSPHATE TRANSPORT | 5 | 5.26e-02 | 5.01e-01 | 2.34e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 5 | 5.26e-02 | -5.01e-01 | 2.34e-01 |
| GOBP TRYPTOPHAN CATABOLIC PROCESS | 7 | 2.19e-02 | -5.00e-01 | 1.37e-01 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 6 | 3.39e-02 | -5.00e-01 | 1.81e-01 |
| GOBP ECTODERMAL PLACODE DEVELOPMENT | 6 | 3.39e-02 | -5.00e-01 | 1.81e-01 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 9 | 9.46e-03 | -5.00e-01 | 7.95e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 36 | 2.14e-07 | -5.00e-01 | 1.56e-05 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 18 | 2.45e-04 | -4.99e-01 | 5.94e-03 |
| GOCC BLOC COMPLEX | 14 | 1.24e-03 | 4.99e-01 | 1.98e-02 |
| GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 5.37e-02 | 4.98e-01 | 2.36e-01 |
| GOMF NEDD8 TRANSFERASE ACTIVITY | 7 | 2.25e-02 | 4.98e-01 | 1.40e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 20 | 1.16e-04 | -4.98e-01 | 3.36e-03 |
| GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 8 | 1.49e-02 | -4.97e-01 | 1.08e-01 |
| GOCC MHC PROTEIN COMPLEX | 22 | 5.55e-05 | -4.96e-01 | 1.83e-03 |
| GOMF LEUCINE BINDING | 6 | 3.53e-02 | -4.96e-01 | 1.85e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 7 | 2.31e-02 | 4.96e-01 | 1.42e-01 |
| GOMF RIBONUCLEASE P ACTIVITY | 11 | 4.44e-03 | 4.95e-01 | 4.79e-02 |
| GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 5.51e-02 | 4.95e-01 | 2.40e-01 |
| GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION | 7 | 2.34e-02 | -4.95e-01 | 1.43e-01 |
| GOBP PHAGOCYTOSIS RECOGNITION | 12 | 3.05e-03 | -4.94e-01 | 3.76e-02 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 11 | 4.60e-03 | -4.94e-01 | 4.85e-02 |
| GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS | 5 | 5.61e-02 | 4.93e-01 | 2.42e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 3.11e-03 | 4.93e-01 | 3.80e-02 |
| GOBP DNA TOPOLOGICAL CHANGE | 9 | 1.05e-02 | -4.93e-01 | 8.53e-02 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 6 | 3.68e-02 | -4.92e-01 | 1.90e-01 |
| GOMF FOLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.67e-02 | 4.92e-01 | 2.43e-01 |
| GOMF PROTEIN KINASE B BINDING | 9 | 1.06e-02 | -4.92e-01 | 8.59e-02 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 11 | 4.72e-03 | -4.92e-01 | 4.92e-02 |
| GOBP DIAPEDESIS | 6 | 3.70e-02 | -4.92e-01 | 1.90e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 9 | 1.07e-02 | -4.91e-01 | 8.66e-02 |
| GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 5.72e-02 | -4.91e-01 | 2.44e-01 |
| GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 5 | 5.73e-02 | -4.91e-01 | 2.44e-01 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 7 | 2.45e-02 | 4.91e-01 | 1.48e-01 |
| GOMF 7SK SNRNA BINDING | 8 | 1.64e-02 | -4.90e-01 | 1.15e-01 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 7 | 2.48e-02 | -4.90e-01 | 1.49e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 14 | 1.52e-03 | -4.89e-01 | 2.29e-02 |
| GOBP T CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 5.82e-02 | -4.89e-01 | 2.47e-01 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 9 | 1.11e-02 | -4.89e-01 | 8.81e-02 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION | 5 | 5.84e-02 | -4.89e-01 | 2.48e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 7 | 2.52e-02 | 4.89e-01 | 1.50e-01 |
| GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER | 6 | 3.82e-02 | -4.89e-01 | 1.93e-01 |
| GOBP FATTY ACID ALPHA OXIDATION | 5 | 5.89e-02 | 4.88e-01 | 2.48e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 8 | 1.70e-02 | -4.87e-01 | 1.18e-01 |
| GOMF CUPROUS ION BINDING | 6 | 3.90e-02 | 4.87e-01 | 1.95e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 26 | 1.80e-05 | -4.86e-01 | 6.89e-04 |
| GOBP CHROMOSOME CONDENSATION | 29 | 5.94e-06 | -4.86e-01 | 2.71e-04 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 11 | 5.29e-03 | 4.86e-01 | 5.33e-02 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 6 | 3.98e-02 | -4.85e-01 | 1.98e-01 |
| GOCC SMAD PROTEIN COMPLEX | 7 | 2.65e-02 | -4.84e-01 | 1.55e-01 |
| GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 10 | 7.99e-03 | 4.84e-01 | 7.06e-02 |
| GOBP LIPID DROPLET DISASSEMBLY | 5 | 6.08e-02 | -4.84e-01 | 2.54e-01 |
| GOMF PHOSPHOLIPASE D ACTIVITY | 5 | 6.09e-02 | -4.84e-01 | 2.54e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 7 | 2.67e-02 | 4.84e-01 | 1.56e-01 |
| GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 7 | 2.67e-02 | 4.84e-01 | 1.56e-01 |
| GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING | 5 | 6.15e-02 | -4.83e-01 | 2.56e-01 |
| GOBP HYALURONAN CATABOLIC PROCESS | 10 | 8.20e-03 | -4.83e-01 | 7.15e-02 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 9 | 1.21e-02 | 4.83e-01 | 9.37e-02 |
| GOMF ARYL HYDROCARBON RECEPTOR BINDING | 6 | 4.06e-02 | -4.83e-01 | 2.01e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 3.79e-03 | 4.83e-01 | 4.34e-02 |
| GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY | 6 | 4.06e-02 | -4.83e-01 | 2.01e-01 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 8 | 1.81e-02 | -4.83e-01 | 1.23e-01 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 10 | 8.26e-03 | -4.82e-01 | 7.19e-02 |
| GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 11 | 5.63e-03 | -4.82e-01 | 5.58e-02 |
| GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 6.20e-02 | -4.82e-01 | 2.57e-01 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 11 | 5.69e-03 | 4.82e-01 | 5.61e-02 |
| GOCC PROTEASOME CORE COMPLEX | 18 | 4.14e-04 | 4.81e-01 | 8.59e-03 |
| GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY | 5 | 6.27e-02 | -4.81e-01 | 2.58e-01 |
| GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY | 5 | 6.28e-02 | -4.81e-01 | 2.58e-01 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 8 | 1.86e-02 | -4.80e-01 | 1.25e-01 |
| GOMF THIOL OXIDASE ACTIVITY | 6 | 4.17e-02 | 4.80e-01 | 2.04e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 13 | 2.76e-03 | -4.79e-01 | 3.52e-02 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 9 | 1.32e-02 | 4.77e-01 | 9.88e-02 |
| GOBP DETECTION OF BACTERIUM | 11 | 6.18e-03 | -4.77e-01 | 5.92e-02 |
| GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 1.96e-02 | 4.76e-01 | 1.29e-01 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 13 | 2.94e-03 | -4.76e-01 | 3.68e-02 |
| GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS | 7 | 2.92e-02 | -4.76e-01 | 1.65e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 8 | 1.98e-02 | 4.76e-01 | 1.30e-01 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 6.56e-02 | 4.76e-01 | 2.66e-01 |
| GOBP PROTEIN DENEDDYLATION | 11 | 6.32e-03 | 4.75e-01 | 6.03e-02 |
| GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 7 | 2.98e-02 | 4.74e-01 | 1.68e-01 |
| GOBP LUNG SACCULE DEVELOPMENT | 5 | 6.66e-02 | -4.74e-01 | 2.68e-01 |
| GOBP NATURAL KILLER CELL PROLIFERATION | 12 | 4.52e-03 | -4.73e-01 | 4.82e-02 |
| GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 3.02e-02 | 4.73e-01 | 1.69e-01 |
| GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 7 | 3.03e-02 | -4.73e-01 | 1.69e-01 |
| GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY | 5 | 6.76e-02 | -4.72e-01 | 2.70e-01 |
| GOBP CARBOHYDRATE MEDIATED SIGNALING | 9 | 1.43e-02 | -4.71e-01 | 1.05e-01 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 7 | 3.09e-02 | -4.71e-01 | 1.71e-01 |
| GOBP OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT | 8 | 2.11e-02 | -4.71e-01 | 1.35e-01 |
| GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 7 | 3.10e-02 | -4.71e-01 | 1.72e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 5 | 6.95e-02 | 4.69e-01 | 2.75e-01 |
| GOBP MONOCYTE EXTRAVASATION | 6 | 4.71e-02 | -4.68e-01 | 2.21e-01 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 6.99e-02 | -4.68e-01 | 2.75e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 5 | 6.99e-02 | -4.68e-01 | 2.75e-01 |
| GOMF CO SMAD BINDING | 8 | 2.19e-02 | -4.68e-01 | 1.38e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR BINDING | 7 | 3.21e-02 | -4.68e-01 | 1.76e-01 |
| GOBP TRANSLATIONAL TERMINATION | 16 | 1.21e-03 | 4.67e-01 | 1.96e-02 |
| GOMF ADENYLATE KINASE ACTIVITY | 8 | 2.21e-02 | 4.67e-01 | 1.38e-01 |
| GOBP NEGATIVE REGULATION OF STEROL TRANSPORT | 5 | 7.04e-02 | -4.67e-01 | 2.76e-01 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 5 | 7.05e-02 | -4.67e-01 | 2.76e-01 |
| GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 5 | 7.05e-02 | -4.67e-01 | 2.76e-01 |
| GOMF L PROLINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 7.08e-02 | -4.67e-01 | 2.77e-01 |
| GOCC ARYL HYDROCARBON RECEPTOR COMPLEX | 5 | 7.10e-02 | -4.66e-01 | 2.77e-01 |
| GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 23 | 1.08e-04 | -4.66e-01 | 3.19e-03 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 15 | 1.78e-03 | 4.66e-01 | 2.54e-02 |
| GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY | 6 | 4.84e-02 | -4.65e-01 | 2.24e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 5 | 7.18e-02 | -4.65e-01 | 2.79e-01 |
| GOBP LEUCINE IMPORT ACROSS PLASMA MEMBRANE | 5 | 7.18e-02 | -4.65e-01 | 2.79e-01 |
| GOMF SUPERCOILED DNA BINDING | 6 | 4.87e-02 | -4.65e-01 | 2.25e-01 |
| GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 7.20e-02 | 4.65e-01 | 2.79e-01 |
| GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 6 | 4.88e-02 | -4.65e-01 | 2.25e-01 |
| GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 8 | 2.29e-02 | 4.65e-01 | 1.41e-01 |
| GOMF AMINOACYL TRNA EDITING ACTIVITY | 8 | 2.29e-02 | 4.65e-01 | 1.41e-01 |
| GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 6 | 4.92e-02 | 4.64e-01 | 2.25e-01 |
| GOBP CELL CYCLE DNA REPLICATION INITIATION | 5 | 7.34e-02 | -4.62e-01 | 2.82e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 3.44e-02 | 4.62e-01 | 1.83e-01 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 17 | 9.98e-04 | 4.61e-01 | 1.68e-02 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 17 | 1.01e-03 | -4.61e-01 | 1.69e-02 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 10 | 1.18e-02 | -4.60e-01 | 9.20e-02 |
| GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 6 | 5.13e-02 | -4.59e-01 | 2.30e-01 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 7 | 3.53e-02 | -4.59e-01 | 1.85e-01 |
| GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS | 5 | 7.55e-02 | 4.59e-01 | 2.86e-01 |
| GOBP LYMPHOCYTE ANERGY | 5 | 7.55e-02 | -4.59e-01 | 2.86e-01 |
| GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY | 5 | 7.58e-02 | 4.59e-01 | 2.87e-01 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 9 | 1.72e-02 | -4.58e-01 | 1.19e-01 |
| GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 5.19e-02 | 4.58e-01 | 2.32e-01 |
| GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN | 5 | 7.62e-02 | -4.58e-01 | 2.87e-01 |
| GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 6 | 5.23e-02 | -4.57e-01 | 2.33e-01 |
| GOCC ORGANELLAR RIBOSOME | 89 | 8.84e-14 | 4.57e-01 | 3.63e-11 |
| GOCC MSL COMPLEX | 5 | 7.68e-02 | -4.57e-01 | 2.88e-01 |
| GOMF HISTONE H4 DEMETHYLASE ACTIVITY | 5 | 7.71e-02 | -4.57e-01 | 2.89e-01 |
| GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT | 7 | 3.65e-02 | -4.57e-01 | 1.89e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 8 | 2.55e-02 | -4.56e-01 | 1.52e-01 |
| GOMF INTERMEDIATE FILAMENT BINDING | 5 | 7.75e-02 | -4.56e-01 | 2.89e-01 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 33 | 6.06e-06 | -4.55e-01 | 2.73e-04 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 45 | 1.29e-07 | -4.55e-01 | 1.06e-05 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE | 6 | 5.36e-02 | -4.55e-01 | 2.36e-01 |
| GOMF HEXOSAMINIDASE ACTIVITY | 12 | 6.39e-03 | -4.55e-01 | 6.06e-02 |
| GOBP RIBOSOME DISASSEMBLY | 13 | 4.59e-03 | 4.54e-01 | 4.85e-02 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 13 | 4.61e-03 | 4.54e-01 | 4.85e-02 |
| GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 5 | 7.89e-02 | -4.54e-01 | 2.92e-01 |
| GOCC U2AF COMPLEX | 5 | 7.90e-02 | -4.54e-01 | 2.92e-01 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 6 | 5.43e-02 | 4.54e-01 | 2.38e-01 |
| GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 3.77e-02 | -4.54e-01 | 1.92e-01 |
| GOMF MALATE DEHYDROGENASE ACTIVITY | 6 | 5.45e-02 | 4.53e-01 | 2.38e-01 |
| GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 3.79e-02 | -4.53e-01 | 1.93e-01 |
| GOBP MESENCHYMAL CELL APOPTOTIC PROCESS | 7 | 3.83e-02 | -4.52e-01 | 1.93e-01 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 7 | 3.84e-02 | -4.52e-01 | 1.94e-01 |
| GOBP AMP BIOSYNTHETIC PROCESS | 11 | 9.53e-03 | 4.51e-01 | 7.99e-02 |
| GOBP SPINDLE ELONGATION | 13 | 4.85e-03 | -4.51e-01 | 5.02e-02 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 2.71e-02 | -4.51e-01 | 1.58e-01 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 19 | 6.64e-04 | -4.51e-01 | 1.23e-02 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 11 | 9.68e-03 | -4.50e-01 | 8.07e-02 |
| GOBP CARTILAGE CONDENSATION | 5 | 8.11e-02 | 4.50e-01 | 2.97e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 43 | 3.34e-07 | -4.50e-01 | 2.29e-05 |
| GOBP XMP METABOLIC PROCESS | 7 | 3.93e-02 | 4.50e-01 | 1.96e-01 |
| GOCC T CELL RECEPTOR COMPLEX | 6 | 5.64e-02 | -4.50e-01 | 2.42e-01 |
| GOBP 2FE 2S CLUSTER ASSEMBLY | 11 | 9.83e-03 | 4.50e-01 | 8.15e-02 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 15 | 2.58e-03 | -4.50e-01 | 3.35e-02 |
| GOBP AMP SALVAGE | 5 | 8.18e-02 | 4.49e-01 | 2.98e-01 |
| GOMF KINETOCHORE BINDING | 6 | 5.67e-02 | -4.49e-01 | 2.43e-01 |
| GOBP HEMIDESMOSOME ASSEMBLY | 5 | 8.21e-02 | -4.49e-01 | 2.99e-01 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 5 | 8.26e-02 | -4.48e-01 | 3.00e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 6 | 5.74e-02 | 4.48e-01 | 2.45e-01 |
| GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 5 | 8.32e-02 | 4.47e-01 | 3.00e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 7 | 4.06e-02 | 4.47e-01 | 2.01e-01 |
| GOMF RAGE RECEPTOR BINDING | 8 | 2.86e-02 | -4.47e-01 | 1.64e-01 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 5 | 8.40e-02 | 4.46e-01 | 3.02e-01 |
| GOBP CELL MIGRATION INVOLVED IN GASTRULATION | 5 | 8.43e-02 | 4.46e-01 | 3.02e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB | 5 | 8.43e-02 | -4.46e-01 | 3.02e-01 |
| GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.86e-02 | -4.46e-01 | 2.48e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 5 | 8.44e-02 | 4.46e-01 | 3.02e-01 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 7 | 4.13e-02 | 4.45e-01 | 2.03e-01 |
| GOCC X CHROMOSOME | 8 | 2.91e-02 | 4.45e-01 | 1.65e-01 |
| GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 11 | 1.07e-02 | -4.44e-01 | 8.65e-02 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 14 | 4.00e-03 | -4.44e-01 | 4.49e-02 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 50 | 5.59e-08 | -4.44e-01 | 5.24e-06 |
| GOMF INSULIN LIKE GROWTH FACTOR I BINDING | 8 | 3.00e-02 | -4.43e-01 | 1.68e-01 |
| GOBP KERATINIZATION | 9 | 2.14e-02 | 4.43e-01 | 1.36e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 7 | 4.32e-02 | -4.41e-01 | 2.09e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 6 | 6.13e-02 | -4.41e-01 | 2.55e-01 |
| GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 8.78e-02 | -4.41e-01 | 3.10e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 7 | 4.35e-02 | -4.41e-01 | 2.10e-01 |
| GOMF PEPTIDE HORMONE BINDING | 15 | 3.14e-03 | -4.40e-01 | 3.83e-02 |
| GOBP MUSCLE ATROPHY | 6 | 6.20e-02 | -4.40e-01 | 2.57e-01 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 22 | 3.58e-04 | -4.40e-01 | 7.68e-03 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 7 | 4.40e-02 | -4.40e-01 | 2.12e-01 |
| GOMF UBIQUINONE BINDING | 6 | 6.23e-02 | 4.40e-01 | 2.57e-01 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 29 | 4.23e-05 | -4.39e-01 | 1.45e-03 |
| GOMF MUTLALPHA COMPLEX BINDING | 6 | 6.33e-02 | -4.38e-01 | 2.60e-01 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 8 | 3.22e-02 | -4.37e-01 | 1.76e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 20 | 7.15e-04 | -4.37e-01 | 1.30e-02 |
| GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 9 | 2.32e-02 | -4.37e-01 | 1.43e-01 |
| GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 6.40e-02 | -4.37e-01 | 2.62e-01 |
| GOBP ESTROUS CYCLE | 11 | 1.22e-02 | -4.37e-01 | 9.37e-02 |
| GOBP RNA GUANINE N7 METHYLATION | 7 | 4.56e-02 | 4.36e-01 | 2.16e-01 |
| GOMF BUBBLE DNA BINDING | 6 | 6.44e-02 | -4.36e-01 | 2.63e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS | 5 | 9.14e-02 | -4.36e-01 | 3.18e-01 |
| GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY | 14 | 4.76e-03 | 4.36e-01 | 4.96e-02 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 9 | 2.38e-02 | -4.35e-01 | 1.45e-01 |
| GOMF MHC PROTEIN COMPLEX BINDING | 28 | 6.74e-05 | -4.35e-01 | 2.14e-03 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 24 | 2.25e-04 | -4.35e-01 | 5.57e-03 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 6 | 6.51e-02 | -4.35e-01 | 2.65e-01 |
| GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.64e-02 | -4.35e-01 | 2.19e-01 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 13 | 6.66e-03 | -4.35e-01 | 6.24e-02 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 8 | 3.34e-02 | 4.34e-01 | 1.80e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 10 | 1.75e-02 | -4.34e-01 | 1.20e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 10 | 1.75e-02 | -4.34e-01 | 1.20e-01 |
| GOBP TESTOSTERONE BIOSYNTHETIC PROCESS | 6 | 6.61e-02 | -4.33e-01 | 2.67e-01 |
| GOBP VAGINA DEVELOPMENT | 5 | 9.38e-02 | -4.33e-01 | 3.22e-01 |
| GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 6.68e-02 | -4.32e-01 | 2.69e-01 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 28 | 7.65e-05 | -4.32e-01 | 2.38e-03 |
| GOBP HEAD MORPHOGENESIS | 22 | 4.56e-04 | -4.32e-01 | 9.21e-03 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 15 | 3.79e-03 | -4.32e-01 | 4.34e-02 |
| GOBP TRNA 5 LEADER REMOVAL | 13 | 7.04e-03 | 4.32e-01 | 6.49e-02 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 10 | 1.81e-02 | -4.32e-01 | 1.23e-01 |
| GOBP PROSTAGLANDIN SECRETION | 12 | 9.64e-03 | 4.32e-01 | 8.04e-02 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 11 | 1.32e-02 | -4.31e-01 | 9.90e-02 |
| GOMF ADENOSINE DEAMINASE ACTIVITY | 8 | 3.49e-02 | 4.31e-01 | 1.84e-01 |
| GOBP FACE MORPHOGENESIS | 18 | 1.56e-03 | -4.31e-01 | 2.33e-02 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 7 | 4.84e-02 | -4.31e-01 | 2.24e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE | 5 | 9.55e-02 | -4.31e-01 | 3.25e-01 |
| GOCC SPERM CONNECTING PIECE | 5 | 9.57e-02 | -4.30e-01 | 3.25e-01 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 18 | 1.59e-03 | 4.30e-01 | 2.35e-02 |
| GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 11 | 1.35e-02 | 4.30e-01 | 1.00e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 8 | 3.54e-02 | -4.30e-01 | 1.85e-01 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 10 | 1.87e-02 | -4.29e-01 | 1.25e-01 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 25 | 2.07e-04 | -4.29e-01 | 5.35e-03 |
| GOBP FAT CELL PROLIFERATION | 9 | 2.59e-02 | -4.29e-01 | 1.53e-01 |
| GOMF UBIQUITIN LIGASE ACTIVATOR ACTIVITY | 5 | 9.70e-02 | -4.29e-01 | 3.28e-01 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 10 | 1.89e-02 | 4.29e-01 | 1.26e-01 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 7 | 4.96e-02 | -4.29e-01 | 2.26e-01 |
| GOBP REGULATION OF TRANSLATIONAL TERMINATION | 9 | 2.61e-02 | 4.28e-01 | 1.54e-01 |
| GOBP PROTEIN DEMETHYLATION | 12 | 1.04e-02 | -4.27e-01 | 8.53e-02 |
| GOBP MITOCHONDRIAL TRANSLATION | 128 | 7.88e-17 | 4.27e-01 | 7.54e-14 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 6 | 7.05e-02 | -4.26e-01 | 2.76e-01 |
| GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 6 | 7.06e-02 | 4.26e-01 | 2.76e-01 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 1.96e-02 | 4.26e-01 | 1.29e-01 |
| GOBP REGULATION OF GTP BINDING | 8 | 3.71e-02 | -4.26e-01 | 1.91e-01 |
| GOBP INTERLEUKIN 23 PRODUCTION | 6 | 7.12e-02 | -4.25e-01 | 2.78e-01 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 14 | 5.87e-03 | -4.25e-01 | 5.70e-02 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 2.72e-02 | -4.25e-01 | 1.58e-01 |
| GOCC EARLY ENDOSOME LUMEN | 5 | 9.97e-02 | 4.25e-01 | 3.33e-01 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.75e-02 | -4.25e-01 | 1.91e-01 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 13 | 8.13e-03 | 4.24e-01 | 7.13e-02 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 15 | 4.48e-03 | 4.24e-01 | 4.81e-02 |
| GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 7 | 5.23e-02 | 4.24e-01 | 2.33e-01 |
| GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING | 6 | 7.28e-02 | -4.23e-01 | 2.81e-01 |
| GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 2.81e-02 | -4.23e-01 | 1.62e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 4.58e-03 | -4.23e-01 | 4.85e-02 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 6 | 7.29e-02 | 4.23e-01 | 2.81e-01 |
| GOBP PROLINE TRANSPORT | 7 | 5.28e-02 | -4.23e-01 | 2.34e-01 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 12 | 1.13e-02 | -4.23e-01 | 8.88e-02 |
| GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 5 | 1.02e-01 | 4.23e-01 | 3.36e-01 |
| GOCC RIBONUCLEASE P COMPLEX | 13 | 8.35e-03 | 4.23e-01 | 7.24e-02 |
| GOMF SIGNAL RECOGNITION PARTICLE BINDING | 6 | 7.31e-02 | 4.22e-01 | 2.81e-01 |
| GOBP NEGATIVE T CELL SELECTION | 6 | 7.33e-02 | -4.22e-01 | 2.81e-01 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 6 | 7.38e-02 | -4.21e-01 | 2.82e-01 |
| GOMF HISTONE H3K4ME H3K4ME2 H3K4ME3 DEMETHYLASE ACTIVITY | 5 | 1.03e-01 | -4.21e-01 | 3.37e-01 |
| GOBP RESPONSE TO DEXAMETHASONE | 26 | 2.03e-04 | -4.21e-01 | 5.29e-03 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 9 | 2.89e-02 | -4.21e-01 | 1.64e-01 |
| GOBP TRYPTOPHAN TRANSPORT | 5 | 1.03e-01 | -4.20e-01 | 3.38e-01 |
| GOBP OXALOACETATE METABOLIC PROCESS | 7 | 5.41e-02 | 4.20e-01 | 2.37e-01 |
| GOBP SEGMENT SPECIFICATION | 7 | 5.41e-02 | -4.20e-01 | 2.37e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 17 | 2.70e-03 | -4.20e-01 | 3.47e-02 |
| GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 5 | 1.04e-01 | 4.20e-01 | 3.39e-01 |
| GOBP VITAMIN D BIOSYNTHETIC PROCESS | 6 | 7.51e-02 | 4.20e-01 | 2.85e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 3.99e-02 | -4.20e-01 | 1.98e-01 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 7.57e-02 | -4.19e-01 | 2.87e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 6 | 7.63e-02 | 4.18e-01 | 2.87e-01 |
| GOBP NEGATIVE REGULATION OF CHROMATIN ORGANIZATION | 5 | 1.06e-01 | -4.18e-01 | 3.42e-01 |
| GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 7 | 5.58e-02 | 4.17e-01 | 2.41e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 9 | 3.01e-02 | -4.17e-01 | 1.69e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 14 | 6.86e-03 | -4.17e-01 | 6.37e-02 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 13 | 9.19e-03 | -4.17e-01 | 7.79e-02 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 9 | 3.03e-02 | -4.17e-01 | 1.69e-01 |
| GOMF COMPLEMENT BINDING | 9 | 3.03e-02 | -4.17e-01 | 1.69e-01 |
| GOBP DNA DEAMINATION | 12 | 1.24e-02 | 4.17e-01 | 9.50e-02 |
| GOBP L SERINE METABOLIC PROCESS | 10 | 2.24e-02 | 4.17e-01 | 1.39e-01 |
| GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 8 | 4.12e-02 | 4.17e-01 | 2.03e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 8 | 4.13e-02 | -4.17e-01 | 2.03e-01 |
| GOBP RESPONSE TO YEAST | 6 | 7.74e-02 | -4.16e-01 | 2.89e-01 |
| GOMF CHROMO SHADOW DOMAIN BINDING | 6 | 7.79e-02 | -4.16e-01 | 2.90e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 1.08e-01 | -4.16e-01 | 3.45e-01 |
| GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 6 | 7.81e-02 | 4.15e-01 | 2.90e-01 |
| GOBP MITOCHONDRIAL DNA REPAIR | 5 | 1.08e-01 | -4.15e-01 | 3.45e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS | 5 | 1.08e-01 | -4.15e-01 | 3.46e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 11 | 1.71e-02 | 4.15e-01 | 1.19e-01 |
| GOBP NOTOCHORD DEVELOPMENT | 5 | 1.09e-01 | -4.14e-01 | 3.47e-01 |
| GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 5 | 1.09e-01 | -4.14e-01 | 3.47e-01 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 13 | 9.73e-03 | 4.14e-01 | 8.09e-02 |
| GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 5 | 1.09e-01 | 4.14e-01 | 3.47e-01 |
| GOBP RESPONSE TO CORTISOL | 5 | 1.09e-01 | -4.14e-01 | 3.47e-01 |
| GOCC EXORIBONUCLEASE COMPLEX | 19 | 1.80e-03 | 4.14e-01 | 2.56e-02 |
| GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 12 | 1.32e-02 | 4.13e-01 | 9.88e-02 |
| GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 5 | 1.10e-01 | -4.13e-01 | 3.48e-01 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 18 | 2.42e-03 | 4.13e-01 | 3.20e-02 |
| GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 7 | 5.86e-02 | -4.13e-01 | 2.48e-01 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 7 | 5.86e-02 | -4.13e-01 | 2.48e-01 |
| GOMF G PROTEIN ACTIVITY | 34 | 3.18e-05 | 4.12e-01 | 1.13e-03 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 12 | 1.34e-02 | 4.12e-01 | 9.99e-02 |
| GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 8.09e-02 | -4.12e-01 | 2.96e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 9 | 3.27e-02 | -4.11e-01 | 1.78e-01 |
| GOBP IRON SULFUR CLUSTER ASSEMBLY | 29 | 1.28e-04 | 4.11e-01 | 3.59e-03 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 1.06e-07 | 4.11e-01 | 9.31e-06 |
| GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION | 6 | 8.14e-02 | -4.11e-01 | 2.97e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE | 10 | 2.46e-02 | 4.10e-01 | 1.48e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 11 | 1.86e-02 | -4.10e-01 | 1.25e-01 |
| GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 8 | 4.47e-02 | -4.10e-01 | 2.14e-01 |
| GOBP KINETOCHORE ORGANIZATION | 21 | 1.15e-03 | -4.10e-01 | 1.88e-02 |
| GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 8 | 4.48e-02 | -4.10e-01 | 2.14e-01 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 9 | 3.34e-02 | -4.10e-01 | 1.80e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 16 | 4.58e-03 | -4.09e-01 | 4.85e-02 |
| GOBP ORNITHINE METABOLIC PROCESS | 6 | 8.29e-02 | 4.09e-01 | 3.00e-01 |
| GOBP RESPONSE TO UV A | 8 | 4.53e-02 | -4.09e-01 | 2.15e-01 |
| GOCC MON1 CCZ1 COMPLEX | 5 | 1.13e-01 | 4.09e-01 | 3.54e-01 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 17 | 3.57e-03 | -4.08e-01 | 4.16e-02 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 9 | 3.42e-02 | -4.08e-01 | 1.82e-01 |
| GOBP DETOXIFICATION OF COPPER ION | 10 | 2.56e-02 | 4.08e-01 | 1.52e-01 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 12 | 1.46e-02 | -4.07e-01 | 1.06e-01 |
| GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 7 | 6.22e-02 | -4.07e-01 | 2.57e-01 |
| GOCC AXON HILLOCK | 5 | 1.15e-01 | -4.07e-01 | 3.57e-01 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 6 | 8.45e-02 | -4.07e-01 | 3.02e-01 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 13 | 1.12e-02 | -4.06e-01 | 8.84e-02 |
| GOMF DENEDDYLASE ACTIVITY | 6 | 8.50e-02 | 4.06e-01 | 3.03e-01 |
| GOCC ENDOPEPTIDASE COMPLEX | 74 | 1.59e-09 | 4.06e-01 | 2.69e-07 |
| GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 6 | 8.54e-02 | -4.06e-01 | 3.04e-01 |
| GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION | 12 | 1.50e-02 | -4.05e-01 | 1.08e-01 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 12 | 1.52e-02 | -4.05e-01 | 1.09e-01 |
| GOBP PROTEIN REPAIR | 6 | 8.62e-02 | 4.05e-01 | 3.06e-01 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 9 | 3.60e-02 | 4.04e-01 | 1.87e-01 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 9 | 3.60e-02 | 4.04e-01 | 1.87e-01 |
| GOBP RESPONSE TO DIETARY EXCESS | 16 | 5.22e-03 | -4.03e-01 | 5.29e-02 |
| GOCC VARICOSITY | 6 | 8.73e-02 | -4.03e-01 | 3.09e-01 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 1.19e-01 | -4.03e-01 | 3.63e-01 |
| GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE | 5 | 1.19e-01 | -4.03e-01 | 3.63e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 6.51e-02 | -4.03e-01 | 2.65e-01 |
| GOCC NUCLEAR INCLUSION BODY | 12 | 1.58e-02 | -4.02e-01 | 1.12e-01 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 11 | 2.09e-02 | -4.02e-01 | 1.34e-01 |
| GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 6 | 8.83e-02 | -4.02e-01 | 3.11e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 5 | 1.20e-01 | -4.02e-01 | 3.64e-01 |
| GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 1.20e-01 | -4.02e-01 | 3.64e-01 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 10 | 2.79e-02 | -4.01e-01 | 1.62e-01 |
| GOCC BBAF COMPLEX | 9 | 3.72e-02 | -4.01e-01 | 1.91e-01 |
| GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 4.94e-02 | 4.01e-01 | 2.26e-01 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 11 | 2.13e-02 | -4.01e-01 | 1.35e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 5 | 1.20e-01 | -4.01e-01 | 3.65e-01 |
| GOBP DORSAL VENTRAL AXIS SPECIFICATION | 5 | 1.21e-01 | -4.01e-01 | 3.66e-01 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 25 | 5.24e-04 | -4.01e-01 | 1.02e-02 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 5 | 1.21e-01 | 4.01e-01 | 3.66e-01 |
| GOBP CHORION DEVELOPMENT | 7 | 6.66e-02 | -4.00e-01 | 2.68e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 8.98e-02 | 4.00e-01 | 3.14e-01 |
| GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 7 | 6.71e-02 | 4.00e-01 | 2.69e-01 |
| GOBP CGMP BIOSYNTHETIC PROCESS | 5 | 1.22e-01 | -4.00e-01 | 3.67e-01 |
| GOMF GUANYLATE CYCLASE ACTIVITY | 5 | 1.22e-01 | -4.00e-01 | 3.67e-01 |
| GOCC DENDRITIC SPINE MEMBRANE | 7 | 6.72e-02 | -4.00e-01 | 2.69e-01 |
| GOBP LUTEOLYSIS | 5 | 1.22e-01 | -3.99e-01 | 3.68e-01 |
| GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 8 | 5.07e-02 | 3.99e-01 | 2.29e-01 |
| GOMF ACID PHOSPHATASE ACTIVITY | 6 | 9.08e-02 | 3.99e-01 | 3.17e-01 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 19 | 2.63e-03 | -3.99e-01 | 3.41e-02 |
| GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION | 6 | 9.16e-02 | 3.98e-01 | 3.18e-01 |
| GOCC CHYLOMICRON | 6 | 9.24e-02 | -3.97e-01 | 3.19e-01 |
| GOBP INDOLALKYLAMINE METABOLIC PROCESS | 9 | 3.95e-02 | -3.96e-01 | 1.97e-01 |
| GOBP TRYPTOPHAN METABOLIC PROCESS | 9 | 3.95e-02 | -3.96e-01 | 1.97e-01 |
| GOBP SPERMIDINE METABOLIC PROCESS | 8 | 5.23e-02 | 3.96e-01 | 2.33e-01 |
| GOBP REGULATION OF GLUCOCORTICOID SECRETION | 6 | 9.31e-02 | 3.96e-01 | 3.20e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 6 | 9.38e-02 | -3.95e-01 | 3.22e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 13 | 1.38e-02 | -3.95e-01 | 1.02e-01 |
| GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION | 6 | 9.46e-02 | -3.94e-01 | 3.23e-01 |
| GOBP PROTEIN LINEAR POLYUBIQUITINATION | 5 | 1.27e-01 | 3.94e-01 | 3.77e-01 |
| GOMF C METHYLTRANSFERASE ACTIVITY | 7 | 7.12e-02 | 3.94e-01 | 2.78e-01 |
| GOBP GANGLION DEVELOPMENT | 9 | 4.08e-02 | -3.94e-01 | 2.01e-01 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 39 | 2.11e-05 | -3.94e-01 | 7.97e-04 |
| GOBP FACIAL NERVE STRUCTURAL ORGANIZATION | 5 | 1.27e-01 | -3.94e-01 | 3.77e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 5 | 1.29e-01 | -3.92e-01 | 3.79e-01 |
| GOMF PRE MRNA INTRONIC BINDING | 10 | 3.17e-02 | -3.92e-01 | 1.74e-01 |
| GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA | 13 | 1.44e-02 | 3.92e-01 | 1.05e-01 |
| GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 7 | 7.26e-02 | -3.92e-01 | 2.80e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 33 | 9.80e-05 | -3.92e-01 | 2.92e-03 |
| GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS | 5 | 1.29e-01 | -3.92e-01 | 3.80e-01 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 2.46e-02 | -3.91e-01 | 1.48e-01 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 14 | 1.12e-02 | 3.91e-01 | 8.86e-02 |
| GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 11 | 2.47e-02 | 3.91e-01 | 1.48e-01 |
| GOBP REGULATION OF TRANSLATIONAL FIDELITY | 13 | 1.47e-02 | 3.91e-01 | 1.07e-01 |
| GOBP CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 6 | 9.77e-02 | 3.90e-01 | 3.29e-01 |
| GOBP SIGNAL COMPLEX ASSEMBLY | 6 | 9.78e-02 | -3.90e-01 | 3.29e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 16 | 6.90e-03 | -3.90e-01 | 6.39e-02 |
| GOBP TAURINE TRANSPORT | 6 | 9.80e-02 | -3.90e-01 | 3.30e-01 |
| GOBP BODY MORPHOGENESIS | 30 | 2.18e-04 | -3.90e-01 | 5.49e-03 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 1.31e-01 | 3.90e-01 | 3.83e-01 |
| GOMF METALLOCHAPERONE ACTIVITY | 12 | 1.94e-02 | 3.90e-01 | 1.29e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 13 | 1.50e-02 | 3.90e-01 | 1.08e-01 |
| GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 8 | 5.65e-02 | 3.89e-01 | 2.42e-01 |
| GOBP GROWTH HORMONE SECRETION | 6 | 9.87e-02 | 3.89e-01 | 3.31e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.32e-02 | 3.89e-01 | 2.09e-01 |
| GOMF CARBON SULFUR LYASE ACTIVITY | 12 | 1.97e-02 | 3.89e-01 | 1.29e-01 |
| GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY | 5 | 1.32e-01 | -3.89e-01 | 3.84e-01 |
| GOBP SUGAR MEDIATED SIGNALING PATHWAY | 7 | 7.50e-02 | -3.89e-01 | 2.85e-01 |
| GOBP ICOSANOID SECRETION | 19 | 3.37e-03 | 3.89e-01 | 4.00e-02 |
| GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 5 | 1.33e-01 | 3.88e-01 | 3.85e-01 |
| GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER | 7 | 7.52e-02 | -3.88e-01 | 2.86e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 9 | 4.39e-02 | 3.88e-01 | 2.12e-01 |
| GOBP NK T CELL DIFFERENTIATION | 7 | 7.57e-02 | -3.88e-01 | 2.87e-01 |
| GOBP CELLULAR RESPONSE TO GLUCAGON STIMULUS | 5 | 1.33e-01 | -3.88e-01 | 3.86e-01 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 17 | 5.71e-03 | -3.87e-01 | 5.62e-02 |
| GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 5 | 1.34e-01 | -3.87e-01 | 3.87e-01 |
| GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 6 | 1.01e-01 | 3.87e-01 | 3.34e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 1.34e-01 | 3.87e-01 | 3.87e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 6 | 1.01e-01 | -3.87e-01 | 3.34e-01 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 11 | 2.63e-02 | -3.87e-01 | 1.55e-01 |
| GOCC CHROMOCENTER | 11 | 2.64e-02 | -3.87e-01 | 1.55e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 17 | 5.81e-03 | 3.86e-01 | 5.66e-02 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 18 | 4.54e-03 | -3.86e-01 | 4.83e-02 |
| GOBP CAMP METABOLIC PROCESS | 15 | 9.59e-03 | -3.86e-01 | 8.03e-02 |
| GOBP ARACHIDONIC ACID SECRETION | 9 | 4.50e-02 | 3.86e-01 | 2.14e-01 |
| GOBP UTERUS DEVELOPMENT | 12 | 2.07e-02 | -3.86e-01 | 1.34e-01 |
| GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY | 5 | 1.35e-01 | -3.86e-01 | 3.89e-01 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 7.73e-02 | 3.86e-01 | 2.89e-01 |
| GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 7 | 7.76e-02 | -3.85e-01 | 2.89e-01 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 18 | 4.67e-03 | -3.85e-01 | 4.89e-02 |
| GOBP PEPTIDE CATABOLIC PROCESS | 17 | 6.01e-03 | -3.85e-01 | 5.79e-02 |
| GOBP TRNA 5 END PROCESSING | 16 | 7.70e-03 | 3.85e-01 | 6.89e-02 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 16 | 7.78e-03 | -3.84e-01 | 6.93e-02 |
| GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 8 | 5.98e-02 | -3.84e-01 | 2.51e-01 |
| GOBP RESPONSE TO INTERLEUKIN 2 | 6 | 1.03e-01 | -3.84e-01 | 3.37e-01 |
| GOBP CYTOSOLIC RIBOSOME ASSEMBLY | 5 | 1.37e-01 | 3.84e-01 | 3.91e-01 |
| GOMF CCR1 CHEMOKINE RECEPTOR BINDING | 5 | 1.37e-01 | 3.84e-01 | 3.91e-01 |
| GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION | 5 | 1.37e-01 | 3.84e-01 | 3.91e-01 |
| GOBP INTESTINAL LIPID ABSORPTION | 8 | 6.04e-02 | 3.83e-01 | 2.53e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 6 | 1.04e-01 | -3.83e-01 | 3.39e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 5 | 1.39e-01 | -3.82e-01 | 3.95e-01 |
| GOMF TAT PROTEIN BINDING | 10 | 3.63e-02 | -3.82e-01 | 1.88e-01 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 7 | 7.99e-02 | -3.82e-01 | 2.94e-01 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 24 | 1.19e-03 | -3.82e-01 | 1.93e-02 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 11 | 2.82e-02 | -3.82e-01 | 1.63e-01 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 25 | 9.47e-04 | -3.82e-01 | 1.62e-02 |
| GOMF CAMP BINDING | 14 | 1.34e-02 | -3.82e-01 | 9.99e-02 |
| GOMF ISOPRENOID BINDING | 11 | 2.84e-02 | -3.82e-01 | 1.63e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION | 5 | 1.40e-01 | -3.82e-01 | 3.96e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 10 | 3.68e-02 | 3.81e-01 | 1.90e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS | 6 | 1.06e-01 | -3.81e-01 | 3.42e-01 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 16 | 8.33e-03 | -3.81e-01 | 7.23e-02 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 12 | 2.23e-02 | -3.81e-01 | 1.39e-01 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 17 | 6.63e-03 | -3.80e-01 | 6.22e-02 |
| GOMF ANKYRIN REPEAT BINDING | 6 | 1.07e-01 | 3.80e-01 | 3.44e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 10 | 3.74e-02 | -3.80e-01 | 1.91e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 16 | 8.54e-03 | -3.80e-01 | 7.37e-02 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 15 | 1.09e-02 | -3.80e-01 | 8.75e-02 |
| GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 5 | 1.42e-01 | -3.80e-01 | 4.00e-01 |
| GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 1.08e-01 | -3.79e-01 | 3.45e-01 |
| GOCC PLATELET DENSE GRANULE LUMEN | 8 | 6.33e-02 | -3.79e-01 | 2.60e-01 |
| GOBP L PROLINE BIOSYNTHETIC PROCESS | 5 | 1.42e-01 | 3.79e-01 | 4.01e-01 |
| GOCC CALCINEURIN COMPLEX | 5 | 1.42e-01 | -3.79e-01 | 4.01e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 20 | 3.36e-03 | -3.79e-01 | 4.00e-02 |
| GOMF UNMETHYLATED CPG BINDING | 9 | 4.92e-02 | -3.79e-01 | 2.25e-01 |
| GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 8 | 6.39e-02 | -3.78e-01 | 2.61e-01 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 23 | 1.70e-03 | -3.78e-01 | 2.46e-02 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 9 | 4.99e-02 | -3.78e-01 | 2.27e-01 |
| GOBP LEUKOTRIENE TRANSPORT | 5 | 1.45e-01 | -3.77e-01 | 4.04e-01 |
| GOBP AMMONIUM TRANSMEMBRANE TRANSPORT | 7 | 8.46e-02 | -3.76e-01 | 3.02e-01 |
| GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.46e-02 | -3.76e-01 | 3.02e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 13 | 1.88e-02 | 3.76e-01 | 1.26e-01 |
| GOBP PROTEIN POLYUFMYLATION | 5 | 1.45e-01 | 3.76e-01 | 4.05e-01 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 8 | 6.55e-02 | 3.76e-01 | 2.66e-01 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 6 | 1.11e-01 | -3.76e-01 | 3.51e-01 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 9 | 5.10e-02 | -3.76e-01 | 2.30e-01 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 5.11e-02 | -3.76e-01 | 2.30e-01 |
| GOBP CONSTITUTIVE SECRETORY PATHWAY | 7 | 8.56e-02 | 3.75e-01 | 3.05e-01 |
| GOCC BETA CATENIN TCF COMPLEX | 11 | 3.13e-02 | -3.75e-01 | 1.73e-01 |
| GOCC LAMELLAR BODY | 6 | 1.12e-01 | 3.75e-01 | 3.51e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 7 | 8.58e-02 | 3.75e-01 | 3.05e-01 |
| GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 5 | 1.47e-01 | -3.75e-01 | 4.07e-01 |
| GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 8 | 6.63e-02 | -3.75e-01 | 2.68e-01 |
| GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 8 | 6.64e-02 | -3.75e-01 | 2.68e-01 |
| GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX | 6 | 1.12e-01 | 3.74e-01 | 3.52e-01 |
| GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 8 | 6.68e-02 | 3.74e-01 | 2.69e-01 |
| GOMF MRF BINDING | 5 | 1.48e-01 | -3.74e-01 | 4.08e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 28 | 6.30e-04 | -3.73e-01 | 1.17e-02 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION | 6 | 1.14e-01 | 3.73e-01 | 3.54e-01 |
| GOMF ALPHA CATENIN BINDING | 5 | 1.49e-01 | -3.73e-01 | 4.09e-01 |
| GOBP POSITIVE REGULATION OF HISTONE ACETYLATION | 9 | 5.27e-02 | -3.73e-01 | 2.34e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 22 | 2.47e-03 | -3.73e-01 | 3.24e-02 |
| GOCC MICOS COMPLEX | 8 | 6.80e-02 | 3.73e-01 | 2.71e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 14 | 1.58e-02 | 3.73e-01 | 1.12e-01 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 7 | 8.78e-02 | -3.73e-01 | 3.10e-01 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 14 | 1.58e-02 | -3.72e-01 | 1.12e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 5 | 1.50e-01 | -3.72e-01 | 4.11e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 5.33e-02 | 3.72e-01 | 2.35e-01 |
| GOBP ELASTIC FIBER ASSEMBLY | 6 | 1.15e-01 | -3.72e-01 | 3.56e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 5 | 1.50e-01 | -3.72e-01 | 4.11e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 8 | 6.88e-02 | 3.72e-01 | 2.73e-01 |
| GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 8.90e-02 | -3.71e-01 | 3.12e-01 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 160 | 5.75e-16 | 3.71e-01 | 4.50e-13 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 5 | 1.51e-01 | 3.71e-01 | 4.12e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 9 | 5.42e-02 | -3.71e-01 | 2.37e-01 |
| GOBP ENDOTHELIAL CELL FATE COMMITMENT | 5 | 1.51e-01 | -3.71e-01 | 4.12e-01 |
| GOBP AMP METABOLIC PROCESS | 17 | 8.17e-03 | 3.71e-01 | 7.15e-02 |
| GOBP NEGATIVE REGULATION OF VASOCONSTRICTION | 6 | 1.17e-01 | -3.70e-01 | 3.59e-01 |
| GOCC NBAF COMPLEX | 13 | 2.09e-02 | -3.70e-01 | 1.34e-01 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 20 | 4.21e-03 | -3.70e-01 | 4.60e-02 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 9 | 5.49e-02 | -3.69e-01 | 2.40e-01 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 38 | 8.22e-05 | 3.69e-01 | 2.54e-03 |
| GOBP ANDROGEN CATABOLIC PROCESS | 5 | 1.53e-01 | -3.69e-01 | 4.15e-01 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 7 | 9.10e-02 | -3.69e-01 | 3.17e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 13 | 2.14e-02 | -3.69e-01 | 1.36e-01 |
| GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 23 | 2.23e-03 | 3.68e-01 | 3.03e-02 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 11 | 3.45e-02 | -3.68e-01 | 1.83e-01 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 33 | 2.52e-04 | -3.68e-01 | 6.07e-03 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 15 | 1.36e-02 | -3.68e-01 | 1.01e-01 |
| GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 6 | 1.19e-01 | 3.68e-01 | 3.62e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 5 | 1.54e-01 | -3.68e-01 | 4.17e-01 |
| GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING | 7 | 9.18e-02 | -3.68e-01 | 3.18e-01 |
| GOCC GROWTH FACTOR COMPLEX | 5 | 1.54e-01 | -3.68e-01 | 4.17e-01 |
| GOCC TETRASPANIN ENRICHED MICRODOMAIN | 10 | 4.41e-02 | -3.68e-01 | 2.12e-01 |
| GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 22 | 2.84e-03 | -3.68e-01 | 3.59e-02 |
| GOBP THALAMUS DEVELOPMENT | 5 | 1.55e-01 | -3.67e-01 | 4.17e-01 |
| GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 4.46e-02 | 3.67e-01 | 2.13e-01 |
| GOBP STRIATUM DEVELOPMENT | 14 | 1.75e-02 | -3.67e-01 | 1.20e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 13 | 2.22e-02 | -3.66e-01 | 1.38e-01 |
| GOBP FACE DEVELOPMENT | 32 | 3.35e-04 | -3.66e-01 | 7.43e-03 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 7 | 9.34e-02 | -3.66e-01 | 3.21e-01 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 3.55e-02 | 3.66e-01 | 1.85e-01 |
| GOCC RIBONUCLEASE MRP COMPLEX | 10 | 4.50e-02 | 3.66e-01 | 2.14e-01 |
| GOBP REGULATION OF RIBOSOME BIOGENESIS | 9 | 5.73e-02 | 3.66e-01 | 2.44e-01 |
| GOBP AZOLE TRANSMEMBRANE TRANSPORT | 7 | 9.36e-02 | 3.66e-01 | 3.22e-01 |
| GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 6 | 1.21e-01 | 3.66e-01 | 3.66e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 20 | 4.64e-03 | -3.66e-01 | 4.88e-02 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 32 | 3.46e-04 | 3.66e-01 | 7.52e-03 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 7 | 9.41e-02 | 3.65e-01 | 3.23e-01 |
| GOBP REGULATION OF ICOSANOID SECRETION | 11 | 3.59e-02 | 3.65e-01 | 1.87e-01 |
| GOCC CHROMOSOME PASSENGER COMPLEX | 6 | 1.22e-01 | -3.65e-01 | 3.67e-01 |
| GOMF OPSONIN BINDING | 8 | 7.42e-02 | -3.65e-01 | 2.83e-01 |
| GOBP GDP MANNOSE METABOLIC PROCESS | 6 | 1.22e-01 | 3.64e-01 | 3.68e-01 |
| GOBP DETECTION OF OTHER ORGANISM | 14 | 1.83e-02 | -3.64e-01 | 1.23e-01 |
| GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS | 9 | 5.84e-02 | -3.64e-01 | 2.48e-01 |
| GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 7 | 9.51e-02 | -3.64e-01 | 3.24e-01 |
| GOBP OVULATION CYCLE | 35 | 1.93e-04 | -3.64e-01 | 5.06e-03 |
| GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS | 5 | 1.59e-01 | -3.64e-01 | 4.24e-01 |
| GOMF VIRION BINDING | 9 | 5.89e-02 | -3.64e-01 | 2.48e-01 |
| GOBP HEPATOCYTE DIFFERENTIATION | 6 | 1.23e-01 | 3.63e-01 | 3.69e-01 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 17 | 9.62e-03 | -3.63e-01 | 8.03e-02 |
| GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 5 | 1.60e-01 | -3.63e-01 | 4.26e-01 |
| GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT | 8 | 7.59e-02 | 3.62e-01 | 2.87e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 24 | 2.13e-03 | -3.62e-01 | 2.93e-02 |
| GOMF POLY A BINDING | 20 | 5.08e-03 | -3.62e-01 | 5.21e-02 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 10 | 4.75e-02 | -3.62e-01 | 2.22e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 8 | 7.64e-02 | -3.62e-01 | 2.87e-01 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 21 | 4.11e-03 | 3.62e-01 | 4.54e-02 |
| GOBP RESPONSE TO LECTIN | 16 | 1.23e-02 | -3.62e-01 | 9.41e-02 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 20 | 5.14e-03 | -3.61e-01 | 5.25e-02 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 8 | 7.71e-02 | 3.61e-01 | 2.89e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 11 | 3.82e-02 | 3.61e-01 | 1.93e-01 |
| GOBP NEURON RECOGNITION | 22 | 3.39e-03 | -3.61e-01 | 4.02e-02 |
| GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING | 8 | 7.73e-02 | -3.61e-01 | 2.89e-01 |
| GOCC ESC E Z COMPLEX | 10 | 4.84e-02 | -3.61e-01 | 2.24e-01 |
| GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 6 | 1.26e-01 | 3.61e-01 | 3.75e-01 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 12 | 3.07e-02 | 3.60e-01 | 1.70e-01 |
| GOBP RNA SECONDARY STRUCTURE UNWINDING | 9 | 6.13e-02 | -3.60e-01 | 2.55e-01 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 6 | 1.27e-01 | -3.60e-01 | 3.76e-01 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 18 | 8.21e-03 | -3.60e-01 | 7.15e-02 |
| GOCC AXON INITIAL SEGMENT | 11 | 3.88e-02 | -3.60e-01 | 1.94e-01 |
| GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 9 | 6.16e-02 | -3.60e-01 | 2.56e-01 |
| GOBP PROTEASOME ASSEMBLY | 12 | 3.10e-02 | 3.60e-01 | 1.72e-01 |
| GOCC STRIATED MUSCLE THIN FILAMENT | 10 | 4.90e-02 | 3.60e-01 | 2.25e-01 |
| GOBP CHROMOSOME SEPARATION | 73 | 1.11e-07 | -3.59e-01 | 9.47e-06 |
| GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 6 | 1.28e-01 | 3.59e-01 | 3.77e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY | 6 | 1.28e-01 | -3.59e-01 | 3.78e-01 |
| GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 5 | 1.65e-01 | -3.59e-01 | 4.33e-01 |
| GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 5 | 1.65e-01 | -3.59e-01 | 4.33e-01 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 16 | 1.30e-02 | 3.59e-01 | 9.81e-02 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 7 | 1.00e-01 | -3.59e-01 | 3.34e-01 |
| GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 1.29e-01 | -3.58e-01 | 3.79e-01 |
| GOBP TRNA SURVEILLANCE | 8 | 7.95e-02 | 3.58e-01 | 2.93e-01 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 7 | 1.01e-01 | 3.58e-01 | 3.35e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 1.29e-01 | -3.58e-01 | 3.80e-01 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 8 | 7.97e-02 | -3.58e-01 | 2.94e-01 |
| GOBP ZYMOGEN INHIBITION | 7 | 1.02e-01 | 3.57e-01 | 3.36e-01 |
| GOBP AXO DENDRITIC PROTEIN TRANSPORT | 5 | 1.67e-01 | -3.57e-01 | 4.35e-01 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 8 | 8.04e-02 | 3.57e-01 | 2.95e-01 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 8.04e-02 | -3.57e-01 | 2.95e-01 |
| GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 1.67e-01 | 3.57e-01 | 4.35e-01 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 11 | 4.07e-02 | -3.56e-01 | 2.01e-01 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 14 | 2.10e-02 | -3.56e-01 | 1.34e-01 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 22 | 3.84e-03 | 3.56e-01 | 4.37e-02 |
| GOBP RESPONSE TO VITAMIN E | 5 | 1.68e-01 | -3.56e-01 | 4.36e-01 |
| GOMF STRUCTURAL CONSTITUENT OF EYE LENS | 6 | 1.31e-01 | -3.56e-01 | 3.83e-01 |
| GOCC G PROTEIN COUPLED RECEPTOR COMPLEX | 5 | 1.68e-01 | -3.56e-01 | 4.36e-01 |
| GOBP RRNA 3 END PROCESSING | 10 | 5.17e-02 | 3.55e-01 | 2.31e-01 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 9 | 6.51e-02 | 3.55e-01 | 2.65e-01 |
| GOBP NON LYTIC VIRAL RELEASE | 14 | 2.14e-02 | 3.55e-01 | 1.36e-01 |
| GOBP POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY | 5 | 1.69e-01 | -3.55e-01 | 4.39e-01 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 26 | 1.74e-03 | -3.55e-01 | 2.49e-02 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC | 17 | 1.13e-02 | 3.55e-01 | 8.90e-02 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 15 | 1.74e-02 | -3.55e-01 | 1.19e-01 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 6 | 1.33e-01 | 3.54e-01 | 3.85e-01 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 16 | 1.42e-02 | 3.54e-01 | 1.04e-01 |
| GOCC UNIPLEX COMPLEX | 6 | 1.34e-01 | 3.54e-01 | 3.87e-01 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 39 | 1.35e-04 | 3.53e-01 | 3.78e-03 |
| GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 6 | 1.34e-01 | -3.53e-01 | 3.87e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 6 | 1.34e-01 | -3.53e-01 | 3.87e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 9 | 6.66e-02 | -3.53e-01 | 2.68e-01 |
| GOBP BOX C D SNORNP ASSEMBLY | 9 | 6.68e-02 | 3.53e-01 | 2.69e-01 |
| GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY | 7 | 1.06e-01 | 3.53e-01 | 3.43e-01 |
| GOBP MATURE B CELL DIFFERENTIATION | 28 | 1.24e-03 | -3.53e-01 | 1.99e-02 |
| GOBP REGULATION OF TELOMERE CAPPING | 23 | 3.42e-03 | -3.53e-01 | 4.04e-02 |
| GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR | 5 | 1.72e-01 | -3.52e-01 | 4.43e-01 |
| GOBP CELLULAR RESPONSE TO CAMP | 31 | 6.87e-04 | -3.52e-01 | 1.26e-02 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 8 | 8.45e-02 | 3.52e-01 | 3.02e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 6 | 1.35e-01 | -3.52e-01 | 3.89e-01 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 10 | 5.39e-02 | -3.52e-01 | 2.37e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 7 | 1.07e-01 | -3.52e-01 | 3.44e-01 |
| GOBP METANEPHRIC TUBULE MORPHOGENESIS | 5 | 1.73e-01 | 3.52e-01 | 4.45e-01 |
| GOBP TRACHEA FORMATION | 6 | 1.36e-01 | -3.51e-01 | 3.90e-01 |
| GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 7 | 1.07e-01 | -3.51e-01 | 3.45e-01 |
| GOBP ARGININE METABOLIC PROCESS | 11 | 4.38e-02 | 3.51e-01 | 2.11e-01 |
| GOBP MITOTIC DNA REPLICATION | 15 | 1.87e-02 | -3.51e-01 | 1.25e-01 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 7 | 1.08e-01 | -3.51e-01 | 3.46e-01 |
| GOMF L ASCORBIC ACID BINDING | 15 | 1.87e-02 | 3.51e-01 | 1.25e-01 |
| GOBP COCHLEA MORPHOGENESIS | 6 | 1.37e-01 | 3.51e-01 | 3.91e-01 |
| GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 1.75e-01 | -3.50e-01 | 4.46e-01 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 10 | 5.51e-02 | -3.50e-01 | 2.40e-01 |
| GOMF COPPER CHAPERONE ACTIVITY | 7 | 1.09e-01 | 3.50e-01 | 3.47e-01 |
| GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 30 | 9.14e-04 | -3.50e-01 | 1.58e-02 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 34 | 4.19e-04 | -3.50e-01 | 8.66e-03 |
| GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 7 | 1.09e-01 | 3.49e-01 | 3.48e-01 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 5 | 1.76e-01 | -3.49e-01 | 4.48e-01 |
| GOBP MAGNESIUM ION TRANSPORT | 16 | 1.56e-02 | 3.49e-01 | 1.11e-01 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 16 | 1.56e-02 | -3.49e-01 | 1.11e-01 |
| GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION | 22 | 4.61e-03 | -3.49e-01 | 4.85e-02 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 9 | 6.99e-02 | 3.49e-01 | 2.75e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 15 | 1.93e-02 | -3.49e-01 | 1.28e-01 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 18 | 1.05e-02 | -3.48e-01 | 8.53e-02 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 14 | 2.40e-02 | -3.48e-01 | 1.46e-01 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 14 | 2.40e-02 | -3.48e-01 | 1.46e-01 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 9 | 7.04e-02 | 3.48e-01 | 2.76e-01 |
| GOBP EOSINOPHIL ACTIVATION | 6 | 1.40e-01 | 3.48e-01 | 3.96e-01 |
| GOMF SYNTAXIN 1 BINDING | 12 | 3.68e-02 | -3.48e-01 | 1.90e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 9 | 7.07e-02 | -3.48e-01 | 2.76e-01 |
| GOBP PIGMENT ACCUMULATION | 10 | 5.68e-02 | 3.48e-01 | 2.43e-01 |
| GOBP PIGMENT GRANULE MATURATION | 10 | 5.68e-02 | 3.48e-01 | 2.43e-01 |
| GOMF 7S RNA BINDING | 7 | 1.11e-01 | 3.48e-01 | 3.51e-01 |
| GOMF GDP PHOSPHATASE ACTIVITY | 7 | 1.11e-01 | 3.48e-01 | 3.51e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 17 | 1.31e-02 | 3.47e-01 | 9.87e-02 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 1.41e-01 | 3.47e-01 | 3.98e-01 |
| GOBP TRNA TRANSPORT | 5 | 1.79e-01 | 3.47e-01 | 4.53e-01 |
| GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 9 | 7.15e-02 | 3.47e-01 | 2.79e-01 |
| GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 7 | 1.12e-01 | 3.47e-01 | 3.52e-01 |
| GOCC PICLN SM PROTEIN COMPLEX | 6 | 1.42e-01 | 3.46e-01 | 4.00e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 5 | 1.80e-01 | -3.46e-01 | 4.55e-01 |
| GOMF GDP BINDING | 60 | 3.64e-06 | 3.46e-01 | 1.78e-04 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 59 | 4.42e-06 | -3.46e-01 | 2.08e-04 |
| GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 1.81e-01 | 3.45e-01 | 4.56e-01 |
| GOMF SNAP RECEPTOR ACTIVITY | 34 | 4.98e-04 | 3.45e-01 | 9.80e-03 |
| GOCC RNA POLYMERASE III COMPLEX | 18 | 1.13e-02 | 3.45e-01 | 8.88e-02 |
| GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 6 | 1.43e-01 | -3.45e-01 | 4.03e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 1.82e-01 | -3.45e-01 | 4.57e-01 |
| GOBP CELLULAR HYPEROSMOTIC RESPONSE | 15 | 2.10e-02 | -3.44e-01 | 1.34e-01 |
| GOCC GTPASE ACTIVATOR COMPLEX | 11 | 4.82e-02 | 3.44e-01 | 2.24e-01 |
| GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 6 | 1.45e-01 | -3.44e-01 | 4.04e-01 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 11 | 4.83e-02 | -3.44e-01 | 2.24e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 10 | 5.97e-02 | -3.44e-01 | 2.50e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 7 | 1.15e-01 | 3.44e-01 | 3.57e-01 |
| GOBP VITAMIN D METABOLIC PROCESS | 8 | 9.22e-02 | 3.44e-01 | 3.19e-01 |
| GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 5 | 1.83e-01 | -3.44e-01 | 4.58e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 11 | 4.84e-02 | -3.44e-01 | 2.24e-01 |
| GOBP CHONDROCYTE HYPERTROPHY | 5 | 1.83e-01 | -3.44e-01 | 4.58e-01 |
| GOCC PRESYNAPTIC CYTOSKELETON | 5 | 1.83e-01 | 3.44e-01 | 4.58e-01 |
| GOMF CGMP BINDING | 7 | 1.15e-01 | -3.44e-01 | 3.57e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 8 | 9.26e-02 | -3.43e-01 | 3.19e-01 |
| GOCC TRAPPII PROTEIN COMPLEX | 11 | 4.86e-02 | 3.43e-01 | 2.24e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 1.84e-01 | -3.43e-01 | 4.59e-01 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 22 | 5.34e-03 | 3.43e-01 | 5.35e-02 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 22 | 5.35e-03 | -3.43e-01 | 5.35e-02 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 12 | 3.96e-02 | -3.43e-01 | 1.97e-01 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 31 | 9.51e-04 | -3.43e-01 | 1.62e-02 |
| GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 1.84e-01 | 3.43e-01 | 4.59e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 5 | 1.84e-01 | -3.43e-01 | 4.59e-01 |
| GOCC RAGULATOR COMPLEX | 5 | 1.85e-01 | 3.43e-01 | 4.59e-01 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 19 | 9.74e-03 | 3.43e-01 | 8.10e-02 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 1.17e-01 | -3.42e-01 | 3.59e-01 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 8 | 9.36e-02 | 3.42e-01 | 3.22e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 6 | 1.47e-01 | -3.42e-01 | 4.07e-01 |
| GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY | 6 | 1.47e-01 | 3.42e-01 | 4.07e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 7 | 1.17e-01 | -3.42e-01 | 3.60e-01 |
| GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 6 | 1.47e-01 | 3.42e-01 | 4.07e-01 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 36 | 3.89e-04 | -3.42e-01 | 8.15e-03 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 7 | 1.18e-01 | 3.41e-01 | 3.61e-01 |
| GOMF RETINAL BINDING | 6 | 1.48e-01 | -3.41e-01 | 4.08e-01 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 9 | 7.67e-02 | -3.41e-01 | 2.88e-01 |
| GOBP CELLULAR RESPONSE TO UV B | 10 | 6.21e-02 | -3.41e-01 | 2.57e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 5 | 1.87e-01 | -3.41e-01 | 4.63e-01 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 115 | 2.93e-10 | -3.40e-01 | 6.02e-08 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 38 | 2.83e-04 | -3.40e-01 | 6.70e-03 |
| GOBP REPLACEMENT OSSIFICATION | 13 | 3.37e-02 | -3.40e-01 | 1.81e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 7 | 1.19e-01 | -3.40e-01 | 3.63e-01 |
| GOMF RNA STEM LOOP BINDING | 15 | 2.26e-02 | -3.40e-01 | 1.40e-01 |
| GOCC WEIBEL PALADE BODY | 5 | 1.88e-01 | 3.40e-01 | 4.64e-01 |
| GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS | 5 | 1.88e-01 | 3.40e-01 | 4.64e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 1.88e-01 | -3.40e-01 | 4.64e-01 |
| GOBP SYMPATHETIC GANGLION DEVELOPMENT | 6 | 1.50e-01 | -3.40e-01 | 4.11e-01 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 8 | 9.61e-02 | -3.40e-01 | 3.26e-01 |
| GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS | 5 | 1.88e-01 | -3.40e-01 | 4.64e-01 |
| GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 9 | 7.77e-02 | 3.40e-01 | 2.89e-01 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 37 | 3.54e-04 | 3.39e-01 | 7.63e-03 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 15 | 2.29e-02 | 3.39e-01 | 1.42e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 28 | 1.90e-03 | 3.39e-01 | 2.67e-02 |
| GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS | 5 | 1.89e-01 | 3.39e-01 | 4.66e-01 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 2.81e-02 | 3.39e-01 | 1.62e-01 |
| GOBP MACROPHAGE FUSION | 6 | 1.51e-01 | -3.39e-01 | 4.12e-01 |
| GOBP RESPONSE TO SALT STRESS | 18 | 1.29e-02 | -3.39e-01 | 9.76e-02 |
| GOBP SUBPALLIUM DEVELOPMENT | 15 | 2.33e-02 | -3.38e-01 | 1.43e-01 |
| GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 9 | 7.90e-02 | 3.38e-01 | 2.92e-01 |
| GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 10 | 6.41e-02 | 3.38e-01 | 2.62e-01 |
| GOBP REGULATION OF GASTRULATION | 7 | 1.22e-01 | -3.38e-01 | 3.67e-01 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 18 | 1.31e-02 | -3.38e-01 | 9.85e-02 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 25 | 3.46e-03 | -3.38e-01 | 4.06e-02 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 6 | 1.52e-01 | -3.38e-01 | 4.13e-01 |
| GOBP EOSINOPHIL MIGRATION | 14 | 2.87e-02 | 3.38e-01 | 1.64e-01 |
| GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS | 5 | 1.91e-01 | 3.37e-01 | 4.69e-01 |
| GOBP REGULATION OF FEVER GENERATION | 5 | 1.91e-01 | 3.37e-01 | 4.69e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 20 | 9.01e-03 | -3.37e-01 | 7.69e-02 |
| GOBP GLIAL CELL ACTIVATION | 38 | 3.21e-04 | -3.37e-01 | 7.23e-03 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 7 | 1.22e-01 | -3.37e-01 | 3.68e-01 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 5 | 1.92e-01 | 3.37e-01 | 4.69e-01 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 13 | 3.54e-02 | 3.37e-01 | 1.85e-01 |
| GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 6 | 1.53e-01 | 3.37e-01 | 4.15e-01 |
| GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX | 5 | 1.92e-01 | -3.37e-01 | 4.69e-01 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 7 | 1.23e-01 | -3.37e-01 | 3.69e-01 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 33 | 8.17e-04 | 3.37e-01 | 1.45e-02 |
| GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 7 | 1.23e-01 | 3.37e-01 | 3.69e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 7 | 1.23e-01 | -3.37e-01 | 3.69e-01 |
| GOBP RRNA CATABOLIC PROCESS | 19 | 1.12e-02 | 3.36e-01 | 8.83e-02 |
| GOBP ELASTIN METABOLIC PROCESS | 7 | 1.24e-01 | -3.36e-01 | 3.70e-01 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 18 | 1.36e-02 | -3.36e-01 | 1.00e-01 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 16 | 2.00e-02 | 3.36e-01 | 1.30e-01 |
| GOBP VACUOLE FUSION | 12 | 4.40e-02 | 3.36e-01 | 2.12e-01 |
| GOCC ORGANELLE ENVELOPE LUMEN | 80 | 2.10e-07 | 3.36e-01 | 1.54e-05 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 14 | 2.97e-02 | -3.36e-01 | 1.68e-01 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 9 | 8.13e-02 | -3.36e-01 | 2.97e-01 |
| GOCC SIGNAL RECOGNITION PARTICLE | 7 | 1.24e-01 | 3.36e-01 | 3.71e-01 |
| GOBP OLIGOPEPTIDE IMPORT ACROSS PLASMA MEMBRANE | 5 | 1.94e-01 | -3.35e-01 | 4.71e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 8 | 1.01e-01 | 3.35e-01 | 3.34e-01 |
| GOBP RESPONSE TO ANGIOTENSIN | 22 | 6.54e-03 | -3.35e-01 | 6.16e-02 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 12 | 4.47e-02 | -3.35e-01 | 2.14e-01 |
| GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 9 | 8.22e-02 | -3.35e-01 | 2.99e-01 |
| GOCC DENDRITIC GROWTH CONE | 7 | 1.25e-01 | -3.34e-01 | 3.74e-01 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 1.95e-01 | -3.34e-01 | 4.73e-01 |
| GOBP PML BODY ORGANIZATION | 6 | 1.56e-01 | 3.34e-01 | 4.19e-01 |
| GOBP ERBB2 SIGNALING PATHWAY | 9 | 8.24e-02 | 3.34e-01 | 2.99e-01 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 57 | 1.28e-05 | -3.34e-01 | 5.22e-04 |
| GOBP REGULATION OF NEURON MIGRATION | 25 | 3.83e-03 | -3.34e-01 | 4.37e-02 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 17 | 1.71e-02 | 3.34e-01 | 1.19e-01 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 8 | 1.02e-01 | -3.34e-01 | 3.36e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 7 | 1.26e-01 | -3.34e-01 | 3.75e-01 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 17 | 1.72e-02 | -3.34e-01 | 1.19e-01 |
| GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 8 | 1.02e-01 | -3.34e-01 | 3.36e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 7 | 1.26e-01 | -3.34e-01 | 3.76e-01 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 7 | 1.27e-01 | 3.33e-01 | 3.76e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 5 | 1.97e-01 | -3.33e-01 | 4.76e-01 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 16 | 2.12e-02 | 3.33e-01 | 1.35e-01 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 6 | 1.58e-01 | 3.33e-01 | 4.22e-01 |
| GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 10 | 6.85e-02 | -3.33e-01 | 2.72e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 9 | 8.41e-02 | -3.33e-01 | 3.02e-01 |
| GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION | 5 | 1.98e-01 | -3.32e-01 | 4.78e-01 |
| GOBP FOLIC ACID METABOLIC PROCESS | 15 | 2.60e-02 | 3.32e-01 | 1.53e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 28 | 2.37e-03 | 3.32e-01 | 3.15e-02 |
| GOBP NEUTROPHIL APOPTOTIC PROCESS | 6 | 1.59e-01 | -3.32e-01 | 4.24e-01 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 30 | 1.68e-03 | -3.31e-01 | 2.44e-02 |
| GOCC FLOTILLIN COMPLEX | 8 | 1.05e-01 | 3.31e-01 | 3.41e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 8 | 1.05e-01 | -3.31e-01 | 3.41e-01 |
| GOBP DENSE CORE GRANULE LOCALIZATION | 5 | 2.01e-01 | 3.31e-01 | 4.80e-01 |
| GOCC SNARE COMPLEX | 40 | 2.99e-04 | 3.31e-01 | 6.91e-03 |
| GOBP UREA CYCLE | 5 | 2.01e-01 | 3.30e-01 | 4.80e-01 |
| GOBP UREA METABOLIC PROCESS | 5 | 2.01e-01 | 3.30e-01 | 4.80e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 34 | 8.61e-04 | -3.30e-01 | 1.51e-02 |
| GOBP EMBRYONIC CLEAVAGE | 7 | 1.30e-01 | -3.30e-01 | 3.82e-01 |
| GOCC CIA COMPLEX | 5 | 2.01e-01 | 3.30e-01 | 4.81e-01 |
| GOBP CDP CHOLINE PATHWAY | 6 | 1.62e-01 | 3.30e-01 | 4.28e-01 |
| GOBP HEART VALVE FORMATION | 7 | 1.31e-01 | 3.30e-01 | 3.82e-01 |
| GOBP DNA CYTOSINE DEAMINATION | 8 | 1.06e-01 | 3.30e-01 | 3.43e-01 |
| GOBP RESPONSE TO SELENIUM ION | 5 | 2.02e-01 | -3.30e-01 | 4.81e-01 |
| GOBP PHOSPHOLIPID EFFLUX | 8 | 1.06e-01 | -3.30e-01 | 3.43e-01 |
| GOBP EOSINOPHIL MEDIATED IMMUNITY | 6 | 1.62e-01 | 3.29e-01 | 4.29e-01 |
| GOBP HISTONE H4 K16 ACETYLATION | 7 | 1.32e-01 | -3.29e-01 | 3.84e-01 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 47 | 9.63e-05 | -3.29e-01 | 2.88e-03 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 14 | 3.32e-02 | -3.29e-01 | 1.79e-01 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST | 5 | 2.03e-01 | -3.29e-01 | 4.83e-01 |
| GOCC INO80 COMPLEX | 15 | 2.76e-02 | 3.29e-01 | 1.60e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 33 | 1.09e-03 | -3.29e-01 | 1.80e-02 |
| GOBP REGULATION OF NEUTROPHIL ACTIVATION | 12 | 4.89e-02 | -3.28e-01 | 2.25e-01 |
| GOBP GMP BIOSYNTHETIC PROCESS | 13 | 4.04e-02 | 3.28e-01 | 2.00e-01 |
| GOMF PEPTIDE ANTIGEN BINDING | 31 | 1.56e-03 | -3.28e-01 | 2.33e-02 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 8 | 1.08e-01 | -3.28e-01 | 3.46e-01 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 17 | 1.92e-02 | -3.28e-01 | 1.28e-01 |
| GOCC PARASPECKLES | 8 | 1.08e-01 | -3.28e-01 | 3.46e-01 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 10 | 7.27e-02 | -3.28e-01 | 2.80e-01 |
| GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 5 | 2.04e-01 | -3.28e-01 | 4.85e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 5 | 2.04e-01 | -3.28e-01 | 4.85e-01 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 7 | 1.33e-01 | 3.28e-01 | 3.86e-01 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 17 | 1.94e-02 | -3.28e-01 | 1.28e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 28 | 2.71e-03 | -3.27e-01 | 3.48e-02 |
| GOBP AXONAL FASCICULATION | 10 | 7.30e-02 | -3.27e-01 | 2.81e-01 |
| GOBP REGULATION OF ENDOSOME SIZE | 13 | 4.11e-02 | 3.27e-01 | 2.02e-01 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 93 | 5.01e-08 | -3.27e-01 | 4.91e-06 |
| GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 14 | 3.41e-02 | -3.27e-01 | 1.82e-01 |
| GOBP CELLULAR EXTRAVASATION | 46 | 1.26e-04 | -3.27e-01 | 3.56e-03 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 41 | 2.95e-04 | -3.27e-01 | 6.85e-03 |
| GOCC EARLY PHAGOSOME | 10 | 7.36e-02 | -3.27e-01 | 2.82e-01 |
| GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.06e-01 | 3.27e-01 | 4.87e-01 |
| GOBP NEUTROPHIL DEGRANULATION | 12 | 5.01e-02 | -3.27e-01 | 2.27e-01 |
| GOCC BRISC COMPLEX | 6 | 1.66e-01 | 3.27e-01 | 4.35e-01 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 7 | 1.35e-01 | -3.26e-01 | 3.88e-01 |
| GOMF INTRACILIARY TRANSPORT PARTICLE B BINDING | 5 | 2.06e-01 | 3.26e-01 | 4.88e-01 |
| GOBP PROSTATE GLAND GROWTH | 6 | 1.66e-01 | -3.26e-01 | 4.35e-01 |
| GOBP RESPONSE TO GLUCAGON | 12 | 5.05e-02 | -3.26e-01 | 2.28e-01 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 15 | 2.88e-02 | -3.26e-01 | 1.64e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX 2 | 5 | 2.08e-01 | 3.25e-01 | 4.89e-01 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 54 | 3.59e-05 | 3.25e-01 | 1.26e-03 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 5 | 2.08e-01 | -3.25e-01 | 4.89e-01 |
| GOBP PODOCYTE CELL MIGRATION | 6 | 1.68e-01 | -3.25e-01 | 4.36e-01 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 32 | 1.47e-03 | 3.25e-01 | 2.24e-02 |
| GOBP DIET INDUCED THERMOGENESIS | 6 | 1.68e-01 | -3.25e-01 | 4.36e-01 |
| GOCC EMC COMPLEX | 10 | 7.53e-02 | 3.25e-01 | 2.86e-01 |
| GOBP AORTA DEVELOPMENT | 36 | 7.51e-04 | -3.25e-01 | 1.35e-02 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 8 | 1.12e-01 | 3.25e-01 | 3.52e-01 |
| GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 6 | 1.69e-01 | -3.24e-01 | 4.38e-01 |
| GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 1.38e-01 | 3.24e-01 | 3.92e-01 |
| GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 5 | 2.10e-01 | 3.24e-01 | 4.92e-01 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 15 | 3.01e-02 | -3.23e-01 | 1.69e-01 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 5 | 2.11e-01 | 3.23e-01 | 4.93e-01 |
| GOCC U5 SNRNP | 19 | 1.47e-02 | 3.23e-01 | 1.07e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 8 | 1.13e-01 | 3.23e-01 | 3.54e-01 |
| GOBP CHITIN METABOLIC PROCESS | 5 | 2.11e-01 | 3.23e-01 | 4.93e-01 |
| GOMF CHITINASE ACTIVITY | 5 | 2.11e-01 | 3.23e-01 | 4.93e-01 |
| GOBP BLEB ASSEMBLY | 10 | 7.70e-02 | -3.23e-01 | 2.89e-01 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 14 | 3.65e-02 | -3.23e-01 | 1.89e-01 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 11 | 6.38e-02 | 3.23e-01 | 2.61e-01 |
| GOCC LSM2 8 COMPLEX | 7 | 1.40e-01 | 3.22e-01 | 3.96e-01 |
| GOBP REGULATION OF HEART GROWTH | 31 | 1.90e-03 | -3.22e-01 | 2.67e-02 |
| GOCC PREFOLDIN COMPLEX | 7 | 1.40e-01 | 3.22e-01 | 3.96e-01 |
| GOBP MECHANOSENSORY BEHAVIOR | 6 | 1.72e-01 | -3.22e-01 | 4.42e-01 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 12 | 5.35e-02 | -3.22e-01 | 2.36e-01 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 21 | 1.07e-02 | -3.22e-01 | 8.65e-02 |
| GOBP FLOOR PLATE DEVELOPMENT | 5 | 2.13e-01 | -3.22e-01 | 4.95e-01 |
| GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 1.41e-01 | -3.22e-01 | 3.98e-01 |
| GOCC MYOSIN FILAMENT | 9 | 9.49e-02 | -3.22e-01 | 3.24e-01 |
| GOMF PROTEASOME BINDING | 16 | 2.61e-02 | 3.21e-01 | 1.54e-01 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 1.41e-01 | -3.21e-01 | 3.98e-01 |
| GOBP SERTOLI CELL DEVELOPMENT | 10 | 7.86e-02 | -3.21e-01 | 2.91e-01 |
| GOBP BASE EXCISION REPAIR GAP FILLING | 13 | 4.50e-02 | -3.21e-01 | 2.14e-01 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 15 | 3.13e-02 | -3.21e-01 | 1.73e-01 |
| GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 6 | 1.74e-01 | -3.21e-01 | 4.45e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 10 | 7.91e-02 | -3.21e-01 | 2.92e-01 |
| GOBP HYPEROSMOTIC SALINITY RESPONSE | 8 | 1.16e-01 | -3.21e-01 | 3.59e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 8 | 1.17e-01 | 3.20e-01 | 3.59e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY | 7 | 1.42e-01 | 3.20e-01 | 4.01e-01 |
| GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 6 | 1.75e-01 | -3.20e-01 | 4.46e-01 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 23 | 7.99e-03 | -3.20e-01 | 7.06e-02 |
| GOMF CYCLASE ACTIVATOR ACTIVITY | 6 | 1.75e-01 | 3.20e-01 | 4.47e-01 |
| GOBP CELLULAR RESPONSE TO X RAY | 7 | 1.43e-01 | -3.19e-01 | 4.03e-01 |
| GOBP REGULATION OF MACROPHAGE PROLIFERATION | 5 | 2.16e-01 | -3.19e-01 | 4.99e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 12 | 5.55e-02 | -3.19e-01 | 2.41e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 10 | 8.05e-02 | -3.19e-01 | 2.95e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 13 | 4.65e-02 | 3.19e-01 | 2.19e-01 |
| GOCC EKC KEOPS COMPLEX | 5 | 2.17e-01 | 3.19e-01 | 5.00e-01 |
| GOBP RESPONSE TO GLYCOPROTEIN | 8 | 1.19e-01 | 3.19e-01 | 3.62e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 25 | 5.85e-03 | 3.19e-01 | 5.68e-02 |
| GOBP TRNA 3 END PROCESSING | 7 | 1.45e-01 | 3.19e-01 | 4.04e-01 |
| GOBP MYOBLAST MIGRATION | 8 | 1.19e-01 | 3.18e-01 | 3.63e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 28 | 3.55e-03 | -3.18e-01 | 4.13e-02 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 22 | 9.79e-03 | -3.18e-01 | 8.13e-02 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 6 | 1.77e-01 | -3.18e-01 | 4.50e-01 |
| GOMF NEUREXIN FAMILY PROTEIN BINDING | 9 | 9.86e-02 | -3.18e-01 | 3.31e-01 |
| GOBP RNA SURVEILLANCE | 17 | 2.33e-02 | 3.18e-01 | 1.43e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 14 | 3.96e-02 | -3.18e-01 | 1.97e-01 |
| GOBP EXPLORATION BEHAVIOR | 13 | 4.74e-02 | -3.18e-01 | 2.21e-01 |
| GOMF CLATHRIN HEAVY CHAIN BINDING | 9 | 9.90e-02 | -3.18e-01 | 3.32e-01 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 43 | 3.15e-04 | -3.18e-01 | 7.17e-03 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 12 | 5.69e-02 | 3.18e-01 | 2.43e-01 |
| GOBP KIDNEY MESENCHYME DEVELOPMENT | 6 | 1.78e-01 | -3.17e-01 | 4.51e-01 |
| GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 6 | 1.78e-01 | -3.17e-01 | 4.51e-01 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 10 | 8.22e-02 | -3.17e-01 | 2.99e-01 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 10 | 8.23e-02 | -3.17e-01 | 2.99e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION | 7 | 1.47e-01 | -3.17e-01 | 4.07e-01 |
| GOBP PROSTAGLANDIN TRANSPORT | 16 | 2.84e-02 | 3.16e-01 | 1.63e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 26 | 5.24e-03 | -3.16e-01 | 5.30e-02 |
| GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY | 7 | 1.47e-01 | -3.16e-01 | 4.07e-01 |
| GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS | 7 | 1.47e-01 | -3.16e-01 | 4.07e-01 |
| GOBP RENAL VESICLE DEVELOPMENT | 7 | 1.47e-01 | -3.16e-01 | 4.07e-01 |
| GOBP THYROID HORMONE GENERATION | 9 | 1.00e-01 | -3.16e-01 | 3.34e-01 |
| GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 10 | 8.34e-02 | 3.16e-01 | 3.01e-01 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 5.80e-02 | -3.16e-01 | 2.46e-01 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 40 | 5.46e-04 | -3.16e-01 | 1.04e-02 |
| GOCC FEMALE PRONUCLEUS | 9 | 1.01e-01 | -3.16e-01 | 3.34e-01 |
| GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 9 | 1.01e-01 | -3.16e-01 | 3.35e-01 |
| GOBP REGULATION OF SENSORY PERCEPTION | 7 | 1.48e-01 | 3.16e-01 | 4.08e-01 |
| GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 6 | 1.81e-01 | -3.16e-01 | 4.55e-01 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 12 | 5.86e-02 | -3.15e-01 | 2.48e-01 |
| GOBP TONGUE MORPHOGENESIS | 6 | 1.82e-01 | -3.15e-01 | 4.56e-01 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 10 | 8.51e-02 | -3.14e-01 | 3.03e-01 |
| GOCC MALE PRONUCLEUS | 7 | 1.50e-01 | -3.14e-01 | 4.11e-01 |
| GOBP REGULATION OF MACROPHAGE FUSION | 5 | 2.24e-01 | -3.14e-01 | 5.07e-01 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 19 | 1.78e-02 | -3.14e-01 | 1.21e-01 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 39 | 6.89e-04 | -3.14e-01 | 1.26e-02 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 17 | 2.50e-02 | -3.14e-01 | 1.50e-01 |
| GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 1.83e-01 | 3.14e-01 | 4.58e-01 |
| GOBP SERTOLI CELL DIFFERENTIATION | 12 | 5.98e-02 | -3.14e-01 | 2.51e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 15 | 3.54e-02 | -3.14e-01 | 1.85e-01 |
| GOBP SCARNA LOCALIZATION TO CAJAL BODY | 5 | 2.25e-01 | 3.14e-01 | 5.09e-01 |
| GOCC DOPAMINERGIC SYNAPSE | 5 | 2.25e-01 | 3.14e-01 | 5.09e-01 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 27 | 4.84e-03 | -3.13e-01 | 5.02e-02 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 11 | 7.20e-02 | 3.13e-01 | 2.79e-01 |
| GOCC PALMITOYLTRANSFERASE COMPLEX | 10 | 8.64e-02 | 3.13e-01 | 3.07e-01 |
| GOBP MACROPHAGE PROLIFERATION | 8 | 1.25e-01 | -3.13e-01 | 3.73e-01 |
| GOBP TAURINE METABOLIC PROCESS | 5 | 2.26e-01 | -3.13e-01 | 5.11e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 15 | 3.62e-02 | 3.12e-01 | 1.88e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 1.85e-01 | -3.12e-01 | 4.60e-01 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 13 | 5.12e-02 | 3.12e-01 | 2.30e-01 |
| GOBP THYMIC T CELL SELECTION | 11 | 7.30e-02 | -3.12e-01 | 2.81e-01 |
| GOMF DEAMINASE ACTIVITY | 24 | 8.11e-03 | 3.12e-01 | 7.12e-02 |
| GOBP UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 5 | 2.27e-01 | 3.12e-01 | 5.12e-01 |
| GOBP PSEUDOURIDINE SYNTHESIS | 18 | 2.21e-02 | 3.12e-01 | 1.38e-01 |
| GOBP HEART GROWTH | 44 | 3.48e-04 | -3.12e-01 | 7.55e-03 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 2.28e-01 | -3.11e-01 | 5.13e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 2.28e-01 | -3.11e-01 | 5.13e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 7 | 1.54e-01 | 3.11e-01 | 4.17e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 23 | 9.84e-03 | -3.11e-01 | 8.15e-02 |
| GOBP PEPTIDYL HISTIDINE MODIFICATION | 8 | 1.28e-01 | 3.11e-01 | 3.78e-01 |
| GOMF RETINOIC ACID BINDING | 5 | 2.29e-01 | -3.11e-01 | 5.14e-01 |
| GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 7 | 1.55e-01 | -3.10e-01 | 4.17e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 1.55e-01 | 3.10e-01 | 4.17e-01 |
| GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 6 | 1.88e-01 | -3.10e-01 | 4.64e-01 |
| GOBP RESPONSE TO ALDOSTERONE | 12 | 6.27e-02 | -3.10e-01 | 2.58e-01 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 11 | 7.47e-02 | -3.10e-01 | 2.85e-01 |
| GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 15 | 3.75e-02 | -3.10e-01 | 1.91e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 3.17e-02 | 3.10e-01 | 1.74e-01 |
| GOMF FATTY ACID LIGASE ACTIVITY | 12 | 6.31e-02 | -3.10e-01 | 2.59e-01 |
| GOBP TETRAPYRROLE CATABOLIC PROCESS | 7 | 1.56e-01 | 3.10e-01 | 4.18e-01 |
| GOCC MIB COMPLEX | 13 | 5.31e-02 | 3.10e-01 | 2.35e-01 |
| GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY | 5 | 2.30e-01 | 3.10e-01 | 5.15e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 12 | 6.35e-02 | -3.09e-01 | 2.60e-01 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 26 | 6.34e-03 | -3.09e-01 | 6.03e-02 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 41 | 6.18e-04 | -3.09e-01 | 1.16e-02 |
| GOBP L PHENYLALANINE METABOLIC PROCESS | 5 | 2.31e-01 | 3.09e-01 | 5.15e-01 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 7 | 1.57e-01 | -3.09e-01 | 4.20e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 8 | 1.31e-01 | 3.09e-01 | 3.82e-01 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 9 | 1.09e-01 | -3.09e-01 | 3.47e-01 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 16 | 3.27e-02 | -3.08e-01 | 1.78e-01 |
| GOBP SEROTONIN UPTAKE | 5 | 2.33e-01 | 3.08e-01 | 5.16e-01 |
| GOBP HYPERSENSITIVITY | 10 | 9.17e-02 | -3.08e-01 | 3.18e-01 |
| GOCC SUPER ELONGATION COMPLEX | 6 | 1.91e-01 | -3.08e-01 | 4.69e-01 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 30 | 3.53e-03 | -3.08e-01 | 4.12e-02 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 42 | 5.59e-04 | -3.08e-01 | 1.06e-02 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 16 | 3.32e-02 | 3.08e-01 | 1.79e-01 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 11 | 7.74e-02 | 3.08e-01 | 2.89e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 18 | 2.40e-02 | 3.07e-01 | 1.46e-01 |
| GOMF HYALURONIC ACID BINDING | 10 | 9.24e-02 | -3.07e-01 | 3.19e-01 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 14 | 4.66e-02 | -3.07e-01 | 2.19e-01 |
| GOBP OVULATION CYCLE PROCESS | 23 | 1.08e-02 | -3.07e-01 | 8.70e-02 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 10 | 9.27e-02 | -3.07e-01 | 3.19e-01 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 97 | 1.77e-07 | 3.07e-01 | 1.38e-05 |
| GOBP ESTABLISHMENT OF SERTOLI CELL BARRIER | 5 | 2.35e-01 | -3.07e-01 | 5.19e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 14 | 4.69e-02 | -3.07e-01 | 2.20e-01 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 16 | 3.37e-02 | -3.07e-01 | 1.81e-01 |
| GOMF I SMAD BINDING | 13 | 5.57e-02 | -3.06e-01 | 2.41e-01 |
| GOBP RESPONSE TO AMYLOID BETA | 33 | 2.32e-03 | -3.06e-01 | 3.11e-02 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 28 | 5.02e-03 | -3.06e-01 | 5.16e-02 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 13 | 5.59e-02 | 3.06e-01 | 2.41e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 14 | 4.73e-02 | -3.06e-01 | 2.21e-01 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 20 | 1.80e-02 | 3.06e-01 | 1.22e-01 |
| GOBP COLLAGEN CATABOLIC PROCESS | 24 | 9.62e-03 | -3.05e-01 | 8.03e-02 |
| GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 6 | 1.95e-01 | 3.05e-01 | 4.73e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 14 | 4.79e-02 | -3.05e-01 | 2.23e-01 |
| GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 7 | 1.62e-01 | 3.05e-01 | 4.29e-01 |
| GOBP 10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS | 5 | 2.38e-01 | 3.05e-01 | 5.23e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL | 8 | 1.35e-01 | -3.05e-01 | 3.89e-01 |
| GOCC AMPHISOME MEMBRANE | 11 | 8.00e-02 | 3.05e-01 | 2.94e-01 |
| GOBP PROTEIN PALMITOYLATION | 26 | 7.17e-03 | 3.05e-01 | 6.55e-02 |
| GOBP FAT PAD DEVELOPMENT | 7 | 1.63e-01 | -3.05e-01 | 4.30e-01 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 16 | 3.51e-02 | -3.04e-01 | 1.84e-01 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 15 | 4.13e-02 | -3.04e-01 | 2.03e-01 |
| GOBP ENDOCARDIUM DEVELOPMENT | 7 | 1.63e-01 | -3.04e-01 | 4.31e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 6 | 1.97e-01 | -3.04e-01 | 4.76e-01 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 20 | 1.86e-02 | -3.04e-01 | 1.25e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 12 | 6.83e-02 | -3.04e-01 | 2.72e-01 |
| GOBP NODAL SIGNALING PATHWAY | 7 | 1.64e-01 | -3.04e-01 | 4.31e-01 |
| GOBP PROTEIN K27 LINKED UBIQUITINATION | 7 | 1.64e-01 | 3.04e-01 | 4.31e-01 |
| GOBP RNA CAPPING | 37 | 1.38e-03 | 3.04e-01 | 2.15e-02 |
| GOBP NEUTROPHIL DIFFERENTIATION | 9 | 1.14e-01 | -3.04e-01 | 3.55e-01 |
| GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 9.63e-02 | -3.04e-01 | 3.26e-01 |
| GOMF LIPOPROTEIN LIPASE ACTIVITY | 6 | 1.98e-01 | -3.04e-01 | 4.77e-01 |
| GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 5 | 2.40e-01 | -3.03e-01 | 5.26e-01 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 23 | 1.19e-02 | -3.03e-01 | 9.22e-02 |
| GOBP MACROPINOCYTOSIS | 10 | 9.71e-02 | -3.03e-01 | 3.28e-01 |
| GOBP PROTEIN LOCALIZATION TO AXON | 5 | 2.41e-01 | -3.03e-01 | 5.28e-01 |
| GOBP CITRULLINE METABOLIC PROCESS | 6 | 1.99e-01 | 3.03e-01 | 4.79e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 16 | 3.62e-02 | 3.02e-01 | 1.88e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 6 | 2.00e-01 | -3.02e-01 | 4.79e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT | 7 | 1.66e-01 | 3.02e-01 | 4.35e-01 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 9 | 1.17e-01 | -3.02e-01 | 3.59e-01 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 11 | 8.28e-02 | -3.02e-01 | 3.00e-01 |
| GOBP TONGUE DEVELOPMENT | 8 | 1.39e-01 | -3.02e-01 | 3.95e-01 |
| GOMF PHOSPHATE ION BINDING | 6 | 2.00e-01 | 3.02e-01 | 4.80e-01 |
| GOBP T CELL TOLERANCE INDUCTION | 9 | 1.17e-01 | -3.02e-01 | 3.59e-01 |
| GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 4.30e-02 | -3.02e-01 | 2.09e-01 |
| GOBP SISTER CHROMATID COHESION | 50 | 2.25e-04 | -3.02e-01 | 5.57e-03 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 8 | 1.39e-01 | -3.02e-01 | 3.96e-01 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 16 | 3.67e-02 | -3.02e-01 | 1.90e-01 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 20 | 1.96e-02 | -3.01e-01 | 1.29e-01 |
| GOCC DYNACTIN COMPLEX | 8 | 1.40e-01 | 3.01e-01 | 3.96e-01 |
| GOBP RESPONSE TO INDOLE 3 METHANOL | 6 | 2.01e-01 | -3.01e-01 | 4.81e-01 |
| GOMF SUMO LIGASE ACTIVITY | 13 | 6.00e-02 | -3.01e-01 | 2.51e-01 |
| GOBP NEGATIVE REGULATION OF FIBRINOLYSIS | 6 | 2.01e-01 | 3.01e-01 | 4.81e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 7 | 1.68e-01 | -3.01e-01 | 4.36e-01 |
| GOCC MICROTUBULE MINUS END | 6 | 2.03e-01 | -3.00e-01 | 4.82e-01 |
| GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.03e-01 | 3.00e-01 | 4.82e-01 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 16 | 3.76e-02 | -3.00e-01 | 1.91e-01 |
| GOCC ATG1 ULK1 KINASE COMPLEX | 6 | 2.03e-01 | 3.00e-01 | 4.83e-01 |
| GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 1.42e-01 | 3.00e-01 | 4.00e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 18 | 2.76e-02 | -3.00e-01 | 1.60e-01 |
| GOBP ISOLEUCINE METABOLIC PROCESS | 7 | 1.70e-01 | 3.00e-01 | 4.39e-01 |
| GOCC PEPTIDASE COMPLEX | 105 | 1.14e-07 | 3.00e-01 | 9.51e-06 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 6 | 2.04e-01 | -3.00e-01 | 4.84e-01 |
| GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY | 15 | 4.45e-02 | 3.00e-01 | 2.13e-01 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 2.04e-01 | -3.00e-01 | 4.84e-01 |
| GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 1.70e-01 | 3.00e-01 | 4.39e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 1.70e-01 | 3.00e-01 | 4.39e-01 |
| GOMF DEMETHYLASE ACTIVITY | 36 | 1.88e-03 | -2.99e-01 | 2.66e-02 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 12 | 7.30e-02 | -2.99e-01 | 2.81e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 15 | 4.51e-02 | 2.99e-01 | 2.14e-01 |
| GOMF ESTROGEN RESPONSE ELEMENT BINDING | 7 | 1.71e-01 | -2.99e-01 | 4.40e-01 |
| GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 1.43e-01 | 2.99e-01 | 4.03e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 23 | 1.32e-02 | -2.99e-01 | 9.88e-02 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 22 | 1.54e-02 | 2.99e-01 | 1.10e-01 |
| GOBP REGULATION OF GONAD DEVELOPMENT | 5 | 2.48e-01 | -2.99e-01 | 5.35e-01 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 284 | 5.77e-18 | 2.98e-01 | 6.22e-15 |
| GOBP RENAL ABSORPTION | 13 | 6.25e-02 | -2.98e-01 | 2.58e-01 |
| GOBP DEPYRIMIDINATION | 8 | 1.44e-01 | 2.98e-01 | 4.04e-01 |
| GOCC PRONUCLEUS | 12 | 7.39e-02 | -2.98e-01 | 2.82e-01 |
| GOCC HOST CELLULAR COMPONENT | 8 | 1.44e-01 | -2.98e-01 | 4.04e-01 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 33 | 3.06e-03 | -2.98e-01 | 3.76e-02 |
| GOBP MICROGLIAL CELL MIGRATION | 5 | 2.49e-01 | 2.98e-01 | 5.37e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 24 | 1.16e-02 | 2.98e-01 | 9.06e-02 |
| GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT | 9 | 1.22e-01 | -2.98e-01 | 3.67e-01 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 10 | 1.03e-01 | -2.98e-01 | 3.37e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT | 5 | 2.49e-01 | -2.98e-01 | 5.37e-01 |
| GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 6 | 2.07e-01 | 2.98e-01 | 4.88e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 11 | 8.76e-02 | 2.97e-01 | 3.09e-01 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 59 | 7.86e-05 | -2.97e-01 | 2.44e-03 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 55 | 1.38e-04 | -2.97e-01 | 3.83e-03 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 10 | 1.04e-01 | 2.97e-01 | 3.38e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE MATURATION | 6 | 2.07e-01 | -2.97e-01 | 4.89e-01 |
| GOBP RELAXATION OF SMOOTH MUSCLE | 7 | 1.73e-01 | -2.97e-01 | 4.45e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 39 | 1.34e-03 | -2.97e-01 | 2.09e-02 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 6 | 2.08e-01 | 2.97e-01 | 4.89e-01 |
| GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY | 8 | 1.46e-01 | -2.97e-01 | 4.06e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 17 | 3.44e-02 | 2.96e-01 | 1.83e-01 |
| GOBP KINETOCHORE ASSEMBLY | 17 | 3.44e-02 | -2.96e-01 | 1.83e-01 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 35 | 2.44e-03 | 2.96e-01 | 3.21e-02 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 14 | 5.51e-02 | -2.96e-01 | 2.40e-01 |
| GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.52e-01 | -2.96e-01 | 5.41e-01 |
| GOBP RESPONSE TO LEUCINE | 12 | 7.61e-02 | -2.96e-01 | 2.87e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 1.76e-01 | 2.96e-01 | 4.47e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 5 | 2.52e-01 | -2.96e-01 | 5.41e-01 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 10 | 1.06e-01 | -2.95e-01 | 3.42e-01 |
| GOBP REGULATION OF B CELL PROLIFERATION | 47 | 4.61e-04 | -2.95e-01 | 9.28e-03 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 10 | 1.06e-01 | 2.95e-01 | 3.42e-01 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 22 | 1.65e-02 | -2.95e-01 | 1.16e-01 |
| GOBP RESPONSE TO ACTINOMYCIN D | 5 | 2.53e-01 | 2.95e-01 | 5.42e-01 |
| GOBP MYOFIBROBLAST DIFFERENTIATION | 9 | 1.26e-01 | -2.95e-01 | 3.74e-01 |
| GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 6 | 2.11e-01 | -2.95e-01 | 4.93e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 29 | 6.00e-03 | -2.95e-01 | 5.79e-02 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 7 | 1.77e-01 | -2.95e-01 | 4.49e-01 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 9 | 1.26e-01 | 2.95e-01 | 3.74e-01 |
| GOCC ENDOLYSOSOME LUMEN | 5 | 2.54e-01 | -2.95e-01 | 5.42e-01 |
| GOBP ENERGY HOMEOSTASIS | 49 | 3.59e-04 | -2.95e-01 | 7.69e-03 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 6 | 2.11e-01 | 2.95e-01 | 4.94e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 6 | 2.11e-01 | 2.95e-01 | 4.94e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 10 | 1.07e-01 | 2.95e-01 | 3.44e-01 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 11 | 9.11e-02 | -2.94e-01 | 3.17e-01 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 15 | 4.86e-02 | 2.94e-01 | 2.24e-01 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 57 | 1.25e-04 | -2.94e-01 | 3.56e-03 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 9.15e-02 | -2.94e-01 | 3.18e-01 |
| GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 8 | 1.50e-01 | -2.94e-01 | 4.11e-01 |
| GOBP REGULATION OF LYSOSOME SIZE | 8 | 1.50e-01 | 2.94e-01 | 4.11e-01 |
| GOCC BORC COMPLEX | 8 | 1.50e-01 | 2.94e-01 | 4.11e-01 |
| GOBP MACROPHAGE ACTIVATION | 76 | 9.94e-06 | -2.93e-01 | 4.18e-04 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 12 | 7.86e-02 | 2.93e-01 | 2.91e-01 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 73 | 1.52e-05 | -2.93e-01 | 6.02e-04 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 11 | 9.26e-02 | 2.93e-01 | 3.19e-01 |
| GOBP COLLAGEN METABOLIC PROCESS | 56 | 1.52e-04 | -2.93e-01 | 4.15e-03 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 2.39e-03 | 2.93e-01 | 3.17e-02 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 24 | 1.31e-02 | -2.93e-01 | 9.86e-02 |
| GOBP FEMALE MEIOSIS I | 9 | 1.29e-01 | -2.93e-01 | 3.79e-01 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 23 | 1.52e-02 | -2.92e-01 | 1.09e-01 |
| GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 5 | 2.58e-01 | -2.92e-01 | 5.47e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 14 | 5.86e-02 | 2.92e-01 | 2.48e-01 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 9 | 1.29e-01 | 2.92e-01 | 3.80e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 1.81e-01 | -2.92e-01 | 4.56e-01 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 18 | 3.21e-02 | -2.92e-01 | 1.76e-01 |
| GOMF CERAMIDE BINDING | 15 | 5.07e-02 | 2.92e-01 | 2.29e-01 |
| GOMF DEAD H BOX RNA HELICASE BINDING | 7 | 1.82e-01 | -2.91e-01 | 4.57e-01 |
| GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 12 | 8.09e-02 | -2.91e-01 | 2.96e-01 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 13 | 6.93e-02 | 2.91e-01 | 2.74e-01 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 33 | 3.83e-03 | -2.91e-01 | 4.37e-02 |
| GOCC IKAPPAB KINASE COMPLEX | 5 | 2.60e-01 | -2.91e-01 | 5.50e-01 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 17 | 3.79e-02 | 2.91e-01 | 1.93e-01 |
| GOBP MITOCHONDRIAL FUSION | 32 | 4.41e-03 | 2.91e-01 | 4.77e-02 |
| GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 5 | 2.60e-01 | 2.91e-01 | 5.50e-01 |
| GOMF FERROUS IRON BINDING | 19 | 2.83e-02 | 2.91e-01 | 1.63e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 11 | 9.51e-02 | -2.91e-01 | 3.24e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 20 | 2.44e-02 | -2.91e-01 | 1.47e-01 |
| GOBP TRACHEA DEVELOPMENT | 11 | 9.52e-02 | -2.91e-01 | 3.24e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 9 | 1.31e-01 | 2.91e-01 | 3.83e-01 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 6 | 2.18e-01 | -2.91e-01 | 5.01e-01 |
| GOBP POSITIVE REGULATION OF PINOCYTOSIS | 6 | 2.18e-01 | -2.90e-01 | 5.01e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 2.18e-01 | -2.90e-01 | 5.01e-01 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 2.61e-01 | -2.90e-01 | 5.51e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 1.55e-01 | 2.90e-01 | 4.18e-01 |
| GOBP BILE ACID SECRETION | 6 | 2.19e-01 | 2.90e-01 | 5.01e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 9 | 1.32e-01 | -2.90e-01 | 3.84e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 2.62e-01 | -2.90e-01 | 5.52e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 5 | 2.62e-01 | -2.90e-01 | 5.52e-01 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 33 | 3.97e-03 | -2.90e-01 | 4.47e-02 |
| GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 2.62e-01 | -2.90e-01 | 5.52e-01 |
| GOBP CGMP MEDIATED SIGNALING | 13 | 7.05e-02 | -2.90e-01 | 2.76e-01 |
| GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 10 | 1.13e-01 | 2.90e-01 | 3.53e-01 |
| GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY | 6 | 2.19e-01 | -2.90e-01 | 5.03e-01 |
| GOCC COPI COATED VESICLE MEMBRANE | 17 | 3.88e-02 | 2.89e-01 | 1.95e-01 |
| GOBP GLYCINE METABOLIC PROCESS | 10 | 1.13e-01 | 2.89e-01 | 3.53e-01 |
| GOCC JUXTAPARANODE REGION OF AXON | 9 | 1.33e-01 | -2.89e-01 | 3.85e-01 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 18 | 3.36e-02 | 2.89e-01 | 1.80e-01 |
| GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 6 | 2.20e-01 | -2.89e-01 | 5.03e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 10 | 1.13e-01 | 2.89e-01 | 3.54e-01 |
| GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 1.57e-01 | -2.89e-01 | 4.20e-01 |
| GOBP UTP METABOLIC PROCESS | 10 | 1.13e-01 | 2.89e-01 | 3.54e-01 |
| GOBP MALATE METABOLIC PROCESS | 7 | 1.85e-01 | 2.89e-01 | 4.60e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 8 | 1.57e-01 | -2.89e-01 | 4.20e-01 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 11 | 9.71e-02 | -2.89e-01 | 3.28e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 15 | 5.28e-02 | -2.89e-01 | 2.34e-01 |
| GOMF OXIDIZED DNA BINDING | 10 | 1.14e-01 | -2.89e-01 | 3.54e-01 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 11 | 9.72e-02 | -2.89e-01 | 3.28e-01 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 19 | 2.94e-02 | 2.89e-01 | 1.66e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 10 | 1.14e-01 | -2.89e-01 | 3.55e-01 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 11 | 9.74e-02 | -2.89e-01 | 3.29e-01 |
| GOBP POLYPRENOL METABOLIC PROCESS | 23 | 1.66e-02 | 2.89e-01 | 1.16e-01 |
| GOBP SNRNA CATABOLIC PROCESS | 5 | 2.64e-01 | -2.89e-01 | 5.54e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 24 | 1.45e-02 | 2.88e-01 | 1.05e-01 |
| GOBP CARNITINE TRANSPORT | 6 | 2.21e-01 | 2.88e-01 | 5.05e-01 |
| GOBP DEFINITIVE HEMOPOIESIS | 12 | 8.39e-02 | -2.88e-01 | 3.01e-01 |
| GOBP FACIAL NERVE MORPHOGENESIS | 6 | 2.22e-01 | -2.88e-01 | 5.05e-01 |
| GOBP CELLULAR RESPONSE TO POTASSIUM ION | 8 | 1.58e-01 | -2.88e-01 | 4.23e-01 |
| GOBP ASTROCYTE CELL MIGRATION | 6 | 2.23e-01 | 2.88e-01 | 5.07e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 2.23e-01 | -2.88e-01 | 5.07e-01 |
| GOCC SEH1 ASSOCIATED COMPLEX | 8 | 1.59e-01 | 2.88e-01 | 4.24e-01 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 10 | 1.16e-01 | -2.87e-01 | 3.57e-01 |
| GOCC R2TP COMPLEX | 5 | 2.66e-01 | 2.87e-01 | 5.56e-01 |
| GOBP SUPEROXIDE ANION GENERATION | 25 | 1.30e-02 | -2.87e-01 | 9.80e-02 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 10 | 1.16e-01 | -2.87e-01 | 3.58e-01 |
| GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 2.24e-01 | 2.87e-01 | 5.07e-01 |
| GOCC CELL POLE | 5 | 2.67e-01 | 2.87e-01 | 5.57e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 10 | 1.16e-01 | -2.87e-01 | 3.59e-01 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 16 | 4.72e-02 | 2.87e-01 | 2.21e-01 |
| GOBP HEART TRABECULA FORMATION | 8 | 1.61e-01 | 2.86e-01 | 4.27e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION | 5 | 2.67e-01 | 2.86e-01 | 5.57e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING | 5 | 2.67e-01 | 2.86e-01 | 5.57e-01 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 7 | 1.90e-01 | 2.86e-01 | 4.66e-01 |
| GOBP RENAL SODIUM ION ABSORPTION | 7 | 1.90e-01 | -2.86e-01 | 4.66e-01 |
| GOBP RENAL SODIUM ION TRANSPORT | 7 | 1.90e-01 | -2.86e-01 | 4.66e-01 |
| GOCC ATG12 ATG5 ATG16 COMPLEX | 5 | 2.67e-01 | 2.86e-01 | 5.57e-01 |
| GOBP CGMP METABOLIC PROCESS | 9 | 1.37e-01 | -2.86e-01 | 3.92e-01 |
| GOCC POLYSOMAL RIBOSOME | 30 | 6.71e-03 | -2.86e-01 | 6.28e-02 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 34 | 3.91e-03 | 2.86e-01 | 4.45e-02 |
| GOMF ANTIGEN BINDING | 50 | 4.71e-04 | -2.86e-01 | 9.42e-03 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 29 | 7.74e-03 | -2.86e-01 | 6.92e-02 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 26 | 1.17e-02 | 2.86e-01 | 9.13e-02 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 13 | 7.46e-02 | 2.86e-01 | 2.84e-01 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 11 | 1.01e-01 | -2.85e-01 | 3.35e-01 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 12 | 8.69e-02 | -2.85e-01 | 3.08e-01 |
| GOCC AP 2 ADAPTOR COMPLEX | 7 | 1.91e-01 | 2.85e-01 | 4.68e-01 |
| GOBP CELLULAR RESPONSE TO ETHANOL | 10 | 1.18e-01 | -2.85e-01 | 3.62e-01 |
| GOBP INTESTINAL CHOLESTEROL ABSORPTION | 6 | 2.26e-01 | 2.85e-01 | 5.11e-01 |
| GOBP LIPID DIGESTION | 6 | 2.26e-01 | 2.85e-01 | 5.11e-01 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 16 | 4.82e-02 | -2.85e-01 | 2.24e-01 |
| GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 7 | 1.92e-01 | -2.85e-01 | 4.69e-01 |
| GOBP REGULATION OF RESPIRATORY BURST | 12 | 8.74e-02 | -2.85e-01 | 3.09e-01 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 17 | 4.20e-02 | -2.85e-01 | 2.05e-01 |
| GOBP CELL FATE SPECIFICATION | 32 | 5.30e-03 | -2.85e-01 | 5.33e-02 |
| GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 6 | 2.27e-01 | -2.85e-01 | 5.12e-01 |
| GOBP DE NOVO PROTEIN FOLDING | 39 | 2.11e-03 | 2.85e-01 | 2.90e-02 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 11 | 1.03e-01 | -2.84e-01 | 3.37e-01 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 21 | 2.42e-02 | 2.84e-01 | 1.46e-01 |
| GOBP TRANSPORT OF VIRUS | 19 | 3.21e-02 | -2.84e-01 | 1.76e-01 |
| GOBP INTRACELLULAR TRANSPORT OF VIRUS | 9 | 1.40e-01 | -2.84e-01 | 3.97e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 11 | 1.03e-01 | 2.84e-01 | 3.37e-01 |
| GOBP POSITIVE REGULATION OF TISSUE REMODELING | 7 | 1.93e-01 | -2.84e-01 | 4.71e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 34 | 4.18e-03 | 2.84e-01 | 4.59e-02 |
| GOBP RENAL WATER HOMEOSTASIS | 9 | 1.40e-01 | -2.84e-01 | 3.98e-01 |
| GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 10 | 1.20e-01 | -2.84e-01 | 3.65e-01 |
| GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY | 5 | 2.72e-01 | 2.84e-01 | 5.63e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 5 | 2.73e-01 | -2.83e-01 | 5.63e-01 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 22 | 2.16e-02 | -2.83e-01 | 1.36e-01 |
| GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS | 5 | 2.73e-01 | 2.83e-01 | 5.64e-01 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 10 | 1.21e-01 | -2.83e-01 | 3.67e-01 |
| GOBP IMMUNOLOGICAL MEMORY PROCESS | 13 | 7.74e-02 | -2.83e-01 | 2.89e-01 |
| GOBP RESPONSE TO COBALT ION | 10 | 1.22e-01 | -2.83e-01 | 3.67e-01 |
| GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 6 | 2.31e-01 | 2.82e-01 | 5.15e-01 |
| GOBP INTERLEUKIN 13 PRODUCTION | 12 | 9.05e-02 | -2.82e-01 | 3.16e-01 |
| GOBP DENDRITE SELF AVOIDANCE | 6 | 2.31e-01 | -2.82e-01 | 5.15e-01 |
| GOCC KERATIN FILAMENT | 9 | 1.43e-01 | 2.82e-01 | 4.02e-01 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 14 | 6.76e-02 | -2.82e-01 | 2.70e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 33 | 5.07e-03 | 2.82e-01 | 5.20e-02 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 2.75e-01 | -2.82e-01 | 5.65e-01 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 226 | 3.11e-13 | -2.82e-01 | 1.12e-10 |
| GOMF PRE MRNA 3 SPLICE SITE BINDING | 5 | 2.75e-01 | -2.82e-01 | 5.65e-01 |
| GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 6 | 2.32e-01 | 2.82e-01 | 5.16e-01 |
| GOCC CATION TRANSPORTING ATPASE COMPLEX | 6 | 2.32e-01 | 2.82e-01 | 5.16e-01 |
| GOBP PROTEIN HYDROXYLATION | 19 | 3.35e-02 | 2.82e-01 | 1.80e-01 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 146 | 4.41e-09 | -2.82e-01 | 6.13e-07 |
| GOCC MAIN AXON | 38 | 2.67e-03 | -2.82e-01 | 3.45e-02 |
| GOCC POLE PLASM | 13 | 7.88e-02 | -2.82e-01 | 2.92e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 14 | 6.82e-02 | -2.82e-01 | 2.71e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 5 | 2.76e-01 | -2.81e-01 | 5.65e-01 |
| GOMF PROTEOGLYCAN BINDING | 19 | 3.38e-02 | -2.81e-01 | 1.81e-01 |
| GOCC GLYCOPROTEIN COMPLEX | 12 | 9.16e-02 | 2.81e-01 | 3.18e-01 |
| GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 2.76e-01 | 2.81e-01 | 5.66e-01 |
| GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 1.06e-01 | -2.81e-01 | 3.43e-01 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 4.50e-02 | 2.81e-01 | 2.14e-01 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 11 | 1.07e-01 | 2.81e-01 | 3.44e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 17 | 4.51e-02 | -2.81e-01 | 2.14e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 13 | 7.98e-02 | -2.81e-01 | 2.94e-01 |
| GOBP HISTONE UBIQUITINATION | 9 | 1.45e-01 | 2.81e-01 | 4.04e-01 |
| GOBP LIPOPHAGY | 7 | 1.99e-01 | 2.81e-01 | 4.78e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 29 | 8.95e-03 | 2.81e-01 | 7.65e-02 |
| GOBP CLATHRIN COAT ASSEMBLY | 12 | 9.27e-02 | -2.80e-01 | 3.19e-01 |
| GOBP SECONDARY PALATE DEVELOPMENT | 11 | 1.07e-01 | -2.80e-01 | 3.45e-01 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 33 | 5.34e-03 | -2.80e-01 | 5.35e-02 |
| GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 9 | 1.46e-01 | -2.80e-01 | 4.05e-01 |
| GOBP MITOCHONDRION MORPHOGENESIS | 19 | 3.46e-02 | 2.80e-01 | 1.83e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 25 | 1.54e-02 | -2.80e-01 | 1.10e-01 |
| GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 6 | 2.35e-01 | 2.80e-01 | 5.19e-01 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 2.79e-01 | 2.80e-01 | 5.68e-01 |
| GOBP PULMONARY VALVE DEVELOPMENT | 14 | 7.01e-02 | -2.80e-01 | 2.76e-01 |
| GOMF 14 3 3 PROTEIN BINDING | 28 | 1.05e-02 | -2.80e-01 | 8.53e-02 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 46 | 1.07e-03 | -2.79e-01 | 1.77e-02 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 12 | 9.43e-02 | 2.79e-01 | 3.23e-01 |
| GOBP STRESS GRANULE DISASSEMBLY | 5 | 2.80e-01 | 2.79e-01 | 5.70e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 8.20e-02 | 2.79e-01 | 2.99e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 23 | 2.08e-02 | -2.78e-01 | 1.34e-01 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 22 | 2.38e-02 | -2.78e-01 | 1.45e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 11 | 1.10e-01 | -2.78e-01 | 3.48e-01 |
| GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 7 | 2.02e-01 | -2.78e-01 | 4.82e-01 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 8 | 1.73e-01 | -2.78e-01 | 4.44e-01 |
| GOMF PROTEIN ANTIGEN BINDING | 5 | 2.81e-01 | -2.78e-01 | 5.71e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 5 | 2.82e-01 | -2.78e-01 | 5.71e-01 |
| GOBP PROSTHETIC GROUP METABOLIC PROCESS | 5 | 2.82e-01 | 2.78e-01 | 5.71e-01 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 14 | 7.18e-02 | -2.78e-01 | 2.79e-01 |
| GOMF ICOSANOID RECEPTOR ACTIVITY | 7 | 2.03e-01 | -2.78e-01 | 4.83e-01 |
| GOMF LYSINE ACETYLATED HISTONE BINDING | 22 | 2.41e-02 | -2.78e-01 | 1.46e-01 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 30 | 8.47e-03 | 2.78e-01 | 7.33e-02 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 9 | 1.49e-01 | -2.78e-01 | 4.10e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 33 | 5.80e-03 | -2.78e-01 | 5.66e-02 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 14 | 7.23e-02 | -2.77e-01 | 2.80e-01 |
| GOBP RESPIRATORY BURST | 30 | 8.59e-03 | -2.77e-01 | 7.41e-02 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 55 | 3.78e-04 | 2.77e-01 | 8.01e-03 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 55 | 3.78e-04 | -2.77e-01 | 8.01e-03 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 14 | 7.26e-02 | -2.77e-01 | 2.80e-01 |
| GOBP NEURAL FOLD FORMATION | 5 | 2.83e-01 | -2.77e-01 | 5.73e-01 |
| GOBP ETHANOL METABOLIC PROCESS | 7 | 2.04e-01 | -2.77e-01 | 4.85e-01 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 9 | 1.50e-01 | 2.77e-01 | 4.11e-01 |
| GOMF TRANSLATION ACTIVATOR ACTIVITY | 7 | 2.04e-01 | 2.77e-01 | 4.85e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 43 | 1.69e-03 | -2.77e-01 | 2.44e-02 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 16 | 5.52e-02 | -2.77e-01 | 2.40e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 10 | 1.30e-01 | -2.77e-01 | 3.80e-01 |
| GOBP FOLIC ACID TRANSPORT | 9 | 1.51e-01 | 2.77e-01 | 4.12e-01 |
| GOBP PROSTATE GLAND DEVELOPMENT | 27 | 1.29e-02 | -2.77e-01 | 9.76e-02 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 19 | 3.69e-02 | -2.77e-01 | 1.90e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 2.41e-01 | -2.77e-01 | 5.27e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 8 | 1.76e-01 | -2.77e-01 | 4.47e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 9 | 1.51e-01 | 2.76e-01 | 4.12e-01 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 11 | 1.13e-01 | -2.76e-01 | 3.52e-01 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 17 | 4.89e-02 | -2.76e-01 | 2.25e-01 |
| GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 5 | 2.85e-01 | -2.76e-01 | 5.75e-01 |
| GOCC RIBBON SYNAPSE | 9 | 1.52e-01 | -2.76e-01 | 4.13e-01 |
| GOBP SPERM EGG RECOGNITION | 23 | 2.21e-02 | 2.76e-01 | 1.38e-01 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 6 | 2.43e-01 | -2.75e-01 | 5.29e-01 |
| GOMF DNA INSERTION OR DELETION BINDING | 6 | 2.43e-01 | -2.75e-01 | 5.29e-01 |
| GOMF FILAMIN BINDING | 9 | 1.53e-01 | 2.75e-01 | 4.15e-01 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 36 | 4.31e-03 | -2.75e-01 | 4.69e-02 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 13 | 8.63e-02 | -2.75e-01 | 3.06e-01 |
| GOCC CALYX OF HELD | 9 | 1.54e-01 | 2.75e-01 | 4.16e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 15 | 6.55e-02 | 2.75e-01 | 2.66e-01 |
| GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 2.88e-01 | -2.75e-01 | 5.78e-01 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 49 | 8.92e-04 | -2.74e-01 | 1.55e-02 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 17 | 5.02e-02 | 2.74e-01 | 2.27e-01 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 11 | 1.15e-01 | -2.74e-01 | 3.57e-01 |
| GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY | 9 | 1.54e-01 | -2.74e-01 | 4.17e-01 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 44 | 1.66e-03 | 2.74e-01 | 2.43e-02 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 10 | 1.33e-01 | 2.74e-01 | 3.86e-01 |
| GOMF MITOCHONDRIAL RIBOSOME BINDING | 8 | 1.80e-01 | 2.74e-01 | 4.54e-01 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 67 | 1.07e-04 | 2.74e-01 | 3.15e-03 |
| GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 5 | 2.89e-01 | -2.74e-01 | 5.79e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 29 | 1.07e-02 | 2.74e-01 | 8.67e-02 |
| GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 6 | 2.46e-01 | -2.74e-01 | 5.33e-01 |
| GOMF DYNACTIN BINDING | 10 | 1.34e-01 | -2.74e-01 | 3.87e-01 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 14 | 7.65e-02 | -2.73e-01 | 2.88e-01 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 15 | 6.68e-02 | 2.73e-01 | 2.69e-01 |
| GOCC SMN SM PROTEIN COMPLEX | 17 | 5.11e-02 | 2.73e-01 | 2.30e-01 |
| GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 6 | 2.46e-01 | -2.73e-01 | 5.34e-01 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 29 | 1.09e-02 | -2.73e-01 | 8.73e-02 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 59 | 2.85e-04 | 2.73e-01 | 6.71e-03 |
| GOMF INSULIN RECEPTOR BINDING | 16 | 5.86e-02 | -2.73e-01 | 2.48e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 21 | 3.03e-02 | -2.73e-01 | 1.69e-01 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 18 | 4.51e-02 | -2.73e-01 | 2.14e-01 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 21 | 3.05e-02 | -2.73e-01 | 1.69e-01 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 20 | 3.48e-02 | -2.73e-01 | 1.84e-01 |
| GOBP INOSITOL METABOLIC PROCESS | 7 | 2.12e-01 | -2.73e-01 | 4.94e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 12 | 1.02e-01 | -2.73e-01 | 3.36e-01 |
| GOMF GLUTAMATE RECEPTOR ACTIVITY | 7 | 2.12e-01 | -2.73e-01 | 4.94e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY | 7 | 2.12e-01 | -2.73e-01 | 4.94e-01 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 7 | 2.12e-01 | 2.73e-01 | 4.94e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 21 | 3.07e-02 | -2.72e-01 | 1.70e-01 |
| GOMF INTERLEUKIN 6 RECEPTOR BINDING | 5 | 2.92e-01 | 2.72e-01 | 5.80e-01 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 14 | 7.77e-02 | -2.72e-01 | 2.89e-01 |
| GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 11 | 1.18e-01 | 2.72e-01 | 3.61e-01 |
| GOBP RRNA PSEUDOURIDINE SYNTHESIS | 8 | 1.82e-01 | 2.72e-01 | 4.57e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 14 | 7.80e-02 | -2.72e-01 | 2.90e-01 |
| GOBP THYMUS DEVELOPMENT | 34 | 6.07e-03 | -2.72e-01 | 5.84e-02 |
| GOMF DYNEIN HEAVY CHAIN BINDING | 8 | 1.83e-01 | 2.72e-01 | 4.58e-01 |
| GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY | 6 | 2.49e-01 | -2.72e-01 | 5.37e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 35 | 5.44e-03 | 2.72e-01 | 5.43e-02 |
| GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 6 | 2.50e-01 | 2.71e-01 | 5.37e-01 |
| GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 7 | 2.14e-01 | -2.71e-01 | 4.97e-01 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 18 | 4.64e-02 | -2.71e-01 | 2.19e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 11 | 1.19e-01 | 2.71e-01 | 3.63e-01 |
| GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 8 | 1.84e-01 | -2.71e-01 | 4.59e-01 |
| GOMF SPHINGOLIPID TRANSFER ACTIVITY | 6 | 2.50e-01 | 2.71e-01 | 5.38e-01 |
| GOBP REGULATION OF ODONTOGENESIS | 5 | 2.94e-01 | 2.71e-01 | 5.82e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 24 | 2.16e-02 | -2.71e-01 | 1.36e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 8 | 1.85e-01 | 2.71e-01 | 4.59e-01 |
| GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 7 | 2.15e-01 | -2.71e-01 | 4.98e-01 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 19 | 4.13e-02 | -2.70e-01 | 2.03e-01 |
| GOBP CORPUS CALLOSUM MORPHOGENESIS | 5 | 2.96e-01 | 2.70e-01 | 5.84e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 18 | 4.73e-02 | -2.70e-01 | 2.21e-01 |
| GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX | 5 | 2.96e-01 | 2.70e-01 | 5.84e-01 |
| GOBP MRNA PSEUDOURIDINE SYNTHESIS | 9 | 1.61e-01 | 2.70e-01 | 4.27e-01 |
| GOBP BONE GROWTH | 15 | 7.04e-02 | -2.70e-01 | 2.76e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 11 | 1.22e-01 | 2.70e-01 | 3.67e-01 |
| GOCC MITOCHONDRIAL CRISTA | 6 | 2.53e-01 | 2.70e-01 | 5.42e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 17 | 5.44e-02 | -2.69e-01 | 2.38e-01 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 26 | 1.74e-02 | -2.69e-01 | 1.19e-01 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 31 | 9.45e-03 | 2.69e-01 | 7.95e-02 |
| GOBP ENDODERM FORMATION | 33 | 7.43e-03 | -2.69e-01 | 6.71e-02 |
| GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 7 | 2.17e-01 | -2.69e-01 | 5.00e-01 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 8.13e-02 | 2.69e-01 | 2.97e-01 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 9 | 1.63e-01 | 2.69e-01 | 4.29e-01 |
| GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS | 7 | 2.18e-01 | 2.69e-01 | 5.01e-01 |
| GOBP RESPONSE TO PROGESTERONE | 24 | 2.28e-02 | -2.69e-01 | 1.41e-01 |
| GOMF POLY PURINE TRACT BINDING | 26 | 1.78e-02 | -2.68e-01 | 1.22e-01 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 30 | 1.10e-02 | -2.68e-01 | 8.77e-02 |
| GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 7 | 2.19e-01 | 2.68e-01 | 5.02e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 41 | 2.96e-03 | -2.68e-01 | 3.69e-02 |
| GOCC PLATELET DENSE GRANULE | 13 | 9.40e-02 | -2.68e-01 | 3.22e-01 |
| GOBP TRNA TRANSCRIPTION | 11 | 1.24e-01 | 2.68e-01 | 3.70e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 37 | 4.80e-03 | 2.68e-01 | 4.99e-02 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 5 | 3.00e-01 | 2.68e-01 | 5.87e-01 |
| GOCC GEMINI OF COILED BODIES | 12 | 1.09e-01 | 2.67e-01 | 3.47e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 60 | 3.43e-04 | -2.67e-01 | 7.48e-03 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 100 | 3.91e-06 | -2.67e-01 | 1.90e-04 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 10 | 1.43e-01 | -2.67e-01 | 4.03e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 13 | 9.53e-02 | 2.67e-01 | 3.25e-01 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 9 | 1.65e-01 | 2.67e-01 | 4.33e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 9 | 1.65e-01 | 2.67e-01 | 4.33e-01 |
| GOBP NEUROINFLAMMATORY RESPONSE | 55 | 6.15e-04 | -2.67e-01 | 1.15e-02 |
| GOBP PROLINE METABOLIC PROCESS | 6 | 2.57e-01 | 2.67e-01 | 5.47e-01 |
| GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 7 | 2.21e-01 | -2.67e-01 | 5.04e-01 |
| GOCC AP 1 ADAPTOR COMPLEX | 10 | 1.44e-01 | -2.67e-01 | 4.03e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 17 | 5.67e-02 | 2.67e-01 | 2.43e-01 |
| GOBP ERYTHROCYTE MATURATION | 12 | 1.09e-01 | -2.67e-01 | 3.48e-01 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 12 | 1.10e-01 | -2.67e-01 | 3.48e-01 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 26 | 1.86e-02 | 2.67e-01 | 1.25e-01 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 12 | 1.10e-01 | -2.67e-01 | 3.48e-01 |
| GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H | 5 | 3.02e-01 | 2.67e-01 | 5.90e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 12 | 1.10e-01 | -2.66e-01 | 3.48e-01 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 5 | 3.02e-01 | -2.66e-01 | 5.90e-01 |
| GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION | 15 | 7.41e-02 | 2.66e-01 | 2.83e-01 |
| GOBP RESPONSE TO REDOX STATE | 10 | 1.45e-01 | 2.66e-01 | 4.04e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN STARVATION | 9 | 1.67e-01 | 2.66e-01 | 4.35e-01 |
| GOCC LUMENAL SIDE OF MEMBRANE | 33 | 8.15e-03 | -2.66e-01 | 7.13e-02 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 10 | 1.45e-01 | 2.66e-01 | 4.05e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 7 | 2.23e-01 | -2.66e-01 | 5.07e-01 |
| GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 6 | 2.59e-01 | -2.66e-01 | 5.49e-01 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 58 | 4.64e-04 | -2.66e-01 | 9.33e-03 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 84 | 2.56e-05 | -2.66e-01 | 9.42e-04 |
| GOMF SPHINGOLIPID BINDING | 19 | 4.49e-02 | 2.66e-01 | 2.14e-01 |
| GOCC CILIARY TIP | 37 | 5.18e-03 | 2.66e-01 | 5.27e-02 |
| GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 25 | 2.16e-02 | 2.66e-01 | 1.36e-01 |
| GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 3.04e-01 | 2.65e-01 | 5.92e-01 |
| GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 12 | 1.11e-01 | -2.65e-01 | 3.51e-01 |
| GOMF EPHRIN RECEPTOR BINDING | 19 | 4.53e-02 | -2.65e-01 | 2.15e-01 |
| GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 11 | 1.28e-01 | 2.65e-01 | 3.77e-01 |
| GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 3.04e-01 | 2.65e-01 | 5.92e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 85 | 2.39e-05 | -2.65e-01 | 8.87e-04 |
| GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 10 | 1.46e-01 | -2.65e-01 | 4.07e-01 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 13 | 9.81e-02 | -2.65e-01 | 3.30e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 29 | 1.36e-02 | 2.65e-01 | 1.01e-01 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 12 | 1.12e-01 | 2.65e-01 | 3.52e-01 |
| GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 8 | 1.95e-01 | -2.65e-01 | 4.72e-01 |
| GOBP POLYAMINE TRANSPORT | 12 | 1.12e-01 | 2.65e-01 | 3.52e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 9 | 1.69e-01 | 2.65e-01 | 4.39e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 9 | 1.69e-01 | 2.64e-01 | 4.39e-01 |
| GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 13 | 9.92e-02 | 2.64e-01 | 3.32e-01 |
| GOBP CRISTAE FORMATION | 17 | 5.95e-02 | 2.64e-01 | 2.50e-01 |
| GOBP RNA 5 END PROCESSING | 22 | 3.21e-02 | 2.64e-01 | 1.76e-01 |
| GOMF TOLL LIKE RECEPTOR BINDING | 13 | 9.93e-02 | -2.64e-01 | 3.32e-01 |
| GOBP UBIQUINONE METABOLIC PROCESS | 19 | 4.64e-02 | 2.64e-01 | 2.19e-01 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 13 | 9.94e-02 | -2.64e-01 | 3.32e-01 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 12 | 1.13e-01 | -2.64e-01 | 3.54e-01 |
| GOMF FLAP ENDONUCLEASE ACTIVITY | 6 | 2.63e-01 | -2.64e-01 | 5.53e-01 |
| GOCC COPI VESICLE COAT | 13 | 9.96e-02 | 2.64e-01 | 3.33e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 49 | 1.42e-03 | -2.64e-01 | 2.18e-02 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 33 | 8.79e-03 | -2.64e-01 | 7.56e-02 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 10 | 1.49e-01 | -2.63e-01 | 4.10e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 30 | 1.26e-02 | -2.63e-01 | 9.62e-02 |
| GOBP RRNA METHYLATION | 22 | 3.27e-02 | 2.63e-01 | 1.78e-01 |
| GOBP MITRAL VALVE DEVELOPMENT | 9 | 1.72e-01 | -2.63e-01 | 4.42e-01 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 43 | 2.85e-03 | -2.63e-01 | 3.60e-02 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 25 | 2.30e-02 | 2.63e-01 | 1.42e-01 |
| GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 6 | 2.65e-01 | -2.63e-01 | 5.55e-01 |
| GOMF TOLL LIKE RECEPTOR 4 BINDING | 5 | 3.09e-01 | -2.63e-01 | 5.98e-01 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 10 | 1.51e-01 | -2.63e-01 | 4.12e-01 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 13 | 1.01e-01 | 2.62e-01 | 3.36e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 16 | 6.93e-02 | 2.62e-01 | 2.74e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 18 | 5.40e-02 | -2.62e-01 | 2.37e-01 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 17 | 6.12e-02 | -2.62e-01 | 2.55e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 7 | 2.30e-01 | -2.62e-01 | 5.15e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 6 | 2.66e-01 | -2.62e-01 | 5.57e-01 |
| GOMF RETROMER COMPLEX BINDING | 9 | 1.74e-01 | 2.62e-01 | 4.45e-01 |
| GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 9 | 1.74e-01 | -2.62e-01 | 4.45e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX | 6 | 2.67e-01 | 2.62e-01 | 5.57e-01 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 34 | 8.25e-03 | -2.62e-01 | 7.19e-02 |
| GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 11 | 1.33e-01 | -2.62e-01 | 3.85e-01 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 74 | 9.96e-05 | -2.62e-01 | 2.96e-03 |
| GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 7 | 2.31e-01 | -2.62e-01 | 5.15e-01 |
| GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT | 7 | 2.31e-01 | -2.62e-01 | 5.15e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 10 | 1.52e-01 | 2.62e-01 | 4.13e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 8 | 2.00e-01 | 2.62e-01 | 4.80e-01 |
| GOMF PHOSPHATIDYLSERINE BINDING | 37 | 5.92e-03 | -2.62e-01 | 5.73e-02 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 10 | 1.52e-01 | -2.62e-01 | 4.14e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 49 | 1.55e-03 | 2.61e-01 | 2.33e-02 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 14 | 9.06e-02 | -2.61e-01 | 3.16e-01 |
| GOMF TESTOSTERONE 17 BETA DEHYDROGENASE NADPPLUS ACTIVITY | 6 | 2.68e-01 | 2.61e-01 | 5.57e-01 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 21 | 3.84e-02 | 2.61e-01 | 1.93e-01 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 25 | 2.39e-02 | -2.61e-01 | 1.45e-01 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 13 | 1.03e-01 | -2.61e-01 | 3.37e-01 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 33 | 9.51e-03 | -2.61e-01 | 7.98e-02 |
| GOMF MICROTUBULE PLUS END BINDING | 19 | 4.90e-02 | -2.61e-01 | 2.25e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 8 | 2.01e-01 | -2.61e-01 | 4.81e-01 |
| GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 6 | 2.69e-01 | -2.61e-01 | 5.58e-01 |
| GOBP INTERLEUKIN 12 PRODUCTION | 48 | 1.80e-03 | -2.61e-01 | 2.55e-02 |
| GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION | 11 | 1.35e-01 | -2.61e-01 | 3.88e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 19 | 4.95e-02 | -2.60e-01 | 2.26e-01 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 1.54e-01 | 2.60e-01 | 4.17e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 66 | 2.61e-04 | -2.60e-01 | 6.24e-03 |
| GOBP IMP BIOSYNTHETIC PROCESS | 10 | 1.55e-01 | 2.60e-01 | 4.17e-01 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 11 | 1.35e-01 | -2.60e-01 | 3.89e-01 |
| GOBP MAST CELL MIGRATION | 10 | 1.55e-01 | -2.60e-01 | 4.17e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 7 | 2.34e-01 | 2.60e-01 | 5.18e-01 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 8 | 2.03e-01 | -2.60e-01 | 4.83e-01 |
| GOMF MYOSIN HEAVY CHAIN BINDING | 6 | 2.71e-01 | 2.60e-01 | 5.60e-01 |
| GOMF CHITIN BINDING | 6 | 2.71e-01 | 2.60e-01 | 5.60e-01 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 40 | 4.53e-03 | -2.59e-01 | 4.83e-02 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 23 | 3.13e-02 | -2.59e-01 | 1.73e-01 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 43 | 3.26e-03 | 2.59e-01 | 3.92e-02 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 84 | 4.05e-05 | -2.59e-01 | 1.40e-03 |
| GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 20 | 4.49e-02 | 2.59e-01 | 2.14e-01 |
| GOBP RRNA MODIFICATION | 31 | 1.25e-02 | 2.59e-01 | 9.59e-02 |
| GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 8 | 2.05e-01 | -2.59e-01 | 4.85e-01 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 8 | 2.05e-01 | -2.59e-01 | 4.85e-01 |
| GOBP ESTROGEN BIOSYNTHETIC PROCESS | 7 | 2.36e-01 | -2.59e-01 | 5.20e-01 |
| GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 5 | 3.17e-01 | 2.59e-01 | 6.06e-01 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 15 | 8.29e-02 | -2.59e-01 | 3.00e-01 |
| GOBP REGULATION OF HYPERSENSITIVITY | 8 | 2.06e-01 | -2.58e-01 | 4.87e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 12 | 1.21e-01 | 2.58e-01 | 3.67e-01 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 36 | 7.34e-03 | -2.58e-01 | 6.66e-02 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 10 | 1.58e-01 | 2.58e-01 | 4.21e-01 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 24 | 2.86e-02 | -2.58e-01 | 1.64e-01 |
| GOBP LACTATE TRANSMEMBRANE TRANSPORT | 5 | 3.18e-01 | -2.58e-01 | 6.07e-01 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 19 | 5.16e-02 | 2.58e-01 | 2.31e-01 |
| GOCC CTF18 RFC LIKE COMPLEX | 6 | 2.74e-01 | -2.58e-01 | 5.64e-01 |
| GOBP ASTROCYTE ACTIVATION | 15 | 8.38e-02 | -2.58e-01 | 3.01e-01 |
| GOBP SYNAPSE PRUNING | 8 | 2.07e-01 | -2.58e-01 | 4.88e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 7 | 2.38e-01 | -2.58e-01 | 5.23e-01 |
| GOBP NEUROTRANSMITTER REUPTAKE | 13 | 1.08e-01 | 2.58e-01 | 3.45e-01 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 39 | 5.39e-03 | 2.58e-01 | 5.38e-02 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 2.58e-02 | 2.58e-01 | 1.53e-01 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 12 | 1.22e-01 | 2.58e-01 | 3.68e-01 |
| GOBP NEURON REMODELING | 7 | 2.38e-01 | -2.57e-01 | 5.24e-01 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 29 | 1.64e-02 | 2.57e-01 | 1.15e-01 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 9 | 1.81e-01 | -2.57e-01 | 4.56e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 9 | 1.81e-01 | -2.57e-01 | 4.56e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 21 | 4.13e-02 | -2.57e-01 | 2.03e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 9 | 1.82e-01 | -2.57e-01 | 4.56e-01 |
| GOMF DNA HELICASE ACTIVITY | 54 | 1.08e-03 | -2.57e-01 | 1.79e-02 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 6 | 2.75e-01 | -2.57e-01 | 5.65e-01 |
| GOMF U2 SNRNA BINDING | 6 | 2.75e-01 | 2.57e-01 | 5.65e-01 |
| GOBP RESPONSE TO CORTICOSTEROID | 86 | 3.83e-05 | -2.57e-01 | 1.33e-03 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 8 | 2.08e-01 | -2.57e-01 | 4.89e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 23 | 3.30e-02 | -2.57e-01 | 1.79e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 20 | 4.67e-02 | -2.57e-01 | 2.20e-01 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 28 | 1.87e-02 | 2.57e-01 | 1.25e-01 |
| GOBP HISTONE METHYLATION | 34 | 9.60e-03 | -2.57e-01 | 8.03e-02 |
| GOCC LSM1 7 PAT1 COMPLEX | 5 | 3.20e-01 | 2.57e-01 | 6.09e-01 |
| GOCC DENDRITIC SHAFT | 23 | 3.32e-02 | -2.57e-01 | 1.79e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 5 | 3.21e-01 | -2.56e-01 | 6.09e-01 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 19 | 5.32e-02 | -2.56e-01 | 2.35e-01 |
| GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS | 5 | 3.21e-01 | -2.56e-01 | 6.10e-01 |
| GOBP P38MAPK CASCADE | 44 | 3.33e-03 | -2.56e-01 | 3.98e-02 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 11 | 1.42e-01 | -2.56e-01 | 4.00e-01 |
| GOMF ARP2 3 COMPLEX BINDING | 12 | 1.25e-01 | -2.56e-01 | 3.73e-01 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 17 | 6.80e-02 | 2.56e-01 | 2.71e-01 |
| GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 6 | 2.78e-01 | -2.56e-01 | 5.68e-01 |
| GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 6 | 2.78e-01 | 2.56e-01 | 5.68e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 111 | 3.39e-06 | -2.55e-01 | 1.67e-04 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 8 | 2.11e-01 | 2.55e-01 | 4.93e-01 |
| GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.42e-01 | 2.55e-01 | 5.29e-01 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 27 | 2.17e-02 | -2.55e-01 | 1.36e-01 |
| GOBP RESPONSE TO UV B | 16 | 7.70e-02 | -2.55e-01 | 2.89e-01 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 70 | 2.23e-04 | -2.55e-01 | 5.56e-03 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 16 | 7.71e-02 | -2.55e-01 | 2.89e-01 |
| GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 5 | 3.23e-01 | -2.55e-01 | 6.10e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 2.79e-01 | 2.55e-01 | 5.68e-01 |
| GOBP MICROGLIAL CELL PROLIFERATION | 5 | 3.23e-01 | -2.55e-01 | 6.10e-01 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 20 | 4.82e-02 | 2.55e-01 | 2.24e-01 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 18 | 6.10e-02 | -2.55e-01 | 2.55e-01 |
| GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 2.79e-01 | 2.55e-01 | 5.68e-01 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 47 | 2.51e-03 | 2.55e-01 | 3.28e-02 |
| GOCC GID COMPLEX | 5 | 3.24e-01 | -2.55e-01 | 6.11e-01 |
| GOBP PROTEIN NEDDYLATION | 27 | 2.20e-02 | 2.55e-01 | 1.38e-01 |
| GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 9 | 1.86e-01 | -2.55e-01 | 4.61e-01 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 10 | 1.63e-01 | -2.55e-01 | 4.31e-01 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 30 | 1.59e-02 | 2.54e-01 | 1.13e-01 |
| GOMF S100 PROTEIN BINDING | 12 | 1.27e-01 | -2.54e-01 | 3.77e-01 |
| GOBP FEVER GENERATION | 7 | 2.44e-01 | 2.54e-01 | 5.30e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 11 | 1.45e-01 | -2.54e-01 | 4.04e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 5 | 3.26e-01 | -2.54e-01 | 6.13e-01 |
| GOCC GROWTH CONE MEMBRANE | 5 | 3.26e-01 | 2.54e-01 | 6.13e-01 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 21 | 4.43e-02 | -2.54e-01 | 2.13e-01 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 8 | 2.14e-01 | -2.54e-01 | 4.97e-01 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 8 | 2.14e-01 | -2.54e-01 | 4.97e-01 |
| GOBP RESPONSE TO CAMP | 52 | 1.57e-03 | -2.54e-01 | 2.34e-02 |
| GOBP REGULATION OF RRNA PROCESSING | 16 | 7.92e-02 | 2.53e-01 | 2.93e-01 |
| GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 8 | 2.14e-01 | -2.53e-01 | 4.97e-01 |
| GOBP TYROSINE METABOLIC PROCESS | 7 | 2.46e-01 | 2.53e-01 | 5.33e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 33 | 1.18e-02 | -2.53e-01 | 9.17e-02 |
| GOCC CLATHRIN COMPLEX | 5 | 3.27e-01 | 2.53e-01 | 6.13e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 9 | 1.88e-01 | -2.53e-01 | 4.64e-01 |
| GOBP PROTEIN HEXAMERIZATION | 8 | 2.15e-01 | -2.53e-01 | 4.97e-01 |
| GOBP BONE CELL DEVELOPMENT | 15 | 8.95e-02 | -2.53e-01 | 3.14e-01 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 16 | 7.98e-02 | -2.53e-01 | 2.94e-01 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 8 | 2.16e-01 | 2.53e-01 | 4.98e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 2.16e-01 | -2.53e-01 | 4.98e-01 |
| GOMF T CELL RECEPTOR BINDING | 8 | 2.16e-01 | -2.53e-01 | 4.98e-01 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 30 | 1.66e-02 | -2.53e-01 | 1.16e-01 |
| GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 9 | 1.89e-01 | -2.53e-01 | 4.66e-01 |
| GOMF IMMUNOGLOBULIN BINDING | 11 | 1.47e-01 | -2.53e-01 | 4.07e-01 |
| GOMF HISTONE KINASE ACTIVITY | 18 | 6.36e-02 | -2.53e-01 | 2.61e-01 |
| GOBP SPINAL CORD PATTERNING | 6 | 2.84e-01 | -2.52e-01 | 5.74e-01 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 24 | 3.24e-02 | -2.52e-01 | 1.76e-01 |
| GOBP NUCLEOBASE CATABOLIC PROCESS | 6 | 2.85e-01 | -2.52e-01 | 5.74e-01 |
| GOBP ACTIVATED T CELL PROLIFERATION | 33 | 1.22e-02 | -2.52e-01 | 9.37e-02 |
| GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 14 | 1.02e-01 | -2.52e-01 | 3.37e-01 |
| GOBP SKELETAL MUSCLE ADAPTATION | 10 | 1.68e-01 | -2.52e-01 | 4.36e-01 |
| GOCC MRNA CAP BINDING COMPLEX | 12 | 1.31e-01 | 2.52e-01 | 3.83e-01 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 10 | 1.68e-01 | -2.52e-01 | 4.36e-01 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 38 | 7.27e-03 | -2.52e-01 | 6.62e-02 |
| GOCC CASPASE COMPLEX | 9 | 1.91e-01 | 2.52e-01 | 4.69e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 12 | 1.31e-01 | 2.52e-01 | 3.83e-01 |
| GOBP RHYTHMIC BEHAVIOR | 25 | 2.95e-02 | -2.51e-01 | 1.67e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 14 | 1.03e-01 | 2.51e-01 | 3.37e-01 |
| GOBP REGULATION OF PROTEIN OLIGOMERIZATION | 5 | 3.30e-01 | 2.51e-01 | 6.16e-01 |
| GOBP GLUCOCORTICOID SECRETION | 8 | 2.18e-01 | 2.51e-01 | 5.01e-01 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 31 | 1.55e-02 | 2.51e-01 | 1.10e-01 |
| GOMF GLUTATHIONE BINDING | 9 | 1.92e-01 | 2.51e-01 | 4.69e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 1.92e-01 | 2.51e-01 | 4.69e-01 |
| GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 2.50e-01 | -2.51e-01 | 5.39e-01 |
| GOBP SOMITE DEVELOPMENT | 36 | 9.21e-03 | -2.51e-01 | 7.80e-02 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 7 | 2.50e-01 | -2.51e-01 | 5.39e-01 |
| GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 13 | 1.17e-01 | 2.51e-01 | 3.60e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 9 | 1.93e-01 | -2.51e-01 | 4.69e-01 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 9 | 1.93e-01 | -2.51e-01 | 4.70e-01 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 36 | 9.24e-03 | -2.51e-01 | 7.82e-02 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 26 | 2.69e-02 | -2.51e-01 | 1.57e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 12 | 1.33e-01 | 2.51e-01 | 3.85e-01 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 25 | 3.02e-02 | -2.50e-01 | 1.69e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 14 | 1.05e-01 | 2.50e-01 | 3.40e-01 |
| GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 6 | 2.88e-01 | -2.50e-01 | 5.78e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 29 | 1.96e-02 | -2.50e-01 | 1.29e-01 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 16 | 8.31e-02 | -2.50e-01 | 3.00e-01 |
| GOBP PLASMA MEMBRANE RAFT ORGANIZATION | 8 | 2.20e-01 | -2.50e-01 | 5.03e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 11 | 1.51e-01 | -2.50e-01 | 4.12e-01 |
| GOBP NEGATIVE REGULATION OF HEART RATE | 6 | 2.89e-01 | 2.50e-01 | 5.79e-01 |
| GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 8 | 2.21e-01 | 2.50e-01 | 5.03e-01 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 8 | 2.21e-01 | 2.50e-01 | 5.03e-01 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 122 | 1.90e-06 | 2.50e-01 | 1.03e-04 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 38 | 7.70e-03 | -2.50e-01 | 6.89e-02 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 6 | 2.89e-01 | -2.50e-01 | 5.79e-01 |
| GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 6 | 2.90e-01 | -2.50e-01 | 5.80e-01 |
| GOBP ETHER METABOLIC PROCESS | 18 | 6.69e-02 | 2.49e-01 | 2.69e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 7 | 2.53e-01 | -2.49e-01 | 5.42e-01 |
| GOBP REGULATION OF CD40 SIGNALING PATHWAY | 6 | 2.90e-01 | -2.49e-01 | 5.80e-01 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 101 | 1.52e-05 | 2.49e-01 | 6.02e-04 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 46 | 3.47e-03 | -2.49e-01 | 4.06e-02 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 68 | 3.84e-04 | -2.49e-01 | 8.09e-03 |
| GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT | 5 | 3.35e-01 | -2.49e-01 | 6.21e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 10 | 1.73e-01 | -2.49e-01 | 4.44e-01 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 30 | 1.83e-02 | 2.49e-01 | 1.24e-01 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 5 | 3.35e-01 | 2.49e-01 | 6.21e-01 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 14 | 1.07e-01 | 2.49e-01 | 3.44e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 6 | 2.91e-01 | -2.49e-01 | 5.80e-01 |
| GOBP PENTOSE METABOLIC PROCESS | 10 | 1.73e-01 | 2.49e-01 | 4.45e-01 |
| GOCC DNA REPAIR COMPLEX | 22 | 4.35e-02 | -2.49e-01 | 2.10e-01 |
| GOMF INSULIN BINDING | 5 | 3.36e-01 | -2.49e-01 | 6.22e-01 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 7 | 2.55e-01 | -2.49e-01 | 5.44e-01 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 6 | 2.92e-01 | -2.48e-01 | 5.81e-01 |
| GOBP SOMITOGENESIS | 29 | 2.07e-02 | -2.48e-01 | 1.34e-01 |
| GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.92e-01 | -2.48e-01 | 5.81e-01 |
| GOCC ENDOCYTIC VESICLE LUMEN | 10 | 1.74e-01 | -2.48e-01 | 4.45e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS | 7 | 2.56e-01 | -2.48e-01 | 5.45e-01 |
| GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 2.93e-01 | 2.48e-01 | 5.81e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 14 | 1.08e-01 | -2.48e-01 | 3.46e-01 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 2.25e-01 | -2.48e-01 | 5.09e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 10 | 1.75e-01 | -2.48e-01 | 4.47e-01 |
| GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 9 | 1.99e-01 | -2.47e-01 | 4.78e-01 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 18 | 6.92e-02 | 2.47e-01 | 2.74e-01 |
| GOBP HYALURONAN METABOLIC PROCESS | 18 | 6.92e-02 | -2.47e-01 | 2.74e-01 |
| GOCC NADPH OXIDASE COMPLEX | 10 | 1.76e-01 | -2.47e-01 | 4.47e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 39 | 7.58e-03 | -2.47e-01 | 6.83e-02 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 21 | 5.02e-02 | 2.47e-01 | 2.27e-01 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 10 | 1.77e-01 | -2.47e-01 | 4.49e-01 |
| GOBP CELL AGGREGATION | 6 | 2.95e-01 | 2.47e-01 | 5.84e-01 |
| GOBP CENTROMERIC SISTER CHROMATID COHESION | 10 | 1.77e-01 | -2.47e-01 | 4.50e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 6 | 2.96e-01 | -2.47e-01 | 5.84e-01 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 23 | 4.08e-02 | 2.46e-01 | 2.01e-01 |
| GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS | 6 | 2.96e-01 | 2.46e-01 | 5.84e-01 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 7 | 2.59e-01 | -2.46e-01 | 5.49e-01 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 48 | 3.15e-03 | -2.46e-01 | 3.84e-02 |
| GOMF DNA BINDING BENDING | 9 | 2.01e-01 | -2.46e-01 | 4.80e-01 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 5 | 3.40e-01 | 2.46e-01 | 6.26e-01 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 19 | 6.31e-02 | -2.46e-01 | 2.59e-01 |
| GOBP MICROGLIA DIFFERENTIATION | 9 | 2.01e-01 | -2.46e-01 | 4.81e-01 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 18 | 7.06e-02 | -2.46e-01 | 2.76e-01 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 11 | 1.58e-01 | -2.46e-01 | 4.22e-01 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 14 | 1.11e-01 | -2.46e-01 | 3.51e-01 |
| GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 6 | 2.97e-01 | 2.46e-01 | 5.85e-01 |
| GOBP INTERLEUKIN 10 PRODUCTION | 42 | 5.85e-03 | -2.46e-01 | 5.68e-02 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 12 | 1.40e-01 | -2.46e-01 | 3.97e-01 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 28 | 2.44e-02 | -2.46e-01 | 1.47e-01 |
| GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 11 | 1.58e-01 | 2.46e-01 | 4.23e-01 |
| GOBP POSITIVE REGULATION OF URINE VOLUME | 5 | 3.41e-01 | -2.46e-01 | 6.28e-01 |
| GOBP ARGININE CATABOLIC PROCESS | 6 | 2.97e-01 | 2.46e-01 | 5.85e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 13 | 1.25e-01 | -2.46e-01 | 3.73e-01 |
| GOBP NUCLEAR RNA SURVEILLANCE | 14 | 1.12e-01 | 2.45e-01 | 3.52e-01 |
| GOBP UBIQUITIN DEPENDENT ERAD PATHWAY | 73 | 2.93e-04 | 2.45e-01 | 6.85e-03 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 37 | 9.87e-03 | -2.45e-01 | 8.16e-02 |
| GOBP DELAMINATION | 5 | 3.42e-01 | -2.45e-01 | 6.28e-01 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 33 | 1.48e-02 | -2.45e-01 | 1.08e-01 |
| GOBP VIRAL BUDDING | 24 | 3.77e-02 | 2.45e-01 | 1.92e-01 |
| GOBP RESPONSE TO IRON II ION | 5 | 3.43e-01 | 2.45e-01 | 6.28e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 16 | 8.97e-02 | -2.45e-01 | 3.14e-01 |
| GOBP HOMOLOGOUS RECOMBINATION | 46 | 4.06e-03 | -2.45e-01 | 4.51e-02 |
| GOBP HETEROCHROMATIN ORGANIZATION | 82 | 1.27e-04 | -2.45e-01 | 3.59e-03 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 130 | 1.46e-06 | -2.45e-01 | 8.27e-05 |
| GOMF OXO ACID LYASE ACTIVITY | 5 | 3.43e-01 | -2.45e-01 | 6.28e-01 |
| GOCC MITOTIC SPINDLE MIDZONE | 11 | 1.60e-01 | -2.45e-01 | 4.26e-01 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 28 | 2.51e-02 | 2.45e-01 | 1.50e-01 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 27 | 2.78e-02 | -2.45e-01 | 1.61e-01 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 15 | 1.01e-01 | 2.45e-01 | 3.35e-01 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 7 | 2.63e-01 | -2.45e-01 | 5.53e-01 |
| GOBP HUMORAL IMMUNE RESPONSE | 93 | 4.66e-05 | -2.45e-01 | 1.56e-03 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 54 | 1.90e-03 | -2.44e-01 | 2.67e-02 |
| GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 8 | 2.31e-01 | -2.44e-01 | 5.15e-01 |
| GOCC INCLUSION BODY | 56 | 1.58e-03 | -2.44e-01 | 2.34e-02 |
| GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 10 | 1.81e-01 | -2.44e-01 | 4.56e-01 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 20 | 5.88e-02 | -2.44e-01 | 2.48e-01 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 11 | 1.61e-01 | -2.44e-01 | 4.28e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 6 | 3.01e-01 | -2.44e-01 | 5.89e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 3.45e-01 | 2.44e-01 | 6.30e-01 |
| GOBP DITERPENOID BIOSYNTHETIC PROCESS | 7 | 2.64e-01 | -2.44e-01 | 5.54e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 19 | 6.57e-02 | -2.44e-01 | 2.66e-01 |
| GOCC ASTROCYTE PROJECTION | 7 | 2.64e-01 | -2.44e-01 | 5.54e-01 |
| GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 8 | 2.32e-01 | -2.44e-01 | 5.16e-01 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 17 | 8.19e-02 | -2.44e-01 | 2.98e-01 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 13 | 1.28e-01 | -2.44e-01 | 3.78e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK | 6 | 3.01e-01 | -2.44e-01 | 5.89e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 6 | 3.01e-01 | -2.44e-01 | 5.89e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 19 | 6.60e-02 | -2.44e-01 | 2.67e-01 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 25 | 3.51e-02 | -2.44e-01 | 1.84e-01 |
| GOMF ACID THIOL LIGASE ACTIVITY | 21 | 5.35e-02 | -2.43e-01 | 2.36e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 3.02e-01 | 2.43e-01 | 5.90e-01 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 15 | 1.03e-01 | -2.43e-01 | 3.37e-01 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 2.12e-02 | -2.43e-01 | 1.35e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 28 | 2.60e-02 | -2.43e-01 | 1.53e-01 |
| GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 1.83e-01 | -2.43e-01 | 4.58e-01 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 44 | 5.30e-03 | -2.43e-01 | 5.33e-02 |
| GOBP I KAPPAB PHOSPHORYLATION | 13 | 1.29e-01 | -2.43e-01 | 3.80e-01 |
| GOBP MATURATION OF 5 8S RRNA | 36 | 1.17e-02 | 2.43e-01 | 9.13e-02 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 5 | 3.47e-01 | -2.43e-01 | 6.32e-01 |
| GOBP ESTROGEN METABOLIC PROCESS | 17 | 8.33e-02 | -2.43e-01 | 3.01e-01 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 29 | 2.38e-02 | 2.43e-01 | 1.45e-01 |
| GOBP NEURON FATE COMMITMENT | 17 | 8.34e-02 | -2.43e-01 | 3.01e-01 |
| GOBP NEURON PROJECTION MAINTENANCE | 8 | 2.35e-01 | -2.42e-01 | 5.19e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 47 | 4.06e-03 | 2.42e-01 | 4.52e-02 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 11 | 1.64e-01 | -2.42e-01 | 4.32e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 7 | 2.67e-01 | -2.42e-01 | 5.57e-01 |
| GOBP TRNA METABOLIC PROCESS | 175 | 3.45e-08 | 2.42e-01 | 3.59e-06 |
| GOMF MISFOLDED PROTEIN BINDING | 17 | 8.40e-02 | 2.42e-01 | 3.02e-01 |
| GOBP RESPONSE TO COCAINE | 26 | 3.27e-02 | -2.42e-01 | 1.78e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 3.05e-01 | -2.42e-01 | 5.93e-01 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 13 | 1.31e-01 | -2.42e-01 | 3.83e-01 |
| GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY | 5 | 3.49e-01 | -2.42e-01 | 6.34e-01 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 145 | 5.14e-07 | 2.42e-01 | 3.46e-05 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 8 | 2.36e-01 | -2.42e-01 | 5.21e-01 |
| GOBP MEMBRANE RAFT ORGANIZATION | 21 | 5.54e-02 | -2.42e-01 | 2.41e-01 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 22 | 5.00e-02 | -2.41e-01 | 2.27e-01 |
| GOBP HYPEROSMOTIC RESPONSE | 21 | 5.56e-02 | -2.41e-01 | 2.41e-01 |
| GOBP PLASMA MEMBRANE TUBULATION | 16 | 9.48e-02 | -2.41e-01 | 3.24e-01 |
| GOBP TRANSCYTOSIS | 16 | 9.48e-02 | -2.41e-01 | 3.24e-01 |
| GOBP L SERINE BIOSYNTHETIC PROCESS | 5 | 3.50e-01 | 2.41e-01 | 6.35e-01 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 12 | 1.48e-01 | -2.41e-01 | 4.08e-01 |
| GOBP SEROTONIN METABOLIC PROCESS | 6 | 3.06e-01 | -2.41e-01 | 5.95e-01 |
| GOBP MUCUS SECRETION | 10 | 1.87e-01 | 2.41e-01 | 4.63e-01 |
| GOBP VIRION ASSEMBLY | 33 | 1.66e-02 | 2.41e-01 | 1.16e-01 |
| GOBP PROXIMAL TUBULE DEVELOPMENT | 7 | 2.70e-01 | 2.41e-01 | 5.59e-01 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 3.03e-02 | 2.41e-01 | 1.69e-01 |
| GOMF SH2 DOMAIN BINDING | 33 | 1.68e-02 | -2.41e-01 | 1.17e-01 |
| GOCC MMXD COMPLEX | 5 | 3.52e-01 | 2.41e-01 | 6.37e-01 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 49 | 3.62e-03 | -2.40e-01 | 4.20e-02 |
| GOBP ENDODERM DEVELOPMENT | 48 | 3.98e-03 | -2.40e-01 | 4.48e-02 |
| GOBP CELLULAR RESPONSE TO LEUCINE | 10 | 1.88e-01 | -2.40e-01 | 4.64e-01 |
| GOCC EUCHROMATIN | 42 | 7.09e-03 | -2.40e-01 | 6.51e-02 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 16 | 9.63e-02 | 2.40e-01 | 3.27e-01 |
| GOBP LEUCINE METABOLIC PROCESS | 7 | 2.71e-01 | 2.40e-01 | 5.61e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 17 | 8.66e-02 | -2.40e-01 | 3.07e-01 |
| GOBP COBALAMIN METABOLIC PROCESS | 8 | 2.40e-01 | 2.40e-01 | 5.26e-01 |
| GOBP MAST CELL MEDIATED IMMUNITY | 42 | 7.12e-03 | -2.40e-01 | 6.53e-02 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 13 | 1.34e-01 | -2.40e-01 | 3.87e-01 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 60 | 1.31e-03 | -2.40e-01 | 2.07e-02 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 95 | 5.38e-05 | -2.40e-01 | 1.78e-03 |
| GOBP CATECHOLAMINE SECRETION | 22 | 5.15e-02 | -2.40e-01 | 2.31e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 36 | 1.28e-02 | -2.40e-01 | 9.73e-02 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 13 | 1.34e-01 | 2.40e-01 | 3.87e-01 |
| GOMF SH3 DOMAIN BINDING | 93 | 6.51e-05 | -2.40e-01 | 2.09e-03 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 19 | 7.05e-02 | -2.40e-01 | 2.76e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 1.51e-01 | -2.40e-01 | 4.12e-01 |
| GOBP NATURAL KILLER CELL CHEMOTAXIS | 7 | 2.72e-01 | 2.40e-01 | 5.63e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 7 | 2.73e-01 | -2.40e-01 | 5.63e-01 |
| GOBP SURFACTANT HOMEOSTASIS | 9 | 2.14e-01 | 2.39e-01 | 4.96e-01 |
| GOBP REGULATION OF P38MAPK CASCADE | 35 | 1.43e-02 | -2.39e-01 | 1.05e-01 |
| GOBP ANATOMICAL STRUCTURE REGRESSION | 5 | 3.54e-01 | -2.39e-01 | 6.40e-01 |
| GOMF PH DOMAIN BINDING | 7 | 2.73e-01 | 2.39e-01 | 5.64e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES | 9 | 2.14e-01 | 2.39e-01 | 4.97e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 8 | 2.42e-01 | 2.39e-01 | 5.28e-01 |
| GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS | 7 | 2.74e-01 | -2.39e-01 | 5.64e-01 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 9 | 2.14e-01 | -2.39e-01 | 4.97e-01 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 11 | 1.70e-01 | -2.39e-01 | 4.39e-01 |
| GOBP B CELL PROLIFERATION | 60 | 1.39e-03 | -2.39e-01 | 2.15e-02 |
| GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 8 | 2.43e-01 | -2.39e-01 | 5.29e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 8 | 2.43e-01 | -2.39e-01 | 5.29e-01 |
| GOCC METHYLOSOME | 12 | 1.53e-01 | 2.38e-01 | 4.15e-01 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 18 | 7.99e-02 | -2.38e-01 | 2.94e-01 |
| GOBP PROSTANOID METABOLIC PROCESS | 34 | 1.62e-02 | 2.38e-01 | 1.14e-01 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 148 | 5.83e-07 | -2.38e-01 | 3.81e-05 |
| GOMF U1 SNRNA BINDING | 8 | 2.43e-01 | 2.38e-01 | 5.29e-01 |
| GOMF NEUROPEPTIDE RECEPTOR ACTIVITY | 5 | 3.56e-01 | 2.38e-01 | 6.43e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 10 | 1.92e-01 | -2.38e-01 | 4.69e-01 |
| GOBP FILOPODIUM ASSEMBLY | 49 | 3.95e-03 | -2.38e-01 | 4.47e-02 |
| GOBP REGULATION OF VESICLE SIZE | 18 | 8.05e-02 | 2.38e-01 | 2.95e-01 |
| GOBP VASCULAR TRANSPORT | 50 | 3.62e-03 | -2.38e-01 | 4.20e-02 |
| GOBP TRNA PROCESSING | 129 | 3.20e-06 | 2.38e-01 | 1.59e-04 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 80 | 2.40e-04 | -2.38e-01 | 5.82e-03 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 7 | 2.76e-01 | 2.38e-01 | 5.66e-01 |
| GOBP RRNA BASE METHYLATION | 8 | 2.45e-01 | 2.37e-01 | 5.31e-01 |
| GOBP RESPONSE TO FRUCTOSE | 6 | 3.14e-01 | 2.37e-01 | 6.02e-01 |
| GOBP MICROTUBULE ANCHORING | 20 | 6.61e-02 | -2.37e-01 | 2.67e-01 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 221 | 1.29e-09 | -2.37e-01 | 2.22e-07 |
| GOCC FEMALE GERM CELL NUCLEUS | 9 | 2.18e-01 | -2.37e-01 | 5.01e-01 |
| GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 12 | 1.55e-01 | 2.37e-01 | 4.17e-01 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 58 | 1.79e-03 | -2.37e-01 | 2.55e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 56 | 2.16e-03 | 2.37e-01 | 2.96e-02 |
| GOBP B CELL LINEAGE COMMITMENT | 5 | 3.59e-01 | -2.37e-01 | 6.45e-01 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 24 | 4.45e-02 | -2.37e-01 | 2.13e-01 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 10 | 1.95e-01 | -2.37e-01 | 4.73e-01 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 80 | 2.56e-04 | -2.37e-01 | 6.13e-03 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 10 | 1.95e-01 | -2.36e-01 | 4.73e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 7 | 2.79e-01 | -2.36e-01 | 5.68e-01 |
| GOCC MICROTUBULE PLUS END | 19 | 7.44e-02 | -2.36e-01 | 2.84e-01 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 36 | 1.41e-02 | 2.36e-01 | 1.04e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 18 | 8.27e-02 | -2.36e-01 | 3.00e-01 |
| GOBP URONIC ACID METABOLIC PROCESS | 7 | 2.79e-01 | 2.36e-01 | 5.68e-01 |
| GOBP INTERLEUKIN 6 PRODUCTION | 111 | 1.74e-05 | -2.36e-01 | 6.80e-04 |
| GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 9 | 2.20e-01 | -2.36e-01 | 5.03e-01 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 1.97e-01 | -2.36e-01 | 4.75e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 3.61e-01 | -2.36e-01 | 6.47e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 58 | 1.91e-03 | -2.36e-01 | 2.68e-02 |
| GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 3.61e-01 | 2.36e-01 | 6.47e-01 |
| GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS | 5 | 3.62e-01 | -2.36e-01 | 6.47e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 6 | 3.18e-01 | -2.35e-01 | 6.07e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 35 | 1.60e-02 | -2.35e-01 | 1.13e-01 |
| GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 7 | 2.81e-01 | -2.35e-01 | 5.71e-01 |
| GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 6 | 3.18e-01 | -2.35e-01 | 6.07e-01 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 30 | 2.57e-02 | -2.35e-01 | 1.52e-01 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 16 | 1.04e-01 | 2.35e-01 | 3.38e-01 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 15 | 1.15e-01 | 2.35e-01 | 3.57e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 106 | 2.99e-05 | -2.35e-01 | 1.08e-03 |
| GOCC ENDOSOME LUMEN | 23 | 5.14e-02 | -2.35e-01 | 2.30e-01 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 122 | 7.75e-06 | 2.35e-01 | 3.41e-04 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 74 | 4.86e-04 | -2.35e-01 | 9.64e-03 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 24 | 4.67e-02 | -2.35e-01 | 2.20e-01 |
| GOMF REGULATORY RNA BINDING | 40 | 1.03e-02 | -2.35e-01 | 8.42e-02 |
| GOBP CELLULAR RESPONSE TO PEPTIDOGLYCAN | 5 | 3.64e-01 | -2.35e-01 | 6.49e-01 |
| GOBP FUCOSYLATION | 10 | 1.99e-01 | 2.35e-01 | 4.79e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 24 | 4.68e-02 | -2.34e-01 | 2.20e-01 |
| GOBP THERMOCEPTION | 5 | 3.64e-01 | -2.34e-01 | 6.49e-01 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 10 | 1.99e-01 | -2.34e-01 | 4.79e-01 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 11 | 1.78e-01 | 2.34e-01 | 4.52e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 57 | 2.23e-03 | 2.34e-01 | 3.03e-02 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 14 | 1.29e-01 | -2.34e-01 | 3.80e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 7 | 2.84e-01 | -2.34e-01 | 5.73e-01 |
| GOBP UTP BIOSYNTHETIC PROCESS | 8 | 2.52e-01 | 2.34e-01 | 5.41e-01 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 28 | 3.23e-02 | -2.34e-01 | 1.76e-01 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 1.80e-01 | 2.34e-01 | 4.54e-01 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 6 | 3.22e-01 | 2.34e-01 | 6.10e-01 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE | 19 | 7.80e-02 | 2.34e-01 | 2.90e-01 |
| GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 12 | 1.61e-01 | -2.34e-01 | 4.28e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 6 | 3.22e-01 | -2.34e-01 | 6.10e-01 |
| GOMF ANAPHASE PROMOTING COMPLEX BINDING | 8 | 2.53e-01 | -2.33e-01 | 5.42e-01 |
| GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING | 5 | 3.66e-01 | -2.33e-01 | 6.51e-01 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 11 | 1.80e-01 | 2.33e-01 | 4.55e-01 |
| GOBP PROTEIN RETENTION IN ER LUMEN | 6 | 3.23e-01 | 2.33e-01 | 6.10e-01 |
| GOCC MANCHETTE | 11 | 1.81e-01 | 2.33e-01 | 4.55e-01 |
| GOCC NUCLEAR LAMINA | 12 | 1.62e-01 | 2.33e-01 | 4.29e-01 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 53 | 3.36e-03 | -2.33e-01 | 4.00e-02 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 42 | 9.05e-03 | -2.33e-01 | 7.70e-02 |
| GOBP OOCYTE CONSTRUCTION | 5 | 3.67e-01 | 2.33e-01 | 6.51e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 7 | 2.86e-01 | -2.33e-01 | 5.76e-01 |
| GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 43 | 8.29e-03 | -2.33e-01 | 7.20e-02 |
| GOBP CYCLIC NUCLEOTIDE TRANSPORT | 8 | 2.54e-01 | -2.33e-01 | 5.43e-01 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 25 | 4.40e-02 | 2.33e-01 | 2.12e-01 |
| GOMF PORIN ACTIVITY | 6 | 3.23e-01 | 2.33e-01 | 6.11e-01 |
| GOBP RESPONSE TO ANTIBIOTIC | 32 | 2.27e-02 | -2.33e-01 | 1.41e-01 |
| GOMF ACYL COA BINDING | 17 | 9.67e-02 | 2.33e-01 | 3.27e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 8 | 2.54e-01 | -2.33e-01 | 5.43e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 51 | 4.06e-03 | 2.33e-01 | 4.51e-02 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 29 | 3.02e-02 | 2.33e-01 | 1.69e-01 |
| GOCC RNA POLYMERASE II HOLOENZYME | 68 | 9.18e-04 | 2.33e-01 | 1.58e-02 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 5 | 3.68e-01 | -2.33e-01 | 6.52e-01 |
| GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 9 | 2.27e-01 | -2.33e-01 | 5.12e-01 |
| GOCC ORGANELLE INNER MEMBRANE | 479 | 4.06e-18 | 2.32e-01 | 5.00e-15 |
| GOCC COP9 SIGNALOSOME | 15 | 1.19e-01 | 2.32e-01 | 3.63e-01 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 80 | 3.38e-04 | -2.32e-01 | 7.46e-03 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 14 | 1.33e-01 | -2.32e-01 | 3.85e-01 |
| GOMF CHANNEL INHIBITOR ACTIVITY | 23 | 5.43e-02 | 2.32e-01 | 2.37e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 13 | 1.48e-01 | -2.32e-01 | 4.08e-01 |
| GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 9 | 2.29e-01 | 2.32e-01 | 5.14e-01 |
| GOMF QUINONE BINDING | 14 | 1.33e-01 | 2.32e-01 | 3.86e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 16 | 1.09e-01 | -2.32e-01 | 3.47e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 65 | 1.25e-03 | -2.32e-01 | 1.99e-02 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 8 | 2.57e-01 | -2.32e-01 | 5.47e-01 |
| GOCC PHAGOCYTIC CUP | 24 | 4.98e-02 | -2.31e-01 | 2.27e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 5 | 3.70e-01 | -2.31e-01 | 6.54e-01 |
| GOCC MITOCHONDRIAL ENVELOPE | 698 | 4.27e-25 | 2.31e-01 | 3.68e-21 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 151 | 9.76e-07 | -2.31e-01 | 5.85e-05 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 12 | 1.66e-01 | -2.31e-01 | 4.34e-01 |
| GOCC BRAHMA COMPLEX | 12 | 1.66e-01 | -2.31e-01 | 4.34e-01 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 28 | 3.45e-02 | -2.31e-01 | 1.83e-01 |
| GOBP LEUKOCYTE DEGRANULATION | 58 | 2.40e-03 | -2.31e-01 | 3.18e-02 |
| GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING | 8 | 2.59e-01 | 2.30e-01 | 5.49e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 92 | 1.35e-04 | -2.30e-01 | 3.78e-03 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 14 | 1.36e-01 | -2.30e-01 | 3.89e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 6 | 3.29e-01 | -2.30e-01 | 6.16e-01 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 46 | 6.97e-03 | -2.30e-01 | 6.44e-02 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 33 | 2.22e-02 | -2.30e-01 | 1.39e-01 |
| GOCC PERICHROMATIN FIBRILS | 5 | 3.74e-01 | -2.30e-01 | 6.56e-01 |
| GOBP SUCKLING BEHAVIOR | 6 | 3.30e-01 | 2.30e-01 | 6.16e-01 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 35 | 1.88e-02 | 2.30e-01 | 1.26e-01 |
| GOBP PHAGOSOME ACIDIFICATION | 7 | 2.93e-01 | -2.30e-01 | 5.81e-01 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 10 | 2.09e-01 | 2.30e-01 | 4.90e-01 |
| GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 2.33e-01 | 2.30e-01 | 5.16e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 14 | 1.37e-01 | -2.30e-01 | 3.91e-01 |
| GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 6 | 3.31e-01 | 2.29e-01 | 6.16e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 8.35e-02 | 2.29e-01 | 3.01e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION | 5 | 3.74e-01 | 2.29e-01 | 6.57e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 45 | 7.78e-03 | 2.29e-01 | 6.93e-02 |
| GOCC GAMMA TUBULIN RING COMPLEX | 7 | 2.93e-01 | 2.29e-01 | 5.82e-01 |
| GOBP AMYLOID BETA CLEARANCE | 30 | 2.98e-02 | -2.29e-01 | 1.68e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 18 | 9.26e-02 | 2.29e-01 | 3.19e-01 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 57 | 2.80e-03 | -2.29e-01 | 3.56e-02 |
| GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 16 | 1.13e-01 | 2.29e-01 | 3.53e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 9 | 2.34e-01 | 2.29e-01 | 5.19e-01 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 78 | 4.79e-04 | -2.29e-01 | 9.52e-03 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 38 | 1.47e-02 | 2.29e-01 | 1.07e-01 |
| GOBP REGULATION OF TORC2 SIGNALING | 8 | 2.63e-01 | -2.29e-01 | 5.53e-01 |
| GOBP SNRNA 3 END PROCESSING | 21 | 6.99e-02 | 2.29e-01 | 2.75e-01 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 8 | 2.63e-01 | 2.29e-01 | 5.53e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 2.63e-01 | -2.28e-01 | 5.53e-01 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 9 | 2.36e-01 | -2.28e-01 | 5.20e-01 |
| GOBP FOREBRAIN MORPHOGENESIS | 5 | 3.77e-01 | 2.28e-01 | 6.59e-01 |
| GOCC LAMIN FILAMENT | 5 | 3.77e-01 | 2.28e-01 | 6.59e-01 |
| GOBP REGULATION OF MITOPHAGY | 14 | 1.39e-01 | -2.28e-01 | 3.96e-01 |
| GOBP VITAMIN K METABOLIC PROCESS | 7 | 2.96e-01 | 2.28e-01 | 5.84e-01 |
| GOBP REGULATION OF SYNAPSE MATURATION | 12 | 1.71e-01 | -2.28e-01 | 4.41e-01 |
| GOBP MAMMALIAN OOGENESIS STAGE | 6 | 3.33e-01 | -2.28e-01 | 6.19e-01 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 88 | 2.21e-04 | -2.28e-01 | 5.53e-03 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 8 | 2.65e-01 | -2.28e-01 | 5.55e-01 |
| GOBP DNA METHYLATION | 39 | 1.39e-02 | -2.28e-01 | 1.03e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 19 | 8.60e-02 | 2.28e-01 | 3.06e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 34 | 2.17e-02 | -2.28e-01 | 1.37e-01 |
| GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 8 | 2.66e-01 | -2.27e-01 | 5.56e-01 |
| GOBP CHEMOKINE PRODUCTION | 67 | 1.31e-03 | -2.27e-01 | 2.07e-02 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 3.35e-01 | -2.27e-01 | 6.22e-01 |
| GOBP CITRATE METABOLIC PROCESS | 5 | 3.80e-01 | -2.27e-01 | 6.61e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 8 | 2.67e-01 | -2.27e-01 | 5.57e-01 |
| GOBP SULFUR AMINO ACID TRANSPORT | 9 | 2.39e-01 | -2.27e-01 | 5.25e-01 |
| GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE | 7 | 2.99e-01 | 2.27e-01 | 5.87e-01 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 1.74e-01 | -2.27e-01 | 4.46e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 108 | 4.83e-05 | 2.27e-01 | 1.61e-03 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 6 | 3.37e-01 | 2.27e-01 | 6.23e-01 |
| GOBP REGULATION OF DNA METHYLATION | 13 | 1.57e-01 | -2.26e-01 | 4.21e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 3.80e-01 | -2.26e-01 | 6.62e-01 |
| GOBP GLANDULAR EPITHELIAL CELL MATURATION | 5 | 3.81e-01 | -2.26e-01 | 6.62e-01 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 37 | 1.72e-02 | -2.26e-01 | 1.19e-01 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 32 | 2.68e-02 | 2.26e-01 | 1.57e-01 |
| GOBP VASCULOGENESIS | 44 | 9.44e-03 | -2.26e-01 | 7.95e-02 |
| GOBP RHYTHMIC PROCESS | 190 | 7.96e-08 | -2.26e-01 | 7.15e-06 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION | 6 | 3.37e-01 | -2.26e-01 | 6.24e-01 |
| GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY | 6 | 3.37e-01 | -2.26e-01 | 6.24e-01 |
| GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY | 7 | 3.00e-01 | 2.26e-01 | 5.88e-01 |
| GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 10 | 2.16e-01 | -2.26e-01 | 4.99e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 12 | 1.75e-01 | -2.26e-01 | 4.47e-01 |
| GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 6 | 3.38e-01 | 2.26e-01 | 6.24e-01 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 25 | 5.06e-02 | 2.26e-01 | 2.29e-01 |
| GOBP RESPONSE TO RETINOIC ACID | 53 | 4.46e-03 | -2.26e-01 | 4.80e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 10 | 2.16e-01 | 2.26e-01 | 4.99e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 3.38e-01 | 2.26e-01 | 6.24e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 2.16e-01 | 2.26e-01 | 4.99e-01 |
| GOBP FEMALE SEX DIFFERENTIATION | 62 | 2.14e-03 | -2.26e-01 | 2.93e-02 |
| GOBP REGULATION OF BEHAVIOR | 35 | 2.09e-02 | -2.26e-01 | 1.34e-01 |
| GOBP REGULATION OF T CELL MIGRATION | 33 | 2.50e-02 | -2.26e-01 | 1.50e-01 |
| GOBP ARTERY DEVELOPMENT | 61 | 2.34e-03 | -2.25e-01 | 3.13e-02 |
| GOCC U4 SNRNP | 10 | 2.17e-01 | 2.25e-01 | 5.00e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 10 | 2.17e-01 | 2.25e-01 | 5.00e-01 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 27 | 4.28e-02 | -2.25e-01 | 2.08e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 50 | 5.87e-03 | -2.25e-01 | 5.70e-02 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 25 | 5.13e-02 | -2.25e-01 | 2.30e-01 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 7 | 3.02e-01 | -2.25e-01 | 5.90e-01 |
| GOCC NADH DEHYDROGENASE COMPLEX | 47 | 7.59e-03 | 2.25e-01 | 6.83e-02 |
| GOMF CARDIOLIPIN BINDING | 8 | 2.70e-01 | 2.25e-01 | 5.60e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 26 | 4.72e-02 | -2.25e-01 | 2.21e-01 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 36 | 1.96e-02 | -2.25e-01 | 1.29e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 14 | 1.45e-01 | 2.25e-01 | 4.05e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 11 | 1.97e-01 | 2.25e-01 | 4.76e-01 |
| GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY | 12 | 1.78e-01 | -2.25e-01 | 4.51e-01 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 41 | 1.29e-02 | -2.25e-01 | 9.76e-02 |
| GOCC MITOCHONDRIAL MATRIX | 442 | 7.47e-16 | 2.25e-01 | 5.37e-13 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 13 | 1.61e-01 | 2.24e-01 | 4.28e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 11 | 1.98e-01 | 2.24e-01 | 4.77e-01 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 106 | 6.75e-05 | 2.24e-01 | 2.14e-03 |
| GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 7 | 3.04e-01 | -2.24e-01 | 5.92e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 6 | 3.42e-01 | 2.24e-01 | 6.28e-01 |
| GOBP REGULATION OF HIPPO SIGNALING | 18 | 9.98e-02 | -2.24e-01 | 3.33e-01 |
| GOBP RESPONSE TO ETHANOL | 66 | 1.65e-03 | -2.24e-01 | 2.43e-02 |
| GOBP NEUTROPHIL CHEMOTAXIS | 66 | 1.66e-03 | -2.24e-01 | 2.43e-02 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 5 | 3.86e-01 | -2.24e-01 | 6.67e-01 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 20 | 8.31e-02 | -2.24e-01 | 3.00e-01 |
| GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 7 | 3.05e-01 | -2.24e-01 | 5.93e-01 |
| GOBP DETECTION OF LIPOPOLYSACCHARIDE | 5 | 3.86e-01 | 2.24e-01 | 6.67e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 40 | 1.44e-02 | -2.24e-01 | 1.05e-01 |
| GOBP SISTER CHROMATID SEGREGATION | 208 | 2.89e-08 | -2.24e-01 | 3.15e-06 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 25 | 5.32e-02 | -2.23e-01 | 2.35e-01 |
| GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 8 | 2.74e-01 | -2.23e-01 | 5.64e-01 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 216 | 1.63e-08 | -2.23e-01 | 1.93e-06 |
| GOCC SORTING ENDOSOME | 5 | 3.87e-01 | -2.23e-01 | 6.68e-01 |
| GOBP TRNA METHYLATION | 43 | 1.13e-02 | 2.23e-01 | 8.89e-02 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 49 | 6.87e-03 | 2.23e-01 | 6.37e-02 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 8 | 2.74e-01 | -2.23e-01 | 5.65e-01 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 20 | 8.42e-02 | -2.23e-01 | 3.02e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 8 | 2.75e-01 | -2.23e-01 | 5.65e-01 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 186 | 1.62e-07 | -2.23e-01 | 1.27e-05 |
| GOCC MICROTUBULE END | 26 | 4.91e-02 | -2.23e-01 | 2.25e-01 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 20 | 8.44e-02 | -2.23e-01 | 3.02e-01 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 12 | 1.81e-01 | 2.23e-01 | 4.56e-01 |
| GOBP GLYOXYLATE METABOLIC PROCESS | 5 | 3.88e-01 | 2.23e-01 | 6.69e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 43 | 1.15e-02 | 2.23e-01 | 9.02e-02 |
| GOBP PROTEIN DEGLYCOSYLATION | 15 | 1.35e-01 | 2.23e-01 | 3.89e-01 |
| GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 15 | 1.36e-01 | -2.23e-01 | 3.89e-01 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 15 | 1.36e-01 | -2.23e-01 | 3.89e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 40 | 1.51e-02 | -2.22e-01 | 1.09e-01 |
| GOCC SPERM PRINCIPAL PIECE | 17 | 1.13e-01 | 2.22e-01 | 3.53e-01 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 179 | 3.11e-07 | -2.22e-01 | 2.16e-05 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 3.46e-01 | -2.22e-01 | 6.31e-01 |
| GOBP PEROXISOME ORGANIZATION | 34 | 2.51e-02 | 2.22e-01 | 1.50e-01 |
| GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 9 | 2.49e-01 | 2.22e-01 | 5.37e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 16 | 1.24e-01 | -2.22e-01 | 3.71e-01 |
| GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 6 | 3.46e-01 | -2.22e-01 | 6.32e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 11 | 2.02e-01 | -2.22e-01 | 4.82e-01 |
| GOBP MUSCLE CELL PROLIFERATION | 123 | 2.20e-05 | -2.22e-01 | 8.27e-04 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 10 | 2.25e-01 | -2.22e-01 | 5.09e-01 |
| GOCC XY BODY | 12 | 1.84e-01 | -2.22e-01 | 4.59e-01 |
| GOBP MEIOTIC SISTER CHROMATID COHESION | 13 | 1.67e-01 | -2.22e-01 | 4.35e-01 |
| GOBP MYELIN MAINTENANCE | 12 | 1.84e-01 | -2.22e-01 | 4.59e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 13 | 1.67e-01 | -2.22e-01 | 4.35e-01 |
| GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL | 5 | 3.91e-01 | -2.21e-01 | 6.72e-01 |
| GOMF SODIUM ION BINDING | 5 | 3.91e-01 | 2.21e-01 | 6.72e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 97 | 1.66e-04 | -2.21e-01 | 4.50e-03 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 22 | 7.23e-02 | -2.21e-01 | 2.80e-01 |
| GOBP RESPONSE TO MUSCLE STRETCH | 17 | 1.14e-01 | -2.21e-01 | 3.55e-01 |
| GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 8 | 2.79e-01 | 2.21e-01 | 5.68e-01 |
| GOMF COLLAGEN BINDING | 43 | 1.21e-02 | -2.21e-01 | 9.37e-02 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 11 | 2.04e-01 | 2.21e-01 | 4.85e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 51 | 6.34e-03 | -2.21e-01 | 6.03e-02 |
| GOBP POSITIVE REGULATION OF MITOPHAGY | 6 | 3.49e-01 | -2.21e-01 | 6.33e-01 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 10 | 2.26e-01 | 2.21e-01 | 5.11e-01 |
| GOBP HEART FIELD SPECIFICATION | 6 | 3.49e-01 | -2.21e-01 | 6.34e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 16 | 1.26e-01 | -2.21e-01 | 3.75e-01 |
| GOBP HORMONE CATABOLIC PROCESS | 9 | 2.51e-01 | -2.21e-01 | 5.40e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 19 | 9.58e-02 | -2.21e-01 | 3.25e-01 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 23 | 6.69e-02 | -2.21e-01 | 2.69e-01 |
| GOBP POLYAMINE METABOLIC PROCESS | 17 | 1.15e-01 | 2.21e-01 | 3.57e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 5 | 3.93e-01 | -2.21e-01 | 6.73e-01 |
| GOBP TRACHEA MORPHOGENESIS | 7 | 3.12e-01 | -2.20e-01 | 6.01e-01 |
| GOMF MIRNA BINDING | 33 | 2.85e-02 | -2.20e-01 | 1.63e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 83 | 5.23e-04 | -2.20e-01 | 1.02e-02 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 11 | 2.06e-01 | -2.20e-01 | 4.87e-01 |
| GOBP MAST CELL ACTIVATION | 49 | 7.65e-03 | -2.20e-01 | 6.86e-02 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 11 | 2.06e-01 | -2.20e-01 | 4.87e-01 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 14 | 1.54e-01 | -2.20e-01 | 4.16e-01 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 94 | 2.26e-04 | -2.20e-01 | 5.59e-03 |
| GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 15 | 1.40e-01 | -2.20e-01 | 3.96e-01 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 17 | 1.16e-01 | 2.20e-01 | 3.58e-01 |
| GOCC NEURON PROJECTION MEMBRANE | 25 | 5.68e-02 | -2.20e-01 | 2.43e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 54 | 5.16e-03 | -2.20e-01 | 5.26e-02 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 8 | 2.81e-01 | -2.20e-01 | 5.71e-01 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 11 | 2.07e-01 | -2.20e-01 | 4.88e-01 |
| GOBP MALE SEX DIFFERENTIATION | 93 | 2.50e-04 | -2.20e-01 | 6.04e-03 |
| GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION | 5 | 3.94e-01 | 2.20e-01 | 6.74e-01 |
| GOCC MKS COMPLEX | 13 | 1.70e-01 | 2.20e-01 | 4.39e-01 |
| GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 3.95e-01 | -2.20e-01 | 6.75e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 26 | 5.24e-02 | 2.20e-01 | 2.33e-01 |
| GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY | 5 | 3.95e-01 | 2.20e-01 | 6.75e-01 |
| GOMF RNA CAP BINDING | 19 | 9.74e-02 | 2.20e-01 | 3.29e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 15 | 1.41e-01 | -2.20e-01 | 3.98e-01 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 11 | 2.07e-01 | 2.20e-01 | 4.89e-01 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 22 | 7.48e-02 | -2.20e-01 | 2.85e-01 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 169 | 8.90e-07 | -2.19e-01 | 5.44e-05 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 11 | 2.08e-01 | 2.19e-01 | 4.89e-01 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 22 | 7.50e-02 | 2.19e-01 | 2.85e-01 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 45 | 1.09e-02 | -2.19e-01 | 8.77e-02 |
| GOCC LAMININ COMPLEX | 7 | 3.15e-01 | 2.19e-01 | 6.04e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 22 | 7.51e-02 | 2.19e-01 | 2.85e-01 |
| GOBP N GLYCAN PROCESSING | 14 | 1.56e-01 | -2.19e-01 | 4.18e-01 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 124 | 2.57e-05 | -2.19e-01 | 9.42e-04 |
| GOMF RNA POLYMERASE II ACTIVITY | 10 | 2.30e-01 | 2.19e-01 | 5.15e-01 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 7 | 3.16e-01 | -2.19e-01 | 6.05e-01 |
| GOCC GLIAL CELL PROJECTION | 18 | 1.08e-01 | -2.19e-01 | 3.46e-01 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 30 | 3.80e-02 | 2.19e-01 | 1.93e-01 |
| GOBP OSTEOCLAST DIFFERENTIATION | 79 | 7.77e-04 | -2.19e-01 | 1.39e-02 |
| GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 5 | 3.97e-01 | -2.19e-01 | 6.77e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 16 | 1.30e-01 | -2.19e-01 | 3.80e-01 |
| GOBP APICAL PROTEIN LOCALIZATION | 8 | 2.84e-01 | 2.19e-01 | 5.73e-01 |
| GOBP RESPONSE TO INTERLEUKIN 18 | 8 | 2.84e-01 | 2.19e-01 | 5.74e-01 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 34 | 2.74e-02 | -2.19e-01 | 1.59e-01 |
| GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 12 | 1.90e-01 | -2.19e-01 | 4.66e-01 |
| GOBP COPPER ION HOMEOSTASIS | 18 | 1.09e-01 | 2.19e-01 | 3.47e-01 |
| GOCC NPBAF COMPLEX | 14 | 1.57e-01 | -2.18e-01 | 4.21e-01 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 20 | 9.10e-02 | -2.18e-01 | 3.17e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 15 | 1.44e-01 | -2.18e-01 | 4.04e-01 |
| GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 7 | 3.18e-01 | -2.18e-01 | 6.07e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 12 | 1.92e-01 | 2.18e-01 | 4.69e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 9 | 2.58e-01 | 2.18e-01 | 5.48e-01 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 13 | 1.74e-01 | 2.18e-01 | 4.46e-01 |
| GOCC COLLAGEN TRIMER | 31 | 3.61e-02 | -2.18e-01 | 1.88e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 11 | 2.12e-01 | -2.17e-01 | 4.95e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 9 | 2.59e-01 | 2.17e-01 | 5.49e-01 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 30 | 3.96e-02 | -2.17e-01 | 1.97e-01 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 12 | 1.93e-01 | -2.17e-01 | 4.70e-01 |
| GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 7 | 3.20e-01 | -2.17e-01 | 6.09e-01 |
| GOCC MICROBODY MEMBRANE | 59 | 3.95e-03 | 2.17e-01 | 4.47e-02 |
| GOBP GASTRIC ACID SECRETION | 5 | 4.01e-01 | -2.17e-01 | 6.81e-01 |
| GOBP L ALANINE TRANSPORT | 7 | 3.20e-01 | -2.17e-01 | 6.09e-01 |
| GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.20e-01 | -2.17e-01 | 6.09e-01 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 7 | 3.20e-01 | -2.17e-01 | 6.09e-01 |
| GOCC CHAPERONIN CONTAINING T COMPLEX | 9 | 2.60e-01 | 2.17e-01 | 5.50e-01 |
| GOBP INTERLEUKIN 5 PRODUCTION | 8 | 2.88e-01 | -2.17e-01 | 5.78e-01 |
| GOCC ISWI TYPE COMPLEX | 14 | 1.60e-01 | -2.17e-01 | 4.26e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 33 | 3.12e-02 | -2.17e-01 | 1.72e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 18 | 1.11e-01 | 2.17e-01 | 3.51e-01 |
| GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 12 | 1.94e-01 | 2.17e-01 | 4.71e-01 |
| GOBP BASE EXCISION REPAIR AP SITE FORMATION | 11 | 2.14e-01 | 2.16e-01 | 4.97e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 7 | 3.22e-01 | -2.16e-01 | 6.10e-01 |
| GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 6 | 3.59e-01 | -2.16e-01 | 6.45e-01 |
| GOBP TELOMERE CAPPING | 36 | 2.50e-02 | -2.16e-01 | 1.50e-01 |
| GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 14 | 1.62e-01 | 2.16e-01 | 4.29e-01 |
| GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 6 | 3.60e-01 | -2.16e-01 | 6.45e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 102 | 1.67e-04 | -2.16e-01 | 4.50e-03 |
| GOMF SUMO TRANSFERASE ACTIVITY | 24 | 6.72e-02 | -2.16e-01 | 2.69e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 24 | 6.74e-02 | 2.16e-01 | 2.69e-01 |
| GOCC SEX CHROMATIN | 5 | 4.04e-01 | 2.16e-01 | 6.83e-01 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 20 | 9.53e-02 | -2.16e-01 | 3.25e-01 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 42 | 1.57e-02 | -2.15e-01 | 1.12e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 11 | 2.16e-01 | -2.15e-01 | 4.99e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 14 | 1.63e-01 | -2.15e-01 | 4.30e-01 |
| GOMF SMAD BINDING | 61 | 3.66e-03 | -2.15e-01 | 4.23e-02 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 11 | 2.16e-01 | -2.15e-01 | 4.99e-01 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 6 | 3.61e-01 | -2.15e-01 | 6.47e-01 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 12 | 1.97e-01 | -2.15e-01 | 4.76e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 8 | 2.93e-01 | 2.15e-01 | 5.81e-01 |
| GOBP THIAMINE TRANSPORT | 5 | 4.05e-01 | 2.15e-01 | 6.85e-01 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 7 | 3.25e-01 | 2.15e-01 | 6.12e-01 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 7 | 3.25e-01 | -2.15e-01 | 6.12e-01 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 18 | 1.15e-01 | 2.15e-01 | 3.56e-01 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 17 | 1.26e-01 | 2.14e-01 | 3.75e-01 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 11 | 2.18e-01 | -2.14e-01 | 5.01e-01 |
| GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 6 | 3.64e-01 | 2.14e-01 | 6.49e-01 |
| GOBP BONE MORPHOGENESIS | 47 | 1.11e-02 | -2.14e-01 | 8.83e-02 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 9 | 2.66e-01 | -2.14e-01 | 5.57e-01 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 2.42e-01 | -2.14e-01 | 5.28e-01 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.64e-01 | -2.14e-01 | 6.50e-01 |
| GOBP REGULATION OF RNA SPLICING | 151 | 5.96e-06 | -2.14e-01 | 2.71e-04 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 10 | 2.42e-01 | -2.14e-01 | 5.29e-01 |
| GOBP CARDIOBLAST PROLIFERATION | 5 | 4.09e-01 | -2.13e-01 | 6.89e-01 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 92 | 4.10e-04 | -2.13e-01 | 8.57e-03 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 25 | 6.50e-02 | -2.13e-01 | 2.65e-01 |
| GOCC PINOSOME | 6 | 3.66e-01 | -2.13e-01 | 6.51e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 30 | 4.33e-02 | 2.13e-01 | 2.10e-01 |
| GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY | 5 | 4.09e-01 | 2.13e-01 | 6.89e-01 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 12 | 2.01e-01 | 2.13e-01 | 4.81e-01 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 25 | 6.54e-02 | -2.13e-01 | 2.66e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING VIA ENDOSOME | 5 | 4.10e-01 | -2.13e-01 | 6.89e-01 |
| GOBP ERAD PATHWAY | 97 | 2.96e-04 | 2.13e-01 | 6.85e-03 |
| GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 8 | 2.97e-01 | -2.13e-01 | 5.85e-01 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 20 | 9.96e-02 | -2.13e-01 | 3.33e-01 |
| GOMF CHROMATIN DNA BINDING | 80 | 1.01e-03 | -2.13e-01 | 1.70e-02 |
| GOBP NEGATIVE REGULATION OF CYTOKINESIS | 5 | 4.10e-01 | -2.13e-01 | 6.90e-01 |
| GOBP MANNOSE METABOLIC PROCESS | 9 | 2.69e-01 | 2.13e-01 | 5.59e-01 |
| GOCC DENDRITE MEMBRANE | 13 | 1.84e-01 | -2.13e-01 | 4.59e-01 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 3.67e-01 | 2.13e-01 | 6.51e-01 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 14 | 1.69e-01 | -2.13e-01 | 4.38e-01 |
| GOBP CELLULAR RESPONSE TO KETONE | 65 | 3.06e-03 | -2.13e-01 | 3.76e-02 |
| GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 15 | 1.54e-01 | 2.13e-01 | 4.17e-01 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 173 | 1.50e-06 | -2.12e-01 | 8.38e-05 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 17 | 1.30e-01 | -2.12e-01 | 3.80e-01 |
| GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 6 | 3.68e-01 | 2.12e-01 | 6.52e-01 |
| GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 6 | 3.68e-01 | -2.12e-01 | 6.52e-01 |
| GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 3.68e-01 | 2.12e-01 | 6.52e-01 |
| GOMF RETINAL DEHYDROGENASE ACTIVITY | 5 | 4.12e-01 | 2.12e-01 | 6.91e-01 |
| GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS | 11 | 2.23e-01 | -2.12e-01 | 5.07e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 4.12e-01 | 2.12e-01 | 6.91e-01 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 8 | 2.99e-01 | -2.12e-01 | 5.87e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 92 | 4.48e-04 | -2.12e-01 | 9.10e-03 |
| GOBP B CELL DIFFERENTIATION | 103 | 2.05e-04 | -2.12e-01 | 5.35e-03 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 6 | 3.69e-01 | -2.12e-01 | 6.52e-01 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 10 | 2.46e-01 | -2.12e-01 | 5.34e-01 |
| GOBP REGULATION OF T CIRCLE FORMATION | 5 | 4.12e-01 | -2.12e-01 | 6.91e-01 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 14 | 1.70e-01 | -2.12e-01 | 4.39e-01 |
| GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS | 5 | 4.13e-01 | 2.12e-01 | 6.91e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 45 | 1.41e-02 | -2.12e-01 | 1.04e-01 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 71 | 2.08e-03 | -2.11e-01 | 2.87e-02 |
| GOBP MYELOID CELL DEVELOPMENT | 60 | 4.64e-03 | -2.11e-01 | 4.88e-02 |
| GOMF HISTONE H3 KINASE ACTIVITY | 10 | 2.47e-01 | -2.11e-01 | 5.35e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 7 | 3.33e-01 | -2.11e-01 | 6.19e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 5 | 4.13e-01 | 2.11e-01 | 6.92e-01 |
| GOBP DIAPHRAGM DEVELOPMENT | 5 | 4.13e-01 | 2.11e-01 | 6.92e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 88 | 6.24e-04 | -2.11e-01 | 1.16e-02 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 9 | 2.73e-01 | -2.11e-01 | 5.63e-01 |
| GOBP URETER DEVELOPMENT | 5 | 4.14e-01 | -2.11e-01 | 6.92e-01 |
| GOBP SODIUM ION HOMEOSTASIS | 14 | 1.72e-01 | 2.11e-01 | 4.42e-01 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 166 | 2.83e-06 | -2.11e-01 | 1.43e-04 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 22 | 8.68e-02 | -2.11e-01 | 3.07e-01 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 23 | 8.00e-02 | -2.11e-01 | 2.94e-01 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 18 | 1.21e-01 | 2.11e-01 | 3.67e-01 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 10 | 2.48e-01 | -2.11e-01 | 5.36e-01 |
| GOBP CAMP MEDIATED SIGNALING | 31 | 4.23e-02 | -2.11e-01 | 2.06e-01 |
| GOMF PROTEIN FOLDING CHAPERONE | 51 | 9.26e-03 | 2.11e-01 | 7.83e-02 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 24 | 7.40e-02 | 2.11e-01 | 2.83e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 106 | 1.83e-04 | -2.11e-01 | 4.83e-03 |
| GOBP GRANULOCYTE CHEMOTAXIS | 80 | 1.15e-03 | -2.10e-01 | 1.88e-02 |
| GOBP MIDBODY ABSCISSION | 16 | 1.45e-01 | 2.10e-01 | 4.05e-01 |
| GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 38 | 2.50e-02 | -2.10e-01 | 1.50e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 35 | 3.15e-02 | -2.10e-01 | 1.73e-01 |
| GOMF MICROTUBULE MINUS END BINDING | 13 | 1.90e-01 | -2.10e-01 | 4.66e-01 |
| GOBP MITOCHONDRIAL FISSION | 35 | 3.16e-02 | 2.10e-01 | 1.74e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 6 | 3.73e-01 | 2.10e-01 | 6.56e-01 |
| GOCC AGGRESOME | 27 | 5.91e-02 | -2.10e-01 | 2.49e-01 |
| GOBP SEGMENTATION | 48 | 1.19e-02 | -2.10e-01 | 9.24e-02 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 14 | 1.74e-01 | 2.10e-01 | 4.45e-01 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 18 | 1.24e-01 | -2.10e-01 | 3.70e-01 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 14 | 1.74e-01 | -2.10e-01 | 4.46e-01 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 24 | 7.56e-02 | 2.10e-01 | 2.86e-01 |
| GOBP MRNA POLYADENYLATION | 23 | 8.21e-02 | -2.09e-01 | 2.99e-01 |
| GOCC PRC1 COMPLEX | 15 | 1.60e-01 | 2.09e-01 | 4.26e-01 |
| GOBP NEUROTRANSMITTER UPTAKE | 19 | 1.14e-01 | 2.09e-01 | 3.55e-01 |
| GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION | 5 | 4.18e-01 | 2.09e-01 | 6.96e-01 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 107 | 1.86e-04 | -2.09e-01 | 4.89e-03 |
| GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 8 | 3.05e-01 | -2.09e-01 | 5.93e-01 |
| GOBP CELL FATE DETERMINATION | 14 | 1.76e-01 | -2.09e-01 | 4.47e-01 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 16 | 1.48e-01 | -2.09e-01 | 4.08e-01 |
| GOBP SNRNA TRANSPORT | 6 | 3.76e-01 | 2.09e-01 | 6.58e-01 |
| GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 7 | 3.39e-01 | -2.09e-01 | 6.25e-01 |
| GOBP REGULATION OF ORGAN GROWTH | 48 | 1.24e-02 | -2.09e-01 | 9.52e-02 |
| GOBP CHONDROCYTE DIFFERENTIATION | 61 | 4.86e-03 | -2.09e-01 | 5.03e-02 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 142 | 1.84e-05 | -2.09e-01 | 7.01e-04 |
| GOBP MAINTENANCE OF LENS TRANSPARENCY | 6 | 3.77e-01 | -2.08e-01 | 6.59e-01 |
| GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 3.40e-01 | 2.08e-01 | 6.26e-01 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 25 | 7.13e-02 | 2.08e-01 | 2.78e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 3.77e-01 | 2.08e-01 | 6.59e-01 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 19 | 1.16e-01 | -2.08e-01 | 3.58e-01 |
| GOCC CONE PHOTORECEPTOR OUTER SEGMENT | 5 | 4.20e-01 | 2.08e-01 | 6.98e-01 |
| GOBP NOREPINEPHRINE METABOLIC PROCESS | 5 | 4.20e-01 | 2.08e-01 | 6.98e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 5 | 4.20e-01 | -2.08e-01 | 6.98e-01 |
| GOBP CYTIDINE TO URIDINE EDITING | 8 | 3.08e-01 | 2.08e-01 | 5.96e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 53 | 8.79e-03 | -2.08e-01 | 7.56e-02 |
| GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS | 17 | 1.37e-01 | -2.08e-01 | 3.92e-01 |
| GOBP LOCOMOTOR RHYTHM | 11 | 2.32e-01 | -2.08e-01 | 5.16e-01 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 16 | 1.50e-01 | -2.08e-01 | 4.11e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 9 | 2.80e-01 | -2.08e-01 | 5.70e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 6 | 3.78e-01 | -2.08e-01 | 6.60e-01 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 17 | 1.38e-01 | 2.08e-01 | 3.94e-01 |
| GOBP VOCALIZATION BEHAVIOR | 10 | 2.56e-01 | -2.08e-01 | 5.45e-01 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 7 | 3.41e-01 | -2.08e-01 | 6.28e-01 |
| GOCC POLAR MICROTUBULE | 5 | 4.22e-01 | -2.08e-01 | 6.98e-01 |
| GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 6 | 3.79e-01 | -2.08e-01 | 6.60e-01 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 19 | 1.17e-01 | -2.08e-01 | 3.60e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY | 6 | 3.79e-01 | -2.07e-01 | 6.60e-01 |
| GOBP MACROPHAGE CHEMOTAXIS | 30 | 4.93e-02 | -2.07e-01 | 2.25e-01 |
| GOMF TORC2 COMPLEX BINDING | 5 | 4.22e-01 | -2.07e-01 | 6.98e-01 |
| GOBP RECOMBINATIONAL REPAIR | 161 | 5.75e-06 | -2.07e-01 | 2.68e-04 |
| GOBP PRIMARY MIRNA PROCESSING | 17 | 1.39e-01 | -2.07e-01 | 3.95e-01 |
| GOBP AMINO ACID ACTIVATION | 26 | 6.72e-02 | 2.07e-01 | 2.69e-01 |
| GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 7 | 3.42e-01 | 2.07e-01 | 6.28e-01 |
| GOBP PROTEIN POLYGLUTAMYLATION | 7 | 3.42e-01 | 2.07e-01 | 6.28e-01 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 80 | 1.36e-03 | -2.07e-01 | 2.12e-02 |
| GOBP REGULATION OF HEMOPOIESIS | 293 | 1.15e-09 | -2.07e-01 | 2.07e-07 |
| GOMF AMYLOID BETA BINDING | 63 | 4.50e-03 | -2.07e-01 | 4.82e-02 |
| GOCC DYNEIN AXONEMAL PARTICLE | 10 | 2.57e-01 | 2.07e-01 | 5.47e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 7 | 3.43e-01 | -2.07e-01 | 6.28e-01 |
| GOBP CORNIFIED ENVELOPE ASSEMBLY | 5 | 4.23e-01 | 2.07e-01 | 7.00e-01 |
| GOCC LYSOSOMAL LUMEN | 71 | 2.61e-03 | -2.07e-01 | 3.38e-02 |
| GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 8 | 3.11e-01 | -2.07e-01 | 6.00e-01 |
| GOBP DNA CONFORMATION CHANGE | 84 | 1.07e-03 | -2.07e-01 | 1.77e-02 |
| GOBP NEUTROPHIL HOMEOSTASIS | 15 | 1.66e-01 | -2.07e-01 | 4.34e-01 |
| GOBP RUFFLE ASSEMBLY | 35 | 3.44e-02 | -2.07e-01 | 1.83e-01 |
| GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 8 | 3.12e-01 | 2.07e-01 | 6.00e-01 |
| GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 7 | 3.44e-01 | -2.07e-01 | 6.29e-01 |
| GOBP PIGMENT CATABOLIC PROCESS | 6 | 3.81e-01 | 2.07e-01 | 6.62e-01 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 37 | 2.98e-02 | -2.07e-01 | 1.68e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 28 | 5.87e-02 | 2.07e-01 | 2.48e-01 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 15 | 1.66e-01 | -2.06e-01 | 4.35e-01 |
| GOBP OSTEOBLAST DEVELOPMENT | 8 | 3.12e-01 | -2.06e-01 | 6.01e-01 |
| GOCC CATENIN COMPLEX | 8 | 3.12e-01 | -2.06e-01 | 6.01e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 13 | 1.98e-01 | -2.06e-01 | 4.77e-01 |
| GOCC SYNAPTIC CLEFT | 7 | 3.45e-01 | -2.06e-01 | 6.30e-01 |
| GOBP EXTRACELLULAR TRANSPORT | 26 | 6.88e-02 | 2.06e-01 | 2.73e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 10 | 2.59e-01 | -2.06e-01 | 5.49e-01 |
| GOBP EXIT FROM MITOSIS | 29 | 5.48e-02 | -2.06e-01 | 2.39e-01 |
| GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 7 | 3.45e-01 | -2.06e-01 | 6.31e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 8 | 3.13e-01 | -2.06e-01 | 6.01e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 9 | 2.85e-01 | -2.06e-01 | 5.75e-01 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 18 | 1.31e-01 | 2.06e-01 | 3.82e-01 |
| GOCC B WICH COMPLEX | 7 | 3.46e-01 | -2.06e-01 | 6.31e-01 |
| GOMF HISTONE DECROTONYLASE ACTIVITY | 5 | 4.26e-01 | -2.06e-01 | 7.03e-01 |
| GOBP TRANSLATIONAL READTHROUGH | 8 | 3.14e-01 | 2.06e-01 | 6.02e-01 |
| GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 24 | 8.15e-02 | 2.05e-01 | 2.97e-01 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 19 | 1.21e-01 | 2.05e-01 | 3.67e-01 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 14 | 1.84e-01 | 2.05e-01 | 4.59e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE | 6 | 3.84e-01 | 2.05e-01 | 6.66e-01 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 14 | 1.84e-01 | -2.05e-01 | 4.59e-01 |
| GOCC CHITOSOME | 14 | 1.84e-01 | 2.05e-01 | 4.59e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 6 | 3.85e-01 | 2.05e-01 | 6.66e-01 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 19 | 1.22e-01 | 2.05e-01 | 3.68e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 5 | 4.28e-01 | 2.05e-01 | 7.04e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 35 | 3.61e-02 | -2.05e-01 | 1.88e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 9 | 2.88e-01 | 2.05e-01 | 5.78e-01 |
| GOBP REGULATION OF DNA LIGATION | 6 | 3.85e-01 | -2.05e-01 | 6.67e-01 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 15 | 1.70e-01 | 2.05e-01 | 4.39e-01 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 56 | 8.12e-03 | 2.05e-01 | 7.12e-02 |
| GOCC STEREOCILIA COUPLING LINK | 5 | 4.28e-01 | -2.05e-01 | 7.05e-01 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 102 | 3.61e-04 | -2.05e-01 | 7.71e-03 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 11 | 2.40e-01 | -2.05e-01 | 5.26e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 23 | 8.95e-02 | -2.05e-01 | 3.14e-01 |
| GOBP TAXIS | 263 | 1.25e-08 | -2.04e-01 | 1.53e-06 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 17 | 1.45e-01 | -2.04e-01 | 4.04e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 20 | 1.14e-01 | -2.04e-01 | 3.54e-01 |
| GOCC BASEMENT MEMBRANE | 41 | 2.37e-02 | -2.04e-01 | 1.45e-01 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 28 | 6.15e-02 | -2.04e-01 | 2.56e-01 |
| GOCC AMPHISOME | 13 | 2.02e-01 | 2.04e-01 | 4.82e-01 |
| GOBP DUMP METABOLIC PROCESS | 6 | 3.87e-01 | -2.04e-01 | 6.68e-01 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 17 | 1.46e-01 | -2.04e-01 | 4.05e-01 |
| GOBP REGULATION OF MRNA PROCESSING | 105 | 3.11e-04 | -2.04e-01 | 7.08e-03 |
| GOBP CELLULAR RESPONSE TO SALT | 127 | 7.41e-05 | -2.04e-01 | 2.31e-03 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 9 | 2.90e-01 | 2.04e-01 | 5.80e-01 |
| GOBP LIPOPROTEIN LOCALIZATION | 14 | 1.87e-01 | 2.04e-01 | 4.63e-01 |
| GOBP CHROMATIN LOOPING | 11 | 2.42e-01 | -2.04e-01 | 5.29e-01 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 71 | 3.05e-03 | -2.04e-01 | 3.76e-02 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 9 | 2.91e-01 | -2.03e-01 | 5.80e-01 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 80 | 1.67e-03 | 2.03e-01 | 2.43e-02 |
| GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 6 | 3.88e-01 | -2.03e-01 | 6.69e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 50 | 1.29e-02 | 2.03e-01 | 9.77e-02 |
| GOBP ADHESION OF SYMBIONT TO HOST CELL | 5 | 4.31e-01 | -2.03e-01 | 7.06e-01 |
| GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 3.89e-01 | 2.03e-01 | 6.69e-01 |
| GOBP CYTIDINE METABOLIC PROCESS | 9 | 2.91e-01 | 2.03e-01 | 5.80e-01 |
| GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 9 | 2.91e-01 | -2.03e-01 | 5.80e-01 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 9 | 2.91e-01 | 2.03e-01 | 5.80e-01 |
| GOCC COPI COATED VESICLE | 22 | 9.90e-02 | 2.03e-01 | 3.32e-01 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 2.66e-01 | -2.03e-01 | 5.57e-01 |
| GOMF OXYSTEROL BINDING | 7 | 3.52e-01 | -2.03e-01 | 6.38e-01 |
| GOBP CHONDROCYTE DEVELOPMENT | 16 | 1.60e-01 | -2.03e-01 | 4.26e-01 |
| GOBP ASTROCYTE DIFFERENTIATION | 50 | 1.31e-02 | -2.03e-01 | 9.85e-02 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 62 | 5.74e-03 | 2.03e-01 | 5.63e-02 |
| GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION | 7 | 3.53e-01 | 2.03e-01 | 6.38e-01 |
| GOMF MAP KINASE KINASE ACTIVITY | 16 | 1.61e-01 | -2.03e-01 | 4.27e-01 |
| GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 9 | 2.93e-01 | -2.02e-01 | 5.81e-01 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 20 | 1.17e-01 | -2.02e-01 | 3.59e-01 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 18 | 1.37e-01 | -2.02e-01 | 3.91e-01 |
| GOBP POSITIVE REGULATION OF TORC2 SIGNALING | 5 | 4.33e-01 | -2.02e-01 | 7.07e-01 |
| GOBP QUINONE METABOLIC PROCESS | 31 | 5.17e-02 | 2.02e-01 | 2.31e-01 |
| GOBP LEFT RIGHT AXIS SPECIFICATION | 10 | 2.69e-01 | -2.02e-01 | 5.58e-01 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 225 | 1.95e-07 | -2.02e-01 | 1.47e-05 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 231 | 1.35e-07 | -2.02e-01 | 1.08e-05 |
| GOBP PHOSPHATE ION TRANSPORT | 17 | 1.50e-01 | 2.02e-01 | 4.11e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 74 | 2.73e-03 | -2.02e-01 | 3.49e-02 |
| GOBP SYNAPTIC VESICLE COATING | 5 | 4.35e-01 | 2.02e-01 | 7.09e-01 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 37 | 3.40e-02 | -2.01e-01 | 1.82e-01 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 22 | 1.02e-01 | -2.01e-01 | 3.36e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 159 | 1.22e-05 | -2.01e-01 | 5.02e-04 |
| GOBP CELLULAR RESPONSE TO ETHER | 6 | 3.93e-01 | -2.01e-01 | 6.73e-01 |
| GOBP HISTONE DEACETYLATION | 22 | 1.02e-01 | -2.01e-01 | 3.36e-01 |
| GOBP PLASMA CELL DIFFERENTIATION | 6 | 3.93e-01 | -2.01e-01 | 6.73e-01 |
| GOBP CELL CHEMOTAXIS | 186 | 2.35e-06 | -2.01e-01 | 1.21e-04 |
| GOBP RESPONSE TO PROTOZOAN | 19 | 1.29e-01 | -2.01e-01 | 3.80e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 114 | 2.13e-04 | -2.01e-01 | 5.41e-03 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 16 | 1.64e-01 | 2.01e-01 | 4.32e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 3.25e-01 | -2.01e-01 | 6.13e-01 |
| GOBP OXIDATIVE PHOSPHORYLATION | 133 | 6.54e-05 | 2.01e-01 | 2.10e-03 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 12 | 2.29e-01 | 2.01e-01 | 5.14e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 3.58e-01 | 2.01e-01 | 6.44e-01 |
| GOMF LAMIN BINDING | 14 | 1.94e-01 | -2.01e-01 | 4.71e-01 |
| GOMF DIPEPTIDASE ACTIVITY | 11 | 2.49e-01 | -2.01e-01 | 5.37e-01 |
| GOBP L GLUTAMATE IMPORT | 25 | 8.26e-02 | -2.01e-01 | 3.00e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 194 | 1.53e-06 | -2.01e-01 | 8.40e-05 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 132 | 7.11e-05 | -2.01e-01 | 2.24e-03 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 25 | 8.28e-02 | 2.00e-01 | 3.00e-01 |
| GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 9 | 2.98e-01 | -2.00e-01 | 5.86e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 9 | 2.98e-01 | 2.00e-01 | 5.86e-01 |
| GOBP LIPID EXPORT FROM CELL | 27 | 7.17e-02 | 2.00e-01 | 2.79e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 35 | 4.04e-02 | 2.00e-01 | 2.00e-01 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 92 | 9.09e-04 | -2.00e-01 | 1.57e-02 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 12 | 2.30e-01 | -2.00e-01 | 5.15e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 22 | 1.04e-01 | -2.00e-01 | 3.39e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 32 | 5.02e-02 | -2.00e-01 | 2.27e-01 |
| GOBP SYNAPTIC VESICLE DOCKING | 5 | 4.39e-01 | 2.00e-01 | 7.10e-01 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 83 | 1.65e-03 | -2.00e-01 | 2.43e-02 |
| GOCC NEUROMUSCULAR JUNCTION | 48 | 1.66e-02 | -2.00e-01 | 1.16e-01 |
| GOBP RIG I SIGNALING PATHWAY | 24 | 9.02e-02 | -2.00e-01 | 3.15e-01 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 44 | 2.19e-02 | -2.00e-01 | 1.38e-01 |
| GOBP ASSOCIATIVE LEARNING | 48 | 1.67e-02 | -2.00e-01 | 1.16e-01 |
| GOMF TUMOR NECROSIS FACTOR BINDING | 7 | 3.60e-01 | -2.00e-01 | 6.45e-01 |
| GOCC ACROSOMAL MEMBRANE | 13 | 2.13e-01 | -2.00e-01 | 4.95e-01 |
| GOBP TRANSFERRIN TRANSPORT | 8 | 3.28e-01 | -2.00e-01 | 6.15e-01 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 10 | 2.74e-01 | -2.00e-01 | 5.65e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT | 6 | 3.97e-01 | 2.00e-01 | 6.78e-01 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 17 | 1.54e-01 | 2.00e-01 | 4.17e-01 |
| GOCC MPP7 DLG1 LIN7 COMPLEX | 5 | 4.40e-01 | 2.00e-01 | 7.11e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 24 | 9.08e-02 | -2.00e-01 | 3.17e-01 |
| GOMF NAD BINDING | 52 | 1.29e-02 | 1.99e-01 | 9.76e-02 |
| GOCC RISC LOADING COMPLEX | 8 | 3.29e-01 | -1.99e-01 | 6.15e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 23 | 9.79e-02 | 1.99e-01 | 3.29e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 12 | 2.32e-01 | 1.99e-01 | 5.16e-01 |
| GOMF PRE MRNA BINDING | 32 | 5.10e-02 | -1.99e-01 | 2.30e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 68 | 4.51e-03 | 1.99e-01 | 4.82e-02 |
| GOBP ORGAN GROWTH | 91 | 1.03e-03 | -1.99e-01 | 1.72e-02 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 12 | 2.32e-01 | -1.99e-01 | 5.16e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 7 | 3.61e-01 | -1.99e-01 | 6.47e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 17 | 1.55e-01 | 1.99e-01 | 4.18e-01 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 266 | 2.48e-08 | -1.99e-01 | 2.81e-06 |
| GOBP REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS | 6 | 3.99e-01 | -1.99e-01 | 6.79e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 13 | 2.14e-01 | -1.99e-01 | 4.97e-01 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 11 | 2.53e-01 | -1.99e-01 | 5.42e-01 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 61 | 7.22e-03 | -1.99e-01 | 6.59e-02 |
| GOBP NEUROBLAST PROLIFERATION | 36 | 3.90e-02 | -1.99e-01 | 1.95e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 9 | 3.02e-01 | -1.99e-01 | 5.90e-01 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 15 | 1.83e-01 | -1.99e-01 | 4.58e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 18 | 1.44e-01 | -1.99e-01 | 4.04e-01 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 36 | 3.92e-02 | -1.99e-01 | 1.96e-01 |
| GOBP RESPONSE TO DISACCHARIDE | 5 | 4.42e-01 | -1.99e-01 | 7.13e-01 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 147 | 3.34e-05 | -1.99e-01 | 1.18e-03 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 9 | 3.03e-01 | 1.99e-01 | 5.90e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 54 | 1.17e-02 | -1.98e-01 | 9.13e-02 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 17 | 1.57e-01 | -1.98e-01 | 4.21e-01 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 27 | 7.47e-02 | -1.98e-01 | 2.85e-01 |
| GOBP MITOCHONDRIAL TRANSPORT | 169 | 9.12e-06 | 1.98e-01 | 3.91e-04 |
| GOBP INTEGRIN ACTIVATION | 16 | 1.70e-01 | -1.98e-01 | 4.39e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 9 | 3.03e-01 | 1.98e-01 | 5.91e-01 |
| GOBP ZYMOGEN ACTIVATION | 37 | 3.71e-02 | 1.98e-01 | 1.91e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 9 | 3.04e-01 | -1.98e-01 | 5.92e-01 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 43 | 2.48e-02 | -1.98e-01 | 1.49e-01 |
| GOBP RESPONSE TO POTASSIUM ION | 11 | 2.56e-01 | -1.98e-01 | 5.45e-01 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 22 | 1.08e-01 | -1.98e-01 | 3.46e-01 |
| GOBP NEURAL PLATE DEVELOPMENT | 5 | 4.44e-01 | 1.98e-01 | 7.13e-01 |
| GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING | 19 | 1.36e-01 | -1.98e-01 | 3.90e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 9 | 3.05e-01 | -1.98e-01 | 5.93e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT | 13 | 2.17e-01 | -1.98e-01 | 5.00e-01 |
| GOMF CARBOXY LYASE ACTIVITY | 24 | 9.39e-02 | 1.98e-01 | 3.22e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 71 | 4.02e-03 | -1.98e-01 | 4.50e-02 |
| GOBP SPERMINE METABOLIC PROCESS | 5 | 4.44e-01 | 1.98e-01 | 7.13e-01 |
| GOBP ZINC ION IMPORT INTO ORGANELLE | 6 | 4.02e-01 | -1.98e-01 | 6.82e-01 |
| GOBP REGULATION OF HISTONE ACETYLATION | 16 | 1.71e-01 | -1.98e-01 | 4.41e-01 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 18 | 1.47e-01 | 1.97e-01 | 4.07e-01 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 2.80e-01 | -1.97e-01 | 5.70e-01 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 1.27e-01 | 1.97e-01 | 3.76e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 5 | 4.45e-01 | -1.97e-01 | 7.13e-01 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 14 | 2.02e-01 | -1.97e-01 | 4.81e-01 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 41 | 2.90e-02 | -1.97e-01 | 1.65e-01 |
| GOCC GATOR2 COMPLEX | 5 | 4.45e-01 | 1.97e-01 | 7.13e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 5 | 4.45e-01 | -1.97e-01 | 7.13e-01 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 7 | 3.67e-01 | -1.97e-01 | 6.51e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 19 | 1.37e-01 | -1.97e-01 | 3.91e-01 |
| GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 6 | 4.03e-01 | 1.97e-01 | 6.83e-01 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 7 | 3.67e-01 | -1.97e-01 | 6.51e-01 |
| GOBP THYROID GLAND DEVELOPMENT | 18 | 1.48e-01 | -1.97e-01 | 4.08e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 15 | 1.87e-01 | -1.97e-01 | 4.63e-01 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 25 | 8.84e-02 | -1.97e-01 | 3.11e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 6 | 4.04e-01 | -1.97e-01 | 6.83e-01 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 13 | 2.20e-01 | -1.97e-01 | 5.03e-01 |
| GOCC RNAI EFFECTOR COMPLEX | 22 | 1.10e-01 | -1.97e-01 | 3.49e-01 |
| GOMF CHEMOREPELLENT ACTIVITY | 12 | 2.38e-01 | -1.97e-01 | 5.24e-01 |
| GOBP ENTRY OF BACTERIUM INTO HOST CELL | 7 | 3.68e-01 | 1.97e-01 | 6.52e-01 |
| GOBP NEUTROPHIL MIGRATION | 82 | 2.10e-03 | -1.97e-01 | 2.90e-02 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 34 | 4.74e-02 | -1.97e-01 | 2.21e-01 |
| GOBP REGULATION OF PINOCYTOSIS | 9 | 3.07e-01 | -1.96e-01 | 5.96e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 37 | 3.88e-02 | 1.96e-01 | 1.94e-01 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 18 | 1.49e-01 | -1.96e-01 | 4.10e-01 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 59 | 9.11e-03 | -1.96e-01 | 7.74e-02 |
| GOMF NADP RETINOL DEHYDROGENASE ACTIVITY | 10 | 2.82e-01 | 1.96e-01 | 5.72e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 13 | 2.20e-01 | -1.96e-01 | 5.03e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 13 | 2.21e-01 | 1.96e-01 | 5.03e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 7 | 3.69e-01 | -1.96e-01 | 6.52e-01 |
| GOCC PERICENTRIC HETEROCHROMATIN | 29 | 6.75e-02 | -1.96e-01 | 2.70e-01 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 13 | 2.21e-01 | -1.96e-01 | 5.04e-01 |
| GOBP SNRNA PROCESSING | 26 | 8.35e-02 | 1.96e-01 | 3.01e-01 |
| GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION | 5 | 4.48e-01 | -1.96e-01 | 7.16e-01 |
| GOBP METANEPHROS MORPHOGENESIS | 12 | 2.40e-01 | -1.96e-01 | 5.26e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT | 5 | 4.48e-01 | 1.96e-01 | 7.16e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 16 | 1.75e-01 | 1.96e-01 | 4.46e-01 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 9 | 3.09e-01 | 1.96e-01 | 5.97e-01 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 20 | 1.29e-01 | -1.96e-01 | 3.80e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 21 | 1.20e-01 | -1.96e-01 | 3.65e-01 |
| GOBP RESPONSE TO ESTROGEN | 42 | 2.82e-02 | -1.96e-01 | 1.63e-01 |
| GOBP ASYMMETRIC NEUROBLAST DIVISION | 5 | 4.49e-01 | 1.96e-01 | 7.17e-01 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 11 | 2.61e-01 | -1.96e-01 | 5.51e-01 |
| GOBP NADH OXIDATION | 5 | 4.49e-01 | 1.96e-01 | 7.17e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 32 | 5.55e-02 | -1.96e-01 | 2.41e-01 |
| GOBP POSITIVE T CELL SELECTION | 24 | 9.72e-02 | -1.96e-01 | 3.28e-01 |
| GOBP ENDODERMAL CELL DIFFERENTIATION | 28 | 7.34e-02 | -1.96e-01 | 2.82e-01 |
| GOBP MALE GENITALIA DEVELOPMENT | 8 | 3.39e-01 | -1.95e-01 | 6.25e-01 |
| GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX | 8 | 3.39e-01 | 1.95e-01 | 6.25e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 13 | 2.23e-01 | 1.95e-01 | 5.07e-01 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 42 | 2.88e-02 | -1.95e-01 | 1.64e-01 |
| GOBP T CELL DIFFERENTIATION | 219 | 6.94e-07 | -1.95e-01 | 4.46e-05 |
| GOMF PEPTIDE BINDING | 198 | 2.34e-06 | -1.95e-01 | 1.21e-04 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 6 | 4.08e-01 | 1.95e-01 | 6.88e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 19 | 1.41e-01 | -1.95e-01 | 3.99e-01 |
| GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT | 6 | 4.08e-01 | 1.95e-01 | 6.88e-01 |
| GOCC RESPIRASOME | 90 | 1.41e-03 | 1.95e-01 | 2.18e-02 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 45 | 2.38e-02 | 1.95e-01 | 1.45e-01 |
| GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 7 | 3.72e-01 | 1.95e-01 | 6.56e-01 |
| GOBP T CELL PROLIFERATION | 154 | 3.14e-05 | -1.95e-01 | 1.12e-03 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 83 | 2.19e-03 | -1.95e-01 | 2.98e-02 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 3.72e-01 | -1.95e-01 | 6.56e-01 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 18 | 1.53e-01 | 1.95e-01 | 4.15e-01 |
| GOBP TRNA MODIFICATION | 92 | 1.27e-03 | 1.95e-01 | 2.02e-02 |
| GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 6 | 4.10e-01 | -1.94e-01 | 6.89e-01 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 10 | 2.87e-01 | -1.94e-01 | 5.78e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 71 | 4.66e-03 | -1.94e-01 | 4.88e-02 |
| GOBP INTERLEUKIN 8 PRODUCTION | 57 | 1.12e-02 | -1.94e-01 | 8.86e-02 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 21 | 1.23e-01 | -1.94e-01 | 3.70e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 22 | 1.15e-01 | 1.94e-01 | 3.56e-01 |
| GOBP RESPONSE TO IRON ION | 22 | 1.15e-01 | -1.94e-01 | 3.57e-01 |
| GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 7 | 3.74e-01 | 1.94e-01 | 6.56e-01 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 49 | 1.88e-02 | 1.94e-01 | 1.26e-01 |
| GOBP RETINA LAYER FORMATION | 12 | 2.44e-01 | 1.94e-01 | 5.31e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 10 | 2.88e-01 | -1.94e-01 | 5.78e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 8 | 3.42e-01 | -1.94e-01 | 6.28e-01 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 38 | 3.86e-02 | -1.94e-01 | 1.94e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 31 | 6.17e-02 | -1.94e-01 | 2.56e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 77 | 3.28e-03 | -1.94e-01 | 3.94e-02 |
| GOCC INNER KINETOCHORE | 17 | 1.66e-01 | -1.94e-01 | 4.35e-01 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 22 | 1.16e-01 | -1.94e-01 | 3.57e-01 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 18 | 1.55e-01 | 1.94e-01 | 4.17e-01 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 35 | 4.73e-02 | -1.94e-01 | 2.21e-01 |
| GOBP RESPONSE TO FOLIC ACID | 6 | 4.11e-01 | -1.94e-01 | 6.90e-01 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 16 | 1.80e-01 | -1.94e-01 | 4.54e-01 |
| GOMF LAMININ BINDING | 15 | 1.94e-01 | 1.94e-01 | 4.71e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 4.11e-01 | -1.94e-01 | 6.91e-01 |
| GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 4.54e-01 | -1.94e-01 | 7.22e-01 |
| GOMF ACTIVIN RECEPTOR BINDING | 5 | 4.54e-01 | 1.94e-01 | 7.22e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 236 | 3.28e-07 | -1.93e-01 | 2.26e-05 |
| GOCC U2 SNRNP | 25 | 9.42e-02 | 1.93e-01 | 3.23e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 11 | 2.67e-01 | -1.93e-01 | 5.57e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 2.67e-01 | 1.93e-01 | 5.57e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 28 | 7.68e-02 | -1.93e-01 | 2.88e-01 |
| GOBP ICOSANOID TRANSPORT | 27 | 8.24e-02 | 1.93e-01 | 2.99e-01 |
| GOBP PYRIMIDINE DIMER REPAIR | 9 | 3.16e-01 | 1.93e-01 | 6.05e-01 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 26 | 8.84e-02 | -1.93e-01 | 3.11e-01 |
| GOBP REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 5 | 4.55e-01 | 1.93e-01 | 7.23e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 10 | 2.91e-01 | -1.93e-01 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 13 | 2.28e-01 | -1.93e-01 | 5.14e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 11 | 2.68e-01 | -1.93e-01 | 5.57e-01 |
| GOBP SEQUESTERING OF IRON ION | 5 | 4.55e-01 | 1.93e-01 | 7.23e-01 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 33 | 5.55e-02 | 1.93e-01 | 2.41e-01 |
| GOBP RESPONSE TO SODIUM PHOSPHATE | 5 | 4.56e-01 | -1.93e-01 | 7.24e-01 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 8 | 3.46e-01 | 1.93e-01 | 6.31e-01 |
| GOBP PHOTOPERIODISM | 23 | 1.10e-01 | -1.93e-01 | 3.48e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 42 | 3.09e-02 | -1.93e-01 | 1.71e-01 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 4.14e-01 | -1.93e-01 | 6.92e-01 |
| GOBP RESPONSE TO AMPHETAMINE | 14 | 2.13e-01 | -1.92e-01 | 4.95e-01 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 20 | 1.36e-01 | 1.92e-01 | 3.90e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 13 | 2.30e-01 | -1.92e-01 | 5.15e-01 |
| GOBP URATE METABOLIC PROCESS | 5 | 4.56e-01 | 1.92e-01 | 7.24e-01 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 56 | 1.29e-02 | -1.92e-01 | 9.76e-02 |
| GOBP PSEUDOPODIUM ORGANIZATION | 11 | 2.70e-01 | -1.92e-01 | 5.59e-01 |
| GOBP SEX DIFFERENTIATION | 146 | 6.22e-05 | -1.92e-01 | 2.02e-03 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 67 | 6.54e-03 | 1.92e-01 | 6.16e-02 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 29 | 7.34e-02 | -1.92e-01 | 2.82e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 25 | 9.64e-02 | -1.92e-01 | 3.27e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 83 | 2.51e-03 | -1.92e-01 | 3.28e-02 |
| GOMF HELICASE ACTIVITY | 138 | 1.00e-04 | -1.92e-01 | 2.98e-03 |
| GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 5 | 4.57e-01 | -1.92e-01 | 7.25e-01 |
| GOBP NEGATIVE REGULATION OF CELL VOLUME | 5 | 4.57e-01 | -1.92e-01 | 7.25e-01 |
| GOBP GTP METABOLIC PROCESS | 22 | 1.19e-01 | 1.92e-01 | 3.63e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 35 | 4.96e-02 | -1.92e-01 | 2.26e-01 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 129 | 1.71e-04 | -1.92e-01 | 4.56e-03 |
| GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 5 | 4.58e-01 | -1.92e-01 | 7.25e-01 |
| GOMF PROTEIN GERANYLGERANYLTRANSFERASE ACTIVITY | 5 | 4.58e-01 | 1.92e-01 | 7.25e-01 |
| GOBP RETINA HOMEOSTASIS | 39 | 3.83e-02 | -1.92e-01 | 1.93e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 13 | 2.31e-01 | -1.92e-01 | 5.15e-01 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 2.31e-01 | -1.92e-01 | 5.15e-01 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 225 | 7.67e-07 | -1.92e-01 | 4.86e-05 |
| GOBP STRAND INVASION | 5 | 4.58e-01 | -1.92e-01 | 7.25e-01 |
| GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 11 | 2.71e-01 | -1.92e-01 | 5.61e-01 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 146 | 6.65e-05 | -1.91e-01 | 2.12e-03 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 49 | 2.05e-02 | -1.91e-01 | 1.33e-01 |
| GOBP RESPONSE TO BMP | 85 | 2.31e-03 | -1.91e-01 | 3.11e-02 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 85 | 2.31e-03 | 1.91e-01 | 3.11e-02 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 30 | 6.99e-02 | 1.91e-01 | 2.75e-01 |
| GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 6 | 4.17e-01 | 1.91e-01 | 6.96e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 5 | 4.59e-01 | 1.91e-01 | 7.26e-01 |
| GOCC FLEMMING BODY | 31 | 6.57e-02 | -1.91e-01 | 2.66e-01 |
| GOBP PLASMA MEMBRANE REPAIR | 26 | 9.18e-02 | 1.91e-01 | 3.18e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 6 | 4.18e-01 | -1.91e-01 | 6.96e-01 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 97 | 1.18e-03 | -1.91e-01 | 1.92e-02 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY | 7 | 3.82e-01 | -1.91e-01 | 6.64e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 7 | 3.82e-01 | -1.91e-01 | 6.64e-01 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 12 | 2.53e-01 | -1.91e-01 | 5.42e-01 |
| GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 3.22e-01 | -1.91e-01 | 6.10e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 15 | 2.02e-01 | -1.90e-01 | 4.81e-01 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 10 | 2.97e-01 | -1.90e-01 | 5.85e-01 |
| GOCC BLEB | 9 | 3.23e-01 | -1.90e-01 | 6.10e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 36 | 4.83e-02 | -1.90e-01 | 2.24e-01 |
| GOBP GRANULOCYTE DIFFERENTIATION | 32 | 6.27e-02 | -1.90e-01 | 2.58e-01 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 5 | 4.62e-01 | -1.90e-01 | 7.28e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 27 | 8.76e-02 | -1.90e-01 | 3.09e-01 |
| GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 6 | 4.21e-01 | -1.90e-01 | 6.98e-01 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 13 | 2.36e-01 | -1.90e-01 | 5.20e-01 |
| GOBP LEUKOCYTE PROLIFERATION | 235 | 5.69e-07 | -1.90e-01 | 3.77e-05 |
| GOBP RESPONSE TO DSRNA | 34 | 5.56e-02 | -1.90e-01 | 2.41e-01 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 9 | 3.25e-01 | 1.90e-01 | 6.12e-01 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 23 | 1.16e-01 | -1.90e-01 | 3.57e-01 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 62 | 9.88e-03 | 1.90e-01 | 8.17e-02 |
| GOBP HEART VALVE DEVELOPMENT | 42 | 3.36e-02 | -1.90e-01 | 1.80e-01 |
| GOBP COPPER ION IMPORT | 5 | 4.63e-01 | -1.90e-01 | 7.30e-01 |
| GOCC ESCRT COMPLEX | 26 | 9.45e-02 | 1.90e-01 | 3.23e-01 |
| GOBP AXONEME ASSEMBLY | 40 | 3.82e-02 | 1.90e-01 | 1.93e-01 |
| GOBP INNER DYNEIN ARM ASSEMBLY | 6 | 4.22e-01 | 1.89e-01 | 6.98e-01 |
| GOBP L LYSINE TRANSPORT | 6 | 4.22e-01 | 1.89e-01 | 6.98e-01 |
| GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.22e-01 | 1.89e-01 | 6.98e-01 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 50 | 2.06e-02 | -1.89e-01 | 1.33e-01 |
| GOBP COBALAMIN TRANSPORT | 5 | 4.63e-01 | -1.89e-01 | 7.30e-01 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 30 | 7.27e-02 | 1.89e-01 | 2.80e-01 |
| GOBP BRADYKININ CATABOLIC PROCESS | 6 | 4.22e-01 | -1.89e-01 | 6.99e-01 |
| GOBP MAGNESIUM ION HOMEOSTASIS | 7 | 3.86e-01 | 1.89e-01 | 6.67e-01 |
| GOCC TRAPPIII PROTEIN COMPLEX | 12 | 2.57e-01 | 1.89e-01 | 5.47e-01 |
| GOCC PLATELET ALPHA GRANULE LUMEN | 43 | 3.22e-02 | -1.89e-01 | 1.76e-01 |
| GOBP LOCOMOTORY EXPLORATION BEHAVIOR | 6 | 4.23e-01 | -1.89e-01 | 7.00e-01 |
| GOMF POLYSACCHARIDE BINDING | 12 | 2.57e-01 | -1.89e-01 | 5.47e-01 |
| GOMF HISTONE BINDING | 215 | 1.94e-06 | -1.89e-01 | 1.05e-04 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 291 | 3.34e-08 | -1.89e-01 | 3.56e-06 |
| GOCC PRECATALYTIC SPLICEOSOME | 52 | 1.87e-02 | 1.89e-01 | 1.25e-01 |
| GOBP REGULATION OF OSSIFICATION | 69 | 6.80e-03 | -1.89e-01 | 6.34e-02 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 18 | 1.66e-01 | -1.89e-01 | 4.35e-01 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 41 | 3.70e-02 | -1.88e-01 | 1.90e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 8 | 3.56e-01 | -1.88e-01 | 6.43e-01 |
| GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 5 | 4.66e-01 | 1.88e-01 | 7.31e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 8 | 3.56e-01 | 1.88e-01 | 6.43e-01 |
| GOCC PHOTORECEPTOR DISC MEMBRANE | 8 | 3.56e-01 | 1.88e-01 | 6.43e-01 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 87 | 2.43e-03 | -1.88e-01 | 3.20e-02 |
| GOBP REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY | 7 | 3.88e-01 | 1.88e-01 | 6.69e-01 |
| GOBP EMBRYONIC HEMOPOIESIS | 15 | 2.07e-01 | -1.88e-01 | 4.88e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 10 | 3.03e-01 | -1.88e-01 | 5.90e-01 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 111 | 6.24e-04 | -1.88e-01 | 1.16e-02 |
| GOBP ATRIOVENTRICULAR VALVE FORMATION | 5 | 4.66e-01 | 1.88e-01 | 7.31e-01 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 17 | 1.80e-01 | -1.88e-01 | 4.54e-01 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 4.25e-01 | -1.88e-01 | 7.02e-01 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 11 | 2.80e-01 | 1.88e-01 | 5.70e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 9 | 3.29e-01 | -1.88e-01 | 6.16e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 12 | 2.60e-01 | -1.88e-01 | 5.50e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 21 | 1.36e-01 | -1.88e-01 | 3.90e-01 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 115 | 5.12e-04 | 1.88e-01 | 1.00e-02 |
| GOBP AUTOPHAGY OF PEROXISOME | 10 | 3.04e-01 | -1.88e-01 | 5.92e-01 |
| GOBP VESICLE FUSION TO PLASMA MEMBRANE | 11 | 2.81e-01 | 1.88e-01 | 5.71e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 7 | 3.90e-01 | -1.88e-01 | 6.71e-01 |
| GOMF S ADENOSYL L METHIONINE BINDING | 16 | 1.94e-01 | 1.88e-01 | 4.71e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES | 6 | 4.26e-01 | 1.88e-01 | 7.03e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 225 | 1.33e-06 | 1.88e-01 | 7.58e-05 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 25 | 1.05e-01 | -1.87e-01 | 3.40e-01 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 38 | 4.56e-02 | 1.87e-01 | 2.16e-01 |
| GOMF NEUROPEPTIDE ACTIVITY | 9 | 3.30e-01 | -1.87e-01 | 6.16e-01 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 8 | 3.59e-01 | 1.87e-01 | 6.45e-01 |
| GOBP PRESYNAPTIC ACTIVE ZONE ORGANIZATION | 5 | 4.68e-01 | 1.87e-01 | 7.33e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 6 | 4.27e-01 | -1.87e-01 | 7.04e-01 |
| GOBP GOLGI RIBBON FORMATION | 9 | 3.31e-01 | 1.87e-01 | 6.16e-01 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 9 | 3.31e-01 | -1.87e-01 | 6.16e-01 |
| GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 6 | 4.27e-01 | -1.87e-01 | 7.04e-01 |
| GOBP RESPONSE TO MINERALOCORTICOID | 20 | 1.47e-01 | -1.87e-01 | 4.07e-01 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 37 | 4.90e-02 | -1.87e-01 | 2.25e-01 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 168 | 2.96e-05 | -1.87e-01 | 1.07e-03 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 72 | 6.10e-03 | 1.87e-01 | 5.85e-02 |
| GOMF PHOSPHATIDYLSERINE FLIPPASE ACTIVITY | 5 | 4.69e-01 | -1.87e-01 | 7.33e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 79 | 4.09e-03 | 1.87e-01 | 4.54e-02 |
| GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 3.92e-01 | 1.87e-01 | 6.72e-01 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 30 | 7.66e-02 | -1.87e-01 | 2.88e-01 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 35 | 5.59e-02 | -1.87e-01 | 2.41e-01 |
| GOBP UV PROTECTION | 10 | 3.06e-01 | -1.87e-01 | 5.95e-01 |
| GOMF FAD BINDING | 32 | 6.76e-02 | 1.87e-01 | 2.70e-01 |
| GOCC TUBULAR ENDOSOME | 5 | 4.70e-01 | -1.87e-01 | 7.33e-01 |
| GOMF SULFURTRANSFERASE ACTIVITY | 11 | 2.84e-01 | 1.87e-01 | 5.73e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 22 | 1.30e-01 | -1.87e-01 | 3.80e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 70 | 6.99e-03 | -1.87e-01 | 6.45e-02 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 51 | 2.13e-02 | 1.86e-01 | 1.35e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 3.93e-01 | 1.86e-01 | 6.73e-01 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 137 | 1.70e-04 | -1.86e-01 | 4.55e-03 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 143 | 1.23e-04 | -1.86e-01 | 3.53e-03 |
| GOBP LATE NUCLEOPHAGY | 7 | 3.94e-01 | -1.86e-01 | 6.74e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 30 | 7.79e-02 | -1.86e-01 | 2.90e-01 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 69 | 7.61e-03 | -1.86e-01 | 6.84e-02 |
| GOCC SPINDLE POLE CENTROSOME | 13 | 2.46e-01 | -1.86e-01 | 5.33e-01 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 12 | 2.65e-01 | 1.86e-01 | 5.55e-01 |
| GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 3.63e-01 | -1.86e-01 | 6.48e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 15 | 2.13e-01 | -1.86e-01 | 4.96e-01 |
| GOMF HISTONE MODIFYING ACTIVITY | 185 | 1.37e-05 | -1.86e-01 | 5.47e-04 |
| GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 6 | 4.31e-01 | -1.86e-01 | 7.06e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 48 | 2.62e-02 | -1.86e-01 | 1.54e-01 |
| GOMF GLUCOSIDASE ACTIVITY | 6 | 4.31e-01 | -1.86e-01 | 7.06e-01 |
| GOCC TERTIARY GRANULE LUMEN | 42 | 3.75e-02 | -1.86e-01 | 1.91e-01 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 5 | 4.73e-01 | -1.85e-01 | 7.35e-01 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 14 | 2.30e-01 | 1.85e-01 | 5.15e-01 |
| GOCC SHELTERIN COMPLEX | 6 | 4.32e-01 | 1.85e-01 | 7.06e-01 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 11 | 2.87e-01 | -1.85e-01 | 5.78e-01 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 23 | 1.24e-01 | -1.85e-01 | 3.71e-01 |
| GOMF PRERIBOSOME BINDING | 8 | 3.65e-01 | 1.85e-01 | 6.50e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 8 | 3.65e-01 | 1.85e-01 | 6.50e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 11 | 2.88e-01 | -1.85e-01 | 5.78e-01 |
| GOBP GRANULOCYTE MIGRATION | 98 | 1.57e-03 | -1.85e-01 | 2.34e-02 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 14 | 2.31e-01 | -1.85e-01 | 5.15e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 12 | 2.68e-01 | 1.85e-01 | 5.57e-01 |
| GOCC MYOSIN II COMPLEX | 10 | 3.12e-01 | 1.85e-01 | 6.00e-01 |
| GOBP CHROMOSOME ORGANIZATION | 514 | 1.01e-12 | -1.85e-01 | 3.10e-10 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 21 | 1.43e-01 | -1.85e-01 | 4.02e-01 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 60 | 1.34e-02 | -1.85e-01 | 9.99e-02 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 22 | 1.34e-01 | -1.85e-01 | 3.87e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 18 | 1.75e-01 | -1.85e-01 | 4.47e-01 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 11 | 2.90e-01 | -1.84e-01 | 5.80e-01 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 23 | 1.26e-01 | -1.84e-01 | 3.74e-01 |
| GOBP LONG TERM MEMORY | 21 | 1.44e-01 | -1.84e-01 | 4.03e-01 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 28 | 9.15e-02 | -1.84e-01 | 3.18e-01 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 17 | 1.88e-01 | 1.84e-01 | 4.64e-01 |
| GOBP PROTEIN DESUMOYLATION | 8 | 3.67e-01 | -1.84e-01 | 6.51e-01 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 94 | 2.05e-03 | -1.84e-01 | 2.83e-02 |
| GOBP PIGMENT GRANULE LOCALIZATION | 22 | 1.35e-01 | 1.84e-01 | 3.88e-01 |
| GOBP MELANOCYTE DIFFERENTIATION | 13 | 2.50e-01 | -1.84e-01 | 5.39e-01 |
| GOBP CHROMOSOME SEGREGATION | 366 | 1.68e-09 | -1.84e-01 | 2.79e-07 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 17 | 1.89e-01 | 1.84e-01 | 4.66e-01 |
| GOBP DEFENSE RESPONSE TO TUMOR CELL | 11 | 2.91e-01 | -1.84e-01 | 5.80e-01 |
| GOBP RNA METHYLATION | 88 | 2.87e-03 | 1.84e-01 | 3.62e-02 |
| GOBP RNA MODIFICATION | 166 | 4.48e-05 | 1.84e-01 | 1.52e-03 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 30 | 8.14e-02 | -1.84e-01 | 2.97e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 102 | 1.35e-03 | -1.84e-01 | 2.11e-02 |
| GOMF CYCLASE ACTIVITY | 16 | 2.03e-01 | -1.84e-01 | 4.83e-01 |
| GOBP GTP BIOSYNTHETIC PROCESS | 9 | 3.40e-01 | 1.84e-01 | 6.26e-01 |
| GOBP PROTEIN REFOLDING | 23 | 1.27e-01 | 1.84e-01 | 3.77e-01 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 18 | 1.77e-01 | -1.84e-01 | 4.50e-01 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 67 | 9.40e-03 | -1.84e-01 | 7.94e-02 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 191 | 1.26e-05 | -1.84e-01 | 5.16e-04 |
| GOMF SIALIC ACID BINDING | 11 | 2.92e-01 | -1.84e-01 | 5.81e-01 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 31 | 7.72e-02 | -1.83e-01 | 2.89e-01 |
| GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING | 6 | 4.37e-01 | 1.83e-01 | 7.09e-01 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 23 | 1.28e-01 | 1.83e-01 | 3.78e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 21 | 1.46e-01 | -1.83e-01 | 4.05e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 233 | 1.52e-06 | -1.83e-01 | 8.38e-05 |
| GOBP DEDIFFERENTIATION | 5 | 4.78e-01 | 1.83e-01 | 7.40e-01 |
| GOMF COPPER ION BINDING | 37 | 5.42e-02 | 1.83e-01 | 2.37e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 54 | 2.01e-02 | 1.83e-01 | 1.31e-01 |
| GOBP REGULATION OF PROTEIN NEDDYLATION | 19 | 1.68e-01 | 1.83e-01 | 4.36e-01 |
| GOCC CONDENSED CHROMOSOME | 244 | 9.13e-07 | -1.83e-01 | 5.51e-05 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 11 | 2.94e-01 | 1.83e-01 | 5.82e-01 |
| GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 6 | 4.38e-01 | 1.83e-01 | 7.10e-01 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 20 | 1.57e-01 | 1.83e-01 | 4.20e-01 |
| GOCC CCR4 NOT COMPLEX | 14 | 2.36e-01 | -1.83e-01 | 5.21e-01 |
| GOBP PINOCYTOSIS | 18 | 1.80e-01 | -1.83e-01 | 4.54e-01 |
| GOCC RIPOPTOSOME | 6 | 4.38e-01 | -1.83e-01 | 7.10e-01 |
| GOBP POLYOL CATABOLIC PROCESS | 7 | 4.03e-01 | -1.83e-01 | 6.82e-01 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 13 | 2.54e-01 | -1.83e-01 | 5.43e-01 |
| GOBP ALPHA BETA T CELL ACTIVATION | 122 | 5.01e-04 | -1.83e-01 | 9.84e-03 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 30 | 8.36e-02 | -1.83e-01 | 3.01e-01 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 14 | 2.37e-01 | -1.83e-01 | 5.22e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION | 53 | 2.17e-02 | -1.82e-01 | 1.37e-01 |
| GOMF INTEGRIN BINDING | 89 | 2.97e-03 | -1.82e-01 | 3.70e-02 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 10 | 3.18e-01 | 1.82e-01 | 6.07e-01 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 12 | 2.74e-01 | 1.82e-01 | 5.65e-01 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 12 | 2.74e-01 | -1.82e-01 | 5.65e-01 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 215 | 4.33e-06 | -1.82e-01 | 2.05e-04 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 10 | 3.18e-01 | -1.82e-01 | 6.07e-01 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 337 | 1.02e-08 | -1.82e-01 | 1.27e-06 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 11 | 2.96e-01 | -1.82e-01 | 5.84e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 33 | 7.03e-02 | -1.82e-01 | 2.76e-01 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 15 | 2.22e-01 | -1.82e-01 | 5.06e-01 |
| GOCC LATERAL PART OF CELL | 5 | 4.81e-01 | -1.82e-01 | 7.40e-01 |
| GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 4.40e-01 | -1.82e-01 | 7.11e-01 |
| GOBP SINGLE STRAND BREAK REPAIR | 10 | 3.19e-01 | -1.82e-01 | 6.08e-01 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 14 | 2.38e-01 | -1.82e-01 | 5.24e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 16 | 2.08e-01 | 1.82e-01 | 4.89e-01 |
| GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM | 5 | 4.81e-01 | 1.82e-01 | 7.40e-01 |
| GOBP CERAMIDE CATABOLIC PROCESS | 12 | 2.75e-01 | -1.82e-01 | 5.65e-01 |
| GOBP MEMBRANE HYPERPOLARIZATION | 5 | 4.81e-01 | -1.82e-01 | 7.40e-01 |
| GOBP FORELIMB MORPHOGENESIS | 16 | 2.08e-01 | -1.82e-01 | 4.89e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 45 | 3.49e-02 | -1.82e-01 | 1.84e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 4.40e-01 | 1.82e-01 | 7.11e-01 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 36 | 5.91e-02 | 1.82e-01 | 2.49e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS | 152 | 1.12e-04 | -1.82e-01 | 3.27e-03 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 11 | 2.97e-01 | -1.82e-01 | 5.85e-01 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 55 | 1.98e-02 | -1.82e-01 | 1.30e-01 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 48 | 2.95e-02 | -1.82e-01 | 1.67e-01 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 15 | 2.23e-01 | -1.82e-01 | 5.07e-01 |
| GOBP REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT | 5 | 4.82e-01 | 1.82e-01 | 7.41e-01 |
| GOMF ORNITHINE DECARBOXYLASE REGULATOR ACTIVITY | 5 | 4.82e-01 | 1.82e-01 | 7.41e-01 |
| GOBP HEART FORMATION | 15 | 2.23e-01 | -1.82e-01 | 5.07e-01 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 24 | 1.24e-01 | 1.81e-01 | 3.71e-01 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 40 | 4.73e-02 | -1.81e-01 | 2.21e-01 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 32 | 7.60e-02 | 1.81e-01 | 2.87e-01 |
| GOBP MRNA SPLICE SITE RECOGNITION | 29 | 9.12e-02 | -1.81e-01 | 3.17e-01 |
| GOMF STEROL TRANSPORTER ACTIVITY | 24 | 1.24e-01 | -1.81e-01 | 3.71e-01 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 16 | 2.09e-01 | -1.81e-01 | 4.91e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 8 | 3.75e-01 | 1.81e-01 | 6.57e-01 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 32 | 7.61e-02 | 1.81e-01 | 2.87e-01 |
| GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE | 5 | 4.83e-01 | 1.81e-01 | 7.41e-01 |
| GOBP CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY | 5 | 4.83e-01 | -1.81e-01 | 7.41e-01 |
| GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 11 | 2.99e-01 | -1.81e-01 | 5.86e-01 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 66 | 1.10e-02 | -1.81e-01 | 8.80e-02 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 23 | 1.33e-01 | -1.81e-01 | 3.86e-01 |
| GOCC TRAPP COMPLEX | 15 | 2.25e-01 | 1.81e-01 | 5.10e-01 |
| GOBP LAMELLIPODIUM ASSEMBLY | 48 | 3.03e-02 | -1.81e-01 | 1.69e-01 |
| GOBP LEUKOCYTE DIFFERENTIATION | 438 | 1.06e-10 | -1.81e-01 | 2.47e-08 |
| GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 3.76e-01 | -1.81e-01 | 6.58e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 28 | 9.81e-02 | -1.81e-01 | 3.30e-01 |
| GOBP T CELL SELECTION | 32 | 7.72e-02 | -1.81e-01 | 2.89e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 34 | 6.86e-02 | -1.81e-01 | 2.73e-01 |
| GOBP BIOLOGICAL PHASE | 5 | 4.85e-01 | -1.80e-01 | 7.43e-01 |
| GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 7 | 4.08e-01 | 1.80e-01 | 6.89e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 67 | 1.07e-02 | -1.80e-01 | 8.65e-02 |
| GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 6 | 4.44e-01 | -1.80e-01 | 7.13e-01 |
| GOBP PIGMENT METABOLIC PROCESS | 53 | 2.32e-02 | 1.80e-01 | 1.43e-01 |
| GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 6 | 4.45e-01 | 1.80e-01 | 7.13e-01 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 9 | 3.49e-01 | -1.80e-01 | 6.34e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 113 | 9.52e-04 | -1.80e-01 | 1.62e-02 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 91 | 3.02e-03 | 1.80e-01 | 3.75e-02 |
| GOBP DIENCEPHALON DEVELOPMENT | 26 | 1.12e-01 | -1.80e-01 | 3.52e-01 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 14 | 2.44e-01 | -1.80e-01 | 5.30e-01 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 18 | 1.87e-01 | -1.80e-01 | 4.62e-01 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 14 | 2.44e-01 | -1.80e-01 | 5.30e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 3.51e-01 | -1.80e-01 | 6.35e-01 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 37 | 5.87e-02 | -1.80e-01 | 2.48e-01 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 23 | 1.36e-01 | 1.80e-01 | 3.90e-01 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 12 | 2.82e-01 | 1.79e-01 | 5.71e-01 |
| GOMF THIAMINE PYROPHOSPHATE BINDING | 5 | 4.87e-01 | -1.79e-01 | 7.45e-01 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 913 | 8.58e-20 | -1.79e-01 | 1.85e-16 |
| GOBP RESPONSE TO ACIDIC PH | 15 | 2.29e-01 | -1.79e-01 | 5.14e-01 |
| GOBP VESICLE COATING | 38 | 5.60e-02 | 1.79e-01 | 2.41e-01 |
| GOBP REGULATION OF T CELL ACTIVATION | 264 | 5.79e-07 | -1.79e-01 | 3.81e-05 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 662 | 5.86e-15 | -1.79e-01 | 3.61e-12 |
| GOBP INTERLEUKIN 17 PRODUCTION | 27 | 1.07e-01 | -1.79e-01 | 3.45e-01 |
| GOCC ANAPHASE PROMOTING COMPLEX | 20 | 1.66e-01 | 1.79e-01 | 4.34e-01 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 12 | 2.83e-01 | -1.79e-01 | 5.72e-01 |
| GOBP REGULATION OF NUCLEAR DIVISION | 107 | 1.40e-03 | -1.79e-01 | 2.16e-02 |
| GOBP CIRCADIAN RHYTHM | 136 | 3.20e-04 | -1.79e-01 | 7.23e-03 |
| GOBP INTERLEUKIN 4 PRODUCTION | 21 | 1.56e-01 | -1.79e-01 | 4.19e-01 |
| GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN | 110 | 1.21e-03 | 1.79e-01 | 1.96e-02 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 22 | 1.47e-01 | 1.79e-01 | 4.07e-01 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 86 | 4.20e-03 | 1.79e-01 | 4.60e-02 |
| GOBP FIBROBLAST MIGRATION | 43 | 4.27e-02 | -1.79e-01 | 2.08e-01 |
| GOBP FOREBRAIN CELL MIGRATION | 36 | 6.37e-02 | -1.79e-01 | 2.61e-01 |
| GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING | 5 | 4.89e-01 | -1.79e-01 | 7.47e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 105 | 1.59e-03 | -1.79e-01 | 2.35e-02 |
| GOBP RESPONSE TO STEROID HORMONE | 212 | 7.79e-06 | -1.79e-01 | 3.41e-04 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 13 | 2.65e-01 | -1.79e-01 | 5.55e-01 |
| GOCC LEWY BODY | 7 | 4.13e-01 | -1.79e-01 | 6.92e-01 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 11 | 3.05e-01 | 1.79e-01 | 5.93e-01 |
| GOBP ACETYL COA METABOLIC PROCESS | 28 | 1.03e-01 | -1.78e-01 | 3.37e-01 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 13 | 2.66e-01 | -1.78e-01 | 5.56e-01 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 20 | 1.68e-01 | -1.78e-01 | 4.36e-01 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 20 | 1.68e-01 | -1.78e-01 | 4.36e-01 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 8 | 3.83e-01 | 1.78e-01 | 6.64e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 28 | 1.03e-01 | -1.78e-01 | 3.37e-01 |
| GOMF RNA DNA HYBRID RIBONUCLEASE ACTIVITY | 5 | 4.90e-01 | -1.78e-01 | 7.47e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 24 | 1.31e-01 | -1.78e-01 | 3.83e-01 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 10 | 3.30e-01 | -1.78e-01 | 6.16e-01 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 18 | 1.91e-01 | 1.78e-01 | 4.68e-01 |
| GOBP DETECTION OF BIOTIC STIMULUS | 24 | 1.31e-01 | -1.78e-01 | 3.83e-01 |
| GOMF MAP KINASE ACTIVITY | 12 | 2.86e-01 | -1.78e-01 | 5.75e-01 |
| GOMF VITAMIN B6 BINDING | 35 | 6.86e-02 | 1.78e-01 | 2.72e-01 |
| GOBP MEMBRANE FISSION | 41 | 4.87e-02 | 1.78e-01 | 2.25e-01 |
| GOBP REGULATION OF MYELINATION | 29 | 9.75e-02 | -1.78e-01 | 3.29e-01 |
| GOBP MEMBRANE BIOGENESIS | 48 | 3.31e-02 | 1.78e-01 | 1.79e-01 |
| GOMF PRIMARY MIRNA BINDING | 10 | 3.30e-01 | -1.78e-01 | 6.16e-01 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 9 | 3.56e-01 | -1.78e-01 | 6.42e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 15 | 2.33e-01 | -1.78e-01 | 5.16e-01 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 53 | 2.53e-02 | -1.78e-01 | 1.51e-01 |
| GOCC TERMINAL BOUTON | 18 | 1.92e-01 | -1.78e-01 | 4.69e-01 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 265 | 6.98e-07 | -1.78e-01 | 4.46e-05 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 8 | 3.85e-01 | -1.77e-01 | 6.66e-01 |
| GOBP HIPPO SIGNALING | 29 | 9.83e-02 | -1.77e-01 | 3.30e-01 |
| GOBP COENZYME A METABOLIC PROCESS | 19 | 1.81e-01 | 1.77e-01 | 4.55e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 5 | 4.92e-01 | -1.77e-01 | 7.48e-01 |
| GOMF THIOESTERASE BINDING | 9 | 3.57e-01 | 1.77e-01 | 6.43e-01 |
| GOBP SERINE TRANSPORT | 8 | 3.86e-01 | -1.77e-01 | 6.67e-01 |
| GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.86e-01 | -1.77e-01 | 6.67e-01 |
| GOBP CELLULAR RESPONSE TO UV | 76 | 7.64e-03 | -1.77e-01 | 6.86e-02 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 213 | 8.78e-06 | -1.77e-01 | 3.80e-04 |
| GOBP ASTROCYTE DEVELOPMENT | 26 | 1.18e-01 | -1.77e-01 | 3.62e-01 |
| GOBP ANOIKIS | 27 | 1.11e-01 | -1.77e-01 | 3.51e-01 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 13 | 2.69e-01 | -1.77e-01 | 5.59e-01 |
| GOBP FATTY ACID CATABOLIC PROCESS | 83 | 5.35e-03 | 1.77e-01 | 5.35e-02 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 87 | 4.36e-03 | -1.77e-01 | 4.73e-02 |
| GOBP FOREBRAIN DEVELOPMENT | 223 | 5.57e-06 | -1.77e-01 | 2.61e-04 |
| GOBP TELOMERIC LOOP DISASSEMBLY | 8 | 3.86e-01 | -1.77e-01 | 6.67e-01 |
| GOCC SIN3 TYPE COMPLEX | 22 | 1.51e-01 | -1.77e-01 | 4.12e-01 |
| GOBP ORGAN INDUCTION | 6 | 4.54e-01 | -1.77e-01 | 7.22e-01 |
| GOCC CHROMOSOMAL REGION | 347 | 1.74e-08 | -1.77e-01 | 2.03e-06 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 44 | 4.27e-02 | -1.77e-01 | 2.08e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 11 | 3.10e-01 | -1.77e-01 | 5.99e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 6 | 4.54e-01 | 1.77e-01 | 7.22e-01 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 58 | 2.01e-02 | 1.77e-01 | 1.31e-01 |
| GOBP DNA REPLICATION INITIATION | 32 | 8.42e-02 | -1.76e-01 | 3.02e-01 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 13 | 2.71e-01 | 1.76e-01 | 5.60e-01 |
| GOCC MLL3 4 COMPLEX | 12 | 2.90e-01 | -1.76e-01 | 5.80e-01 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 24 | 1.35e-01 | -1.76e-01 | 3.89e-01 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 21 | 1.62e-01 | 1.76e-01 | 4.29e-01 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 9 | 3.60e-01 | 1.76e-01 | 6.45e-01 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 25 | 1.28e-01 | -1.76e-01 | 3.77e-01 |
| GOBP ALANINE TRANSPORT | 11 | 3.12e-01 | -1.76e-01 | 6.01e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 35 | 7.16e-02 | 1.76e-01 | 2.79e-01 |
| GOCC BRCA1 C COMPLEX | 6 | 4.56e-01 | -1.76e-01 | 7.24e-01 |
| GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS | 8 | 3.89e-01 | 1.76e-01 | 6.70e-01 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 15 | 2.39e-01 | 1.76e-01 | 5.24e-01 |
| GOMF SERINE HYDROLASE ACTIVITY | 82 | 6.00e-03 | -1.76e-01 | 5.79e-02 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 9 | 3.62e-01 | -1.76e-01 | 6.47e-01 |
| GOCC WNT SIGNALOSOME | 9 | 3.62e-01 | -1.76e-01 | 6.47e-01 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 38 | 6.13e-02 | -1.75e-01 | 2.55e-01 |
| GOMF PEPTIDE HORMONE RECEPTOR BINDING | 5 | 4.97e-01 | 1.75e-01 | 7.51e-01 |
| GOMF LIPID KINASE ACTIVITY | 35 | 7.26e-02 | -1.75e-01 | 2.80e-01 |
| GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION | 5 | 4.97e-01 | -1.75e-01 | 7.51e-01 |
| GOBP NUCLEOSOME ORGANIZATION | 59 | 1.99e-02 | -1.75e-01 | 1.30e-01 |
| GOBP RESPONSE TO ACTIVITY | 48 | 3.56e-02 | -1.75e-01 | 1.86e-01 |
| GOBP PLATELET ACTIVATION | 88 | 4.50e-03 | -1.75e-01 | 4.82e-02 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 20 | 1.75e-01 | 1.75e-01 | 4.46e-01 |
| GOCC ENZYME ACTIVATOR COMPLEX | 16 | 2.25e-01 | 1.75e-01 | 5.10e-01 |
| GOBP ENDOSOMAL LUMEN ACIDIFICATION | 13 | 2.75e-01 | 1.75e-01 | 5.65e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 5 | 4.98e-01 | -1.75e-01 | 7.51e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 14 | 2.58e-01 | -1.75e-01 | 5.47e-01 |
| GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 7 | 4.23e-01 | 1.75e-01 | 7.00e-01 |
| GOBP RESPONSE TO KETONE | 121 | 9.17e-04 | -1.75e-01 | 1.58e-02 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 14 | 2.58e-01 | 1.75e-01 | 5.48e-01 |
| GOCC VACUOLAR LUMEN | 131 | 5.74e-04 | -1.74e-01 | 1.08e-02 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 24 | 1.39e-01 | -1.74e-01 | 3.95e-01 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 19 | 1.88e-01 | -1.74e-01 | 4.64e-01 |
| GOBP INFLAMMATORY RESPONSE | 526 | 1.01e-11 | -1.74e-01 | 2.73e-09 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 41 | 5.40e-02 | -1.74e-01 | 2.37e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 108 | 1.81e-03 | -1.74e-01 | 2.56e-02 |
| GOBP TYPE 2 IMMUNE RESPONSE | 28 | 1.11e-01 | -1.74e-01 | 3.51e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 395 | 3.53e-09 | -1.74e-01 | 5.04e-07 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 29 | 1.05e-01 | -1.74e-01 | 3.41e-01 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 82 | 6.56e-03 | -1.74e-01 | 6.17e-02 |
| GOBP POSITIVE REGULATION OF MYELINATION | 9 | 3.67e-01 | -1.74e-01 | 6.51e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 57 | 2.34e-02 | -1.74e-01 | 1.43e-01 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 287 | 4.44e-07 | -1.74e-01 | 3.02e-05 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 8 | 3.95e-01 | -1.74e-01 | 6.75e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 18 | 2.02e-01 | -1.74e-01 | 4.82e-01 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 15 | 2.44e-01 | -1.74e-01 | 5.30e-01 |
| GOBP ELECTRON TRANSPORT CHAIN | 151 | 2.36e-04 | 1.74e-01 | 5.77e-03 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 6 | 4.62e-01 | -1.74e-01 | 7.28e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 19 | 1.90e-01 | 1.74e-01 | 4.67e-01 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 14 | 2.61e-01 | 1.73e-01 | 5.51e-01 |
| GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 5 | 5.02e-01 | 1.73e-01 | 7.54e-01 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 86 | 5.49e-03 | -1.73e-01 | 5.45e-02 |
| GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 5.02e-01 | 1.73e-01 | 7.54e-01 |
| GOMF BETA CATENIN BINDING | 56 | 2.50e-02 | -1.73e-01 | 1.50e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 28 | 1.13e-01 | -1.73e-01 | 3.52e-01 |
| GOMF KINASE ACTIVATOR ACTIVITY | 99 | 2.94e-03 | -1.73e-01 | 3.68e-02 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 32 | 9.03e-02 | 1.73e-01 | 3.15e-01 |
| GOMF MHC PROTEIN BINDING | 21 | 1.70e-01 | -1.73e-01 | 4.39e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 7 | 4.28e-01 | -1.73e-01 | 7.05e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 8 | 3.97e-01 | -1.73e-01 | 6.78e-01 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 13 | 2.81e-01 | -1.73e-01 | 5.70e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 21 | 1.71e-01 | -1.73e-01 | 4.40e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 200 | 2.65e-05 | -1.73e-01 | 9.65e-04 |
| GOCC U6 SNRNP | 8 | 3.98e-01 | 1.73e-01 | 6.78e-01 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 8 | 3.98e-01 | -1.73e-01 | 6.78e-01 |
| GOBP POSITIVE REGULATION OF HYPERSENSITIVITY | 5 | 5.04e-01 | -1.73e-01 | 7.54e-01 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 24 | 1.44e-01 | -1.73e-01 | 4.03e-01 |
| GOCC CHROMOSOME CENTROMERIC REGION | 223 | 9.52e-06 | -1.72e-01 | 4.04e-04 |
| GOCC TRNA METHYLTRANSFERASE COMPLEX | 7 | 4.29e-01 | 1.72e-01 | 7.05e-01 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 5 | 5.04e-01 | -1.72e-01 | 7.54e-01 |
| GOBP GOLGI VESICLE BUDDING | 10 | 3.45e-01 | -1.72e-01 | 6.31e-01 |
| GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 6 | 4.65e-01 | -1.72e-01 | 7.30e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 9 | 3.71e-01 | -1.72e-01 | 6.54e-01 |
| GOBP CELL JUNCTION DISASSEMBLY | 16 | 2.33e-01 | -1.72e-01 | 5.16e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 80 | 7.77e-03 | -1.72e-01 | 6.93e-02 |
| GOBP HEMOPOIESIS | 670 | 4.32e-14 | -1.72e-01 | 2.07e-11 |
| GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 11 | 3.23e-01 | -1.72e-01 | 6.10e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 62 | 1.91e-02 | 1.72e-01 | 1.27e-01 |
| GOMF GLUCOSE BINDING | 9 | 3.71e-01 | -1.72e-01 | 6.55e-01 |
| GOCC PRE SNORNP COMPLEX | 7 | 4.30e-01 | 1.72e-01 | 7.05e-01 |
| GOBP RESPONSE TO ESTRADIOL | 69 | 1.35e-02 | -1.72e-01 | 1.00e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 17 | 2.19e-01 | -1.72e-01 | 5.02e-01 |
| GOBP CELLULAR SENESCENCE | 80 | 7.85e-03 | -1.72e-01 | 6.97e-02 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 19 | 1.94e-01 | 1.72e-01 | 4.71e-01 |
| GOMF ANNEALING ACTIVITY | 9 | 3.72e-01 | -1.72e-01 | 6.56e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 14 | 2.66e-01 | 1.72e-01 | 5.56e-01 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 8 | 4.00e-01 | -1.72e-01 | 6.80e-01 |
| GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 11 | 3.24e-01 | 1.72e-01 | 6.11e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 27 | 1.23e-01 | -1.72e-01 | 3.69e-01 |
| GOBP DEFENSE RESPONSE TO FUNGUS | 21 | 1.74e-01 | -1.72e-01 | 4.45e-01 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 18 | 2.08e-01 | -1.71e-01 | 4.89e-01 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 14 | 2.67e-01 | -1.71e-01 | 5.57e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 23 | 1.55e-01 | -1.71e-01 | 4.18e-01 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 8 | 4.02e-01 | 1.71e-01 | 6.82e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 8 | 4.02e-01 | -1.71e-01 | 6.82e-01 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 44 | 4.96e-02 | -1.71e-01 | 2.26e-01 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 34 | 8.43e-02 | -1.71e-01 | 3.02e-01 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 26 | 1.31e-01 | 1.71e-01 | 3.83e-01 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 21 | 1.75e-01 | -1.71e-01 | 4.46e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 22 | 1.65e-01 | 1.71e-01 | 4.33e-01 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 38 | 6.82e-02 | 1.71e-01 | 2.71e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 8 | 4.02e-01 | -1.71e-01 | 6.82e-01 |
| GOBP AMINO ACID SALVAGE | 5 | 5.08e-01 | 1.71e-01 | 7.56e-01 |
| GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 5.08e-01 | 1.71e-01 | 7.56e-01 |
| GOBP LAMELLIPODIUM ORGANIZATION | 65 | 1.72e-02 | -1.71e-01 | 1.19e-01 |
| GOBP COMPLEMENT ACTIVATION | 29 | 1.11e-01 | -1.71e-01 | 3.51e-01 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 36 | 7.63e-02 | -1.71e-01 | 2.87e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 31 | 1.00e-01 | -1.71e-01 | 3.33e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 36 | 7.63e-02 | 1.71e-01 | 2.87e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1091 | 5.01e-21 | -1.71e-01 | 1.44e-17 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 40 | 6.20e-02 | -1.71e-01 | 2.57e-01 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 17 | 2.23e-01 | 1.71e-01 | 5.07e-01 |
| GOBP GUANINE NUCLEOTIDE TRANSPORT | 8 | 4.03e-01 | -1.71e-01 | 6.83e-01 |
| GOCC NURF COMPLEX | 7 | 4.35e-01 | -1.70e-01 | 7.09e-01 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 151 | 3.07e-04 | -1.70e-01 | 7.04e-03 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 12 | 3.07e-01 | -1.70e-01 | 5.95e-01 |
| GOBP MIRNA PROCESSING | 40 | 6.24e-02 | -1.70e-01 | 2.57e-01 |
| GOCC NUCLEOID | 42 | 5.63e-02 | 1.70e-01 | 2.42e-01 |
| GOBP MEIOTIC CYTOKINESIS | 6 | 4.70e-01 | 1.70e-01 | 7.33e-01 |
| GOMF DEUBIQUITINASE ACTIVATOR ACTIVITY | 5 | 5.10e-01 | 1.70e-01 | 7.57e-01 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 12 | 3.07e-01 | -1.70e-01 | 5.96e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 12 | 3.08e-01 | 1.70e-01 | 5.96e-01 |
| GOBP REGULATION OF PHAGOCYTOSIS | 72 | 1.26e-02 | -1.70e-01 | 9.62e-02 |
| GOBP REGULATION OF CELL DEVELOPMENT | 529 | 2.82e-11 | -1.70e-01 | 7.14e-09 |
| GOCC RNA POLYMERASE COMPLEX | 95 | 4.22e-03 | 1.70e-01 | 4.61e-02 |
| GOCC ER UBIQUITIN LIGASE COMPLEX | 7 | 4.36e-01 | 1.70e-01 | 7.09e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 227 | 1.07e-05 | -1.70e-01 | 4.46e-04 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 20 | 1.88e-01 | 1.70e-01 | 4.64e-01 |
| GOBP METENCEPHALON DEVELOPMENT | 69 | 1.47e-02 | -1.70e-01 | 1.07e-01 |
| GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 11 | 3.29e-01 | -1.70e-01 | 6.16e-01 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 9 | 3.78e-01 | -1.70e-01 | 6.59e-01 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 149 | 3.54e-04 | -1.70e-01 | 7.63e-03 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 184 | 7.35e-05 | -1.70e-01 | 2.30e-03 |
| GOMF TAU PROTEIN BINDING | 38 | 7.04e-02 | -1.70e-01 | 2.76e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 10 | 3.53e-01 | -1.70e-01 | 6.39e-01 |
| GOBP NEURON MATURATION | 28 | 1.20e-01 | -1.70e-01 | 3.65e-01 |
| GOBP STARTLE RESPONSE | 13 | 2.90e-01 | -1.70e-01 | 5.80e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 48 | 4.23e-02 | 1.70e-01 | 2.06e-01 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 115 | 1.71e-03 | -1.69e-01 | 2.47e-02 |
| GOBP MEMBRANE REPOLARIZATION | 25 | 1.43e-01 | 1.69e-01 | 4.01e-01 |
| GOBP PEXOPHAGY | 6 | 4.73e-01 | -1.69e-01 | 7.35e-01 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 4.73e-01 | -1.69e-01 | 7.35e-01 |
| GOMF ATP GATED ION CHANNEL ACTIVITY | 6 | 4.73e-01 | 1.69e-01 | 7.35e-01 |
| GOCC KATANIN COMPLEX | 5 | 5.12e-01 | 1.69e-01 | 7.59e-01 |
| GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 4.73e-01 | 1.69e-01 | 7.35e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 4.73e-01 | 1.69e-01 | 7.35e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 6 | 4.73e-01 | 1.69e-01 | 7.35e-01 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 56 | 2.86e-02 | -1.69e-01 | 1.64e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 56 | 2.86e-02 | -1.69e-01 | 1.64e-01 |
| GOBP PIGMENT GRANULE ORGANIZATION | 37 | 7.51e-02 | 1.69e-01 | 2.85e-01 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 24 | 1.52e-01 | 1.69e-01 | 4.13e-01 |
| GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 5.13e-01 | 1.69e-01 | 7.59e-01 |
| GOMF CYCLIN BINDING | 32 | 9.80e-02 | -1.69e-01 | 3.30e-01 |
| GOBP MYELOID CELL DIFFERENTIATION | 314 | 2.84e-07 | -1.69e-01 | 2.02e-05 |
| GOBP AXONOGENESIS INVOLVED IN INNERVATION | 5 | 5.13e-01 | -1.69e-01 | 7.59e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 14 | 2.74e-01 | -1.69e-01 | 5.64e-01 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 13 | 2.92e-01 | -1.69e-01 | 5.81e-01 |
| GOBP REGULATION OF BONE MINERALIZATION | 45 | 5.01e-02 | -1.69e-01 | 2.27e-01 |
| GOBP POSITIVE CHEMOTAXIS | 28 | 1.22e-01 | -1.69e-01 | 3.68e-01 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 10 | 3.55e-01 | -1.69e-01 | 6.42e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 7 | 4.39e-01 | 1.69e-01 | 7.11e-01 |
| GOBP POST EMBRYONIC DEVELOPMENT | 69 | 1.54e-02 | -1.69e-01 | 1.10e-01 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 96 | 4.30e-03 | -1.69e-01 | 4.69e-02 |
| GOBP NEURON CELL CELL ADHESION | 6 | 4.74e-01 | -1.69e-01 | 7.37e-01 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 64 | 1.97e-02 | -1.69e-01 | 1.29e-01 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 43 | 5.60e-02 | -1.68e-01 | 2.41e-01 |
| GOBP MITOCHONDRION ORGANIZATION | 491 | 2.02e-10 | 1.68e-01 | 4.35e-08 |
| GOMF CARGO RECEPTOR ACTIVITY | 40 | 6.54e-02 | -1.68e-01 | 2.66e-01 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 6 | 4.75e-01 | -1.68e-01 | 7.37e-01 |
| GOBP VESICLE TETHERING TO GOLGI | 5 | 5.15e-01 | -1.68e-01 | 7.60e-01 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 98 | 4.04e-03 | -1.68e-01 | 4.51e-02 |
| GOBP SNRNA TRANSCRIPTION | 17 | 2.30e-01 | -1.68e-01 | 5.15e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 4.41e-01 | -1.68e-01 | 7.12e-01 |
| GOBP LOCOMOTION | 746 | 8.77e-15 | -1.68e-01 | 5.04e-12 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 16 | 2.44e-01 | -1.68e-01 | 5.30e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 10 | 3.57e-01 | 1.68e-01 | 6.43e-01 |
| GOMF CHROMATIN BINDING | 453 | 1.06e-09 | -1.68e-01 | 2.02e-07 |
| GOMF SINGLE STRANDED RNA BINDING | 68 | 1.67e-02 | -1.68e-01 | 1.16e-01 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 185 | 8.40e-05 | -1.68e-01 | 2.59e-03 |
| GOMF HISTONE CHAPERONE ACTIVITY | 11 | 3.35e-01 | -1.68e-01 | 6.21e-01 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 25 | 1.46e-01 | -1.68e-01 | 4.07e-01 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 30 | 1.12e-01 | 1.68e-01 | 3.51e-01 |
| GOBP ISOCITRATE METABOLIC PROCESS | 6 | 4.77e-01 | 1.68e-01 | 7.38e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 6 | 4.77e-01 | 1.68e-01 | 7.38e-01 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 30 | 1.12e-01 | -1.68e-01 | 3.52e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY | 5 | 5.16e-01 | 1.68e-01 | 7.61e-01 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 19 | 2.06e-01 | 1.68e-01 | 4.87e-01 |
| GOBP PROTEIN DELIPIDATION | 5 | 5.16e-01 | 1.68e-01 | 7.61e-01 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 98 | 4.19e-03 | -1.68e-01 | 4.60e-02 |
| GOBP PALLIUM DEVELOPMENT | 115 | 1.94e-03 | -1.68e-01 | 2.71e-02 |
| GOMF RECEPTOR ANTAGONIST ACTIVITY | 5 | 5.17e-01 | 1.67e-01 | 7.61e-01 |
| GOBP BONE DEVELOPMENT | 122 | 1.42e-03 | -1.67e-01 | 2.19e-02 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 3.85e-01 | -1.67e-01 | 6.66e-01 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 8 | 4.12e-01 | -1.67e-01 | 6.91e-01 |
| GOBP NEUROTRANSMITTER CATABOLIC PROCESS | 6 | 4.78e-01 | -1.67e-01 | 7.39e-01 |
| GOCC AXOLEMMA | 8 | 4.12e-01 | -1.67e-01 | 6.91e-01 |
| GOBP JNK CASCADE | 129 | 1.05e-03 | -1.67e-01 | 1.75e-02 |
| GOBP REGULATION OF CELL KILLING | 69 | 1.63e-02 | -1.67e-01 | 1.15e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 22 | 1.75e-01 | -1.67e-01 | 4.46e-01 |
| GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 3.60e-01 | 1.67e-01 | 6.45e-01 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 11 | 3.37e-01 | -1.67e-01 | 6.24e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 18 | 2.20e-01 | 1.67e-01 | 5.03e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 141 | 6.27e-04 | -1.67e-01 | 1.17e-02 |
| GOMF MYOSIN II BINDING | 7 | 4.44e-01 | 1.67e-01 | 7.13e-01 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 45 | 5.27e-02 | -1.67e-01 | 2.34e-01 |
| GOBP INTERLEUKIN 2 PRODUCTION | 46 | 5.02e-02 | -1.67e-01 | 2.27e-01 |
| GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 8 | 4.13e-01 | 1.67e-01 | 6.92e-01 |
| GOMF MOLECULAR TAG ACTIVITY | 12 | 3.17e-01 | 1.67e-01 | 6.06e-01 |
| GOMF ADENYLATE CYCLASE ACTIVITY | 10 | 3.61e-01 | -1.67e-01 | 6.46e-01 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 13 | 2.97e-01 | 1.67e-01 | 5.85e-01 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 33 | 9.71e-02 | 1.67e-01 | 3.28e-01 |
| GOBP CAMP BIOSYNTHETIC PROCESS | 7 | 4.45e-01 | -1.67e-01 | 7.13e-01 |
| GOBP DEHYDROASCORBIC ACID TRANSPORT | 5 | 5.18e-01 | -1.67e-01 | 7.63e-01 |
| GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.18e-01 | -1.67e-01 | 7.63e-01 |
| GOMF D GLUCOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.18e-01 | -1.67e-01 | 7.63e-01 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 3.61e-01 | 1.67e-01 | 6.47e-01 |
| GOCC GOLGI TRANSPORT COMPLEX | 9 | 3.87e-01 | 1.67e-01 | 6.67e-01 |
| GOCC ATAC COMPLEX | 13 | 2.98e-01 | 1.67e-01 | 5.86e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 8 | 4.15e-01 | 1.67e-01 | 6.92e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 4.45e-01 | -1.67e-01 | 7.13e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION | 6 | 4.80e-01 | -1.67e-01 | 7.40e-01 |
| GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 19 | 2.09e-01 | -1.67e-01 | 4.90e-01 |
| GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 4.46e-01 | -1.66e-01 | 7.14e-01 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 26 | 1.42e-01 | -1.66e-01 | 4.00e-01 |
| GOMF ATPASE REGULATOR ACTIVITY | 44 | 5.62e-02 | 1.66e-01 | 2.42e-01 |
| GOBP MICROTUBULE NUCLEATION | 44 | 5.63e-02 | -1.66e-01 | 2.42e-01 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 20 | 1.98e-01 | 1.66e-01 | 4.77e-01 |
| GOBP DUMP CATABOLIC PROCESS | 5 | 5.20e-01 | -1.66e-01 | 7.64e-01 |
| GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY | 6 | 4.81e-01 | -1.66e-01 | 7.40e-01 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 165 | 2.34e-04 | -1.66e-01 | 5.75e-03 |
| GOBP AUTOPHAGOSOME LYSOSOME FUSION | 9 | 3.88e-01 | 1.66e-01 | 6.69e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 11 | 3.40e-01 | 1.66e-01 | 6.26e-01 |
| GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 6 | 4.81e-01 | 1.66e-01 | 7.40e-01 |
| GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 6 | 4.81e-01 | -1.66e-01 | 7.40e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 135 | 8.77e-04 | -1.66e-01 | 1.52e-02 |
| GOBP SIRNA PROCESSING | 8 | 4.16e-01 | 1.66e-01 | 6.94e-01 |
| GOBP BASIC AMINO ACID TRANSPORT | 14 | 2.82e-01 | 1.66e-01 | 5.72e-01 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 156 | 3.57e-04 | -1.66e-01 | 7.67e-03 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 19 | 2.11e-01 | -1.66e-01 | 4.93e-01 |
| GOBP DENDRITE MORPHOGENESIS | 89 | 6.88e-03 | -1.66e-01 | 6.38e-02 |
| GOBP DENDRITE ARBORIZATION | 5 | 5.21e-01 | -1.66e-01 | 7.65e-01 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 293 | 1.13e-06 | -1.66e-01 | 6.62e-05 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 31 | 1.10e-01 | -1.66e-01 | 3.49e-01 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 35 | 8.98e-02 | -1.66e-01 | 3.14e-01 |
| GOBP PITUITARY GLAND DEVELOPMENT | 10 | 3.64e-01 | -1.66e-01 | 6.50e-01 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 4.82e-01 | 1.66e-01 | 7.41e-01 |
| GOBP GENITALIA DEVELOPMENT | 21 | 1.89e-01 | -1.66e-01 | 4.65e-01 |
| GOBP CELL RECOGNITION | 75 | 1.32e-02 | -1.66e-01 | 9.90e-02 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 28 | 1.30e-01 | 1.65e-01 | 3.80e-01 |
| GOBP RESPONSE TO FUNGUS | 31 | 1.11e-01 | -1.65e-01 | 3.51e-01 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 43 | 6.07e-02 | 1.65e-01 | 2.53e-01 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 13 | 3.02e-01 | -1.65e-01 | 5.90e-01 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 66 | 2.04e-02 | -1.65e-01 | 1.32e-01 |
| GOCC SUMO LIGASE COMPLEX | 13 | 3.03e-01 | -1.65e-01 | 5.90e-01 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 46 | 5.28e-02 | 1.65e-01 | 2.34e-01 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 16 | 2.53e-01 | -1.65e-01 | 5.42e-01 |
| GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 4.50e-01 | -1.65e-01 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 7 | 4.50e-01 | -1.65e-01 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 18 | 2.26e-01 | -1.65e-01 | 5.10e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 6 | 4.84e-01 | -1.65e-01 | 7.42e-01 |
| GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 9 | 3.92e-01 | -1.65e-01 | 6.72e-01 |
| GOCC MYOFILAMENT | 13 | 3.03e-01 | 1.65e-01 | 5.91e-01 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 9 | 3.92e-01 | -1.65e-01 | 6.72e-01 |
| GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 3.67e-01 | 1.65e-01 | 6.51e-01 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 59 | 2.86e-02 | -1.65e-01 | 1.64e-01 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 43 | 6.16e-02 | 1.65e-01 | 2.56e-01 |
| GOBP CARDIAC CELL DEVELOPMENT | 47 | 5.08e-02 | -1.65e-01 | 2.29e-01 |
| GOBP DENDRITIC CELL APOPTOTIC PROCESS | 6 | 4.85e-01 | 1.65e-01 | 7.43e-01 |
| GOMF CHANNEL REGULATOR ACTIVITY | 70 | 1.72e-02 | 1.65e-01 | 1.19e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 20 | 2.02e-01 | -1.65e-01 | 4.82e-01 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 28 | 1.32e-01 | -1.65e-01 | 3.84e-01 |
| GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 45 | 5.62e-02 | 1.65e-01 | 2.42e-01 |
| GOBP RESPONSE TO OSMOTIC STRESS | 67 | 1.99e-02 | -1.65e-01 | 1.30e-01 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 24 | 1.63e-01 | -1.65e-01 | 4.30e-01 |
| GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY | 5 | 5.24e-01 | 1.64e-01 | 7.68e-01 |
| GOBP GANGLIOSIDE CATABOLIC PROCESS | 5 | 5.24e-01 | -1.64e-01 | 7.68e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 14 | 2.87e-01 | -1.64e-01 | 5.77e-01 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 73 | 1.52e-02 | 1.64e-01 | 1.09e-01 |
| GOCC RUFFLE | 155 | 4.22e-04 | -1.64e-01 | 8.70e-03 |
| GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY | 9 | 3.93e-01 | 1.64e-01 | 6.73e-01 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 35 | 9.26e-02 | -1.64e-01 | 3.19e-01 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 17 | 2.41e-01 | -1.64e-01 | 5.28e-01 |
| GOBP ECTODERMAL CELL DIFFERENTIATION | 5 | 5.25e-01 | 1.64e-01 | 7.68e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 19 | 2.15e-01 | -1.64e-01 | 4.98e-01 |
| GOBP RESPONSE TO PH | 21 | 1.93e-01 | -1.64e-01 | 4.70e-01 |
| GOMF NADPLUS BINDING | 17 | 2.41e-01 | 1.64e-01 | 5.28e-01 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 17 | 2.41e-01 | -1.64e-01 | 5.28e-01 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 3.25e-01 | 1.64e-01 | 6.12e-01 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 526 | 1.53e-10 | -1.64e-01 | 3.39e-08 |
| GOBP POSITIVE REGULATION OF HISTONE DEACETYLATION | 5 | 5.25e-01 | -1.64e-01 | 7.68e-01 |
| GOBP REGULATION OF HISTONE DEACETYLATION | 5 | 5.25e-01 | -1.64e-01 | 7.68e-01 |
| GOBP T CELL ACTIVATION | 389 | 3.20e-08 | -1.64e-01 | 3.45e-06 |
| GOCC MITOCHONDRION | 1413 | 3.02e-24 | 1.64e-01 | 1.30e-20 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 20 | 2.05e-01 | -1.64e-01 | 4.85e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 17 | 2.42e-01 | -1.64e-01 | 5.29e-01 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 31 | 1.14e-01 | -1.64e-01 | 3.56e-01 |
| GOMF RNA POLYMERASE ACTIVITY | 30 | 1.20e-01 | 1.64e-01 | 3.65e-01 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 39 | 7.68e-02 | -1.64e-01 | 2.88e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 38 | 8.07e-02 | -1.64e-01 | 2.96e-01 |
| GOBP CELL FATE COMMITMENT | 108 | 3.30e-03 | -1.64e-01 | 3.96e-02 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 11 | 3.47e-01 | -1.64e-01 | 6.32e-01 |
| GOBP REGULATION OF CHEMOTAXIS | 136 | 9.92e-04 | -1.64e-01 | 1.68e-02 |
| GOBP AUTOPHAGOSOME MATURATION | 60 | 2.84e-02 | 1.64e-01 | 1.63e-01 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 36 | 8.93e-02 | 1.64e-01 | 3.14e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 14 | 2.89e-01 | -1.64e-01 | 5.79e-01 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 21 | 1.94e-01 | -1.64e-01 | 4.71e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 10 | 3.70e-01 | 1.64e-01 | 6.54e-01 |
| GOCC OMEGASOME | 5 | 5.26e-01 | 1.64e-01 | 7.69e-01 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 12 | 3.27e-01 | -1.64e-01 | 6.13e-01 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 3.48e-01 | 1.64e-01 | 6.32e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 27 | 1.42e-01 | -1.63e-01 | 4.00e-01 |
| GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 3.96e-01 | -1.63e-01 | 6.76e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 310 | 8.23e-07 | -1.63e-01 | 5.17e-05 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 6 | 4.88e-01 | 1.63e-01 | 7.46e-01 |
| GOBP RESPONSE TO UV C | 12 | 3.28e-01 | 1.63e-01 | 6.15e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 16 | 2.59e-01 | -1.63e-01 | 5.48e-01 |
| GOBP REGULATION OF CELL ACTIVATION | 453 | 3.14e-09 | -1.63e-01 | 4.59e-07 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 56 | 3.49e-02 | -1.63e-01 | 1.84e-01 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 26 | 1.50e-01 | -1.63e-01 | 4.11e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 12 | 3.28e-01 | 1.63e-01 | 6.15e-01 |
| GOCC RSC TYPE COMPLEX | 14 | 2.91e-01 | -1.63e-01 | 5.80e-01 |
| GOCC SCHMIDT LANTERMAN INCISURE | 5 | 5.28e-01 | 1.63e-01 | 7.69e-01 |
| GOBP RUFFLE ORGANIZATION | 45 | 5.89e-02 | -1.63e-01 | 2.48e-01 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 12 | 3.29e-01 | -1.63e-01 | 6.15e-01 |
| GOBP LEUCINE CATABOLIC PROCESS | 5 | 5.29e-01 | 1.63e-01 | 7.69e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 3.98e-01 | -1.63e-01 | 6.78e-01 |
| GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 6 | 4.90e-01 | -1.63e-01 | 7.47e-01 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 20 | 2.08e-01 | -1.63e-01 | 4.89e-01 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 141 | 8.67e-04 | -1.63e-01 | 1.51e-02 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 15 | 2.75e-01 | -1.63e-01 | 5.65e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 20 | 2.08e-01 | 1.63e-01 | 4.89e-01 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 14 | 2.93e-01 | 1.63e-01 | 5.81e-01 |
| GOBP CELL CELL ADHESION | 523 | 2.58e-10 | -1.62e-01 | 5.42e-08 |
| GOBP MIRNA CATABOLIC PROCESS | 16 | 2.61e-01 | -1.62e-01 | 5.51e-01 |
| GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 6 | 4.91e-01 | -1.62e-01 | 7.47e-01 |
| GOCC CYTOCHROME COMPLEX | 32 | 1.12e-01 | 1.62e-01 | 3.52e-01 |
| GOBP GERM CELL PROLIFERATION | 9 | 3.99e-01 | 1.62e-01 | 6.80e-01 |
| GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 6 | 4.91e-01 | -1.62e-01 | 7.47e-01 |
| GOBP TISSUE REMODELING | 105 | 4.12e-03 | -1.62e-01 | 4.55e-02 |
| GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 12 | 3.31e-01 | 1.62e-01 | 6.16e-01 |
| GOBP PROTEIN UFMYLATION | 6 | 4.92e-01 | 1.62e-01 | 7.47e-01 |
| GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 8 | 4.27e-01 | 1.62e-01 | 7.04e-01 |
| GOBP MIRNA METABOLIC PROCESS | 77 | 1.40e-02 | -1.62e-01 | 1.03e-01 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 9 | 4.00e-01 | -1.62e-01 | 6.80e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 43 | 6.60e-02 | -1.62e-01 | 2.67e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 14 | 2.94e-01 | 1.62e-01 | 5.82e-01 |
| GOBP AMINO ACID METABOLIC PROCESS | 189 | 1.27e-04 | 1.62e-01 | 3.58e-03 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 15 | 2.77e-01 | -1.62e-01 | 5.67e-01 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 41 | 7.30e-02 | -1.62e-01 | 2.81e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 37 | 8.86e-02 | 1.62e-01 | 3.11e-01 |
| GOCC SMN COMPLEX | 10 | 3.76e-01 | 1.62e-01 | 6.58e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 34 | 1.03e-01 | -1.62e-01 | 3.37e-01 |
| GOBP SELF PROTEOLYSIS | 8 | 4.28e-01 | -1.62e-01 | 7.05e-01 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 42 | 7.00e-02 | 1.62e-01 | 2.75e-01 |
| GOMF ELECTRON TRANSFER ACTIVITY | 103 | 4.66e-03 | 1.62e-01 | 4.88e-02 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 73 | 1.72e-02 | -1.61e-01 | 1.19e-01 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 5 | 5.32e-01 | 1.61e-01 | 7.73e-01 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 33 | 1.09e-01 | -1.61e-01 | 3.47e-01 |
| GOBP R LOOP PROCESSING | 6 | 4.94e-01 | -1.61e-01 | 7.49e-01 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 20 | 2.12e-01 | -1.61e-01 | 4.95e-01 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 159 | 4.70e-04 | -1.61e-01 | 9.42e-03 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 26 | 1.56e-01 | 1.61e-01 | 4.18e-01 |
| GOCC PML BODY | 97 | 6.22e-03 | -1.61e-01 | 5.95e-02 |
| GOCC INTEGRIN COMPLEX | 24 | 1.73e-01 | -1.61e-01 | 4.43e-01 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 185 | 1.67e-04 | -1.61e-01 | 4.50e-03 |
| GOBP MRNA ALTERNATIVE POLYADENYLATION | 5 | 5.34e-01 | -1.61e-01 | 7.73e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 147 | 7.85e-04 | -1.61e-01 | 1.40e-02 |
| GOBP RESPONSE TO ALCOHOL | 147 | 7.86e-04 | -1.61e-01 | 1.40e-02 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 58 | 3.44e-02 | -1.61e-01 | 1.83e-01 |
| GOMF LYSOPHOSPHATIDIC ACID BINDING | 5 | 5.34e-01 | -1.61e-01 | 7.73e-01 |
| GOBP REGULATION OF URINE VOLUME | 9 | 4.04e-01 | -1.61e-01 | 6.83e-01 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 23 | 1.83e-01 | -1.61e-01 | 4.57e-01 |
| GOBP ANIMAL ORGAN FORMATION | 29 | 1.35e-01 | -1.61e-01 | 3.88e-01 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 44 | 6.57e-02 | -1.60e-01 | 2.66e-01 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 359 | 1.98e-07 | -1.60e-01 | 1.48e-05 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 8 | 4.32e-01 | 1.60e-01 | 7.06e-01 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 2.39e-01 | 1.60e-01 | 5.25e-01 |
| GOCC MEIOTIC COHESIN COMPLEX | 5 | 5.35e-01 | 1.60e-01 | 7.74e-01 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 54 | 4.19e-02 | -1.60e-01 | 2.05e-01 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 24 | 1.75e-01 | 1.60e-01 | 4.46e-01 |
| GOBP REGULATION OF HEART RATE | 48 | 5.53e-02 | 1.60e-01 | 2.40e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 70 | 2.08e-02 | -1.60e-01 | 1.34e-01 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 22 | 1.94e-01 | -1.60e-01 | 4.71e-01 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 29 | 1.36e-01 | -1.60e-01 | 3.90e-01 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 16 | 2.68e-01 | 1.60e-01 | 5.57e-01 |
| GOBP T CELL APOPTOTIC PROCESS | 44 | 6.68e-02 | 1.60e-01 | 2.69e-01 |
| GOBP LEUCINE TRANSPORT | 8 | 4.34e-01 | -1.60e-01 | 7.08e-01 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 171 | 3.22e-04 | -1.60e-01 | 7.24e-03 |
| GOCC EXCITATORY SYNAPSE | 29 | 1.37e-01 | -1.60e-01 | 3.91e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 77 | 1.55e-02 | 1.60e-01 | 1.11e-01 |
| GOBP NEURON PROJECTION ORGANIZATION | 65 | 2.61e-02 | -1.60e-01 | 1.54e-01 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 10 | 3.82e-01 | -1.60e-01 | 6.64e-01 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 15 | 2.85e-01 | -1.60e-01 | 5.74e-01 |
| GOBP HISTONE H3 K4 METHYLATION | 19 | 2.29e-01 | -1.60e-01 | 5.14e-01 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 19 | 2.29e-01 | -1.60e-01 | 5.14e-01 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 22 | 1.96e-01 | -1.59e-01 | 4.73e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 26 | 1.60e-01 | -1.59e-01 | 4.25e-01 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 8 | 4.35e-01 | -1.59e-01 | 7.09e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 100 | 5.95e-03 | -1.59e-01 | 5.76e-02 |
| GOBP VITAMIN METABOLIC PROCESS | 72 | 1.96e-02 | 1.59e-01 | 1.29e-01 |
| GOBP ORGANELLE FUSION | 134 | 1.50e-03 | 1.59e-01 | 2.26e-02 |
| GOBP FATTY ACID BETA OXIDATION | 63 | 2.91e-02 | 1.59e-01 | 1.65e-01 |
| GOBP TELENCEPHALON DEVELOPMENT | 160 | 5.31e-04 | -1.59e-01 | 1.03e-02 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 13 | 3.21e-01 | -1.59e-01 | 6.10e-01 |
| GOBP REGULATION OF VASOCONSTRICTION | 28 | 1.46e-01 | -1.59e-01 | 4.05e-01 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 12 | 3.41e-01 | -1.59e-01 | 6.27e-01 |
| GOBP GLAND DEVELOPMENT | 255 | 1.33e-05 | -1.59e-01 | 5.33e-04 |
| GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 7 | 4.67e-01 | 1.59e-01 | 7.32e-01 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 22 | 1.98e-01 | 1.59e-01 | 4.77e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 21 | 2.08e-01 | 1.59e-01 | 4.89e-01 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 15 | 2.88e-01 | 1.59e-01 | 5.78e-01 |
| GOCC HISTONE DEACETYLASE COMPLEX | 76 | 1.70e-02 | -1.58e-01 | 1.18e-01 |
| GOBP REGULATION OF HISTONE METHYLATION | 17 | 2.58e-01 | -1.58e-01 | 5.48e-01 |
| GOMF PROTEIN KINASE ACTIVITY | 432 | 1.92e-08 | -1.58e-01 | 2.20e-06 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 74 | 1.86e-02 | -1.58e-01 | 1.25e-01 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 1.55e-01 | 1.58e-01 | 4.17e-01 |
| GOBP ERYTHROCYTE DEVELOPMENT | 28 | 1.47e-01 | -1.58e-01 | 4.07e-01 |
| GOBP REGULATION OF NK T CELL ACTIVATION | 8 | 4.38e-01 | 1.58e-01 | 7.10e-01 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 48 | 5.80e-02 | -1.58e-01 | 2.46e-01 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 44 | 6.96e-02 | -1.58e-01 | 2.75e-01 |
| GOBP RESPONSE TO PAIN | 14 | 3.06e-01 | 1.58e-01 | 5.94e-01 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 12 | 3.43e-01 | -1.58e-01 | 6.28e-01 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 36 | 1.01e-01 | 1.58e-01 | 3.35e-01 |
| GOBP LEUKOCYTE MIGRATION | 253 | 1.58e-05 | -1.58e-01 | 6.23e-04 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 12 | 3.43e-01 | -1.58e-01 | 6.29e-01 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 19 | 2.33e-01 | 1.58e-01 | 5.16e-01 |
| GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 11 | 3.64e-01 | 1.58e-01 | 6.50e-01 |
| GOBP MOTOR NEURON AXON GUIDANCE | 12 | 3.44e-01 | -1.58e-01 | 6.29e-01 |
| GOBP RESPONSE TO HYDROSTATIC PRESSURE | 5 | 5.41e-01 | -1.58e-01 | 7.77e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 6 | 5.03e-01 | -1.58e-01 | 7.54e-01 |
| GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY | 5 | 5.41e-01 | 1.58e-01 | 7.77e-01 |
| GOBP RIBOSOME ASSEMBLY | 57 | 3.95e-02 | 1.58e-01 | 1.97e-01 |
| GOMF PEPTIDOGLYCAN BINDING | 7 | 4.70e-01 | -1.58e-01 | 7.33e-01 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 55 | 4.32e-02 | -1.58e-01 | 2.09e-01 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 18 | 2.47e-01 | -1.58e-01 | 5.35e-01 |
| GOMF TITIN BINDING | 8 | 4.40e-01 | -1.58e-01 | 7.11e-01 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 34 | 1.12e-01 | -1.58e-01 | 3.51e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 664 | 5.98e-12 | -1.58e-01 | 1.66e-09 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 13 | 3.25e-01 | -1.58e-01 | 6.12e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 12 | 3.45e-01 | -1.58e-01 | 6.30e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 13 | 3.25e-01 | -1.58e-01 | 6.12e-01 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 36 | 1.02e-01 | -1.58e-01 | 3.36e-01 |
| GOBP CARTILAGE DEVELOPMENT | 101 | 6.26e-03 | -1.58e-01 | 5.98e-02 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 4.40e-01 | 1.58e-01 | 7.11e-01 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 23 | 1.91e-01 | -1.58e-01 | 4.68e-01 |
| GOCC COMPACT MYELIN | 7 | 4.70e-01 | 1.58e-01 | 7.33e-01 |
| GOBP NAIL DEVELOPMENT | 6 | 5.04e-01 | -1.58e-01 | 7.54e-01 |
| GOBP CELL ADHESION | 846 | 1.28e-14 | -1.57e-01 | 6.91e-12 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 59 | 3.65e-02 | -1.57e-01 | 1.89e-01 |
| GOBP RESPONSE TO ALKALOID | 58 | 3.82e-02 | -1.57e-01 | 1.93e-01 |
| GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 6 | 5.04e-01 | -1.57e-01 | 7.54e-01 |
| GOBP MONOCYTE ACTIVATION | 12 | 3.45e-01 | -1.57e-01 | 6.31e-01 |
| GOMF FERRIC IRON BINDING | 5 | 5.42e-01 | 1.57e-01 | 7.78e-01 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 20 | 2.23e-01 | 1.57e-01 | 5.07e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 19 | 2.35e-01 | -1.57e-01 | 5.20e-01 |
| GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 5.43e-01 | 1.57e-01 | 7.78e-01 |
| GOCC ENDONUCLEASE COMPLEX | 37 | 9.84e-02 | 1.57e-01 | 3.31e-01 |
| GOBP DENDRITE DEVELOPMENT | 154 | 7.85e-04 | -1.57e-01 | 1.40e-02 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 15 | 2.92e-01 | 1.57e-01 | 5.81e-01 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 41 | 8.22e-02 | -1.57e-01 | 2.99e-01 |
| GOBP MEMBRANE FUSION | 135 | 1.67e-03 | 1.57e-01 | 2.43e-02 |
| GOCC DENSE CORE GRANULE | 13 | 3.27e-01 | -1.57e-01 | 6.15e-01 |
| GOMF ALDO KETO REDUCTASE NADP ACTIVITY | 20 | 2.25e-01 | 1.57e-01 | 5.09e-01 |
| GOCC PARANODAL JUNCTION | 5 | 5.44e-01 | -1.57e-01 | 7.78e-01 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 23 | 1.93e-01 | -1.57e-01 | 4.70e-01 |
| GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY | 5 | 5.44e-01 | -1.57e-01 | 7.79e-01 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 17 | 2.63e-01 | -1.57e-01 | 5.53e-01 |
| GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 16 | 2.79e-01 | -1.56e-01 | 5.68e-01 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 31 | 1.32e-01 | 1.56e-01 | 3.84e-01 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 29 | 1.45e-01 | -1.56e-01 | 4.04e-01 |
| GOMF PRE MIRNA BINDING | 8 | 4.44e-01 | 1.56e-01 | 7.13e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 10 | 3.92e-01 | -1.56e-01 | 6.73e-01 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 51 | 5.36e-02 | -1.56e-01 | 2.36e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES | 5 | 5.45e-01 | -1.56e-01 | 7.80e-01 |
| GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 9 | 4.17e-01 | -1.56e-01 | 6.96e-01 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 14 | 3.12e-01 | 1.56e-01 | 6.00e-01 |
| GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 5.08e-01 | 1.56e-01 | 7.56e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSPORT | 8 | 4.44e-01 | 1.56e-01 | 7.13e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 10 | 3.93e-01 | 1.56e-01 | 6.73e-01 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 946 | 8.24e-16 | -1.56e-01 | 5.47e-13 |
| GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 7 | 4.75e-01 | -1.56e-01 | 7.37e-01 |
| GOBP B CELL HOMEOSTASIS | 29 | 1.46e-01 | -1.56e-01 | 4.05e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 10 | 3.93e-01 | -1.56e-01 | 6.73e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 31 | 1.33e-01 | -1.56e-01 | 3.85e-01 |
| GOBP OSTEOBLAST DIFFERENTIATION | 132 | 2.00e-03 | -1.56e-01 | 2.78e-02 |
| GOMF SULFATIDE BINDING | 6 | 5.08e-01 | -1.56e-01 | 7.56e-01 |
| GOBP RESPONSE TO INTERLEUKIN 3 | 7 | 4.75e-01 | -1.56e-01 | 7.37e-01 |
| GOBP MEMBRANE DOCKING | 75 | 1.97e-02 | 1.56e-01 | 1.29e-01 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 13 | 3.31e-01 | 1.56e-01 | 6.16e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 341 | 8.40e-07 | -1.56e-01 | 5.21e-05 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 32 | 1.27e-01 | 1.56e-01 | 3.77e-01 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 48 | 6.21e-02 | 1.56e-01 | 2.57e-01 |
| GOBP REGULATION OF CELL CELL ADHESION | 326 | 1.47e-06 | -1.56e-01 | 8.27e-05 |
| GOMF ALPHA TUBULIN BINDING | 34 | 1.16e-01 | -1.56e-01 | 3.59e-01 |
| GOBP DETECTION OF VIRUS | 5 | 5.47e-01 | -1.56e-01 | 7.81e-01 |
| GOBP NEURON MIGRATION | 98 | 7.86e-03 | -1.56e-01 | 6.97e-02 |
| GOBP PROTEIN GERANYLGERANYLATION | 6 | 5.10e-01 | 1.56e-01 | 7.57e-01 |
| GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 11 | 3.72e-01 | -1.56e-01 | 6.56e-01 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 102 | 6.72e-03 | -1.55e-01 | 6.28e-02 |
| GOBP TOLERANCE INDUCTION | 18 | 2.54e-01 | -1.55e-01 | 5.42e-01 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 9 | 4.20e-01 | -1.55e-01 | 6.97e-01 |
| GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 13 | 3.32e-01 | 1.55e-01 | 6.18e-01 |
| GOBP PROTEIN FOLDING | 184 | 2.88e-04 | 1.55e-01 | 6.74e-03 |
| GOMF GLYCOLIPID BINDING | 20 | 2.30e-01 | 1.55e-01 | 5.15e-01 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 46 | 6.88e-02 | 1.55e-01 | 2.73e-01 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 17 | 2.68e-01 | -1.55e-01 | 5.57e-01 |
| GOBP ENDOSOME ORGANIZATION | 89 | 1.15e-02 | 1.55e-01 | 9.02e-02 |
| GOCC COMMITMENT COMPLEX | 5 | 5.48e-01 | 1.55e-01 | 7.81e-01 |
| GOMF R SMAD BINDING | 21 | 2.19e-01 | -1.55e-01 | 5.02e-01 |
| GOBP FATTY ACYL COA CATABOLIC PROCESS | 6 | 5.11e-01 | 1.55e-01 | 7.58e-01 |
| GOBP GLUCOSE CATABOLIC PROCESS | 21 | 2.19e-01 | 1.55e-01 | 5.02e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 14 | 3.16e-01 | -1.55e-01 | 6.05e-01 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 16 | 2.83e-01 | -1.55e-01 | 5.73e-01 |
| GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 5.49e-01 | 1.55e-01 | 7.81e-01 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 18 | 2.55e-01 | 1.55e-01 | 5.45e-01 |
| GOBP RESCUE OF STALLED RIBOSOME | 25 | 1.80e-01 | 1.55e-01 | 4.55e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 25 | 1.81e-01 | -1.55e-01 | 4.55e-01 |
| GOBP MATURATION OF SSU RRNA | 50 | 5.85e-02 | 1.55e-01 | 2.48e-01 |
| GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 7 | 4.78e-01 | 1.55e-01 | 7.40e-01 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 3.16e-01 | -1.55e-01 | 6.05e-01 |
| GOBP RESPONSE TO L ASCORBIC ACID | 5 | 5.49e-01 | -1.55e-01 | 7.82e-01 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 184 | 3.04e-04 | -1.55e-01 | 6.98e-03 |
| GOBP CELLULAR RESPONSE TO PEPTIDE | 253 | 2.38e-05 | -1.55e-01 | 8.87e-04 |
| GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 7 | 4.79e-01 | 1.55e-01 | 7.40e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 20 | 2.31e-01 | -1.55e-01 | 5.15e-01 |
| GOBP FIBRINOLYSIS | 11 | 3.75e-01 | -1.54e-01 | 6.57e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 48 | 6.43e-02 | -1.54e-01 | 2.62e-01 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 22 | 2.10e-01 | 1.54e-01 | 4.92e-01 |
| GOBP T CELL MEDIATED IMMUNITY | 91 | 1.10e-02 | -1.54e-01 | 8.79e-02 |
| GOMF HORMONE BINDING | 34 | 1.20e-01 | -1.54e-01 | 3.64e-01 |
| GOMF FK506 BINDING | 9 | 4.23e-01 | 1.54e-01 | 7.00e-01 |
| GOMF MACROLIDE BINDING | 9 | 4.23e-01 | 1.54e-01 | 7.00e-01 |
| GOBP RIBOSOME BIOGENESIS | 310 | 3.21e-06 | 1.54e-01 | 1.59e-04 |
| GOBP REGULATION OF ACYL COA BIOSYNTHETIC PROCESS | 5 | 5.50e-01 | 1.54e-01 | 7.82e-01 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 14 | 3.18e-01 | 1.54e-01 | 6.07e-01 |
| GOMF HISTONE READER ACTIVITY | 11 | 3.76e-01 | -1.54e-01 | 6.59e-01 |
| GOBP ADENINE TRANSPORT | 6 | 5.13e-01 | 1.54e-01 | 7.60e-01 |
| GOBP INTRACILIARY TRANSPORT | 41 | 8.80e-02 | 1.54e-01 | 3.10e-01 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 88 | 1.26e-02 | -1.54e-01 | 9.62e-02 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 8 | 4.51e-01 | -1.54e-01 | 7.19e-01 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 10 | 3.99e-01 | -1.54e-01 | 6.80e-01 |
| GOBP DOPAMINE SECRETION | 16 | 2.87e-01 | -1.54e-01 | 5.77e-01 |
| GOBP CLEAVAGE FURROW FORMATION | 7 | 4.81e-01 | -1.54e-01 | 7.40e-01 |
| GOCC STEREOCILIUM BUNDLE | 38 | 1.01e-01 | -1.54e-01 | 3.35e-01 |
| GOBP GLYCINE TRANSPORT | 6 | 5.14e-01 | -1.54e-01 | 7.60e-01 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 19 | 2.46e-01 | 1.54e-01 | 5.33e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE A | 8 | 4.52e-01 | 1.54e-01 | 7.20e-01 |
| GOCC LEADING EDGE MEMBRANE | 122 | 3.41e-03 | -1.54e-01 | 4.03e-02 |
| GOBP STRIATED MUSCLE ADAPTATION | 22 | 2.12e-01 | -1.54e-01 | 4.95e-01 |
| GOBP CALCIUM ION IMPORT | 25 | 1.84e-01 | 1.54e-01 | 4.59e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 197 | 2.10e-04 | -1.53e-01 | 5.37e-03 |
| GOBP CELL ACTIVATION | 754 | 1.13e-12 | -1.53e-01 | 3.35e-10 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 184 | 3.40e-04 | -1.53e-01 | 7.48e-03 |
| GOBP CYTOKINE PRODUCTION | 545 | 1.14e-09 | -1.53e-01 | 2.07e-07 |
| GOMF NUCLEAR RECEPTOR ACTIVITY | 32 | 1.33e-01 | -1.53e-01 | 3.86e-01 |
| GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 9 | 4.26e-01 | -1.53e-01 | 7.03e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 14 | 3.21e-01 | -1.53e-01 | 6.09e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS | 5 | 5.53e-01 | -1.53e-01 | 7.84e-01 |
| GOBP CELL VOLUME HOMEOSTASIS | 26 | 1.76e-01 | -1.53e-01 | 4.48e-01 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 129 | 2.68e-03 | -1.53e-01 | 3.45e-02 |
| GOBP REGULATION OF CELL SHAPE | 109 | 5.78e-03 | -1.53e-01 | 5.65e-02 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 54 | 5.16e-02 | -1.53e-01 | 2.31e-01 |
| GOMF MYOSIN V BINDING | 10 | 4.02e-01 | 1.53e-01 | 6.82e-01 |
| GOBP ENDOTHELIAL CELL ACTIVATION | 6 | 5.16e-01 | -1.53e-01 | 7.61e-01 |
| GOBP VESICLE DOCKING | 50 | 6.12e-02 | 1.53e-01 | 2.55e-01 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 275 | 1.33e-05 | -1.53e-01 | 5.33e-04 |
| GOCC PROTEIN DNA COMPLEX | 856 | 5.49e-14 | -1.53e-01 | 2.49e-11 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 142 | 1.70e-03 | -1.53e-01 | 2.46e-02 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 88 | 1.34e-02 | -1.53e-01 | 9.99e-02 |
| GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 8 | 4.55e-01 | -1.53e-01 | 7.23e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 155 | 1.06e-03 | -1.53e-01 | 1.76e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 17 | 2.76e-01 | -1.53e-01 | 5.66e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 23 | 2.05e-01 | 1.53e-01 | 4.86e-01 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 256 | 2.77e-05 | -1.53e-01 | 1.00e-03 |
| GOBP IMMUNE EFFECTOR PROCESS | 415 | 1.11e-07 | -1.53e-01 | 9.47e-06 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 848 | 7.88e-14 | -1.53e-01 | 3.40e-11 |
| GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 6 | 5.18e-01 | -1.52e-01 | 7.63e-01 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 151 | 1.24e-03 | -1.52e-01 | 1.99e-02 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 16 | 2.91e-01 | -1.52e-01 | 5.80e-01 |
| GOBP MONOCYTE DIFFERENTIATION | 30 | 1.49e-01 | -1.52e-01 | 4.09e-01 |
| GOCC GRANULAR COMPONENT | 6 | 5.18e-01 | -1.52e-01 | 7.63e-01 |
| GOBP CHROMOSOME LOCALIZATION | 105 | 7.10e-03 | -1.52e-01 | 6.51e-02 |
| GOBP ARTERY MORPHOGENESIS | 40 | 9.59e-02 | -1.52e-01 | 3.26e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 43 | 8.43e-02 | 1.52e-01 | 3.02e-01 |
| GOBP EMBRYO IMPLANTATION | 36 | 1.14e-01 | -1.52e-01 | 3.55e-01 |
| GOBP AEROBIC RESPIRATION | 178 | 4.76e-04 | 1.52e-01 | 9.47e-03 |
| GOBP RESPONSE TO UV | 127 | 3.11e-03 | -1.52e-01 | 3.80e-02 |
| GOBP LIPID GLYCOSYLATION | 5 | 5.56e-01 | 1.52e-01 | 7.86e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 35 | 1.20e-01 | -1.52e-01 | 3.64e-01 |
| GOMF MRNA 5 PHOSPHATASE ACTIVITY | 11 | 3.83e-01 | -1.52e-01 | 6.64e-01 |
| GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.30e-01 | -1.52e-01 | 7.05e-01 |
| GOBP RESPONSE TO PARATHYROID HORMONE | 7 | 4.87e-01 | -1.52e-01 | 7.44e-01 |
| GOBP UV DAMAGE EXCISION REPAIR | 12 | 3.63e-01 | -1.52e-01 | 6.48e-01 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 5 | 5.57e-01 | -1.52e-01 | 7.87e-01 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 32 | 1.37e-01 | -1.52e-01 | 3.92e-01 |
| GOBP LEUKOCYTE AGGREGATION | 10 | 4.06e-01 | -1.52e-01 | 6.86e-01 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 755 | 1.98e-12 | -1.52e-01 | 5.68e-10 |
| GOBP AXON GUIDANCE | 102 | 8.19e-03 | -1.52e-01 | 7.15e-02 |
| GOBP OSMOSENSORY SIGNALING PATHWAY | 5 | 5.57e-01 | -1.52e-01 | 7.87e-01 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 43 | 8.55e-02 | -1.52e-01 | 3.05e-01 |
| GOMF ICOSANOID BINDING | 7 | 4.87e-01 | -1.52e-01 | 7.45e-01 |
| GOCC GOLGI LUMEN | 39 | 1.02e-01 | -1.52e-01 | 3.36e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 40 | 9.73e-02 | -1.52e-01 | 3.28e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 15 | 3.10e-01 | -1.52e-01 | 5.98e-01 |
| GOBP REGULATION OF LOCOMOTION | 649 | 6.14e-11 | -1.52e-01 | 1.47e-08 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 14 | 3.26e-01 | 1.52e-01 | 6.13e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 21 | 2.30e-01 | 1.51e-01 | 5.15e-01 |
| GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 5 | 5.58e-01 | 1.51e-01 | 7.87e-01 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 7 | 4.88e-01 | -1.51e-01 | 7.45e-01 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 38 | 1.07e-01 | 1.51e-01 | 3.43e-01 |
| GOBP MACROPHAGE DIFFERENTIATION | 45 | 7.91e-02 | -1.51e-01 | 2.92e-01 |
| GOBP FOAM CELL DIFFERENTIATION | 25 | 1.90e-01 | 1.51e-01 | 4.67e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 93 | 1.18e-02 | -1.51e-01 | 9.17e-02 |
| GOCC SPLICEOSOMAL SNRNP COMPLEX | 65 | 3.51e-02 | 1.51e-01 | 1.84e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 9 | 4.32e-01 | -1.51e-01 | 7.06e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 86 | 1.54e-02 | -1.51e-01 | 1.10e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 5.58e-01 | -1.51e-01 | 7.87e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 25 | 1.91e-01 | 1.51e-01 | 4.68e-01 |
| GOBP AMINE TRANSPORT | 43 | 8.66e-02 | -1.51e-01 | 3.07e-01 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 13 | 3.46e-01 | 1.51e-01 | 6.31e-01 |
| GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 21 | 2.31e-01 | -1.51e-01 | 5.15e-01 |
| GOCC RECEPTOR COMPLEX | 192 | 3.17e-04 | -1.51e-01 | 7.19e-03 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 116 | 5.02e-03 | 1.51e-01 | 5.16e-02 |
| GOBP REGULATION OF LIPID KINASE ACTIVITY | 22 | 2.20e-01 | -1.51e-01 | 5.03e-01 |
| GOBP BONE REMODELING | 58 | 4.68e-02 | -1.51e-01 | 2.20e-01 |
| GOMF MODIFIED AMINO ACID BINDING | 51 | 6.23e-02 | -1.51e-01 | 2.57e-01 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 24 | 2.01e-01 | -1.51e-01 | 4.80e-01 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 13 | 3.46e-01 | -1.51e-01 | 6.31e-01 |
| GOBP CELLULAR RESPIRATION | 214 | 1.48e-04 | 1.51e-01 | 4.04e-03 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION | 5 | 5.59e-01 | -1.51e-01 | 7.88e-01 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 136 | 2.43e-03 | -1.51e-01 | 3.20e-02 |
| GOBP COGNITION | 178 | 5.37e-04 | -1.51e-01 | 1.03e-02 |
| GOBP CARDIAC ATRIUM MORPHOGENESIS | 12 | 3.66e-01 | -1.51e-01 | 6.51e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION | 8 | 4.61e-01 | 1.51e-01 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 23 | 2.11e-01 | -1.51e-01 | 4.94e-01 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 19 | 2.56e-01 | -1.51e-01 | 5.45e-01 |
| GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 4.90e-01 | -1.51e-01 | 7.47e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 11 | 3.87e-01 | 1.51e-01 | 6.68e-01 |
| GOCC CALCIUM CHANNEL COMPLEX | 41 | 9.56e-02 | 1.50e-01 | 3.25e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 354 | 1.27e-06 | -1.50e-01 | 7.34e-05 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 26 | 1.85e-01 | -1.50e-01 | 4.59e-01 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 91 | 1.33e-02 | -1.50e-01 | 9.94e-02 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 12 | 3.67e-01 | -1.50e-01 | 6.51e-01 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 41 | 9.61e-02 | -1.50e-01 | 3.26e-01 |
| GOCC SITE OF POLARIZED GROWTH | 127 | 3.50e-03 | -1.50e-01 | 4.10e-02 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 48 | 7.19e-02 | -1.50e-01 | 2.79e-01 |
| GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 5 | 5.61e-01 | -1.50e-01 | 7.89e-01 |
| GOBP REGULATION OF VASCULOGENESIS | 10 | 4.11e-01 | -1.50e-01 | 6.90e-01 |
| GOMF AMINO ACID BINDING | 26 | 1.85e-01 | -1.50e-01 | 4.60e-01 |
| GOBP NECROPTOTIC SIGNALING PATHWAY | 7 | 4.92e-01 | 1.50e-01 | 7.47e-01 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 9 | 4.36e-01 | 1.50e-01 | 7.09e-01 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 462 | 3.84e-08 | -1.50e-01 | 3.89e-06 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 11 | 3.89e-01 | -1.50e-01 | 6.70e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 9 | 4.36e-01 | 1.50e-01 | 7.09e-01 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 569 | 1.23e-09 | -1.50e-01 | 2.17e-07 |
| GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 5.62e-01 | 1.50e-01 | 7.90e-01 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 14 | 3.32e-01 | -1.50e-01 | 6.17e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 115 | 5.55e-03 | -1.50e-01 | 5.51e-02 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 12 | 3.69e-01 | -1.50e-01 | 6.52e-01 |
| GOBP PROTEIN DEPOLYMERIZATION | 84 | 1.77e-02 | -1.50e-01 | 1.21e-01 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 73 | 2.70e-02 | -1.50e-01 | 1.58e-01 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 384 | 5.24e-07 | -1.50e-01 | 3.50e-05 |
| GOMF MOLECULAR TRANSDUCER ACTIVITY | 467 | 3.45e-08 | -1.50e-01 | 3.59e-06 |
| GOBP NEURONAL ACTION POTENTIAL PROPAGATION | 5 | 5.62e-01 | -1.50e-01 | 7.90e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 24 | 2.05e-01 | 1.50e-01 | 4.85e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 5 | 5.62e-01 | -1.50e-01 | 7.90e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 29 | 1.63e-01 | 1.50e-01 | 4.30e-01 |
| GOBP PLATELET MORPHOGENESIS | 18 | 2.72e-01 | -1.50e-01 | 5.62e-01 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 38 | 1.11e-01 | -1.50e-01 | 3.51e-01 |
| GOBP RESPONSE TO GROWTH FACTOR | 433 | 1.10e-07 | -1.49e-01 | 9.47e-06 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 132 | 3.07e-03 | -1.49e-01 | 3.76e-02 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 8 | 4.65e-01 | 1.49e-01 | 7.30e-01 |
| GOCC AXONEMAL MICROTUBULE | 16 | 3.02e-01 | 1.49e-01 | 5.90e-01 |
| GOCC ENVELOPE | 1083 | 2.66e-16 | 1.49e-01 | 2.29e-13 |
| GOCC CHROMOSOME | 1312 | 4.10e-19 | -1.49e-01 | 7.06e-16 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 17 | 2.87e-01 | 1.49e-01 | 5.78e-01 |
| GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 5 | 5.64e-01 | -1.49e-01 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 181 | 5.58e-04 | -1.49e-01 | 1.06e-02 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 99 | 1.05e-02 | -1.49e-01 | 8.53e-02 |
| GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 5 | 5.64e-01 | -1.49e-01 | 7.91e-01 |
| GOBP MACROPHAGE MIGRATION | 40 | 1.03e-01 | -1.49e-01 | 3.37e-01 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 15 | 3.18e-01 | -1.49e-01 | 6.07e-01 |
| GOBP OLFACTORY BEHAVIOR | 6 | 5.28e-01 | -1.49e-01 | 7.69e-01 |
| GOBP KERATAN SULFATE METABOLIC PROCESS | 13 | 3.53e-01 | -1.49e-01 | 6.38e-01 |
| GOMF POTASSIUM ION BINDING | 7 | 4.95e-01 | 1.49e-01 | 7.50e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 27 | 1.81e-01 | -1.49e-01 | 4.55e-01 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 191 | 4.02e-04 | -1.49e-01 | 8.42e-03 |
| GOBP COBALT ION TRANSPORT | 6 | 5.28e-01 | 1.49e-01 | 7.69e-01 |
| GOCC LATERAL PLASMA MEMBRANE | 42 | 9.56e-02 | 1.49e-01 | 3.25e-01 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 12 | 3.73e-01 | 1.49e-01 | 6.56e-01 |
| GOBP LYMPHOCYTE ACTIVATION | 559 | 2.33e-09 | -1.49e-01 | 3.72e-07 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 16 | 3.03e-01 | 1.49e-01 | 5.91e-01 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 39 | 1.08e-01 | -1.49e-01 | 3.46e-01 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 158 | 1.29e-03 | -1.49e-01 | 2.04e-02 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 155 | 1.44e-03 | -1.49e-01 | 2.20e-02 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 11 | 3.94e-01 | -1.49e-01 | 6.74e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 12 | 3.73e-01 | 1.48e-01 | 6.56e-01 |
| GOBP MITOTIC NUCLEAR DIVISION | 242 | 7.25e-05 | -1.48e-01 | 2.28e-03 |
| GOBP RESPONSE TO CHEMOKINE | 43 | 9.23e-02 | -1.48e-01 | 3.19e-01 |
| GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 7 | 4.97e-01 | 1.48e-01 | 7.51e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 348 | 2.15e-06 | -1.48e-01 | 1.14e-04 |
| GOBP HEME TRANSPORT | 8 | 4.68e-01 | 1.48e-01 | 7.32e-01 |
| GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 4.68e-01 | 1.48e-01 | 7.32e-01 |
| GOMF KINASE REGULATOR ACTIVITY | 197 | 3.43e-04 | -1.48e-01 | 7.48e-03 |
| GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 4.97e-01 | 1.48e-01 | 7.51e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 22 | 2.29e-01 | -1.48e-01 | 5.15e-01 |
| GOBP FOREGUT MORPHOGENESIS | 6 | 5.30e-01 | -1.48e-01 | 7.70e-01 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 14 | 3.38e-01 | -1.48e-01 | 6.24e-01 |
| GOBP RESPONSE TO NICOTINE | 23 | 2.20e-01 | -1.48e-01 | 5.03e-01 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 17 | 2.91e-01 | -1.48e-01 | 5.80e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 15 | 3.22e-01 | -1.48e-01 | 6.10e-01 |
| GOMF METHYL CPG BINDING | 20 | 2.53e-01 | -1.48e-01 | 5.42e-01 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 13 | 3.57e-01 | 1.48e-01 | 6.43e-01 |
| GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.68e-01 | -1.48e-01 | 7.93e-01 |
| GOBP NEURON APOPTOTIC PROCESS | 179 | 6.80e-04 | -1.47e-01 | 1.25e-02 |
| GOBP MEMBRANE RAFT ASSEMBLY | 8 | 4.70e-01 | -1.47e-01 | 7.33e-01 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 8 | 4.70e-01 | -1.47e-01 | 7.33e-01 |
| GOBP CELL MIGRATION IN HINDBRAIN | 9 | 4.44e-01 | -1.47e-01 | 7.13e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 9 | 4.44e-01 | -1.47e-01 | 7.13e-01 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 20 | 2.54e-01 | -1.47e-01 | 5.42e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1311 | 1.05e-18 | -1.47e-01 | 1.50e-15 |
| GOBP RESPONSE TO PEPTIDE | 345 | 2.83e-06 | -1.47e-01 | 1.43e-04 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 101 | 1.07e-02 | 1.47e-01 | 8.65e-02 |
| GOBP PROTEIN TRIMERIZATION | 12 | 3.77e-01 | -1.47e-01 | 6.59e-01 |
| GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 7 | 5.00e-01 | 1.47e-01 | 7.53e-01 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 38 | 1.17e-01 | -1.47e-01 | 3.59e-01 |
| GOMF ISOMERASE ACTIVITY | 139 | 2.81e-03 | 1.47e-01 | 3.56e-02 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 9 | 4.45e-01 | 1.47e-01 | 7.13e-01 |
| GOCC CELL LEADING EDGE | 322 | 6.38e-06 | -1.47e-01 | 2.86e-04 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 140 | 2.78e-03 | -1.47e-01 | 3.53e-02 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 27 | 1.87e-01 | -1.47e-01 | 4.63e-01 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 56 | 5.81e-02 | 1.46e-01 | 2.47e-01 |
| GOBP TROPHOBLAST CELL MIGRATION | 11 | 4.00e-01 | -1.46e-01 | 6.80e-01 |
| GOMF PHOSPHATIDIC ACID BINDING | 16 | 3.10e-01 | -1.46e-01 | 5.99e-01 |
| GOBP VIRAL RNA GENOME REPLICATION | 27 | 1.88e-01 | -1.46e-01 | 4.64e-01 |
| GOCC SPECTRIN ASSOCIATED CYTOSKELETON | 5 | 5.71e-01 | 1.46e-01 | 7.94e-01 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 12 | 3.80e-01 | -1.46e-01 | 6.62e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 24 | 2.15e-01 | -1.46e-01 | 4.97e-01 |
| GOMF HEPARIN BINDING | 68 | 3.71e-02 | -1.46e-01 | 1.91e-01 |
| GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 5 | 5.71e-01 | 1.46e-01 | 7.95e-01 |
| GOMF ANKYRIN BINDING | 10 | 4.23e-01 | -1.46e-01 | 7.00e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 16 | 3.12e-01 | 1.46e-01 | 6.00e-01 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 8 | 4.74e-01 | -1.46e-01 | 7.37e-01 |
| GOCC CHROMOSOME TELOMERIC REGION | 137 | 3.19e-03 | -1.46e-01 | 3.87e-02 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 52 | 6.86e-02 | -1.46e-01 | 2.72e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 17 | 2.97e-01 | 1.46e-01 | 5.85e-01 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 155 | 1.74e-03 | -1.46e-01 | 2.50e-02 |
| GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 16 | 3.13e-01 | -1.46e-01 | 6.01e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 45 | 9.07e-02 | 1.46e-01 | 3.16e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 283 | 2.61e-05 | -1.46e-01 | 9.52e-04 |
| GOBP HEAT ACCLIMATION | 6 | 5.37e-01 | -1.46e-01 | 7.75e-01 |
| GOBP MYOBLAST DIFFERENTIATION | 72 | 3.27e-02 | -1.46e-01 | 1.78e-01 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 43 | 9.86e-02 | -1.46e-01 | 3.31e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 147 | 2.35e-03 | -1.46e-01 | 3.13e-02 |
| GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 24 | 2.17e-01 | -1.46e-01 | 5.00e-01 |
| GOCC NUCLEOSOME | 33 | 1.48e-01 | -1.46e-01 | 4.08e-01 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 101 | 1.16e-02 | 1.46e-01 | 9.08e-02 |
| GOBP GASTRULATION | 114 | 7.38e-03 | -1.45e-01 | 6.69e-02 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 25 | 2.08e-01 | -1.45e-01 | 4.89e-01 |
| GOBP DERMATAN SULFATE METABOLIC PROCESS | 9 | 4.50e-01 | 1.45e-01 | 7.19e-01 |
| GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 8 | 4.77e-01 | 1.45e-01 | 7.38e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 363 | 2.21e-06 | -1.45e-01 | 1.16e-04 |
| GOCC MISMATCH REPAIR COMPLEX | 7 | 5.06e-01 | 1.45e-01 | 7.55e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 16 | 3.16e-01 | 1.45e-01 | 6.05e-01 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 49 | 7.94e-02 | -1.45e-01 | 2.93e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 20 | 2.62e-01 | -1.45e-01 | 5.52e-01 |
| GOBP ODONTOBLAST DIFFERENTIATION | 8 | 4.78e-01 | -1.45e-01 | 7.39e-01 |
| GOMF U1 SNRNP BINDING | 6 | 5.39e-01 | -1.45e-01 | 7.76e-01 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 15 | 3.31e-01 | -1.45e-01 | 6.17e-01 |
| GOCC SEC61 TRANSLOCON COMPLEX | 5 | 5.75e-01 | -1.45e-01 | 7.97e-01 |
| GOBP MICROVILLUS ASSEMBLY | 20 | 2.62e-01 | -1.45e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 5 | 5.75e-01 | 1.45e-01 | 7.97e-01 |
| GOBP MESONEPHROS DEVELOPMENT | 42 | 1.05e-01 | -1.45e-01 | 3.40e-01 |
| GOBP STEM CELL DIFFERENTIATION | 150 | 2.24e-03 | -1.45e-01 | 3.04e-02 |
| GOBP REGULATION OF MIRNA METABOLIC PROCESS | 61 | 5.07e-02 | -1.45e-01 | 2.29e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR | 271 | 4.37e-05 | -1.45e-01 | 1.49e-03 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 124 | 5.46e-03 | -1.45e-01 | 5.43e-02 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 19 | 2.75e-01 | -1.45e-01 | 5.65e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 23 | 2.30e-01 | 1.45e-01 | 5.15e-01 |
| GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 6 | 5.40e-01 | -1.44e-01 | 7.77e-01 |
| GOBP FEMALE GAMETE GENERATION | 93 | 1.62e-02 | -1.44e-01 | 1.14e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 29 | 1.79e-01 | -1.44e-01 | 4.52e-01 |
| GOBP INNATE IMMUNE RESPONSE IN MUCOSA | 5 | 5.76e-01 | -1.44e-01 | 7.98e-01 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 23 | 2.31e-01 | -1.44e-01 | 5.15e-01 |
| GOMF 5 3 DNA HELICASE ACTIVITY | 7 | 5.09e-01 | -1.44e-01 | 7.56e-01 |
| GOBP VIRAL RELEASE FROM HOST CELL | 27 | 1.95e-01 | 1.44e-01 | 4.72e-01 |
| GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 7 | 5.09e-01 | 1.44e-01 | 7.56e-01 |
| GOBP SALIVARY GLAND DEVELOPMENT | 18 | 2.90e-01 | -1.44e-01 | 5.80e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 70 | 3.72e-02 | -1.44e-01 | 1.91e-01 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 17 | 3.04e-01 | -1.44e-01 | 5.92e-01 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 22 | 2.42e-01 | 1.44e-01 | 5.29e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 5.42e-01 | 1.44e-01 | 7.77e-01 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 124 | 5.71e-03 | 1.44e-01 | 5.62e-02 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 209 | 3.46e-04 | -1.44e-01 | 7.52e-03 |
| GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.42e-01 | 1.44e-01 | 7.77e-01 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 5 | 5.77e-01 | 1.44e-01 | 7.99e-01 |
| GOMF TELOMERASE ACTIVITY | 5 | 5.77e-01 | 1.44e-01 | 7.99e-01 |
| GOCC GOLGI CIS CISTERNA | 9 | 4.55e-01 | -1.44e-01 | 7.23e-01 |
| GOMF G QUADRUPLEX RNA BINDING | 6 | 5.42e-01 | -1.44e-01 | 7.77e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 25 | 2.13e-01 | -1.44e-01 | 4.96e-01 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 18 | 2.91e-01 | 1.44e-01 | 5.80e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 61 | 5.24e-02 | -1.44e-01 | 2.33e-01 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 25 | 2.14e-01 | -1.44e-01 | 4.97e-01 |
| GOBP SCHWANN CELL DIFFERENTIATION | 29 | 1.81e-01 | -1.44e-01 | 4.56e-01 |
| GOCC OXIDOREDUCTASE COMPLEX | 112 | 8.80e-03 | 1.43e-01 | 7.56e-02 |
| GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 4.56e-01 | 1.43e-01 | 7.24e-01 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 383 | 1.60e-06 | -1.43e-01 | 8.72e-05 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 48 | 8.61e-02 | -1.43e-01 | 3.06e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 889 | 7.19e-13 | -1.43e-01 | 2.30e-10 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 5.79e-01 | 1.43e-01 | 8.00e-01 |
| GOBP ZINC ION TRANSPORT | 20 | 2.68e-01 | 1.43e-01 | 5.57e-01 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 65 | 4.61e-02 | -1.43e-01 | 2.18e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 17 | 3.07e-01 | 1.43e-01 | 5.96e-01 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 5.79e-01 | 1.43e-01 | 8.00e-01 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 174 | 1.15e-03 | -1.43e-01 | 1.88e-02 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 288 | 3.11e-05 | -1.43e-01 | 1.11e-03 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 53 | 7.18e-02 | 1.43e-01 | 2.79e-01 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 15 | 3.38e-01 | 1.43e-01 | 6.24e-01 |
| GOBP REGULATION OF PROTON TRANSPORT | 13 | 3.72e-01 | 1.43e-01 | 6.56e-01 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 18 | 2.94e-01 | 1.43e-01 | 5.82e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 3.91e-01 | -1.43e-01 | 6.72e-01 |
| GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 6 | 5.44e-01 | -1.43e-01 | 7.79e-01 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 119 | 7.17e-03 | -1.43e-01 | 6.55e-02 |
| GOBP MUSCLE HYPERTROPHY | 55 | 6.70e-02 | -1.43e-01 | 2.69e-01 |
| GOMF CTPASE ACTIVITY | 5 | 5.80e-01 | 1.43e-01 | 8.00e-01 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 5 | 5.80e-01 | -1.43e-01 | 8.00e-01 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 220 | 2.73e-04 | -1.43e-01 | 6.48e-03 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 57 | 6.27e-02 | -1.43e-01 | 2.58e-01 |
| GOBP REGULATION OF CELL ADHESION | 524 | 2.79e-08 | -1.43e-01 | 3.09e-06 |
| GOBP REGULATION OF HEAT GENERATION | 8 | 4.85e-01 | -1.43e-01 | 7.43e-01 |
| GOBP GLUCOSE IMPORT | 48 | 8.77e-02 | -1.43e-01 | 3.09e-01 |
| GOCC MICROFIBRIL | 6 | 5.46e-01 | -1.42e-01 | 7.80e-01 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 35 | 1.45e-01 | 1.42e-01 | 4.04e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 52 | 7.58e-02 | -1.42e-01 | 2.87e-01 |
| GOMF TROPOMYOSIN BINDING | 7 | 5.14e-01 | 1.42e-01 | 7.60e-01 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 20 | 2.70e-01 | 1.42e-01 | 5.60e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 11 | 4.14e-01 | 1.42e-01 | 6.92e-01 |
| GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY | 7 | 5.14e-01 | 1.42e-01 | 7.60e-01 |
| GOMF ATPASE BINDING | 63 | 5.10e-02 | 1.42e-01 | 2.29e-01 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 68 | 4.26e-02 | -1.42e-01 | 2.08e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 7 | 5.15e-01 | -1.42e-01 | 7.60e-01 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 146 | 3.05e-03 | -1.42e-01 | 3.76e-02 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 403 | 1.08e-06 | -1.42e-01 | 6.36e-05 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 51 | 7.92e-02 | -1.42e-01 | 2.93e-01 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 101 | 1.37e-02 | -1.42e-01 | 1.01e-01 |
| GOCC SWR1 COMPLEX | 13 | 3.75e-01 | -1.42e-01 | 6.57e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 38 | 1.31e-01 | -1.42e-01 | 3.82e-01 |
| GOBP T CELL CHEMOTAXIS | 15 | 3.42e-01 | -1.42e-01 | 6.28e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 26 | 2.11e-01 | -1.42e-01 | 4.94e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 5.48e-01 | -1.42e-01 | 7.81e-01 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 57 | 6.44e-02 | -1.42e-01 | 2.63e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 7 | 5.16e-01 | 1.42e-01 | 7.61e-01 |
| GOBP MAST CELL PROLIFERATION | 5 | 5.83e-01 | -1.42e-01 | 8.02e-01 |
| GOBP REGULATION OF XENOPHAGY | 8 | 4.88e-01 | -1.42e-01 | 7.45e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 183 | 9.74e-04 | -1.42e-01 | 1.65e-02 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 63 | 5.20e-02 | -1.42e-01 | 2.32e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 13 | 3.77e-01 | -1.41e-01 | 6.59e-01 |
| GOBP NEGATIVE CHEMOTAXIS | 21 | 2.62e-01 | -1.41e-01 | 5.52e-01 |
| GOBP TRANSLESION SYNTHESIS | 24 | 2.30e-01 | -1.41e-01 | 5.15e-01 |
| GOBP SYNAPSE MATURATION | 17 | 3.13e-01 | -1.41e-01 | 6.01e-01 |
| GOBP AMINO ACID BETAINE TRANSPORT | 10 | 4.39e-01 | 1.41e-01 | 7.11e-01 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 122 | 7.08e-03 | -1.41e-01 | 6.51e-02 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 47 | 9.38e-02 | -1.41e-01 | 3.22e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 22 | 2.51e-01 | -1.41e-01 | 5.40e-01 |
| GOBP ALDITOL METABOLIC PROCESS | 16 | 3.28e-01 | 1.41e-01 | 6.15e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 5.17e-01 | 1.41e-01 | 7.62e-01 |
| GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 10 | 4.39e-01 | -1.41e-01 | 7.11e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 38 | 1.32e-01 | -1.41e-01 | 3.84e-01 |
| GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 5 | 5.85e-01 | 1.41e-01 | 8.03e-01 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 8 | 4.90e-01 | 1.41e-01 | 7.47e-01 |
| GOMF TRANSCRIPTION FACTOR BINDING | 477 | 1.52e-07 | -1.41e-01 | 1.20e-05 |
| GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 9 | 4.64e-01 | 1.41e-01 | 7.30e-01 |
| GOBP TRNA CATABOLIC PROCESS | 16 | 3.29e-01 | 1.41e-01 | 6.15e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY | 43 | 1.10e-01 | 1.41e-01 | 3.48e-01 |
| GOBP NUCLEUS LOCALIZATION | 26 | 2.14e-01 | -1.41e-01 | 4.96e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 23 | 2.42e-01 | 1.41e-01 | 5.29e-01 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 13 | 3.79e-01 | 1.41e-01 | 6.61e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 61 | 5.72e-02 | -1.41e-01 | 2.44e-01 |
| GOBP REGULATION OF T CELL CHEMOTAXIS | 8 | 4.90e-01 | -1.41e-01 | 7.47e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 3.01e-01 | 1.41e-01 | 5.89e-01 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 219 | 3.41e-04 | -1.41e-01 | 7.48e-03 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 74 | 3.65e-02 | -1.41e-01 | 1.89e-01 |
| GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 8 | 4.91e-01 | -1.41e-01 | 7.47e-01 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 83 | 2.68e-02 | -1.41e-01 | 1.57e-01 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 20 | 2.76e-01 | -1.41e-01 | 5.66e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 13 | 3.80e-01 | 1.41e-01 | 6.62e-01 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 85 | 2.52e-02 | 1.41e-01 | 1.50e-01 |
| GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 11 | 4.20e-01 | 1.41e-01 | 6.97e-01 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 22 | 2.54e-01 | -1.41e-01 | 5.42e-01 |
| GOCC M BAND | 17 | 3.16e-01 | 1.41e-01 | 6.05e-01 |
| GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 10 | 4.42e-01 | 1.41e-01 | 7.12e-01 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 137 | 4.57e-03 | 1.41e-01 | 4.85e-02 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 23 | 2.44e-01 | 1.40e-01 | 5.30e-01 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 52 | 7.99e-02 | -1.40e-01 | 2.94e-01 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 186 | 9.81e-04 | -1.40e-01 | 1.66e-02 |
| GOBP SPHINGOLIPID CATABOLIC PROCESS | 20 | 2.77e-01 | -1.40e-01 | 5.67e-01 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 5.87e-01 | 1.40e-01 | 8.04e-01 |
| GOMF EXOPEPTIDASE ACTIVITY | 68 | 4.56e-02 | -1.40e-01 | 2.16e-01 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 12 | 4.00e-01 | -1.40e-01 | 6.80e-01 |
| GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 7 | 5.20e-01 | -1.40e-01 | 7.65e-01 |
| GOMF MRNA 3 UTR BINDING | 84 | 2.65e-02 | -1.40e-01 | 1.55e-01 |
| GOBP PRIMARY ALCOHOL CATABOLIC PROCESS | 5 | 5.87e-01 | -1.40e-01 | 8.04e-01 |
| GOBP RESPONSE TO GONADOTROPIN | 12 | 4.01e-01 | -1.40e-01 | 6.81e-01 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 357 | 5.90e-06 | -1.40e-01 | 2.71e-04 |
| GOCC RIBOSOMAL SUBUNIT | 180 | 1.21e-03 | 1.40e-01 | 1.96e-02 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 40 | 1.25e-01 | 1.40e-01 | 3.74e-01 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 20 | 2.78e-01 | 1.40e-01 | 5.68e-01 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 149 | 3.23e-03 | -1.40e-01 | 3.90e-02 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 8 | 4.93e-01 | 1.40e-01 | 7.48e-01 |
| GOBP PHASIC SMOOTH MUSCLE CONTRACTION | 6 | 5.53e-01 | 1.40e-01 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 5.88e-01 | 1.40e-01 | 8.04e-01 |
| GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 8 | 4.93e-01 | 1.40e-01 | 7.48e-01 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 53 | 7.86e-02 | -1.40e-01 | 2.91e-01 |
| GOMF SCAFFOLD PROTEIN BINDING | 49 | 9.09e-02 | -1.40e-01 | 3.17e-01 |
| GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 15 | 3.49e-01 | 1.40e-01 | 6.34e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 31 | 1.79e-01 | -1.40e-01 | 4.52e-01 |
| GOBP PROTEIN NITROSYLATION | 12 | 4.02e-01 | -1.40e-01 | 6.82e-01 |
| GOBP REGULATION OF LIPOPHAGY | 5 | 5.89e-01 | 1.40e-01 | 8.04e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION | 45 | 1.05e-01 | 1.40e-01 | 3.41e-01 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 8 | 4.94e-01 | -1.40e-01 | 7.49e-01 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 55 | 7.38e-02 | -1.39e-01 | 2.82e-01 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 9 | 4.69e-01 | -1.39e-01 | 7.33e-01 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 21 | 2.69e-01 | 1.39e-01 | 5.58e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 12 | 4.03e-01 | -1.39e-01 | 6.83e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 374 | 4.06e-06 | -1.39e-01 | 1.95e-04 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 105 | 1.38e-02 | -1.39e-01 | 1.02e-01 |
| GOBP CHROMATIN REMODELING | 494 | 1.36e-07 | -1.39e-01 | 1.08e-05 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 8 | 4.95e-01 | 1.39e-01 | 7.50e-01 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 424 | 9.94e-07 | -1.39e-01 | 5.91e-05 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 65 | 5.25e-02 | -1.39e-01 | 2.34e-01 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 15 | 3.51e-01 | 1.39e-01 | 6.37e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 9 | 4.70e-01 | 1.39e-01 | 7.33e-01 |
| GOBP EPITHELIAL TUBE FORMATION | 87 | 2.52e-02 | -1.39e-01 | 1.50e-01 |
| GOBP GOLGI VESICLE TRANSPORT | 270 | 8.86e-05 | 1.39e-01 | 2.69e-03 |
| GOBP CELL MOTILITY | 1013 | 1.40e-13 | -1.39e-01 | 5.49e-11 |
| GOBP REGULATION OF GLUCOSE IMPORT | 38 | 1.38e-01 | -1.39e-01 | 3.94e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 25 | 2.29e-01 | -1.39e-01 | 5.15e-01 |
| GOBP RESPONSE TO ATP | 20 | 2.82e-01 | 1.39e-01 | 5.72e-01 |
| GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 7 | 5.25e-01 | -1.39e-01 | 7.68e-01 |
| GOBP POSITIVE REGULATION OF T CELL MIGRATION | 25 | 2.30e-01 | -1.39e-01 | 5.15e-01 |
| GOCC CIS GOLGI NETWORK | 49 | 9.30e-02 | 1.39e-01 | 3.20e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 14 | 3.69e-01 | 1.39e-01 | 6.52e-01 |
| GOMF ALDITOL NADPPLUS 1 OXIDOREDUCTASE ACTIVITY | 6 | 5.56e-01 | 1.39e-01 | 7.86e-01 |
| GOBP TIGHT JUNCTION ORGANIZATION | 45 | 1.07e-01 | -1.39e-01 | 3.45e-01 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 3.22e-01 | -1.39e-01 | 6.10e-01 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 24 | 2.40e-01 | 1.39e-01 | 5.26e-01 |
| GOBP TUBE FORMATION | 96 | 1.90e-02 | -1.39e-01 | 1.27e-01 |
| GOBP REGULATION OF APOPTOTIC CELL CLEARANCE | 8 | 4.97e-01 | -1.39e-01 | 7.51e-01 |
| GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 5.26e-01 | 1.39e-01 | 7.69e-01 |
| GOBP L ASCORBIC ACID METABOLIC PROCESS | 8 | 4.98e-01 | -1.38e-01 | 7.51e-01 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 44 | 1.12e-01 | -1.38e-01 | 3.52e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 90 | 2.34e-02 | -1.38e-01 | 1.43e-01 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 109 | 1.27e-02 | -1.38e-01 | 9.64e-02 |
| GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 50 | 9.09e-02 | -1.38e-01 | 3.17e-01 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 19 | 2.97e-01 | -1.38e-01 | 5.85e-01 |
| GOBP REGULATION OF FEAR RESPONSE | 7 | 5.27e-01 | -1.38e-01 | 7.69e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 838 | 1.68e-11 | -1.38e-01 | 4.38e-09 |
| GOBP RESPONSE TO ACETYLCHOLINE | 18 | 3.10e-01 | -1.38e-01 | 5.99e-01 |
| GOBP REGULATION OF GTPASE ACTIVITY | 213 | 5.27e-04 | -1.38e-01 | 1.02e-02 |
| GOCC SECONDARY LYSOSOME | 17 | 3.24e-01 | -1.38e-01 | 6.11e-01 |
| GOCC CILIARY ROOTLET | 11 | 4.28e-01 | -1.38e-01 | 7.05e-01 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 7 | 5.27e-01 | 1.38e-01 | 7.69e-01 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 20 | 2.85e-01 | -1.38e-01 | 5.75e-01 |
| GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 154 | 3.17e-03 | -1.38e-01 | 3.84e-02 |
| GOMF ALKALI METAL ION BINDING | 11 | 4.28e-01 | 1.38e-01 | 7.05e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 245 | 2.07e-04 | -1.38e-01 | 5.35e-03 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 5.27e-01 | 1.38e-01 | 7.69e-01 |
| GOMF DEATH RECEPTOR BINDING | 16 | 3.40e-01 | -1.38e-01 | 6.26e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 174 | 1.74e-03 | -1.38e-01 | 2.49e-02 |
| GOCC CONTRACTILE RING | 10 | 4.51e-01 | -1.38e-01 | 7.19e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 2.00e-01 | -1.38e-01 | 4.79e-01 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 81 | 3.25e-02 | -1.38e-01 | 1.77e-01 |
| GOBP LIPOXYGENASE PATHWAY | 5 | 5.94e-01 | -1.38e-01 | 8.07e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 31 | 1.85e-01 | -1.38e-01 | 4.60e-01 |
| GOBP T CELL MIGRATION | 48 | 9.95e-02 | -1.38e-01 | 3.32e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 8 | 5.01e-01 | 1.37e-01 | 7.53e-01 |
| GOBP RESPONSE TO HYDROPEROXIDE | 12 | 4.10e-01 | -1.37e-01 | 6.89e-01 |
| GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 14 | 3.73e-01 | -1.37e-01 | 6.56e-01 |
| GOBP MOTILE CILIUM ASSEMBLY | 36 | 1.54e-01 | 1.37e-01 | 4.17e-01 |
| GOBP NEURAL CREST FORMATION | 9 | 4.76e-01 | 1.37e-01 | 7.38e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 30 | 1.93e-01 | -1.37e-01 | 4.70e-01 |
| GOBP NEUROBLAST DIVISION | 9 | 4.76e-01 | -1.37e-01 | 7.38e-01 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 1092 | 3.91e-14 | -1.37e-01 | 1.98e-11 |
| GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 9 | 4.76e-01 | -1.37e-01 | 7.38e-01 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 95 | 2.09e-02 | -1.37e-01 | 1.34e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 15 | 3.58e-01 | -1.37e-01 | 6.44e-01 |
| GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 16 | 3.42e-01 | 1.37e-01 | 6.28e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 11 | 4.31e-01 | -1.37e-01 | 7.06e-01 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 246 | 2.23e-04 | -1.37e-01 | 5.56e-03 |
| GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 8 | 5.02e-01 | 1.37e-01 | 7.54e-01 |
| GOBP G1 TO G0 TRANSITION | 14 | 3.75e-01 | -1.37e-01 | 6.57e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 26 | 2.27e-01 | -1.37e-01 | 5.12e-01 |
| GOBP REGULATION OF COAGULATION | 41 | 1.30e-01 | -1.37e-01 | 3.81e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 15 | 3.59e-01 | -1.37e-01 | 6.45e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 9 | 4.78e-01 | -1.37e-01 | 7.39e-01 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 46 | 1.09e-01 | -1.37e-01 | 3.47e-01 |
| GOBP PEPTIDYL ARGININE METHYLATION | 5 | 5.97e-01 | -1.37e-01 | 8.09e-01 |
| GOBP DEMETHYLATION | 39 | 1.40e-01 | -1.37e-01 | 3.96e-01 |
| GOBP REGULATION OF KINASE ACTIVITY | 411 | 2.23e-06 | -1.37e-01 | 1.16e-04 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 8 | 5.03e-01 | 1.37e-01 | 7.54e-01 |
| GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 8 | 5.04e-01 | 1.37e-01 | 7.54e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 187 | 1.32e-03 | -1.36e-01 | 2.07e-02 |
| GOBP CELL MATRIX ADHESION | 150 | 3.97e-03 | -1.36e-01 | 4.47e-02 |
| GOBP VASCULATURE DEVELOPMENT | 447 | 8.58e-07 | -1.36e-01 | 5.28e-05 |
| GOBP GLAND MORPHOGENESIS | 64 | 5.92e-02 | -1.36e-01 | 2.49e-01 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 13 | 3.95e-01 | -1.36e-01 | 6.75e-01 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 9 | 4.79e-01 | -1.36e-01 | 7.40e-01 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 51 | 9.23e-02 | -1.36e-01 | 3.19e-01 |
| GOCC MYELIN SHEATH ABAXONAL REGION | 5 | 5.98e-01 | 1.36e-01 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 12 | 4.14e-01 | 1.36e-01 | 6.92e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 24 | 2.49e-01 | 1.36e-01 | 5.37e-01 |
| GOBP PHAGOSOME MATURATION | 28 | 2.13e-01 | -1.36e-01 | 4.96e-01 |
| GOBP ATP BIOSYNTHETIC PROCESS | 93 | 2.36e-02 | 1.36e-01 | 1.44e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 35 | 1.64e-01 | -1.36e-01 | 4.32e-01 |
| GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 5 | 5.99e-01 | -1.36e-01 | 8.10e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 11 | 4.36e-01 | 1.36e-01 | 7.09e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 7 | 5.34e-01 | -1.36e-01 | 7.74e-01 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 28 | 2.14e-01 | -1.36e-01 | 4.97e-01 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 6 | 5.65e-01 | 1.36e-01 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 5 | 5.99e-01 | -1.36e-01 | 8.10e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 8 | 5.07e-01 | -1.36e-01 | 7.55e-01 |
| GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 6 | 5.65e-01 | 1.36e-01 | 7.91e-01 |
| GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION | 6 | 5.66e-01 | 1.35e-01 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 5 | 6.00e-01 | -1.35e-01 | 8.10e-01 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 363 | 1.02e-05 | -1.35e-01 | 4.28e-04 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 18 | 3.20e-01 | -1.35e-01 | 6.09e-01 |
| GOBP CELLULAR RESPONSE TO DSRNA | 18 | 3.20e-01 | -1.35e-01 | 6.09e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 41 | 1.34e-01 | -1.35e-01 | 3.87e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 25 | 2.42e-01 | -1.35e-01 | 5.29e-01 |
| GOBP INTESTINAL EPITHELIAL CELL MATURATION | 5 | 6.01e-01 | -1.35e-01 | 8.10e-01 |
| GOBP PEPTIDYL LYSINE MONOMETHYLATION | 9 | 4.83e-01 | -1.35e-01 | 7.41e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 28 | 2.16e-01 | 1.35e-01 | 4.99e-01 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 12 | 4.18e-01 | -1.35e-01 | 6.96e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 36 | 1.61e-01 | -1.35e-01 | 4.28e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 6 | 5.67e-01 | 1.35e-01 | 7.92e-01 |
| GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 8 | 5.09e-01 | -1.35e-01 | 7.56e-01 |
| GOBP VASOCONSTRICTION | 36 | 1.62e-01 | -1.35e-01 | 4.28e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 5 | 6.02e-01 | 1.35e-01 | 8.11e-01 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 50 | 9.93e-02 | 1.35e-01 | 3.32e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 443 | 1.30e-06 | -1.35e-01 | 7.48e-05 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 65 | 6.05e-02 | -1.35e-01 | 2.53e-01 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 27 | 2.26e-01 | -1.35e-01 | 5.10e-01 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1040 | 3.97e-13 | -1.35e-01 | 1.37e-10 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 18 | 3.23e-01 | -1.35e-01 | 6.10e-01 |
| GOBP MESENCHYME DEVELOPMENT | 164 | 2.98e-03 | -1.35e-01 | 3.70e-02 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 26 | 2.35e-01 | -1.35e-01 | 5.19e-01 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 22 | 2.75e-01 | 1.35e-01 | 5.65e-01 |
| GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION | 5 | 6.02e-01 | 1.35e-01 | 8.11e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 11 | 4.40e-01 | 1.34e-01 | 7.11e-01 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 1066 | 2.39e-13 | -1.34e-01 | 8.96e-11 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 62 | 6.75e-02 | -1.34e-01 | 2.70e-01 |
| GOCC MOTILE CILIUM | 141 | 5.96e-03 | 1.34e-01 | 5.76e-02 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 11 | 4.41e-01 | -1.34e-01 | 7.11e-01 |
| GOBP ANDROGEN METABOLIC PROCESS | 18 | 3.24e-01 | -1.34e-01 | 6.11e-01 |
| GOBP REGULATION OF IMMUNE RESPONSE | 641 | 8.50e-09 | -1.34e-01 | 1.11e-06 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 8 | 5.11e-01 | -1.34e-01 | 7.58e-01 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 504 | 2.90e-07 | -1.34e-01 | 2.05e-05 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 17 | 3.38e-01 | -1.34e-01 | 6.24e-01 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 88 | 2.98e-02 | -1.34e-01 | 1.68e-01 |
| GOCC CKM COMPLEX | 5 | 6.04e-01 | -1.34e-01 | 8.12e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 8 | 5.12e-01 | -1.34e-01 | 7.58e-01 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 15 | 3.69e-01 | -1.34e-01 | 6.52e-01 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 23 | 2.66e-01 | -1.34e-01 | 5.56e-01 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 4.63e-01 | 1.34e-01 | 7.30e-01 |
| GOBP RESPONSE TO L GLUTAMATE | 11 | 4.42e-01 | -1.34e-01 | 7.13e-01 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 81 | 3.74e-02 | -1.34e-01 | 1.91e-01 |
| GOCC TERTIARY GRANULE | 132 | 8.02e-03 | -1.34e-01 | 7.08e-02 |
| GOBP CARDIOCYTE DIFFERENTIATION | 84 | 3.42e-02 | -1.34e-01 | 1.82e-01 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 37 | 1.59e-01 | 1.34e-01 | 4.24e-01 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 21 | 2.89e-01 | -1.34e-01 | 5.79e-01 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 72 | 5.00e-02 | -1.34e-01 | 2.27e-01 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 8 | 5.13e-01 | -1.34e-01 | 7.59e-01 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 9 | 4.87e-01 | -1.34e-01 | 7.45e-01 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 104 | 1.87e-02 | -1.34e-01 | 1.25e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 54 | 8.96e-02 | -1.34e-01 | 3.14e-01 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 156 | 4.04e-03 | -1.34e-01 | 4.51e-02 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 16 | 3.55e-01 | -1.34e-01 | 6.41e-01 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 6 | 5.71e-01 | -1.34e-01 | 7.94e-01 |
| GOCC PROTEIN KINASE COMPLEX | 124 | 1.03e-02 | -1.34e-01 | 8.45e-02 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 22 | 2.78e-01 | 1.34e-01 | 5.68e-01 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 64 | 6.49e-02 | -1.34e-01 | 2.64e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 13 | 4.05e-01 | -1.34e-01 | 6.84e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 20 | 3.02e-01 | 1.33e-01 | 5.90e-01 |
| GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION | 7 | 5.41e-01 | -1.33e-01 | 7.77e-01 |
| GOBP REGULATION OF MIRNA TRANSCRIPTION | 48 | 1.10e-01 | -1.33e-01 | 3.48e-01 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 269 | 1.73e-04 | -1.33e-01 | 4.60e-03 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 380 | 8.80e-06 | -1.33e-01 | 3.80e-04 |
| GOBP SKIN MORPHOGENESIS | 9 | 4.89e-01 | -1.33e-01 | 7.46e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 22 | 2.79e-01 | 1.33e-01 | 5.68e-01 |
| GOBP REFLEX | 6 | 5.72e-01 | 1.33e-01 | 7.95e-01 |
| GOBP REGULATION OF B CELL ACTIVATION | 101 | 2.08e-02 | -1.33e-01 | 1.34e-01 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 105 | 1.84e-02 | 1.33e-01 | 1.24e-01 |
| GOCC FILOPODIUM MEMBRANE | 13 | 4.05e-01 | 1.33e-01 | 6.85e-01 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 81 | 3.84e-02 | 1.33e-01 | 1.93e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 30 | 2.07e-01 | -1.33e-01 | 4.88e-01 |
| GOBP TRANSLATIONAL ELONGATION | 61 | 7.23e-02 | 1.33e-01 | 2.80e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 36 | 1.67e-01 | 1.33e-01 | 4.36e-01 |
| GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS | 5 | 6.06e-01 | -1.33e-01 | 8.13e-01 |
| GOMF SELENIUM BINDING | 5 | 6.07e-01 | -1.33e-01 | 8.13e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 247 | 3.30e-04 | -1.33e-01 | 7.36e-03 |
| GOCC SMC5 SMC6 COMPLEX | 9 | 4.90e-01 | -1.33e-01 | 7.47e-01 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 161 | 3.68e-03 | -1.33e-01 | 4.25e-02 |
| GOMF ADENINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.07e-01 | 1.33e-01 | 8.13e-01 |
| GOMF 5S RRNA BINDING | 9 | 4.90e-01 | 1.33e-01 | 7.47e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 19 | 3.17e-01 | -1.33e-01 | 6.06e-01 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 11 | 4.46e-01 | 1.33e-01 | 7.14e-01 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 89 | 3.07e-02 | -1.33e-01 | 1.70e-01 |
| GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 6.07e-01 | -1.33e-01 | 8.13e-01 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 120 | 1.22e-02 | -1.33e-01 | 9.40e-02 |
| GOBP MUSCLE ADAPTATION | 64 | 6.68e-02 | -1.33e-01 | 2.69e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 6.08e-01 | -1.33e-01 | 8.14e-01 |
| GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY | 8 | 5.16e-01 | 1.33e-01 | 7.61e-01 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 93 | 2.74e-02 | -1.33e-01 | 1.59e-01 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 25 | 2.52e-01 | -1.33e-01 | 5.40e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 10 | 4.68e-01 | 1.32e-01 | 7.33e-01 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 37 | 1.63e-01 | -1.32e-01 | 4.31e-01 |
| GOBP SPLEEN DEVELOPMENT | 26 | 2.43e-01 | -1.32e-01 | 5.29e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 73 | 5.07e-02 | 1.32e-01 | 2.29e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 10 | 4.69e-01 | 1.32e-01 | 7.33e-01 |
| GOBP BASE EXCISION REPAIR | 41 | 1.43e-01 | -1.32e-01 | 4.02e-01 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 267 | 2.09e-04 | -1.32e-01 | 5.37e-03 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 518 | 3.06e-07 | -1.32e-01 | 2.15e-05 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 7 | 5.45e-01 | 1.32e-01 | 7.80e-01 |
| GOBP RRNA TRANSPORT | 5 | 6.09e-01 | -1.32e-01 | 8.14e-01 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 24 | 2.63e-01 | -1.32e-01 | 5.53e-01 |
| GOBP PHAGOCYTOSIS | 176 | 2.56e-03 | -1.32e-01 | 3.34e-02 |
| GOBP DENDRITIC SPINE MAINTENANCE | 18 | 3.33e-01 | -1.32e-01 | 6.19e-01 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 24 | 2.63e-01 | -1.32e-01 | 5.53e-01 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 11 | 4.49e-01 | 1.32e-01 | 7.17e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 25 | 2.54e-01 | 1.32e-01 | 5.42e-01 |
| GOBP PLASMINOGEN ACTIVATION | 16 | 3.61e-01 | 1.32e-01 | 6.47e-01 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 17 | 3.47e-01 | -1.32e-01 | 6.32e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 8 | 5.19e-01 | -1.32e-01 | 7.63e-01 |
| GOBP SPERM CAPACITATION | 10 | 4.71e-01 | 1.32e-01 | 7.34e-01 |
| GOBP GERMINAL CENTER FORMATION | 12 | 4.30e-01 | 1.32e-01 | 7.05e-01 |
| GOBP PRESYNAPSE ORGANIZATION | 22 | 2.85e-01 | 1.32e-01 | 5.75e-01 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 19 | 3.21e-01 | -1.32e-01 | 6.09e-01 |
| GOBP DNA BIOSYNTHETIC PROCESS | 161 | 4.03e-03 | -1.32e-01 | 4.51e-02 |
| GOMF KINASE INHIBITOR ACTIVITY | 61 | 7.59e-02 | -1.32e-01 | 2.87e-01 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 227 | 6.66e-04 | -1.31e-01 | 1.23e-02 |
| GOBP STEM CELL DEVELOPMENT | 49 | 1.12e-01 | -1.31e-01 | 3.51e-01 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 39 | 1.56e-01 | -1.31e-01 | 4.19e-01 |
| GOBP REGULATION OF LIPASE ACTIVITY | 42 | 1.41e-01 | -1.31e-01 | 3.99e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 51 | 1.05e-01 | 1.31e-01 | 3.41e-01 |
| GOCC PODOSOME | 30 | 2.14e-01 | -1.31e-01 | 4.96e-01 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 45 | 1.28e-01 | 1.31e-01 | 3.78e-01 |
| GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 6 | 5.78e-01 | 1.31e-01 | 8.00e-01 |
| GOMF HSP70 PROTEIN BINDING | 40 | 1.52e-01 | 1.31e-01 | 4.13e-01 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 91 | 3.09e-02 | -1.31e-01 | 1.71e-01 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 27 | 2.39e-01 | 1.31e-01 | 5.24e-01 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 26 | 2.48e-01 | 1.31e-01 | 5.35e-01 |
| GOBP IRON COORDINATION ENTITY TRANSPORT | 9 | 4.96e-01 | 1.31e-01 | 7.51e-01 |
| GOBP NEURON FATE SPECIFICATION | 7 | 5.49e-01 | -1.31e-01 | 7.81e-01 |
| GOBP SECRETION BY TISSUE | 19 | 3.23e-01 | 1.31e-01 | 6.10e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 14 | 3.96e-01 | 1.31e-01 | 6.77e-01 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 23 | 2.77e-01 | -1.31e-01 | 5.67e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 5 | 6.12e-01 | 1.31e-01 | 8.16e-01 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 8 | 5.22e-01 | -1.31e-01 | 7.66e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 10 | 4.75e-01 | -1.31e-01 | 7.37e-01 |
| GOBP HINDBRAIN MORPHOGENESIS | 28 | 2.32e-01 | -1.31e-01 | 5.16e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 6 | 5.80e-01 | -1.31e-01 | 8.00e-01 |
| GOBP HEAD DEVELOPMENT | 455 | 2.06e-06 | -1.31e-01 | 1.10e-04 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 20 | 3.13e-01 | 1.30e-01 | 6.01e-01 |
| GOBP COCHLEA DEVELOPMENT | 17 | 3.52e-01 | 1.30e-01 | 6.37e-01 |
| GOBP EPITHELIAL FLUID TRANSPORT | 5 | 6.14e-01 | 1.30e-01 | 8.17e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 6 | 5.80e-01 | 1.30e-01 | 8.00e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 23 | 2.79e-01 | -1.30e-01 | 5.68e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 41 | 1.49e-01 | 1.30e-01 | 4.10e-01 |
| GOBP INTERMEMBRANE LIPID TRANSFER | 35 | 1.83e-01 | 1.30e-01 | 4.57e-01 |
| GOMF LIPID TRANSFER ACTIVITY | 35 | 1.83e-01 | 1.30e-01 | 4.57e-01 |
| GOBP RRNA METABOLIC PROCESS | 246 | 4.50e-04 | 1.30e-01 | 9.14e-03 |
| GOBP PANCREATIC JUICE SECRETION | 5 | 6.14e-01 | -1.30e-01 | 8.17e-01 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 51 | 1.08e-01 | -1.30e-01 | 3.46e-01 |
| GOBP MALONYL COA METABOLIC PROCESS | 6 | 5.81e-01 | -1.30e-01 | 8.00e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 79 | 4.57e-02 | -1.30e-01 | 2.16e-01 |
| GOBP DNA RECOMBINATION | 274 | 2.21e-04 | -1.30e-01 | 5.53e-03 |
| GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 219 | 9.42e-04 | -1.30e-01 | 1.62e-02 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 818 | 3.88e-10 | -1.30e-01 | 7.61e-08 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 8 | 5.25e-01 | -1.30e-01 | 7.68e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 209 | 1.24e-03 | -1.30e-01 | 1.99e-02 |
| GOMF FLOPPASE ACTIVITY | 13 | 4.18e-01 | -1.30e-01 | 6.96e-01 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 6.15e-01 | -1.30e-01 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 291 | 1.46e-04 | -1.30e-01 | 4.02e-03 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 16 | 3.69e-01 | -1.30e-01 | 6.52e-01 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 241 | 5.38e-04 | -1.30e-01 | 1.03e-02 |
| GOBP NEUROENDOCRINE CELL DIFFERENTIATION | 5 | 6.15e-01 | 1.30e-01 | 8.17e-01 |
| GOBP FERROPTOSIS | 5 | 6.15e-01 | -1.30e-01 | 8.17e-01 |
| GOCC OUTER MEMBRANE | 212 | 1.17e-03 | 1.30e-01 | 1.90e-02 |
| GOBP PROTEIN TARGETING TO PEROXISOME | 19 | 3.28e-01 | 1.30e-01 | 6.15e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 13 | 4.18e-01 | -1.30e-01 | 6.96e-01 |
| GOBP NCRNA PROCESSING | 398 | 9.93e-06 | 1.30e-01 | 4.18e-04 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 6 | 5.83e-01 | -1.30e-01 | 8.01e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 15 | 3.85e-01 | -1.30e-01 | 6.67e-01 |
| GOMF NUCLEOTIDASE ACTIVITY | 9 | 5.01e-01 | -1.30e-01 | 7.54e-01 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 86 | 3.82e-02 | -1.29e-01 | 1.93e-01 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 33 | 1.99e-01 | -1.29e-01 | 4.78e-01 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 563 | 1.86e-07 | -1.29e-01 | 1.42e-05 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 4.58e-01 | -1.29e-01 | 7.25e-01 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 33 | 1.99e-01 | 1.29e-01 | 4.78e-01 |
| GOBP RESPONSE TO VITAMIN | 48 | 1.22e-01 | -1.29e-01 | 3.67e-01 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 53 | 1.04e-01 | 1.29e-01 | 3.38e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 91 | 3.35e-02 | 1.29e-01 | 1.80e-01 |
| GOBP REGULATION OF DNA DUPLEX UNWINDING | 5 | 6.17e-01 | 1.29e-01 | 8.18e-01 |
| GOBP TELOMERASE RNA LOCALIZATION | 19 | 3.30e-01 | 1.29e-01 | 6.16e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 17 | 3.57e-01 | 1.29e-01 | 6.43e-01 |
| GOBP PEROXISOMAL TRANSPORT | 22 | 2.95e-01 | 1.29e-01 | 5.84e-01 |
| GOBP EMBRYONIC MORPHOGENESIS | 328 | 6.34e-05 | -1.29e-01 | 2.05e-03 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 83 | 4.25e-02 | 1.29e-01 | 2.07e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 5 | 6.18e-01 | -1.29e-01 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 12 | 4.40e-01 | -1.29e-01 | 7.11e-01 |
| GOBP SPERM AXONEME ASSEMBLY | 17 | 3.58e-01 | 1.29e-01 | 6.44e-01 |
| GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 8 | 5.28e-01 | 1.29e-01 | 7.69e-01 |
| GOBP ALCOHOL CATABOLIC PROCESS | 18 | 3.45e-01 | -1.29e-01 | 6.30e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 14 | 4.05e-01 | -1.29e-01 | 6.84e-01 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 33 | 2.01e-01 | -1.29e-01 | 4.81e-01 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 30 | 2.23e-01 | 1.29e-01 | 5.07e-01 |
| GOBP PROTEIN TARGETING | 288 | 1.83e-04 | 1.29e-01 | 4.83e-03 |
| GOBP EPIDERMIS MORPHOGENESIS | 14 | 4.05e-01 | 1.29e-01 | 6.85e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 24 | 2.76e-01 | 1.28e-01 | 5.66e-01 |
| GOBP CELL CYCLE DNA REPLICATION | 39 | 1.66e-01 | -1.28e-01 | 4.34e-01 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 11 | 4.61e-01 | -1.28e-01 | 7.28e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 255 | 4.35e-04 | -1.28e-01 | 8.91e-03 |
| GOCC RUFFLE MEMBRANE | 83 | 4.35e-02 | -1.28e-01 | 2.10e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 8 | 5.30e-01 | 1.28e-01 | 7.70e-01 |
| GOCC PRESPLICEOSOME | 16 | 3.74e-01 | -1.28e-01 | 6.57e-01 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 50 | 1.17e-01 | -1.28e-01 | 3.59e-01 |
| GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT | 5 | 6.20e-01 | -1.28e-01 | 8.18e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 7 | 5.57e-01 | -1.28e-01 | 7.87e-01 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 54 | 1.04e-01 | 1.28e-01 | 3.38e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 7 | 5.57e-01 | -1.28e-01 | 7.87e-01 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 277 | 2.54e-04 | -1.28e-01 | 6.11e-03 |
| GOMF ENDOPEPTIDASE ACTIVITY | 206 | 1.57e-03 | -1.28e-01 | 2.34e-02 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 334 | 6.17e-05 | -1.28e-01 | 2.01e-03 |
| GOBP METHIONINE METABOLIC PROCESS | 12 | 4.43e-01 | 1.28e-01 | 7.13e-01 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 14 | 4.07e-01 | 1.28e-01 | 6.87e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 83 | 4.40e-02 | -1.28e-01 | 2.12e-01 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 29 | 2.33e-01 | 1.28e-01 | 5.16e-01 |
| GOBP ORGANELLE MEMBRANE FUSION | 101 | 2.65e-02 | 1.28e-01 | 1.55e-01 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 38 | 1.73e-01 | -1.28e-01 | 4.43e-01 |
| GOBP REGULATION OF JNK CASCADE | 104 | 2.44e-02 | -1.28e-01 | 1.47e-01 |
| GOCC SAGA TYPE COMPLEX | 36 | 1.84e-01 | 1.28e-01 | 4.59e-01 |
| GOCC REPLISOME | 14 | 4.08e-01 | -1.28e-01 | 6.88e-01 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 12 | 4.43e-01 | -1.28e-01 | 7.13e-01 |
| GOMF MOLECULAR CARRIER ACTIVITY | 79 | 4.97e-02 | 1.28e-01 | 2.27e-01 |
| GOBP PEPTIDYL LYSINE HYDROXYLATION | 6 | 5.88e-01 | 1.28e-01 | 8.04e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 339 | 5.72e-05 | -1.28e-01 | 1.88e-03 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 12 | 4.44e-01 | -1.28e-01 | 7.13e-01 |
| GOBP CHEMOSENSORY BEHAVIOR | 8 | 5.32e-01 | -1.28e-01 | 7.73e-01 |
| GOBP AMINE CATABOLIC PROCESS | 11 | 4.64e-01 | 1.28e-01 | 7.30e-01 |
| GOCC MICROBODY LUMEN | 41 | 1.58e-01 | 1.28e-01 | 4.22e-01 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 10 | 4.85e-01 | -1.28e-01 | 7.43e-01 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 1.98e-01 | 1.27e-01 | 4.78e-01 |
| GOCC PERICENTRIOLAR MATERIAL | 20 | 3.24e-01 | -1.27e-01 | 6.11e-01 |
| GOMF CD4 RECEPTOR BINDING | 6 | 5.89e-01 | -1.27e-01 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 32 | 2.12e-01 | -1.27e-01 | 4.95e-01 |
| GOCC CATSPER COMPLEX | 6 | 5.89e-01 | 1.27e-01 | 8.04e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 14 | 4.09e-01 | -1.27e-01 | 6.89e-01 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 134 | 1.10e-02 | -1.27e-01 | 8.79e-02 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 18 | 3.50e-01 | 1.27e-01 | 6.34e-01 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 25 | 2.70e-01 | -1.27e-01 | 5.60e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 12 | 4.45e-01 | 1.27e-01 | 7.13e-01 |
| GOBP TISSUE HOMEOSTASIS | 159 | 5.68e-03 | -1.27e-01 | 5.61e-02 |
| GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY | 6 | 5.89e-01 | 1.27e-01 | 8.04e-01 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 27 | 2.52e-01 | -1.27e-01 | 5.41e-01 |
| GOBP CELLULAR PIGMENTATION | 57 | 9.68e-02 | 1.27e-01 | 3.28e-01 |
| GOCC NUCLEAR PORE | 87 | 4.04e-02 | 1.27e-01 | 2.00e-01 |
| GOBP PROTEIN ACETYLATION | 88 | 3.93e-02 | -1.27e-01 | 1.96e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 10 | 4.86e-01 | -1.27e-01 | 7.44e-01 |
| GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX | 5 | 6.23e-01 | -1.27e-01 | 8.20e-01 |
| GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX | 5 | 6.23e-01 | -1.27e-01 | 8.20e-01 |
| GOBP ATP METABOLIC PROCESS | 118 | 1.72e-02 | 1.27e-01 | 1.19e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 99 | 2.90e-02 | 1.27e-01 | 1.65e-01 |
| GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 5.34e-01 | -1.27e-01 | 7.73e-01 |
| GOBP STEM CELL PROLIFERATION | 60 | 8.89e-02 | -1.27e-01 | 3.12e-01 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 30 | 2.29e-01 | 1.27e-01 | 5.14e-01 |
| GOBP HEART DEVELOPMENT | 353 | 4.41e-05 | -1.27e-01 | 1.50e-03 |
| GOCC AUTOLYSOSOME | 12 | 4.46e-01 | -1.27e-01 | 7.14e-01 |
| GOMF NEUROTRANSMITTER BINDING | 5 | 6.23e-01 | -1.27e-01 | 8.20e-01 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 16 | 3.79e-01 | -1.27e-01 | 6.61e-01 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 13 | 4.28e-01 | -1.27e-01 | 7.05e-01 |
| GOBP TELOMERIC D LOOP DISASSEMBLY | 6 | 5.90e-01 | -1.27e-01 | 8.05e-01 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 11 | 4.66e-01 | -1.27e-01 | 7.31e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 14 | 4.11e-01 | -1.27e-01 | 6.90e-01 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 48 | 1.29e-01 | -1.27e-01 | 3.79e-01 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 11 | 4.66e-01 | 1.27e-01 | 7.31e-01 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 25 | 2.73e-01 | -1.27e-01 | 5.63e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 5 | 6.24e-01 | -1.27e-01 | 8.20e-01 |
| GOMF NUCLEAR RECEPTOR BINDING | 117 | 1.80e-02 | -1.27e-01 | 1.22e-01 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 13 | 4.29e-01 | -1.27e-01 | 7.05e-01 |
| GOBP NOSE DEVELOPMENT | 8 | 5.35e-01 | -1.27e-01 | 7.74e-01 |
| GOBP RESPONSE TO TESTOSTERONE | 30 | 2.30e-01 | -1.27e-01 | 5.15e-01 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 67 | 7.31e-02 | -1.27e-01 | 2.81e-01 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 43 | 1.51e-01 | -1.27e-01 | 4.12e-01 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 28 | 2.46e-01 | 1.27e-01 | 5.33e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 14 | 4.12e-01 | 1.27e-01 | 6.91e-01 |
| GOMF CHLORIDE ION BINDING | 5 | 6.24e-01 | -1.27e-01 | 8.20e-01 |
| GOBP NADPH REGENERATION | 20 | 3.27e-01 | -1.27e-01 | 6.14e-01 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 13 | 4.29e-01 | -1.27e-01 | 7.05e-01 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 132 | 1.22e-02 | -1.27e-01 | 9.37e-02 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 21 | 3.16e-01 | -1.27e-01 | 6.05e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 114 | 1.98e-02 | 1.26e-01 | 1.30e-01 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 660 | 3.80e-08 | -1.26e-01 | 3.89e-06 |
| GOMF DNA POLYMERASE ACTIVITY | 28 | 2.47e-01 | -1.26e-01 | 5.35e-01 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 9 | 5.12e-01 | 1.26e-01 | 7.58e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 10 | 4.89e-01 | -1.26e-01 | 7.47e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 39 | 1.73e-01 | -1.26e-01 | 4.43e-01 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 77 | 5.57e-02 | -1.26e-01 | 2.41e-01 |
| GOBP DEVELOPMENTAL INDUCTION | 10 | 4.89e-01 | -1.26e-01 | 7.47e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 5 | 6.25e-01 | 1.26e-01 | 8.21e-01 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 86 | 4.33e-02 | -1.26e-01 | 2.09e-01 |
| GOBP CELLULAR RESPONSE TO STARVATION | 144 | 9.05e-03 | -1.26e-01 | 7.70e-02 |
| GOBP AORTA MORPHOGENESIS | 19 | 3.41e-01 | -1.26e-01 | 6.27e-01 |
| GOBP BONE MARROW DEVELOPMENT | 7 | 5.63e-01 | -1.26e-01 | 7.91e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 18 | 3.54e-01 | 1.26e-01 | 6.41e-01 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 11 | 4.69e-01 | -1.26e-01 | 7.33e-01 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 56 | 1.03e-01 | -1.26e-01 | 3.37e-01 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 24 | 2.85e-01 | 1.26e-01 | 5.75e-01 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 26 | 2.67e-01 | 1.26e-01 | 5.57e-01 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 23 | 2.96e-01 | -1.26e-01 | 5.84e-01 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 285 | 2.69e-04 | -1.26e-01 | 6.40e-03 |
| GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 7 | 5.65e-01 | -1.26e-01 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 283 | 2.86e-04 | -1.26e-01 | 6.71e-03 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 35 | 1.98e-01 | -1.26e-01 | 4.78e-01 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 87 | 4.30e-02 | 1.26e-01 | 2.09e-01 |
| GOMF KINASE BINDING | 590 | 2.22e-07 | -1.26e-01 | 1.61e-05 |
| GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 5.94e-01 | -1.26e-01 | 8.07e-01 |
| GOBP TYPE II INTERFERON PRODUCTION | 72 | 6.59e-02 | -1.25e-01 | 2.67e-01 |
| GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 8 | 5.39e-01 | -1.25e-01 | 7.76e-01 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 65 | 8.05e-02 | -1.25e-01 | 2.95e-01 |
| GOBP MEIOTIC TELOMERE CLUSTERING | 6 | 5.95e-01 | 1.25e-01 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 76 | 5.91e-02 | -1.25e-01 | 2.49e-01 |
| GOBP POSITIVE REGULATION OF DNA LIGATION | 5 | 6.28e-01 | -1.25e-01 | 8.23e-01 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 20 | 3.32e-01 | -1.25e-01 | 6.19e-01 |
| GOBP HISTONE MODIFICATION | 110 | 2.35e-02 | -1.25e-01 | 1.44e-01 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 49 | 1.30e-01 | 1.25e-01 | 3.81e-01 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 6.28e-01 | -1.25e-01 | 8.23e-01 |
| GOBP LIPID IMPORT INTO CELL | 14 | 4.18e-01 | -1.25e-01 | 6.96e-01 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 59 | 9.71e-02 | -1.25e-01 | 3.28e-01 |
| GOBP CELLULAR RESPONSE TO ZINC ION | 16 | 3.87e-01 | 1.25e-01 | 6.68e-01 |
| GOBP GLUTAMINE METABOLIC PROCESS | 20 | 3.34e-01 | 1.25e-01 | 6.19e-01 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 33 | 2.14e-01 | -1.25e-01 | 4.97e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 19 | 3.46e-01 | 1.25e-01 | 6.31e-01 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 10 | 4.94e-01 | 1.25e-01 | 7.49e-01 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 21 | 3.22e-01 | -1.25e-01 | 6.10e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 76 | 6.03e-02 | -1.25e-01 | 2.52e-01 |
| GOCC U1 SNRNP | 19 | 3.47e-01 | 1.25e-01 | 6.32e-01 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 19 | 3.47e-01 | 1.25e-01 | 6.32e-01 |
| GOCC NUCLEAR SPECK | 366 | 4.54e-05 | -1.25e-01 | 1.53e-03 |
| GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 6.29e-01 | -1.25e-01 | 8.24e-01 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 21 | 3.23e-01 | 1.25e-01 | 6.10e-01 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 31 | 2.30e-01 | 1.25e-01 | 5.15e-01 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 97 | 3.43e-02 | -1.24e-01 | 1.83e-01 |
| GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 6 | 5.98e-01 | -1.24e-01 | 8.09e-01 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 9 | 5.18e-01 | -1.24e-01 | 7.63e-01 |
| GOMF LNCRNA BINDING | 11 | 4.75e-01 | -1.24e-01 | 7.37e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 79 | 5.62e-02 | -1.24e-01 | 2.42e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT | 7 | 5.69e-01 | 1.24e-01 | 7.93e-01 |
| GOBP RESPONSE TO HORMONE | 557 | 6.19e-07 | -1.24e-01 | 4.01e-05 |
| GOBP RESPONSE TO LEPTIN | 13 | 4.38e-01 | -1.24e-01 | 7.10e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION | 5 | 6.30e-01 | 1.24e-01 | 8.25e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 31 | 2.31e-01 | -1.24e-01 | 5.15e-01 |
| GOBP CHOLESTEROL CATABOLIC PROCESS | 5 | 6.31e-01 | -1.24e-01 | 8.25e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 6 | 5.99e-01 | 1.24e-01 | 8.10e-01 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 271 | 4.54e-04 | -1.24e-01 | 9.19e-03 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 25 | 2.83e-01 | -1.24e-01 | 5.72e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 8 | 5.44e-01 | -1.24e-01 | 7.78e-01 |
| GOBP T HELPER 1 CELL CYTOKINE PRODUCTION | 6 | 5.99e-01 | -1.24e-01 | 8.10e-01 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 92 | 4.00e-02 | -1.24e-01 | 1.99e-01 |
| GOMF E BOX BINDING | 24 | 2.93e-01 | -1.24e-01 | 5.82e-01 |
| GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 13 | 4.39e-01 | -1.24e-01 | 7.11e-01 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 21 | 3.26e-01 | -1.24e-01 | 6.13e-01 |
| GOMF MANNOSIDASE ACTIVITY | 15 | 4.06e-01 | 1.24e-01 | 6.86e-01 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 9 | 5.20e-01 | -1.24e-01 | 7.64e-01 |
| GOCC REPLICATION FORK | 61 | 9.46e-02 | -1.24e-01 | 3.23e-01 |
| GOBP ORGANELLE INHERITANCE | 15 | 4.06e-01 | -1.24e-01 | 6.86e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 10 | 4.98e-01 | -1.24e-01 | 7.51e-01 |
| GOBP COPII COATED VESICLE BUDDING | 41 | 1.71e-01 | 1.24e-01 | 4.40e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY | 6 | 6.00e-01 | -1.24e-01 | 8.10e-01 |
| GOBP MICROTUBULE POLYMERIZATION | 79 | 5.79e-02 | -1.24e-01 | 2.46e-01 |
| GOBP NUCLEAR MIGRATION | 20 | 3.39e-01 | -1.23e-01 | 6.25e-01 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 36 | 2.00e-01 | -1.23e-01 | 4.80e-01 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 58 | 1.04e-01 | -1.23e-01 | 3.39e-01 |
| GOMF AMIDE BINDING | 262 | 6.04e-04 | -1.23e-01 | 1.13e-02 |
| GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 53 | 1.20e-01 | 1.23e-01 | 3.65e-01 |
| GOBP HYPOTHALAMUS CELL DIFFERENTIATION | 6 | 6.01e-01 | -1.23e-01 | 8.10e-01 |
| GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION | 6 | 6.01e-01 | -1.23e-01 | 8.10e-01 |
| GOBP APPENDAGE MORPHOGENESIS | 74 | 6.67e-02 | -1.23e-01 | 2.69e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 807 | 3.57e-09 | -1.23e-01 | 5.04e-07 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 17 | 3.79e-01 | -1.23e-01 | 6.60e-01 |
| GOBP RESPONSE TO INSULIN | 197 | 2.90e-03 | -1.23e-01 | 3.65e-02 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 62 | 9.33e-02 | -1.23e-01 | 3.21e-01 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 687 | 4.59e-08 | -1.23e-01 | 4.55e-06 |
| GOBP CENTROSOME DUPLICATION | 67 | 8.14e-02 | -1.23e-01 | 2.97e-01 |
| GOCC ACTIN BASED CELL PROJECTION | 143 | 1.11e-02 | -1.23e-01 | 8.82e-02 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 345 | 8.97e-05 | -1.23e-01 | 2.71e-03 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 16 | 3.94e-01 | -1.23e-01 | 6.74e-01 |
| GOBP INTERFERON ALPHA PRODUCTION | 24 | 2.97e-01 | -1.23e-01 | 5.85e-01 |
| GOMF GTPASE ACTIVITY | 250 | 8.32e-04 | 1.23e-01 | 1.47e-02 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 10 | 5.00e-01 | 1.23e-01 | 7.53e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 33 | 2.21e-01 | -1.23e-01 | 5.05e-01 |
| GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME | 13 | 4.43e-01 | -1.23e-01 | 7.13e-01 |
| GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 5.23e-01 | 1.23e-01 | 7.67e-01 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 10 | 5.01e-01 | 1.23e-01 | 7.53e-01 |
| GOBP GMP METABOLIC PROCESS | 26 | 2.78e-01 | 1.23e-01 | 5.68e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 11 | 4.80e-01 | 1.23e-01 | 7.40e-01 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 229 | 1.39e-03 | 1.23e-01 | 2.15e-02 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 40 | 1.79e-01 | -1.23e-01 | 4.52e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 5 | 6.34e-01 | -1.23e-01 | 8.26e-01 |
| GOMF DNA REPLICATION ORIGIN BINDING | 14 | 4.26e-01 | -1.23e-01 | 7.03e-01 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 670 | 7.35e-08 | -1.23e-01 | 6.67e-06 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 11 | 4.81e-01 | 1.23e-01 | 7.40e-01 |
| GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 6 | 6.03e-01 | -1.23e-01 | 8.11e-01 |
| GOBP PROTEIN PHOSPHORYLATION | 925 | 3.76e-10 | -1.23e-01 | 7.54e-08 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 6 | 6.03e-01 | -1.23e-01 | 8.11e-01 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 10 | 5.02e-01 | 1.23e-01 | 7.54e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 8 | 5.48e-01 | -1.23e-01 | 7.81e-01 |
| GOMF ANDROSTAN 3 ALPHA 17 BETA DIOL DEHYDROGENASE ACTIVITY | 5 | 6.35e-01 | 1.23e-01 | 8.27e-01 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 22 | 3.19e-01 | 1.23e-01 | 6.08e-01 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 34 | 2.16e-01 | 1.23e-01 | 4.99e-01 |
| GOBP IMP METABOLIC PROCESS | 13 | 4.44e-01 | 1.23e-01 | 7.13e-01 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 7 | 5.74e-01 | -1.23e-01 | 7.97e-01 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 29 | 2.54e-01 | -1.22e-01 | 5.42e-01 |
| GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 13 | 4.45e-01 | -1.22e-01 | 7.13e-01 |
| GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.04e-01 | -1.22e-01 | 8.12e-01 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 11 | 4.82e-01 | 1.22e-01 | 7.41e-01 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 15 | 4.12e-01 | -1.22e-01 | 6.91e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR | 5 | 6.36e-01 | 1.22e-01 | 8.28e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 28 | 2.63e-01 | -1.22e-01 | 5.53e-01 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 24 | 3.00e-01 | -1.22e-01 | 5.88e-01 |
| GOBP BASEMENT MEMBRANE ASSEMBLY | 6 | 6.04e-01 | -1.22e-01 | 8.12e-01 |
| GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 10 | 5.04e-01 | -1.22e-01 | 7.54e-01 |
| GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 9 | 5.26e-01 | 1.22e-01 | 7.69e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 18 | 3.70e-01 | -1.22e-01 | 6.53e-01 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 53 | 1.24e-01 | -1.22e-01 | 3.71e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 35 | 2.12e-01 | -1.22e-01 | 4.94e-01 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 18 | 3.70e-01 | -1.22e-01 | 6.54e-01 |
| GOBP MISMATCH REPAIR | 26 | 2.82e-01 | -1.22e-01 | 5.71e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 11 | 4.84e-01 | -1.22e-01 | 7.42e-01 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 32 | 2.33e-01 | -1.22e-01 | 5.16e-01 |
| GOBP BONE RESORPTION | 46 | 1.53e-01 | -1.22e-01 | 4.15e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 102 | 3.35e-02 | -1.22e-01 | 1.80e-01 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 15 | 4.14e-01 | -1.22e-01 | 6.92e-01 |
| GOCC MICROBODY | 120 | 2.13e-02 | 1.22e-01 | 1.35e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY | 5 | 6.37e-01 | -1.22e-01 | 8.28e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 19 | 3.58e-01 | 1.22e-01 | 6.44e-01 |
| GOMF DYSTROGLYCAN BINDING | 8 | 5.51e-01 | -1.22e-01 | 7.83e-01 |
| GOBP HORMONE METABOLIC PROCESS | 121 | 2.08e-02 | -1.22e-01 | 1.34e-01 |
| GOBP FIBROBLAST PROLIFERATION | 74 | 7.04e-02 | -1.22e-01 | 2.76e-01 |
| GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 6 | 6.06e-01 | 1.22e-01 | 8.13e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 4.85e-01 | 1.22e-01 | 7.43e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 219 | 1.97e-03 | -1.22e-01 | 2.75e-02 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 161 | 7.89e-03 | 1.22e-01 | 6.99e-02 |
| GOBP MESENCHYMAL CELL MIGRATION | 30 | 2.49e-01 | -1.22e-01 | 5.37e-01 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 26 | 2.84e-01 | -1.22e-01 | 5.73e-01 |
| GOMF SIRNA BINDING | 9 | 5.28e-01 | -1.21e-01 | 7.69e-01 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 10 | 5.06e-01 | -1.21e-01 | 7.55e-01 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 152 | 9.92e-03 | -1.21e-01 | 8.18e-02 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 61 | 1.02e-01 | -1.21e-01 | 3.36e-01 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 31 | 2.43e-01 | -1.21e-01 | 5.29e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 25 | 2.94e-01 | 1.21e-01 | 5.83e-01 |
| GOBP HAIR FOLLICLE MATURATION | 10 | 5.07e-01 | -1.21e-01 | 7.56e-01 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 9 | 5.30e-01 | -1.21e-01 | 7.70e-01 |
| GOBP RNA DESTABILIZATION | 96 | 4.06e-02 | -1.21e-01 | 2.01e-01 |
| GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 5.08e-01 | 1.21e-01 | 7.56e-01 |
| GOBP RIBONUCLEOTIDE CATABOLIC PROCESS | 42 | 1.75e-01 | -1.21e-01 | 4.46e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 59 | 1.08e-01 | -1.21e-01 | 3.46e-01 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 276 | 5.67e-04 | 1.21e-01 | 1.07e-02 |
| GOMF METAL CLUSTER BINDING | 65 | 9.23e-02 | 1.21e-01 | 3.19e-01 |
| GOMF STEROID HYDROXYLASE ACTIVITY | 7 | 5.80e-01 | -1.21e-01 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1316 | 4.46e-13 | -1.21e-01 | 1.48e-10 |
| GOBP SNORNA LOCALIZATION | 6 | 6.09e-01 | -1.21e-01 | 8.14e-01 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 19 | 3.62e-01 | -1.21e-01 | 6.48e-01 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 59 | 1.09e-01 | -1.21e-01 | 3.47e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 36 | 2.10e-01 | 1.21e-01 | 4.93e-01 |
| GOBP CELL MORPHOGENESIS | 579 | 8.28e-07 | -1.21e-01 | 5.17e-05 |
| GOBP TUBE MORPHOGENESIS | 505 | 3.98e-06 | -1.21e-01 | 1.92e-04 |
| GOMF BETA TUBULIN BINDING | 34 | 2.24e-01 | -1.21e-01 | 5.08e-01 |
| GOMF P53 BINDING | 57 | 1.16e-01 | -1.21e-01 | 3.58e-01 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 22 | 3.28e-01 | -1.20e-01 | 6.15e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 24 | 3.07e-01 | -1.20e-01 | 5.96e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 12 | 4.70e-01 | -1.20e-01 | 7.33e-01 |
| GOMF PHOSPHOLIPASE BINDING | 17 | 3.90e-01 | -1.20e-01 | 6.71e-01 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 63 | 9.92e-02 | -1.20e-01 | 3.32e-01 |
| GOMF SIGNAL SEQUENCE BINDING | 39 | 1.94e-01 | 1.20e-01 | 4.71e-01 |
| GOBP INTESTINAL ABSORPTION | 22 | 3.30e-01 | 1.20e-01 | 6.16e-01 |
| GOBP LIVER MORPHOGENESIS | 16 | 4.06e-01 | -1.20e-01 | 6.86e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 48 | 1.50e-01 | -1.20e-01 | 4.11e-01 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 16 | 4.06e-01 | -1.20e-01 | 6.86e-01 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 119 | 2.39e-02 | -1.20e-01 | 1.46e-01 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 13 | 4.54e-01 | -1.20e-01 | 7.22e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 77 | 6.91e-02 | 1.20e-01 | 2.74e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 514 | 3.72e-06 | -1.20e-01 | 1.81e-04 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 63 | 1.00e-01 | -1.20e-01 | 3.33e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 6 | 6.11e-01 | 1.20e-01 | 8.15e-01 |
| GOCC PLATELET ALPHA GRANULE | 62 | 1.03e-01 | -1.20e-01 | 3.37e-01 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 11 | 4.92e-01 | -1.20e-01 | 7.47e-01 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 19 | 3.66e-01 | 1.20e-01 | 6.51e-01 |
| GOBP TRABECULA FORMATION | 13 | 4.55e-01 | -1.20e-01 | 7.23e-01 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 53 | 1.32e-01 | -1.20e-01 | 3.84e-01 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 5.84e-01 | 1.20e-01 | 8.02e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 75 | 7.34e-02 | -1.20e-01 | 2.82e-01 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 41 | 1.85e-01 | -1.20e-01 | 4.60e-01 |
| GOCC MITOTIC SPINDLE POLE | 35 | 2.21e-01 | -1.20e-01 | 5.04e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 8 | 5.58e-01 | -1.20e-01 | 7.87e-01 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 174 | 6.63e-03 | -1.20e-01 | 6.22e-02 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 30 | 2.58e-01 | -1.19e-01 | 5.47e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING | 5 | 6.44e-01 | -1.19e-01 | 8.32e-01 |
| GOBP RESPONSE TO COPPER ION | 25 | 3.02e-01 | 1.19e-01 | 5.90e-01 |
| GOBP RESPONSE TO NUTRIENT | 95 | 4.47e-02 | -1.19e-01 | 2.14e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 203 | 3.46e-03 | -1.19e-01 | 4.06e-02 |
| GOMF FIBRONECTIN BINDING | 19 | 3.68e-01 | -1.19e-01 | 6.52e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 822 | 8.91e-09 | -1.19e-01 | 1.13e-06 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 4.25e-01 | 1.19e-01 | 7.02e-01 |
| GOMF O ACETYLTRANSFERASE ACTIVITY | 6 | 6.13e-01 | 1.19e-01 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 5 | 6.45e-01 | 1.19e-01 | 8.32e-01 |
| GOCC POLYSOME | 63 | 1.02e-01 | -1.19e-01 | 3.37e-01 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 10 | 5.15e-01 | -1.19e-01 | 7.60e-01 |
| GOBP LATERAL MESODERM DEVELOPMENT | 6 | 6.14e-01 | -1.19e-01 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 60 | 1.11e-01 | -1.19e-01 | 3.51e-01 |
| GOCC PHOSPHORYLASE KINASE COMPLEX | 5 | 6.45e-01 | -1.19e-01 | 8.33e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 8 | 5.61e-01 | -1.19e-01 | 7.89e-01 |
| GOBP RESPONSE TO CALCIUM ION | 92 | 4.91e-02 | -1.19e-01 | 2.25e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 27 | 2.85e-01 | 1.19e-01 | 5.75e-01 |
| GOBP HEMOSTASIS | 140 | 1.54e-02 | -1.19e-01 | 1.10e-01 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 8 | 5.61e-01 | -1.19e-01 | 7.90e-01 |
| GOBP CELLULAR RESPONSE TO ATP | 14 | 4.42e-01 | 1.19e-01 | 7.13e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 23 | 3.25e-01 | -1.19e-01 | 6.12e-01 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 34 | 2.32e-01 | -1.19e-01 | 5.16e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 7 | 5.87e-01 | -1.19e-01 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 109 | 3.27e-02 | -1.19e-01 | 1.78e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 741 | 5.16e-08 | -1.18e-01 | 5.00e-06 |
| GOBP FAT CELL DIFFERENTIATION | 155 | 1.10e-02 | -1.18e-01 | 8.80e-02 |
| GOCC BCL 2 FAMILY PROTEIN COMPLEX | 9 | 5.38e-01 | 1.18e-01 | 7.76e-01 |
| GOBP RESPONSE TO LITHIUM ION | 9 | 5.38e-01 | -1.18e-01 | 7.76e-01 |
| GOBP RENAL SYSTEM DEVELOPMENT | 174 | 7.16e-03 | -1.18e-01 | 6.55e-02 |
| GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 7 | 5.88e-01 | -1.18e-01 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 9 | 5.39e-01 | -1.18e-01 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 6 | 6.16e-01 | -1.18e-01 | 8.17e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 64 | 1.02e-01 | -1.18e-01 | 3.36e-01 |
| GOCC PRERIBOSOME | 103 | 3.83e-02 | 1.18e-01 | 1.93e-01 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 34 | 2.33e-01 | -1.18e-01 | 5.16e-01 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 9 | 5.39e-01 | -1.18e-01 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 106 | 3.58e-02 | -1.18e-01 | 1.87e-01 |
| GOBP REGULATION OF CHROMATIN BINDING | 11 | 4.98e-01 | -1.18e-01 | 7.51e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 69 | 9.01e-02 | -1.18e-01 | 3.15e-01 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 23 | 3.27e-01 | 1.18e-01 | 6.14e-01 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 32 | 2.48e-01 | 1.18e-01 | 5.35e-01 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 79 | 6.99e-02 | 1.18e-01 | 2.75e-01 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 25 | 3.07e-01 | -1.18e-01 | 5.96e-01 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 3.49e-01 | 1.18e-01 | 6.34e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 11 | 4.98e-01 | 1.18e-01 | 7.51e-01 |
| GOMF RIBOSOME BINDING | 103 | 3.88e-02 | 1.18e-01 | 1.94e-01 |
| GOCC PHAGOLYSOSOME | 5 | 6.48e-01 | -1.18e-01 | 8.34e-01 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 128 | 2.14e-02 | -1.18e-01 | 1.36e-01 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 20 | 3.61e-01 | -1.18e-01 | 6.47e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 17 | 4.00e-01 | -1.18e-01 | 6.80e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 8 | 5.64e-01 | -1.18e-01 | 7.91e-01 |
| GOBP MEMORY | 64 | 1.03e-01 | -1.18e-01 | 3.37e-01 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 6 | 6.17e-01 | -1.18e-01 | 8.18e-01 |
| GOBP RESPONSE TO X RAY | 24 | 3.18e-01 | -1.18e-01 | 6.07e-01 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 110 | 3.30e-02 | -1.18e-01 | 1.79e-01 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 33 | 2.42e-01 | -1.18e-01 | 5.29e-01 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 191 | 5.12e-03 | -1.18e-01 | 5.23e-02 |
| GOMF HISTONE DEACETYLASE BINDING | 93 | 5.02e-02 | -1.18e-01 | 2.27e-01 |
| GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 13 | 4.63e-01 | 1.18e-01 | 7.30e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT | 9 | 5.41e-01 | -1.18e-01 | 7.77e-01 |
| GOBP FATTY ACID TRANSPORT | 62 | 1.10e-01 | 1.18e-01 | 3.48e-01 |
| GOBP DNA INTEGRATION | 6 | 6.18e-01 | 1.18e-01 | 8.18e-01 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 43 | 1.83e-01 | -1.18e-01 | 4.57e-01 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 31 | 2.58e-01 | -1.18e-01 | 5.47e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 8 | 5.65e-01 | -1.17e-01 | 7.91e-01 |
| GOMF DAMAGED DNA BINDING | 67 | 9.67e-02 | -1.17e-01 | 3.27e-01 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 10 | 5.20e-01 | -1.17e-01 | 7.64e-01 |
| GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 13 | 4.64e-01 | -1.17e-01 | 7.30e-01 |
| GOCC GLYCOGEN GRANULE | 7 | 5.91e-01 | 1.17e-01 | 8.05e-01 |
| GOBP MICROVILLUS ORGANIZATION | 23 | 3.30e-01 | -1.17e-01 | 6.16e-01 |
| GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT | 6 | 6.19e-01 | -1.17e-01 | 8.18e-01 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 25 | 3.10e-01 | -1.17e-01 | 5.99e-01 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 49 | 1.56e-01 | -1.17e-01 | 4.18e-01 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 108 | 3.55e-02 | -1.17e-01 | 1.85e-01 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 13 | 4.64e-01 | -1.17e-01 | 7.30e-01 |
| GOBP GRANULOCYTE ACTIVATION | 36 | 2.24e-01 | -1.17e-01 | 5.07e-01 |
| GOMF HORMONE RECEPTOR BINDING | 8 | 5.66e-01 | 1.17e-01 | 7.92e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 11 | 5.01e-01 | 1.17e-01 | 7.53e-01 |
| GOBP CELLULAR DEFENSE RESPONSE | 27 | 2.92e-01 | -1.17e-01 | 5.81e-01 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 58 | 1.23e-01 | -1.17e-01 | 3.69e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 20 | 3.65e-01 | -1.17e-01 | 6.50e-01 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 20 | 3.65e-01 | -1.17e-01 | 6.50e-01 |
| GOBP SKELETAL MUSCLE CONTRACTION | 21 | 3.53e-01 | 1.17e-01 | 6.39e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2 COMPLEX | 5 | 6.51e-01 | -1.17e-01 | 8.37e-01 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 45 | 1.75e-01 | -1.17e-01 | 4.46e-01 |
| GOBP CELL CELL SIGNALING BY WNT | 290 | 6.39e-04 | -1.17e-01 | 1.18e-02 |
| GOBP GAP JUNCTION ASSEMBLY | 7 | 5.92e-01 | -1.17e-01 | 8.06e-01 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 20 | 3.66e-01 | -1.17e-01 | 6.51e-01 |
| GOCC TIGHT JUNCTION | 74 | 8.26e-02 | -1.17e-01 | 3.00e-01 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 206 | 3.95e-03 | -1.17e-01 | 4.47e-02 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 55 | 1.34e-01 | 1.17e-01 | 3.87e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 44 | 1.81e-01 | -1.17e-01 | 4.55e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 10 | 5.23e-01 | -1.17e-01 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 19 | 3.79e-01 | -1.17e-01 | 6.60e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 6 | 6.21e-01 | -1.17e-01 | 8.20e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 5 | 6.52e-01 | -1.16e-01 | 8.37e-01 |
| GOBP ERK1 AND ERK2 CASCADE | 190 | 5.75e-03 | -1.16e-01 | 5.63e-02 |
| GOMF NADPH BINDING | 15 | 4.35e-01 | -1.16e-01 | 7.09e-01 |
| GOCC RIBOSOME | 224 | 2.76e-03 | 1.16e-01 | 3.52e-02 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 12 | 4.85e-01 | 1.16e-01 | 7.43e-01 |
| GOMF SYMPORTER ACTIVITY | 80 | 7.24e-02 | -1.16e-01 | 2.80e-01 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 13 | 4.68e-01 | -1.16e-01 | 7.33e-01 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 23 | 3.35e-01 | -1.16e-01 | 6.21e-01 |
| GOBP DISTAL TUBULE DEVELOPMENT | 6 | 6.22e-01 | -1.16e-01 | 8.20e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 290 | 6.92e-04 | -1.16e-01 | 1.26e-02 |
| GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 8 | 5.69e-01 | -1.16e-01 | 7.93e-01 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 10 | 5.25e-01 | -1.16e-01 | 7.68e-01 |
| GOBP INHIBITORY SYNAPSE ASSEMBLY | 6 | 6.23e-01 | -1.16e-01 | 8.20e-01 |
| GOMF ENZYME REGULATOR ACTIVITY | 943 | 2.37e-09 | -1.16e-01 | 3.72e-07 |
| GOMF KINASE ACTIVITY | 574 | 2.38e-06 | -1.16e-01 | 1.22e-04 |
| GOBP VESICLE TARGETING | 61 | 1.18e-01 | 1.16e-01 | 3.60e-01 |
| GOBP REGULATION OF PHOSPHORYLATION | 710 | 1.79e-07 | -1.16e-01 | 1.38e-05 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 22 | 3.47e-01 | -1.16e-01 | 6.32e-01 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 752 | 8.35e-08 | -1.16e-01 | 7.42e-06 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 33 | 2.50e-01 | -1.16e-01 | 5.38e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 28 | 2.89e-01 | -1.16e-01 | 5.79e-01 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 72 | 8.98e-02 | -1.16e-01 | 3.14e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 7 | 5.96e-01 | -1.16e-01 | 8.08e-01 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 37 | 2.24e-01 | -1.16e-01 | 5.08e-01 |
| GOMF OXYGEN BINDING | 9 | 5.48e-01 | -1.16e-01 | 7.81e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 521 | 7.26e-06 | -1.16e-01 | 3.21e-04 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 6 | 6.24e-01 | -1.15e-01 | 8.20e-01 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 6.25e-01 | -1.15e-01 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 28 | 2.91e-01 | -1.15e-01 | 5.80e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 142 | 1.78e-02 | -1.15e-01 | 1.22e-01 |
| GOBP GLIAL CELL DIFFERENTIATION | 138 | 1.95e-02 | -1.15e-01 | 1.29e-01 |
| GOBP RESPONSE TO NITROSATIVE STRESS | 9 | 5.49e-01 | 1.15e-01 | 7.82e-01 |
| GOCC NEURONAL DENSE CORE VESICLE | 7 | 5.98e-01 | -1.15e-01 | 8.09e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 5 | 6.56e-01 | 1.15e-01 | 8.38e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS | 5 | 6.56e-01 | 1.15e-01 | 8.38e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 25 | 3.19e-01 | -1.15e-01 | 6.08e-01 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 22 | 3.50e-01 | -1.15e-01 | 6.35e-01 |
| GOMF U3 SNORNA BINDING | 10 | 5.28e-01 | 1.15e-01 | 7.69e-01 |
| GOBP STRESS FIBER ASSEMBLY | 82 | 7.18e-02 | -1.15e-01 | 2.79e-01 |
| GOMF MRNA BINDING | 267 | 1.26e-03 | -1.15e-01 | 2.00e-02 |
| GOCC SPECIFIC GRANULE LUMEN | 46 | 1.78e-01 | -1.15e-01 | 4.51e-01 |
| GOBP CELL SUBSTRATE ADHESION | 222 | 3.24e-03 | -1.15e-01 | 3.90e-02 |
| GOBP THYROID HORMONE TRANSPORT | 6 | 6.26e-01 | -1.15e-01 | 8.21e-01 |
| GOCC ENDOLYSOSOME | 24 | 3.30e-01 | -1.15e-01 | 6.16e-01 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 88 | 6.29e-02 | -1.15e-01 | 2.58e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 6 | 6.26e-01 | 1.15e-01 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 165 | 1.11e-02 | -1.15e-01 | 8.82e-02 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 69 | 9.95e-02 | -1.15e-01 | 3.32e-01 |
| GOBP RESPONSE TO STARVATION | 169 | 1.02e-02 | -1.15e-01 | 8.38e-02 |
| GOBP MYELOID CELL HOMEOSTASIS | 136 | 2.11e-02 | -1.15e-01 | 1.35e-01 |
| GOMF ADP BINDING | 33 | 2.55e-01 | -1.15e-01 | 5.43e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 7 | 5.99e-01 | 1.15e-01 | 8.10e-01 |
| GOBP PRE MIRNA PROCESSING | 14 | 4.58e-01 | -1.15e-01 | 7.25e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 41 | 2.05e-01 | -1.14e-01 | 4.85e-01 |
| GOMF PHOSPHOLIPID BINDING | 343 | 2.85e-04 | -1.14e-01 | 6.71e-03 |
| GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 8 | 5.75e-01 | -1.14e-01 | 7.97e-01 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 38 | 2.23e-01 | -1.14e-01 | 5.07e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 6.58e-01 | -1.14e-01 | 8.40e-01 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 137 | 2.11e-02 | -1.14e-01 | 1.35e-01 |
| GOMF SINGLE STRANDED DNA BINDING | 104 | 4.44e-02 | -1.14e-01 | 2.13e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 20 | 3.77e-01 | -1.14e-01 | 6.59e-01 |
| GOBP MITOTIC CELL CYCLE PROCESS | 645 | 9.06e-07 | -1.14e-01 | 5.50e-05 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 68 | 1.04e-01 | -1.14e-01 | 3.39e-01 |
| GOBP MAPK CASCADE | 488 | 1.79e-05 | -1.14e-01 | 6.89e-04 |
| GOMF FLIPPASE ACTIVITY | 12 | 4.94e-01 | -1.14e-01 | 7.49e-01 |
| GOCC NUCLEAR CHROMOSOME | 189 | 7.05e-03 | -1.14e-01 | 6.50e-02 |
| GOBP B CELL ACTIVATION | 199 | 5.72e-03 | -1.14e-01 | 5.62e-02 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 373 | 1.70e-04 | -1.14e-01 | 4.55e-03 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 16 | 4.30e-01 | 1.14e-01 | 7.05e-01 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 41 | 2.07e-01 | -1.14e-01 | 4.89e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 13 | 4.78e-01 | 1.14e-01 | 7.39e-01 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 30 | 2.81e-01 | -1.14e-01 | 5.71e-01 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 43 | 1.97e-01 | 1.14e-01 | 4.76e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 55 | 1.45e-01 | -1.14e-01 | 4.04e-01 |
| GOBP SYNAPSE ASSEMBLY | 84 | 7.19e-02 | -1.14e-01 | 2.79e-01 |
| GOMF SIGNALING RECEPTOR BINDING | 766 | 1.13e-07 | -1.14e-01 | 9.51e-06 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 125 | 2.85e-02 | 1.14e-01 | 1.63e-01 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 5.78e-01 | -1.14e-01 | 8.00e-01 |
| GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 7 | 6.03e-01 | 1.14e-01 | 8.11e-01 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 68 | 1.06e-01 | -1.14e-01 | 3.42e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 23 | 3.46e-01 | 1.14e-01 | 6.31e-01 |
| GOBP PROTEIN KINASE A SIGNALING | 22 | 3.57e-01 | -1.13e-01 | 6.43e-01 |
| GOBP CYTOPLASMIC TRANSLATION | 146 | 1.82e-02 | -1.13e-01 | 1.23e-01 |
| GOBP SYNAPTIC VESICLE PRIMING | 11 | 5.15e-01 | 1.13e-01 | 7.61e-01 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 19 | 3.93e-01 | 1.13e-01 | 6.73e-01 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 28 | 3.00e-01 | -1.13e-01 | 5.88e-01 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 7 | 6.04e-01 | -1.13e-01 | 8.12e-01 |
| GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 6.61e-01 | 1.13e-01 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 37 | 2.34e-01 | -1.13e-01 | 5.17e-01 |
| GOBP NEUROGENESIS | 997 | 2.26e-09 | -1.13e-01 | 3.67e-07 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 12 | 4.98e-01 | -1.13e-01 | 7.51e-01 |
| GOCC HETEROCHROMATIN | 67 | 1.10e-01 | -1.13e-01 | 3.48e-01 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 12 | 4.98e-01 | -1.13e-01 | 7.51e-01 |
| GOBP ENSHEATHMENT OF NEURONS | 94 | 5.84e-02 | -1.13e-01 | 2.48e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 9 | 5.57e-01 | -1.13e-01 | 7.87e-01 |
| GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 7 | 6.05e-01 | -1.13e-01 | 8.12e-01 |
| GOMF TAP BINDING | 7 | 6.05e-01 | 1.13e-01 | 8.12e-01 |
| GOBP DNA LIGATION | 16 | 4.34e-01 | -1.13e-01 | 7.08e-01 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 268 | 1.50e-03 | -1.13e-01 | 2.26e-02 |
| GOBP ADAPTATION OF SIGNALING PATHWAY | 12 | 4.98e-01 | -1.13e-01 | 7.51e-01 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 16 | 4.34e-01 | 1.13e-01 | 7.08e-01 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 43 | 2.00e-01 | -1.13e-01 | 4.80e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 95 | 5.76e-02 | 1.13e-01 | 2.45e-01 |
| GOCC SITE OF DOUBLE STRAND BREAK | 80 | 8.13e-02 | -1.13e-01 | 2.97e-01 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 369 | 2.10e-04 | -1.13e-01 | 5.37e-03 |
| GOMF PLATELET DERIVED GROWTH FACTOR BINDING | 5 | 6.62e-01 | -1.13e-01 | 8.43e-01 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 58 | 1.38e-01 | -1.13e-01 | 3.92e-01 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 2.86e-01 | 1.13e-01 | 5.75e-01 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 117 | 3.55e-02 | -1.13e-01 | 1.85e-01 |
| GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 5.81e-01 | -1.13e-01 | 8.01e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 9 | 5.59e-01 | -1.13e-01 | 7.87e-01 |
| GOMF WNT RECEPTOR ACTIVITY | 10 | 5.38e-01 | 1.13e-01 | 7.76e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 217 | 4.35e-03 | -1.13e-01 | 4.72e-02 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 78 | 8.59e-02 | 1.13e-01 | 3.06e-01 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 99 | 5.32e-02 | 1.13e-01 | 2.35e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 36 | 2.43e-01 | 1.12e-01 | 5.29e-01 |
| GOCC MITOTIC SPINDLE | 157 | 1.52e-02 | -1.12e-01 | 1.09e-01 |
| GOCC BLOOD MICROPARTICLE | 50 | 1.69e-01 | -1.12e-01 | 4.39e-01 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 36 | 2.43e-01 | -1.12e-01 | 5.29e-01 |
| GOCC INO80 TYPE COMPLEX | 26 | 3.21e-01 | 1.12e-01 | 6.10e-01 |
| GOBP DEVELOPMENTAL GROWTH | 399 | 1.25e-04 | -1.12e-01 | 3.56e-03 |
| GOCC RNA CAP BINDING COMPLEX | 20 | 3.84e-01 | 1.12e-01 | 6.66e-01 |
| GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 6 | 6.34e-01 | 1.12e-01 | 8.26e-01 |
| GOBP INTERFERON BETA PRODUCTION | 52 | 1.61e-01 | -1.12e-01 | 4.28e-01 |
| GOCC GBAF COMPLEX | 13 | 4.83e-01 | 1.12e-01 | 7.41e-01 |
| GOBP CILIUM MOVEMENT | 85 | 7.38e-02 | 1.12e-01 | 2.82e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 10 | 5.39e-01 | -1.12e-01 | 7.76e-01 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 25 | 3.31e-01 | 1.12e-01 | 6.17e-01 |
| GOBP REGULATION OF HISTONE MODIFICATION | 35 | 2.51e-01 | -1.12e-01 | 5.39e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 10 | 5.39e-01 | 1.12e-01 | 7.76e-01 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 16 | 4.37e-01 | 1.12e-01 | 7.10e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 9 | 5.60e-01 | 1.12e-01 | 7.89e-01 |
| GOBP MELANOSOME ASSEMBLY | 19 | 3.98e-01 | 1.12e-01 | 6.78e-01 |
| GOMF HEAT SHOCK PROTEIN BINDING | 106 | 4.65e-02 | 1.12e-01 | 2.19e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 56 | 1.47e-01 | -1.12e-01 | 4.07e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 14 | 4.68e-01 | -1.12e-01 | 7.33e-01 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 46 | 1.90e-01 | 1.12e-01 | 4.66e-01 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 17 | 4.25e-01 | 1.12e-01 | 7.02e-01 |
| GOBP INNERVATION | 12 | 5.03e-01 | -1.12e-01 | 7.54e-01 |
| GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION | 6 | 6.36e-01 | 1.12e-01 | 8.28e-01 |
| GOBP HYPOTHALAMUS CELL MIGRATION | 5 | 6.66e-01 | -1.12e-01 | 8.44e-01 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 14 | 4.70e-01 | -1.12e-01 | 7.33e-01 |
| GOCC NUCLEAR PORE OUTER RING | 9 | 5.62e-01 | -1.12e-01 | 7.90e-01 |
| GOBP GENERATION OF NEURONS | 841 | 5.22e-08 | -1.12e-01 | 5.00e-06 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 15 | 4.54e-01 | -1.12e-01 | 7.23e-01 |
| GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.66e-01 | -1.12e-01 | 8.44e-01 |
| GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 7 | 6.10e-01 | -1.11e-01 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 14 | 4.70e-01 | -1.11e-01 | 7.33e-01 |
| GOBP TRNA THIO MODIFICATION | 5 | 6.66e-01 | -1.11e-01 | 8.44e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 122 | 3.39e-02 | -1.11e-01 | 1.81e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 30 | 2.92e-01 | -1.11e-01 | 5.81e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 37 | 2.42e-01 | 1.11e-01 | 5.29e-01 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 24 | 3.46e-01 | -1.11e-01 | 6.31e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 7 | 6.11e-01 | 1.11e-01 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 20 | 3.90e-01 | -1.11e-01 | 6.71e-01 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 22 | 3.67e-01 | -1.11e-01 | 6.51e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 166 | 1.38e-02 | -1.11e-01 | 1.02e-01 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 270 | 1.75e-03 | -1.11e-01 | 2.50e-02 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 51 | 1.71e-01 | -1.11e-01 | 4.40e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 9 | 5.64e-01 | 1.11e-01 | 7.91e-01 |
| GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 6.11e-01 | 1.11e-01 | 8.15e-01 |
| GOBP CYTOSKELETON ORGANIZATION | 1039 | 2.43e-09 | -1.11e-01 | 3.74e-07 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 112 | 4.30e-02 | 1.11e-01 | 2.09e-01 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 9 | 5.65e-01 | 1.11e-01 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 82 | 8.32e-02 | -1.11e-01 | 3.00e-01 |
| GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS | 5 | 6.68e-01 | -1.11e-01 | 8.46e-01 |
| GOBP HINDBRAIN DEVELOPMENT | 90 | 6.97e-02 | -1.11e-01 | 2.75e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 36 | 2.51e-01 | 1.11e-01 | 5.40e-01 |
| GOBP REGULATION OF NEUROGENESIS | 221 | 4.71e-03 | -1.11e-01 | 4.91e-02 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 33 | 2.72e-01 | -1.11e-01 | 5.62e-01 |
| GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING | 35 | 2.58e-01 | -1.10e-01 | 5.48e-01 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 48 | 1.86e-01 | -1.10e-01 | 4.61e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 11 | 5.26e-01 | -1.10e-01 | 7.69e-01 |
| GOMF CALCIUM RELEASE CHANNEL ACTIVITY | 15 | 4.59e-01 | -1.10e-01 | 7.26e-01 |
| GOBP REGULATION OF NADP METABOLIC PROCESS | 8 | 5.89e-01 | 1.10e-01 | 8.04e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 13 | 4.91e-01 | -1.10e-01 | 7.47e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 202 | 6.97e-03 | -1.10e-01 | 6.44e-02 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 26 | 3.30e-01 | -1.10e-01 | 6.16e-01 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 178 | 1.13e-02 | -1.10e-01 | 8.89e-02 |
| GOBP GLYCOLIPID TRANSPORT | 8 | 5.89e-01 | 1.10e-01 | 8.04e-01 |
| GOBP HISTONE H4 ACETYLATION | 12 | 5.09e-01 | -1.10e-01 | 7.56e-01 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 11 | 5.27e-01 | 1.10e-01 | 7.69e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 7 | 6.14e-01 | 1.10e-01 | 8.17e-01 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 68 | 1.17e-01 | -1.10e-01 | 3.59e-01 |
| GOMF GLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 5 | 6.70e-01 | 1.10e-01 | 8.47e-01 |
| GOBP VIRAL TRANSCRIPTION | 46 | 1.97e-01 | -1.10e-01 | 4.75e-01 |
| GOBP FOREBRAIN REGIONALIZATION | 5 | 6.70e-01 | 1.10e-01 | 8.47e-01 |
| GOCC STEREOCILIUM TIP | 11 | 5.28e-01 | -1.10e-01 | 7.69e-01 |
| GOBP EPIBOLY | 27 | 3.23e-01 | 1.10e-01 | 6.10e-01 |
| GOMF CENTROMERIC DNA BINDING | 5 | 6.70e-01 | -1.10e-01 | 8.47e-01 |
| GOMF CARBON CARBON LYASE ACTIVITY | 37 | 2.48e-01 | 1.10e-01 | 5.35e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 12 | 5.10e-01 | 1.10e-01 | 7.57e-01 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 410 | 1.46e-04 | 1.10e-01 | 4.02e-03 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 33 | 2.75e-01 | -1.10e-01 | 5.65e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 11 | 5.29e-01 | -1.10e-01 | 7.69e-01 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 13 | 4.93e-01 | 1.10e-01 | 7.48e-01 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 21 | 3.84e-01 | 1.10e-01 | 6.66e-01 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 17 | 4.34e-01 | 1.10e-01 | 7.08e-01 |
| GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 8 | 5.92e-01 | 1.10e-01 | 8.06e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 10 | 5.49e-01 | -1.09e-01 | 7.82e-01 |
| GOBP SPINDLE LOCALIZATION | 46 | 1.99e-01 | -1.09e-01 | 4.79e-01 |
| GOCC AZUROPHIL GRANULE LUMEN | 73 | 1.06e-01 | -1.09e-01 | 3.43e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 49 | 1.86e-01 | 1.09e-01 | 4.60e-01 |
| GOBP IMPORT INTO CELL | 615 | 4.26e-06 | -1.09e-01 | 2.03e-04 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 8 | 5.92e-01 | 1.09e-01 | 8.06e-01 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 46 | 2.00e-01 | 1.09e-01 | 4.79e-01 |
| GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 8 | 5.92e-01 | -1.09e-01 | 8.06e-01 |
| GOCC INHIBITORY SYNAPSE | 5 | 6.72e-01 | 1.09e-01 | 8.48e-01 |
| GOBP TORC2 SIGNALING | 15 | 4.64e-01 | -1.09e-01 | 7.30e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 84 | 8.37e-02 | -1.09e-01 | 3.01e-01 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1255 | 1.42e-10 | -1.09e-01 | 3.22e-08 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 239 | 3.71e-03 | -1.09e-01 | 4.28e-02 |
| GOCC VESICLE COAT | 54 | 1.65e-01 | 1.09e-01 | 4.33e-01 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 9 | 5.71e-01 | 1.09e-01 | 7.94e-01 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 15 | 4.64e-01 | -1.09e-01 | 7.30e-01 |
| GOBP METHIONINE BIOSYNTHETIC PROCESS | 10 | 5.50e-01 | 1.09e-01 | 7.82e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 255 | 2.77e-03 | -1.09e-01 | 3.53e-02 |
| GOBP MONONUCLEAR CELL MIGRATION | 132 | 3.07e-02 | -1.09e-01 | 1.70e-01 |
| GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE | 5 | 6.73e-01 | -1.09e-01 | 8.48e-01 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 39 | 2.39e-01 | 1.09e-01 | 5.25e-01 |
| GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 8 | 5.94e-01 | -1.09e-01 | 8.07e-01 |
| GOCC PLASMA MEMBRANE RAFT | 67 | 1.23e-01 | -1.09e-01 | 3.70e-01 |
| GOCC DYNEIN COMPLEX | 33 | 2.79e-01 | 1.09e-01 | 5.68e-01 |
| GOBP REGULATION OF BLOOD VESSEL REMODELING | 5 | 6.73e-01 | 1.09e-01 | 8.48e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 12 | 5.14e-01 | -1.09e-01 | 7.60e-01 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 54 | 1.67e-01 | -1.09e-01 | 4.35e-01 |
| GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 6 | 6.44e-01 | 1.09e-01 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1036 | 4.89e-09 | -1.09e-01 | 6.69e-07 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 23 | 3.66e-01 | -1.09e-01 | 6.51e-01 |
| GOBP ACTIN FILAMENT BASED PROCESS | 544 | 1.60e-05 | -1.09e-01 | 6.29e-04 |
| GOMF TRNA BINDING | 68 | 1.21e-01 | 1.09e-01 | 3.67e-01 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 70 | 1.16e-01 | -1.09e-01 | 3.58e-01 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.45e-01 | 1.09e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 23 | 3.67e-01 | 1.09e-01 | 6.51e-01 |
| GOCC CILIARY MEMBRANE | 45 | 2.07e-01 | 1.09e-01 | 4.89e-01 |
| GOBP PHOSPHORYLATION | 1135 | 1.11e-09 | -1.09e-01 | 2.07e-07 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 9 | 5.72e-01 | -1.09e-01 | 7.96e-01 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 58 | 1.53e-01 | -1.09e-01 | 4.15e-01 |
| GOBP SMOOTH MUSCLE CONTRACTION | 53 | 1.72e-01 | -1.09e-01 | 4.41e-01 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 6.74e-01 | 1.09e-01 | 8.48e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 22 | 3.78e-01 | 1.09e-01 | 6.60e-01 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 11 | 5.33e-01 | 1.09e-01 | 7.73e-01 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 34 | 2.74e-01 | -1.08e-01 | 5.64e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 25 | 3.48e-01 | -1.08e-01 | 6.33e-01 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 11 | 5.34e-01 | 1.08e-01 | 7.73e-01 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 5.53e-01 | -1.08e-01 | 7.84e-01 |
| GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 5 | 6.75e-01 | 1.08e-01 | 8.49e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 17 | 4.40e-01 | -1.08e-01 | 7.11e-01 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 5 | 6.75e-01 | 1.08e-01 | 8.49e-01 |
| GOBP CENTRIOLE ELONGATION | 8 | 5.96e-01 | 1.08e-01 | 8.08e-01 |
| GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 5.74e-01 | -1.08e-01 | 7.97e-01 |
| GOBP SARCOMERE ORGANIZATION | 20 | 4.02e-01 | 1.08e-01 | 6.82e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 128 | 3.48e-02 | 1.08e-01 | 1.84e-01 |
| GOMF PROTEIN CARRIER CHAPERONE | 33 | 2.82e-01 | 1.08e-01 | 5.72e-01 |
| GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 5.74e-01 | -1.08e-01 | 7.97e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 22 | 3.80e-01 | -1.08e-01 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 10 | 5.54e-01 | -1.08e-01 | 7.85e-01 |
| GOBP RNA STABILIZATION | 55 | 1.66e-01 | -1.08e-01 | 4.35e-01 |
| GOBP ASYMMETRIC CELL DIVISION | 13 | 5.00e-01 | 1.08e-01 | 7.53e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 56 | 1.62e-01 | -1.08e-01 | 4.29e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE | 5 | 6.76e-01 | -1.08e-01 | 8.49e-01 |
| GOBP TRANSLATIONAL INITIATION | 114 | 4.67e-02 | 1.08e-01 | 2.20e-01 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 115 | 4.58e-02 | -1.08e-01 | 2.16e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 155 | 2.06e-02 | -1.08e-01 | 1.33e-01 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 84 | 8.75e-02 | -1.08e-01 | 3.09e-01 |
| GOBP NEURAL TUBE FORMATION | 78 | 9.99e-02 | -1.08e-01 | 3.33e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 49 | 1.92e-01 | 1.08e-01 | 4.69e-01 |
| GOBP CARDIOBLAST DIFFERENTIATION | 8 | 5.97e-01 | -1.08e-01 | 8.09e-01 |
| GOCC TRANSPORTER COMPLEX | 217 | 6.37e-03 | 1.08e-01 | 6.05e-02 |
| GOBP ENDOCYTOSIS | 508 | 3.60e-05 | -1.08e-01 | 1.26e-03 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 245 | 3.78e-03 | -1.08e-01 | 4.34e-02 |
| GOBP MAINTENANCE OF CELL NUMBER | 139 | 2.87e-02 | -1.08e-01 | 1.64e-01 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 36 | 2.64e-01 | 1.08e-01 | 5.54e-01 |
| GOCC CHLORIDE CHANNEL COMPLEX | 17 | 4.43e-01 | 1.08e-01 | 7.13e-01 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 30 | 3.08e-01 | -1.08e-01 | 5.96e-01 |
| GOBP RESPONSE TO EXTRACELLULAR STIMULUS | 360 | 4.90e-04 | -1.07e-01 | 9.67e-03 |
| GOBP AORTIC VALVE MORPHOGENESIS | 17 | 4.43e-01 | -1.07e-01 | 7.13e-01 |
| GOMF ISOCITRATE DEHYDROGENASE NAD P PLUS ACTIVITY | 5 | 6.78e-01 | 1.07e-01 | 8.50e-01 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 198 | 9.44e-03 | -1.07e-01 | 7.95e-02 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 93 | 7.42e-02 | 1.07e-01 | 2.83e-01 |
| GOBP REGULATION OF DNA RECOMBINATION | 113 | 4.93e-02 | -1.07e-01 | 2.25e-01 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 10 | 5.57e-01 | -1.07e-01 | 7.87e-01 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 13 | 5.04e-01 | 1.07e-01 | 7.54e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 23 | 3.74e-01 | -1.07e-01 | 6.57e-01 |
| GOMF JUN KINASE BINDING | 9 | 5.78e-01 | 1.07e-01 | 8.00e-01 |
| GOMF MISMATCHED DNA BINDING | 13 | 5.04e-01 | 1.07e-01 | 7.54e-01 |
| GOBP ACTIN NUCLEATION | 45 | 2.14e-01 | 1.07e-01 | 4.97e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 30 | 3.10e-01 | -1.07e-01 | 5.99e-01 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 30 | 3.10e-01 | -1.07e-01 | 5.99e-01 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 11 | 5.39e-01 | 1.07e-01 | 7.76e-01 |
| GOMF BIOTIN BINDING | 5 | 6.79e-01 | -1.07e-01 | 8.51e-01 |
| GOBP DEFENSE RESPONSE | 1114 | 2.73e-09 | -1.07e-01 | 4.13e-07 |
| GOBP POSTREPLICATION REPAIR | 33 | 2.88e-01 | -1.07e-01 | 5.78e-01 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 91 | 7.82e-02 | 1.07e-01 | 2.90e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 37 | 2.61e-01 | -1.07e-01 | 5.51e-01 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 9 | 5.79e-01 | -1.07e-01 | 8.00e-01 |
| GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 6 | 6.51e-01 | -1.07e-01 | 8.37e-01 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 185 | 1.24e-02 | -1.07e-01 | 9.52e-02 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 50 | 1.92e-01 | -1.07e-01 | 4.69e-01 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 19 | 4.21e-01 | 1.07e-01 | 6.98e-01 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 11 | 5.40e-01 | -1.07e-01 | 7.77e-01 |
| GOMF CHONDROITIN SULFATE BINDING | 6 | 6.51e-01 | -1.07e-01 | 8.37e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 9 | 5.80e-01 | -1.07e-01 | 8.00e-01 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 10 | 5.60e-01 | -1.07e-01 | 7.88e-01 |
| GOCC NUCLEAR BODY | 727 | 1.24e-06 | -1.06e-01 | 7.24e-05 |
| GOMF GLUTAMATE RECEPTOR BINDING | 27 | 3.38e-01 | -1.06e-01 | 6.25e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 15 | 4.75e-01 | -1.06e-01 | 7.37e-01 |
| GOMF GLYCOSPHINGOLIPID BINDING | 5 | 6.80e-01 | 1.06e-01 | 8.51e-01 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 35 | 2.76e-01 | -1.06e-01 | 5.66e-01 |
| GOBP OSSIFICATION | 237 | 4.90e-03 | -1.06e-01 | 5.06e-02 |
| GOBP RESPONSE TO GRAVITY | 5 | 6.80e-01 | -1.06e-01 | 8.52e-01 |
| GOCC NUCLEAR ENVELOPE LUMEN | 8 | 6.03e-01 | 1.06e-01 | 8.11e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 9 | 5.81e-01 | 1.06e-01 | 8.00e-01 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 9 | 5.81e-01 | 1.06e-01 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 101 | 6.54e-02 | -1.06e-01 | 2.66e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE | 5 | 6.81e-01 | -1.06e-01 | 8.52e-01 |
| GOCC CELL SURFACE | 455 | 1.13e-04 | -1.06e-01 | 3.29e-03 |
| GOBP ORGANELLE FISSION | 383 | 3.86e-04 | -1.06e-01 | 8.12e-03 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 9 | 5.82e-01 | 1.06e-01 | 8.01e-01 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 13 | 5.08e-01 | -1.06e-01 | 7.56e-01 |
| GOBP FUCOSE METABOLIC PROCESS | 10 | 5.62e-01 | 1.06e-01 | 7.90e-01 |
| GOBP CELLULAR RESPONSE TO LIPID | 398 | 3.03e-04 | -1.06e-01 | 6.98e-03 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 11 | 5.43e-01 | -1.06e-01 | 7.78e-01 |
| GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 6.53e-01 | 1.06e-01 | 8.37e-01 |
| GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 16 | 4.63e-01 | -1.06e-01 | 7.30e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 24 | 3.69e-01 | -1.06e-01 | 6.52e-01 |
| GOBP REGULATION OF STEROL TRANSPORT | 39 | 2.53e-01 | -1.06e-01 | 5.42e-01 |
| GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT | 5 | 6.82e-01 | -1.06e-01 | 8.52e-01 |
| GOBP NUCLEOSIDE TRANSPORT | 5 | 6.82e-01 | -1.06e-01 | 8.52e-01 |
| GOCC SPINDLE POLE | 154 | 2.36e-02 | -1.06e-01 | 1.44e-01 |
| GOBP TUBE DEVELOPMENT | 638 | 5.88e-06 | -1.06e-01 | 2.71e-04 |
| GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 5.82e-01 | -1.06e-01 | 8.01e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 9 | 5.83e-01 | -1.06e-01 | 8.01e-01 |
| GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.82e-01 | 1.06e-01 | 8.52e-01 |
| GOBP REGULATION OF GLYCOLYTIC PROCESS | 42 | 2.36e-01 | -1.06e-01 | 5.20e-01 |
| GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 6 | 6.54e-01 | -1.06e-01 | 8.38e-01 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 14 | 4.93e-01 | 1.06e-01 | 7.48e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 12 | 5.26e-01 | 1.06e-01 | 7.69e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 80 | 1.03e-01 | -1.06e-01 | 3.37e-01 |
| GOBP COLLECTING DUCT DEVELOPMENT | 5 | 6.83e-01 | 1.06e-01 | 8.52e-01 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 10 | 5.63e-01 | -1.06e-01 | 7.91e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 17 | 4.51e-01 | 1.06e-01 | 7.20e-01 |
| GOBP RESPONSE TO METAL ION | 237 | 5.26e-03 | -1.06e-01 | 5.31e-02 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 31 | 3.10e-01 | 1.05e-01 | 5.98e-01 |
| GOMF U6 SNRNA BINDING | 14 | 4.94e-01 | -1.05e-01 | 7.49e-01 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 31 | 3.10e-01 | -1.05e-01 | 5.98e-01 |
| GOBP SPINDLE ASSEMBLY | 122 | 4.46e-02 | -1.05e-01 | 2.13e-01 |
| GOBP UBIQUITIN RECYCLING | 13 | 5.11e-01 | -1.05e-01 | 7.58e-01 |
| GOBP CELL CYCLE PHASE TRANSITION | 458 | 1.21e-04 | -1.05e-01 | 3.49e-03 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 10 | 5.64e-01 | 1.05e-01 | 7.91e-01 |
| GOBP NEGATIVE REGULATION OF BINDING | 88 | 8.81e-02 | -1.05e-01 | 3.10e-01 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 1037 | 1.49e-08 | -1.05e-01 | 1.81e-06 |
| GOBP EMBRYO DEVELOPMENT | 693 | 2.80e-06 | -1.05e-01 | 1.43e-04 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 86 | 9.19e-02 | -1.05e-01 | 3.18e-01 |
| GOMF RNA POLYMERASE I ACTIVITY | 9 | 5.85e-01 | 1.05e-01 | 8.03e-01 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 15 | 4.81e-01 | -1.05e-01 | 7.40e-01 |
| GOCC LATERAL ELEMENT | 9 | 5.85e-01 | -1.05e-01 | 8.03e-01 |
| GOBP ATP TRANSPORT | 15 | 4.81e-01 | -1.05e-01 | 7.40e-01 |
| GOCC SET1C COMPASS COMPLEX | 13 | 5.12e-01 | 1.05e-01 | 7.59e-01 |
| GOMF SNORNA BINDING | 32 | 3.04e-01 | 1.05e-01 | 5.92e-01 |
| GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 5.86e-01 | -1.05e-01 | 8.03e-01 |
| GOBP MITOTIC RECOMBINATION | 22 | 3.94e-01 | -1.05e-01 | 6.74e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 98 | 7.31e-02 | -1.05e-01 | 2.81e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 73 | 1.22e-01 | 1.05e-01 | 3.68e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 6 | 6.57e-01 | -1.05e-01 | 8.39e-01 |
| GOBP ENTRY INTO HOST | 116 | 5.18e-02 | -1.05e-01 | 2.31e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 10 | 5.67e-01 | 1.05e-01 | 7.92e-01 |
| GOCC SERINE TYPE PEPTIDASE COMPLEX | 6 | 6.57e-01 | -1.05e-01 | 8.39e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC | 5 | 6.86e-01 | 1.05e-01 | 8.54e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 39 | 2.59e-01 | 1.05e-01 | 5.49e-01 |
| GOBP KERATINOCYTE PROLIFERATION | 27 | 3.47e-01 | 1.04e-01 | 6.32e-01 |
| GOBP RESPIRATORY SYSTEM PROCESS | 22 | 3.97e-01 | 1.04e-01 | 6.77e-01 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 30 | 3.23e-01 | -1.04e-01 | 6.10e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 14 | 4.99e-01 | 1.04e-01 | 7.52e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 26 | 3.57e-01 | 1.04e-01 | 6.43e-01 |
| GOMF SUMO POLYMER BINDING | 5 | 6.86e-01 | -1.04e-01 | 8.54e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 8 | 6.10e-01 | -1.04e-01 | 8.14e-01 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 53 | 1.89e-01 | 1.04e-01 | 4.66e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 434 | 2.11e-04 | -1.04e-01 | 5.37e-03 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 589 | 1.76e-05 | -1.04e-01 | 6.85e-04 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 19 | 4.32e-01 | 1.04e-01 | 7.06e-01 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 97 | 7.67e-02 | 1.04e-01 | 2.88e-01 |
| GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 5.89e-01 | 1.04e-01 | 8.04e-01 |
| GOMF SODIUM CHANNEL ACTIVITY | 16 | 4.71e-01 | -1.04e-01 | 7.34e-01 |
| GOMF NUCLEOSOME BINDING | 53 | 1.90e-01 | -1.04e-01 | 4.67e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 9 | 5.89e-01 | 1.04e-01 | 8.04e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 9 | 5.89e-01 | 1.04e-01 | 8.04e-01 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 5.89e-01 | 1.04e-01 | 8.04e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 6 | 6.59e-01 | 1.04e-01 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 7 | 6.34e-01 | -1.04e-01 | 8.26e-01 |
| GOBP SCHWANN CELL PROLIFERATION | 7 | 6.34e-01 | -1.04e-01 | 8.26e-01 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 729 | 2.14e-06 | -1.04e-01 | 1.14e-04 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 56 | 1.79e-01 | -1.04e-01 | 4.52e-01 |
| GOBP MANGANESE ION TRANSPORT | 9 | 5.89e-01 | 1.04e-01 | 8.04e-01 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 551 | 3.39e-05 | -1.04e-01 | 1.19e-03 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 13 | 5.17e-01 | 1.04e-01 | 7.61e-01 |
| GOBP LIVER REGENERATION | 20 | 4.21e-01 | -1.04e-01 | 6.98e-01 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 63 | 1.54e-01 | 1.04e-01 | 4.17e-01 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 18 | 4.46e-01 | 1.04e-01 | 7.14e-01 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 25 | 3.69e-01 | -1.04e-01 | 6.53e-01 |
| GOBP CYCLOOXYGENASE PATHWAY | 8 | 6.12e-01 | 1.04e-01 | 8.15e-01 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 37 | 2.75e-01 | -1.04e-01 | 5.65e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 109 | 6.20e-02 | -1.04e-01 | 2.57e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 61 | 1.62e-01 | 1.04e-01 | 4.29e-01 |
| GOMF GUANYL NUCLEOTIDE BINDING | 302 | 2.03e-03 | 1.04e-01 | 2.82e-02 |
| GOMF FATTY ACID DERIVATIVE BINDING | 14 | 5.02e-01 | 1.04e-01 | 7.54e-01 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 69 | 1.37e-01 | 1.04e-01 | 3.91e-01 |
| GOBP REGULATION OF ANOIKIS | 17 | 4.60e-01 | -1.04e-01 | 7.27e-01 |
| GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 12 | 5.35e-01 | 1.04e-01 | 7.74e-01 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 5 | 6.89e-01 | -1.04e-01 | 8.56e-01 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 365 | 7.19e-04 | -1.03e-01 | 1.31e-02 |
| GOCC 9PLUS2 MOTILE CILIUM | 93 | 8.50e-02 | 1.03e-01 | 3.03e-01 |
| GOBP MEMBRANE DEPOLARIZATION | 39 | 2.64e-01 | 1.03e-01 | 5.54e-01 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 59 | 1.70e-01 | -1.03e-01 | 4.39e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 17 | 4.61e-01 | 1.03e-01 | 7.27e-01 |
| GOCC BBSOME | 8 | 6.13e-01 | 1.03e-01 | 8.16e-01 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 15 | 4.89e-01 | 1.03e-01 | 7.46e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 530 | 5.36e-05 | -1.03e-01 | 1.78e-03 |
| GOBP FRUCTOSE METABOLIC PROCESS | 11 | 5.54e-01 | -1.03e-01 | 7.85e-01 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 6 | 6.62e-01 | -1.03e-01 | 8.42e-01 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 16 | 4.75e-01 | -1.03e-01 | 7.37e-01 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 118 | 5.34e-02 | -1.03e-01 | 2.36e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN | 16 | 4.76e-01 | 1.03e-01 | 7.38e-01 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 7 | 6.37e-01 | 1.03e-01 | 8.28e-01 |
| GOBP LIPID OXIDATION | 88 | 9.54e-02 | 1.03e-01 | 3.25e-01 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 64 | 1.55e-01 | 1.03e-01 | 4.17e-01 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 21 | 4.14e-01 | -1.03e-01 | 6.92e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 12 | 5.37e-01 | 1.03e-01 | 7.76e-01 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 32 | 3.14e-01 | -1.03e-01 | 6.02e-01 |
| GOCC BRCA1 A COMPLEX | 8 | 6.14e-01 | -1.03e-01 | 8.17e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 28 | 3.46e-01 | -1.03e-01 | 6.31e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 57 | 1.79e-01 | 1.03e-01 | 4.54e-01 |
| GOBP CELL CYCLE PROCESS | 1022 | 3.95e-08 | -1.03e-01 | 3.96e-06 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 10 | 5.74e-01 | 1.03e-01 | 7.97e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 8 | 6.15e-01 | -1.03e-01 | 8.17e-01 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 75 | 1.24e-01 | -1.03e-01 | 3.71e-01 |
| GOCC DISTAL AXON | 166 | 2.27e-02 | -1.03e-01 | 1.40e-01 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 30 | 3.30e-01 | -1.03e-01 | 6.16e-01 |
| GOCC MYOSIN COMPLEX | 28 | 3.47e-01 | -1.03e-01 | 6.32e-01 |
| GOBP RESPONSE TO THYROID HORMONE | 21 | 4.15e-01 | -1.03e-01 | 6.94e-01 |
| GOBP EXTRACELLULAR EXOSOME ASSEMBLY | 6 | 6.63e-01 | -1.03e-01 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 651 | 9.34e-06 | -1.03e-01 | 3.99e-04 |
| GOBP CRANIAL NERVE DEVELOPMENT | 31 | 3.23e-01 | -1.03e-01 | 6.10e-01 |
| GOMF ACTIVIN BINDING | 10 | 5.74e-01 | 1.03e-01 | 7.97e-01 |
| GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 6.39e-01 | 1.03e-01 | 8.29e-01 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 8 | 6.16e-01 | 1.03e-01 | 8.17e-01 |
| GOBP FEEDING BEHAVIOR | 40 | 2.62e-01 | -1.03e-01 | 5.52e-01 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 39 | 2.68e-01 | -1.02e-01 | 5.57e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 11 | 5.56e-01 | 1.02e-01 | 7.86e-01 |
| GOMF MANNOSE BINDING | 13 | 5.23e-01 | -1.02e-01 | 7.67e-01 |
| GOBP RECEPTOR INTERNALIZATION | 87 | 9.91e-02 | -1.02e-01 | 3.32e-01 |
| GOCC TERTIARY GRANULE MEMBRANE | 60 | 1.71e-01 | -1.02e-01 | 4.40e-01 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 61 | 1.68e-01 | 1.02e-01 | 4.36e-01 |
| GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 8 | 6.17e-01 | 1.02e-01 | 8.18e-01 |
| GOBP REGULATION OF DENDRITE EXTENSION | 15 | 4.93e-01 | -1.02e-01 | 7.48e-01 |
| GOBP T CELL CYTOKINE PRODUCTION | 26 | 3.67e-01 | -1.02e-01 | 6.51e-01 |
| GOBP SPINDLE ORGANIZATION | 181 | 1.80e-02 | -1.02e-01 | 1.22e-01 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 18 | 4.53e-01 | 1.02e-01 | 7.22e-01 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 86 | 1.02e-01 | -1.02e-01 | 3.36e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 43 | 2.47e-01 | -1.02e-01 | 5.35e-01 |
| GOCC WASH COMPLEX | 10 | 5.76e-01 | -1.02e-01 | 7.98e-01 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 280 | 3.41e-03 | -1.02e-01 | 4.03e-02 |
| GOBP NEUROTRANSMITTER METABOLIC PROCESS | 12 | 5.41e-01 | -1.02e-01 | 7.77e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 10 | 5.77e-01 | -1.02e-01 | 7.98e-01 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 139 | 3.83e-02 | 1.02e-01 | 1.93e-01 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 20 | 4.30e-01 | -1.02e-01 | 7.05e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 68 | 1.47e-01 | -1.02e-01 | 4.07e-01 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 24 | 3.88e-01 | -1.02e-01 | 6.69e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 36 | 2.91e-01 | -1.02e-01 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 6 | 6.66e-01 | -1.02e-01 | 8.44e-01 |
| GOBP REGULATION OF TISSUE REMODELING | 49 | 2.18e-01 | -1.02e-01 | 5.01e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 232 | 7.78e-03 | -1.02e-01 | 6.93e-02 |
| GOBP RESPONSE TO SALT | 224 | 8.92e-03 | -1.02e-01 | 7.63e-02 |
| GOBP G QUADRUPLEX DNA UNWINDING | 7 | 6.42e-01 | -1.02e-01 | 8.31e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING | 5 | 6.94e-01 | -1.02e-01 | 8.59e-01 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 41 | 2.60e-01 | -1.02e-01 | 5.50e-01 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 21 | 4.20e-01 | -1.02e-01 | 6.98e-01 |
| GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 6.19e-01 | -1.02e-01 | 8.18e-01 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 158 | 2.78e-02 | -1.02e-01 | 1.61e-01 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 35 | 2.99e-01 | -1.02e-01 | 5.86e-01 |
| GOBP REGULATION OF RESPONSE TO TUMOR CELL | 16 | 4.82e-01 | 1.01e-01 | 7.41e-01 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 112 | 6.40e-02 | -1.01e-01 | 2.62e-01 |
| GOBP ENDOTHELIUM DEVELOPMENT | 86 | 1.04e-01 | -1.01e-01 | 3.39e-01 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 10 | 5.79e-01 | -1.01e-01 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 48 | 2.25e-01 | -1.01e-01 | 5.09e-01 |
| GOBP RESPONSE TO FOOD | 18 | 4.57e-01 | -1.01e-01 | 7.25e-01 |
| GOBP PLACENTA DEVELOPMENT | 103 | 7.60e-02 | -1.01e-01 | 2.87e-01 |
| GOBP PROTEIN AUTOPROCESSING | 16 | 4.83e-01 | 1.01e-01 | 7.41e-01 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 20 | 4.33e-01 | -1.01e-01 | 7.07e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 36 | 2.93e-01 | 1.01e-01 | 5.82e-01 |
| GOCC CHROMATOID BODY | 6 | 6.68e-01 | 1.01e-01 | 8.46e-01 |
| GOBP LEUKOCYTE HOMEOSTASIS | 83 | 1.12e-01 | -1.01e-01 | 3.51e-01 |
| GOBP SUCCINATE METABOLIC PROCESS | 5 | 6.95e-01 | -1.01e-01 | 8.59e-01 |
| GOBP ALDITOL CATABOLIC PROCESS | 6 | 6.68e-01 | -1.01e-01 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 8 | 6.21e-01 | 1.01e-01 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 11 | 5.62e-01 | -1.01e-01 | 7.90e-01 |
| GOMF LIPASE INHIBITOR ACTIVITY | 10 | 5.81e-01 | -1.01e-01 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 8 | 6.21e-01 | -1.01e-01 | 8.20e-01 |
| GOBP DENDRITIC CELL MIGRATION | 25 | 3.83e-01 | -1.01e-01 | 6.64e-01 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 147 | 3.50e-02 | -1.01e-01 | 1.84e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 9 | 6.00e-01 | 1.01e-01 | 8.10e-01 |
| GOBP CELLULAR RESPONSE TO VIRUS | 46 | 2.37e-01 | -1.01e-01 | 5.22e-01 |
| GOCC CATION CHANNEL COMPLEX | 79 | 1.22e-01 | 1.01e-01 | 3.67e-01 |
| GOMF UNFOLDED PROTEIN BINDING | 97 | 8.67e-02 | 1.01e-01 | 3.07e-01 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 357 | 1.12e-03 | -1.01e-01 | 1.85e-02 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 20 | 4.36e-01 | 1.01e-01 | 7.09e-01 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 96 | 8.85e-02 | -1.01e-01 | 3.11e-01 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 41 | 2.65e-01 | 1.01e-01 | 5.55e-01 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 11 | 5.63e-01 | -1.01e-01 | 7.91e-01 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 89 | 1.01e-01 | 1.01e-01 | 3.36e-01 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 48 | 2.29e-01 | -1.00e-01 | 5.14e-01 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 808 | 1.52e-06 | -1.00e-01 | 8.38e-05 |
| GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 17 | 4.73e-01 | -1.00e-01 | 7.36e-01 |
| GOBP NAD METABOLIC PROCESS | 31 | 3.33e-01 | -1.00e-01 | 6.19e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 14 | 5.16e-01 | -1.00e-01 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 122 | 5.60e-02 | -1.00e-01 | 2.41e-01 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 87 | 1.06e-01 | -1.00e-01 | 3.43e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 12 | 5.48e-01 | -1.00e-01 | 7.81e-01 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 26 | 3.76e-01 | 1.00e-01 | 6.59e-01 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 13 | 5.32e-01 | 1.00e-01 | 7.72e-01 |
| GOBP NK T CELL ACTIVATION | 10 | 5.84e-01 | 1.00e-01 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 6.71e-01 | -1.00e-01 | 8.47e-01 |
| GOBP CELL JUNCTION ASSEMBLY | 234 | 8.52e-03 | -1.00e-01 | 7.36e-02 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 57 | 1.92e-01 | -1.00e-01 | 4.69e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 11 | 5.66e-01 | -9.99e-02 | 7.92e-01 |
| GOBP SINGLE FERTILIZATION | 65 | 1.64e-01 | 9.98e-02 | 4.32e-01 |
| GOCC NSL COMPLEX | 11 | 5.67e-01 | -9.98e-02 | 7.92e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 24 | 3.98e-01 | -9.98e-02 | 6.78e-01 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 12 | 5.50e-01 | -9.97e-02 | 7.82e-01 |
| GOBP RESPONSE TO INTERLEUKIN 12 | 10 | 5.85e-01 | -9.97e-02 | 8.03e-01 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 65 | 1.65e-01 | -9.96e-02 | 4.33e-01 |
| GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 6 | 6.73e-01 | 9.96e-02 | 8.48e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 8 | 6.26e-01 | 9.96e-02 | 8.21e-01 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 26 | 3.80e-01 | -9.96e-02 | 6.61e-01 |
| GOCC KINESIN COMPLEX | 33 | 3.23e-01 | -9.95e-02 | 6.10e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 102 | 8.29e-02 | -9.95e-02 | 3.00e-01 |
| GOCC THO COMPLEX | 6 | 6.73e-01 | 9.95e-02 | 8.48e-01 |
| GOMF PROTEIN CONTAINING COMPLEX BINDING | 1298 | 3.09e-09 | -9.95e-02 | 4.59e-07 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 120 | 6.02e-02 | -9.94e-02 | 2.52e-01 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 156 | 3.24e-02 | 9.94e-02 | 1.76e-01 |
| GOCC EXOCYST | 11 | 5.68e-01 | -9.94e-02 | 7.93e-01 |
| GOBP RESPONSE TO LIGHT STIMULUS | 227 | 1.01e-02 | -9.93e-02 | 8.32e-02 |
| GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 6.74e-01 | -9.93e-02 | 8.48e-01 |
| GOBP CELL CELL RECOGNITION | 37 | 2.96e-01 | 9.93e-02 | 5.84e-01 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 24 | 4.00e-01 | -9.93e-02 | 6.80e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 345 | 1.61e-03 | 9.92e-02 | 2.38e-02 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 479 | 2.17e-04 | -9.92e-02 | 5.49e-03 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 27 | 3.73e-01 | -9.91e-02 | 6.56e-01 |
| GOBP CELL KILLING | 117 | 6.44e-02 | -9.91e-02 | 2.63e-01 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 23 | 4.11e-01 | 9.90e-02 | 6.91e-01 |
| GOBP CELL PART MORPHOGENESIS | 397 | 7.61e-04 | -9.89e-02 | 1.37e-02 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 66 | 1.65e-01 | -9.89e-02 | 4.33e-01 |
| GOCC SITE OF DNA DAMAGE | 106 | 7.91e-02 | -9.88e-02 | 2.92e-01 |
| GOBP LYMPHOCYTE MIGRATION | 72 | 1.47e-01 | -9.88e-02 | 4.07e-01 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 201 | 1.60e-02 | 9.88e-02 | 1.13e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 11 | 5.71e-01 | 9.88e-02 | 7.94e-01 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 28 | 3.66e-01 | -9.87e-02 | 6.51e-01 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 16 | 4.94e-01 | -9.87e-02 | 7.49e-01 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 93 | 1.01e-01 | -9.86e-02 | 3.34e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 5.55e-01 | 9.85e-02 | 7.85e-01 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 65 | 1.70e-01 | 9.84e-02 | 4.40e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 7.03e-01 | 9.84e-02 | 8.64e-01 |
| GOCC APICAL DENDRITE | 10 | 5.90e-01 | -9.84e-02 | 8.05e-01 |
| GOBP GLIAL CELL MIGRATION | 43 | 2.65e-01 | -9.84e-02 | 5.55e-01 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 166 | 2.92e-02 | -9.83e-02 | 1.65e-01 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 21 | 4.36e-01 | 9.83e-02 | 7.09e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 8 | 6.30e-01 | -9.82e-02 | 8.25e-01 |
| GOBP ORGANIC CATION TRANSPORT | 32 | 3.36e-01 | -9.82e-02 | 6.23e-01 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 11 | 5.73e-01 | -9.82e-02 | 7.96e-01 |
| GOBP LIPID HOMEOSTASIS | 102 | 8.70e-02 | 9.82e-02 | 3.08e-01 |
| GOBP CENTRIOLE ASSEMBLY | 41 | 2.77e-01 | -9.82e-02 | 5.67e-01 |
| GOBP SECOND MESSENGER MEDIATED SIGNALING | 166 | 2.94e-02 | -9.81e-02 | 1.67e-01 |
| GOBP PROTEIN ACTIVATION CASCADE | 7 | 6.53e-01 | -9.81e-02 | 8.37e-01 |
| GOBP STRESS INDUCED PREMATURE SENESCENCE | 5 | 7.04e-01 | -9.81e-02 | 8.65e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 74 | 1.45e-01 | 9.81e-02 | 4.04e-01 |
| GOCC CELL SUBSTRATE JUNCTION | 363 | 1.39e-03 | -9.81e-02 | 2.15e-02 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 8 | 6.31e-01 | -9.81e-02 | 8.25e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 66 | 1.69e-01 | -9.80e-02 | 4.38e-01 |
| GOBP CHOLESTEROL EFFLUX | 36 | 3.09e-01 | -9.80e-02 | 5.98e-01 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 99 | 9.23e-02 | -9.80e-02 | 3.19e-01 |
| GOMF CYCLOSPORIN A BINDING | 17 | 4.85e-01 | -9.80e-02 | 7.43e-01 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 327 | 2.42e-03 | -9.79e-02 | 3.20e-02 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 17 | 4.85e-01 | -9.79e-02 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 13 | 5.41e-01 | 9.79e-02 | 7.77e-01 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 125 | 5.94e-02 | 9.78e-02 | 2.49e-01 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 58 | 1.98e-01 | -9.78e-02 | 4.77e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 24 | 4.07e-01 | -9.77e-02 | 6.87e-01 |
| GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 6.54e-01 | -9.77e-02 | 8.38e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 743 | 6.91e-06 | 9.77e-02 | 3.07e-04 |
| GOBP NEURON DEVELOPMENT | 673 | 1.80e-05 | -9.77e-02 | 6.89e-04 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 10 | 5.93e-01 | 9.77e-02 | 8.06e-01 |
| GOBP REGULATION OF DNA DEMETHYLATION | 7 | 6.55e-01 | -9.76e-02 | 8.38e-01 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 48 | 2.43e-01 | -9.75e-02 | 5.29e-01 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 32 | 3.40e-01 | 9.75e-02 | 6.26e-01 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 70 | 1.59e-01 | 9.75e-02 | 4.24e-01 |
| GOBP HEART VALVE MORPHOGENESIS | 33 | 3.33e-01 | -9.75e-02 | 6.19e-01 |
| GOBP PROTEIN SUMOYLATION | 60 | 1.92e-01 | -9.75e-02 | 4.69e-01 |
| GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 7 | 6.55e-01 | -9.74e-02 | 8.38e-01 |
| GOBP MEMBRANE RAFT LOCALIZATION | 6 | 6.80e-01 | -9.74e-02 | 8.51e-01 |
| GOBP STRESS GRANULE ASSEMBLY | 28 | 3.73e-01 | -9.74e-02 | 6.56e-01 |
| GOBP MITOTIC CYTOKINESIS | 82 | 1.28e-01 | -9.74e-02 | 3.78e-01 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 23 | 4.19e-01 | 9.73e-02 | 6.97e-01 |
| GOBP VACUOLAR TRANSPORT | 147 | 4.21e-02 | 9.73e-02 | 2.06e-01 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 270 | 6.10e-03 | -9.73e-02 | 5.85e-02 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 5 | 7.07e-01 | 9.73e-02 | 8.66e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 14 | 5.29e-01 | 9.72e-02 | 7.69e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 31 | 3.49e-01 | 9.72e-02 | 6.34e-01 |
| GOBP MEIOTIC CELL CYCLE | 188 | 2.18e-02 | -9.72e-02 | 1.37e-01 |
| GOBP MITOTIC CELL CYCLE | 753 | 6.88e-06 | -9.71e-02 | 3.07e-04 |
| GOBP PLATELET AGGREGATION | 49 | 2.40e-01 | -9.71e-02 | 5.26e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1119 | 6.43e-08 | -9.71e-02 | 5.90e-06 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 434 | 5.62e-04 | -9.70e-02 | 1.06e-02 |
| GOBP RESPONSE TO ZINC ION | 33 | 3.35e-01 | -9.70e-02 | 6.21e-01 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1137 | 5.30e-08 | -9.70e-02 | 5.02e-06 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 13 | 5.45e-01 | 9.70e-02 | 7.80e-01 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 13 | 5.46e-01 | 9.68e-02 | 7.80e-01 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 84 | 1.26e-01 | -9.68e-02 | 3.74e-01 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 68 | 1.68e-01 | -9.68e-02 | 4.36e-01 |
| GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 8 | 6.36e-01 | 9.67e-02 | 8.27e-01 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 25 | 4.03e-01 | -9.66e-02 | 6.83e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 18 | 4.78e-01 | 9.66e-02 | 7.39e-01 |
| GOBP GLOMERULUS DEVELOPMENT | 35 | 3.23e-01 | -9.66e-02 | 6.10e-01 |
| GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 6 | 6.82e-01 | -9.66e-02 | 8.52e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 7 | 6.58e-01 | -9.65e-02 | 8.40e-01 |
| GOCC TOR COMPLEX | 11 | 5.79e-01 | -9.65e-02 | 8.00e-01 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 17 | 4.91e-01 | -9.65e-02 | 7.47e-01 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 22 | 4.34e-01 | 9.64e-02 | 7.08e-01 |
| GOCC AZUROPHIL GRANULE | 129 | 5.90e-02 | -9.64e-02 | 2.48e-01 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 6 | 6.83e-01 | -9.64e-02 | 8.52e-01 |
| GOMF POLY G BINDING | 8 | 6.37e-01 | -9.64e-02 | 8.28e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 73 | 1.55e-01 | -9.64e-02 | 4.17e-01 |
| GOCC CYTOSOLIC RIBOSOME | 110 | 8.13e-02 | -9.63e-02 | 2.97e-01 |
| GOBP HEART TRABECULA MORPHOGENESIS | 19 | 4.67e-01 | 9.63e-02 | 7.32e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 149 | 4.28e-02 | -9.63e-02 | 2.08e-01 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 57 | 2.10e-01 | -9.61e-02 | 4.91e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 17 | 4.93e-01 | -9.61e-02 | 7.48e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 11 | 5.81e-01 | -9.61e-02 | 8.00e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 61 | 1.94e-01 | -9.61e-02 | 4.72e-01 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 39 | 2.99e-01 | -9.61e-02 | 5.87e-01 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 88 | 1.20e-01 | -9.61e-02 | 3.64e-01 |
| GOBP SPERM DNA CONDENSATION | 7 | 6.60e-01 | 9.61e-02 | 8.41e-01 |
| GOCC MEIOTIC SPINDLE | 10 | 5.99e-01 | -9.60e-02 | 8.10e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 12 | 5.65e-01 | 9.60e-02 | 7.91e-01 |
| GOMF EXTRACELLULAR MATRIX BINDING | 23 | 4.25e-01 | 9.60e-02 | 7.03e-01 |
| GOCC GAP JUNCTION | 8 | 6.38e-01 | 9.60e-02 | 8.29e-01 |
| GOBP CELLULAR RESPONSE TO NICOTINE | 5 | 7.10e-01 | 9.60e-02 | 8.68e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 52 | 2.32e-01 | 9.60e-02 | 5.15e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 451 | 5.12e-04 | 9.59e-02 | 1.00e-02 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 19 | 4.69e-01 | -9.59e-02 | 7.33e-01 |
| GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 7 | 6.60e-01 | -9.59e-02 | 8.42e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 391 | 1.21e-03 | 9.58e-02 | 1.95e-02 |
| GOCC CILIARY TRANSITION FIBER | 7 | 6.61e-01 | -9.57e-02 | 8.42e-01 |
| GOBP REGULATION OF ERAD PATHWAY | 20 | 4.59e-01 | 9.56e-02 | 7.26e-01 |
| GOBP LEARNING | 85 | 1.28e-01 | -9.56e-02 | 3.78e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 12 | 5.67e-01 | -9.56e-02 | 7.92e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 40 | 2.96e-01 | 9.55e-02 | 5.84e-01 |
| GOCC LAMELLIPODIUM | 167 | 3.36e-02 | -9.55e-02 | 1.80e-01 |
| GOCC ORIGIN RECOGNITION COMPLEX | 9 | 6.20e-01 | -9.54e-02 | 8.19e-01 |
| GOBP MAST CELL CHEMOTAXIS | 7 | 6.62e-01 | -9.54e-02 | 8.43e-01 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 380 | 1.49e-03 | -9.53e-02 | 2.26e-02 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 148 | 4.58e-02 | -9.53e-02 | 2.17e-01 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 22 | 4.40e-01 | 9.52e-02 | 7.11e-01 |
| GOCC CLATHRIN COAT OF COATED PIT | 14 | 5.37e-01 | 9.52e-02 | 7.76e-01 |
| GOCC ZYMOGEN GRANULE | 7 | 6.63e-01 | -9.52e-02 | 8.43e-01 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 11 | 5.85e-01 | -9.51e-02 | 8.03e-01 |
| GOBP MYELIN ASSEMBLY | 15 | 5.24e-01 | -9.51e-02 | 7.68e-01 |
| GOBP CYSTEINE METABOLIC PROCESS | 7 | 6.63e-01 | -9.51e-02 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 473 | 4.25e-04 | -9.51e-02 | 8.75e-03 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 63 | 1.92e-01 | 9.51e-02 | 4.69e-01 |
| GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 6.87e-01 | -9.50e-02 | 8.55e-01 |
| GOMF MICROTUBULE BINDING | 213 | 1.72e-02 | -9.50e-02 | 1.19e-01 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 18 | 4.86e-01 | -9.49e-02 | 7.43e-01 |
| GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 7 | 6.64e-01 | -9.49e-02 | 8.43e-01 |
| GOCC AZUROPHIL GRANULE MEMBRANE | 51 | 2.41e-01 | -9.49e-02 | 5.28e-01 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 12 | 5.70e-01 | -9.48e-02 | 7.94e-01 |
| GOBP INNER EAR MORPHOGENESIS | 37 | 3.19e-01 | 9.48e-02 | 6.08e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 13 | 5.54e-01 | -9.48e-02 | 7.85e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 7 | 6.64e-01 | -9.47e-02 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 46 | 2.67e-01 | -9.47e-02 | 5.57e-01 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 24 | 4.22e-01 | -9.47e-02 | 6.99e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE | 549 | 1.64e-04 | -9.47e-02 | 4.45e-03 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 34 | 3.40e-01 | -9.46e-02 | 6.26e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 6.88e-01 | -9.46e-02 | 8.56e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 14 | 5.40e-01 | 9.46e-02 | 7.77e-01 |
| GOMF PROLINE RICH REGION BINDING | 15 | 5.26e-01 | -9.46e-02 | 7.69e-01 |
| GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 6.88e-01 | 9.45e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 6.05e-01 | -9.45e-02 | 8.12e-01 |
| GOMF NUCLEOSOMAL DNA BINDING | 23 | 4.33e-01 | -9.45e-02 | 7.07e-01 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 29 | 3.79e-01 | -9.44e-02 | 6.60e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 8 | 6.44e-01 | -9.44e-02 | 8.32e-01 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1388 | 6.74e-09 | 9.44e-02 | 8.93e-07 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 6 | 6.89e-01 | 9.44e-02 | 8.56e-01 |
| GOBP MRNA 3 END PROCESSING | 48 | 2.59e-01 | -9.43e-02 | 5.48e-01 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 43 | 2.85e-01 | -9.43e-02 | 5.75e-01 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 147 | 4.89e-02 | -9.43e-02 | 2.25e-01 |
| GOMF WW DOMAIN BINDING | 16 | 5.14e-01 | -9.42e-02 | 7.60e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 6 | 6.89e-01 | 9.42e-02 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 10 | 6.06e-01 | -9.42e-02 | 8.13e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 7 | 6.66e-01 | -9.42e-02 | 8.44e-01 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 6 | 6.90e-01 | -9.42e-02 | 8.56e-01 |
| GOBP ANIMAL ORGAN REGENERATION | 39 | 3.10e-01 | -9.40e-02 | 5.98e-01 |
| GOBP VITAMIN TRANSPORT | 30 | 3.74e-01 | 9.39e-02 | 6.56e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 38 | 3.17e-01 | 9.39e-02 | 6.06e-01 |
| GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 10 | 6.07e-01 | -9.38e-02 | 8.13e-01 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 17 | 5.03e-01 | -9.38e-02 | 7.54e-01 |
| GOBP B CELL MEDIATED IMMUNITY | 94 | 1.17e-01 | -9.38e-02 | 3.59e-01 |
| GOBP PROTEIN POLYMERIZATION | 219 | 1.72e-02 | -9.37e-02 | 1.19e-01 |
| GOBP REGULATION OF NCRNA TRANSCRIPTION | 65 | 1.92e-01 | -9.36e-02 | 4.69e-01 |
| GOBP FERTILIZATION | 84 | 1.39e-01 | 9.36e-02 | 3.94e-01 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 71 | 1.73e-01 | -9.36e-02 | 4.44e-01 |
| GOMF VITAMIN BINDING | 91 | 1.23e-01 | 9.35e-02 | 3.70e-01 |
| GOCC CLATHRIN COATED PIT | 60 | 2.11e-01 | -9.35e-02 | 4.93e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING | 1151 | 1.32e-07 | -9.35e-02 | 1.07e-05 |
| GOBP NADH METABOLIC PROCESS | 10 | 6.09e-01 | 9.35e-02 | 8.14e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 12 | 5.75e-01 | 9.34e-02 | 7.97e-01 |
| GOBP PROTEIN MATURATION | 409 | 1.26e-03 | 9.34e-02 | 2.00e-02 |
| GOBP AXON DEVELOPMENT | 274 | 8.06e-03 | -9.33e-02 | 7.10e-02 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 9 | 6.28e-01 | -9.33e-02 | 8.23e-01 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 16 | 5.19e-01 | 9.32e-02 | 7.63e-01 |
| GOBP REGULATION OF HELICASE ACTIVITY | 11 | 5.93e-01 | -9.32e-02 | 8.06e-01 |
| GOBP NCRNA METABOLIC PROCESS | 539 | 2.36e-04 | 9.32e-02 | 5.77e-03 |
| GOBP EXOCYTIC PROCESS | 56 | 2.28e-01 | 9.31e-02 | 5.14e-01 |
| GOBP CIRCULATORY SYSTEM PROCESS | 308 | 5.11e-03 | -9.31e-02 | 5.23e-02 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 29 | 3.86e-01 | 9.31e-02 | 6.67e-01 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 5 | 7.19e-01 | 9.31e-02 | 8.74e-01 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 15 | 5.33e-01 | 9.31e-02 | 7.73e-01 |
| GOCC DENDRITE CYTOPLASM | 21 | 4.60e-01 | -9.31e-02 | 7.27e-01 |
| GOBP MESENCHYMAL STEM CELL PROLIFERATION | 5 | 7.19e-01 | -9.31e-02 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION | 5 | 7.19e-01 | -9.31e-02 | 8.74e-01 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 75 | 1.64e-01 | -9.30e-02 | 4.31e-01 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 96 | 1.16e-01 | -9.30e-02 | 3.57e-01 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 14 | 5.47e-01 | -9.30e-02 | 7.81e-01 |
| GOCC 90S PRERIBOSOME | 25 | 4.21e-01 | 9.30e-02 | 6.98e-01 |
| GOCC ANCHORING JUNCTION | 619 | 8.84e-05 | -9.30e-02 | 2.69e-03 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 311 | 4.99e-03 | -9.29e-02 | 5.14e-02 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 48 | 2.66e-01 | -9.29e-02 | 5.56e-01 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 894 | 3.16e-06 | 9.28e-02 | 1.59e-04 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 233 | 1.50e-02 | -9.28e-02 | 1.08e-01 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 21 | 4.62e-01 | -9.27e-02 | 7.29e-01 |
| GOBP CELLULAR COMPONENT MORPHOGENESIS | 450 | 8.16e-04 | -9.25e-02 | 1.45e-02 |
| GOMF NEUROPEPTIDE RECEPTOR BINDING | 12 | 5.80e-01 | 9.24e-02 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 672 | 5.27e-05 | -9.22e-02 | 1.75e-03 |
| GOMF ACTIN BINDING | 306 | 5.75e-03 | -9.21e-02 | 5.63e-02 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 12 | 5.81e-01 | 9.20e-02 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 7.22e-01 | -9.20e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF HISTONE METHYLATION | 14 | 5.52e-01 | -9.19e-02 | 7.83e-01 |
| GOMF LRR DOMAIN BINDING | 13 | 5.66e-01 | 9.19e-02 | 7.92e-01 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 82 | 1.51e-01 | -9.19e-02 | 4.12e-01 |
| GOCC HOPS COMPLEX | 9 | 6.33e-01 | -9.19e-02 | 8.26e-01 |
| GOBP GLYCOSYLATION | 166 | 4.15e-02 | 9.19e-02 | 2.03e-01 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 6 | 6.97e-01 | -9.19e-02 | 8.61e-01 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 14 | 5.52e-01 | 9.18e-02 | 7.84e-01 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 214 | 2.09e-02 | -9.18e-02 | 1.34e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 5 | 7.22e-01 | -9.18e-02 | 8.76e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 5 | 7.22e-01 | -9.17e-02 | 8.76e-01 |
| GOCC CCR4 NOT CORE COMPLEX | 6 | 6.97e-01 | -9.17e-02 | 8.61e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1348 | 2.77e-08 | 9.17e-02 | 3.09e-06 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 123 | 7.96e-02 | 9.16e-02 | 2.94e-01 |
| GOBP ACUTE PHASE RESPONSE | 24 | 4.37e-01 | -9.16e-02 | 7.10e-01 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 9 | 6.34e-01 | -9.16e-02 | 8.26e-01 |
| GOMF LIPID BINDING | 558 | 2.38e-04 | -9.16e-02 | 5.80e-03 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 328 | 4.51e-03 | -9.16e-02 | 4.82e-02 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 44 | 2.94e-01 | -9.15e-02 | 5.82e-01 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 61 | 2.17e-01 | 9.15e-02 | 5.00e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 18 | 5.02e-01 | -9.15e-02 | 7.54e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 8 | 6.54e-01 | 9.14e-02 | 8.38e-01 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 572 | 2.07e-04 | -9.14e-02 | 5.35e-03 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 6.00e-01 | -9.14e-02 | 8.10e-01 |
| GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 7 | 6.76e-01 | 9.13e-02 | 8.49e-01 |
| GOMF CARD DOMAIN BINDING | 13 | 5.69e-01 | 9.12e-02 | 7.93e-01 |
| GOBP REGULATION OF PROTEIN GLYCOSYLATION | 10 | 6.18e-01 | 9.12e-02 | 8.18e-01 |
| GOMF OMEGA PEPTIDASE ACTIVITY | 10 | 6.18e-01 | 9.12e-02 | 8.18e-01 |
| GOBP SMOOTH MUSCLE CELL CHEMOTAXIS | 5 | 7.24e-01 | -9.11e-02 | 8.76e-01 |
| GOBP BONE MINERALIZATION | 68 | 1.94e-01 | -9.11e-02 | 4.71e-01 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 806 | 1.32e-05 | 9.11e-02 | 5.33e-04 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 12 | 5.85e-01 | -9.11e-02 | 8.03e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 22 | 4.60e-01 | -9.10e-02 | 7.27e-01 |
| GOBP ENDOTHELIAL CELL MIGRATION | 139 | 6.44e-02 | -9.10e-02 | 2.63e-01 |
| GOBP RESPONSE TO CORTICOSTERONE | 5 | 7.25e-01 | 9.10e-02 | 8.76e-01 |
| GOCC TRANSLATION PREINITIATION COMPLEX | 18 | 5.04e-01 | -9.09e-02 | 7.54e-01 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 24 | 4.41e-01 | 9.09e-02 | 7.12e-01 |
| GOBP REGULATION OF ENDOCYTOSIS | 205 | 2.52e-02 | -9.09e-02 | 1.50e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 6 | 7.00e-01 | -9.09e-02 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 27 | 4.14e-01 | -9.08e-02 | 6.92e-01 |
| GOBP COPI COATED VESICLE BUDDING | 6 | 7.00e-01 | 9.08e-02 | 8.63e-01 |
| GOBP SULFUR COMPOUND TRANSPORT | 38 | 3.33e-01 | -9.08e-02 | 6.19e-01 |
| GOBP FATTY ACID ELONGATION | 10 | 6.19e-01 | 9.08e-02 | 8.18e-01 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 505 | 5.20e-04 | 9.07e-02 | 1.01e-02 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 16 | 5.30e-01 | -9.06e-02 | 7.71e-01 |
| GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 6 | 7.01e-01 | -9.06e-02 | 8.63e-01 |
| GOMF URIDYLYLTRANSFERASE ACTIVITY | 7 | 6.78e-01 | -9.06e-02 | 8.51e-01 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 56 | 2.42e-01 | 9.05e-02 | 5.28e-01 |
| GOCC MITOTIC COHESIN COMPLEX | 6 | 7.01e-01 | -9.05e-02 | 8.63e-01 |
| GOBP DESMOSOME ORGANIZATION | 6 | 7.01e-01 | -9.05e-02 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 8 | 6.58e-01 | -9.05e-02 | 8.40e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 404 | 1.92e-03 | -9.04e-02 | 2.68e-02 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 7 | 6.79e-01 | -9.04e-02 | 8.51e-01 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 37 | 3.42e-01 | -9.04e-02 | 6.28e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 99 | 1.21e-01 | -9.04e-02 | 3.66e-01 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 19 | 4.96e-01 | -9.03e-02 | 7.50e-01 |
| GOCC NUCLEAR OUTER MEMBRANE | 22 | 4.63e-01 | 9.03e-02 | 7.30e-01 |
| GOBP GLIOGENESIS | 197 | 2.93e-02 | -9.03e-02 | 1.66e-01 |
| GOCC CHROMAFFIN GRANULE | 9 | 6.39e-01 | -9.02e-02 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 187 | 3.37e-02 | -9.02e-02 | 1.81e-01 |
| GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 31 | 3.85e-01 | 9.02e-02 | 6.66e-01 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 25 | 4.35e-01 | -9.02e-02 | 7.09e-01 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 7.27e-01 | -9.02e-02 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 10 | 6.21e-01 | 9.02e-02 | 8.20e-01 |
| GOMF DOPAMINE RECEPTOR BINDING | 11 | 6.05e-01 | -9.02e-02 | 8.12e-01 |
| GOBP B CELL APOPTOTIC PROCESS | 23 | 4.55e-01 | -9.01e-02 | 7.23e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 24 | 4.45e-01 | -9.01e-02 | 7.13e-01 |
| GOBP SPERM MOTILITY | 56 | 2.44e-01 | 9.01e-02 | 5.30e-01 |
| GOBP WATER TRANSPORT | 10 | 6.22e-01 | -9.00e-02 | 8.20e-01 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 7 | 6.80e-01 | 9.00e-02 | 8.51e-01 |
| GOBP APPENDAGE DEVELOPMENT | 98 | 1.24e-01 | -9.00e-02 | 3.71e-01 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 151 | 5.68e-02 | -9.00e-02 | 2.43e-01 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 15 | 5.47e-01 | 8.99e-02 | 7.81e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 4.28e-01 | 8.99e-02 | 7.04e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 67 | 2.04e-01 | -8.99e-02 | 4.84e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 6 | 7.03e-01 | -8.99e-02 | 8.64e-01 |
| GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 17 | 5.21e-01 | 8.99e-02 | 7.66e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 50 | 2.72e-01 | -8.98e-02 | 5.62e-01 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 18 | 5.10e-01 | 8.98e-02 | 7.57e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 58 | 2.37e-01 | 8.98e-02 | 5.22e-01 |
| GOMF SUMO BINDING | 16 | 5.34e-01 | 8.97e-02 | 7.74e-01 |
| GOMF RNA NUCLEASE ACTIVITY | 109 | 1.07e-01 | 8.96e-02 | 3.43e-01 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 23 | 4.57e-01 | 8.96e-02 | 7.25e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 102 | 1.19e-01 | -8.95e-02 | 3.62e-01 |
| GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 6 | 7.04e-01 | 8.95e-02 | 8.65e-01 |
| GOCC MICROVILLUS | 55 | 2.51e-01 | -8.95e-02 | 5.40e-01 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 56 | 2.47e-01 | -8.95e-02 | 5.35e-01 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 19 | 5.00e-01 | -8.94e-02 | 7.53e-01 |
| GOMF LEUCINE ZIPPER DOMAIN BINDING | 9 | 6.42e-01 | 8.94e-02 | 8.31e-01 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 10 | 6.25e-01 | -8.94e-02 | 8.20e-01 |
| GOBP RESPONSE TO CADMIUM ION | 46 | 2.95e-01 | -8.94e-02 | 5.83e-01 |
| GOBP REGULATION OF LIPID STORAGE | 41 | 3.22e-01 | -8.94e-02 | 6.10e-01 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 356 | 3.92e-03 | -8.94e-02 | 4.45e-02 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 7 | 6.83e-01 | -8.93e-02 | 8.52e-01 |
| GOBP PROTEIN AUTOUBIQUITINATION | 60 | 2.32e-01 | 8.92e-02 | 5.16e-01 |
| GOBP CERAMIDE TRANSPORT | 11 | 6.08e-01 | 8.92e-02 | 8.14e-01 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 60 | 2.32e-01 | -8.92e-02 | 5.16e-01 |
| GOBP GROWTH | 591 | 2.33e-04 | -8.92e-02 | 5.75e-03 |
| GOBP BLASTODERM SEGMENTATION | 12 | 5.93e-01 | -8.92e-02 | 8.06e-01 |
| GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 7.30e-01 | 8.92e-02 | 8.78e-01 |
| GOMF S METHYLTRANSFERASE ACTIVITY | 6 | 7.05e-01 | -8.92e-02 | 8.65e-01 |
| GOBP BEHAVIOR | 348 | 4.43e-03 | -8.91e-02 | 4.79e-02 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 74 | 1.85e-01 | -8.91e-02 | 4.60e-01 |
| GOCC APICAL JUNCTION COMPLEX | 89 | 1.47e-01 | -8.91e-02 | 4.07e-01 |
| GOBP COLLATERAL SPROUTING | 15 | 5.51e-01 | -8.89e-02 | 7.83e-01 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 19 | 5.02e-01 | 8.89e-02 | 7.54e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 36 | 3.56e-01 | -8.89e-02 | 6.43e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING KINASE ACTIVITY | 5 | 7.31e-01 | 8.88e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 343 | 4.86e-03 | -8.88e-02 | 5.03e-02 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 47 | 2.92e-01 | 8.88e-02 | 5.81e-01 |
| GOBP REPLICATIVE SENESCENCE | 13 | 5.79e-01 | -8.88e-02 | 8.00e-01 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 62 | 2.28e-01 | -8.86e-02 | 5.13e-01 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 686 | 8.62e-05 | -8.86e-02 | 2.65e-03 |
| GOBP NECROPTOTIC PROCESS | 34 | 3.72e-01 | -8.86e-02 | 6.56e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 50 | 2.79e-01 | -8.85e-02 | 5.68e-01 |
| GOMF U4 SNRNA BINDING | 6 | 7.07e-01 | -8.85e-02 | 8.67e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 5 | 7.32e-01 | -8.85e-02 | 8.79e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 540 | 4.72e-04 | -8.85e-02 | 9.43e-03 |
| GOBP DETECTION OF STIMULUS | 115 | 1.02e-01 | -8.85e-02 | 3.36e-01 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 28 | 4.18e-01 | 8.85e-02 | 6.96e-01 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 16 | 5.40e-01 | -8.84e-02 | 7.77e-01 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 160 | 5.41e-02 | 8.84e-02 | 2.37e-01 |
| GOBP XENOBIOTIC TRANSPORT | 28 | 4.18e-01 | 8.84e-02 | 6.96e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 47 | 2.95e-01 | -8.84e-02 | 5.84e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 16 | 5.41e-01 | -8.83e-02 | 7.77e-01 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 105 | 1.18e-01 | 8.83e-02 | 3.62e-01 |
| GOBP REGULATION OF MICROTUBULE NUCLEATION | 19 | 5.06e-01 | -8.82e-02 | 7.55e-01 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 41 | 3.29e-01 | -8.82e-02 | 6.15e-01 |
| GOCC POSTSYNAPTIC ENDOSOME | 10 | 6.29e-01 | 8.82e-02 | 8.24e-01 |
| GOBP DTMP METABOLIC PROCESS | 6 | 7.09e-01 | -8.81e-02 | 8.67e-01 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 23 | 4.64e-01 | 8.81e-02 | 7.30e-01 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 135 | 7.75e-02 | -8.81e-02 | 2.89e-01 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 92 | 1.44e-01 | -8.81e-02 | 4.04e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 19 | 5.06e-01 | -8.81e-02 | 7.55e-01 |
| GOBP ENDOCYTIC RECYCLING | 73 | 1.94e-01 | 8.81e-02 | 4.71e-01 |
| GOBP REGULATION OF TUBE SIZE | 66 | 2.17e-01 | -8.80e-02 | 4.99e-01 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 32 | 3.89e-01 | -8.80e-02 | 6.70e-01 |
| GOMF WNT PROTEIN BINDING | 14 | 5.69e-01 | 8.79e-02 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 18 | 5.19e-01 | 8.78e-02 | 7.63e-01 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 78 | 1.81e-01 | -8.77e-02 | 4.55e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 7.34e-01 | 8.77e-02 | 8.80e-01 |
| GOBP SULFATE TRANSPORT | 10 | 6.31e-01 | -8.77e-02 | 8.25e-01 |
| GOBP REGULATION OF SYSTEM PROCESS | 273 | 1.29e-02 | -8.77e-02 | 9.77e-02 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 6 | 7.10e-01 | -8.77e-02 | 8.68e-01 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 161 | 5.54e-02 | 8.76e-02 | 2.41e-01 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 10 | 6.32e-01 | -8.76e-02 | 8.25e-01 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 955 | 5.83e-06 | -8.76e-02 | 2.70e-04 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 36 | 3.64e-01 | -8.75e-02 | 6.49e-01 |
| GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 6.50e-01 | 8.75e-02 | 8.36e-01 |
| GOCC GTPASE COMPLEX | 26 | 4.40e-01 | 8.75e-02 | 7.11e-01 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 17 | 5.33e-01 | -8.74e-02 | 7.73e-01 |
| GOBP REPRODUCTION | 830 | 2.29e-05 | -8.74e-02 | 8.59e-04 |
| GOBP PEPTIDYL SERINE MODIFICATION | 218 | 2.66e-02 | -8.74e-02 | 1.56e-01 |
| GOBP PEPTIDYL LYSINE METHYLATION | 47 | 3.00e-01 | -8.74e-02 | 5.88e-01 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 41 | 3.34e-01 | 8.73e-02 | 6.20e-01 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 14 | 5.72e-01 | -8.73e-02 | 7.95e-01 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 89 | 1.55e-01 | -8.72e-02 | 4.18e-01 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 33 | 3.86e-01 | 8.72e-02 | 6.67e-01 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 16 | 5.46e-01 | -8.72e-02 | 7.80e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 29 | 4.17e-01 | -8.72e-02 | 6.95e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 10 | 6.33e-01 | -8.72e-02 | 8.26e-01 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 24 | 4.60e-01 | 8.72e-02 | 7.27e-01 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 14 | 5.72e-01 | -8.72e-02 | 7.96e-01 |
| GOBP ASPARAGINE METABOLIC PROCESS | 5 | 7.36e-01 | 8.72e-02 | 8.81e-01 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 55 | 2.64e-01 | -8.71e-02 | 5.54e-01 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 11 | 6.17e-01 | -8.71e-02 | 8.18e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 30 | 4.09e-01 | -8.71e-02 | 6.89e-01 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 9 | 6.51e-01 | -8.71e-02 | 8.37e-01 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 31 | 4.02e-01 | 8.71e-02 | 6.82e-01 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 234 | 2.21e-02 | -8.71e-02 | 1.38e-01 |
| GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 7 | 6.90e-01 | -8.70e-02 | 8.56e-01 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 5 | 7.36e-01 | 8.70e-02 | 8.81e-01 |
| GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR | 9 | 6.51e-01 | 8.70e-02 | 8.37e-01 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 17 | 5.35e-01 | 8.70e-02 | 7.74e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 9 | 6.52e-01 | 8.70e-02 | 8.37e-01 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 27 | 4.34e-01 | 8.69e-02 | 7.08e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 9 | 6.52e-01 | -8.69e-02 | 8.37e-01 |
| GOBP DENTATE GYRUS DEVELOPMENT | 11 | 6.18e-01 | 8.69e-02 | 8.18e-01 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 41 | 3.36e-01 | -8.69e-02 | 6.22e-01 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 13 | 5.88e-01 | 8.68e-02 | 8.04e-01 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 12 | 6.03e-01 | 8.68e-02 | 8.11e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 7 | 6.91e-01 | -8.67e-02 | 8.56e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 14 | 5.74e-01 | -8.67e-02 | 7.97e-01 |
| GOBP CHOLESTEROL STORAGE | 21 | 4.92e-01 | 8.67e-02 | 7.47e-01 |
| GOBP REGULATION OF CENTROSOME CYCLE | 48 | 2.99e-01 | -8.66e-02 | 5.87e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 10 | 6.35e-01 | 8.66e-02 | 8.27e-01 |
| GOCC CLATHRIN VESICLE COAT | 27 | 4.37e-01 | 8.65e-02 | 7.09e-01 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 9 | 6.53e-01 | -8.65e-02 | 8.37e-01 |
| GOBP ORGANELLE DISASSEMBLY | 134 | 8.42e-02 | 8.65e-02 | 3.02e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 13 | 5.89e-01 | -8.65e-02 | 8.04e-01 |
| GOMF NADP BINDING | 43 | 3.27e-01 | -8.65e-02 | 6.14e-01 |
| GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 13 | 5.89e-01 | 8.65e-02 | 8.04e-01 |
| GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN | 77 | 1.90e-01 | 8.64e-02 | 4.67e-01 |
| GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 6 | 7.14e-01 | 8.64e-02 | 8.71e-01 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 12 | 6.05e-01 | 8.63e-02 | 8.12e-01 |
| GOBP MULTICELLULAR ORGANISM REPRODUCTION | 517 | 8.54e-04 | -8.62e-02 | 1.50e-02 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 129 | 9.15e-02 | -8.62e-02 | 3.18e-01 |
| GOBP TELOMERE MAINTENANCE | 145 | 7.39e-02 | -8.61e-02 | 2.82e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 8 | 6.73e-01 | -8.61e-02 | 8.48e-01 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 32 | 4.00e-01 | -8.60e-02 | 6.80e-01 |
| GOMF DIACYLGLYCEROL BINDING | 10 | 6.38e-01 | -8.60e-02 | 8.28e-01 |
| GOBP DNA REPLICATION | 249 | 1.98e-02 | -8.60e-02 | 1.30e-01 |
| GOBP RESPONSE TO LIPID | 571 | 4.87e-04 | -8.60e-02 | 9.64e-03 |
| GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE | 6 | 7.16e-01 | -8.59e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 11 | 6.22e-01 | 8.59e-02 | 8.20e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 52 | 2.84e-01 | -8.59e-02 | 5.74e-01 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 128 | 9.45e-02 | -8.57e-02 | 3.23e-01 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 41 | 3.43e-01 | -8.57e-02 | 6.28e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 16 | 5.53e-01 | 8.57e-02 | 7.85e-01 |
| GOMF CORECEPTOR ACTIVITY | 28 | 4.33e-01 | -8.56e-02 | 7.07e-01 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 28 | 4.33e-01 | -8.56e-02 | 7.07e-01 |
| GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 6.23e-01 | 8.56e-02 | 8.20e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 17 | 5.41e-01 | -8.56e-02 | 7.77e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 9 | 6.57e-01 | 8.56e-02 | 8.39e-01 |
| GOBP SEQUESTERING OF METAL ION | 8 | 6.76e-01 | -8.55e-02 | 8.49e-01 |
| GOCC SWI SNF COMPLEX | 26 | 4.51e-01 | -8.54e-02 | 7.19e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 29 | 4.26e-01 | 8.54e-02 | 7.03e-01 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 276 | 1.49e-02 | -8.54e-02 | 1.08e-01 |
| GOBP ECTODERM DEVELOPMENT | 14 | 5.80e-01 | 8.54e-02 | 8.00e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 34 | 3.89e-01 | 8.54e-02 | 6.70e-01 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 548 | 6.80e-04 | -8.54e-02 | 1.25e-02 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 61 | 2.49e-01 | -8.54e-02 | 5.37e-01 |
| GOCC CILIARY BASE | 30 | 4.19e-01 | 8.54e-02 | 6.96e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 720 | 1.10e-04 | -8.53e-02 | 3.22e-03 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 26 | 4.51e-01 | -8.53e-02 | 7.20e-01 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 53 | 2.83e-01 | -8.53e-02 | 5.72e-01 |
| GOBP ISOPRENOID METABOLIC PROCESS | 81 | 1.85e-01 | 8.53e-02 | 4.59e-01 |
| GOBP INTRACELLULAR TRANSPORT | 1347 | 2.37e-07 | 8.53e-02 | 1.70e-05 |
| GOCC SPINDLE MICROTUBULE | 74 | 2.05e-01 | -8.53e-02 | 4.85e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 421 | 2.83e-03 | -8.53e-02 | 3.58e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 27 | 4.43e-01 | 8.52e-02 | 7.13e-01 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 10 | 6.41e-01 | 8.52e-02 | 8.30e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 6.77e-01 | 8.52e-02 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 90 | 1.63e-01 | -8.51e-02 | 4.30e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 7.42e-01 | 8.51e-02 | 8.84e-01 |
| GOBP VESICLE LOCALIZATION | 181 | 4.90e-02 | 8.50e-02 | 2.25e-01 |
| GOBP MATING BEHAVIOR | 15 | 5.69e-01 | -8.49e-02 | 7.93e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 8 | 6.78e-01 | -8.49e-02 | 8.50e-01 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 245 | 2.25e-02 | -8.49e-02 | 1.40e-01 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 51 | 2.95e-01 | 8.48e-02 | 5.84e-01 |
| GOCC NEURON TO NEURON SYNAPSE | 225 | 2.88e-02 | -8.48e-02 | 1.64e-01 |
| GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 7 | 6.98e-01 | 8.47e-02 | 8.62e-01 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 45 | 3.26e-01 | 8.47e-02 | 6.13e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 18 | 5.34e-01 | -8.47e-02 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 28 | 4.38e-01 | -8.47e-02 | 7.10e-01 |
| GOBP MONOAMINE TRANSPORT | 35 | 3.87e-01 | -8.46e-02 | 6.68e-01 |
| GOCC AXON | 390 | 4.33e-03 | -8.45e-02 | 4.71e-02 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 53 | 2.87e-01 | 8.45e-02 | 5.78e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 11 | 6.27e-01 | -8.45e-02 | 8.23e-01 |
| GOBP GLUTAMINE TRANSPORT | 7 | 6.99e-01 | -8.45e-02 | 8.62e-01 |
| GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.99e-01 | -8.45e-02 | 8.62e-01 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 952 | 1.26e-05 | -8.45e-02 | 5.16e-04 |
| GOBP CILIUM ORGANIZATION | 308 | 1.11e-02 | 8.45e-02 | 8.81e-02 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 13 | 5.98e-01 | 8.45e-02 | 8.10e-01 |
| GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 16 | 5.59e-01 | -8.44e-02 | 7.88e-01 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 178 | 5.26e-02 | -8.44e-02 | 2.34e-01 |
| GOBP REGULATION OF PLATELET ACTIVATION | 32 | 4.09e-01 | -8.44e-02 | 6.89e-01 |
| GOCC VESICLE LUMEN | 252 | 2.15e-02 | -8.43e-02 | 1.36e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 26 | 4.57e-01 | 8.43e-02 | 7.25e-01 |
| GOBP NERVE DEVELOPMENT | 46 | 3.23e-01 | -8.43e-02 | 6.10e-01 |
| GOBP RECEPTOR RECYCLING | 39 | 3.63e-01 | 8.42e-02 | 6.48e-01 |
| GOBP INSULIN METABOLIC PROCESS | 11 | 6.29e-01 | 8.42e-02 | 8.24e-01 |
| GOBP LENS FIBER CELL DEVELOPMENT | 7 | 7.00e-01 | -8.42e-02 | 8.63e-01 |
| GOBP LYMPHANGIOGENESIS | 8 | 6.80e-01 | -8.42e-02 | 8.51e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 40 | 3.57e-01 | -8.42e-02 | 6.43e-01 |
| GOMF RNA POLYMERASE BINDING | 55 | 2.80e-01 | -8.42e-02 | 5.70e-01 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 12 | 6.14e-01 | -8.42e-02 | 8.17e-01 |
| GOBP CELL MATURATION | 98 | 1.51e-01 | -8.41e-02 | 4.12e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 14 | 5.86e-01 | -8.41e-02 | 8.03e-01 |
| GOBP REGULATION OF MYOBLAST FUSION | 14 | 5.86e-01 | 8.41e-02 | 8.03e-01 |
| GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 9 | 6.62e-01 | 8.41e-02 | 8.43e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 20 | 5.16e-01 | -8.40e-02 | 7.61e-01 |
| GOBP RESPONSE TO BACTERIUM | 392 | 4.51e-03 | -8.40e-02 | 4.82e-02 |
| GOBP ADHERENS JUNCTION MAINTENANCE | 5 | 7.45e-01 | -8.39e-02 | 8.85e-01 |
| GOBP CELL JUNCTION ORGANIZATION | 417 | 3.45e-03 | -8.39e-02 | 4.05e-02 |
| GOBP CELL CYCLE | 1419 | 2.00e-07 | -8.38e-02 | 1.48e-05 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 6 | 7.22e-01 | -8.38e-02 | 8.76e-01 |
| GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 5 | 7.46e-01 | -8.38e-02 | 8.85e-01 |
| GOMF C ACETYLTRANSFERASE ACTIVITY | 7 | 7.01e-01 | 8.38e-02 | 8.63e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 21 | 5.07e-01 | 8.37e-02 | 7.55e-01 |
| GOCC ADHERENS JUNCTION | 126 | 1.05e-01 | -8.37e-02 | 3.41e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 11 | 6.31e-01 | -8.37e-02 | 8.25e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 6.31e-01 | -8.37e-02 | 8.25e-01 |
| GOBP CELL ADHESION INVOLVED IN HEART MORPHOGENESIS | 5 | 7.46e-01 | -8.36e-02 | 8.85e-01 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 38 | 3.73e-01 | -8.36e-02 | 6.56e-01 |
| GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 6.83e-01 | 8.35e-02 | 8.52e-01 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 7.47e-01 | -8.35e-02 | 8.85e-01 |
| GOBP PHAGOSOME LYSOSOME FUSION | 13 | 6.02e-01 | -8.35e-02 | 8.11e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 284 | 1.59e-02 | -8.35e-02 | 1.12e-01 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 68 | 2.35e-01 | -8.34e-02 | 5.19e-01 |
| GOBP REGULATION OF PROTEIN BINDING | 111 | 1.30e-01 | -8.34e-02 | 3.80e-01 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 4.29e-01 | 8.34e-02 | 7.05e-01 |
| GOBP TRABECULA MORPHOGENESIS | 27 | 4.53e-01 | -8.34e-02 | 7.22e-01 |
| GOBP ANIMAL ORGAN MATURATION | 17 | 5.52e-01 | -8.33e-02 | 7.84e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 37 | 3.81e-01 | -8.33e-02 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 25 | 4.71e-01 | 8.33e-02 | 7.34e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 10 | 6.49e-01 | 8.32e-02 | 8.35e-01 |
| GOBP CARNITINE METABOLIC PROCESS | 9 | 6.66e-01 | 8.32e-02 | 8.44e-01 |
| GOBP NOTCH RECEPTOR PROCESSING | 8 | 6.84e-01 | 8.32e-02 | 8.52e-01 |
| GOMF EXOGENOUS PROTEIN BINDING | 57 | 2.78e-01 | -8.31e-02 | 5.68e-01 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 10 | 6.49e-01 | -8.31e-02 | 8.35e-01 |
| GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.84e-01 | 8.31e-02 | 8.52e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 6 | 7.24e-01 | -8.31e-02 | 8.76e-01 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 32 | 4.16e-01 | -8.31e-02 | 6.94e-01 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 37 | 3.82e-01 | 8.31e-02 | 6.63e-01 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 58 | 2.74e-01 | -8.31e-02 | 5.64e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 16 | 5.65e-01 | 8.31e-02 | 7.91e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 63 | 2.55e-01 | -8.31e-02 | 5.43e-01 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 29 | 4.39e-01 | 8.31e-02 | 7.11e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 171 | 6.15e-02 | -8.30e-02 | 2.56e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 15 | 5.78e-01 | -8.30e-02 | 8.00e-01 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 19 | 5.31e-01 | 8.30e-02 | 7.72e-01 |
| GOBP VESICLE ORGANIZATION | 302 | 1.35e-02 | 8.30e-02 | 1.00e-01 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 53 | 2.97e-01 | -8.29e-02 | 5.85e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 17 | 5.54e-01 | 8.28e-02 | 7.85e-01 |
| GOBP REGULATORY NCRNA PROCESSING | 63 | 2.56e-01 | -8.28e-02 | 5.45e-01 |
| GOCC AP 3 ADAPTOR COMPLEX | 9 | 6.67e-01 | -8.28e-02 | 8.45e-01 |
| GOCC PHAGOCYTIC VESICLE | 130 | 1.04e-01 | -8.28e-02 | 3.38e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 272 | 1.92e-02 | -8.27e-02 | 1.28e-01 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 33 | 4.11e-01 | -8.27e-02 | 6.90e-01 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 517 | 1.38e-03 | -8.27e-02 | 2.15e-02 |
| GOMF TELOMERASE INHIBITOR ACTIVITY | 5 | 7.49e-01 | 8.26e-02 | 8.87e-01 |
| GOBP RESPONSE TO INTERLEUKIN 9 | 6 | 7.26e-01 | -8.26e-02 | 8.77e-01 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 6 | 7.26e-01 | -8.25e-02 | 8.77e-01 |
| GOMF DESUMOYLASE ACTIVITY | 7 | 7.05e-01 | 8.25e-02 | 8.65e-01 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 60 | 2.69e-01 | -8.25e-02 | 5.59e-01 |
| GOMF ANTIPORTER ACTIVITY | 91 | 1.74e-01 | 8.25e-02 | 4.45e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 18 | 5.45e-01 | -8.25e-02 | 7.79e-01 |
| GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 8 | 6.86e-01 | -8.24e-02 | 8.55e-01 |
| GOBP REGULATION OF VIRAL PROCESS | 132 | 1.02e-01 | -8.24e-02 | 3.37e-01 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 131 | 1.04e-01 | -8.24e-02 | 3.38e-01 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 103 | 1.49e-01 | -8.24e-02 | 4.10e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 161 | 7.17e-02 | -8.24e-02 | 2.79e-01 |
| GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 6.87e-01 | 8.23e-02 | 8.55e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 10 | 6.53e-01 | 8.22e-02 | 8.37e-01 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 69 | 2.38e-01 | 8.22e-02 | 5.24e-01 |
| GOBP RESPONSE TO IMMOBILIZATION STRESS | 14 | 5.95e-01 | -8.22e-02 | 8.07e-01 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 42 | 3.57e-01 | -8.21e-02 | 6.43e-01 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 6.08e-01 | 8.21e-02 | 8.14e-01 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 188 | 5.27e-02 | 8.21e-02 | 2.34e-01 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 26 | 4.69e-01 | -8.21e-02 | 7.33e-01 |
| GOBP GROOMING BEHAVIOR | 6 | 7.28e-01 | 8.20e-02 | 8.78e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 211 | 4.05e-02 | -8.20e-02 | 2.00e-01 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 17 | 5.58e-01 | 8.20e-02 | 7.87e-01 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 30 | 4.38e-01 | 8.19e-02 | 7.10e-01 |
| GOBP REGULATION OF RNA BINDING | 9 | 6.71e-01 | 8.19e-02 | 8.47e-01 |
| GOBP MRNA CATABOLIC PROCESS | 212 | 4.05e-02 | -8.18e-02 | 2.00e-01 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 13 | 6.10e-01 | -8.18e-02 | 8.14e-01 |
| GOBP AMIDE CATABOLIC PROCESS | 11 | 6.39e-01 | -8.17e-02 | 8.29e-01 |
| GOCC CELL BODY MEMBRANE | 13 | 6.10e-01 | -8.17e-02 | 8.14e-01 |
| GOBP ENDOSOMAL VESICLE FUSION | 12 | 6.24e-01 | 8.17e-02 | 8.20e-01 |
| GOMF CALCIUM ION BINDING | 321 | 1.22e-02 | -8.17e-02 | 9.37e-02 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 406 | 4.93e-03 | -8.17e-02 | 5.09e-02 |
| GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 8 | 6.89e-01 | -8.17e-02 | 8.56e-01 |
| GOCC ENDOCYTIC VESICLE | 258 | 2.43e-02 | -8.17e-02 | 1.47e-01 |
| GOBP REGENERATION | 113 | 1.34e-01 | -8.17e-02 | 3.87e-01 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 12 | 6.25e-01 | -8.16e-02 | 8.20e-01 |
| GOBP HEPARIN METABOLIC PROCESS | 12 | 6.25e-01 | 8.16e-02 | 8.20e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 99 | 1.61e-01 | 8.16e-02 | 4.28e-01 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 14 | 5.97e-01 | 8.15e-02 | 8.09e-01 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 10 | 6.55e-01 | -8.15e-02 | 8.38e-01 |
| GOCC PERIKARYON | 76 | 2.20e-01 | -8.15e-02 | 5.03e-01 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 22 | 5.08e-01 | 8.15e-02 | 7.56e-01 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 25 | 4.81e-01 | -8.15e-02 | 7.40e-01 |
| GOBP RESPONSE TO WATER | 8 | 6.90e-01 | -8.14e-02 | 8.56e-01 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 6 | 7.30e-01 | 8.14e-02 | 8.78e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 60 | 2.76e-01 | -8.14e-02 | 5.65e-01 |
| GOBP REGULATION OF BODY FLUID LEVELS | 210 | 4.27e-02 | -8.13e-02 | 2.08e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS | 6 | 7.30e-01 | -8.13e-02 | 8.79e-01 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 19 | 5.40e-01 | -8.13e-02 | 7.77e-01 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 189 | 5.45e-02 | -8.13e-02 | 2.38e-01 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 28 | 4.57e-01 | -8.12e-02 | 7.25e-01 |
| GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 25 | 4.82e-01 | -8.12e-02 | 7.41e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 480 | 2.45e-03 | 8.12e-02 | 3.22e-02 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 7 | 7.10e-01 | -8.12e-02 | 8.68e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 7.53e-01 | 8.12e-02 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF G0 TO G1 TRANSITION | 5 | 7.53e-01 | -8.11e-02 | 8.88e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 28 | 4.58e-01 | -8.11e-02 | 7.25e-01 |
| GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY | 5 | 7.54e-01 | -8.11e-02 | 8.88e-01 |
| GOBP SEROTONIN RECEPTOR SIGNALING PATHWAY | 5 | 7.54e-01 | -8.11e-02 | 8.88e-01 |
| GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY | 5 | 7.54e-01 | -8.11e-02 | 8.88e-01 |
| GOMF SEROTONIN RECEPTOR ACTIVITY | 5 | 7.54e-01 | -8.11e-02 | 8.88e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 5 | 7.54e-01 | 8.11e-02 | 8.88e-01 |
| GOCC GOLGI MEMBRANE | 528 | 1.55e-03 | 8.10e-02 | 2.32e-02 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 9 | 6.74e-01 | 8.10e-02 | 8.48e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 793 | 1.23e-04 | -8.09e-02 | 3.53e-03 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 8 | 6.92e-01 | 8.09e-02 | 8.57e-01 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 10 | 6.58e-01 | -8.09e-02 | 8.40e-01 |
| GOBP MEMBRANE ORGANIZATION | 639 | 5.36e-04 | 8.09e-02 | 1.03e-02 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 5 | 7.54e-01 | -8.08e-02 | 8.88e-01 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 21 | 5.22e-01 | 8.08e-02 | 7.66e-01 |
| GOBP TISSUE MIGRATION | 198 | 5.05e-02 | -8.08e-02 | 2.28e-01 |
| GOMF AMINOPEPTIDASE ACTIVITY | 34 | 4.15e-01 | -8.07e-02 | 6.94e-01 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 276 | 2.14e-02 | -8.07e-02 | 1.36e-01 |
| GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 5 | 7.55e-01 | -8.07e-02 | 8.88e-01 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 24 | 4.94e-01 | -8.07e-02 | 7.49e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 8 | 6.93e-01 | 8.07e-02 | 8.58e-01 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 189 | 5.64e-02 | -8.06e-02 | 2.42e-01 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 11 | 6.43e-01 | -8.06e-02 | 8.31e-01 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 34 | 4.16e-01 | 8.06e-02 | 6.94e-01 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 10 | 6.59e-01 | 8.06e-02 | 8.40e-01 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 25 | 4.86e-01 | 8.06e-02 | 7.43e-01 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 19 | 5.43e-01 | -8.06e-02 | 7.78e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 45 | 3.51e-01 | -8.05e-02 | 6.35e-01 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 13 | 6.15e-01 | -8.05e-02 | 8.17e-01 |
| GOMF HORMONE ACTIVITY | 26 | 4.78e-01 | 8.05e-02 | 7.39e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 5 | 7.55e-01 | -8.05e-02 | 8.89e-01 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 238 | 3.30e-02 | -8.04e-02 | 1.79e-01 |
| GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 6 | 7.33e-01 | -8.04e-02 | 8.79e-01 |
| GOBP LUNG CELL DIFFERENTIATION | 14 | 6.03e-01 | -8.03e-02 | 8.11e-01 |
| GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN | 6 | 7.33e-01 | -8.03e-02 | 8.79e-01 |
| GOCC UNCONVENTIONAL MYOSIN COMPLEX | 8 | 6.94e-01 | 8.03e-02 | 8.59e-01 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 6.94e-01 | -8.03e-02 | 8.59e-01 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 41 | 3.74e-01 | 8.02e-02 | 6.57e-01 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 25 | 4.88e-01 | 8.02e-02 | 7.45e-01 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 141 | 1.01e-01 | -8.02e-02 | 3.34e-01 |
| GOMF MUTSALPHA COMPLEX BINDING | 6 | 7.34e-01 | -8.02e-02 | 8.80e-01 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 52 | 3.18e-01 | -8.01e-02 | 6.07e-01 |
| GOMF HSP90 PROTEIN BINDING | 34 | 4.19e-01 | 8.01e-02 | 6.97e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION | 146 | 9.54e-02 | -8.01e-02 | 3.25e-01 |
| GOMF LYASE ACTIVITY | 144 | 9.77e-02 | 8.01e-02 | 3.29e-01 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 891 | 6.10e-05 | -8.00e-02 | 1.99e-03 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 66 | 2.61e-01 | 8.00e-02 | 5.51e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 582 | 1.05e-03 | -8.00e-02 | 1.76e-02 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 7.14e-01 | 7.99e-02 | 8.71e-01 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 27 | 4.73e-01 | 7.98e-02 | 7.35e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 33 | 4.28e-01 | 7.98e-02 | 7.04e-01 |
| GOBP NCRNA TRANSCRIPTION | 103 | 1.63e-01 | -7.96e-02 | 4.30e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 189 | 5.97e-02 | 7.96e-02 | 2.50e-01 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 15 | 5.94e-01 | -7.96e-02 | 8.07e-01 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 267 | 2.57e-02 | 7.96e-02 | 1.52e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 7 | 7.16e-01 | 7.94e-02 | 8.72e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 17 | 5.71e-01 | 7.94e-02 | 7.94e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR | 7 | 7.16e-01 | -7.93e-02 | 8.72e-01 |
| GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 11 | 6.49e-01 | 7.93e-02 | 8.35e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY | 10 | 6.64e-01 | 7.93e-02 | 8.43e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 81 | 2.18e-01 | -7.92e-02 | 5.01e-01 |
| GOBP DNA REPAIR | 530 | 1.95e-03 | -7.91e-02 | 2.73e-02 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 23 | 5.11e-01 | -7.91e-02 | 7.58e-01 |
| GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 9 | 6.81e-01 | 7.91e-02 | 8.52e-01 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 30 | 4.54e-01 | -7.91e-02 | 7.22e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 26 | 4.85e-01 | -7.91e-02 | 7.43e-01 |
| GOCC SECRETORY GRANULE | 610 | 9.72e-04 | -7.88e-02 | 1.65e-02 |
| GOBP RESPONSE TO STEROL DEPLETION | 15 | 5.98e-01 | 7.87e-02 | 8.09e-01 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 253 | 3.18e-02 | -7.86e-02 | 1.74e-01 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 14 | 6.11e-01 | -7.86e-02 | 8.15e-01 |
| GOCC COATED VESICLE | 240 | 3.64e-02 | 7.86e-02 | 1.89e-01 |
| GOBP GLUTAMATE METABOLIC PROCESS | 19 | 5.53e-01 | -7.86e-02 | 7.85e-01 |
| GOBP ACROSOME REACTION | 15 | 5.99e-01 | 7.85e-02 | 8.10e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 274 | 2.57e-02 | -7.85e-02 | 1.52e-01 |
| GOCC CELL CORTEX REGION | 22 | 5.24e-01 | -7.85e-02 | 7.68e-01 |
| GOCC SECRETORY GRANULE MEMBRANE | 235 | 3.87e-02 | -7.85e-02 | 1.94e-01 |
| GOMF PEPTIDASE ACTIVITY | 350 | 1.20e-02 | -7.85e-02 | 9.30e-02 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 61 | 2.90e-01 | -7.84e-02 | 5.80e-01 |
| GOCC AXON CYTOPLASM | 50 | 3.38e-01 | 7.84e-02 | 6.24e-01 |
| GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 54 | 3.20e-01 | -7.83e-02 | 6.09e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 30 | 4.58e-01 | 7.83e-02 | 7.25e-01 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 54 | 3.20e-01 | 7.82e-02 | 6.09e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING | 7 | 7.20e-01 | 7.82e-02 | 8.75e-01 |
| GOMF ACETYLCHOLINE RECEPTOR ACTIVITY | 5 | 7.62e-01 | -7.82e-02 | 8.92e-01 |
| GOBP LIPID STORAGE | 68 | 2.65e-01 | -7.82e-02 | 5.55e-01 |
| GOBP VESICLE UNCOATING | 6 | 7.40e-01 | 7.81e-02 | 8.83e-01 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 21 | 5.36e-01 | -7.81e-02 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 56 | 3.13e-01 | -7.80e-02 | 6.01e-01 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 324 | 1.62e-02 | -7.80e-02 | 1.14e-01 |
| GOBP CYTOPLASM ORGANIZATION | 12 | 6.40e-01 | 7.80e-02 | 8.30e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 39 | 4.00e-01 | -7.80e-02 | 6.80e-01 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 108 | 1.62e-01 | 7.80e-02 | 4.29e-01 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 746 | 3.29e-04 | -7.79e-02 | 7.35e-03 |
| GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 8 | 7.03e-01 | -7.79e-02 | 8.64e-01 |
| GOCC IMMUNOLOGICAL SYNAPSE | 36 | 4.19e-01 | -7.78e-02 | 6.97e-01 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 44 | 3.72e-01 | -7.78e-02 | 6.56e-01 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 29 | 4.69e-01 | -7.77e-02 | 7.33e-01 |
| GOBP POSTSYNAPSE ORGANIZATION | 119 | 1.44e-01 | -7.77e-02 | 4.03e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 31 | 4.54e-01 | -7.77e-02 | 7.23e-01 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 435 | 5.74e-03 | -7.76e-02 | 5.63e-02 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 518 | 2.66e-03 | -7.76e-02 | 3.44e-02 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 6 | 7.42e-01 | 7.76e-02 | 8.84e-01 |
| GOBP RESPONSE TO HEAT | 78 | 2.37e-01 | 7.75e-02 | 5.22e-01 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 9 | 6.87e-01 | -7.75e-02 | 8.55e-01 |
| GOBP TELOMERE ORGANIZATION | 150 | 1.02e-01 | -7.75e-02 | 3.36e-01 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 42 | 3.85e-01 | 7.75e-02 | 6.67e-01 |
| GOCC CHROMAFFIN GRANULE MEMBRANE | 7 | 7.23e-01 | 7.74e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 7 | 7.23e-01 | 7.74e-02 | 8.76e-01 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 529 | 2.47e-03 | 7.74e-02 | 3.23e-02 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 5 | 7.65e-01 | 7.73e-02 | 8.92e-01 |
| GOMF CALMODULIN BINDING | 131 | 1.27e-01 | -7.73e-02 | 3.77e-01 |
| GOBP SCHWANN CELL MIGRATION | 5 | 7.65e-01 | -7.73e-02 | 8.92e-01 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 22 | 5.31e-01 | 7.73e-02 | 7.71e-01 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 16 | 5.93e-01 | 7.72e-02 | 8.06e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 13 | 6.30e-01 | 7.72e-02 | 8.24e-01 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 9 | 6.89e-01 | 7.72e-02 | 8.56e-01 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 95 | 1.94e-01 | -7.71e-02 | 4.71e-01 |
| GOBP KETONE BODY METABOLIC PROCESS | 6 | 7.44e-01 | 7.71e-02 | 8.85e-01 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 33 | 4.43e-01 | -7.71e-02 | 7.13e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN | 5 | 7.65e-01 | -7.71e-02 | 8.92e-01 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 10 | 6.73e-01 | -7.71e-02 | 8.48e-01 |
| GOMF MRNA 5 UTR BINDING | 24 | 5.14e-01 | -7.70e-02 | 7.60e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 10 | 6.73e-01 | 7.70e-02 | 8.48e-01 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 14 | 6.18e-01 | 7.70e-02 | 8.18e-01 |
| GOBP AXONAL TRANSPORT | 52 | 3.37e-01 | 7.70e-02 | 6.24e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING | 925 | 8.73e-05 | -7.69e-02 | 2.67e-03 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 34 | 4.38e-01 | -7.69e-02 | 7.10e-01 |
| GOBP DORSAL AORTA DEVELOPMENT | 6 | 7.44e-01 | 7.69e-02 | 8.85e-01 |
| GOBP DORSAL AORTA MORPHOGENESIS | 6 | 7.44e-01 | 7.69e-02 | 8.85e-01 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 6.19e-01 | -7.69e-02 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 278 | 2.80e-02 | -7.68e-02 | 1.62e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 84 | 2.24e-01 | -7.68e-02 | 5.08e-01 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 19 | 5.63e-01 | -7.68e-02 | 7.90e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 33 | 4.46e-01 | -7.68e-02 | 7.14e-01 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 59 | 3.08e-01 | -7.67e-02 | 5.96e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 169 | 8.60e-02 | 7.67e-02 | 3.06e-01 |
| GOBP PROTEIN DEPHOSPHORYLATION | 165 | 8.98e-02 | -7.67e-02 | 3.14e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 5 | 7.67e-01 | 7.67e-02 | 8.93e-01 |
| GOBP EPITHELIAL CELL MATURATION | 15 | 6.07e-01 | -7.67e-02 | 8.13e-01 |
| GOBP CELL DIVISION | 521 | 2.91e-03 | -7.67e-02 | 3.66e-02 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 185 | 7.27e-02 | 7.67e-02 | 2.80e-01 |
| GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 6.91e-01 | -7.67e-02 | 8.56e-01 |
| GOBP NORADRENERGIC NEURON DIFFERENTIATION | 5 | 7.67e-01 | 7.66e-02 | 8.93e-01 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 16 | 5.96e-01 | -7.66e-02 | 8.08e-01 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 18 | 5.74e-01 | -7.66e-02 | 7.97e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 18 | 5.74e-01 | -7.65e-02 | 7.97e-01 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 272 | 3.03e-02 | -7.65e-02 | 1.69e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 8 | 7.08e-01 | 7.65e-02 | 8.67e-01 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 99 | 1.89e-01 | -7.65e-02 | 4.66e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 18 | 5.74e-01 | -7.65e-02 | 7.97e-01 |
| GOBP RECEPTOR METABOLIC PROCESS | 62 | 2.98e-01 | 7.64e-02 | 5.86e-01 |
| GOMF GTPASE INHIBITOR ACTIVITY | 11 | 6.61e-01 | 7.64e-02 | 8.42e-01 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 5.09e-01 | 7.64e-02 | 7.56e-01 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 39 | 4.09e-01 | 7.64e-02 | 6.89e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 6 | 7.46e-01 | -7.64e-02 | 8.85e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 10 | 6.76e-01 | 7.63e-02 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 33 | 4.48e-01 | -7.63e-02 | 7.16e-01 |
| GOCC SODIUM CHANNEL COMPLEX | 8 | 7.09e-01 | 7.63e-02 | 8.68e-01 |
| GOBP LIPID DROPLET FORMATION | 11 | 6.61e-01 | -7.63e-02 | 8.42e-01 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 10 | 6.76e-01 | 7.63e-02 | 8.49e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 119 | 1.51e-01 | 7.63e-02 | 4.12e-01 |
| GOBP ENDOSOMAL TRANSPORT | 220 | 5.18e-02 | 7.63e-02 | 2.31e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 81 | 2.36e-01 | -7.63e-02 | 5.20e-01 |
| GOBP DENDRITE EXTENSION | 23 | 5.27e-01 | -7.62e-02 | 7.69e-01 |
| GOCC MEDIATOR COMPLEX | 36 | 4.29e-01 | -7.62e-02 | 7.05e-01 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 219 | 5.28e-02 | 7.61e-02 | 2.34e-01 |
| GOBP VESICLE TETHERING | 32 | 4.56e-01 | 7.61e-02 | 7.24e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 7.09e-01 | -7.61e-02 | 8.68e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 86 | 2.23e-01 | -7.61e-02 | 5.07e-01 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 36 | 4.30e-01 | -7.61e-02 | 7.05e-01 |
| GOBP MALE MEIOSIS I | 15 | 6.10e-01 | 7.61e-02 | 8.14e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY | 529 | 2.94e-03 | 7.60e-02 | 3.68e-02 |
| GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 5 | 7.69e-01 | 7.59e-02 | 8.94e-01 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 189 | 7.24e-02 | -7.59e-02 | 2.80e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 46 | 3.73e-01 | -7.59e-02 | 6.56e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 11 | 6.63e-01 | 7.59e-02 | 8.43e-01 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 6.63e-01 | -7.59e-02 | 8.43e-01 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 491 | 4.18e-03 | -7.59e-02 | 4.59e-02 |
| GOBP CELL REDOX HOMEOSTASIS | 36 | 4.31e-01 | 7.59e-02 | 7.06e-01 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 457 | 5.68e-03 | -7.59e-02 | 5.61e-02 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 20 | 5.58e-01 | 7.58e-02 | 7.87e-01 |
| GOBP NEURONAL SIGNAL TRANSDUCTION | 5 | 7.69e-01 | -7.58e-02 | 8.94e-01 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 21 | 5.48e-01 | -7.58e-02 | 7.81e-01 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 26 | 5.04e-01 | 7.58e-02 | 7.54e-01 |
| GOBP CELLULAR RESPONSE TO PH | 14 | 6.24e-01 | -7.58e-02 | 8.20e-01 |
| GOBP INSULIN PROCESSING | 6 | 7.48e-01 | 7.58e-02 | 8.86e-01 |
| GOBP AGGRESOME ASSEMBLY | 5 | 7.69e-01 | 7.57e-02 | 8.94e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 205 | 6.23e-02 | -7.57e-02 | 2.57e-01 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 35 | 4.39e-01 | -7.57e-02 | 7.10e-01 |
| GOBP COPULATION | 7 | 7.29e-01 | 7.57e-02 | 8.78e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 8 | 7.11e-01 | 7.56e-02 | 8.69e-01 |
| GOBP PHOTOTRANSDUCTION | 17 | 5.90e-01 | 7.56e-02 | 8.04e-01 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 70 | 2.75e-01 | 7.55e-02 | 5.65e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 9 | 6.95e-01 | -7.55e-02 | 8.59e-01 |
| GOBP NATURAL KILLER CELL DEGRANULATION | 9 | 6.95e-01 | -7.55e-02 | 8.59e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 7 | 7.29e-01 | -7.55e-02 | 8.78e-01 |
| GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 7.49e-01 | -7.55e-02 | 8.87e-01 |
| GOCC DENDRITIC TREE | 361 | 1.42e-02 | -7.55e-02 | 1.04e-01 |
| GOBP PUTRESCINE METABOLIC PROCESS | 7 | 7.30e-01 | 7.54e-02 | 8.78e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 99 | 1.95e-01 | -7.54e-02 | 4.73e-01 |
| GOBP CELL CELL SIGNALING | 877 | 1.78e-04 | -7.54e-02 | 4.72e-03 |
| GOBP RESPONSE TO CYTOKINE | 632 | 1.33e-03 | -7.53e-02 | 2.09e-02 |
| GOMF TUBULIN BINDING | 293 | 2.71e-02 | -7.53e-02 | 1.58e-01 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 8 | 7.12e-01 | -7.53e-02 | 8.70e-01 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 86 | 2.28e-01 | -7.53e-02 | 5.14e-01 |
| GOBP RRNA 5 END PROCESSING | 5 | 7.71e-01 | -7.51e-02 | 8.95e-01 |
| GOBP KERATINOCYTE DEVELOPMENT | 5 | 7.71e-01 | -7.51e-02 | 8.95e-01 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 84 | 2.35e-01 | 7.51e-02 | 5.19e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 338 | 1.81e-02 | -7.51e-02 | 1.23e-01 |
| GOBP ERBB SIGNALING PATHWAY | 85 | 2.32e-01 | -7.51e-02 | 5.16e-01 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 12 | 6.53e-01 | 7.51e-02 | 8.37e-01 |
| GOBP RESPONSE TO CARBOHYDRATE | 145 | 1.20e-01 | -7.49e-02 | 3.64e-01 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 16 | 6.04e-01 | 7.49e-02 | 8.12e-01 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 70 | 2.79e-01 | 7.49e-02 | 5.68e-01 |
| GOBP ACTIN FILAMENT ORGANIZATION | 330 | 2.00e-02 | -7.48e-02 | 1.30e-01 |
| GOCC NURD COMPLEX | 15 | 6.16e-01 | -7.48e-02 | 8.17e-01 |
| GOBP PURINE RIBONUCLEOSIDE SALVAGE | 7 | 7.32e-01 | 7.48e-02 | 8.79e-01 |
| GOMF SULFOTRANSFERASE ACTIVITY | 20 | 5.63e-01 | -7.48e-02 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 16 | 6.05e-01 | 7.47e-02 | 8.12e-01 |
| GOBP MESODERM DEVELOPMENT | 64 | 3.02e-01 | -7.47e-02 | 5.90e-01 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 534 | 3.34e-03 | -7.47e-02 | 3.99e-02 |
| GOBP HEART MORPHOGENESIS | 137 | 1.32e-01 | -7.46e-02 | 3.84e-01 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 53 | 3.48e-01 | 7.46e-02 | 6.32e-01 |
| GOBP GDP METABOLIC PROCESS | 11 | 6.68e-01 | 7.46e-02 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 125 | 1.50e-01 | -7.46e-02 | 4.11e-01 |
| GOCC DENDRITE TERMINUS | 10 | 6.83e-01 | -7.46e-02 | 8.52e-01 |
| GOBP SNO S RNA PROCESSING | 12 | 6.55e-01 | 7.45e-02 | 8.38e-01 |
| GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.33e-01 | -7.45e-02 | 8.79e-01 |
| GOCC CILIUM | 454 | 6.81e-03 | 7.45e-02 | 6.34e-02 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 6 | 7.52e-01 | -7.45e-02 | 8.88e-01 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 6.18e-01 | 7.45e-02 | 8.18e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 15 | 6.18e-01 | 7.44e-02 | 8.18e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 31 | 4.74e-01 | -7.44e-02 | 7.36e-01 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 10 | 6.84e-01 | -7.44e-02 | 8.52e-01 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 13 | 6.43e-01 | -7.43e-02 | 8.31e-01 |
| GOBP RESPONSE TO TYPE III INTERFERON | 7 | 7.34e-01 | -7.43e-02 | 8.79e-01 |
| GOCC POTASSIUM CHANNEL COMPLEX | 34 | 4.54e-01 | 7.43e-02 | 7.22e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 25 | 5.21e-01 | -7.42e-02 | 7.65e-01 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 108 | 1.84e-01 | 7.42e-02 | 4.59e-01 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 251 | 4.37e-02 | -7.42e-02 | 2.11e-01 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 186 | 8.19e-02 | -7.41e-02 | 2.98e-01 |
| GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 4.82e-01 | -7.41e-02 | 7.41e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION | 247 | 4.55e-02 | -7.41e-02 | 2.16e-01 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 28 | 4.98e-01 | -7.41e-02 | 7.51e-01 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 13 | 6.44e-01 | 7.40e-02 | 8.32e-01 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 143 | 1.27e-01 | -7.40e-02 | 3.77e-01 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 7 | 7.35e-01 | 7.39e-02 | 8.80e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 7.35e-01 | 7.39e-02 | 8.80e-01 |
| GOCC PROTEIN LIPID COMPLEX | 23 | 5.40e-01 | -7.38e-02 | 7.77e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 12 | 6.58e-01 | -7.38e-02 | 8.40e-01 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 29 | 4.92e-01 | -7.38e-02 | 7.47e-01 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 472 | 6.34e-03 | 7.37e-02 | 6.03e-02 |
| GOCC MEMBRANE PROTEIN COMPLEX | 809 | 4.16e-04 | 7.37e-02 | 8.62e-03 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 21 | 5.59e-01 | -7.37e-02 | 7.88e-01 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 42 | 4.09e-01 | 7.36e-02 | 6.89e-01 |
| GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY | 6 | 7.55e-01 | -7.36e-02 | 8.88e-01 |
| GOCC FILOPODIUM | 76 | 2.68e-01 | -7.36e-02 | 5.57e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 76 | 2.68e-01 | -7.35e-02 | 5.57e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 49 | 3.74e-01 | -7.35e-02 | 6.56e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 7.55e-01 | 7.35e-02 | 8.88e-01 |
| GOBP GENOMIC IMPRINTING | 14 | 6.34e-01 | -7.35e-02 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 18 | 5.90e-01 | -7.35e-02 | 8.04e-01 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 64 | 3.10e-01 | -7.35e-02 | 5.98e-01 |
| GOBP REGULATION OF CILIUM MOVEMENT | 15 | 6.22e-01 | 7.34e-02 | 8.20e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 33 | 4.66e-01 | -7.34e-02 | 7.31e-01 |
| GOCC ORGANELLE SUBCOMPARTMENT | 1123 | 4.25e-05 | 7.34e-02 | 1.45e-03 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 27 | 5.09e-01 | -7.34e-02 | 7.57e-01 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 60 | 3.26e-01 | 7.34e-02 | 6.13e-01 |
| GOBP GAMETE GENERATION | 435 | 9.05e-03 | -7.34e-02 | 7.70e-02 |
| GOCC FILOPODIUM TIP | 14 | 6.35e-01 | -7.33e-02 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 782 | 5.53e-04 | -7.33e-02 | 1.05e-02 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 11 | 6.74e-01 | 7.33e-02 | 8.48e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 35 | 4.53e-01 | 7.33e-02 | 7.22e-01 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 16 | 6.12e-01 | -7.33e-02 | 8.16e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 25 | 5.26e-01 | 7.32e-02 | 7.69e-01 |
| GOBP REGULATION OF BINDING | 199 | 7.56e-02 | -7.32e-02 | 2.86e-01 |
| GOCC NUCLEAR STRESS GRANULE | 6 | 7.56e-01 | 7.32e-02 | 8.89e-01 |
| GOBP PROTEIN DEACETYLATION | 51 | 3.66e-01 | -7.32e-02 | 6.51e-01 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 16 | 6.13e-01 | -7.31e-02 | 8.16e-01 |
| GOBP RESPONSE TO GAMMA RADIATION | 44 | 4.01e-01 | -7.31e-02 | 6.82e-01 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 17 | 6.02e-01 | -7.31e-02 | 8.11e-01 |
| GOMF DNA DEMETHYLASE ACTIVITY | 5 | 7.77e-01 | 7.31e-02 | 8.99e-01 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 660 | 1.49e-03 | 7.30e-02 | 2.26e-02 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1322 | 1.15e-05 | 7.30e-02 | 4.79e-04 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 60 | 3.29e-01 | -7.30e-02 | 6.15e-01 |
| GOBP INTERLEUKIN 1 PRODUCTION | 80 | 2.60e-01 | -7.29e-02 | 5.50e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 15 | 6.25e-01 | -7.29e-02 | 8.21e-01 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 121 | 1.67e-01 | -7.28e-02 | 4.35e-01 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 57 | 3.42e-01 | -7.28e-02 | 6.28e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 5 | 7.78e-01 | -7.28e-02 | 8.99e-01 |
| GOMF ENDONUCLEASE ACTIVITY | 105 | 1.98e-01 | 7.28e-02 | 4.77e-01 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 10 | 6.90e-01 | 7.28e-02 | 8.56e-01 |
| GOBP REGULATION OF PROTEIN TARGETING | 68 | 3.00e-01 | 7.28e-02 | 5.87e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 22 | 5.55e-01 | 7.28e-02 | 7.85e-01 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 30 | 4.91e-01 | -7.26e-02 | 7.47e-01 |
| GOBP SYNAPSE ORGANIZATION | 250 | 4.88e-02 | -7.26e-02 | 2.25e-01 |
| GOBP REGULATION OF GLUCONEOGENESIS | 37 | 4.45e-01 | -7.25e-02 | 7.13e-01 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 104 | 2.02e-01 | -7.25e-02 | 4.81e-01 |
| GOCC SPECIFIC GRANULE | 127 | 1.59e-01 | -7.25e-02 | 4.24e-01 |
| GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 6 | 7.59e-01 | 7.25e-02 | 8.90e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 19 | 5.85e-01 | 7.25e-02 | 8.03e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 49 | 3.81e-01 | 7.24e-02 | 6.62e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 114 | 1.82e-01 | -7.24e-02 | 4.57e-01 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 288 | 3.51e-02 | -7.24e-02 | 1.84e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 9 | 7.07e-01 | -7.24e-02 | 8.67e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 7 | 7.41e-01 | -7.23e-02 | 8.83e-01 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 10 | 6.92e-01 | 7.23e-02 | 8.57e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 56 | 3.50e-01 | -7.23e-02 | 6.35e-01 |
| GOMF TELOMERIC DNA BINDING | 37 | 4.47e-01 | -7.22e-02 | 7.15e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 134 | 1.50e-01 | 7.21e-02 | 4.11e-01 |
| GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 10 | 6.93e-01 | 7.21e-02 | 8.58e-01 |
| GOBP EPITHELIUM DEVELOPMENT | 654 | 1.79e-03 | -7.21e-02 | 2.55e-02 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 8 | 7.24e-01 | -7.21e-02 | 8.76e-01 |
| GOMF DNA CLAMP LOADER ACTIVITY | 8 | 7.24e-01 | -7.21e-02 | 8.76e-01 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 16 | 6.18e-01 | -7.20e-02 | 8.18e-01 |
| GOBP DNA METABOLIC PROCESS | 863 | 3.79e-04 | -7.20e-02 | 8.01e-03 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 64 | 3.20e-01 | 7.20e-02 | 6.09e-01 |
| GOBP NUCLEAR BODY ORGANIZATION | 14 | 6.42e-01 | 7.18e-02 | 8.31e-01 |
| GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 7 | 7.42e-01 | -7.18e-02 | 8.84e-01 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.42e-01 | -7.18e-02 | 8.84e-01 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 14 | 6.42e-01 | -7.18e-02 | 8.31e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 6.94e-01 | 7.18e-02 | 8.59e-01 |
| GOBP HAIR CELL DIFFERENTIATION | 28 | 5.11e-01 | -7.18e-02 | 7.58e-01 |
| GOMF STEROL BINDING | 43 | 4.16e-01 | -7.18e-02 | 6.94e-01 |
| GOBP POSITIVE REGULATION OF DNA DEMETHYLATION | 6 | 7.61e-01 | -7.18e-02 | 8.91e-01 |
| GOBP DIGESTION | 48 | 3.90e-01 | -7.17e-02 | 6.71e-01 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 7 | 7.43e-01 | -7.17e-02 | 8.85e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 91 | 2.39e-01 | -7.16e-02 | 5.24e-01 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 242 | 5.59e-02 | -7.16e-02 | 2.41e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 98 | 2.21e-01 | -7.15e-02 | 5.05e-01 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 13 | 6.55e-01 | -7.15e-02 | 8.38e-01 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 638 | 2.22e-03 | 7.15e-02 | 3.03e-02 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 25 | 5.36e-01 | -7.15e-02 | 7.75e-01 |
| GOBP MICROTUBULE BASED TRANSPORT | 165 | 1.14e-01 | 7.14e-02 | 3.55e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 11 | 6.82e-01 | -7.14e-02 | 8.52e-01 |
| GOMF DOUBLE STRANDED RNA BINDING | 64 | 3.24e-01 | -7.13e-02 | 6.11e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 166 | 1.14e-01 | -7.13e-02 | 3.54e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 286 | 3.86e-02 | -7.13e-02 | 1.94e-01 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 20 | 5.81e-01 | 7.12e-02 | 8.01e-01 |
| GOBP MAMMARY GLAND DEVELOPMENT | 75 | 2.87e-01 | -7.12e-02 | 5.77e-01 |
| GOBP TYPE I INTERFERON PRODUCTION | 108 | 2.02e-01 | -7.12e-02 | 4.81e-01 |
| GOBP DIOL METABOLIC PROCESS | 23 | 5.55e-01 | 7.12e-02 | 7.85e-01 |
| GOBP LOCOMOTORY BEHAVIOR | 107 | 2.04e-01 | -7.11e-02 | 4.85e-01 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 29 | 5.08e-01 | 7.11e-02 | 7.56e-01 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 39 | 4.43e-01 | 7.11e-02 | 7.13e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 9 | 7.12e-01 | -7.10e-02 | 8.70e-01 |
| GOBP REGULATION OF BONE REMODELING | 33 | 4.81e-01 | -7.10e-02 | 7.40e-01 |
| GOBP HEXOSE CATABOLIC PROCESS | 31 | 4.94e-01 | 7.10e-02 | 7.49e-01 |
| GOBP SEMICIRCULAR CANAL DEVELOPMENT | 5 | 7.84e-01 | 7.10e-02 | 9.03e-01 |
| GOBP RESPONSE TO RADIATION | 318 | 3.02e-02 | -7.09e-02 | 1.69e-01 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 9 | 7.13e-01 | -7.09e-02 | 8.70e-01 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 53 | 3.72e-01 | -7.09e-02 | 6.56e-01 |
| GOBP L AMINO ACID TRANSPORT | 56 | 3.59e-01 | -7.09e-02 | 6.45e-01 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 29 | 5.09e-01 | -7.08e-02 | 7.56e-01 |
| GOBP BODY FLUID SECRETION | 49 | 3.92e-01 | 7.08e-02 | 6.72e-01 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 12 | 6.72e-01 | -7.07e-02 | 8.48e-01 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 49 | 3.93e-01 | -7.06e-02 | 6.73e-01 |
| GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS | 5 | 7.85e-01 | -7.06e-02 | 9.03e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 8 | 7.30e-01 | -7.05e-02 | 8.78e-01 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 46 | 4.08e-01 | -7.05e-02 | 6.88e-01 |
| GOBP POTASSIUM ION HOMEOSTASIS | 17 | 6.15e-01 | -7.05e-02 | 8.17e-01 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 30 | 5.04e-01 | -7.05e-02 | 7.54e-01 |
| GOMF NUCLEASE ACTIVITY | 181 | 1.03e-01 | 7.04e-02 | 3.37e-01 |
| GOCC TORC1 COMPLEX | 6 | 7.65e-01 | -7.04e-02 | 8.92e-01 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 51 | 3.85e-01 | -7.04e-02 | 6.66e-01 |
| GOBP CUT CATABOLIC PROCESS | 5 | 7.85e-01 | 7.04e-02 | 9.03e-01 |
| GOBP KYNURENINE METABOLIC PROCESS | 9 | 7.15e-01 | -7.03e-02 | 8.72e-01 |
| GOCC MEMBRANE COAT | 85 | 2.63e-01 | 7.03e-02 | 5.53e-01 |
| GOBP SYNAPTIC VESICLE CLUSTERING | 7 | 7.47e-01 | 7.03e-02 | 8.85e-01 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 191 | 9.44e-02 | -7.03e-02 | 3.23e-01 |
| GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 7.85e-01 | -7.03e-02 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 8 | 7.31e-01 | -7.03e-02 | 8.79e-01 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 17 | 6.16e-01 | -7.02e-02 | 8.17e-01 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 20 | 5.87e-01 | -7.02e-02 | 8.04e-01 |
| GOMF MONOCARBOXYLIC ACID BINDING | 44 | 4.21e-01 | -7.02e-02 | 6.98e-01 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 6.74e-01 | 7.02e-02 | 8.48e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 20 | 5.87e-01 | -7.01e-02 | 8.04e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 77 | 2.88e-01 | 7.01e-02 | 5.78e-01 |
| GOBP RESPONSE TO SORBITOL | 6 | 7.66e-01 | 7.00e-02 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 8 | 7.32e-01 | 7.00e-02 | 8.79e-01 |
| GOCC SPECIFIC GRANULE MEMBRANE | 75 | 2.95e-01 | -7.00e-02 | 5.84e-01 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 31 | 5.01e-01 | -6.99e-02 | 7.53e-01 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 23 | 5.62e-01 | 6.99e-02 | 7.90e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 64 | 3.34e-01 | -6.99e-02 | 6.20e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 22 | 5.71e-01 | -6.99e-02 | 7.94e-01 |
| GOCC SPINDLE | 368 | 2.20e-02 | -6.98e-02 | 1.38e-01 |
| GOCC RNA POLYMERASE I COMPLEX | 10 | 7.02e-01 | 6.98e-02 | 8.64e-01 |
| GOBP ER OVERLOAD RESPONSE | 11 | 6.89e-01 | 6.98e-02 | 8.56e-01 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 24 | 5.54e-01 | -6.98e-02 | 7.85e-01 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 10 | 7.02e-01 | -6.98e-02 | 8.64e-01 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 14 | 6.51e-01 | -6.98e-02 | 8.37e-01 |
| GOMF ENZYME INHIBITOR ACTIVITY | 233 | 6.73e-02 | -6.98e-02 | 2.69e-01 |
| GOMF CHEMOATTRACTANT ACTIVITY | 14 | 6.51e-01 | 6.97e-02 | 8.37e-01 |
| GOBP MYOSIN FILAMENT ORGANIZATION | 5 | 7.87e-01 | -6.97e-02 | 9.04e-01 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 6 | 7.68e-01 | -6.97e-02 | 8.93e-01 |
| GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.50e-01 | 6.97e-02 | 8.87e-01 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 243 | 6.22e-02 | 6.97e-02 | 2.57e-01 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 42 | 4.35e-01 | -6.96e-02 | 7.09e-01 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 466 | 1.04e-02 | 6.96e-02 | 8.52e-02 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 13 | 6.64e-01 | 6.96e-02 | 8.43e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 7.50e-01 | 6.96e-02 | 8.87e-01 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.50e-01 | -6.96e-02 | 8.87e-01 |
| GOBP SENSORY ORGAN DEVELOPMENT | 280 | 4.58e-02 | -6.96e-02 | 2.16e-01 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 43 | 4.30e-01 | -6.96e-02 | 7.05e-01 |
| GOBP RESPONSE TO OXYGEN RADICAL | 19 | 6.00e-01 | 6.95e-02 | 8.10e-01 |
| GOCC SARCOPLASMIC RETICULUM | 42 | 4.36e-01 | -6.95e-02 | 7.09e-01 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 38 | 4.59e-01 | 6.95e-02 | 7.25e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 13 | 6.64e-01 | 6.95e-02 | 8.43e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 14 | 6.53e-01 | -6.95e-02 | 8.37e-01 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 11 | 6.90e-01 | -6.95e-02 | 8.56e-01 |
| GOBP NK T CELL PROLIFERATION | 8 | 7.34e-01 | -6.95e-02 | 8.80e-01 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 24 | 5.56e-01 | -6.94e-02 | 7.86e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 16 | 6.31e-01 | 6.93e-02 | 8.25e-01 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 109 | 2.12e-01 | 6.93e-02 | 4.94e-01 |
| GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 7 | 7.51e-01 | 6.93e-02 | 8.87e-01 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 12 | 6.78e-01 | -6.93e-02 | 8.50e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY | 8 | 7.34e-01 | -6.93e-02 | 8.80e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 678 | 2.29e-03 | -6.93e-02 | 3.09e-02 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 15 | 6.43e-01 | 6.92e-02 | 8.31e-01 |
| GOBP NUCLEOPHAGY | 18 | 6.11e-01 | 6.92e-02 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 16 | 6.32e-01 | 6.92e-02 | 8.25e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 6 | 7.69e-01 | 6.92e-02 | 8.94e-01 |
| GOCC MEMBRANE MICRODOMAIN | 191 | 1.01e-01 | -6.91e-02 | 3.34e-01 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 49 | 4.04e-01 | 6.90e-02 | 6.83e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 150 | 1.45e-01 | 6.90e-02 | 4.05e-01 |
| GOMF LIGASE ACTIVITY | 125 | 1.84e-01 | 6.89e-02 | 4.59e-01 |
| GOMF G QUADRUPLEX DNA BINDING | 11 | 6.93e-01 | 6.89e-02 | 8.57e-01 |
| GOBP DOSAGE COMPENSATION | 30 | 5.14e-01 | -6.89e-02 | 7.60e-01 |
| GOBP DNA CATABOLIC PROCESS | 24 | 5.59e-01 | 6.88e-02 | 7.88e-01 |
| GOBP APICAL JUNCTION ASSEMBLY | 44 | 4.30e-01 | -6.88e-02 | 7.05e-01 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 23 | 5.68e-01 | -6.88e-02 | 7.93e-01 |
| GOBP KETONE CATABOLIC PROCESS | 11 | 6.93e-01 | 6.88e-02 | 8.58e-01 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 19 | 6.04e-01 | 6.88e-02 | 8.12e-01 |
| GOMF ADRENERGIC RECEPTOR BINDING | 10 | 7.07e-01 | 6.87e-02 | 8.67e-01 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 35 | 4.82e-01 | -6.87e-02 | 7.41e-01 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 64 | 3.43e-01 | -6.86e-02 | 6.28e-01 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 23 | 5.69e-01 | 6.86e-02 | 7.93e-01 |
| GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 6 | 7.71e-01 | 6.86e-02 | 8.95e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 409 | 1.80e-02 | -6.85e-02 | 1.22e-01 |
| GOCC SIDE OF MEMBRANE | 395 | 2.00e-02 | -6.85e-02 | 1.30e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 38 | 4.65e-01 | 6.85e-02 | 7.31e-01 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 44 | 4.32e-01 | 6.85e-02 | 7.06e-01 |
| GOBP SULFATION | 8 | 7.37e-01 | -6.84e-02 | 8.82e-01 |
| GOMF SODIUM CHANNEL INHIBITOR ACTIVITY | 5 | 7.91e-01 | 6.84e-02 | 9.06e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 9 | 7.23e-01 | -6.84e-02 | 8.76e-01 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 125 | 1.88e-01 | 6.83e-02 | 4.64e-01 |
| GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 9 | 7.23e-01 | -6.83e-02 | 8.76e-01 |
| GOBP SENSORY PERCEPTION OF TASTE | 13 | 6.70e-01 | 6.83e-02 | 8.47e-01 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 183 | 1.12e-01 | 6.83e-02 | 3.51e-01 |
| GOBP PARTURITION | 6 | 7.72e-01 | -6.83e-02 | 8.95e-01 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 146 | 1.55e-01 | -6.82e-02 | 4.18e-01 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 34 | 4.92e-01 | -6.82e-02 | 7.47e-01 |
| GOBP REGULATION OF CELLULAR PH REDUCTION | 5 | 7.92e-01 | -6.82e-02 | 9.07e-01 |
| GOMF ACTIN FILAMENT BINDING | 145 | 1.57e-01 | -6.81e-02 | 4.21e-01 |
| GOMF CELL ADHESION MOLECULE BINDING | 385 | 2.23e-02 | -6.81e-02 | 1.39e-01 |
| GOBP ICOSANOID METABOLIC PROCESS | 61 | 3.58e-01 | 6.81e-02 | 6.44e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 240 | 7.03e-02 | -6.80e-02 | 2.76e-01 |
| GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.73e-01 | 6.80e-02 | 8.96e-01 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 24 | 5.64e-01 | -6.80e-02 | 7.91e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 23 | 5.73e-01 | 6.79e-02 | 7.96e-01 |
| GOBP RESPONSE TO MONOSACCHARIDE | 125 | 1.90e-01 | -6.79e-02 | 4.67e-01 |
| GOBP AXIS SPECIFICATION | 45 | 4.31e-01 | -6.79e-02 | 7.06e-01 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 9 | 7.25e-01 | 6.78e-02 | 8.76e-01 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 8 | 7.40e-01 | -6.78e-02 | 8.83e-01 |
| GOBP REGULATION OF CELL MATURATION | 11 | 6.97e-01 | -6.78e-02 | 8.61e-01 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 40 | 4.59e-01 | -6.78e-02 | 7.25e-01 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 174 | 1.24e-01 | -6.77e-02 | 3.71e-01 |
| GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 5 | 7.93e-01 | -6.77e-02 | 9.07e-01 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 82 | 2.90e-01 | 6.77e-02 | 5.80e-01 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 9 | 7.25e-01 | 6.77e-02 | 8.77e-01 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 9 | 7.25e-01 | 6.77e-02 | 8.77e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 24 | 5.66e-01 | 6.76e-02 | 7.92e-01 |
| GOBP KILLING BY HOST OF SYMBIONT CELLS | 8 | 7.41e-01 | -6.76e-02 | 8.83e-01 |
| GOBP REGULATION OF GROWTH | 390 | 2.26e-02 | -6.75e-02 | 1.40e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 42 | 4.49e-01 | 6.75e-02 | 7.17e-01 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 16 | 6.40e-01 | -6.75e-02 | 8.30e-01 |
| GOCC NUCLEAR REPLICATION FORK | 29 | 5.29e-01 | -6.75e-02 | 7.70e-01 |
| GOCC ACTIN FILAMENT BUNDLE | 58 | 3.75e-01 | 6.74e-02 | 6.57e-01 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 31 | 5.16e-01 | -6.74e-02 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 21 | 5.93e-01 | -6.74e-02 | 8.06e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 14 | 6.63e-01 | 6.73e-02 | 8.43e-01 |
| GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 7 | 7.58e-01 | 6.72e-02 | 8.90e-01 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 17 | 6.32e-01 | -6.72e-02 | 8.25e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 86 | 2.82e-01 | -6.71e-02 | 5.72e-01 |
| GOCC CELL PROJECTION MEMBRANE | 221 | 8.63e-02 | -6.71e-02 | 3.06e-01 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 13 | 6.75e-01 | 6.71e-02 | 8.49e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 6 | 7.76e-01 | -6.71e-02 | 8.98e-01 |
| GOCC CELL CELL JUNCTION | 297 | 4.76e-02 | -6.71e-02 | 2.22e-01 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 13 | 6.76e-01 | 6.70e-02 | 8.49e-01 |
| GOBP TRANSEPITHELIAL TRANSPORT | 17 | 6.32e-01 | 6.70e-02 | 8.26e-01 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 61 | 3.66e-01 | 6.70e-02 | 6.51e-01 |
| GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT | 5 | 7.95e-01 | -6.70e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 5 | 7.95e-01 | -6.70e-02 | 9.08e-01 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 5 | 7.95e-01 | -6.70e-02 | 9.08e-01 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 655 | 3.73e-03 | 6.69e-02 | 4.30e-02 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 9 | 7.28e-01 | 6.69e-02 | 8.78e-01 |
| GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS | 107 | 2.33e-01 | 6.69e-02 | 5.16e-01 |
| GOBP AMELOGENESIS | 14 | 6.65e-01 | -6.68e-02 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 112 | 2.23e-01 | 6.68e-02 | 5.07e-01 |
| GOBP REPRODUCTIVE BEHAVIOR | 19 | 6.15e-01 | -6.67e-02 | 8.17e-01 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 14 | 6.66e-01 | -6.67e-02 | 8.44e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 20 | 6.06e-01 | -6.67e-02 | 8.13e-01 |
| GOBP RESPONSE TO LIGHT INTENSITY | 12 | 6.89e-01 | 6.66e-02 | 8.56e-01 |
| GOBP INTERLEUKIN 18 PRODUCTION | 10 | 7.15e-01 | -6.66e-02 | 8.72e-01 |
| GOCC BRUSH BORDER MEMBRANE | 30 | 5.28e-01 | -6.66e-02 | 7.69e-01 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 8 | 7.44e-01 | -6.66e-02 | 8.85e-01 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 89 | 2.78e-01 | 6.66e-02 | 5.68e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 37 | 4.84e-01 | 6.65e-02 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 11 | 7.02e-01 | 6.65e-02 | 8.64e-01 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 15 | 6.56e-01 | 6.65e-02 | 8.38e-01 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 68 | 3.43e-01 | -6.65e-02 | 6.28e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 19 | 6.16e-01 | 6.65e-02 | 8.17e-01 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 387 | 2.54e-02 | -6.65e-02 | 1.51e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 5.90e-01 | 6.65e-02 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 15 | 6.56e-01 | 6.64e-02 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 16 | 6.46e-01 | -6.64e-02 | 8.33e-01 |
| GOBP MACROMOLECULE DEACYLATION | 62 | 3.66e-01 | -6.64e-02 | 6.51e-01 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 92 | 2.72e-01 | -6.64e-02 | 5.62e-01 |
| GOBP REGULATION OF LYASE ACTIVITY | 24 | 5.74e-01 | 6.63e-02 | 7.97e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 39 | 4.74e-01 | -6.63e-02 | 7.36e-01 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 21 | 5.99e-01 | -6.63e-02 | 8.10e-01 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 720 | 2.66e-03 | -6.63e-02 | 3.44e-02 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 7 | 7.61e-01 | 6.63e-02 | 8.92e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 24 | 5.75e-01 | 6.62e-02 | 7.97e-01 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 16 | 6.47e-01 | 6.62e-02 | 8.34e-01 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 17 | 6.37e-01 | -6.62e-02 | 8.28e-01 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 11 | 7.04e-01 | 6.62e-02 | 8.65e-01 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 16 | 6.48e-01 | 6.60e-02 | 8.34e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 7.98e-01 | 6.60e-02 | 9.10e-01 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 9 | 7.32e-01 | 6.60e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 53 | 4.06e-01 | -6.60e-02 | 6.86e-01 |
| GOBP AMINE METABOLIC PROCESS | 65 | 3.58e-01 | 6.59e-02 | 6.44e-01 |
| GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 8 | 7.47e-01 | 6.59e-02 | 8.85e-01 |
| GOBP PONS DEVELOPMENT | 7 | 7.63e-01 | -6.58e-02 | 8.92e-01 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 49 | 4.26e-01 | 6.57e-02 | 7.03e-01 |
| GOBP REGULATION OF RESPONSE TO STRESS | 1071 | 3.35e-04 | -6.57e-02 | 7.43e-03 |
| GOCC BOX C D RNP COMPLEX | 5 | 7.99e-01 | -6.57e-02 | 9.10e-01 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 47 | 4.37e-01 | -6.56e-02 | 7.09e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 119 | 2.17e-01 | -6.56e-02 | 5.00e-01 |
| GOBP OUTER EAR MORPHOGENESIS | 5 | 8.00e-01 | -6.56e-02 | 9.10e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 19 | 6.21e-01 | 6.55e-02 | 8.20e-01 |
| GOCC ESCRT I COMPLEX | 10 | 7.20e-01 | 6.55e-02 | 8.74e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 7 | 7.64e-01 | -6.55e-02 | 8.92e-01 |
| GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 7 | 7.64e-01 | -6.55e-02 | 8.92e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 65 | 3.61e-01 | 6.55e-02 | 6.47e-01 |
| GOBP MYOTUBE CELL DEVELOPMENT | 23 | 5.87e-01 | 6.54e-02 | 8.04e-01 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 32 | 5.22e-01 | -6.54e-02 | 7.66e-01 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 143 | 1.78e-01 | -6.54e-02 | 4.51e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 15 | 6.61e-01 | -6.53e-02 | 8.42e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 17 | 6.41e-01 | 6.53e-02 | 8.30e-01 |
| GOBP MEMBRANE INVAGINATION | 55 | 4.02e-01 | -6.53e-02 | 6.82e-01 |
| GOMF FOLIC ACID BINDING | 10 | 7.21e-01 | 6.53e-02 | 8.75e-01 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 26 | 5.65e-01 | 6.53e-02 | 7.91e-01 |
| GOMF CYTOKINE BINDING | 80 | 3.13e-01 | -6.53e-02 | 6.01e-01 |
| GOBP CELLULAR RESPONSE TO CAFFEINE | 7 | 7.65e-01 | 6.53e-02 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 14 | 6.73e-01 | 6.52e-02 | 8.48e-01 |
| GOBP MRNA METHYLATION | 18 | 6.32e-01 | -6.52e-02 | 8.25e-01 |
| GOBP IRON IMPORT INTO CELL | 5 | 8.01e-01 | -6.52e-02 | 9.11e-01 |
| GOCC CLEAVAGE FURROW | 46 | 4.45e-01 | -6.52e-02 | 7.13e-01 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 295 | 5.51e-02 | -6.51e-02 | 2.40e-01 |
| GOMF NOTCH BINDING | 16 | 6.53e-01 | -6.50e-02 | 8.37e-01 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 20 | 6.15e-01 | -6.50e-02 | 8.17e-01 |
| GOBP CARDIAC CONDUCTION | 47 | 4.41e-01 | 6.50e-02 | 7.12e-01 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 30 | 5.38e-01 | 6.49e-02 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 9 | 7.36e-01 | -6.49e-02 | 8.81e-01 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 32 | 5.25e-01 | -6.49e-02 | 7.68e-01 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 26 | 5.67e-01 | -6.49e-02 | 7.92e-01 |
| GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 10 | 7.22e-01 | 6.49e-02 | 8.76e-01 |
| GOBP PATTERN SPECIFICATION PROCESS | 215 | 1.02e-01 | -6.49e-02 | 3.36e-01 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 17 | 6.43e-01 | -6.49e-02 | 8.31e-01 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 9 | 7.36e-01 | -6.49e-02 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 151 | 1.70e-01 | -6.48e-02 | 4.39e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 20 | 6.16e-01 | -6.48e-02 | 8.17e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 16 | 6.54e-01 | -6.47e-02 | 8.38e-01 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 7.67e-01 | -6.47e-02 | 8.93e-01 |
| GOBP RESPONSE TO DOPAMINE | 31 | 5.33e-01 | -6.47e-02 | 7.73e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 117 | 2.28e-01 | -6.46e-02 | 5.14e-01 |
| GOBP RESPONSE TO AMINE | 24 | 5.84e-01 | -6.45e-02 | 8.03e-01 |
| GOBP REGULATION OF CELL CYCLE | 861 | 1.47e-03 | -6.45e-02 | 2.25e-02 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 315 | 4.99e-02 | -6.45e-02 | 2.27e-01 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 142 | 1.86e-01 | -6.45e-02 | 4.60e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 27 | 5.62e-01 | -6.44e-02 | 7.90e-01 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 14 | 6.76e-01 | -6.44e-02 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 78 | 3.26e-01 | -6.44e-02 | 6.13e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION | 6 | 7.85e-01 | 6.44e-02 | 9.03e-01 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 32 | 5.29e-01 | -6.44e-02 | 7.69e-01 |
| GOBP AXIS ELONGATION | 9 | 7.38e-01 | 6.44e-02 | 8.82e-01 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 31 | 5.36e-01 | -6.43e-02 | 7.74e-01 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 36 | 5.05e-01 | 6.43e-02 | 7.54e-01 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 206 | 1.12e-01 | -6.43e-02 | 3.52e-01 |
| GOBP LYMPH VESSEL DEVELOPMENT | 14 | 6.77e-01 | 6.43e-02 | 8.50e-01 |
| GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 8.03e-01 | 6.43e-02 | 9.12e-01 |
| GOCC SECRETORY VESICLE | 712 | 3.76e-03 | -6.43e-02 | 4.33e-02 |
| GOBP MOTOR BEHAVIOR | 16 | 6.56e-01 | -6.42e-02 | 8.39e-01 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 15 | 6.67e-01 | -6.42e-02 | 8.45e-01 |
| GOBP FLUID TRANSPORT | 16 | 6.57e-01 | 6.42e-02 | 8.39e-01 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 84 | 3.10e-01 | -6.41e-02 | 5.99e-01 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 25 | 5.79e-01 | -6.41e-02 | 8.00e-01 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 23 | 5.95e-01 | -6.41e-02 | 8.08e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 8 | 7.54e-01 | -6.40e-02 | 8.88e-01 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 36 | 5.07e-01 | 6.40e-02 | 7.55e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 34 | 5.19e-01 | 6.40e-02 | 7.63e-01 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 303 | 5.63e-02 | -6.40e-02 | 2.42e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 7 | 7.69e-01 | 6.40e-02 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 33 | 5.25e-01 | -6.40e-02 | 7.68e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 8 | 7.54e-01 | 6.39e-02 | 8.88e-01 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 14 | 6.79e-01 | -6.39e-02 | 8.51e-01 |
| GOBP RETICULOPHAGY | 17 | 6.48e-01 | 6.39e-02 | 8.35e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 27 | 5.66e-01 | -6.38e-02 | 7.92e-01 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 30 | 5.45e-01 | -6.38e-02 | 7.80e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 203 | 1.18e-01 | -6.38e-02 | 3.61e-01 |
| GOMF DEATH RECEPTOR ACTIVITY | 9 | 7.40e-01 | 6.38e-02 | 8.83e-01 |
| GOBP CALCIUM MEDIATED SIGNALING | 119 | 2.30e-01 | -6.38e-02 | 5.15e-01 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 735 | 3.52e-03 | 6.38e-02 | 4.11e-02 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 84 | 3.13e-01 | -6.37e-02 | 6.01e-01 |
| GOMF DIOXYGENASE ACTIVITY | 75 | 3.41e-01 | -6.37e-02 | 6.27e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 20 | 6.22e-01 | 6.36e-02 | 8.20e-01 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 42 | 4.76e-01 | -6.36e-02 | 7.38e-01 |
| GOBP TISSUE MORPHOGENESIS | 341 | 4.45e-02 | -6.36e-02 | 2.13e-01 |
| GOBP POSITIVE REGULATION OF CELL MATURATION | 6 | 7.88e-01 | 6.35e-02 | 9.05e-01 |
| GOBP NEURON PROJECTION REGENERATION | 37 | 5.04e-01 | -6.35e-02 | 7.54e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 17 | 6.51e-01 | 6.34e-02 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 14 | 6.82e-01 | 6.33e-02 | 8.52e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 52 | 4.30e-01 | -6.32e-02 | 7.05e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 382 | 3.46e-02 | 6.32e-02 | 1.83e-01 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 779 | 2.94e-03 | 6.32e-02 | 3.68e-02 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 7.57e-01 | -6.32e-02 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 6 | 7.89e-01 | -6.31e-02 | 9.05e-01 |
| GOCC COSTAMERE | 14 | 6.83e-01 | 6.31e-02 | 8.52e-01 |
| GOCC FICOLIN 1 RICH GRANULE | 170 | 1.57e-01 | -6.31e-02 | 4.20e-01 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 47 | 4.55e-01 | 6.30e-02 | 7.23e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 73 | 3.52e-01 | 6.30e-02 | 6.38e-01 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 38 | 5.02e-01 | 6.30e-02 | 7.54e-01 |
| GOBP CELL PROJECTION ORGANIZATION | 1033 | 7.31e-04 | -6.29e-02 | 1.32e-02 |
| GOBP SYNAPTIC SIGNALING | 379 | 3.63e-02 | -6.29e-02 | 1.88e-01 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 98 | 2.82e-01 | -6.29e-02 | 5.72e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 9 | 7.44e-01 | 6.29e-02 | 8.85e-01 |
| GOBP MONOCYTE CHEMOTAXIS | 34 | 5.26e-01 | 6.29e-02 | 7.69e-01 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 37 | 5.09e-01 | -6.28e-02 | 7.56e-01 |
| GOBP FEAR RESPONSE | 24 | 5.94e-01 | -6.28e-02 | 8.07e-01 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 210 | 1.18e-01 | 6.28e-02 | 3.61e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 13 | 6.95e-01 | -6.28e-02 | 8.59e-01 |
| GOBP OUTER DYNEIN ARM ASSEMBLY | 7 | 7.74e-01 | 6.27e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 13 | 6.96e-01 | -6.27e-02 | 8.59e-01 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 63 | 3.90e-01 | -6.27e-02 | 6.71e-01 |
| GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 5 | 8.08e-01 | -6.27e-02 | 9.14e-01 |
| GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 6 | 7.90e-01 | -6.27e-02 | 9.06e-01 |
| GOBP REGULATION OF FIBRINOLYSIS | 8 | 7.59e-01 | 6.26e-02 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 30 | 5.53e-01 | 6.26e-02 | 7.85e-01 |
| GOCC VESICLE TETHERING COMPLEX | 52 | 4.36e-01 | 6.25e-02 | 7.09e-01 |
| GOMF ACYL COA OXIDASE ACTIVITY | 5 | 8.09e-01 | 6.25e-02 | 9.15e-01 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 33 | 5.34e-01 | 6.25e-02 | 7.74e-01 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 23 | 6.04e-01 | 6.24e-02 | 8.12e-01 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 773 | 3.43e-03 | -6.24e-02 | 4.04e-02 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 66 | 3.81e-01 | -6.24e-02 | 6.62e-01 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 24 | 5.97e-01 | -6.24e-02 | 8.09e-01 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 43 | 4.79e-01 | -6.24e-02 | 7.40e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON BETA | 19 | 6.38e-01 | 6.24e-02 | 8.28e-01 |
| GOBP DETOXIFICATION | 97 | 2.89e-01 | 6.24e-02 | 5.79e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 27 | 5.75e-01 | -6.24e-02 | 7.97e-01 |
| GOBP REGULATION OF PROTEIN MATURATION | 47 | 4.60e-01 | 6.23e-02 | 7.27e-01 |
| GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 7.75e-01 | -6.23e-02 | 8.98e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 21 | 6.21e-01 | 6.23e-02 | 8.20e-01 |
| GOCC SAGA COMPLEX | 23 | 6.05e-01 | 6.23e-02 | 8.12e-01 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 15 | 6.76e-01 | -6.23e-02 | 8.49e-01 |
| GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 11 | 7.21e-01 | 6.23e-02 | 8.75e-01 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 61 | 4.01e-01 | 6.23e-02 | 6.81e-01 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 41 | 4.91e-01 | -6.23e-02 | 7.47e-01 |
| GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY | 9 | 7.47e-01 | 6.22e-02 | 8.85e-01 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 34 | 5.30e-01 | -6.22e-02 | 7.71e-01 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 103 | 2.76e-01 | -6.22e-02 | 5.66e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 16 | 6.67e-01 | -6.22e-02 | 8.45e-01 |
| GOBP POSTSYNAPSE ASSEMBLY | 17 | 6.58e-01 | 6.21e-02 | 8.40e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 9 | 7.47e-01 | -6.21e-02 | 8.85e-01 |
| GOBP TRANSITION METAL ION TRANSPORT | 69 | 3.73e-01 | 6.21e-02 | 6.56e-01 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 85 | 3.23e-01 | -6.21e-02 | 6.10e-01 |
| GOBP REGULATION OF CYTOKINESIS | 73 | 3.60e-01 | -6.21e-02 | 6.45e-01 |
| GOBP GOLGI LUMEN ACIDIFICATION | 13 | 6.99e-01 | 6.21e-02 | 8.62e-01 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 21 | 6.23e-01 | 6.20e-02 | 8.20e-01 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 18 | 6.49e-01 | -6.20e-02 | 8.35e-01 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 250 | 9.23e-02 | -6.20e-02 | 3.19e-01 |
| GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 6 | 7.93e-01 | 6.20e-02 | 9.07e-01 |
| GOBP AUTOPHAGIC CELL DEATH | 9 | 7.47e-01 | -6.20e-02 | 8.85e-01 |
| GOBP TOXIN METABOLIC PROCESS | 6 | 7.93e-01 | -6.19e-02 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 39 | 5.04e-01 | 6.19e-02 | 7.54e-01 |
| GOBP DETECTION OF ABIOTIC STIMULUS | 67 | 3.82e-01 | -6.18e-02 | 6.63e-01 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 28 | 5.71e-01 | -6.18e-02 | 7.95e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 11 | 7.23e-01 | -6.18e-02 | 8.76e-01 |
| GOCC CENTRIOLAR SATELLITE | 94 | 3.01e-01 | -6.18e-02 | 5.89e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 29 | 5.65e-01 | -6.18e-02 | 7.91e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 15 | 6.79e-01 | 6.17e-02 | 8.51e-01 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 188 | 1.45e-01 | -6.17e-02 | 4.05e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 62 | 4.02e-01 | 6.16e-02 | 6.82e-01 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 6.90e-01 | 6.15e-02 | 8.56e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 28 | 5.74e-01 | -6.15e-02 | 7.97e-01 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 48 | 4.62e-01 | -6.15e-02 | 7.28e-01 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 142 | 2.07e-01 | -6.15e-02 | 4.88e-01 |
| GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 10 | 7.37e-01 | 6.14e-02 | 8.81e-01 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 42 | 4.92e-01 | 6.13e-02 | 7.47e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 8 | 7.64e-01 | -6.13e-02 | 8.92e-01 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 7 | 7.79e-01 | -6.12e-02 | 9.00e-01 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 46 | 4.73e-01 | 6.12e-02 | 7.35e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 13 | 7.02e-01 | -6.12e-02 | 8.64e-01 |
| GOCC MULTIVESICULAR BODY | 44 | 4.83e-01 | 6.12e-02 | 7.41e-01 |
| GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 9 | 7.51e-01 | -6.12e-02 | 8.87e-01 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 69 | 3.80e-01 | -6.12e-02 | 6.62e-01 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 12 | 7.14e-01 | 6.11e-02 | 8.71e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 5 | 8.13e-01 | 6.11e-02 | 9.17e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME | 5 | 8.13e-01 | -6.11e-02 | 9.17e-01 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 255 | 9.41e-02 | -6.11e-02 | 3.23e-01 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 77 | 3.55e-01 | 6.10e-02 | 6.42e-01 |
| GOCC POSTSYNAPSE | 382 | 4.16e-02 | -6.10e-02 | 2.04e-01 |
| GOCC CDC73 PAF1 COMPLEX | 6 | 7.96e-01 | -6.10e-02 | 9.09e-01 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 90 | 3.18e-01 | 6.09e-02 | 6.07e-01 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 22 | 6.21e-01 | -6.09e-02 | 8.20e-01 |
| GOBP ADULT BEHAVIOR | 77 | 3.57e-01 | -6.08e-02 | 6.43e-01 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 26 | 5.92e-01 | -6.08e-02 | 8.06e-01 |
| GOBP SEROTONIN TRANSPORT | 9 | 7.52e-01 | 6.07e-02 | 8.88e-01 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 12 | 7.16e-01 | 6.07e-02 | 8.72e-01 |
| GOMF CARBOHYDRATE BINDING | 147 | 2.05e-01 | -6.07e-02 | 4.85e-01 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 12 | 7.16e-01 | -6.07e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 7.97e-01 | -6.05e-02 | 9.10e-01 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 33 | 5.47e-01 | -6.05e-02 | 7.81e-01 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 8 | 7.67e-01 | -6.05e-02 | 8.93e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE | 43 | 4.93e-01 | -6.05e-02 | 7.48e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 38 | 5.19e-01 | -6.05e-02 | 7.63e-01 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 12 | 7.17e-01 | -6.04e-02 | 8.73e-01 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 550 | 1.61e-02 | -6.04e-02 | 1.13e-01 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 6 | 7.98e-01 | 6.04e-02 | 9.10e-01 |
| GOBP MACROAUTOPHAGY | 307 | 6.99e-02 | 6.04e-02 | 2.75e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 353 | 5.25e-02 | -6.03e-02 | 2.34e-01 |
| GOBP DEVELOPMENTAL CELL GROWTH | 146 | 2.09e-01 | -6.03e-02 | 4.91e-01 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 33 | 5.49e-01 | -6.03e-02 | 7.82e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 6 | 7.98e-01 | 6.03e-02 | 9.10e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 10 | 7.42e-01 | 6.02e-02 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 20 | 6.41e-01 | -6.02e-02 | 8.30e-01 |
| GOBP STEM CELL DIVISION | 21 | 6.33e-01 | 6.01e-02 | 8.26e-01 |
| GOBP NEURAL TUBE DEVELOPMENT | 115 | 2.67e-01 | -6.00e-02 | 5.57e-01 |
| GOMF PEROXIREDOXIN ACTIVITY | 8 | 7.69e-01 | 6.00e-02 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 86 | 3.38e-01 | -5.99e-02 | 6.24e-01 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 688 | 7.96e-03 | -5.98e-02 | 7.05e-02 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 9 | 7.56e-01 | 5.98e-02 | 8.89e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 13 | 7.09e-01 | 5.97e-02 | 8.68e-01 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 11 | 7.32e-01 | -5.97e-02 | 8.79e-01 |
| GOMF ALDEHYDE LYASE ACTIVITY | 6 | 8.00e-01 | -5.97e-02 | 9.10e-01 |
| GOCC CD40 RECEPTOR COMPLEX | 11 | 7.32e-01 | -5.97e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 20 | 6.45e-01 | 5.96e-02 | 8.32e-01 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 11 | 7.32e-01 | 5.96e-02 | 8.79e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 120 | 2.61e-01 | -5.96e-02 | 5.50e-01 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 11 | 7.32e-01 | 5.95e-02 | 8.79e-01 |
| GOBP PRO B CELL DIFFERENTIATION | 10 | 7.45e-01 | -5.95e-02 | 8.85e-01 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 6.21e-01 | 5.95e-02 | 8.20e-01 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 37 | 5.32e-01 | -5.94e-02 | 7.72e-01 |
| GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 8 | 7.71e-01 | 5.94e-02 | 8.95e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 21 | 6.38e-01 | -5.93e-02 | 8.28e-01 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 74 | 3.78e-01 | 5.93e-02 | 6.60e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 8.01e-01 | 5.93e-02 | 9.11e-01 |
| GOMF MYOSIN BINDING | 44 | 4.96e-01 | 5.93e-02 | 7.51e-01 |
| GOBP BONE MATURATION | 15 | 6.91e-01 | -5.93e-02 | 8.56e-01 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 56 | 4.44e-01 | 5.92e-02 | 7.13e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 48 | 4.79e-01 | -5.91e-02 | 7.40e-01 |
| GOMF PROTEIN KINASE A BINDING | 37 | 5.34e-01 | -5.91e-02 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 28 | 5.89e-01 | 5.90e-02 | 8.04e-01 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 10 | 7.47e-01 | 5.90e-02 | 8.85e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 80 | 3.63e-01 | -5.89e-02 | 6.48e-01 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 507 | 2.41e-02 | -5.89e-02 | 1.46e-01 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 16 | 6.84e-01 | 5.89e-02 | 8.52e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 48 | 4.81e-01 | -5.88e-02 | 7.40e-01 |
| GOBP REGULATION OF BLOOD PRESSURE | 88 | 3.41e-01 | -5.88e-02 | 6.27e-01 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1263 | 5.41e-04 | -5.88e-02 | 1.03e-02 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 19 | 6.57e-01 | 5.88e-02 | 8.39e-01 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 71 | 3.93e-01 | -5.87e-02 | 6.73e-01 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 24 | 6.19e-01 | -5.87e-02 | 8.18e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 7 | 7.88e-01 | 5.86e-02 | 9.05e-01 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 129 | 2.51e-01 | -5.86e-02 | 5.40e-01 |
| GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 7.74e-01 | -5.86e-02 | 8.97e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY | 7 | 7.89e-01 | -5.85e-02 | 9.05e-01 |
| GOBP ACTION POTENTIAL | 74 | 3.85e-01 | 5.85e-02 | 6.66e-01 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 14 | 7.05e-01 | -5.85e-02 | 8.65e-01 |
| GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 10 | 7.49e-01 | 5.85e-02 | 8.87e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION CENTROMERIC | 5 | 8.21e-01 | -5.85e-02 | 9.22e-01 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 42 | 5.12e-01 | -5.84e-02 | 7.59e-01 |
| GOMF IRON ION BINDING | 75 | 3.82e-01 | 5.84e-02 | 6.64e-01 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 21 | 6.43e-01 | 5.84e-02 | 8.31e-01 |
| GOBP VACUOLAR ACIDIFICATION | 32 | 5.68e-01 | 5.84e-02 | 7.93e-01 |
| GOBP NEURONAL ION CHANNEL CLUSTERING | 8 | 7.75e-01 | -5.84e-02 | 8.98e-01 |
| GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY | 5 | 8.21e-01 | -5.83e-02 | 9.22e-01 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 78 | 3.73e-01 | 5.83e-02 | 6.56e-01 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 45 | 4.99e-01 | -5.83e-02 | 7.52e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING | 59 | 4.39e-01 | -5.83e-02 | 7.11e-01 |
| GOCC PRP19 COMPLEX | 12 | 7.27e-01 | -5.83e-02 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 595 | 1.60e-02 | -5.82e-02 | 1.13e-01 |
| GOMF ZINC ION BINDING | 580 | 1.74e-02 | -5.82e-02 | 1.19e-01 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 32 | 5.69e-01 | 5.82e-02 | 7.93e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 18 | 6.69e-01 | 5.81e-02 | 8.47e-01 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 142 | 2.33e-01 | 5.81e-02 | 5.16e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 30 | 5.82e-01 | 5.81e-02 | 8.01e-01 |
| GOBP REGULATION OF MICROTUBULE BINDING | 6 | 8.06e-01 | -5.80e-02 | 9.13e-01 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 10 | 7.51e-01 | 5.80e-02 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 34 | 5.58e-01 | -5.80e-02 | 7.87e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 22 | 6.38e-01 | -5.80e-02 | 8.28e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 9 | 7.63e-01 | 5.80e-02 | 8.92e-01 |
| GOBP DIGESTIVE SYSTEM PROCESS | 45 | 5.01e-01 | -5.79e-02 | 7.54e-01 |
| GOMF ATP DEPENDENT ACTIVITY | 443 | 3.76e-02 | -5.79e-02 | 1.91e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 104 | 3.08e-01 | 5.79e-02 | 5.96e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 40 | 5.27e-01 | 5.79e-02 | 7.69e-01 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 1039 | 1.84e-03 | -5.79e-02 | 2.60e-02 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 14 | 7.08e-01 | -5.79e-02 | 8.67e-01 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 23 | 6.31e-01 | 5.79e-02 | 8.25e-01 |
| GOBP GOLGI ORGANIZATION | 129 | 2.58e-01 | 5.78e-02 | 5.47e-01 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 5 | 8.23e-01 | -5.78e-02 | 9.22e-01 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 18 | 6.72e-01 | -5.77e-02 | 8.48e-01 |
| GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY | 49 | 4.85e-01 | -5.76e-02 | 7.43e-01 |
| GOBP T CELL LINEAGE COMMITMENT | 21 | 6.48e-01 | -5.76e-02 | 8.34e-01 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 23 | 6.33e-01 | 5.76e-02 | 8.26e-01 |
| GOCC PLATELET ALPHA GRANULE MEMBRANE | 13 | 7.19e-01 | 5.76e-02 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 398 | 5.00e-02 | -5.75e-02 | 2.27e-01 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 45 | 5.05e-01 | 5.75e-02 | 7.54e-01 |
| GOBP ENDODERMAL CELL FATE COMMITMENT | 7 | 7.92e-01 | -5.75e-02 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 9 | 7.65e-01 | -5.75e-02 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 24 | 6.26e-01 | -5.74e-02 | 8.22e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 23 | 6.34e-01 | -5.74e-02 | 8.26e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 6 | 8.08e-01 | -5.74e-02 | 9.14e-01 |
| GOCC CELL DIVISION SITE | 63 | 4.32e-01 | -5.73e-02 | 7.06e-01 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 110 | 2.99e-01 | -5.73e-02 | 5.87e-01 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 156 | 2.18e-01 | 5.73e-02 | 5.01e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 5 | 8.25e-01 | -5.73e-02 | 9.23e-01 |
| GOBP DNA DAMAGE RESPONSE | 773 | 7.28e-03 | -5.73e-02 | 6.62e-02 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 26 | 6.13e-01 | 5.73e-02 | 8.17e-01 |
| GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 7 | 7.93e-01 | -5.72e-02 | 9.07e-01 |
| GOCC CUTICULAR PLATE | 5 | 8.25e-01 | 5.72e-02 | 9.23e-01 |
| GOBP P BODY ASSEMBLY | 21 | 6.50e-01 | -5.72e-02 | 8.37e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 14 | 7.11e-01 | 5.72e-02 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION | 5 | 8.25e-01 | -5.71e-02 | 9.23e-01 |
| GOMF MICROTUBULE SEVERING ATPASE ACTIVITY | 5 | 8.25e-01 | -5.71e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 39 | 5.38e-01 | -5.71e-02 | 7.76e-01 |
| GOMF PHOSPHOPROTEIN BINDING | 76 | 3.90e-01 | -5.70e-02 | 6.71e-01 |
| GOCC NUCLEAR PERIPHERY | 134 | 2.55e-01 | -5.70e-02 | 5.44e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 62 | 4.38e-01 | -5.70e-02 | 7.10e-01 |
| GOCC PHOSPHATASE COMPLEX | 46 | 5.04e-01 | 5.70e-02 | 7.54e-01 |
| GOBP XENOPHAGY | 13 | 7.22e-01 | -5.70e-02 | 8.76e-01 |
| GOCC GABA ERGIC SYNAPSE | 23 | 6.36e-01 | 5.70e-02 | 8.28e-01 |
| GOCC CAVEOLA | 51 | 4.82e-01 | -5.69e-02 | 7.41e-01 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 213 | 1.53e-01 | -5.69e-02 | 4.15e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 24 | 6.30e-01 | -5.69e-02 | 8.24e-01 |
| GOBP DEPHOSPHORYLATION | 238 | 1.32e-01 | -5.69e-02 | 3.84e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 15 | 7.03e-01 | -5.69e-02 | 8.64e-01 |
| GOBP RNA EXPORT FROM NUCLEUS | 82 | 3.74e-01 | -5.68e-02 | 6.57e-01 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 9 | 7.68e-01 | -5.68e-02 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 11 | 7.44e-01 | -5.68e-02 | 8.85e-01 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 55 | 4.67e-01 | -5.68e-02 | 7.32e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 17 | 6.85e-01 | 5.67e-02 | 8.54e-01 |
| GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS | 6 | 8.10e-01 | 5.67e-02 | 9.15e-01 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 28 | 6.04e-01 | 5.67e-02 | 8.12e-01 |
| GOCC PLASMA MEMBRANE REGION | 726 | 9.89e-03 | -5.67e-02 | 8.17e-02 |
| GOCC CELL BODY | 318 | 8.36e-02 | -5.66e-02 | 3.01e-01 |
| GOBP RESPONSE TO ISCHEMIA | 44 | 5.16e-01 | -5.66e-02 | 7.61e-01 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 58 | 4.56e-01 | -5.66e-02 | 7.24e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 47 | 5.02e-01 | 5.66e-02 | 7.54e-01 |
| GOBP AGGREPHAGY | 8 | 7.82e-01 | 5.65e-02 | 9.02e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 51 | 4.86e-01 | 5.65e-02 | 7.43e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 96 | 3.40e-01 | 5.64e-02 | 6.26e-01 |
| GOCC SARCOPLASM | 56 | 4.65e-01 | -5.64e-02 | 7.31e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 47 | 5.04e-01 | -5.64e-02 | 7.54e-01 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 10 | 7.58e-01 | 5.63e-02 | 8.90e-01 |
| GOBP SCHWANN CELL DEVELOPMENT | 22 | 6.48e-01 | -5.63e-02 | 8.34e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 9 | 7.70e-01 | -5.63e-02 | 8.94e-01 |
| GOCC SOMATODENDRITIC COMPARTMENT | 483 | 3.52e-02 | -5.63e-02 | 1.85e-01 |
| GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 8.28e-01 | 5.63e-02 | 9.24e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 362 | 6.73e-02 | -5.62e-02 | 2.69e-01 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 29 | 6.00e-01 | -5.62e-02 | 8.10e-01 |
| GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 5 | 8.28e-01 | -5.62e-02 | 9.24e-01 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 8 | 7.83e-01 | -5.62e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 10 | 7.59e-01 | 5.61e-02 | 8.90e-01 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 91 | 3.56e-01 | 5.61e-02 | 6.42e-01 |
| GOBP LYSOSOMAL TRANSPORT | 114 | 3.02e-01 | 5.61e-02 | 5.90e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSPORT | 31 | 5.89e-01 | 5.61e-02 | 8.04e-01 |
| GOBP LYMPH NODE DEVELOPMENT | 12 | 7.37e-01 | 5.60e-02 | 8.81e-01 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 31 | 5.90e-01 | 5.59e-02 | 8.05e-01 |
| GOBP INNATE IMMUNE RESPONSE | 631 | 1.73e-02 | -5.59e-02 | 1.19e-01 |
| GOCC COHESIN COMPLEX | 8 | 7.84e-01 | 5.59e-02 | 9.03e-01 |
| GOBP RNA SPLICING | 402 | 5.55e-02 | -5.59e-02 | 2.41e-01 |
| GOMF ACTININ BINDING | 19 | 6.73e-01 | -5.59e-02 | 8.48e-01 |
| GOCC CILIARY BASAL BODY | 136 | 2.61e-01 | 5.59e-02 | 5.51e-01 |
| GOBP SEXUAL REPRODUCTION | 600 | 2.03e-02 | -5.59e-02 | 1.32e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 732 | 1.08e-02 | -5.58e-02 | 8.70e-02 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 49 | 4.99e-01 | -5.58e-02 | 7.53e-01 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 39 | 5.47e-01 | -5.57e-02 | 7.81e-01 |
| GOBP IRON ION TRANSPORT | 39 | 5.47e-01 | 5.57e-02 | 7.81e-01 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 98 | 3.42e-01 | -5.56e-02 | 6.28e-01 |
| GOMF CHEMOKINE RECEPTOR BINDING | 24 | 6.37e-01 | 5.56e-02 | 8.28e-01 |
| GOBP SPROUTING ANGIOGENESIS | 70 | 4.21e-01 | 5.56e-02 | 6.98e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 22 | 6.52e-01 | 5.56e-02 | 8.37e-01 |
| GOBP CYTOSOLIC TRANSPORT | 167 | 2.16e-01 | 5.56e-02 | 4.99e-01 |
| GOCC GOLGI TRANS CISTERNA | 9 | 7.73e-01 | -5.56e-02 | 8.96e-01 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 11 | 7.50e-01 | 5.55e-02 | 8.87e-01 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 13 | 7.29e-01 | 5.54e-02 | 8.78e-01 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 73 | 4.13e-01 | -5.54e-02 | 6.92e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 68 | 4.30e-01 | -5.54e-02 | 7.05e-01 |
| GOBP REGULATION OF AXON GUIDANCE | 6 | 8.14e-01 | -5.54e-02 | 9.17e-01 |
| GOMF FRIZZLED BINDING | 12 | 7.40e-01 | 5.54e-02 | 8.83e-01 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 20 | 6.68e-01 | 5.53e-02 | 8.46e-01 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 42 | 5.36e-01 | 5.52e-02 | 7.74e-01 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 80 | 3.94e-01 | 5.52e-02 | 6.74e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 7 | 8.00e-01 | -5.52e-02 | 9.11e-01 |
| GOCC PRESYNAPTIC CYTOSOL | 11 | 7.51e-01 | 5.52e-02 | 8.87e-01 |
| GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 121 | 2.95e-01 | -5.52e-02 | 5.84e-01 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 159 | 2.31e-01 | -5.51e-02 | 5.15e-01 |
| GOCC NEURON PROJECTION | 763 | 1.02e-02 | -5.51e-02 | 8.40e-02 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 25 | 6.34e-01 | -5.51e-02 | 8.26e-01 |
| GOCC ASTER | 9 | 7.75e-01 | 5.51e-02 | 8.98e-01 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 86 | 3.78e-01 | -5.50e-02 | 6.60e-01 |
| GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 7.88e-01 | 5.50e-02 | 9.05e-01 |
| GOMF C C CHEMOKINE BINDING | 7 | 8.01e-01 | -5.50e-02 | 9.11e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 100 | 3.43e-01 | -5.50e-02 | 6.28e-01 |
| GOMF PROTEIN SELF ASSOCIATION | 52 | 4.94e-01 | -5.49e-02 | 7.49e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 13 | 7.32e-01 | 5.49e-02 | 8.79e-01 |
| GOBP OXALATE TRANSPORT | 5 | 8.32e-01 | -5.48e-02 | 9.27e-01 |
| GOMF ARYLSULFATASE ACTIVITY | 8 | 7.88e-01 | 5.48e-02 | 9.05e-01 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 38 | 5.59e-01 | 5.48e-02 | 7.88e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1117 | 2.32e-03 | -5.47e-02 | 3.11e-02 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 50 | 5.03e-01 | 5.47e-02 | 7.54e-01 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 20 | 6.72e-01 | 5.47e-02 | 8.48e-01 |
| GOBP REGULATION OF LIPID TRANSPORT | 83 | 3.89e-01 | 5.47e-02 | 6.70e-01 |
| GOBP NUCLEAR PORE LOCALIZATION | 5 | 8.32e-01 | -5.47e-02 | 9.27e-01 |
| GOBP FIBROBLAST ACTIVATION | 10 | 7.65e-01 | -5.46e-02 | 8.92e-01 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 73 | 4.20e-01 | -5.46e-02 | 6.98e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 14 | 7.24e-01 | -5.46e-02 | 8.76e-01 |
| GOMF PHOSPHOLIPASE A1 ACTIVITY | 10 | 7.65e-01 | -5.46e-02 | 8.92e-01 |
| GOBP MRNA PROCESSING | 430 | 5.36e-02 | -5.46e-02 | 2.36e-01 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 171 | 2.20e-01 | 5.45e-02 | 5.03e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 11 | 7.54e-01 | 5.45e-02 | 8.88e-01 |
| GOMF DYNEIN COMPLEX BINDING | 19 | 6.81e-01 | -5.44e-02 | 8.52e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 32 | 5.94e-01 | 5.44e-02 | 8.07e-01 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 335 | 8.86e-02 | -5.43e-02 | 3.11e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 23 | 6.52e-01 | -5.43e-02 | 8.37e-01 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 366 | 7.59e-02 | -5.43e-02 | 2.87e-01 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 57 | 4.80e-01 | 5.42e-02 | 7.40e-01 |
| GOBP RENAL SYSTEM PROCESS | 53 | 4.96e-01 | -5.41e-02 | 7.50e-01 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 38 | 5.64e-01 | -5.41e-02 | 7.91e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 19 | 6.83e-01 | -5.40e-02 | 8.52e-01 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 316 | 9.99e-02 | 5.40e-02 | 3.33e-01 |
| GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 6 | 8.19e-01 | -5.40e-02 | 9.21e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 260 | 1.35e-01 | -5.40e-02 | 3.88e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 13 | 7.36e-01 | -5.40e-02 | 8.81e-01 |
| GOCC INTERCALATED DISC | 34 | 5.86e-01 | -5.40e-02 | 8.03e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 55 | 4.89e-01 | -5.39e-02 | 7.47e-01 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 21 | 6.69e-01 | -5.39e-02 | 8.46e-01 |
| GOMF GUANYLYLTRANSFERASE ACTIVITY | 7 | 8.06e-01 | -5.37e-02 | 9.13e-01 |
| GOBP SODIUM ION TRANSPORT | 110 | 3.31e-01 | 5.37e-02 | 6.16e-01 |
| GOMF DNA NUCLEASE ACTIVITY | 55 | 4.91e-01 | 5.37e-02 | 7.47e-01 |
| GOCC A BAND | 22 | 6.63e-01 | 5.37e-02 | 8.43e-01 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 8.35e-01 | -5.37e-02 | 9.28e-01 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 16 | 7.10e-01 | -5.36e-02 | 8.68e-01 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING | 10 | 7.69e-01 | -5.36e-02 | 8.94e-01 |
| GOCC PSEUDOPODIUM | 13 | 7.38e-01 | -5.36e-02 | 8.82e-01 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 25 | 6.43e-01 | -5.35e-02 | 8.31e-01 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 416 | 6.23e-02 | 5.35e-02 | 2.57e-01 |
| GOBP NERVOUS SYSTEM PROCESS | 522 | 3.79e-02 | -5.34e-02 | 1.93e-01 |
| GOCC SEPTIN CYTOSKELETON | 13 | 7.39e-01 | 5.34e-02 | 8.83e-01 |
| GOCC MICROVILLUS MEMBRANE | 18 | 6.95e-01 | 5.34e-02 | 8.59e-01 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 7.81e-01 | -5.34e-02 | 9.02e-01 |
| GOBP MUSCLE CELL DIFFERENTIATION | 235 | 1.60e-01 | -5.33e-02 | 4.26e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 257 | 1.43e-01 | -5.32e-02 | 4.03e-01 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 54 | 5.00e-01 | -5.32e-02 | 7.53e-01 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 78 | 4.17e-01 | -5.32e-02 | 6.96e-01 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 154 | 2.56e-01 | -5.31e-02 | 5.45e-01 |
| GOBP LIPID PHOSPHORYLATION | 9 | 7.83e-01 | -5.31e-02 | 9.02e-01 |
| GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 9 | 7.83e-01 | -5.31e-02 | 9.02e-01 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 40 | 5.62e-01 | -5.31e-02 | 7.90e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 29 | 6.21e-01 | 5.31e-02 | 8.20e-01 |
| GOCC BASAL PART OF CELL | 186 | 2.13e-01 | -5.31e-02 | 4.96e-01 |
| GOBP GLYCOSIDE CATABOLIC PROCESS | 7 | 8.08e-01 | 5.31e-02 | 9.14e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 56 | 4.93e-01 | 5.30e-02 | 7.48e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS | 7 | 8.08e-01 | 5.30e-02 | 9.14e-01 |
| GOMF GROWTH FACTOR ACTIVITY | 55 | 4.97e-01 | 5.30e-02 | 7.51e-01 |
| GOBP PLATELET DEGRANULATION | 6 | 8.22e-01 | 5.29e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 36 | 5.83e-01 | -5.29e-02 | 8.01e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 10 | 7.72e-01 | 5.29e-02 | 8.95e-01 |
| GOBP MYOBLAST FUSION | 26 | 6.41e-01 | 5.29e-02 | 8.30e-01 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 15 | 7.23e-01 | 5.29e-02 | 8.76e-01 |
| GOBP LIPID CATABOLIC PROCESS | 213 | 1.84e-01 | 5.29e-02 | 4.59e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 9 | 7.84e-01 | 5.29e-02 | 9.03e-01 |
| GOMF MANGANESE ION BINDING | 53 | 5.06e-01 | -5.28e-02 | 7.55e-01 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 46 | 5.36e-01 | -5.28e-02 | 7.74e-01 |
| GOCC CATALYTIC COMPLEX | 1498 | 8.04e-04 | 5.28e-02 | 1.43e-02 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 43 | 5.50e-01 | -5.27e-02 | 7.82e-01 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 14 | 7.33e-01 | 5.27e-02 | 8.79e-01 |
| GOBP RECEPTOR CATABOLIC PROCESS | 24 | 6.55e-01 | 5.27e-02 | 8.38e-01 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 21 | 6.76e-01 | 5.27e-02 | 8.49e-01 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 32 | 6.06e-01 | -5.27e-02 | 8.13e-01 |
| GOMF DNA METHYLTRANSFERASE ACTIVITY | 5 | 8.39e-01 | 5.26e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 31 | 6.12e-01 | -5.26e-02 | 8.16e-01 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 17 | 7.07e-01 | -5.26e-02 | 8.67e-01 |
| GOBP INCLUSION BODY ASSEMBLY | 20 | 6.84e-01 | 5.26e-02 | 8.52e-01 |
| GOCC AXONEMAL DYNEIN COMPLEX | 9 | 7.85e-01 | -5.26e-02 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF GROWTH | 159 | 2.54e-01 | -5.26e-02 | 5.42e-01 |
| GOBP BLOOD VESSEL MATURATION | 6 | 8.24e-01 | 5.25e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 5 | 8.39e-01 | 5.25e-02 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 9 | 7.85e-01 | 5.25e-02 | 9.03e-01 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 41 | 5.61e-01 | 5.25e-02 | 7.90e-01 |
| GOBP SKIN DEVELOPMENT | 144 | 2.78e-01 | -5.25e-02 | 5.68e-01 |
| GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.10e-01 | -5.24e-02 | 9.15e-01 |
| GOBP T CELL EXTRAVASATION | 11 | 7.63e-01 | -5.24e-02 | 8.92e-01 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 11 | 7.64e-01 | 5.24e-02 | 8.92e-01 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 257 | 1.50e-01 | 5.23e-02 | 4.11e-01 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 82 | 4.14e-01 | -5.22e-02 | 6.92e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 6 | 8.25e-01 | 5.22e-02 | 9.23e-01 |
| GOBP RESPONSE TO MAGNESIUM ION | 10 | 7.75e-01 | 5.22e-02 | 8.98e-01 |
| GOBP REGULATION OF CELL SIZE | 134 | 2.97e-01 | -5.22e-02 | 5.85e-01 |
| GOMF CLATHRIN BINDING | 49 | 5.28e-01 | -5.22e-02 | 7.69e-01 |
| GOBP RETINAL ROD CELL DEVELOPMENT | 5 | 8.40e-01 | -5.22e-02 | 9.30e-01 |
| GOBP PEPTIDE TRANSPORT | 147 | 2.76e-01 | -5.22e-02 | 5.65e-01 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 75 | 4.35e-01 | -5.22e-02 | 7.09e-01 |
| GOBP RESPONSE TO LEAD ION | 16 | 7.18e-01 | 5.21e-02 | 8.74e-01 |
| GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 66 | 4.64e-01 | -5.21e-02 | 7.30e-01 |
| GOBP LYSOSOMAL MICROAUTOPHAGY | 13 | 7.45e-01 | -5.21e-02 | 8.85e-01 |
| GOBP REGULATION OF SREBP SIGNALING PATHWAY | 6 | 8.25e-01 | -5.21e-02 | 9.23e-01 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 17 | 7.10e-01 | 5.21e-02 | 8.68e-01 |
| GOBP GOLGI LOCALIZATION | 13 | 7.45e-01 | -5.20e-02 | 8.85e-01 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 44 | 5.51e-01 | -5.20e-02 | 7.82e-01 |
| GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE | 6 | 8.25e-01 | 5.20e-02 | 9.23e-01 |
| GOBP STEROL HOMEOSTASIS | 50 | 5.25e-01 | 5.20e-02 | 7.68e-01 |
| GOBP ABSCISSION | 6 | 8.26e-01 | -5.19e-02 | 9.23e-01 |
| GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 8 | 7.99e-01 | -5.19e-02 | 9.10e-01 |
| GOBP SECRETORY GRANULE LOCALIZATION | 8 | 7.99e-01 | 5.19e-02 | 9.10e-01 |
| GOBP NEPHRON MORPHOGENESIS | 31 | 6.17e-01 | 5.19e-02 | 8.18e-01 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 160 | 2.58e-01 | -5.19e-02 | 5.48e-01 |
| GOMF PROFILIN BINDING | 10 | 7.76e-01 | -5.19e-02 | 8.98e-01 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 28 | 6.35e-01 | -5.18e-02 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 28 | 6.35e-01 | 5.18e-02 | 8.27e-01 |
| GOBP DEVELOPMENTAL MATURATION | 182 | 2.29e-01 | -5.18e-02 | 5.15e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 21 | 6.81e-01 | -5.18e-02 | 8.52e-01 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 15 | 7.29e-01 | -5.18e-02 | 8.78e-01 |
| GOBP PROTEIN CATABOLIC PROCESS | 834 | 1.20e-02 | 5.17e-02 | 9.30e-02 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 98 | 3.77e-01 | -5.17e-02 | 6.59e-01 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 130 | 3.09e-01 | -5.17e-02 | 5.98e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 13 | 7.47e-01 | 5.17e-02 | 8.85e-01 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 34 | 6.03e-01 | 5.16e-02 | 8.11e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 617 | 3.00e-02 | 5.16e-02 | 1.68e-01 |
| GOBP CELLULAR RESPONSE TO ACIDIC PH | 8 | 8.01e-01 | 5.15e-02 | 9.11e-01 |
| GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 267 | 1.49e-01 | 5.15e-02 | 4.09e-01 |
| GOBP STEROID HORMONE SECRETION | 13 | 7.48e-01 | -5.15e-02 | 8.86e-01 |
| GOBP MIDDLE EAR MORPHOGENESIS | 9 | 7.89e-01 | -5.15e-02 | 9.05e-01 |
| GOBP MRNA 5 SPLICE SITE RECOGNITION | 6 | 8.27e-01 | 5.14e-02 | 9.24e-01 |
| GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS | 5 | 8.42e-01 | 5.14e-02 | 9.31e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 15 | 7.30e-01 | -5.14e-02 | 8.79e-01 |
| GOBP NUCLEOTIDE TRANSPORT | 36 | 5.95e-01 | 5.13e-02 | 8.08e-01 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 10 | 7.79e-01 | -5.12e-02 | 9.00e-01 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 87 | 4.10e-01 | -5.11e-02 | 6.90e-01 |
| GOCC CORTICAL CYTOSKELETON | 75 | 4.44e-01 | -5.11e-02 | 7.13e-01 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 12 | 7.59e-01 | -5.11e-02 | 8.90e-01 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 94 | 3.92e-01 | -5.11e-02 | 6.73e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 48 | 5.40e-01 | -5.11e-02 | 7.77e-01 |
| GOBP FATTY ACID METABOLIC PROCESS | 266 | 1.53e-01 | 5.10e-02 | 4.16e-01 |
| GOMF NAD RETINOL DEHYDROGENASE ACTIVITY | 8 | 8.03e-01 | 5.10e-02 | 9.12e-01 |
| GOBP MRNA METABOLIC PROCESS | 643 | 2.86e-02 | -5.10e-02 | 1.64e-01 |
| GOBP HOMEOSTATIC PROCESS | 1083 | 5.26e-03 | -5.09e-02 | 5.31e-02 |
| GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 81 | 4.29e-01 | -5.08e-02 | 7.05e-01 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 178 | 2.43e-01 | 5.08e-02 | 5.29e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 18 | 7.09e-01 | -5.08e-02 | 8.68e-01 |
| GOCC BRUSH BORDER | 62 | 4.90e-01 | -5.08e-02 | 7.47e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 47 | 5.48e-01 | -5.07e-02 | 7.81e-01 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 34 | 6.09e-01 | 5.07e-02 | 8.14e-01 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 110 | 3.59e-01 | 5.07e-02 | 6.45e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 16 | 7.26e-01 | 5.06e-02 | 8.77e-01 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 41 | 5.76e-01 | 5.05e-02 | 7.98e-01 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 10 | 7.82e-01 | -5.05e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 8 | 8.05e-01 | -5.05e-02 | 9.13e-01 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 76 | 4.47e-01 | 5.05e-02 | 7.15e-01 |
| GOCC ACROSOMAL VESICLE | 66 | 4.79e-01 | -5.05e-02 | 7.40e-01 |
| GOBP RNA CATABOLIC PROCESS | 262 | 1.61e-01 | -5.04e-02 | 4.28e-01 |
| GOBP TOR SIGNALING | 138 | 3.07e-01 | -5.04e-02 | 5.96e-01 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 66 | 4.79e-01 | -5.04e-02 | 7.40e-01 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 6 | 8.31e-01 | 5.04e-02 | 9.26e-01 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 10 | 7.83e-01 | 5.04e-02 | 9.02e-01 |
| GOCC EARLY ENDOSOME MEMBRANE | 146 | 2.95e-01 | -5.03e-02 | 5.83e-01 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 8.31e-01 | -5.03e-02 | 9.26e-01 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 29 | 6.39e-01 | 5.03e-02 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 71 | 4.64e-01 | -5.03e-02 | 7.30e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 31 | 6.29e-01 | -5.02e-02 | 8.24e-01 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 32 | 6.24e-01 | 5.02e-02 | 8.20e-01 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 33 | 6.19e-01 | 5.01e-02 | 8.18e-01 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 8 | 8.06e-01 | -5.01e-02 | 9.14e-01 |
| GOBP RESPONSE TO WOUNDING | 336 | 1.16e-01 | -5.00e-02 | 3.59e-01 |
| GOBP GLIAL CELL DEVELOPMENT | 71 | 4.67e-01 | -5.00e-02 | 7.32e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 545 | 4.77e-02 | -4.99e-02 | 2.22e-01 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 7 | 8.19e-01 | 4.99e-02 | 9.21e-01 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 70 | 4.71e-01 | -4.99e-02 | 7.34e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 71 | 4.68e-01 | -4.98e-02 | 7.33e-01 |
| GOBP ACROSOME ASSEMBLY | 13 | 7.56e-01 | -4.98e-02 | 8.89e-01 |
| GOBP ORGANIC ANION TRANSPORT | 247 | 1.79e-01 | 4.98e-02 | 4.53e-01 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 18 | 7.15e-01 | 4.98e-02 | 8.72e-01 |
| GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 7 | 8.20e-01 | 4.98e-02 | 9.21e-01 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 206 | 2.19e-01 | -4.98e-02 | 5.02e-01 |
| GOBP ACID SECRETION | 18 | 7.15e-01 | -4.97e-02 | 8.72e-01 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 20 | 7.00e-01 | -4.97e-02 | 8.63e-01 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 68 | 4.79e-01 | -4.97e-02 | 7.40e-01 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 36 | 6.06e-01 | -4.97e-02 | 8.13e-01 |
| GOBP NEUROTRANSMITTER SECRETION | 84 | 4.32e-01 | 4.96e-02 | 7.06e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 5 | 8.48e-01 | 4.96e-02 | 9.33e-01 |
| GOBP RESPONSE TO FATTY ACID | 36 | 6.07e-01 | -4.96e-02 | 8.13e-01 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 62 | 5.01e-01 | 4.95e-02 | 7.53e-01 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 46 | 5.62e-01 | 4.94e-02 | 7.90e-01 |
| GOCC ZONULA ADHERENS | 7 | 8.21e-01 | 4.94e-02 | 9.22e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL | 5 | 8.48e-01 | 4.93e-02 | 9.33e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 12 | 7.67e-01 | 4.93e-02 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 14 | 7.50e-01 | 4.92e-02 | 8.87e-01 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 6.90e-01 | 4.92e-02 | 8.56e-01 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 272 | 1.65e-01 | 4.91e-02 | 4.32e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 114 | 3.66e-01 | -4.91e-02 | 6.51e-01 |
| GOCC INTERCELLULAR BRIDGE | 63 | 5.01e-01 | -4.90e-02 | 7.54e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 11 | 7.78e-01 | -4.90e-02 | 9.00e-01 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 17 | 7.27e-01 | -4.90e-02 | 8.77e-01 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 22 | 6.91e-01 | -4.89e-02 | 8.56e-01 |
| GOBP MALE GAMETE GENERATION | 323 | 1.32e-01 | -4.89e-02 | 3.84e-01 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 71 | 4.77e-01 | -4.89e-02 | 7.38e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 18 | 7.20e-01 | -4.89e-02 | 8.74e-01 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 13 | 7.61e-01 | 4.88e-02 | 8.91e-01 |
| GOCC CLATHRIN COAT | 40 | 5.94e-01 | 4.88e-02 | 8.07e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 78 | 4.57e-01 | 4.87e-02 | 7.25e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 121 | 3.55e-01 | 4.87e-02 | 6.42e-01 |
| GOBP NUCLEOLUS ORGANIZATION | 17 | 7.28e-01 | 4.87e-02 | 8.78e-01 |
| GOMF AMP BINDING | 13 | 7.62e-01 | -4.86e-02 | 8.92e-01 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 82 | 4.47e-01 | -4.86e-02 | 7.15e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 55 | 5.34e-01 | -4.86e-02 | 7.73e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 30 | 6.45e-01 | 4.86e-02 | 8.33e-01 |
| GOBP ADAPTIVE THERMOGENESIS | 115 | 3.69e-01 | -4.85e-02 | 6.53e-01 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 31 | 6.40e-01 | 4.85e-02 | 8.30e-01 |
| GOBP PROTEIN OXIDATION | 6 | 8.37e-01 | -4.85e-02 | 9.29e-01 |
| GOBP KERATINOCYTE MIGRATION | 11 | 7.81e-01 | 4.85e-02 | 9.02e-01 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 50 | 5.54e-01 | -4.84e-02 | 7.85e-01 |
| GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 7 | 8.24e-01 | 4.84e-02 | 9.23e-01 |
| GOBP REGULATION OF NK T CELL PROLIFERATION | 6 | 8.37e-01 | -4.84e-02 | 9.29e-01 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 11 | 7.81e-01 | 4.84e-02 | 9.02e-01 |
| GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 50 | 5.54e-01 | -4.84e-02 | 7.85e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 19 | 7.15e-01 | -4.84e-02 | 8.72e-01 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 114 | 3.73e-01 | 4.83e-02 | 6.56e-01 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 27 | 6.64e-01 | 4.83e-02 | 8.43e-01 |
| GOBP RESPONSE TO MANGANESE ION | 15 | 7.46e-01 | -4.83e-02 | 8.85e-01 |
| GOBP EATING BEHAVIOR | 16 | 7.38e-01 | -4.83e-02 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 64 | 5.05e-01 | -4.83e-02 | 7.54e-01 |
| GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 9 | 8.02e-01 | -4.82e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 124 | 3.54e-01 | -4.82e-02 | 6.41e-01 |
| GOBP VIRAL GENE EXPRESSION | 94 | 4.20e-01 | -4.82e-02 | 6.97e-01 |
| GOCC NON MOTILE CILIUM | 97 | 4.12e-01 | 4.82e-02 | 6.91e-01 |
| GOBP ORGANIC ACID TRANSPORT | 195 | 2.47e-01 | 4.82e-02 | 5.35e-01 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 35 | 6.22e-01 | 4.82e-02 | 8.20e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 7 | 8.26e-01 | 4.80e-02 | 9.23e-01 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 51 | 5.54e-01 | -4.80e-02 | 7.85e-01 |
| GOMF TRANSPORTER ACTIVITY | 705 | 3.14e-02 | 4.80e-02 | 1.73e-01 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 10 | 7.93e-01 | 4.79e-02 | 9.07e-01 |
| GOBP MOLTING CYCLE | 54 | 5.44e-01 | -4.77e-02 | 7.79e-01 |
| GOBP RESPONSE TO INTERFERON BETA | 25 | 6.80e-01 | 4.77e-02 | 8.51e-01 |
| GOBP REGULATION OF MRNA 3 END PROCESSING | 12 | 7.75e-01 | 4.77e-02 | 8.98e-01 |
| GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 5 | 8.53e-01 | -4.77e-02 | 9.35e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 8.53e-01 | 4.77e-02 | 9.35e-01 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 10 | 7.94e-01 | -4.77e-02 | 9.08e-01 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 774 | 2.54e-02 | -4.77e-02 | 1.51e-01 |
| GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE | 7 | 8.27e-01 | 4.76e-02 | 9.24e-01 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 55 | 5.42e-01 | 4.76e-02 | 7.77e-01 |
| GOBP PYRUVATE TRANSPORT | 5 | 8.54e-01 | -4.76e-02 | 9.36e-01 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 44 | 5.85e-01 | 4.76e-02 | 8.03e-01 |
| GOBP AMYLOID FIBRIL FORMATION | 33 | 6.37e-01 | 4.75e-02 | 8.28e-01 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 298 | 1.60e-01 | -4.75e-02 | 4.25e-01 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 49 | 5.66e-01 | 4.75e-02 | 7.92e-01 |
| GOBP OSTEOCLAST PROLIFERATION | 7 | 8.28e-01 | -4.74e-02 | 9.25e-01 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 675 | 3.74e-02 | 4.74e-02 | 1.91e-01 |
| GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY | 6 | 8.41e-01 | -4.74e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 43 | 5.91e-01 | 4.74e-02 | 8.06e-01 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 12 | 7.77e-01 | 4.73e-02 | 8.98e-01 |
| GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 7.96e-01 | -4.73e-02 | 9.09e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 12 | 7.77e-01 | -4.73e-02 | 8.98e-01 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 56 | 5.41e-01 | -4.72e-02 | 7.77e-01 |
| GOBP V D J RECOMBINATION | 16 | 7.44e-01 | -4.71e-02 | 8.85e-01 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 177 | 2.81e-01 | -4.71e-02 | 5.70e-01 |
| GOCC CELL CORTEX | 221 | 2.29e-01 | -4.71e-02 | 5.14e-01 |
| GOCC COATED VESICLE MEMBRANE | 155 | 3.13e-01 | 4.71e-02 | 6.01e-01 |
| GOBP TOLL SIGNALING PATHWAY | 10 | 7.97e-01 | -4.70e-02 | 9.09e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 41 | 6.02e-01 | 4.70e-02 | 8.11e-01 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 38 | 6.16e-01 | -4.70e-02 | 8.17e-01 |
| GOMF GUANYLATE KINASE ACTIVITY | 9 | 8.07e-01 | 4.70e-02 | 9.14e-01 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 11 | 7.87e-01 | 4.70e-02 | 9.04e-01 |
| GOBP OSTEOCLAST FUSION | 6 | 8.42e-01 | -4.70e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 39 | 6.13e-01 | -4.69e-02 | 8.16e-01 |
| GOMF APOLIPOPROTEIN BINDING | 10 | 7.97e-01 | -4.69e-02 | 9.10e-01 |
| GOBP SPHINGOSINE BIOSYNTHETIC PROCESS | 10 | 7.98e-01 | 4.68e-02 | 9.10e-01 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 20 | 7.17e-01 | -4.68e-02 | 8.73e-01 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 87 | 4.51e-01 | 4.68e-02 | 7.20e-01 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 18 | 7.31e-01 | 4.68e-02 | 8.79e-01 |
| GOMF PHOSPHATASE BINDING | 155 | 3.16e-01 | -4.68e-02 | 6.05e-01 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 95 | 4.32e-01 | -4.67e-02 | 7.06e-01 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 13 | 7.71e-01 | 4.67e-02 | 8.95e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 16 | 7.47e-01 | -4.66e-02 | 8.85e-01 |
| GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE | 6 | 8.43e-01 | -4.66e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 36 | 6.29e-01 | -4.66e-02 | 8.24e-01 |
| GOBP PHOSPHOLIPID TRANSPORT | 69 | 5.04e-01 | 4.65e-02 | 7.54e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 9 | 8.09e-01 | -4.65e-02 | 9.15e-01 |
| GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 5 | 8.57e-01 | 4.65e-02 | 9.38e-01 |
| GOBP PIGMENT CELL DIFFERENTIATION | 24 | 6.94e-01 | -4.65e-02 | 8.58e-01 |
| GOCC PIGMENT GRANULE | 99 | 4.26e-01 | -4.64e-02 | 7.03e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 25 | 6.89e-01 | 4.63e-02 | 8.56e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 21 | 7.13e-01 | -4.63e-02 | 8.71e-01 |
| GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 7 | 8.33e-01 | 4.62e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 22 | 7.08e-01 | 4.61e-02 | 8.67e-01 |
| GOBP DETECTION OF VISIBLE LIGHT | 23 | 7.02e-01 | 4.61e-02 | 8.64e-01 |
| GOBP NOTCH SIGNALING PATHWAY | 108 | 4.09e-01 | 4.61e-02 | 6.89e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 23 | 7.03e-01 | -4.60e-02 | 8.64e-01 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 21 | 7.15e-01 | -4.60e-02 | 8.72e-01 |
| GOBP PRENYLATION | 10 | 8.01e-01 | 4.60e-02 | 9.11e-01 |
| GOBP MDA 5 SIGNALING PATHWAY | 10 | 8.02e-01 | 4.59e-02 | 9.11e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 17 | 7.44e-01 | 4.58e-02 | 8.85e-01 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 11 | 7.93e-01 | 4.58e-02 | 9.07e-01 |
| GOMF PHOSPHOLIPASE ACTIVITY | 60 | 5.40e-01 | 4.58e-02 | 7.77e-01 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 14 | 7.67e-01 | -4.57e-02 | 8.93e-01 |
| GOCC COPII VESICLE COAT | 15 | 7.59e-01 | 4.57e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 104 | 4.21e-01 | 4.57e-02 | 6.98e-01 |
| GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 19 | 7.30e-01 | 4.57e-02 | 8.79e-01 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 17 | 7.44e-01 | -4.57e-02 | 8.85e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 6 | 8.47e-01 | -4.56e-02 | 9.32e-01 |
| GOBP RETINOL METABOLIC PROCESS | 23 | 7.05e-01 | 4.56e-02 | 8.65e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 55 | 5.59e-01 | -4.56e-02 | 7.87e-01 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 19 | 7.31e-01 | -4.56e-02 | 8.79e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 23 | 7.05e-01 | 4.56e-02 | 8.65e-01 |
| GOBP MOLTING CYCLE PROCESS | 46 | 5.93e-01 | -4.56e-02 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 9 | 8.13e-01 | 4.55e-02 | 9.17e-01 |
| GOBP REGULATION OF CELL PROJECTION SIZE | 5 | 8.60e-01 | 4.55e-02 | 9.39e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 15 | 7.60e-01 | 4.55e-02 | 8.91e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 19 | 7.32e-01 | 4.55e-02 | 8.79e-01 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 144 | 3.47e-01 | -4.55e-02 | 6.32e-01 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 124 | 3.83e-01 | -4.55e-02 | 6.64e-01 |
| GOCC SCAR COMPLEX | 11 | 7.94e-01 | 4.54e-02 | 9.08e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 43 | 6.07e-01 | -4.53e-02 | 8.13e-01 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 14 | 7.69e-01 | -4.53e-02 | 8.94e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 9 | 8.14e-01 | -4.53e-02 | 9.17e-01 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 168 | 3.12e-01 | -4.53e-02 | 6.01e-01 |
| GOCC MICROTUBULE | 342 | 1.52e-01 | -4.53e-02 | 4.13e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 11 | 7.95e-01 | 4.53e-02 | 9.08e-01 |
| GOBP NEPHRON DEVELOPMENT | 72 | 5.07e-01 | -4.53e-02 | 7.56e-01 |
| GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE | 14 | 7.69e-01 | -4.52e-02 | 8.94e-01 |
| GOBP RESPONSE TO TYPE I INTERFERON | 63 | 5.35e-01 | -4.52e-02 | 7.74e-01 |
| GOCC TRANSPORT VESICLE MEMBRANE | 157 | 3.29e-01 | -4.52e-02 | 6.16e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 158 | 3.28e-01 | -4.52e-02 | 6.15e-01 |
| GOBP CYTOKINESIS | 158 | 3.29e-01 | -4.51e-02 | 6.15e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 7 | 8.36e-01 | -4.51e-02 | 9.29e-01 |
| GOBP NUCLEAR EXPORT | 153 | 3.37e-01 | 4.51e-02 | 6.23e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 173 | 3.07e-01 | 4.51e-02 | 5.96e-01 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 15 | 7.63e-01 | -4.50e-02 | 8.92e-01 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 15 | 7.63e-01 | -4.50e-02 | 8.92e-01 |
| GOMF FATTY ACID BINDING | 30 | 6.70e-01 | -4.50e-02 | 8.47e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 16 | 7.56e-01 | 4.49e-02 | 8.89e-01 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 12 | 7.88e-01 | -4.49e-02 | 9.05e-01 |
| GOMF TBP CLASS PROTEIN BINDING | 23 | 7.10e-01 | -4.49e-02 | 8.68e-01 |
| GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 7 | 8.37e-01 | 4.48e-02 | 9.29e-01 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 15 | 7.64e-01 | 4.48e-02 | 8.92e-01 |
| GOCC INTEGRATOR COMPLEX | 16 | 7.56e-01 | -4.48e-02 | 8.89e-01 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 225 | 2.49e-01 | 4.48e-02 | 5.37e-01 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 8 | 8.27e-01 | -4.46e-02 | 9.24e-01 |
| GOBP EXCRETION | 9 | 8.17e-01 | -4.46e-02 | 9.19e-01 |
| GOBP PROTEIN DESTABILIZATION | 44 | 6.09e-01 | -4.45e-02 | 8.14e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 7 | 8.39e-01 | -4.44e-02 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 9 | 8.18e-01 | 4.44e-02 | 9.20e-01 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 90 | 4.67e-01 | 4.44e-02 | 7.32e-01 |
| GOBP SUCCINYL COA METABOLIC PROCESS | 10 | 8.08e-01 | 4.44e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 8 | 8.28e-01 | 4.44e-02 | 9.25e-01 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 56 | 5.66e-01 | -4.44e-02 | 7.92e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 63 | 5.43e-01 | 4.43e-02 | 7.78e-01 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 112 | 4.18e-01 | -4.43e-02 | 6.96e-01 |
| GOMF ADENYLATE CYCLASE BINDING | 5 | 8.64e-01 | -4.43e-02 | 9.41e-01 |
| GOBP ENDOCRINE HORMONE SECRETION | 24 | 7.07e-01 | -4.43e-02 | 8.67e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 120 | 4.03e-01 | -4.43e-02 | 6.82e-01 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 14 | 7.74e-01 | -4.42e-02 | 8.98e-01 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 200 | 2.82e-01 | -4.42e-02 | 5.72e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 7 | 8.40e-01 | -4.42e-02 | 9.30e-01 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 180 | 3.08e-01 | -4.42e-02 | 5.96e-01 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 6.56e-01 | 4.42e-02 | 8.38e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 36 | 6.47e-01 | -4.41e-02 | 8.34e-01 |
| GOBP IMPORT INTO NUCLEUS | 138 | 3.72e-01 | -4.41e-02 | 6.56e-01 |
| GOMF TELOMERASE RNA BINDING | 21 | 7.27e-01 | -4.41e-02 | 8.77e-01 |
| GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 19 | 7.40e-01 | 4.40e-02 | 8.83e-01 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 66 | 5.37e-01 | -4.40e-02 | 7.75e-01 |
| GOBP KIDNEY MORPHOGENESIS | 43 | 6.18e-01 | -4.40e-02 | 8.18e-01 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 112 | 4.22e-01 | -4.40e-02 | 6.98e-01 |
| GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 7 | 8.40e-01 | 4.40e-02 | 9.30e-01 |
| GOMF SPECTRIN BINDING | 19 | 7.40e-01 | -4.40e-02 | 8.83e-01 |
| GOBP HEART PROCESS | 131 | 3.87e-01 | 4.39e-02 | 6.67e-01 |
| GOBP TRANSLOCATION OF MOLECULES INTO HOST | 8 | 8.30e-01 | -4.38e-02 | 9.26e-01 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 51 | 5.89e-01 | -4.38e-02 | 8.04e-01 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 81 | 4.96e-01 | -4.38e-02 | 7.51e-01 |
| GOBP PROTEIN K29 LINKED UBIQUITINATION | 6 | 8.53e-01 | 4.38e-02 | 9.35e-01 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 31 | 6.74e-01 | 4.37e-02 | 8.48e-01 |
| GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 6 | 8.53e-01 | 4.37e-02 | 9.35e-01 |
| GOBP POLYKETIDE METABOLIC PROCESS | 6 | 8.53e-01 | 4.37e-02 | 9.35e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 6 | 8.53e-01 | -4.37e-02 | 9.35e-01 |
| GOCC ANNULATE LAMELLAE | 5 | 8.66e-01 | -4.36e-02 | 9.42e-01 |
| GOBP NEUROTRANSMITTER TRANSPORT | 109 | 4.32e-01 | 4.36e-02 | 7.06e-01 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 64 | 5.47e-01 | -4.36e-02 | 7.81e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 21 | 7.30e-01 | -4.36e-02 | 8.78e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 17 | 7.56e-01 | 4.36e-02 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 67 | 5.38e-01 | -4.35e-02 | 7.76e-01 |
| GOCC HAUS COMPLEX | 8 | 8.31e-01 | 4.35e-02 | 9.26e-01 |
| GOBP VISUAL BEHAVIOR | 32 | 6.70e-01 | -4.35e-02 | 8.47e-01 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 24 | 7.12e-01 | -4.35e-02 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 401 | 1.37e-01 | -4.35e-02 | 3.91e-01 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 37 | 6.47e-01 | 4.35e-02 | 8.34e-01 |
| GOCC TRANSPORT VESICLE | 297 | 1.99e-01 | 4.35e-02 | 4.79e-01 |
| GOBP RESPONSE TO CATECHOLAMINE | 41 | 6.31e-01 | -4.34e-02 | 8.25e-01 |
| GOBP MUSCLE CELL MIGRATION | 57 | 5.71e-01 | -4.34e-02 | 7.94e-01 |
| GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY | 5 | 8.67e-01 | -4.33e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 58 | 5.69e-01 | -4.33e-02 | 7.93e-01 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 73 | 5.23e-01 | -4.33e-02 | 7.67e-01 |
| GOBP RECEPTOR CLUSTERING | 39 | 6.41e-01 | -4.32e-02 | 8.30e-01 |
| GOCC SYNAPSE | 870 | 3.23e-02 | -4.32e-02 | 1.76e-01 |
| GOBP RECEPTOR SIGNALING PATHWAY VIA STAT | 106 | 4.44e-01 | -4.31e-02 | 7.13e-01 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 7 | 8.43e-01 | -4.31e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 13 | 7.88e-01 | 4.31e-02 | 9.05e-01 |
| GOBP PURINE NUCLEOTIDE TRANSPORT | 30 | 6.83e-01 | -4.31e-02 | 8.52e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 7 | 8.44e-01 | -4.30e-02 | 9.31e-01 |
| GOCC CHROMATIN SILENCING COMPLEX | 13 | 7.88e-01 | -4.30e-02 | 9.05e-01 |
| GOBP AXO DENDRITIC TRANSPORT | 63 | 5.55e-01 | 4.30e-02 | 7.85e-01 |
| GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 5 | 8.68e-01 | -4.30e-02 | 9.43e-01 |
| GOBP GLUTATHIONE TRANSPORT | 6 | 8.55e-01 | 4.30e-02 | 9.37e-01 |
| GOMF ACTIN MONOMER BINDING | 20 | 7.39e-01 | -4.30e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 65 | 5.49e-01 | -4.30e-02 | 7.82e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 8.44e-01 | -4.29e-02 | 9.32e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 12 | 7.97e-01 | 4.28e-02 | 9.10e-01 |
| GOBP POLYOL METABOLIC PROCESS | 74 | 5.25e-01 | -4.28e-02 | 7.68e-01 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 12 | 7.98e-01 | 4.28e-02 | 9.10e-01 |
| GOMF MONOSACCHARIDE BINDING | 53 | 5.91e-01 | 4.28e-02 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 21 | 7.35e-01 | -4.27e-02 | 8.80e-01 |
| GOBP HEAT GENERATION | 11 | 8.06e-01 | -4.27e-02 | 9.14e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 10 | 8.15e-01 | 4.27e-02 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 65 | 5.52e-01 | -4.27e-02 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF BINDING | 98 | 4.66e-01 | -4.27e-02 | 7.31e-01 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 8 | 8.35e-01 | 4.26e-02 | 9.28e-01 |
| GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.69e-01 | -4.26e-02 | 9.44e-01 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 38 | 6.50e-01 | -4.26e-02 | 8.36e-01 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 45 | 6.21e-01 | -4.26e-02 | 8.20e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 72 | 5.33e-01 | 4.26e-02 | 7.73e-01 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 146 | 3.76e-01 | 4.26e-02 | 6.58e-01 |
| GOBP MACROMOLECULE METHYLATION | 185 | 3.19e-01 | 4.26e-02 | 6.08e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 12 | 7.99e-01 | -4.25e-02 | 9.10e-01 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 107 | 4.48e-01 | -4.25e-02 | 7.16e-01 |
| GOBP MICROTUBULE BASED MOVEMENT | 262 | 2.38e-01 | 4.25e-02 | 5.23e-01 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 9 | 8.25e-01 | -4.25e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 5 | 8.69e-01 | 4.25e-02 | 9.44e-01 |
| GOBP SEQUESTERING OF CALCIUM ION | 82 | 5.07e-01 | -4.25e-02 | 7.55e-01 |
| GOMF SYNTAXIN BINDING | 47 | 6.15e-01 | -4.24e-02 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 17 | 7.62e-01 | -4.24e-02 | 8.92e-01 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 16 | 7.69e-01 | -4.24e-02 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 19 | 7.49e-01 | -4.24e-02 | 8.87e-01 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 8.08e-01 | -4.24e-02 | 9.14e-01 |
| GOBP REGULATION OF HAIR CYCLE | 14 | 7.84e-01 | -4.23e-02 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 38 | 6.52e-01 | 4.23e-02 | 8.37e-01 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 15 | 7.77e-01 | 4.23e-02 | 8.99e-01 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 41 | 6.40e-01 | -4.23e-02 | 8.30e-01 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 11 | 8.08e-01 | 4.22e-02 | 9.14e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 42 | 6.36e-01 | 4.22e-02 | 8.28e-01 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 12 | 8.00e-01 | 4.22e-02 | 9.10e-01 |
| GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 6 | 8.58e-01 | 4.22e-02 | 9.38e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 26 | 7.10e-01 | -4.22e-02 | 8.68e-01 |
| GOBP TRANSPOSITION | 20 | 7.44e-01 | 4.22e-02 | 8.85e-01 |
| GOCC GAMMA SECRETASE COMPLEX | 7 | 8.47e-01 | -4.22e-02 | 9.33e-01 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 23 | 7.26e-01 | 4.22e-02 | 8.77e-01 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 54 | 5.92e-01 | 4.22e-02 | 8.06e-01 |
| GOBP SUBSTANTIA NIGRA DEVELOPMENT | 35 | 6.66e-01 | 4.21e-02 | 8.44e-01 |
| GOCC SPINDLE MIDZONE | 34 | 6.71e-01 | -4.21e-02 | 8.47e-01 |
| GOBP RESPONSE TO ACID CHEMICAL | 94 | 4.81e-01 | -4.21e-02 | 7.40e-01 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 18 | 7.58e-01 | -4.20e-02 | 8.90e-01 |
| GOBP HINDLIMB MORPHOGENESIS | 13 | 7.93e-01 | -4.20e-02 | 9.07e-01 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 179 | 3.34e-01 | -4.20e-02 | 6.19e-01 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 86 | 5.01e-01 | -4.20e-02 | 7.54e-01 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 76 | 5.28e-01 | -4.19e-02 | 7.69e-01 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 51 | 6.05e-01 | -4.19e-02 | 8.12e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 95 | 4.81e-01 | -4.19e-02 | 7.40e-01 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 12 | 8.02e-01 | -4.18e-02 | 9.11e-01 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 203 | 3.06e-01 | -4.18e-02 | 5.94e-01 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 20 | 7.47e-01 | 4.17e-02 | 8.85e-01 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 25 | 7.18e-01 | -4.17e-02 | 8.74e-01 |
| GOBP MAINTENANCE OF LOCATION | 240 | 2.68e-01 | -4.17e-02 | 5.57e-01 |
| GOBP PROGESTERONE METABOLIC PROCESS | 9 | 8.29e-01 | 4.17e-02 | 9.25e-01 |
| GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 8.38e-01 | -4.16e-02 | 9.29e-01 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 145 | 3.88e-01 | -4.16e-02 | 6.69e-01 |
| GOBP SNRNA METABOLIC PROCESS | 53 | 6.01e-01 | 4.15e-02 | 8.11e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 11 | 8.12e-01 | 4.15e-02 | 9.16e-01 |
| GOBP PANCREAS DEVELOPMENT | 38 | 6.58e-01 | -4.15e-02 | 8.40e-01 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 15 | 7.81e-01 | -4.14e-02 | 9.02e-01 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 71 | 5.46e-01 | -4.14e-02 | 7.81e-01 |
| GOBP TRANSPORT ALONG MICROTUBULE | 142 | 3.95e-01 | 4.14e-02 | 6.75e-01 |
| GOCC SMALL SUBUNIT PROCESSOME | 70 | 5.49e-01 | 4.14e-02 | 7.82e-01 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 133 | 4.10e-01 | -4.14e-02 | 6.90e-01 |
| GOBP O GLYCAN PROCESSING | 32 | 6.86e-01 | 4.13e-02 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 16 | 7.75e-01 | 4.12e-02 | 8.98e-01 |
| GOBP TONIC SMOOTH MUSCLE CONTRACTION | 5 | 8.73e-01 | -4.12e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 12 | 8.05e-01 | -4.12e-02 | 9.13e-01 |
| GOCC NUCLEAR INNER MEMBRANE | 44 | 6.37e-01 | -4.11e-02 | 8.28e-01 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 8.22e-01 | -4.11e-02 | 9.22e-01 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 50 | 6.15e-01 | 4.11e-02 | 8.17e-01 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 12 | 8.05e-01 | -4.11e-02 | 9.13e-01 |
| GOMF VINCULIN BINDING | 9 | 8.31e-01 | -4.10e-02 | 9.26e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 48 | 6.23e-01 | -4.10e-02 | 8.20e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 24 | 7.28e-01 | 4.10e-02 | 8.78e-01 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 202 | 3.17e-01 | 4.09e-02 | 6.06e-01 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 30 | 6.98e-01 | -4.09e-02 | 8.62e-01 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 9 | 8.32e-01 | 4.08e-02 | 9.27e-01 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 14 | 7.91e-01 | -4.08e-02 | 9.06e-01 |
| GOBP REGULATION OF WOUND HEALING | 70 | 5.55e-01 | -4.08e-02 | 7.85e-01 |
| GOBP MICROTUBULE BUNDLE FORMATION | 61 | 5.83e-01 | 4.07e-02 | 8.01e-01 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 57 | 5.95e-01 | -4.07e-02 | 8.08e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 11 | 8.16e-01 | -4.06e-02 | 9.18e-01 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 36 | 6.74e-01 | -4.06e-02 | 8.48e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 110 | 4.63e-01 | -4.05e-02 | 7.30e-01 |
| GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE | 8 | 8.43e-01 | 4.05e-02 | 9.31e-01 |
| GOBP CELLULAR RESPONSE TO STRESS | 1584 | 8.40e-03 | -4.05e-02 | 7.27e-02 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 230 | 2.91e-01 | -4.05e-02 | 5.80e-01 |
| GOBP RESPONSE TO AXON INJURY | 52 | 6.14e-01 | -4.05e-02 | 8.17e-01 |
| GOBP AMIDE METABOLIC PROCESS | 944 | 3.74e-02 | 4.04e-02 | 1.91e-01 |
| GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX | 5 | 8.76e-01 | -4.04e-02 | 9.47e-01 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 60 | 5.89e-01 | -4.04e-02 | 8.04e-01 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 809 | 5.37e-02 | 4.03e-02 | 2.36e-01 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 130 | 4.29e-01 | 4.03e-02 | 7.05e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 26 | 7.23e-01 | -4.02e-02 | 8.76e-01 |
| GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 9 | 8.35e-01 | -4.02e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 26 | 7.23e-01 | 4.02e-02 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 38 | 6.69e-01 | -4.01e-02 | 8.46e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 27 | 7.18e-01 | -4.01e-02 | 8.74e-01 |
| GOBP G0 TO G1 TRANSITION | 33 | 6.91e-01 | -4.01e-02 | 8.56e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 8 | 8.45e-01 | 4.00e-02 | 9.32e-01 |
| GOBP PEPTIDE METABOLIC PROCESS | 731 | 6.81e-02 | 4.00e-02 | 2.71e-01 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 8 | 8.45e-01 | -3.99e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 134 | 4.27e-01 | -3.98e-02 | 7.03e-01 |
| GOMF TOXIC SUBSTANCE BINDING | 5 | 8.77e-01 | -3.98e-02 | 9.47e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 155 | 3.93e-01 | -3.98e-02 | 6.73e-01 |
| GOBP PREPULSE INHIBITION | 6 | 8.66e-01 | -3.97e-02 | 9.42e-01 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 9 | 8.36e-01 | 3.97e-02 | 9.29e-01 |
| GOCC SYNAPTIC MEMBRANE | 180 | 3.59e-01 | -3.97e-02 | 6.45e-01 |
| GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 7 | 8.56e-01 | 3.97e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 40 | 6.65e-01 | 3.96e-02 | 8.44e-01 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 43 | 6.53e-01 | 3.96e-02 | 8.37e-01 |
| GOMF INTERLEUKIN 1 BINDING | 6 | 8.67e-01 | 3.96e-02 | 9.43e-01 |
| GOBP REGULATION OF DNA REPAIR | 195 | 3.42e-01 | -3.95e-02 | 6.28e-01 |
| GOBP REGULATION OF ACTION POTENTIAL | 31 | 7.03e-01 | 3.95e-02 | 8.64e-01 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 16 | 7.85e-01 | -3.95e-02 | 9.03e-01 |
| GOBP METHYLATION | 236 | 2.98e-01 | 3.95e-02 | 5.85e-01 |
| GOCC CILIARY PLASM | 87 | 5.25e-01 | 3.95e-02 | 7.68e-01 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 8 | 8.47e-01 | -3.94e-02 | 9.33e-01 |
| GOBP KERATINOCYTE APOPTOTIC PROCESS | 6 | 8.67e-01 | -3.94e-02 | 9.43e-01 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 24 | 7.38e-01 | -3.94e-02 | 8.82e-01 |
| GOBP MAINTENANCE OF CELL POLARITY | 14 | 7.99e-01 | 3.94e-02 | 9.10e-01 |
| GOCC SYNAPTONEMAL STRUCTURE | 23 | 7.44e-01 | -3.93e-02 | 8.85e-01 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 12 | 8.14e-01 | -3.93e-02 | 9.17e-01 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 278 | 2.61e-01 | -3.93e-02 | 5.51e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 7 | 8.57e-01 | 3.93e-02 | 9.38e-01 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 12 | 8.14e-01 | 3.93e-02 | 9.17e-01 |
| GOBP DECIDUALIZATION | 19 | 7.67e-01 | 3.93e-02 | 8.93e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 47 | 6.42e-01 | -3.92e-02 | 8.31e-01 |
| GOBP MICROTUBULE BASED PROCESS | 672 | 8.55e-02 | -3.92e-02 | 3.05e-01 |
| GOBP PEPTIDE CROSS LINKING | 7 | 8.58e-01 | -3.92e-02 | 9.38e-01 |
| GOBP BLASTOCYST GROWTH | 19 | 7.68e-01 | -3.92e-02 | 8.93e-01 |
| GOMF SULFUR COMPOUND BINDING | 137 | 4.30e-01 | -3.91e-02 | 7.05e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 54 | 6.19e-01 | 3.91e-02 | 8.18e-01 |
| GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 5 | 8.80e-01 | -3.91e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 47 | 6.43e-01 | -3.91e-02 | 8.31e-01 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 23 | 7.45e-01 | 3.91e-02 | 8.85e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 38 | 6.77e-01 | -3.91e-02 | 8.50e-01 |
| GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 83 | 5.39e-01 | -3.91e-02 | 7.76e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 321 | 2.31e-01 | -3.91e-02 | 5.15e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 5 | 8.80e-01 | -3.91e-02 | 9.49e-01 |
| GOCC NEURON SPINE | 100 | 5.01e-01 | -3.90e-02 | 7.53e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 15 | 7.94e-01 | -3.90e-02 | 9.07e-01 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 17 | 7.81e-01 | -3.90e-02 | 9.02e-01 |
| GOCC NEURON PROJECTION TERMINUS | 62 | 5.96e-01 | -3.90e-02 | 8.08e-01 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 428 | 1.70e-01 | 3.89e-02 | 4.39e-01 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 117 | 4.68e-01 | -3.89e-02 | 7.33e-01 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 26 | 7.32e-01 | -3.88e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 92 | 5.20e-01 | -3.88e-02 | 7.64e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 23 | 7.47e-01 | -3.88e-02 | 8.85e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 15 | 7.95e-01 | -3.87e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 175 | 3.78e-01 | 3.87e-02 | 6.60e-01 |
| GOBP POSITIVE REGULATION OF GROWTH | 150 | 4.14e-01 | -3.87e-02 | 6.92e-01 |
| GOBP NCRNA CATABOLIC PROCESS | 50 | 6.37e-01 | 3.87e-02 | 8.28e-01 |
| GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 6 | 8.70e-01 | -3.86e-02 | 9.44e-01 |
| GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 7 | 8.60e-01 | -3.86e-02 | 9.38e-01 |
| GOBP CD40 SIGNALING PATHWAY | 14 | 8.03e-01 | -3.86e-02 | 9.11e-01 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 62 | 5.99e-01 | -3.86e-02 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 78 | 5.56e-01 | -3.86e-02 | 7.87e-01 |
| GOMF EXONUCLEASE ACTIVITY | 76 | 5.62e-01 | 3.85e-02 | 7.90e-01 |
| GOBP ACTIN CROSSLINK FORMATION | 11 | 8.25e-01 | 3.84e-02 | 9.23e-01 |
| GOBP REGULATED EXOCYTOSIS | 143 | 4.29e-01 | -3.84e-02 | 7.05e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 123 | 4.63e-01 | 3.84e-02 | 7.30e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 245 | 3.02e-01 | 3.84e-02 | 5.90e-01 |
| GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY | 5 | 8.82e-01 | -3.84e-02 | 9.50e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 41 | 6.71e-01 | 3.84e-02 | 8.47e-01 |
| GOCC LAMELLIPODIUM MEMBRANE | 18 | 7.78e-01 | -3.83e-02 | 9.00e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 104 | 5.01e-01 | -3.83e-02 | 7.53e-01 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 38 | 6.83e-01 | -3.82e-02 | 8.52e-01 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 8.34e-01 | 3.82e-02 | 9.28e-01 |
| GOBP REGULATION OF HEART CONTRACTION | 101 | 5.08e-01 | 3.81e-02 | 7.56e-01 |
| GOBP BRAIN MORPHOGENESIS | 22 | 7.57e-01 | 3.81e-02 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 13 | 8.12e-01 | 3.81e-02 | 9.17e-01 |
| GOCC SUPRAMOLECULAR COMPLEX | 907 | 5.48e-02 | -3.80e-02 | 2.39e-01 |
| GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 8.72e-01 | 3.80e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 49 | 6.46e-01 | -3.80e-02 | 8.33e-01 |
| GOCC AUTOPHAGOSOME | 103 | 5.06e-01 | 3.80e-02 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING | 5 | 8.83e-01 | 3.80e-02 | 9.51e-01 |
| GOMF TRANSITION METAL ION BINDING | 731 | 8.35e-02 | -3.79e-02 | 3.01e-01 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 64 | 6.00e-01 | -3.79e-02 | 8.10e-01 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 13 | 8.13e-01 | 3.78e-02 | 9.17e-01 |
| GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 7 | 8.63e-01 | -3.78e-02 | 9.41e-01 |
| GOMF NUCLEOSIDE KINASE ACTIVITY | 9 | 8.45e-01 | -3.78e-02 | 9.32e-01 |
| GOCC ACETYLTRANSFERASE COMPLEX | 92 | 5.33e-01 | -3.77e-02 | 7.73e-01 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 458 | 1.70e-01 | -3.76e-02 | 4.39e-01 |
| GOMF STEROID BINDING | 61 | 6.12e-01 | -3.76e-02 | 8.16e-01 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 32 | 7.13e-01 | 3.76e-02 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 121 | 4.76e-01 | -3.75e-02 | 7.38e-01 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 18 | 7.83e-01 | 3.75e-02 | 9.02e-01 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 25 | 7.45e-01 | 3.75e-02 | 8.85e-01 |
| GOBP REGULATION OF STEM CELL DIVISION | 8 | 8.54e-01 | -3.75e-02 | 9.36e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 56 | 6.28e-01 | 3.74e-02 | 8.23e-01 |
| GOBP VIRAL GENOME REPLICATION | 112 | 4.95e-01 | -3.74e-02 | 7.49e-01 |
| GOBP CENTROSOME SEPARATION | 13 | 8.16e-01 | -3.73e-02 | 9.18e-01 |
| GOBP MONOATOMIC ANION TRANSPORT | 81 | 5.62e-01 | 3.73e-02 | 7.90e-01 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 6 | 8.74e-01 | -3.73e-02 | 9.47e-01 |
| GOBP SENSORY PERCEPTION OF SMELL | 14 | 8.09e-01 | 3.73e-02 | 9.15e-01 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 201 | 3.64e-01 | -3.72e-02 | 6.49e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 51 | 6.46e-01 | 3.72e-02 | 8.33e-01 |
| GOMF MHC CLASS IB PROTEIN BINDING | 5 | 8.86e-01 | -3.72e-02 | 9.52e-01 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 18 | 7.85e-01 | -3.72e-02 | 9.03e-01 |
| GOMF NF KAPPAB BINDING | 28 | 7.34e-01 | 3.71e-02 | 8.80e-01 |
| GOBP OOCYTE MATURATION | 16 | 7.97e-01 | -3.71e-02 | 9.10e-01 |
| GOCC I BAND | 87 | 5.50e-01 | -3.71e-02 | 7.82e-01 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 19 | 7.80e-01 | 3.70e-02 | 9.01e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 64 | 6.09e-01 | -3.70e-02 | 8.14e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 11 | 8.32e-01 | 3.69e-02 | 9.27e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 53 | 6.43e-01 | -3.68e-02 | 8.31e-01 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 44 | 6.73e-01 | 3.68e-02 | 8.48e-01 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 148 | 4.41e-01 | 3.68e-02 | 7.12e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 5 | 8.87e-01 | -3.67e-02 | 9.53e-01 |
| GOMF CARGO ADAPTOR ACTIVITY | 16 | 7.99e-01 | -3.67e-02 | 9.10e-01 |
| GOBP REGULATION OF DNA REPLICATION | 107 | 5.12e-01 | -3.67e-02 | 7.59e-01 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 74 | 5.86e-01 | 3.67e-02 | 8.03e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 966 | 5.65e-02 | -3.67e-02 | 2.42e-01 |
| GOBP EXOCYTOSIS | 234 | 3.35e-01 | 3.67e-02 | 6.21e-01 |
| GOBP PRIMITIVE HEMOPOIESIS | 6 | 8.76e-01 | -3.67e-02 | 9.47e-01 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 55 | 6.39e-01 | -3.66e-02 | 8.29e-01 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 126 | 4.79e-01 | 3.66e-02 | 7.40e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 24 | 7.57e-01 | -3.65e-02 | 8.89e-01 |
| GOBP INSULIN SECRETION | 114 | 5.02e-01 | 3.65e-02 | 7.54e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 9 | 8.50e-01 | -3.64e-02 | 9.34e-01 |
| GOCC TRANS GOLGI NETWORK | 215 | 3.59e-01 | -3.64e-02 | 6.45e-01 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 49 | 6.60e-01 | -3.64e-02 | 8.41e-01 |
| GOMF CHEMOKINE BINDING | 15 | 8.07e-01 | 3.64e-02 | 9.14e-01 |
| GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 6 | 8.77e-01 | 3.64e-02 | 9.47e-01 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 11 | 8.35e-01 | 3.64e-02 | 9.28e-01 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 225 | 3.49e-01 | 3.63e-02 | 6.34e-01 |
| GOBP AMIDE TRANSPORT | 201 | 3.76e-01 | -3.63e-02 | 6.58e-01 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 14 | 8.14e-01 | -3.63e-02 | 9.17e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 97 | 5.38e-01 | 3.62e-02 | 7.76e-01 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 80 | 5.76e-01 | -3.62e-02 | 7.98e-01 |
| GOCC MLL1 2 COMPLEX | 32 | 7.24e-01 | 3.60e-02 | 8.76e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 28 | 7.41e-01 | -3.60e-02 | 8.84e-01 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 18 | 7.91e-01 | -3.60e-02 | 9.06e-01 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 1080 | 4.85e-02 | 3.60e-02 | 2.24e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 361 | 2.43e-01 | 3.59e-02 | 5.29e-01 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 22 | 7.71e-01 | 3.59e-02 | 8.95e-01 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 14 | 8.16e-01 | -3.59e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 23 | 7.66e-01 | -3.58e-02 | 8.93e-01 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 74 | 5.95e-01 | 3.57e-02 | 8.08e-01 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 70 | 6.06e-01 | -3.57e-02 | 8.13e-01 |
| GOBP RESPONSE TO EPINEPHRINE | 10 | 8.45e-01 | 3.56e-02 | 9.32e-01 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 8.05e-01 | -3.56e-02 | 9.13e-01 |
| GOMF STEROL TRANSFER ACTIVITY | 13 | 8.24e-01 | 3.56e-02 | 9.23e-01 |
| GOBP DETECTION OF LIGHT STIMULUS | 29 | 7.40e-01 | 3.55e-02 | 8.83e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 32 | 7.28e-01 | -3.55e-02 | 8.78e-01 |
| GOCC CORNIFIED ENVELOPE | 15 | 8.12e-01 | 3.54e-02 | 9.17e-01 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 126 | 4.93e-01 | 3.54e-02 | 7.48e-01 |
| GOBP METANEPHROS DEVELOPMENT | 41 | 6.95e-01 | -3.54e-02 | 8.59e-01 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 8.62e-01 | -3.54e-02 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 26 | 7.55e-01 | -3.54e-02 | 8.88e-01 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 28 | 7.46e-01 | -3.54e-02 | 8.85e-01 |
| GOMF PROTEASE BINDING | 99 | 5.43e-01 | 3.54e-02 | 7.78e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 24 | 7.64e-01 | -3.54e-02 | 8.92e-01 |
| GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 5 | 8.91e-01 | 3.54e-02 | 9.54e-01 |
| GOCC PORE COMPLEX | 19 | 7.90e-01 | 3.54e-02 | 9.05e-01 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 7.90e-01 | 3.53e-02 | 9.05e-01 |
| GOBP REGULATION OF HORMONE LEVELS | 273 | 3.18e-01 | -3.53e-02 | 6.07e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 27 | 7.51e-01 | -3.52e-02 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 38 | 7.07e-01 | 3.52e-02 | 8.67e-01 |
| GOBP VIRAL LIFE CYCLE | 256 | 3.33e-01 | -3.52e-02 | 6.19e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 229 | 3.60e-01 | -3.52e-02 | 6.45e-01 |
| GOBP MRNA EXPORT FROM NUCLEUS | 63 | 6.29e-01 | -3.52e-02 | 8.24e-01 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 8.33e-01 | 3.52e-02 | 9.27e-01 |
| GOBP DNA MODIFICATION | 82 | 5.82e-01 | -3.52e-02 | 8.01e-01 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 40 | 7.01e-01 | -3.52e-02 | 8.63e-01 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 8 | 8.63e-01 | 3.51e-02 | 9.41e-01 |
| GOCC POSTSYNAPTIC MEMBRANE | 108 | 5.29e-01 | -3.51e-02 | 7.70e-01 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 131 | 4.89e-01 | -3.51e-02 | 7.46e-01 |
| GOMF MHC CLASS I RECEPTOR ACTIVITY | 9 | 8.55e-01 | 3.51e-02 | 9.37e-01 |
| GOCC PRESYNAPTIC MEMBRANE | 79 | 5.91e-01 | -3.50e-02 | 8.05e-01 |
| GOBP DTTP METABOLIC PROCESS | 5 | 8.92e-01 | -3.50e-02 | 9.55e-01 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 710 | 1.16e-01 | 3.50e-02 | 3.57e-01 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 66 | 6.24e-01 | 3.49e-02 | 8.20e-01 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 117 | 5.15e-01 | 3.49e-02 | 7.61e-01 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 30 | 7.41e-01 | 3.48e-02 | 8.84e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 16 | 8.10e-01 | 3.48e-02 | 9.15e-01 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 11 | 8.42e-01 | 3.48e-02 | 9.31e-01 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 119 | 5.13e-01 | 3.48e-02 | 7.59e-01 |
| GOMF MONOOXYGENASE ACTIVITY | 36 | 7.18e-01 | 3.48e-02 | 8.74e-01 |
| GOMF PHOSPHATASE ACTIVITY | 199 | 3.99e-01 | -3.47e-02 | 6.80e-01 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 53 | 6.62e-01 | -3.47e-02 | 8.43e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 9 | 8.57e-01 | -3.47e-02 | 9.38e-01 |
| GOCC CORE MEDIATOR COMPLEX | 26 | 7.60e-01 | 3.47e-02 | 8.90e-01 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 21 | 7.83e-01 | 3.47e-02 | 9.03e-01 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 21 | 7.83e-01 | 3.47e-02 | 9.03e-01 |
| GOBP MACROMOLECULE DEPALMITOYLATION | 11 | 8.42e-01 | -3.46e-02 | 9.31e-01 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 11 | 8.42e-01 | -3.46e-02 | 9.31e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 40 | 7.05e-01 | 3.46e-02 | 8.65e-01 |
| GOBP TRICARBOXYLIC ACID CYCLE | 29 | 7.47e-01 | -3.46e-02 | 8.85e-01 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 11 | 8.42e-01 | 3.46e-02 | 9.31e-01 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 14 | 8.23e-01 | -3.46e-02 | 9.22e-01 |
| GOMF CELL MATRIX ADHESION MEDIATOR ACTIVITY | 5 | 8.94e-01 | 3.45e-02 | 9.56e-01 |
| GOCC LATE ENDOSOME MEMBRANE | 148 | 4.69e-01 | 3.45e-02 | 7.33e-01 |
| GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 8 | 8.66e-01 | 3.45e-02 | 9.42e-01 |
| GOBP CHRONIC INFLAMMATORY RESPONSE | 13 | 8.29e-01 | 3.45e-02 | 9.25e-01 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 10 | 8.50e-01 | 3.45e-02 | 9.34e-01 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 54 | 6.62e-01 | -3.45e-02 | 8.42e-01 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 25 | 7.66e-01 | 3.44e-02 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 10 | 8.50e-01 | -3.44e-02 | 9.34e-01 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 6 | 8.84e-01 | -3.44e-02 | 9.51e-01 |
| GOBP CMP METABOLIC PROCESS | 7 | 8.75e-01 | 3.43e-02 | 9.47e-01 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 415 | 2.33e-01 | 3.43e-02 | 5.16e-01 |
| GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 8.84e-01 | -3.43e-02 | 9.51e-01 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 17 | 8.07e-01 | -3.43e-02 | 9.14e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 35 | 7.26e-01 | 3.42e-02 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 5 | 8.95e-01 | 3.42e-02 | 9.56e-01 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 33 | 7.34e-01 | 3.42e-02 | 8.80e-01 |
| GOBP VACUOLE ORGANIZATION | 205 | 4.01e-01 | 3.41e-02 | 6.81e-01 |
| GOBP NOREPINEPHRINE TRANSPORT | 7 | 8.76e-01 | 3.41e-02 | 9.47e-01 |
| GOBP RELAXATION OF MUSCLE | 23 | 7.77e-01 | -3.41e-02 | 8.99e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 49 | 6.80e-01 | -3.40e-02 | 8.51e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 16 | 8.14e-01 | -3.40e-02 | 9.17e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 43 | 7.00e-01 | -3.40e-02 | 8.63e-01 |
| GOMF PROTEIN PHOSPHATASE BINDING | 116 | 5.27e-01 | -3.40e-02 | 7.69e-01 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 32 | 7.39e-01 | 3.40e-02 | 8.83e-01 |
| GOCC DESMOSOME | 11 | 8.45e-01 | 3.40e-02 | 9.32e-01 |
| GOBP PIRNA PROCESSING | 9 | 8.60e-01 | -3.39e-02 | 9.39e-01 |
| GOBP NEURON PROJECTION ARBORIZATION | 20 | 7.93e-01 | -3.39e-02 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 31 | 7.44e-01 | 3.39e-02 | 8.85e-01 |
| GOMF CHOLESTEROL BINDING | 34 | 7.33e-01 | -3.39e-02 | 8.79e-01 |
| GOMF TPR DOMAIN BINDING | 7 | 8.77e-01 | 3.39e-02 | 9.47e-01 |
| GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 8 | 8.68e-01 | -3.39e-02 | 9.43e-01 |
| GOBP PROTEIN DEPALMITOYLATION | 8 | 8.68e-01 | 3.39e-02 | 9.43e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 23 | 7.79e-01 | -3.38e-02 | 9.00e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 13 | 8.33e-01 | -3.38e-02 | 9.27e-01 |
| GOBP HETEROCYCLE CATABOLIC PROCESS | 394 | 2.52e-01 | -3.38e-02 | 5.41e-01 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 913 | 8.72e-02 | -3.38e-02 | 3.08e-01 |
| GOBP LIPID LOCALIZATION | 295 | 3.21e-01 | 3.37e-02 | 6.10e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 263 | 3.48e-01 | -3.37e-02 | 6.33e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 56 | 6.63e-01 | 3.37e-02 | 8.43e-01 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 318 | 3.04e-01 | -3.37e-02 | 5.92e-01 |
| GOBP FOCAL ADHESION ASSEMBLY | 63 | 6.44e-01 | -3.37e-02 | 8.32e-01 |
| GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 8 | 8.69e-01 | -3.36e-02 | 9.44e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 61 | 6.50e-01 | 3.36e-02 | 8.36e-01 |
| GOMF CYTOKINE ACTIVITY | 79 | 6.06e-01 | -3.36e-02 | 8.13e-01 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 113 | 5.38e-01 | -3.36e-02 | 7.76e-01 |
| GOMF THIOREDOXIN DISULFIDE REDUCTASE NADP ACTIVITY | 6 | 8.87e-01 | 3.35e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 31 | 7.47e-01 | 3.35e-02 | 8.85e-01 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 14 | 8.28e-01 | -3.35e-02 | 9.25e-01 |
| GOBP APOPTOTIC PROCESS | 1345 | 4.30e-02 | -3.34e-02 | 2.09e-01 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 82 | 6.01e-01 | -3.34e-02 | 8.11e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 8 | 8.70e-01 | 3.34e-02 | 9.44e-01 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 11 | 8.48e-01 | -3.34e-02 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 12 | 8.41e-01 | -3.34e-02 | 9.31e-01 |
| GOCC RECYCLING ENDOSOME | 152 | 4.79e-01 | 3.33e-02 | 7.40e-01 |
| GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 8 | 8.70e-01 | 3.33e-02 | 9.44e-01 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 45 | 6.99e-01 | 3.33e-02 | 8.63e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 51 | 6.81e-01 | -3.33e-02 | 8.52e-01 |
| GOBP CELLULAR RESPONSE TO HEAT | 52 | 6.78e-01 | 3.33e-02 | 8.51e-01 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 9 | 8.63e-01 | 3.32e-02 | 9.41e-01 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 11 | 8.49e-01 | 3.32e-02 | 9.33e-01 |
| GOBP MUSCLE CONTRACTION | 184 | 4.38e-01 | 3.32e-02 | 7.10e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 5 | 8.98e-01 | 3.32e-02 | 9.58e-01 |
| GOMF ADENOSINE RECEPTOR BINDING | 5 | 8.98e-01 | 3.32e-02 | 9.58e-01 |
| GOBP CHLORIDE TRANSPORT | 51 | 6.82e-01 | 3.32e-02 | 8.52e-01 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 11 | 8.49e-01 | 3.32e-02 | 9.33e-01 |
| GOBP AMINO ACID CATABOLIC PROCESS | 76 | 6.17e-01 | 3.32e-02 | 8.18e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 100 | 5.67e-01 | -3.32e-02 | 7.92e-01 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 85 | 5.98e-01 | -3.31e-02 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 12 | 8.43e-01 | -3.31e-02 | 9.31e-01 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 15 | 8.24e-01 | 3.31e-02 | 9.23e-01 |
| GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT | 6 | 8.88e-01 | -3.31e-02 | 9.54e-01 |
| GOMF EXTRACELLULARLY ATP GATED MONOATOMIC CATION CHANNEL ACTIVITY | 5 | 8.98e-01 | 3.31e-02 | 9.58e-01 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 46 | 6.98e-01 | -3.31e-02 | 8.62e-01 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 9 | 8.64e-01 | -3.31e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 11 | 8.49e-01 | -3.31e-02 | 9.34e-01 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 211 | 4.09e-01 | -3.31e-02 | 6.89e-01 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 81 | 6.09e-01 | 3.30e-02 | 8.14e-01 |
| GOBP EAR DEVELOPMENT | 100 | 5.70e-01 | -3.29e-02 | 7.94e-01 |
| GOMF ORGANIC ACID BINDING | 115 | 5.42e-01 | -3.29e-02 | 7.78e-01 |
| GOCC GOLGI ASSOCIATED VESICLE | 72 | 6.30e-01 | 3.29e-02 | 8.24e-01 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 45 | 7.03e-01 | 3.29e-02 | 8.64e-01 |
| GOMF ALPHA ACTININ BINDING | 14 | 8.32e-01 | -3.28e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 7 | 8.80e-01 | 3.28e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD | 6 | 8.89e-01 | -3.28e-02 | 9.54e-01 |
| GOBP REGULATION OF RESPONSE TO FOOD | 6 | 8.89e-01 | -3.28e-02 | 9.54e-01 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 139 | 5.05e-01 | 3.28e-02 | 7.54e-01 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 118 | 5.39e-01 | 3.28e-02 | 7.76e-01 |
| GOBP LATE ENDOSOME TO GOLGI TRANSPORT | 5 | 8.99e-01 | 3.28e-02 | 9.59e-01 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 20 | 8.00e-01 | -3.27e-02 | 9.10e-01 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 62 | 6.56e-01 | -3.27e-02 | 8.38e-01 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 88 | 5.96e-01 | -3.27e-02 | 8.08e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 28 | 7.65e-01 | -3.27e-02 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 13 | 8.38e-01 | -3.27e-02 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 10 | 8.58e-01 | -3.27e-02 | 9.38e-01 |
| GOCC GAMMA TUBULIN COMPLEX | 16 | 8.21e-01 | 3.26e-02 | 9.22e-01 |
| GOBP ENAMEL MINERALIZATION | 10 | 8.58e-01 | 3.26e-02 | 9.38e-01 |
| GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 11 | 8.52e-01 | -3.26e-02 | 9.35e-01 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 14 | 8.33e-01 | 3.25e-02 | 9.27e-01 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 42 | 7.16e-01 | 3.25e-02 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 171 | 4.64e-01 | -3.25e-02 | 7.30e-01 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 18 | 8.11e-01 | -3.25e-02 | 9.16e-01 |
| GOBP MATURATION OF LSU RRNA | 28 | 7.66e-01 | 3.25e-02 | 8.93e-01 |
| GOBP OOGENESIS | 59 | 6.67e-01 | -3.25e-02 | 8.45e-01 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 56 | 6.76e-01 | 3.23e-02 | 8.49e-01 |
| GOBP RESPONSE TO INTERFERON ALPHA | 14 | 8.34e-01 | -3.23e-02 | 9.28e-01 |
| GOCC P BODY | 88 | 6.02e-01 | 3.22e-02 | 8.11e-01 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 17 | 8.18e-01 | 3.22e-02 | 9.20e-01 |
| GOBP RESPONSE TO TUMOR CELL | 32 | 7.53e-01 | -3.21e-02 | 8.88e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 8.92e-01 | -3.21e-02 | 9.55e-01 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 277 | 3.60e-01 | -3.21e-02 | 6.45e-01 |
| GOBP REGULATION OF BLOOD CIRCULATION | 124 | 5.40e-01 | -3.19e-02 | 7.77e-01 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 17 | 8.20e-01 | -3.19e-02 | 9.21e-01 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 8.10e-01 | -3.19e-02 | 9.15e-01 |
| GOBP REGULATION OF CELL DIVISION | 125 | 5.39e-01 | -3.19e-02 | 7.76e-01 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 10 | 8.62e-01 | -3.18e-02 | 9.40e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 18 | 8.16e-01 | -3.18e-02 | 9.18e-01 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 19 | 8.11e-01 | -3.17e-02 | 9.16e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 24 | 7.88e-01 | -3.17e-02 | 9.05e-01 |
| GOCC PCG PROTEIN COMPLEX | 34 | 7.49e-01 | -3.17e-02 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL | 5 | 9.02e-01 | 3.17e-02 | 9.61e-01 |
| GOCC EXTRINSIC COMPONENT OF ENDOSOME MEMBRANE | 5 | 9.02e-01 | 3.17e-02 | 9.61e-01 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 44 | 7.17e-01 | -3.17e-02 | 8.72e-01 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1145 | 7.53e-02 | 3.16e-02 | 2.86e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 12 | 8.50e-01 | 3.16e-02 | 9.34e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 19 | 8.12e-01 | -3.15e-02 | 9.16e-01 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 381 | 2.93e-01 | 3.15e-02 | 5.81e-01 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 8 | 8.77e-01 | 3.15e-02 | 9.47e-01 |
| GOBP KERATINOCYTE DIFFERENTIATION | 69 | 6.51e-01 | -3.15e-02 | 8.37e-01 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 13 | 8.44e-01 | 3.14e-02 | 9.32e-01 |
| GOBP PROTEIN ACYLATION | 122 | 5.49e-01 | -3.14e-02 | 7.82e-01 |
| GOBP CELLULAR RESPONSE TO SODIUM ARSENITE | 5 | 9.03e-01 | 3.14e-02 | 9.61e-01 |
| GOBP RESPONSE TO SODIUM ARSENITE | 5 | 9.03e-01 | 3.14e-02 | 9.61e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 11 | 8.57e-01 | -3.13e-02 | 9.38e-01 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 11 | 8.57e-01 | -3.13e-02 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 24 | 7.91e-01 | -3.12e-02 | 9.06e-01 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 12 | 8.51e-01 | 3.12e-02 | 9.35e-01 |
| GOBP FATTY ACID HOMEOSTASIS | 11 | 8.58e-01 | 3.12e-02 | 9.38e-01 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 83 | 6.24e-01 | -3.12e-02 | 8.20e-01 |
| GOCC FICOLIN 1 RICH GRANULE LUMEN | 120 | 5.56e-01 | -3.12e-02 | 7.86e-01 |
| GOBP RESPONSE TO HYPEROXIA | 14 | 8.40e-01 | 3.12e-02 | 9.30e-01 |
| GOMF COA HYDROLASE ACTIVITY | 16 | 8.29e-01 | 3.11e-02 | 9.25e-01 |
| GOMF GAMMA CATENIN BINDING | 5 | 9.04e-01 | 3.11e-02 | 9.61e-01 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 10 | 8.65e-01 | 3.11e-02 | 9.42e-01 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 46 | 7.15e-01 | -3.11e-02 | 8.72e-01 |
| GOBP EAR MORPHOGENESIS | 47 | 7.12e-01 | 3.11e-02 | 8.70e-01 |
| GOBP MRNA MODIFICATION | 30 | 7.68e-01 | 3.11e-02 | 8.94e-01 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 14 | 8.41e-01 | 3.11e-02 | 9.30e-01 |
| GOBP TRANSMEMBRANE TRANSPORT | 867 | 1.25e-01 | 3.11e-02 | 3.71e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 37 | 7.44e-01 | -3.11e-02 | 8.85e-01 |
| GOBP CELL GROWTH | 330 | 3.34e-01 | -3.10e-02 | 6.20e-01 |
| GOBP RENAL FILTRATION | 11 | 8.59e-01 | -3.10e-02 | 9.38e-01 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 387 | 2.98e-01 | -3.10e-02 | 5.86e-01 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 55 | 6.92e-01 | -3.09e-02 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 12 | 8.53e-01 | 3.09e-02 | 9.35e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 13 | 8.47e-01 | 3.09e-02 | 9.33e-01 |
| GOBP REGULATION OF NEURON MATURATION | 6 | 8.96e-01 | 3.09e-02 | 9.57e-01 |
| GOBP NUCLEOSIDE SALVAGE | 10 | 8.66e-01 | 3.08e-02 | 9.42e-01 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 176 | 4.81e-01 | -3.08e-02 | 7.40e-01 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 446 | 2.67e-01 | -3.08e-02 | 5.57e-01 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 371 | 3.11e-01 | 3.08e-02 | 5.99e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 123 | 5.56e-01 | -3.08e-02 | 7.86e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 28 | 7.78e-01 | 3.08e-02 | 9.00e-01 |
| GOBP ONE CARBON METABOLIC PROCESS | 24 | 7.94e-01 | 3.08e-02 | 9.08e-01 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 43 | 7.27e-01 | 3.08e-02 | 8.78e-01 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 91 | 6.13e-01 | -3.07e-02 | 8.16e-01 |
| GOBP REGULATION OF PROTEIN SECRETION | 158 | 5.06e-01 | 3.07e-02 | 7.55e-01 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 9 | 8.73e-01 | -3.07e-02 | 9.46e-01 |
| GOBP CILIUM DISASSEMBLY | 5 | 9.06e-01 | -3.06e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 165 | 4.98e-01 | 3.06e-02 | 7.51e-01 |
| GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 7 | 8.88e-01 | -3.06e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 32 | 7.65e-01 | -3.06e-02 | 8.92e-01 |
| GOCC EARLY ENDOSOME | 335 | 3.40e-01 | -3.04e-02 | 6.26e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 20 | 8.14e-01 | -3.04e-02 | 9.17e-01 |
| GOBP SYNAPTIC VESICLE BUDDING | 8 | 8.82e-01 | -3.04e-02 | 9.50e-01 |
| GOBP HISTONE H3 ACETYLATION | 6 | 8.98e-01 | -3.03e-02 | 9.58e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 12 | 8.56e-01 | -3.03e-02 | 9.37e-01 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 14 | 8.45e-01 | -3.02e-02 | 9.32e-01 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 9 | 8.76e-01 | -3.01e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 13 | 8.51e-01 | 3.01e-02 | 9.34e-01 |
| GOCC MIDBODY | 187 | 4.79e-01 | -3.01e-02 | 7.40e-01 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 96 | 6.11e-01 | -3.01e-02 | 8.15e-01 |
| GOMF PROTEIN KINASE C BINDING | 37 | 7.52e-01 | -3.00e-02 | 8.88e-01 |
| GOBP ALLANTOIN METABOLIC PROCESS | 5 | 9.08e-01 | 3.00e-02 | 9.63e-01 |
| GOBP MITOPHAGY | 35 | 7.59e-01 | -2.99e-02 | 8.90e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 60 | 6.90e-01 | 2.98e-02 | 8.56e-01 |
| GOBP RESPONSE TO COLD | 33 | 7.67e-01 | -2.98e-02 | 8.93e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 299 | 3.78e-01 | 2.98e-02 | 6.59e-01 |
| GOBP PHOSPHOLIPID TRANSLOCATION | 34 | 7.64e-01 | -2.97e-02 | 8.92e-01 |
| GOBP RESPONSE TO IONIZING RADIATION | 119 | 5.76e-01 | -2.97e-02 | 7.98e-01 |
| GOMF BH3 DOMAIN BINDING | 5 | 9.08e-01 | -2.97e-02 | 9.63e-01 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 31 | 7.75e-01 | -2.97e-02 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 83 | 6.41e-01 | 2.97e-02 | 8.30e-01 |
| GOBP EYE MORPHOGENESIS | 80 | 6.47e-01 | -2.97e-02 | 8.34e-01 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 51 | 7.14e-01 | -2.97e-02 | 8.71e-01 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 32 | 7.72e-01 | -2.96e-02 | 8.95e-01 |
| GOBP VALINE METABOLIC PROCESS | 7 | 8.92e-01 | -2.96e-02 | 9.55e-01 |
| GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 6 | 9.00e-01 | -2.96e-02 | 9.60e-01 |
| GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 9.00e-01 | -2.96e-02 | 9.60e-01 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 28 | 7.87e-01 | -2.96e-02 | 9.04e-01 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 140 | 5.46e-01 | 2.96e-02 | 7.81e-01 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 14 | 8.48e-01 | -2.95e-02 | 9.33e-01 |
| GOMF SNRNA BINDING | 45 | 7.32e-01 | -2.95e-02 | 8.79e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 29 | 7.83e-01 | 2.95e-02 | 9.03e-01 |
| GOBP CEREBELLAR CORTEX FORMATION | 16 | 8.38e-01 | 2.95e-02 | 9.29e-01 |
| GOMF DIPHOSPHOTRANSFERASE ACTIVITY | 5 | 9.09e-01 | -2.94e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 38 | 7.54e-01 | -2.94e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 38 | 7.54e-01 | 2.94e-02 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 9 | 8.79e-01 | -2.94e-02 | 9.49e-01 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 25 | 7.99e-01 | 2.94e-02 | 9.10e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 172 | 5.08e-01 | -2.93e-02 | 7.56e-01 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 8.39e-01 | 2.93e-02 | 9.30e-01 |
| GOBP REGULATION OF ACTIN NUCLEATION | 30 | 7.82e-01 | 2.93e-02 | 9.02e-01 |
| GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 8 | 8.86e-01 | 2.92e-02 | 9.52e-01 |
| GOBP IRIS MORPHOGENESIS | 5 | 9.10e-01 | -2.92e-02 | 9.63e-01 |
| GOBP STRIATED MUSCLE CONTRACTION | 98 | 6.19e-01 | 2.91e-02 | 8.18e-01 |
| GOBP PEPTIDYL LYSINE DEACETYLATION | 7 | 8.94e-01 | 2.91e-02 | 9.56e-01 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 24 | 8.06e-01 | 2.90e-02 | 9.13e-01 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 255 | 4.26e-01 | -2.90e-02 | 7.03e-01 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 8.46e-01 | -2.90e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 29 | 7.87e-01 | 2.90e-02 | 9.04e-01 |
| GOBP SENSORY PERCEPTION OF BITTER TASTE | 6 | 9.02e-01 | -2.90e-02 | 9.61e-01 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 68 | 6.80e-01 | -2.90e-02 | 8.51e-01 |
| GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 8.74e-01 | -2.89e-02 | 9.46e-01 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 64 | 6.89e-01 | -2.89e-02 | 8.56e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 11 | 8.68e-01 | -2.89e-02 | 9.43e-01 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 46 | 7.35e-01 | -2.89e-02 | 8.80e-01 |
| GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 8.88e-01 | -2.88e-02 | 9.53e-01 |
| GOBP CELL PROJECTION ASSEMBLY | 452 | 2.98e-01 | -2.87e-02 | 5.85e-01 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 295 | 3.98e-01 | 2.87e-02 | 6.78e-01 |
| GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 7 | 8.95e-01 | -2.87e-02 | 9.57e-01 |
| GOCC ATPASE COMPLEX | 133 | 5.69e-01 | 2.86e-02 | 7.93e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 9 | 8.82e-01 | 2.86e-02 | 9.50e-01 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 22 | 8.16e-01 | 2.86e-02 | 9.19e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 11 | 8.70e-01 | 2.85e-02 | 9.44e-01 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 13 | 8.59e-01 | -2.85e-02 | 9.38e-01 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 50 | 7.28e-01 | -2.85e-02 | 8.78e-01 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 154 | 5.43e-01 | -2.85e-02 | 7.78e-01 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 39 | 7.59e-01 | -2.84e-02 | 8.90e-01 |
| GOBP DNA PROTECTION | 5 | 9.12e-01 | 2.84e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 8 | 8.90e-01 | -2.84e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 52 | 7.24e-01 | 2.83e-02 | 8.76e-01 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 89 | 6.45e-01 | -2.83e-02 | 8.32e-01 |
| GOBP MIDBRAIN DEVELOPMENT | 57 | 7.12e-01 | 2.83e-02 | 8.70e-01 |
| GOMF DNA POLYMERASE BINDING | 21 | 8.22e-01 | -2.83e-02 | 9.22e-01 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 46 | 7.40e-01 | 2.83e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 19 | 8.31e-01 | -2.83e-02 | 9.26e-01 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 37 | 7.66e-01 | -2.83e-02 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 153 | 5.47e-01 | -2.82e-02 | 7.81e-01 |
| GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 353 | 3.65e-01 | 2.82e-02 | 6.50e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 45 | 7.44e-01 | -2.81e-02 | 8.85e-01 |
| GOBP CELLULAR RESPONSE TO MANGANESE ION | 8 | 8.90e-01 | -2.81e-02 | 9.54e-01 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 131 | 5.79e-01 | -2.81e-02 | 8.00e-01 |
| GOCC CYTOPLASMIC STRESS GRANULE | 77 | 6.70e-01 | -2.81e-02 | 8.47e-01 |
| GOBP WOUND HEALING | 253 | 4.43e-01 | -2.81e-02 | 7.13e-01 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 26 | 8.04e-01 | -2.81e-02 | 9.13e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 38 | 7.65e-01 | -2.81e-02 | 8.92e-01 |
| GOBP SPECIFICATION OF SYMMETRY | 77 | 6.71e-01 | -2.81e-02 | 8.47e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS | 6 | 9.05e-01 | 2.80e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 18 | 8.37e-01 | 2.80e-02 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 42 | 7.54e-01 | -2.80e-02 | 8.88e-01 |
| GOBP DNA STRAND ELONGATION | 36 | 7.72e-01 | -2.79e-02 | 8.95e-01 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 131 | 5.82e-01 | -2.79e-02 | 8.01e-01 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 9 | 8.85e-01 | 2.79e-02 | 9.52e-01 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 16 | 8.47e-01 | -2.79e-02 | 9.33e-01 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 410 | 3.36e-01 | -2.78e-02 | 6.22e-01 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 19 | 8.34e-01 | -2.78e-02 | 9.27e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 39 | 7.64e-01 | 2.78e-02 | 8.92e-01 |
| GOCC PERICILIARY MEMBRANE COMPARTMENT | 5 | 9.14e-01 | 2.78e-02 | 9.65e-01 |
| GOBP CYTOLYSIS | 5 | 9.15e-01 | -2.77e-02 | 9.65e-01 |
| GOBP REGULATION OF STEROID HORMONE SECRETION | 11 | 8.74e-01 | -2.77e-02 | 9.46e-01 |
| GOMF PDZ DOMAIN BINDING | 54 | 7.25e-01 | -2.76e-02 | 8.77e-01 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 131 | 5.85e-01 | 2.76e-02 | 8.03e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 10 | 8.80e-01 | -2.76e-02 | 9.49e-01 |
| GOBP REGULATION OF CELL GROWTH | 279 | 4.29e-01 | -2.76e-02 | 7.05e-01 |
| GOBP PYROPTOSIS | 27 | 8.04e-01 | -2.76e-02 | 9.13e-01 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 15 | 8.53e-01 | 2.76e-02 | 9.35e-01 |
| GOMF PURINE NUCLEOTIDE BINDING | 1530 | 7.74e-02 | -2.75e-02 | 2.89e-01 |
| GOMF ANTIOXIDANT ACTIVITY | 55 | 7.24e-01 | 2.75e-02 | 8.76e-01 |
| GOCC GOLGI CISTERNA MEMBRANE | 57 | 7.20e-01 | 2.75e-02 | 8.74e-01 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 192 | 5.12e-01 | 2.75e-02 | 7.59e-01 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 21 | 8.28e-01 | -2.75e-02 | 9.24e-01 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 91 | 6.52e-01 | 2.74e-02 | 8.37e-01 |
| GOCC CLATHRIN COATED VESICLE | 154 | 5.58e-01 | 2.74e-02 | 7.87e-01 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 291 | 4.23e-01 | -2.74e-02 | 7.00e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION | 6 | 9.08e-01 | -2.74e-02 | 9.63e-01 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 9.00e-01 | 2.74e-02 | 9.60e-01 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 26 | 8.09e-01 | -2.73e-02 | 9.15e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 7 | 9.01e-01 | 2.72e-02 | 9.60e-01 |
| GOCC MRNA EDITING COMPLEX | 13 | 8.65e-01 | -2.72e-02 | 9.42e-01 |
| GOBP NCRNA EXPORT FROM NUCLEUS | 9 | 8.88e-01 | 2.71e-02 | 9.53e-01 |
| GOCC SPECTRIN | 6 | 9.08e-01 | -2.71e-02 | 9.63e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 313 | 4.11e-01 | -2.71e-02 | 6.91e-01 |
| GOMF RRNA BINDING | 64 | 7.08e-01 | 2.71e-02 | 8.67e-01 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 133 | 5.90e-01 | -2.71e-02 | 8.05e-01 |
| GOBP REGULATION OF CATABOLIC PROCESS | 841 | 1.87e-01 | -2.70e-02 | 4.63e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 8 | 8.95e-01 | -2.70e-02 | 9.56e-01 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 419 | 3.46e-01 | -2.70e-02 | 6.31e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 46 | 7.52e-01 | -2.69e-02 | 8.88e-01 |
| GOCC KINOCILIUM | 6 | 9.09e-01 | 2.69e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 8 | 8.95e-01 | -2.69e-02 | 9.57e-01 |
| GOMF ATP HYDROLYSIS ACTIVITY | 321 | 4.09e-01 | -2.69e-02 | 6.89e-01 |
| GOBP CARDIAC MUSCLE CONTRACTION | 76 | 6.85e-01 | 2.69e-02 | 8.54e-01 |
| GOBP CELLULAR RESPONSE TO RADIATION | 142 | 5.81e-01 | -2.69e-02 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 59 | 7.21e-01 | -2.69e-02 | 8.75e-01 |
| GOBP TUBULIN COMPLEX ASSEMBLY | 9 | 8.89e-01 | 2.69e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 5 | 9.17e-01 | 2.69e-02 | 9.65e-01 |
| GOBP RRNA TRANSCRIPTION | 33 | 7.90e-01 | -2.68e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 42 | 7.64e-01 | -2.67e-02 | 8.92e-01 |
| GOCC NEURON PROJECTION CYTOPLASM | 69 | 7.01e-01 | 2.67e-02 | 8.63e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 123 | 6.09e-01 | -2.67e-02 | 8.14e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 21 | 8.32e-01 | 2.67e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 48 | 7.49e-01 | -2.67e-02 | 8.87e-01 |
| GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL | 5 | 9.18e-01 | -2.67e-02 | 9.65e-01 |
| GOBP VESICLE CARGO LOADING | 27 | 8.11e-01 | -2.67e-02 | 9.16e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 252 | 4.68e-01 | 2.66e-02 | 7.33e-01 |
| GOMF D1 DOPAMINE RECEPTOR BINDING | 5 | 9.18e-01 | -2.66e-02 | 9.65e-01 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 20 | 8.37e-01 | 2.66e-02 | 9.29e-01 |
| GOBP SYNAPTIC VESICLE MATURATION | 21 | 8.33e-01 | 2.65e-02 | 9.27e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 10 | 8.85e-01 | -2.65e-02 | 9.52e-01 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 113 | 6.27e-01 | -2.65e-02 | 8.22e-01 |
| GOCC CELL CELL CONTACT ZONE | 48 | 7.51e-01 | 2.65e-02 | 8.87e-01 |
| GOMF DEATH DOMAIN BINDING | 10 | 8.85e-01 | 2.65e-02 | 9.52e-01 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 24 | 8.22e-01 | 2.65e-02 | 9.22e-01 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 12 | 8.74e-01 | 2.64e-02 | 9.46e-01 |
| GOBP DOPAMINE METABOLIC PROCESS | 18 | 8.46e-01 | 2.64e-02 | 9.32e-01 |
| GOMF SNRNP BINDING | 9 | 8.91e-01 | -2.64e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 23 | 8.27e-01 | -2.63e-02 | 9.24e-01 |
| GOBP PROTEIN POLYUBIQUITINATION | 197 | 5.25e-01 | 2.63e-02 | 7.68e-01 |
| GOBP RNA PROCESSING | 863 | 1.95e-01 | 2.63e-02 | 4.72e-01 |
| GOBP REGULATION OF DNA BINDING | 62 | 7.21e-01 | -2.63e-02 | 8.75e-01 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 7 | 9.05e-01 | 2.62e-02 | 9.61e-01 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 21 | 8.36e-01 | 2.61e-02 | 9.29e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 28 | 8.11e-01 | 2.61e-02 | 9.16e-01 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 120 | 6.23e-01 | 2.60e-02 | 8.20e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 210 | 5.17e-01 | 2.60e-02 | 7.62e-01 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 12 | 8.76e-01 | -2.60e-02 | 9.47e-01 |
| GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 26 | 8.19e-01 | -2.59e-02 | 9.21e-01 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 132 | 6.08e-01 | -2.59e-02 | 8.14e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER | 700 | 2.47e-01 | -2.59e-02 | 5.35e-01 |
| GOMF FMN BINDING | 9 | 8.93e-01 | -2.58e-02 | 9.56e-01 |
| GOBP WALKING BEHAVIOR | 20 | 8.42e-01 | 2.58e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 117 | 6.31e-01 | 2.57e-02 | 8.25e-01 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 11 | 8.83e-01 | -2.57e-02 | 9.51e-01 |
| GOBP REGULATION OF AXONOGENESIS | 92 | 6.71e-01 | -2.57e-02 | 8.47e-01 |
| GOBP MESENCHYME MORPHOGENESIS | 26 | 8.21e-01 | 2.57e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 65 | 7.21e-01 | -2.56e-02 | 8.75e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 82 | 6.89e-01 | -2.56e-02 | 8.56e-01 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 14 | 8.68e-01 | 2.56e-02 | 9.43e-01 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 458 | 3.51e-01 | -2.56e-02 | 6.36e-01 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 26 | 8.22e-01 | 2.56e-02 | 9.22e-01 |
| GOBP APOPTOTIC CELL CLEARANCE | 31 | 8.06e-01 | 2.55e-02 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 38 | 7.85e-01 | -2.55e-02 | 9.03e-01 |
| GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 8 | 9.01e-01 | -2.55e-02 | 9.60e-01 |
| GOMF BILE ACID BINDING | 5 | 9.21e-01 | -2.55e-02 | 9.67e-01 |
| GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX | 7 | 9.07e-01 | 2.55e-02 | 9.63e-01 |
| GOMF LIPASE ACTIVITY | 71 | 7.11e-01 | 2.55e-02 | 8.69e-01 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 222 | 5.15e-01 | -2.54e-02 | 7.60e-01 |
| GOBP EPITHELIAL CELL CELL ADHESION | 12 | 8.79e-01 | -2.54e-02 | 9.49e-01 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 209 | 5.27e-01 | -2.54e-02 | 7.69e-01 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 22 | 8.37e-01 | -2.54e-02 | 9.29e-01 |
| GOBP L KYNURENINE METABOLIC PROCESS | 6 | 9.14e-01 | 2.54e-02 | 9.65e-01 |
| GOCC UBIQUITIN LIGASE COMPLEX | 284 | 4.64e-01 | 2.53e-02 | 7.30e-01 |
| GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 9.08e-01 | -2.53e-02 | 9.63e-01 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 147 | 5.98e-01 | 2.52e-02 | 8.10e-01 |
| GOCC TRANSLOCON COMPLEX | 6 | 9.15e-01 | -2.52e-02 | 9.65e-01 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 64 | 7.28e-01 | -2.52e-02 | 8.78e-01 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 59 | 7.39e-01 | 2.51e-02 | 8.83e-01 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 25 | 8.28e-01 | 2.51e-02 | 9.25e-01 |
| GOBP SPHINGOID METABOLIC PROCESS | 17 | 8.58e-01 | -2.50e-02 | 9.38e-01 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 15 | 8.67e-01 | 2.50e-02 | 9.43e-01 |
| GOMF METALLOPEPTIDASE ACTIVITY | 103 | 6.62e-01 | -2.50e-02 | 8.42e-01 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 11 | 8.86e-01 | 2.50e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 82 | 6.96e-01 | 2.50e-02 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 40 | 7.85e-01 | -2.49e-02 | 9.03e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 55 | 7.50e-01 | -2.48e-02 | 8.87e-01 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 152 | 5.99e-01 | -2.47e-02 | 8.10e-01 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 62 | 7.36e-01 | -2.47e-02 | 8.81e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 7 | 9.10e-01 | -2.47e-02 | 9.63e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 25 | 8.31e-01 | 2.47e-02 | 9.26e-01 |
| GOMF KINESIN BINDING | 33 | 8.07e-01 | 2.46e-02 | 9.14e-01 |
| GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 6 | 9.17e-01 | -2.46e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 22 | 8.42e-01 | -2.46e-02 | 9.31e-01 |
| GOBP STEROID METABOLIC PROCESS | 184 | 5.68e-01 | -2.45e-02 | 7.93e-01 |
| GOBP PORE COMPLEX ASSEMBLY | 20 | 8.50e-01 | -2.45e-02 | 9.34e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 14 | 8.74e-01 | 2.44e-02 | 9.46e-01 |
| GOBP MANNOSYLATION | 20 | 8.50e-01 | -2.44e-02 | 9.34e-01 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 30 | 8.17e-01 | -2.44e-02 | 9.19e-01 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 12 | 8.84e-01 | -2.44e-02 | 9.51e-01 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 29 | 8.20e-01 | 2.44e-02 | 9.21e-01 |
| GOBP INTERLEUKIN 1 ALPHA PRODUCTION | 5 | 9.25e-01 | 2.44e-02 | 9.67e-01 |
| GOBP STEROL METABOLIC PROCESS | 98 | 6.77e-01 | 2.44e-02 | 8.50e-01 |
| GOCC ACTIN CYTOSKELETON | 347 | 4.37e-01 | -2.44e-02 | 7.10e-01 |
| GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 9.18e-01 | -2.43e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 25 | 8.33e-01 | 2.43e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 6 | 9.18e-01 | -2.43e-02 | 9.65e-01 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 31 | 8.15e-01 | -2.43e-02 | 9.18e-01 |
| GOBP REGULATION OF AUTOPHAGY | 307 | 4.66e-01 | -2.43e-02 | 7.31e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 9.00e-01 | -2.43e-02 | 9.59e-01 |
| GOCC SUPRAMOLECULAR POLYMER | 598 | 3.15e-01 | -2.42e-02 | 6.04e-01 |
| GOBP COPPER ION TRANSPORT | 14 | 8.76e-01 | 2.42e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 14 | 8.76e-01 | -2.42e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 13 | 8.80e-01 | 2.41e-02 | 9.49e-01 |
| GOBP REGULATION OF APPETITE | 8 | 9.06e-01 | -2.41e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 99 | 6.80e-01 | 2.40e-02 | 8.51e-01 |
| GOBP POSITIVE REGULATION OF RNA BINDING | 7 | 9.12e-01 | -2.40e-02 | 9.64e-01 |
| GOBP REGULATION OF INSULIN SECRETION | 93 | 6.89e-01 | 2.40e-02 | 8.56e-01 |
| GOCC NUCLEAR MEMBRANE | 260 | 5.07e-01 | -2.40e-02 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 31 | 8.17e-01 | -2.40e-02 | 9.19e-01 |
| GOMF GATED CHANNEL ACTIVITY | 119 | 6.52e-01 | 2.40e-02 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 12 | 8.86e-01 | -2.40e-02 | 9.52e-01 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 105 | 6.72e-01 | -2.39e-02 | 8.48e-01 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 18 | 8.61e-01 | 2.38e-02 | 9.39e-01 |
| GOBP SPHINGOMYELIN CATABOLIC PROCESS | 5 | 9.27e-01 | 2.37e-02 | 9.68e-01 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 744 | 2.75e-01 | 2.37e-02 | 5.65e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 8 | 9.08e-01 | -2.37e-02 | 9.63e-01 |
| GOBP REGULATION OF PROTEIN FOLDING | 8 | 9.08e-01 | 2.37e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 56 | 7.59e-01 | -2.37e-02 | 8.90e-01 |
| GOCC SPERM MIDPIECE | 30 | 8.22e-01 | 2.37e-02 | 9.22e-01 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 24 | 8.41e-01 | 2.37e-02 | 9.30e-01 |
| GOMF ALCOHOL BINDING | 51 | 7.70e-01 | -2.37e-02 | 8.94e-01 |
| GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 5 | 9.27e-01 | 2.37e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 8 | 9.08e-01 | -2.36e-02 | 9.63e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 38 | 8.02e-01 | -2.35e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 15 | 8.75e-01 | 2.35e-02 | 9.47e-01 |
| GOBP OPTIC NERVE DEVELOPMENT | 13 | 8.84e-01 | 2.35e-02 | 9.51e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 104 | 6.81e-01 | -2.34e-02 | 8.52e-01 |
| GOBP RESPONSE TO VIRUS | 328 | 4.69e-01 | -2.33e-02 | 7.33e-01 |
| GOBP NEURON PROJECTION EXTENSION | 114 | 6.68e-01 | -2.33e-02 | 8.46e-01 |
| GOBP ALCOHOL METABOLIC PROCESS | 238 | 5.37e-01 | 2.33e-02 | 7.75e-01 |
| GOBP VIRAL PROCESS | 354 | 4.55e-01 | -2.32e-02 | 7.23e-01 |
| GOBP NUCLEOBASE TRANSPORT | 9 | 9.04e-01 | -2.32e-02 | 9.61e-01 |
| GOCC AXONAL GROWTH CONE | 18 | 8.65e-01 | 2.32e-02 | 9.42e-01 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 56 | 7.64e-01 | -2.32e-02 | 8.92e-01 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 25 | 8.41e-01 | -2.32e-02 | 9.30e-01 |
| GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 9 | 9.04e-01 | 2.31e-02 | 9.61e-01 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 156 | 6.19e-01 | 2.31e-02 | 8.18e-01 |
| GOMF STAT FAMILY PROTEIN BINDING | 8 | 9.10e-01 | -2.31e-02 | 9.63e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 21 | 8.55e-01 | 2.31e-02 | 9.36e-01 |
| GOBP CRANIAL NERVE FORMATION | 6 | 9.22e-01 | 2.31e-02 | 9.67e-01 |
| GOBP PROTEIN STABILIZATION | 177 | 5.98e-01 | 2.30e-02 | 8.09e-01 |
| GOCC APICOLATERAL PLASMA MEMBRANE | 9 | 9.05e-01 | 2.30e-02 | 9.61e-01 |
| GOBP TORC1 SIGNALING | 90 | 7.07e-01 | -2.30e-02 | 8.67e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 14 | 8.82e-01 | 2.29e-02 | 9.50e-01 |
| GOMF LIPID TRANSPORTER ACTIVITY | 103 | 6.88e-01 | -2.29e-02 | 8.56e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 57 | 7.65e-01 | 2.29e-02 | 8.92e-01 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 252 | 5.32e-01 | -2.29e-02 | 7.73e-01 |
| GOBP NEURAL TUBE PATTERNING | 25 | 8.43e-01 | -2.29e-02 | 9.31e-01 |
| GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY | 5 | 9.30e-01 | 2.28e-02 | 9.70e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 38 | 8.08e-01 | -2.27e-02 | 9.14e-01 |
| GOCC FIBRILLAR CENTER | 129 | 6.56e-01 | -2.27e-02 | 8.39e-01 |
| GOBP SOMATIC STEM CELL DIVISION | 6 | 9.23e-01 | -2.27e-02 | 9.67e-01 |
| GOMF LONG CHAIN FATTY ACID BINDING | 11 | 8.96e-01 | 2.27e-02 | 9.57e-01 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 12 | 8.92e-01 | 2.27e-02 | 9.55e-01 |
| GOBP REGULATION OF SECRETION | 358 | 4.64e-01 | -2.26e-02 | 7.30e-01 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 11 | 8.97e-01 | -2.26e-02 | 9.58e-01 |
| GOBP RETINAL METABOLIC PROCESS | 11 | 8.97e-01 | -2.26e-02 | 9.58e-01 |
| GOBP CELLULAR HOMEOSTASIS | 522 | 3.81e-01 | -2.25e-02 | 6.62e-01 |
| GOMF NF KAPPAB INDUCING KINASE ACTIVITY | 6 | 9.24e-01 | 2.25e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 68 | 7.49e-01 | -2.25e-02 | 8.87e-01 |
| GOCC CORVET COMPLEX | 7 | 9.18e-01 | 2.24e-02 | 9.65e-01 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 79 | 7.31e-01 | -2.24e-02 | 8.79e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 81 | 7.27e-01 | -2.24e-02 | 8.78e-01 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 11 | 8.98e-01 | -2.24e-02 | 9.58e-01 |
| GOBP TELOMERE LOCALIZATION | 7 | 9.18e-01 | 2.24e-02 | 9.65e-01 |
| GOBP CELL JUNCTION MAINTENANCE | 25 | 8.46e-01 | 2.24e-02 | 9.32e-01 |
| GOMF PROTEIN KINASE C ACTIVITY | 11 | 8.98e-01 | 2.24e-02 | 9.58e-01 |
| GOBP GERM CELL DEVELOPMENT | 182 | 6.08e-01 | -2.21e-02 | 8.14e-01 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 9 | 9.09e-01 | 2.20e-02 | 9.63e-01 |
| GOBP CYTOKINETIC PROCESS | 41 | 8.07e-01 | 2.20e-02 | 9.14e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 8 | 9.14e-01 | -2.20e-02 | 9.65e-01 |
| GOCC MALE GERM CELL NUCLEUS | 37 | 8.17e-01 | 2.20e-02 | 9.19e-01 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 9 | 9.09e-01 | -2.20e-02 | 9.63e-01 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 30 | 8.35e-01 | 2.20e-02 | 9.28e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 6 | 9.26e-01 | 2.20e-02 | 9.68e-01 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 17 | 8.76e-01 | 2.19e-02 | 9.47e-01 |
| GOBP PROTEIN PROCESSING | 161 | 6.32e-01 | 2.19e-02 | 8.26e-01 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 24 | 8.53e-01 | -2.18e-02 | 9.35e-01 |
| GOBP AMINO ACID TRANSPORT | 86 | 7.27e-01 | -2.18e-02 | 8.77e-01 |
| GOCC CYTOPLASMIC MICROTUBULE | 64 | 7.64e-01 | -2.17e-02 | 8.92e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 7 | 9.22e-01 | -2.15e-02 | 9.67e-01 |
| GOBP NEGATIVE REGULATION OF SECRETION | 93 | 7.21e-01 | -2.15e-02 | 8.75e-01 |
| GOBP SENSORY PERCEPTION OF PAIN | 37 | 8.21e-01 | 2.15e-02 | 9.22e-01 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 122 | 6.83e-01 | -2.14e-02 | 8.52e-01 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 175 | 6.26e-01 | -2.14e-02 | 8.21e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 44 | 8.06e-01 | -2.14e-02 | 9.14e-01 |
| GOBP ACTIN FILAMENT NETWORK FORMATION | 8 | 9.17e-01 | -2.14e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 11 | 9.02e-01 | -2.14e-02 | 9.61e-01 |
| GOBP RNA LOCALIZATION | 178 | 6.24e-01 | -2.13e-02 | 8.20e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 74 | 7.52e-01 | -2.13e-02 | 8.88e-01 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 70 | 7.59e-01 | -2.12e-02 | 8.90e-01 |
| GOBP FAS SIGNALING PATHWAY | 6 | 9.28e-01 | 2.12e-02 | 9.69e-01 |
| GOBP STEROL TRANSPORT | 85 | 7.36e-01 | -2.11e-02 | 8.81e-01 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 15 | 8.87e-01 | -2.11e-02 | 9.53e-01 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 110 | 7.02e-01 | -2.11e-02 | 8.64e-01 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 168 | 6.39e-01 | -2.10e-02 | 8.29e-01 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 22 | 8.65e-01 | 2.10e-02 | 9.42e-01 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 14 | 8.92e-01 | -2.10e-02 | 9.55e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 32 | 8.37e-01 | 2.10e-02 | 9.29e-01 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 11 | 9.04e-01 | -2.10e-02 | 9.61e-01 |
| GOBP CHONDROCYTE PROLIFERATION | 9 | 9.13e-01 | 2.09e-02 | 9.65e-01 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 212 | 6.00e-01 | -2.09e-02 | 8.10e-01 |
| GOCC METHYLTRANSFERASE COMPLEX | 93 | 7.28e-01 | -2.09e-02 | 8.78e-01 |
| GOBP MRNA TRANSPORT | 112 | 7.03e-01 | -2.09e-02 | 8.64e-01 |
| GOBP OXIDATIVE DEMETHYLATION | 7 | 9.24e-01 | 2.08e-02 | 9.67e-01 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 112 | 7.06e-01 | -2.07e-02 | 8.66e-01 |
| GOBP BILE ACID METABOLIC PROCESS | 28 | 8.50e-01 | -2.07e-02 | 9.34e-01 |
| GOBP DEVELOPMENTAL PIGMENTATION | 32 | 8.40e-01 | -2.06e-02 | 9.30e-01 |
| GOBP INORGANIC ANION TRANSPORT | 80 | 7.50e-01 | 2.06e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 9.25e-01 | -2.05e-02 | 9.67e-01 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 7 | 9.25e-01 | 2.05e-02 | 9.67e-01 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 514 | 4.29e-01 | 2.05e-02 | 7.05e-01 |
| GOBP NUCLEOTIDE SALVAGE | 16 | 8.87e-01 | 2.04e-02 | 9.53e-01 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 296 | 5.47e-01 | -2.04e-02 | 7.81e-01 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 212 | 6.09e-01 | 2.04e-02 | 8.14e-01 |
| GOCC ACTOMYOSIN | 57 | 7.90e-01 | -2.04e-02 | 9.05e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 9 | 9.16e-01 | -2.04e-02 | 9.65e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 283 | 5.57e-01 | -2.04e-02 | 7.87e-01 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 151 | 6.66e-01 | 2.04e-02 | 8.44e-01 |
| GOCC LATE ENDOSOME | 250 | 5.80e-01 | 2.04e-02 | 8.00e-01 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 65 | 7.77e-01 | 2.04e-02 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 51 | 8.02e-01 | -2.03e-02 | 9.11e-01 |
| GOBP REGULATION OF PROTEOLYSIS | 453 | 4.62e-01 | -2.03e-02 | 7.28e-01 |
| GOMF PROTON CHANNEL ACTIVITY | 20 | 8.75e-01 | -2.03e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 5 | 9.37e-01 | 2.03e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 5 | 9.37e-01 | 2.03e-02 | 9.72e-01 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 37 | 8.31e-01 | 2.03e-02 | 9.26e-01 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 679 | 3.72e-01 | 2.03e-02 | 6.56e-01 |
| GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 9.26e-01 | 2.02e-02 | 9.68e-01 |
| GOBP MRNA TRANSCRIPTION | 47 | 8.11e-01 | -2.02e-02 | 9.16e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 10 | 9.12e-01 | -2.01e-02 | 9.64e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 22 | 8.70e-01 | -2.01e-02 | 9.44e-01 |
| GOBP RESPONSE TO CAFFEINE | 10 | 9.12e-01 | -2.01e-02 | 9.64e-01 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 21 | 8.74e-01 | -2.00e-02 | 9.46e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 83 | 7.54e-01 | -1.99e-02 | 8.88e-01 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.18e-01 | 1.99e-02 | 9.65e-01 |
| GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.33e-01 | 1.99e-02 | 9.71e-01 |
| GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 7 | 9.27e-01 | 1.99e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 21 | 8.75e-01 | -1.99e-02 | 9.47e-01 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 11 | 9.09e-01 | -1.98e-02 | 9.63e-01 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 139 | 6.87e-01 | -1.98e-02 | 8.55e-01 |
| GOMF DEUBIQUITINASE ACTIVITY | 90 | 7.45e-01 | -1.98e-02 | 8.85e-01 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 142 | 6.84e-01 | 1.98e-02 | 8.52e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 9.39e-01 | -1.98e-02 | 9.73e-01 |
| GOBP NADP METABOLIC PROCESS | 38 | 8.33e-01 | -1.98e-02 | 9.27e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 542 | 4.34e-01 | 1.98e-02 | 7.08e-01 |
| GOBP MICROTUBULE SEVERING | 7 | 9.28e-01 | 1.97e-02 | 9.69e-01 |
| GOBP OOCYTE DIFFERENTIATION | 35 | 8.40e-01 | -1.97e-02 | 9.30e-01 |
| GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.39e-01 | -1.97e-02 | 9.73e-01 |
| GOBP RESPONSE TO ETHER | 10 | 9.14e-01 | 1.97e-02 | 9.65e-01 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 8 | 9.23e-01 | -1.97e-02 | 9.67e-01 |
| GOMF DNA DNA ANNEALING ACTIVITY | 6 | 9.34e-01 | -1.97e-02 | 9.71e-01 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 169 | 6.60e-01 | -1.97e-02 | 8.41e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 11 | 9.10e-01 | -1.96e-02 | 9.63e-01 |
| GOBP OXIDATIVE RNA DEMETHYLATION | 5 | 9.39e-01 | 1.96e-02 | 9.73e-01 |
| GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 9.39e-01 | 1.96e-02 | 9.73e-01 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 66 | 7.83e-01 | 1.96e-02 | 9.02e-01 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 19 | 8.83e-01 | -1.96e-02 | 9.51e-01 |
| GOMF CADHERIN BINDING | 270 | 5.81e-01 | -1.96e-02 | 8.01e-01 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 20 | 8.80e-01 | -1.96e-02 | 9.49e-01 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 20 | 8.80e-01 | 1.96e-02 | 9.49e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 26 | 8.63e-01 | -1.95e-02 | 9.41e-01 |
| GOBP L SERINE TRANSPORT | 6 | 9.34e-01 | -1.95e-02 | 9.71e-01 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.34e-01 | -1.95e-02 | 9.71e-01 |
| GOBP RESPONSE TO HYDROXYUREA | 10 | 9.15e-01 | -1.95e-02 | 9.65e-01 |
| GOBP ADP TRANSPORT | 10 | 9.15e-01 | -1.94e-02 | 9.65e-01 |
| GOBP RENAL TUBULE DEVELOPMENT | 42 | 8.28e-01 | 1.93e-02 | 9.25e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 34 | 8.46e-01 | 1.93e-02 | 9.32e-01 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 475 | 4.74e-01 | -1.93e-02 | 7.37e-01 |
| GOCC GOLGI MEDIAL CISTERNA | 11 | 9.12e-01 | 1.92e-02 | 9.64e-01 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 9.41e-01 | -1.92e-02 | 9.74e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 137 | 6.99e-01 | -1.92e-02 | 8.62e-01 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 123 | 7.14e-01 | -1.92e-02 | 8.71e-01 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 145 | 6.92e-01 | -1.91e-02 | 8.57e-01 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 53 | 8.10e-01 | -1.91e-02 | 9.15e-01 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 27 | 8.64e-01 | -1.91e-02 | 9.41e-01 |
| GOBP TOXIN TRANSPORT | 6 | 9.35e-01 | -1.91e-02 | 9.71e-01 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 10 | 9.17e-01 | -1.91e-02 | 9.65e-01 |
| GOCC SARCOLEMMA | 85 | 7.62e-01 | 1.90e-02 | 8.92e-01 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 84 | 7.63e-01 | 1.90e-02 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 583 | 4.37e-01 | -1.90e-02 | 7.09e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 8 | 9.26e-01 | -1.90e-02 | 9.68e-01 |
| GOCC VACUOLAR MEMBRANE | 419 | 5.09e-01 | 1.89e-02 | 7.56e-01 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 76 | 7.76e-01 | -1.89e-02 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 14 | 9.03e-01 | 1.88e-02 | 9.61e-01 |
| GOBP LIPID DROPLET ORGANIZATION | 26 | 8.68e-01 | 1.88e-02 | 9.43e-01 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 36 | 8.45e-01 | 1.88e-02 | 9.32e-01 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 214 | 6.36e-01 | 1.88e-02 | 8.28e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 61 | 8.00e-01 | -1.88e-02 | 9.10e-01 |
| GOMF GAMMA TUBULIN BINDING | 31 | 8.56e-01 | 1.88e-02 | 9.37e-01 |
| GOCC FILAMENTOUS ACTIN | 19 | 8.87e-01 | 1.88e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 40 | 8.37e-01 | -1.88e-02 | 9.29e-01 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 7 | 9.32e-01 | 1.87e-02 | 9.71e-01 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 159 | 6.85e-01 | -1.87e-02 | 8.54e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 19 | 8.88e-01 | -1.86e-02 | 9.54e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 14 | 9.04e-01 | -1.86e-02 | 9.61e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 11 | 9.15e-01 | -1.86e-02 | 9.65e-01 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 96 | 7.53e-01 | -1.86e-02 | 8.88e-01 |
| GOBP HORMONE TRANSPORT | 167 | 6.80e-01 | -1.85e-02 | 8.51e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 50 | 8.21e-01 | -1.85e-02 | 9.22e-01 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 15 | 9.01e-01 | -1.85e-02 | 9.60e-01 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 16 | 8.99e-01 | -1.84e-02 | 9.59e-01 |
| GOBP CELLULAR RESPONSE TO STEROL | 12 | 9.12e-01 | -1.84e-02 | 9.64e-01 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 13 | 9.09e-01 | 1.84e-02 | 9.63e-01 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 27 | 8.69e-01 | -1.83e-02 | 9.44e-01 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 102 | 7.49e-01 | -1.83e-02 | 8.87e-01 |
| GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 8 | 9.29e-01 | -1.83e-02 | 9.69e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 19 | 8.90e-01 | -1.83e-02 | 9.54e-01 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 8.88e-01 | 1.83e-02 | 9.53e-01 |
| GOBP BLASTOCYST DEVELOPMENT | 89 | 7.66e-01 | -1.82e-02 | 8.93e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 21 | 8.85e-01 | 1.82e-02 | 9.52e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 10 | 9.21e-01 | 1.82e-02 | 9.67e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 107 | 7.46e-01 | -1.82e-02 | 8.85e-01 |
| GOCC CYTOPLASMIC REGION | 177 | 6.78e-01 | 1.81e-02 | 8.51e-01 |
| GOBP NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT | 7 | 9.34e-01 | 1.81e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 36 | 8.51e-01 | -1.81e-02 | 9.34e-01 |
| GOBP REGULATION OF HISTONE H3 K4 METHYLATION | 12 | 9.14e-01 | -1.80e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 5 | 9.45e-01 | -1.79e-02 | 9.75e-01 |
| GOBP PEPTIDYL LYSINE TRIMETHYLATION | 10 | 9.22e-01 | 1.79e-02 | 9.67e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 210 | 6.56e-01 | 1.79e-02 | 8.38e-01 |
| GOBP REGULATION OF GERM CELL PROLIFERATION | 7 | 9.35e-01 | -1.79e-02 | 9.71e-01 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 154 | 7.03e-01 | -1.78e-02 | 8.64e-01 |
| GOBP POTASSIUM ION TRANSPORT | 101 | 7.58e-01 | -1.78e-02 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 26 | 8.75e-01 | -1.78e-02 | 9.47e-01 |
| GOBP TISSUE REGENERATION | 42 | 8.43e-01 | -1.77e-02 | 9.31e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 16 | 9.03e-01 | -1.77e-02 | 9.61e-01 |
| GOCC MICROTUBULE CYTOSKELETON | 1086 | 3.32e-01 | -1.77e-02 | 6.18e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 31 | 8.65e-01 | 1.77e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 8 | 9.31e-01 | -1.76e-02 | 9.71e-01 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 34 | 8.60e-01 | -1.75e-02 | 9.38e-01 |
| GOBP LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION | 5 | 9.46e-01 | 1.75e-02 | 9.75e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST | 7 | 9.36e-01 | 1.75e-02 | 9.71e-01 |
| GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 8 | 9.32e-01 | 1.75e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 6 | 9.41e-01 | -1.75e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 11 | 9.20e-01 | 1.75e-02 | 9.67e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 21 | 8.90e-01 | -1.74e-02 | 9.54e-01 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 106 | 7.58e-01 | -1.74e-02 | 8.90e-01 |
| GOCC ENDOSOME MEMBRANE | 455 | 5.28e-01 | 1.73e-02 | 7.69e-01 |
| GOBP MEMBRANE DISASSEMBLY | 11 | 9.21e-01 | 1.73e-02 | 9.67e-01 |
| GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 13 | 9.14e-01 | -1.73e-02 | 9.65e-01 |
| GOBP ACTIN FILAMENT SEVERING | 14 | 9.11e-01 | -1.73e-02 | 9.63e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 10 | 9.25e-01 | -1.73e-02 | 9.67e-01 |
| GOCC GOLGI STACK | 101 | 7.64e-01 | 1.73e-02 | 8.92e-01 |
| GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 5 | 9.47e-01 | 1.73e-02 | 9.75e-01 |
| GOBP NEURONAL ACTION POTENTIAL | 16 | 9.05e-01 | -1.72e-02 | 9.61e-01 |
| GOCC CELL BODY FIBER | 5 | 9.47e-01 | 1.72e-02 | 9.75e-01 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 41 | 8.49e-01 | -1.72e-02 | 9.33e-01 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 47 | 8.39e-01 | -1.72e-02 | 9.29e-01 |
| GOBP NUCLEAR TRANSPORT | 287 | 6.18e-01 | -1.72e-02 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY | 5 | 9.47e-01 | -1.72e-02 | 9.76e-01 |
| GOBP EPIDERMIS DEVELOPMENT | 173 | 6.98e-01 | -1.71e-02 | 8.62e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 9 | 9.29e-01 | -1.71e-02 | 9.69e-01 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 85 | 7.85e-01 | -1.71e-02 | 9.03e-01 |
| GOBP LIPID MODIFICATION | 142 | 7.26e-01 | 1.71e-02 | 8.77e-01 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 49 | 8.36e-01 | 1.71e-02 | 9.29e-01 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 8 | 9.33e-01 | 1.71e-02 | 9.71e-01 |
| GOBP VACUOLAR LOCALIZATION | 70 | 8.06e-01 | -1.70e-02 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 15 | 9.09e-01 | -1.70e-02 | 9.63e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 7 | 9.38e-01 | -1.70e-02 | 9.72e-01 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 37 | 8.59e-01 | -1.69e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 40 | 8.54e-01 | -1.68e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 15 | 9.10e-01 | 1.68e-02 | 9.63e-01 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 44 | 8.48e-01 | 1.67e-02 | 9.33e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 9 | 9.31e-01 | -1.67e-02 | 9.70e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 537 | 5.10e-01 | 1.67e-02 | 7.57e-01 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 11 | 9.24e-01 | -1.67e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 18 | 9.03e-01 | -1.66e-02 | 9.61e-01 |
| GOBP REGULATION OF TRANSPORT | 1079 | 3.64e-01 | -1.66e-02 | 6.49e-01 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 8 | 9.35e-01 | 1.66e-02 | 9.71e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 60 | 8.25e-01 | -1.66e-02 | 9.23e-01 |
| GOCC GLUTAMATERGIC SYNAPSE | 248 | 6.54e-01 | -1.66e-02 | 8.38e-01 |
| GOBP ORGANELLE ASSEMBLY | 780 | 4.36e-01 | 1.65e-02 | 7.09e-01 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 15 | 9.12e-01 | -1.65e-02 | 9.64e-01 |
| GOBP STEROID CATABOLIC PROCESS | 15 | 9.12e-01 | -1.65e-02 | 9.64e-01 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 199 | 6.89e-01 | 1.65e-02 | 8.56e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 11 | 9.25e-01 | -1.65e-02 | 9.67e-01 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 9.12e-01 | 1.64e-02 | 9.64e-01 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 75 | 8.06e-01 | 1.64e-02 | 9.14e-01 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 11 | 9.25e-01 | 1.64e-02 | 9.67e-01 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 47 | 8.46e-01 | 1.64e-02 | 9.32e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 120 | 7.60e-01 | 1.62e-02 | 8.91e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 9 | 9.33e-01 | 1.62e-02 | 9.71e-01 |
| GOBP REELIN MEDIATED SIGNALING PATHWAY | 6 | 9.45e-01 | 1.61e-02 | 9.75e-01 |
| GOBP GLUCOSE METABOLIC PROCESS | 144 | 7.39e-01 | -1.61e-02 | 8.83e-01 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 37 | 8.66e-01 | -1.61e-02 | 9.42e-01 |
| GOBP SNARE COMPLEX ASSEMBLY | 19 | 9.04e-01 | 1.61e-02 | 9.61e-01 |
| GOBP LIPID METABOLIC PROCESS | 912 | 4.18e-01 | 1.60e-02 | 6.96e-01 |
| GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION | 13 | 9.21e-01 | 1.60e-02 | 9.67e-01 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 7 | 9.42e-01 | 1.60e-02 | 9.74e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 11 | 9.27e-01 | -1.60e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 69 | 8.19e-01 | 1.59e-02 | 9.21e-01 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 11 | 9.27e-01 | -1.59e-02 | 9.68e-01 |
| GOBP PROTEIN KINASE C SIGNALING | 18 | 9.07e-01 | -1.59e-02 | 9.63e-01 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 8 | 9.38e-01 | -1.59e-02 | 9.72e-01 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 18 | 9.07e-01 | 1.59e-02 | 9.63e-01 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 17 | 9.10e-01 | -1.58e-02 | 9.63e-01 |
| GOBP WYBUTOSINE METABOLIC PROCESS | 6 | 9.46e-01 | -1.58e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 9.51e-01 | -1.58e-02 | 9.78e-01 |
| GOBP MAINTENANCE OF CENTROSOME LOCATION | 6 | 9.47e-01 | -1.58e-02 | 9.75e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 9 | 9.35e-01 | 1.58e-02 | 9.71e-01 |
| GOBP PYRUVATE METABOLIC PROCESS | 96 | 7.90e-01 | 1.58e-02 | 9.05e-01 |
| GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 9 | 9.35e-01 | -1.57e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 25 | 8.92e-01 | -1.57e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 60 | 8.34e-01 | -1.56e-02 | 9.28e-01 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 106 | 7.82e-01 | 1.56e-02 | 9.02e-01 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 311 | 6.38e-01 | 1.56e-02 | 8.28e-01 |
| GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 9.43e-01 | -1.56e-02 | 9.74e-01 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 12 | 9.26e-01 | 1.55e-02 | 9.68e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 40 | 8.65e-01 | 1.55e-02 | 9.42e-01 |
| GOCC LIPID DROPLET | 82 | 8.08e-01 | -1.55e-02 | 9.14e-01 |
| GOBP DENDRITIC TRANSPORT | 10 | 9.33e-01 | -1.55e-02 | 9.71e-01 |
| GOCC T TUBULE | 31 | 8.82e-01 | 1.54e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF SECRETION | 182 | 7.21e-01 | -1.54e-02 | 8.75e-01 |
| GOCC CENTROSOME | 546 | 5.41e-01 | -1.54e-02 | 7.77e-01 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 142 | 7.52e-01 | -1.54e-02 | 8.88e-01 |
| GOBP MYOTUBE DIFFERENTIATION | 72 | 8.23e-01 | 1.53e-02 | 9.22e-01 |
| GOBP CLATHRIN COATED VESICLE CARGO LOADING | 7 | 9.44e-01 | -1.53e-02 | 9.75e-01 |
| GOCC GERM CELL NUCLEUS | 46 | 8.58e-01 | -1.53e-02 | 9.38e-01 |
| GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 6 | 9.48e-01 | 1.53e-02 | 9.76e-01 |
| GOCC POSTSYNAPTIC CYTOSOL | 10 | 9.33e-01 | -1.53e-02 | 9.71e-01 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 102 | 7.90e-01 | 1.52e-02 | 9.06e-01 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 32 | 8.81e-01 | -1.52e-02 | 9.50e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 107 | 7.87e-01 | 1.52e-02 | 9.04e-01 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 14 | 9.22e-01 | -1.51e-02 | 9.67e-01 |
| GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 459 | 5.82e-01 | 1.51e-02 | 8.01e-01 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 147 | 7.53e-01 | 1.51e-02 | 8.88e-01 |
| GOBP NEURAL RETINA DEVELOPMENT | 36 | 8.76e-01 | -1.50e-02 | 9.47e-01 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 8 | 9.42e-01 | 1.50e-02 | 9.74e-01 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 6 | 9.49e-01 | 1.50e-02 | 9.77e-01 |
| GOBP RNA DECAPPING | 19 | 9.10e-01 | 1.50e-02 | 9.63e-01 |
| GOBP CARBOHYDRATE TRANSPORT | 100 | 7.96e-01 | 1.49e-02 | 9.09e-01 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 471 | 5.81e-01 | -1.49e-02 | 8.01e-01 |
| GOCC CELL TRAILING EDGE | 13 | 9.26e-01 | 1.49e-02 | 9.68e-01 |
| GOBP SPINAL CORD DEVELOPMENT | 43 | 8.66e-01 | 1.49e-02 | 9.42e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 404 | 6.09e-01 | -1.49e-02 | 8.14e-01 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 17 | 9.16e-01 | -1.48e-02 | 9.65e-01 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 16 | 9.18e-01 | 1.48e-02 | 9.65e-01 |
| GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY | 7 | 9.46e-01 | -1.48e-02 | 9.75e-01 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 11 | 9.33e-01 | 1.47e-02 | 9.71e-01 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 49 | 8.59e-01 | -1.47e-02 | 9.38e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 12 | 9.30e-01 | 1.46e-02 | 9.70e-01 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 142 | 7.64e-01 | -1.46e-02 | 8.92e-01 |
| GOMF 3 5 RNA HELICASE ACTIVITY | 5 | 9.55e-01 | -1.45e-02 | 9.80e-01 |
| GOBP STORE OPERATED CALCIUM ENTRY | 16 | 9.20e-01 | 1.45e-02 | 9.66e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 14 | 9.25e-01 | 1.45e-02 | 9.67e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 50 | 8.59e-01 | -1.45e-02 | 9.38e-01 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 126 | 7.79e-01 | 1.45e-02 | 9.00e-01 |
| GOBP COPII COATED VESICLE CARGO LOADING | 15 | 9.23e-01 | 1.45e-02 | 9.67e-01 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 8.89e-01 | -1.45e-02 | 9.54e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 5 | 9.56e-01 | -1.44e-02 | 9.80e-01 |
| GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 6 | 9.52e-01 | 1.43e-02 | 9.78e-01 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 45 | 8.68e-01 | 1.43e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 23 | 9.06e-01 | -1.43e-02 | 9.62e-01 |
| GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY | 7 | 9.48e-01 | -1.43e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 117 | 7.90e-01 | 1.43e-02 | 9.05e-01 |
| GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 9.44e-01 | 1.43e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 6 | 9.52e-01 | -1.42e-02 | 9.78e-01 |
| GOBP REGULATION OF LIPID LOCALIZATION | 104 | 8.02e-01 | 1.42e-02 | 9.11e-01 |
| GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS | 57 | 8.53e-01 | 1.42e-02 | 9.35e-01 |
| GOBP PROTEIN TETRAMERIZATION | 68 | 8.40e-01 | 1.42e-02 | 9.30e-01 |
| GOBP GLUTAMATE CATABOLIC PROCESS | 5 | 9.56e-01 | 1.41e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 15 | 9.25e-01 | -1.41e-02 | 9.67e-01 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 205 | 7.29e-01 | 1.41e-02 | 8.78e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 60 | 8.51e-01 | 1.40e-02 | 9.34e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 45 | 8.71e-01 | 1.40e-02 | 9.45e-01 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1089 | 4.42e-01 | -1.40e-02 | 7.13e-01 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 20 | 9.14e-01 | 1.39e-02 | 9.65e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL BUD | 5 | 9.57e-01 | 1.39e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 5 | 9.57e-01 | 1.39e-02 | 9.81e-01 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 9.57e-01 | 1.38e-02 | 9.81e-01 |
| GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.53e-01 | 1.38e-02 | 9.79e-01 |
| GOMF UBIQUITIN BINDING | 100 | 8.13e-01 | 1.37e-02 | 9.17e-01 |
| GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 7 | 9.50e-01 | 1.36e-02 | 9.77e-01 |
| GOBP RESPONSE TO NITRIC OXIDE | 14 | 9.30e-01 | -1.36e-02 | 9.70e-01 |
| GOBP INTRACELLULAR PH REDUCTION | 49 | 8.70e-01 | 1.36e-02 | 9.44e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 93 | 8.23e-01 | 1.35e-02 | 9.22e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 696 | 5.50e-01 | -1.34e-02 | 7.82e-01 |
| GOCC KINETOCHORE MICROTUBULE | 19 | 9.19e-01 | 1.34e-02 | 9.66e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 45 | 8.76e-01 | 1.34e-02 | 9.47e-01 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 13 | 9.33e-01 | 1.34e-02 | 9.71e-01 |
| GOBP RNA 3 END PROCESSING | 89 | 8.28e-01 | 1.34e-02 | 9.25e-01 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 68 | 8.49e-01 | -1.33e-02 | 9.33e-01 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 540 | 5.98e-01 | 1.33e-02 | 8.10e-01 |
| GOMF MAGNESIUM ION BINDING | 182 | 7.57e-01 | 1.33e-02 | 8.89e-01 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 10 | 9.42e-01 | -1.33e-02 | 9.74e-01 |
| GOBP CRD MEDIATED MRNA STABILIZATION | 10 | 9.42e-01 | -1.33e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 6 | 9.55e-01 | 1.32e-02 | 9.80e-01 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 9 | 9.45e-01 | 1.32e-02 | 9.75e-01 |
| GOBP REGULATION OF MITOTIC RECOMBINATION | 5 | 9.59e-01 | -1.32e-02 | 9.81e-01 |
| GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 9.21e-01 | 1.31e-02 | 9.67e-01 |
| GOCC SEX CHROMOSOME | 28 | 9.04e-01 | 1.31e-02 | 9.61e-01 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 18 | 9.23e-01 | 1.31e-02 | 9.67e-01 |
| GOBP PLASMA MEMBRANE FUSION | 10 | 9.43e-01 | 1.31e-02 | 9.74e-01 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 9.40e-01 | 1.31e-02 | 9.73e-01 |
| GOMF CYCLASE REGULATOR ACTIVITY | 8 | 9.49e-01 | 1.31e-02 | 9.76e-01 |
| GOBP CALCIUM ION TRANSPORT | 246 | 7.24e-01 | -1.31e-02 | 8.76e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 89 | 8.32e-01 | -1.30e-02 | 9.27e-01 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 10 | 9.44e-01 | -1.29e-02 | 9.74e-01 |
| GOCC DNA POLYMERASE COMPLEX | 19 | 9.22e-01 | 1.29e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 13 | 9.36e-01 | -1.29e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 20 | 9.20e-01 | -1.29e-02 | 9.67e-01 |
| GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.60e-01 | 1.29e-02 | 9.82e-01 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.47e-01 | -1.29e-02 | 9.75e-01 |
| GOCC GOLGI APPARATUS | 1184 | 4.61e-01 | 1.29e-02 | 7.28e-01 |
| GOBP MESODERM MORPHOGENESIS | 35 | 8.95e-01 | -1.29e-02 | 9.57e-01 |
| GOBP OSTEOBLAST PROLIFERATION | 17 | 9.27e-01 | 1.28e-02 | 9.68e-01 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 15 | 9.32e-01 | -1.27e-02 | 9.71e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 11 | 9.42e-01 | -1.27e-02 | 9.74e-01 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 11 | 9.42e-01 | -1.27e-02 | 9.74e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 55 | 8.71e-01 | 1.27e-02 | 9.45e-01 |
| GOBP PROTEIN MONOUBIQUITINATION | 41 | 8.89e-01 | -1.26e-02 | 9.54e-01 |
| GOBP BLASTOCYST FORMATION | 34 | 8.99e-01 | 1.26e-02 | 9.59e-01 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 16 | 9.30e-01 | 1.26e-02 | 9.70e-01 |
| GOMF PALMITOYL COA HYDROLASE ACTIVITY | 13 | 9.37e-01 | -1.26e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 41 | 8.90e-01 | -1.25e-02 | 9.54e-01 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 42 | 8.89e-01 | -1.25e-02 | 9.54e-01 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 109 | 8.22e-01 | 1.25e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 271 | 7.25e-01 | 1.25e-02 | 8.77e-01 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 9.36e-01 | 1.24e-02 | 9.71e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 142 | 7.99e-01 | -1.24e-02 | 9.10e-01 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 10 | 9.46e-01 | 1.24e-02 | 9.75e-01 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 69 | 8.59e-01 | -1.24e-02 | 9.38e-01 |
| GOBP DEFENSE RESPONSE TO SYMBIONT | 256 | 7.33e-01 | -1.24e-02 | 8.79e-01 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 487 | 6.42e-01 | 1.24e-02 | 8.31e-01 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 58 | 8.71e-01 | 1.23e-02 | 9.45e-01 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 13 | 9.39e-01 | -1.23e-02 | 9.73e-01 |
| GOBP OVULATION | 6 | 9.58e-01 | 1.23e-02 | 9.81e-01 |
| GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 7 | 9.55e-01 | -1.23e-02 | 9.80e-01 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 7 | 9.55e-01 | 1.23e-02 | 9.80e-01 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 11 | 9.44e-01 | 1.23e-02 | 9.74e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 403 | 6.74e-01 | -1.23e-02 | 8.48e-01 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 24 | 9.17e-01 | 1.22e-02 | 9.65e-01 |
| GOMF COBALAMIN BINDING | 8 | 9.53e-01 | 1.21e-02 | 9.79e-01 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 13 | 9.40e-01 | -1.21e-02 | 9.73e-01 |
| GOBP MONOATOMIC CATION TRANSPORT | 573 | 6.23e-01 | 1.21e-02 | 8.20e-01 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 5 | 9.63e-01 | 1.21e-02 | 9.82e-01 |
| GOBP RESPONSE TO STEROL | 20 | 9.25e-01 | -1.21e-02 | 9.67e-01 |
| GOBP REGULATION OF IRON ION TRANSPORT | 5 | 9.63e-01 | 1.21e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 76 | 8.56e-01 | -1.21e-02 | 9.37e-01 |
| GOMF FUCOSYLTRANSFERASE ACTIVITY | 6 | 9.59e-01 | -1.20e-02 | 9.81e-01 |
| GOBP LYMPHOCYTE COSTIMULATION | 30 | 9.10e-01 | -1.19e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 18 | 9.30e-01 | -1.19e-02 | 9.70e-01 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 23 | 9.21e-01 | -1.19e-02 | 9.67e-01 |
| GOCC VESICLE MEMBRANE | 903 | 5.50e-01 | -1.19e-02 | 7.82e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 127 | 8.18e-01 | -1.18e-02 | 9.20e-01 |
| GOBP REGULATION OF PIGMENTATION | 10 | 9.49e-01 | 1.18e-02 | 9.76e-01 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 22 | 9.24e-01 | 1.18e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 174 | 7.89e-01 | -1.18e-02 | 9.05e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 90 | 8.49e-01 | 1.17e-02 | 9.33e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 43 | 8.95e-01 | -1.16e-02 | 9.57e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 6 | 9.61e-01 | 1.16e-02 | 9.82e-01 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 24 | 9.22e-01 | 1.16e-02 | 9.67e-01 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 16 | 9.36e-01 | -1.15e-02 | 9.71e-01 |
| GOBP REGULATION OF AXON EXTENSION | 60 | 8.77e-01 | -1.15e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 17 | 9.35e-01 | -1.15e-02 | 9.71e-01 |
| GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 8 | 9.55e-01 | -1.15e-02 | 9.80e-01 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 21 | 9.28e-01 | -1.14e-02 | 9.68e-01 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 25 | 9.22e-01 | -1.13e-02 | 9.67e-01 |
| GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 9.59e-01 | -1.13e-02 | 9.81e-01 |
| GOBP METHYLGUANOSINE CAP DECAPPING | 16 | 9.38e-01 | 1.13e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 96 | 8.48e-01 | -1.13e-02 | 9.33e-01 |
| GOBP SECONDARY METABOLIC PROCESS | 29 | 9.16e-01 | -1.13e-02 | 9.65e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 40 | 9.02e-01 | -1.13e-02 | 9.61e-01 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 16 | 9.38e-01 | -1.13e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 84 | 8.59e-01 | 1.12e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 9.62e-01 | 1.11e-02 | 9.82e-01 |
| GOBP DNA DEALKYLATION | 29 | 9.18e-01 | 1.11e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 5 | 9.66e-01 | -1.10e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 5 | 9.66e-01 | -1.10e-02 | 9.84e-01 |
| GOCC MYELIN SHEATH | 28 | 9.20e-01 | -1.10e-02 | 9.66e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 6 | 9.63e-01 | 1.10e-02 | 9.82e-01 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 19 | 9.34e-01 | 1.10e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 99 | 8.53e-01 | -1.08e-02 | 9.35e-01 |
| GOBP REGULATION OF METAL ION TRANSPORT | 212 | 7.88e-01 | -1.08e-02 | 9.05e-01 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 13 | 9.47e-01 | 1.07e-02 | 9.75e-01 |
| GOBP REGULATION OF EXOCYTOSIS | 126 | 8.36e-01 | -1.07e-02 | 9.29e-01 |
| GOBP HISTIDINE METABOLIC PROCESS | 6 | 9.64e-01 | -1.06e-02 | 9.83e-01 |
| GOCC NODE OF RANVIER | 8 | 9.59e-01 | -1.06e-02 | 9.81e-01 |
| GOCC CENTRIOLE | 129 | 8.36e-01 | -1.05e-02 | 9.29e-01 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 249 | 7.75e-01 | 1.05e-02 | 8.98e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 31 | 9.19e-01 | -1.05e-02 | 9.66e-01 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 35 | 9.15e-01 | 1.04e-02 | 9.65e-01 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 516 | 6.89e-01 | -1.03e-02 | 8.56e-01 |
| GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 6 | 9.65e-01 | 1.03e-02 | 9.83e-01 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 29 | 9.24e-01 | 1.03e-02 | 9.67e-01 |
| GOCC CYTOSOLIC REGION | 17 | 9.42e-01 | 1.02e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 96 | 8.63e-01 | 1.02e-02 | 9.41e-01 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 83 | 8.73e-01 | 1.02e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 35 | 9.17e-01 | 1.02e-02 | 9.65e-01 |
| GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 9.69e-01 | -1.02e-02 | 9.85e-01 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 60 | 8.92e-01 | -1.01e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 6 | 9.66e-01 | 1.01e-02 | 9.84e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 6 | 9.66e-01 | -1.01e-02 | 9.84e-01 |
| GOBP PIGMENTATION | 83 | 8.74e-01 | -1.01e-02 | 9.46e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 69 | 8.86e-01 | -1.00e-02 | 9.52e-01 |
| GOBP TEMPERATURE HOMEOSTASIS | 124 | 8.48e-01 | 1.00e-02 | 9.33e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 18 | 9.42e-01 | -9.97e-03 | 9.74e-01 |
| GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 18 | 9.42e-01 | -9.97e-03 | 9.74e-01 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 220 | 7.99e-01 | 9.97e-03 | 9.10e-01 |
| GOBP GLYCOLYTIC PROCESS | 72 | 8.84e-01 | 9.96e-03 | 9.51e-01 |
| GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE | 9 | 9.59e-01 | -9.94e-03 | 9.81e-01 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 7 | 9.64e-01 | -9.92e-03 | 9.83e-01 |
| GOBP T CELL HOMEOSTASIS | 36 | 9.18e-01 | -9.89e-03 | 9.65e-01 |
| GOBP THIOESTER METABOLIC PROCESS | 74 | 8.83e-01 | 9.87e-03 | 9.51e-01 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 61 | 8.94e-01 | -9.86e-03 | 9.56e-01 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 26 | 9.31e-01 | 9.85e-03 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 31 | 9.24e-01 | -9.85e-03 | 9.67e-01 |
| GOBP REGULATION OF GLIOGENESIS | 57 | 8.98e-01 | 9.83e-03 | 9.58e-01 |
| GOBP GLUTAMATE SECRETION | 12 | 9.53e-01 | -9.80e-03 | 9.79e-01 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 17 | 9.45e-01 | -9.70e-03 | 9.75e-01 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 56 | 9.02e-01 | -9.56e-03 | 9.60e-01 |
| GOMF RDNA BINDING | 9 | 9.60e-01 | 9.55e-03 | 9.82e-01 |
| GOCC SPLICEOSOMAL COMPLEX | 189 | 8.21e-01 | -9.55e-03 | 9.22e-01 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 158 | 8.36e-01 | 9.54e-03 | 9.29e-01 |
| GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 5 | 9.71e-01 | 9.53e-03 | 9.86e-01 |
| GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.61e-01 | 9.52e-03 | 9.82e-01 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 81 | 8.83e-01 | 9.50e-03 | 9.51e-01 |
| GOBP PROTEOLYSIS | 1179 | 5.90e-01 | 9.44e-03 | 8.05e-01 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 54 | 9.05e-01 | 9.43e-03 | 9.61e-01 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 20 | 9.42e-01 | 9.37e-03 | 9.74e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 55 | 9.05e-01 | 9.34e-03 | 9.61e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 12 | 9.56e-01 | -9.29e-03 | 9.80e-01 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 43 | 9.16e-01 | 9.25e-03 | 9.65e-01 |
| GOCC CILIARY TRANSITION ZONE | 59 | 9.03e-01 | 9.21e-03 | 9.61e-01 |
| GOBP DOPAMINE TRANSPORT | 21 | 9.42e-01 | 9.14e-03 | 9.74e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 76 | 8.91e-01 | 9.14e-03 | 9.54e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 10 | 9.60e-01 | -9.08e-03 | 9.82e-01 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 12 | 9.57e-01 | 9.06e-03 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 47 | 9.15e-01 | -9.05e-03 | 9.65e-01 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 283 | 7.94e-01 | -9.04e-03 | 9.08e-01 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 8 | 9.65e-01 | 9.00e-03 | 9.83e-01 |
| GOBP NUCLEUS ORGANIZATION | 127 | 8.61e-01 | 8.99e-03 | 9.40e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 27 | 9.36e-01 | -8.93e-03 | 9.71e-01 |
| GOMF HYDRO LYASE ACTIVITY | 41 | 9.22e-01 | -8.89e-03 | 9.67e-01 |
| GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 5 | 9.73e-01 | -8.82e-03 | 9.87e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 7 | 9.68e-01 | 8.79e-03 | 9.85e-01 |
| GOMF BH DOMAIN BINDING | 7 | 9.68e-01 | 8.73e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 16 | 9.52e-01 | 8.72e-03 | 9.78e-01 |
| GOCC ACTIN FILAMENT | 83 | 8.91e-01 | 8.68e-03 | 9.55e-01 |
| GOMF ACETYLCHOLINE RECEPTOR BINDING | 8 | 9.66e-01 | -8.64e-03 | 9.84e-01 |
| GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 6 | 9.71e-01 | 8.62e-03 | 9.86e-01 |
| GOBP VIRAL PROTEIN PROCESSING | 30 | 9.35e-01 | -8.60e-03 | 9.71e-01 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 697 | 7.02e-01 | 8.59e-03 | 8.64e-01 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 28 | 9.38e-01 | 8.52e-03 | 9.72e-01 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 30 | 9.36e-01 | -8.49e-03 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 9.74e-01 | -8.49e-03 | 9.87e-01 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 9.56e-01 | 8.44e-03 | 9.81e-01 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 24 | 9.43e-01 | -8.43e-03 | 9.74e-01 |
| GOCC APICAL PART OF CELL | 238 | 8.25e-01 | -8.37e-03 | 9.23e-01 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 142 | 8.64e-01 | -8.31e-03 | 9.42e-01 |
| GOBP DETECTION OF CALCIUM ION | 9 | 9.66e-01 | 8.31e-03 | 9.84e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 41 | 9.27e-01 | -8.29e-03 | 9.68e-01 |
| GOCC GOLGI CISTERNA | 76 | 9.01e-01 | -8.27e-03 | 9.60e-01 |
| GOBP METANEPHRIC GLOMERULUS DEVELOPMENT | 6 | 9.72e-01 | -8.23e-03 | 9.86e-01 |
| GOCC CLATHRIN SCULPTED GAMMA AMINOBUTYRIC ACID TRANSPORT VESICLE | 5 | 9.75e-01 | 8.21e-03 | 9.87e-01 |
| GOCC CLATHRIN SCULPTED VESICLE | 5 | 9.75e-01 | 8.21e-03 | 9.87e-01 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 57 | 9.15e-01 | 8.21e-03 | 9.65e-01 |
| GOCC EXON EXON JUNCTION COMPLEX | 11 | 9.63e-01 | -8.19e-03 | 9.82e-01 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 71 | 9.06e-01 | 8.11e-03 | 9.62e-01 |
| GOBP TOOTH MINERALIZATION | 14 | 9.58e-01 | 8.09e-03 | 9.81e-01 |
| GOBP LACTATE METABOLIC PROCESS | 14 | 9.58e-01 | -8.08e-03 | 9.81e-01 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 18 | 9.53e-01 | -8.08e-03 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 35 | 9.34e-01 | 8.03e-03 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 26 | 9.44e-01 | -8.01e-03 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 50 | 9.22e-01 | -7.99e-03 | 9.67e-01 |
| GOBP PERICARDIUM DEVELOPMENT | 9 | 9.67e-01 | -7.93e-03 | 9.84e-01 |
| GOBP SPERMATID DIFFERENTIATION | 98 | 8.92e-01 | 7.93e-03 | 9.55e-01 |
| GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 9.73e-01 | -7.88e-03 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 21 | 9.51e-01 | -7.83e-03 | 9.77e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 62 | 9.16e-01 | -7.74e-03 | 9.65e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 12 | 9.63e-01 | -7.65e-03 | 9.83e-01 |
| GOBP VIRAL TRANSLATION | 20 | 9.53e-01 | -7.64e-03 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 17 | 9.57e-01 | -7.63e-03 | 9.81e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 9.70e-01 | -7.63e-03 | 9.86e-01 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 46 | 9.29e-01 | -7.62e-03 | 9.69e-01 |
| GOBP MUSCLE CELL DEVELOPMENT | 106 | 8.92e-01 | -7.62e-03 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 17 | 9.57e-01 | 7.62e-03 | 9.81e-01 |
| GOBP SNRNA MODIFICATION | 7 | 9.72e-01 | 7.61e-03 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF COAGULATION | 19 | 9.55e-01 | -7.55e-03 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 17 | 9.57e-01 | 7.55e-03 | 9.81e-01 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 9 | 9.69e-01 | 7.55e-03 | 9.85e-01 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 25 | 9.48e-01 | 7.53e-03 | 9.76e-01 |
| GOBP ACROSOMAL VESICLE EXOCYTOSIS | 6 | 9.75e-01 | -7.52e-03 | 9.87e-01 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 14 | 9.61e-01 | -7.48e-03 | 9.82e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 54 | 9.24e-01 | -7.46e-03 | 9.67e-01 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 25 | 9.49e-01 | -7.44e-03 | 9.76e-01 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 55 | 9.24e-01 | 7.44e-03 | 9.67e-01 |
| GOBP TUBULIN DEACETYLATION | 19 | 9.55e-01 | 7.42e-03 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 9.77e-01 | -7.42e-03 | 9.88e-01 |
| GOBP VESICLE MEDIATED TRANSPORT | 1156 | 6.76e-01 | 7.40e-03 | 8.49e-01 |
| GOCC RETROMER COMPLEX | 12 | 9.65e-01 | 7.38e-03 | 9.83e-01 |
| GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 6 | 9.75e-01 | 7.29e-03 | 9.88e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 42 | 9.35e-01 | 7.28e-03 | 9.71e-01 |
| GOBP SIGNAL RELEASE | 262 | 8.40e-01 | 7.28e-03 | 9.30e-01 |
| GOCC PRESYNAPSE | 333 | 8.22e-01 | 7.19e-03 | 9.22e-01 |
| GOBP SENSORY PERCEPTION | 242 | 8.48e-01 | -7.18e-03 | 9.33e-01 |
| GOCC AUTOPHAGOSOME MEMBRANE | 46 | 9.33e-01 | 7.15e-03 | 9.71e-01 |
| GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 76 | 9.14e-01 | -7.14e-03 | 9.65e-01 |
| GOMF DNA EXONUCLEASE ACTIVITY | 22 | 9.54e-01 | 7.14e-03 | 9.79e-01 |
| GOBP REGULATION OF LIGASE ACTIVITY | 9 | 9.71e-01 | -7.06e-03 | 9.86e-01 |
| GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 60 | 9.25e-01 | 7.06e-03 | 9.67e-01 |
| GOBP LYTIC VACUOLE ORGANIZATION | 95 | 9.06e-01 | 7.05e-03 | 9.62e-01 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 8 | 9.73e-01 | -7.03e-03 | 9.87e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 36 | 9.42e-01 | -7.01e-03 | 9.74e-01 |
| GOBP MELANIN METABOLIC PROCESS | 16 | 9.61e-01 | -6.98e-03 | 9.82e-01 |
| GOBP LINOLEIC ACID METABOLIC PROCESS | 10 | 9.70e-01 | -6.97e-03 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 271 | 8.44e-01 | -6.95e-03 | 9.32e-01 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 384 | 8.16e-01 | -6.94e-03 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 34 | 9.45e-01 | 6.84e-03 | 9.75e-01 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 37 | 9.43e-01 | 6.84e-03 | 9.74e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 82 | 9.15e-01 | 6.79e-03 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 14 | 9.65e-01 | 6.78e-03 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 20 | 9.58e-01 | -6.75e-03 | 9.81e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY | 563 | 7.86e-01 | 6.75e-03 | 9.03e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 68 | 9.24e-01 | -6.66e-03 | 9.67e-01 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 9.68e-01 | 6.65e-03 | 9.85e-01 |
| GOBP GOLGI DISASSEMBLY | 6 | 9.78e-01 | -6.56e-03 | 9.89e-01 |
| GOCC ENDOLYSOSOME MEMBRANE | 16 | 9.64e-01 | -6.53e-03 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 56 | 9.33e-01 | 6.50e-03 | 9.71e-01 |
| GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 8 | 9.75e-01 | 6.43e-03 | 9.87e-01 |
| GOCC CONTRACTILE FIBER | 147 | 8.93e-01 | 6.42e-03 | 9.56e-01 |
| GOBP BRANCH ELONGATION OF AN EPITHELIUM | 6 | 9.79e-01 | 6.35e-03 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 64 | 9.30e-01 | -6.32e-03 | 9.70e-01 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 96 | 9.15e-01 | -6.29e-03 | 9.65e-01 |
| GOBP SECRETION | 567 | 8.00e-01 | 6.26e-03 | 9.10e-01 |
| GOBP GALACTOSE METABOLIC PROCESS | 8 | 9.76e-01 | -6.10e-03 | 9.88e-01 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 25 | 9.59e-01 | 5.98e-03 | 9.81e-01 |
| GOBP ENDOCRINE PROCESS | 37 | 9.51e-01 | -5.85e-03 | 9.78e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 15 | 9.69e-01 | -5.83e-03 | 9.85e-01 |
| GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 9.76e-01 | -5.83e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 5 | 9.82e-01 | -5.83e-03 | 9.91e-01 |
| GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 9.79e-01 | 5.73e-03 | 9.89e-01 |
| GOMF MHC CLASS I PROTEIN BINDING | 14 | 9.71e-01 | -5.68e-03 | 9.86e-01 |
| GOBP LACTATION | 28 | 9.59e-01 | -5.59e-03 | 9.81e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 274 | 8.74e-01 | -5.59e-03 | 9.46e-01 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 9.77e-01 | 5.58e-03 | 9.88e-01 |
| GOBP REGULATION OF RENAL SYSTEM PROCESS | 6 | 9.81e-01 | 5.55e-03 | 9.91e-01 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 43 | 9.50e-01 | -5.54e-03 | 9.77e-01 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 22 | 9.64e-01 | -5.52e-03 | 9.83e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 7 | 9.80e-01 | -5.49e-03 | 9.90e-01 |
| GOBP MUSCLE SYSTEM PROCESS | 241 | 8.84e-01 | -5.48e-03 | 9.51e-01 |
| GOBP BICARBONATE TRANSPORT | 18 | 9.68e-01 | 5.44e-03 | 9.85e-01 |
| GOMF CHEMOKINE ACTIVITY | 17 | 9.69e-01 | 5.41e-03 | 9.85e-01 |
| GOBP REGULATION OF PROTEIN STABILITY | 270 | 8.79e-01 | -5.41e-03 | 9.49e-01 |
| GOMF GTPASE BINDING | 272 | 8.80e-01 | 5.33e-03 | 9.49e-01 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 545 | 8.33e-01 | -5.32e-03 | 9.27e-01 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 10 | 9.77e-01 | 5.31e-03 | 9.88e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 68 | 9.40e-01 | -5.29e-03 | 9.73e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 39 | 9.55e-01 | 5.28e-03 | 9.80e-01 |
| GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 8 | 9.80e-01 | 5.23e-03 | 9.90e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 83 | 9.34e-01 | 5.22e-03 | 9.71e-01 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 70 | 9.41e-01 | -5.12e-03 | 9.74e-01 |
| GOCC CYTOLYTIC GRANULE | 8 | 9.80e-01 | -5.06e-03 | 9.90e-01 |
| GOBP REGULATION OF PLATELET AGGREGATION | 18 | 9.71e-01 | -5.02e-03 | 9.86e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 10 | 9.78e-01 | 5.01e-03 | 9.89e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 11 | 9.77e-01 | 4.96e-03 | 9.88e-01 |
| GOCC F ACTIN CAPPING PROTEIN COMPLEX | 7 | 9.82e-01 | -4.91e-03 | 9.91e-01 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 111 | 9.29e-01 | -4.87e-03 | 9.70e-01 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 17 | 9.73e-01 | 4.78e-03 | 9.87e-01 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 36 | 9.61e-01 | 4.75e-03 | 9.82e-01 |
| GOBP BLOOD VESSEL REMODELING | 24 | 9.68e-01 | -4.74e-03 | 9.85e-01 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 15 | 9.75e-01 | 4.73e-03 | 9.87e-01 |
| GOBP ORGANELLE LOCALIZATION | 494 | 8.59e-01 | -4.68e-03 | 9.38e-01 |
| GOBP CERAMIDE METABOLIC PROCESS | 72 | 9.45e-01 | 4.68e-03 | 9.75e-01 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 172 | 9.16e-01 | -4.65e-03 | 9.65e-01 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 17 | 9.74e-01 | 4.65e-03 | 9.87e-01 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 311 | 8.88e-01 | -4.65e-03 | 9.54e-01 |
| GOMF TETRAPYRROLE BINDING | 74 | 9.45e-01 | 4.61e-03 | 9.75e-01 |
| GOBP N TERMINAL PROTEIN LIPIDATION | 5 | 9.86e-01 | 4.59e-03 | 9.93e-01 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 47 | 9.57e-01 | -4.50e-03 | 9.81e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 19 | 9.73e-01 | -4.41e-03 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 12 | 9.79e-01 | 4.37e-03 | 9.89e-01 |
| GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 347 | 8.89e-01 | -4.36e-03 | 9.54e-01 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1221 | 8.01e-01 | 4.34e-03 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 7 | 9.84e-01 | 4.32e-03 | 9.92e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 34 | 9.65e-01 | 4.30e-03 | 9.84e-01 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 43 | 9.61e-01 | 4.27e-03 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 53 | 9.57e-01 | -4.26e-03 | 9.81e-01 |
| GOBP REGULATION OF HORMONE SECRETION | 133 | 9.33e-01 | -4.20e-03 | 9.71e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 21 | 9.74e-01 | -4.09e-03 | 9.87e-01 |
| GOBP RESPONSE TO TYPE II INTERFERON | 100 | 9.44e-01 | -4.08e-03 | 9.75e-01 |
| GOBP AXON EXTENSION | 82 | 9.50e-01 | 4.05e-03 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 7 | 9.85e-01 | 4.05e-03 | 9.93e-01 |
| GOBP INNER CELL MASS CELL DIFFERENTIATION | 5 | 9.88e-01 | 4.02e-03 | 9.94e-01 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 36 | 9.67e-01 | 3.98e-03 | 9.84e-01 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 152 | 9.33e-01 | -3.96e-03 | 9.71e-01 |
| GOBP RESPONSE TO OXYGEN LEVELS | 227 | 9.19e-01 | 3.95e-03 | 9.65e-01 |
| GOBP CHEMICAL HOMEOSTASIS | 614 | 8.73e-01 | -3.81e-03 | 9.46e-01 |
| GOCC CAJAL BODY | 57 | 9.61e-01 | -3.78e-03 | 9.82e-01 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 129 | 9.41e-01 | -3.77e-03 | 9.74e-01 |
| GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 5 | 9.88e-01 | -3.74e-03 | 9.94e-01 |
| GOBP MONOATOMIC ION TRANSPORT | 670 | 8.71e-01 | 3.71e-03 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 93 | 9.51e-01 | 3.71e-03 | 9.78e-01 |
| GOBP CELLULAR RESPONSE TO COLD | 10 | 9.84e-01 | 3.65e-03 | 9.92e-01 |
| GOBP REGULATION OF VESICLE FUSION | 14 | 9.81e-01 | 3.65e-03 | 9.91e-01 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 337 | 9.10e-01 | 3.60e-03 | 9.63e-01 |
| GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT | 5 | 9.89e-01 | 3.58e-03 | 9.94e-01 |
| GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 8 | 9.86e-01 | 3.48e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 20 | 9.79e-01 | -3.46e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 12 | 9.84e-01 | -3.44e-03 | 9.92e-01 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 56 | 9.65e-01 | 3.43e-03 | 9.83e-01 |
| GOCC TORC2 COMPLEX | 9 | 9.86e-01 | -3.41e-03 | 9.93e-01 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 47 | 9.68e-01 | -3.40e-03 | 9.85e-01 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 69 | 9.61e-01 | -3.38e-03 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 23 | 9.78e-01 | -3.33e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 6 | 9.89e-01 | -3.31e-03 | 9.94e-01 |
| GOMF DEACETYLASE ACTIVITY | 34 | 9.74e-01 | -3.28e-03 | 9.87e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 39 | 9.72e-01 | -3.26e-03 | 9.86e-01 |
| GOBP RETROGRADE AXONAL TRANSPORT | 14 | 9.83e-01 | 3.19e-03 | 9.92e-01 |
| GOBP DAMP METABOLIC PROCESS | 5 | 9.90e-01 | 3.19e-03 | 9.95e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 36 | 9.74e-01 | 3.19e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 18 | 9.82e-01 | 3.16e-03 | 9.91e-01 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 50 | 9.69e-01 | 3.14e-03 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 78 | 9.62e-01 | 3.09e-03 | 9.82e-01 |
| GOBP SYNCYTIUM FORMATION | 40 | 9.73e-01 | -3.06e-03 | 9.87e-01 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 53 | 9.69e-01 | -3.05e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 96 | 9.59e-01 | -3.01e-03 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 20 | 9.81e-01 | -3.00e-03 | 9.91e-01 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 11 | 9.87e-01 | -2.94e-03 | 9.93e-01 |
| GOCC VACUOLE | 692 | 8.97e-01 | -2.92e-03 | 9.58e-01 |
| GOMF GLYCOGEN BINDING | 6 | 9.90e-01 | -2.90e-03 | 9.95e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 6 | 9.90e-01 | 2.90e-03 | 9.95e-01 |
| GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 6 | 9.90e-01 | 2.90e-03 | 9.95e-01 |
| GOBP CONVERGENT EXTENSION | 8 | 9.89e-01 | 2.88e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 12 | 9.86e-01 | -2.87e-03 | 9.93e-01 |
| GOBP SELECTIVE AUTOPHAGY | 90 | 9.64e-01 | 2.79e-03 | 9.83e-01 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 123 | 9.58e-01 | 2.78e-03 | 9.81e-01 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 19 | 9.84e-01 | 2.74e-03 | 9.92e-01 |
| GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 9.87e-01 | -2.74e-03 | 9.94e-01 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 24 | 9.82e-01 | -2.72e-03 | 9.91e-01 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 94 | 9.64e-01 | -2.72e-03 | 9.83e-01 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 201 | 9.47e-01 | 2.71e-03 | 9.76e-01 |
| GOBP PODOSOME ASSEMBLY | 18 | 9.84e-01 | 2.68e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 11 | 9.88e-01 | -2.61e-03 | 9.94e-01 |
| GOMF POLY ADP D RIBOSE BINDING | 6 | 9.91e-01 | -2.58e-03 | 9.95e-01 |
| GOBP GLUCAN METABOLIC PROCESS | 57 | 9.74e-01 | -2.52e-03 | 9.87e-01 |
| GOBP LUNG MORPHOGENESIS | 30 | 9.82e-01 | 2.44e-03 | 9.91e-01 |
| GOBP NEUROMUSCULAR PROCESS | 85 | 9.69e-01 | 2.42e-03 | 9.85e-01 |
| GOMF SNARE BINDING | 78 | 9.71e-01 | 2.38e-03 | 9.86e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 264 | 9.47e-01 | 2.36e-03 | 9.76e-01 |
| GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 164 | 9.58e-01 | 2.36e-03 | 9.81e-01 |
| GOBP MITOCHONDRION LOCALIZATION | 38 | 9.80e-01 | 2.34e-03 | 9.90e-01 |
| GOBP MITOCHONDRION DISTRIBUTION | 13 | 9.88e-01 | 2.34e-03 | 9.94e-01 |
| GOBP ODONTOGENESIS | 56 | 9.76e-01 | -2.28e-03 | 9.88e-01 |
| GOCC ENDOSOME | 802 | 9.15e-01 | -2.25e-03 | 9.65e-01 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 95 | 9.70e-01 | -2.24e-03 | 9.85e-01 |
| GOBP SEQUESTERING OF ACTIN MONOMERS | 8 | 9.91e-01 | 2.18e-03 | 9.95e-01 |
| GOBP EXPORT FROM CELL | 538 | 9.32e-01 | -2.15e-03 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 11 | 9.90e-01 | -2.10e-03 | 9.95e-01 |
| GOBP VASODILATION | 23 | 9.87e-01 | -2.04e-03 | 9.93e-01 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 71 | 9.77e-01 | 1.98e-03 | 9.88e-01 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 34 | 9.84e-01 | -1.98e-03 | 9.92e-01 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 376 | 9.49e-01 | 1.94e-03 | 9.76e-01 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 11 | 9.91e-01 | -1.86e-03 | 9.95e-01 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 13 | 9.91e-01 | -1.81e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 22 | 9.89e-01 | 1.72e-03 | 9.94e-01 |
| GOBP PROTEIN METHYLATION | 70 | 9.80e-01 | -1.72e-03 | 9.90e-01 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 15 | 9.91e-01 | -1.72e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 9.95e-01 | 1.66e-03 | 9.98e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 188 | 9.69e-01 | 1.63e-03 | 9.85e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 25 | 9.89e-01 | -1.62e-03 | 9.94e-01 |
| GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING | 5 | 9.95e-01 | -1.58e-03 | 9.98e-01 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 18 | 9.91e-01 | 1.53e-03 | 9.95e-01 |
| GOBP REGULATION OF PH | 73 | 9.83e-01 | 1.48e-03 | 9.91e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 8 | 9.94e-01 | -1.47e-03 | 9.97e-01 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 30 | 9.89e-01 | 1.39e-03 | 9.95e-01 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 17 | 9.93e-01 | -1.30e-03 | 9.96e-01 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 520 | 9.60e-01 | 1.30e-03 | 9.81e-01 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 21 | 9.92e-01 | 1.28e-03 | 9.96e-01 |
| GOMF NUCLEOSIDE BINDING | 7 | 9.95e-01 | -1.28e-03 | 9.98e-01 |
| GOBP TERPENOID METABOLIC PROCESS | 48 | 9.88e-01 | -1.27e-03 | 9.94e-01 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 9.94e-01 | -1.26e-03 | 9.97e-01 |
| GOBP CALCIUM ION HOMEOSTASIS | 188 | 9.77e-01 | 1.24e-03 | 9.88e-01 |
| GOBP INORGANIC ION HOMEOSTASIS | 316 | 9.70e-01 | 1.22e-03 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 5 | 9.96e-01 | -1.17e-03 | 9.98e-01 |
| GOMF GROWTH FACTOR BINDING | 73 | 9.86e-01 | -1.15e-03 | 9.93e-01 |
| GOBP RESPONSE TO FORSKOLIN | 7 | 9.96e-01 | 1.15e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 10 | 9.95e-01 | -1.08e-03 | 9.98e-01 |
| GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 10 | 9.95e-01 | 1.04e-03 | 9.98e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 23 | 9.93e-01 | 1.01e-03 | 9.97e-01 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 11 | 9.96e-01 | -8.67e-04 | 9.98e-01 |
| GOMF GABA RECEPTOR BINDING | 10 | 9.96e-01 | -8.23e-04 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 141 | 9.87e-01 | 8.21e-04 | 9.93e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 9 | 9.97e-01 | -7.85e-04 | 9.98e-01 |
| GOBP SECRETORY GRANULE ORGANIZATION | 44 | 9.93e-01 | -7.37e-04 | 9.97e-01 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 31 | 9.95e-01 | -6.98e-04 | 9.98e-01 |
| GOCC NUCLEAR ENVELOPE | 409 | 9.82e-01 | 6.67e-04 | 9.91e-01 |
| GOCC TRANSFERASE COMPLEX | 753 | 9.76e-01 | -6.50e-04 | 9.88e-01 |
| GOCC EXOCYTIC VESICLE | 145 | 9.89e-01 | 6.47e-04 | 9.94e-01 |
| GOBP REGULATION OF MACROAUTOPHAGY | 144 | 9.93e-01 | -4.48e-04 | 9.96e-01 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 26 | 9.97e-01 | 4.28e-04 | 9.98e-01 |
| GOBP RESPONSE TO GROWTH HORMONE | 23 | 9.97e-01 | 4.09e-04 | 9.99e-01 |
| GOBP GLIAL CELL PROLIFERATION | 37 | 9.97e-01 | -3.73e-04 | 9.98e-01 |
| GOBP HISTAMINE SECRETION | 10 | 9.98e-01 | 3.70e-04 | 9.99e-01 |
| GOBP HISTAMINE TRANSPORT | 10 | 9.98e-01 | 3.70e-04 | 9.99e-01 |
| GOBP REGULATION OF GERMINAL CENTER FORMATION | 7 | 9.99e-01 | -3.62e-04 | 9.99e-01 |
| GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION | 5 | 9.99e-01 | -3.43e-04 | 9.99e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 49 | 9.97e-01 | -3.35e-04 | 9.98e-01 |
| GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 9 | 9.99e-01 | -3.28e-04 | 9.99e-01 |
| GOBP CELLULAR CATABOLIC PROCESS | 1224 | 9.86e-01 | -2.96e-04 | 9.93e-01 |
| GOCC NUCLEOLUS | 895 | 9.88e-01 | 2.94e-04 | 9.94e-01 |
| GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 7 | 9.99e-01 | -2.64e-04 | 9.99e-01 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 38 | 9.98e-01 | 2.57e-04 | 9.99e-01 |
| GOMF CYTOKINE RECEPTOR BINDING | 135 | 9.98e-01 | -1.26e-04 | 9.99e-01 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 59 | 9.99e-01 | 7.11e-05 | 9.99e-01 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 1.00e+00 | 3.74e-05 | 1.00e+00 |
| GOBP RESPONSE TO VITAMIN D | 21 | 1.00e+00 | -3.27e-06 | 1.00e+00 |
Detailed Gene set reports
GOCC KNL1 SPC105 COMPLEX
| set | GOCC KNL1 SPC105 COMPLEX |
| setSize | 5 |
| pANOVA | 0.000308 |
| s.dist | -0.932 |
| p.adjustANOVA | 0.00704 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SPC25 | -7130 |
| KNL1 | -6888 |
| NDC80 | -6739 |
| ZWINT | -6475 |
| NUF2 | -6101 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SPC25 | -7130 |
| KNL1 | -6888 |
| NDC80 | -6739 |
| ZWINT | -6475 |
| NUF2 | -6101 |
GOBP OPSONIZATION
| set | GOBP OPSONIZATION |
| setSize | 5 |
| pANOVA | 0.00082 |
| s.dist | -0.864 |
| p.adjustANOVA | 0.0145 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FCN1 | -7094 |
| SPON2 | -7007 |
| MYO18A | -6479 |
| CFP | -5386 |
| PTX3 | -4893 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FCN1 | -7094 |
| SPON2 | -7007 |
| MYO18A | -6479 |
| CFP | -5386 |
| PTX3 | -4893 |
GOMF PROTEASOME ACTIVATING ACTIVITY
| set | GOMF PROTEASOME ACTIVATING ACTIVITY |
| setSize | 6 |
| pANOVA | 0.000538 |
| s.dist | 0.816 |
| p.adjustANOVA | 0.0103 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMC4 | 7042 |
| PSMC5 | 6751 |
| PSMC3 | 6466 |
| PSMC2 | 6375 |
| PSMC1 | 5172 |
| PSMC6 | 4671 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PSMC4 | 7042 |
| PSMC5 | 6751 |
| PSMC3 | 6466 |
| PSMC2 | 6375 |
| PSMC1 | 5172 |
| PSMC6 | 4671 |
GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY
| set | GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY |
| setSize | 5 |
| pANOVA | 0.00166 |
| s.dist | -0.812 |
| p.adjustANOVA | 0.0243 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| WBP1L | -6799 |
| OXSR1 | -6238 |
| STK39 | -6083 |
| TREM2 | -5147 |
| CXCR4 | -4708 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| WBP1L | -6799 |
| OXSR1 | -6238 |
| STK39 | -6083 |
| TREM2 | -5147 |
| CXCR4 | -4708 |
GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION
| set | GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION |
| setSize | 5 |
| pANOVA | 0.00168 |
| s.dist | -0.811 |
| p.adjustANOVA | 0.0244 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FOXP1 | -6359 |
| GPR183 | -6264 |
| RC3H1 | -6144 |
| ASCL2 | -5173 |
| RC3H2 | -4994 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FOXP1 | -6359 |
| GPR183 | -6264 |
| RC3H1 | -6144 |
| ASCL2 | -5173 |
| RC3H2 | -4994 |
GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY
| set | GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY |
| setSize | 8 |
| pANOVA | 9.11e-05 |
| s.dist | -0.799 |
| p.adjustANOVA | 0.00275 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DUSP16 | -6911 |
| DUSP7 | -6662 |
| DUSP4 | -6349 |
| DUSP5 | -6061 |
| DUSP2 | -5972 |
| DUSP1 | -5063 |
| DUSP10 | -5020 |
| DUSP6 | -3527 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| DUSP16 | -6911 |
| DUSP7 | -6662 |
| DUSP4 | -6349 |
| DUSP5 | -6061 |
| DUSP2 | -5972 |
| DUSP1 | -5063 |
| DUSP10 | -5020 |
| DUSP6 | -3527 |
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX
| set | GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX |
| setSize | 7 |
| pANOVA | 0.000318 |
| s.dist | 0.786 |
| p.adjustANOVA | 0.0072 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMA7 | 6983 |
| PSMA6 | 6725 |
| PSMA4 | 6665 |
| PSMA2 | 6196 |
| PSMA3 | 5743 |
| PSMA1 | 4536 |
| PSMA5 | 4165 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PSMA7 | 6983 |
| PSMA6 | 6725 |
| PSMA4 | 6665 |
| PSMA2 | 6196 |
| PSMA3 | 5743 |
| PSMA1 | 4536 |
| PSMA5 | 4165 |
GOCC MCM COMPLEX
| set | GOCC MCM COMPLEX |
| setSize | 8 |
| pANOVA | 0.000138 |
| s.dist | -0.778 |
| p.adjustANOVA | 0.00383 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MCM7 | -6996 |
| MCM5 | -6668 |
| MCM3 | -6064 |
| MCM6 | -6040 |
| MCM2 | -5659 |
| MCM4 | -5574 |
| MCM9 | -4302 |
| MCM8 | -3049 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MCM7 | -6996 |
| MCM5 | -6668 |
| MCM3 | -6064 |
| MCM6 | -6040 |
| MCM2 | -5659 |
| MCM4 | -5574 |
| MCM9 | -4302 |
| MCM8 | -3049 |
GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX
| set | GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX |
| setSize | 7 |
| pANOVA | 0.000366 |
| s.dist | 0.778 |
| p.adjustANOVA | 0.00779 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMD8 | 7304 |
| PSMD3 | 6760 |
| PSMD14 | 6351 |
| PSMD12 | 5705 |
| ADRM1 | 5449 |
| PSMD11 | 4732 |
| PSMD13 | 4306 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PSMD8 | 7304 |
| PSMD3 | 6760 |
| PSMD14 | 6351 |
| PSMD12 | 5705 |
| ADRM1 | 5449 |
| PSMD11 | 4732 |
| PSMD13 | 4306 |
GOMF COMPLEMENT RECEPTOR ACTIVITY
| set | GOMF COMPLEMENT RECEPTOR ACTIVITY |
| setSize | 8 |
| pANOVA | 0.000146 |
| s.dist | -0.775 |
| p.adjustANOVA | 0.00402 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FPR2 | -6861 |
| CR1 | -6684 |
| FPR3 | -6355 |
| FPR1 | -6269 |
| CMKLR1 | -6230 |
| C3AR1 | -6132 |
| C5AR2 | -5971 |
| C5AR1 | 312 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FPR2 | -6861 |
| CR1 | -6684 |
| FPR3 | -6355 |
| FPR1 | -6269 |
| CMKLR1 | -6230 |
| C3AR1 | -6132 |
| C5AR2 | -5971 |
| C5AR1 | 312 |
GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS
| set | GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS |
| setSize | 5 |
| pANOVA | 0.00271 |
| s.dist | -0.774 |
| p.adjustANOVA | 0.0348 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NOTCH3 | -7029 |
| PKD2 | -6270 |
| NRP1 | -5814 |
| PDGFRA | -5355 |
| NOTCH2 | -3120 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NOTCH3 | -7029 |
| PKD2 | -6270 |
| NRP1 | -5814 |
| PDGFRA | -5355 |
| NOTCH2 | -3120 |
GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION
| set | GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION |
| setSize | 7 |
| pANOVA | 0.000437 |
| s.dist | -0.767 |
| p.adjustANOVA | 0.00893 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FGL2 | -7096 |
| FCGR2B | -6422 |
| HFE | -6322 |
| LILRB2 | -6210 |
| TAPBPL | -5755 |
| HLA-DOA | -5556 |
| CD68 | -910 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FGL2 | -7096 |
| FCGR2B | -6422 |
| HFE | -6322 |
| LILRB2 | -6210 |
| TAPBPL | -5755 |
| HLA-DOA | -5556 |
| CD68 | -910 |
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN
| set | GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN |
| setSize | 5 |
| pANOVA | 0.00364 |
| s.dist | -0.751 |
| p.adjustANOVA | 0.0422 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HFE | -6322 |
| TAPBPL | -5755 |
| HLA-DOA | -5556 |
| TREM2 | -5147 |
| PYCARD | -3956 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HFE | -6322 |
| TAPBPL | -5755 |
| HLA-DOA | -5556 |
| TREM2 | -5147 |
| PYCARD | -3956 |
GOMF IGG BINDING
| set | GOMF IGG BINDING |
| setSize | 6 |
| pANOVA | 0.00151 |
| s.dist | -0.748 |
| p.adjustANOVA | 0.0228 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FCGR3A | -6597 |
| FCGR2B | -6422 |
| FCGRT | -5920 |
| FCGR1A | -5531 |
| FCGR2A | -4366 |
| FCER1G | -3109 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FCGR3A | -6597 |
| FCGR2B | -6422 |
| FCGRT | -5920 |
| FCGR1A | -5531 |
| FCGR2A | -4366 |
| FCER1G | -3109 |
GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION
| set | GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION |
| setSize | 5 |
| pANOVA | 0.0038 |
| s.dist | -0.747 |
| p.adjustANOVA | 0.0434 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TENT4B | -7107 |
| TENT4A | -6700 |
| LARP4B | -6467 |
| ELAVL4 | -5243 |
| METTL16 | -1092 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TENT4B | -7107 |
| TENT4A | -6700 |
| LARP4B | -6467 |
| ELAVL4 | -5243 |
| METTL16 | -1092 |
GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES
| set | GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES |
| setSize | 6 |
| pANOVA | 0.00161 |
| s.dist | -0.743 |
| p.adjustANOVA | 0.0238 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GEN1 | -6595 |
| XRCC3 | -5748 |
| RMI1 | -5357 |
| BLM | -4976 |
| TOP3A | -4545 |
| RMI2 | -4530 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GEN1 | -6595 |
| XRCC3 | -5748 |
| RMI1 | -5357 |
| BLM | -4976 |
| TOP3A | -4545 |
| RMI2 | -4530 |
GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION
| set | GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION |
| setSize | 5 |
| pANOVA | 0.00406 |
| s.dist | -0.742 |
| p.adjustANOVA | 0.0451 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOE | -6986 |
| ABL1 | -5993 |
| NRP1 | -5814 |
| RALBP1 | -3883 |
| ABCA1 | -3738 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| APOE | -6986 |
| ABL1 | -5993 |
| NRP1 | -5814 |
| RALBP1 | -3883 |
| ABCA1 | -3738 |
GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS
| set | GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS |
| setSize | 5 |
| pANOVA | 0.00414 |
| s.dist | 0.74 |
| p.adjustANOVA | 0.0457 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| UST | 7325 |
| CHST14 | 7100 |
| DSEL | 5325 |
| CHST12 | 4183 |
| DSE | 3715 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| UST | 7325 |
| CHST14 | 7100 |
| DSEL | 5325 |
| CHST12 | 4183 |
| DSE | 3715 |
GOBP APOPTOTIC CHROMOSOME CONDENSATION
| set | GOBP APOPTOTIC CHROMOSOME CONDENSATION |
| setSize | 5 |
| pANOVA | 0.00469 |
| s.dist | -0.73 |
| p.adjustANOVA | 0.049 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TOP2A | -7131 |
| GPER1 | -6357 |
| ACIN1 | -4855 |
| DFFB | -4678 |
| KDM4A | -2958 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TOP2A | -7131 |
| GPER1 | -6357 |
| ACIN1 | -4855 |
| DFFB | -4678 |
| KDM4A | -2958 |
GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING
| set | GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING |
| setSize | 7 |
| pANOVA | 0.000867 |
| s.dist | -0.727 |
| p.adjustANOVA | 0.0151 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MBOAT1 | -6866 |
| MBOAT2 | -6714 |
| OSBPL8 | -6028 |
| LPCAT3 | -5019 |
| OSBPL5 | -4772 |
| PLA1A | -3745 |
| LPCAT4 | -3054 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MBOAT1 | -6866 |
| MBOAT2 | -6714 |
| OSBPL8 | -6028 |
| LPCAT3 | -5019 |
| OSBPL5 | -4772 |
| PLA1A | -3745 |
| LPCAT4 | -3054 |
GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS
| set | GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS |
| setSize | 5 |
| pANOVA | 0.00546 |
| s.dist | 0.718 |
| p.adjustANOVA | 0.0543 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CCL3 | 7342 |
| CCL5 | 6002 |
| CCL7 | 5267 |
| CCL2 | 5029 |
| CCL4 | 3176 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CCL3 | 7342 |
| CCL5 | 6002 |
| CCL7 | 5267 |
| CCL2 | 5029 |
| CCL4 | 3176 |
GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE
| set | GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE |
| setSize | 5 |
| pANOVA | 0.00546 |
| s.dist | -0.718 |
| p.adjustANOVA | 0.0543 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOE | -6986 |
| APOC2 | -6548 |
| APOC1 | -4418 |
| LIPA | -4023 |
| LIPC | -3546 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| APOE | -6986 |
| APOC2 | -6548 |
| APOC1 | -4418 |
| LIPA | -4023 |
| LIPC | -3546 |
GOCC PROTEASOME REGULATORY PARTICLE
| set | GOCC PROTEASOME REGULATORY PARTICLE |
| setSize | 19 |
| pANOVA | 6.21e-08 |
| s.dist | 0.717 |
| p.adjustANOVA | 5.76e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMD8 | 7304 |
| PSMC4 | 7042 |
| PSMD3 | 6760 |
| PSMC5 | 6751 |
| PSMC3 | 6466 |
| PSMC2 | 6375 |
| PSMD14 | 6351 |
| PSMD7 | 6135 |
| PSMD6 | 5829 |
| PSMD12 | 5705 |
| ADRM1 | 5449 |
| PSMC1 | 5172 |
| PSMD11 | 4732 |
| PSMC6 | 4671 |
| PSMD13 | 4306 |
| PSMD1 | 4272 |
| PSMD4 | 3504 |
| PSMD9 | 2768 |
| PSMD2 | 2144 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PSMD8 | 7304 |
| PSMC4 | 7042 |
| PSMD3 | 6760 |
| PSMC5 | 6751 |
| PSMC3 | 6466 |
| PSMC2 | 6375 |
| PSMD14 | 6351 |
| PSMD7 | 6135 |
| PSMD6 | 5829 |
| PSMD12 | 5705 |
| ADRM1 | 5449 |
| PSMC1 | 5172 |
| PSMD11 | 4732 |
| PSMC6 | 4671 |
| PSMD13 | 4306 |
| PSMD1 | 4272 |
| PSMD4 | 3504 |
| PSMD9 | 2768 |
| PSMD2 | 2144 |
GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION
| set | GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION |
| setSize | 7 |
| pANOVA | 0.00106 |
| s.dist | -0.715 |
| p.adjustANOVA | 0.0176 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IQSEC2 | -6247 |
| LILRB2 | -6210 |
| ADCY8 | -5715 |
| AGER | -5056 |
| SHANK3 | -4715 |
| FMR1 | -4303 |
| STAU2 | -3323 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IQSEC2 | -6247 |
| LILRB2 | -6210 |
| ADCY8 | -5715 |
| AGER | -5056 |
| SHANK3 | -4715 |
| FMR1 | -4303 |
| STAU2 | -3323 |
GOCC PROTEASE INHIBITOR COMPLEX
| set | GOCC PROTEASE INHIBITOR COMPLEX |
| setSize | 5 |
| pANOVA | 0.00625 |
| s.dist | 0.706 |
| p.adjustANOVA | 0.0598 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PLAU | 7338 |
| CASP1 | 7274 |
| CARD16 | 5494 |
| SERPINE1 | 4951 |
| SERPINB6 | 1339 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PLAU | 7338 |
| CASP1 | 7274 |
| CARD16 | 5494 |
| SERPINE1 | 4951 |
| SERPINB6 | 1339 |
GOMF ANGIOTENSIN RECEPTOR BINDING
| set | GOMF ANGIOTENSIN RECEPTOR BINDING |
| setSize | 5 |
| pANOVA | 0.00643 |
| s.dist | -0.704 |
| p.adjustANOVA | 0.0609 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ARAP1 | -6652 |
| JAK2 | -5865 |
| ARRB1 | -4672 |
| TYK2 | -4508 |
| ARRB2 | -3316 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ARAP1 | -6652 |
| JAK2 | -5865 |
| ARRB1 | -4672 |
| TYK2 | -4508 |
| ARRB2 | -3316 |
GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR
| set | GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR |
| setSize | 5 |
| pANOVA | 0.00648 |
| s.dist | 0.703 |
| p.adjustANOVA | 0.0613 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DNAJC19 | 6434 |
| DNAJC15 | 5712 |
| GRPEL1 | 5264 |
| PAM16 | 5122 |
| GRPEL2 | 3755 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| DNAJC19 | 6434 |
| DNAJC15 | 5712 |
| GRPEL1 | 5264 |
| PAM16 | 5122 |
| GRPEL2 | 3755 |
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION
| set | GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION |
| setSize | 6 |
| pANOVA | 0.00301 |
| s.dist | -0.699 |
| p.adjustANOVA | 0.0374 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PTPRC | -6906 |
| SOX13 | -6622 |
| SOX4 | -5525 |
| NCKAP1L | -5347 |
| STAT5B | -3600 |
| SYK | -1822 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PTPRC | -6906 |
| SOX13 | -6622 |
| SOX4 | -5525 |
| NCKAP1L | -5347 |
| STAT5B | -3600 |
| SYK | -1822 |
GOMF AMINOACYL TRNA HYDROLASE ACTIVITY
| set | GOMF AMINOACYL TRNA HYDROLASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00678 |
| s.dist | 0.699 |
| p.adjustANOVA | 0.0633 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ETF1 | 7190 |
| PTRH1 | 6563 |
| PTRHD1 | 6130 |
| MRPL58 | 5508 |
| PTRH2 | 753 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ETF1 | 7190 |
| PTRH1 | 6563 |
| PTRHD1 | 6130 |
| MRPL58 | 5508 |
| PTRH2 | 753 |
GOBP RESPONSE TO VITAMIN A
| set | GOBP RESPONSE TO VITAMIN A |
| setSize | 6 |
| pANOVA | 0.00316 |
| s.dist | -0.696 |
| p.adjustANOVA | 0.0384 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TYMS | -7146 |
| CAT | -6301 |
| RARA | -6037 |
| DNMT3A | -5104 |
| LIPA | -4023 |
| ALDH1A2 | -1061 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TYMS | -7146 |
| CAT | -6301 |
| RARA | -6037 |
| DNMT3A | -5104 |
| LIPA | -4023 |
| ALDH1A2 | -1061 |
GOBP RESPONSE TO FUNGICIDE
| set | GOBP RESPONSE TO FUNGICIDE |
| setSize | 6 |
| pANOVA | 0.00332 |
| s.dist | -0.692 |
| p.adjustANOVA | 0.0397 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| KDM5B | -7068 |
| KDM1A | -5962 |
| SRD5A1 | -5780 |
| KDM6B | -5630 |
| EHMT1 | -3642 |
| EHMT2 | -1433 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| KDM5B | -7068 |
| KDM1A | -5962 |
| SRD5A1 | -5780 |
| KDM6B | -5630 |
| EHMT1 | -3642 |
| EHMT2 | -1433 |
GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS
| set | GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS |
| setSize | 5 |
| pANOVA | 0.00741 |
| s.dist | 0.692 |
| p.adjustANOVA | 0.067 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CAPN2 | 7307 |
| LPCAT1 | 5676 |
| RAB38 | 5403 |
| FABP3 | 4437 |
| ACSL3 | 3042 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CAPN2 | 7307 |
| LPCAT1 | 5676 |
| RAB38 | 5403 |
| FABP3 | 4437 |
| ACSL3 | 3042 |
GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX
| set | GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX |
| setSize | 9 |
| pANOVA | 0.000342 |
| s.dist | 0.689 |
| p.adjustANOVA | 0.00748 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PSMC4 | 7042 |
| PSMC5 | 6751 |
| PSMC3 | 6466 |
| PSMC2 | 6375 |
| PSMC1 | 5172 |
| PSMC6 | 4671 |
| PSMD1 | 4272 |
| PSMD4 | 3504 |
| PSMD2 | 2144 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PSMC4 | 7042 |
| PSMC5 | 6751 |
| PSMC3 | 6466 |
| PSMC2 | 6375 |
| PSMC1 | 5172 |
| PSMC6 | 4671 |
| PSMD1 | 4272 |
| PSMD4 | 3504 |
| PSMD2 | 2144 |
GOBP POSITIVE REGULATION OF RECEPTOR BINDING
| set | GOBP POSITIVE REGULATION OF RECEPTOR BINDING |
| setSize | 5 |
| pANOVA | 0.00763 |
| s.dist | -0.689 |
| p.adjustANOVA | 0.0686 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HFE | -6322 |
| MMP9 | -5883 |
| NRP1 | -5814 |
| ANXA2 | -4911 |
| B2M | -1546 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HFE | -6322 |
| MMP9 | -5883 |
| NRP1 | -5814 |
| ANXA2 | -4911 |
| B2M | -1546 |
GOCC MHC CLASS II PROTEIN COMPLEX
| set | GOCC MHC CLASS II PROTEIN COMPLEX |
| setSize | 14 |
| pANOVA | 8.55e-06 |
| s.dist | -0.687 |
| p.adjustANOVA | 0.000372 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HLA-DMA | -6979 |
| HLA-DPB1 | -6782 |
| HLA-DMB | -6672 |
| HLA-DRA | -6471 |
| HLA-DPA1 | -6438 |
| CD74 | -6078 |
| HLA-DOA | -5556 |
| HLA-DRB1 | -4949 |
| HLA-DQA1 | -4075 |
| HLA-DQA2 | -4000 |
| HLA-DRB5 | -3952 |
| HLA-DQB1 | -2709 |
| HLA-DQB2 | -2079 |
| B2M | -1546 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HLA-DMA | -6979 |
| HLA-DPB1 | -6782 |
| HLA-DMB | -6672 |
| HLA-DRA | -6471 |
| HLA-DPA1 | -6438 |
| CD74 | -6078 |
| HLA-DOA | -5556 |
| HLA-DRB1 | -4949 |
| HLA-DQA1 | -4075 |
| HLA-DQA2 | -4000 |
| HLA-DRB5 | -3952 |
| HLA-DQB1 | -2709 |
| HLA-DQB2 | -2079 |
| B2M | -1546 |
GOBP GLOMERULUS MORPHOGENESIS
| set | GOBP GLOMERULUS MORPHOGENESIS |
| setSize | 5 |
| pANOVA | 0.00811 |
| s.dist | -0.684 |
| p.adjustANOVA | 0.0712 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NOTCH3 | -7029 |
| PDGFRA | -5355 |
| MTSS1 | -4785 |
| MEF2C | -3994 |
| NOTCH2 | -3120 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NOTCH3 | -7029 |
| PDGFRA | -5355 |
| MTSS1 | -4785 |
| MEF2C | -3994 |
| NOTCH2 | -3120 |
GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY
| set | GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY |
| setSize | 6 |
| pANOVA | 0.00377 |
| s.dist | 0.683 |
| p.adjustANOVA | 0.0434 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NUDT9 | 7146 |
| NUDT14 | 7124 |
| NUDT5 | 6337 |
| TRPM2 | 6241 |
| NUDT6 | 5194 |
| ADPRM | -1386 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NUDT9 | 7146 |
| NUDT14 | 7124 |
| NUDT5 | 6337 |
| TRPM2 | 6241 |
| NUDT6 | 5194 |
| ADPRM | -1386 |
GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY
| set | GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY |
| setSize | 6 |
| pANOVA | 0.00397 |
| s.dist | -0.679 |
| p.adjustANOVA | 0.0447 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| JUNB | -6982 |
| SP3 | -6635 |
| EMP2 | -6338 |
| ACSL4 | -5451 |
| CITED2 | -3374 |
| TLE6 | -160 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| JUNB | -6982 |
| SP3 | -6635 |
| EMP2 | -6338 |
| ACSL4 | -5451 |
| CITED2 | -3374 |
| TLE6 | -160 |
GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS
| set | GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS |
| setSize | 5 |
| pANOVA | 0.00871 |
| s.dist | -0.677 |
| p.adjustANOVA | 0.075 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IGF1R | -7084 |
| TRERF1 | -6951 |
| VPS54 | -5617 |
| CYP1B1 | -4984 |
| SRC | 579 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IGF1R | -7084 |
| TRERF1 | -6951 |
| VPS54 | -5617 |
| CYP1B1 | -4984 |
| SRC | 579 |
GOBP CELLULAR HYPOTONIC RESPONSE
| set | GOBP CELLULAR HYPOTONIC RESPONSE |
| setSize | 9 |
| pANOVA | 0.000435 |
| s.dist | -0.677 |
| p.adjustANOVA | 0.00891 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CAB39 | -6317 |
| MYLK | -6291 |
| OXSR1 | -6238 |
| STK39 | -6083 |
| TRPV4 | -6048 |
| FBP1 | -5322 |
| SLC12A6 | -4084 |
| SLC4A11 | -3880 |
| TSPO | 991 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CAB39 | -6317 |
| MYLK | -6291 |
| OXSR1 | -6238 |
| STK39 | -6083 |
| TRPV4 | -6048 |
| FBP1 | -5322 |
| SLC12A6 | -4084 |
| SLC4A11 | -3880 |
| TSPO | 991 |
GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING
| set | GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING |
| setSize | 6 |
| pANOVA | 0.0041 |
| s.dist | -0.677 |
| p.adjustANOVA | 0.0454 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PTAFR | -7103 |
| GCNT1 | -6978 |
| CHST2 | -6715 |
| ITGA4 | -5105 |
| ST3GAL4 | -4370 |
| FUT4 | 1438 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PTAFR | -7103 |
| GCNT1 | -6978 |
| CHST2 | -6715 |
| ITGA4 | -5105 |
| ST3GAL4 | -4370 |
| FUT4 | 1438 |
GOBP CATECHOLAMINE UPTAKE
| set | GOBP CATECHOLAMINE UPTAKE |
| setSize | 6 |
| pANOVA | 0.00413 |
| s.dist | 0.676 |
| p.adjustANOVA | 0.0456 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SNCA | 7239 |
| TOR1A | 6998 |
| SLC22A1 | 6967 |
| PARK7 | 5798 |
| PRKN | 2494 |
| ACTB | 866 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SNCA | 7239 |
| TOR1A | 6998 |
| SLC22A1 | 6967 |
| PARK7 | 5798 |
| PRKN | 2494 |
| ACTB | 866 |
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX
| set | GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX |
| setSize | 13 |
| pANOVA | 2.56e-05 |
| s.dist | -0.674 |
| p.adjustANOVA | 0.000942 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HLA-DMA | -6979 |
| HLA-DPB1 | -6782 |
| HLA-DMB | -6672 |
| HLA-DRA | -6471 |
| HLA-DPA1 | -6438 |
| HLA-DOA | -5556 |
| HLA-DRB1 | -4949 |
| HLA-DQA1 | -4075 |
| HLA-DQA2 | -4000 |
| HLA-DRB5 | -3952 |
| HLA-DQB1 | -2709 |
| HLA-DQB2 | -2079 |
| B2M | -1546 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HLA-DMA | -6979 |
| HLA-DPB1 | -6782 |
| HLA-DMB | -6672 |
| HLA-DRA | -6471 |
| HLA-DPA1 | -6438 |
| HLA-DOA | -5556 |
| HLA-DRB1 | -4949 |
| HLA-DQA1 | -4075 |
| HLA-DQA2 | -4000 |
| HLA-DRB5 | -3952 |
| HLA-DQB1 | -2709 |
| HLA-DQB2 | -2079 |
| B2M | -1546 |
GOBP ADP METABOLIC PROCESS
| set | GOBP ADP METABOLIC PROCESS |
| setSize | 7 |
| pANOVA | 0.00206 |
| s.dist | 0.673 |
| p.adjustANOVA | 0.0285 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NUDT9 | 7146 |
| AK3 | 7001 |
| BAD | 5689 |
| AK4 | 5642 |
| AK2 | 4346 |
| AK1 | 3516 |
| AK5 | 1900 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NUDT9 | 7146 |
| AK3 | 7001 |
| BAD | 5689 |
| AK4 | 5642 |
| AK2 | 4346 |
| AK1 | 3516 |
| AK5 | 1900 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY
| set | GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
| setSize | 5 |
| pANOVA | 0.00949 |
| s.dist | -0.67 |
| p.adjustANOVA | 0.0797 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CASP3 | -6677 |
| CASP2 | -6532 |
| CASP9 | -5038 |
| CASP10 | -4536 |
| CASP8 | -997 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CASP3 | -6677 |
| CASP2 | -6532 |
| CASP9 | -5038 |
| CASP10 | -4536 |
| CASP8 | -997 |
GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY
| set | GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY |
| setSize | 6 |
| pANOVA | 0.00456 |
| s.dist | -0.669 |
| p.adjustANOVA | 0.0485 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLC27A1 | -6331 |
| SLC27A3 | -6312 |
| ACSL4 | -5451 |
| SLC27A4 | -4683 |
| ACSF3 | -4110 |
| SLC27A5 | -1598 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SLC27A1 | -6331 |
| SLC27A3 | -6312 |
| ACSL4 | -5451 |
| SLC27A4 | -4683 |
| ACSF3 | -4110 |
| SLC27A5 | -1598 |
GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION
| set | GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION |
| setSize | 7 |
| pANOVA | 0.00228 |
| s.dist | -0.666 |
| p.adjustANOVA | 0.0308 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FGL2 | -7096 |
| FCGR2B | -6422 |
| CD74 | -6078 |
| NOD2 | -4378 |
| SLC11A1 | -4310 |
| NOD1 | -3894 |
| CD68 | -910 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FGL2 | -7096 |
| FCGR2B | -6422 |
| CD74 | -6078 |
| NOD2 | -4378 |
| SLC11A1 | -4310 |
| NOD1 | -3894 |
| CD68 | -910 |
GOCC CMG COMPLEX
| set | GOCC CMG COMPLEX |
| setSize | 10 |
| pANOVA | 0.000295 |
| s.dist | -0.661 |
| p.adjustANOVA | 0.00685 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GINS2 | -7019 |
| MCM7 | -6996 |
| MCM5 | -6668 |
| MCM3 | -6064 |
| MCM6 | -6040 |
| MCM2 | -5659 |
| MCM4 | -5574 |
| GINS4 | -3750 |
| GINS1 | -2525 |
| GINS3 | 3400 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GINS2 | -7019 |
| MCM7 | -6996 |
| MCM5 | -6668 |
| MCM3 | -6064 |
| MCM6 | -6040 |
| MCM2 | -5659 |
| MCM4 | -5574 |
| GINS4 | -3750 |
| GINS1 | -2525 |
| GINS3 | 3400 |
GOCC HEMIDESMOSOME
| set | GOCC HEMIDESMOSOME |
| setSize | 6 |
| pANOVA | 0.00515 |
| s.dist | -0.659 |
| p.adjustANOVA | 0.0525 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ITGB4 | -7031 |
| JUP | -6667 |
| DST | -6287 |
| PLEC | -3529 |
| LAMA3 | -3201 |
| ERBIN | -1366 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ITGB4 | -7031 |
| JUP | -6667 |
| DST | -6287 |
| PLEC | -3529 |
| LAMA3 | -3201 |
| ERBIN | -1366 |
GOBP MEIOTIC CHROMOSOME SEPARATION
| set | GOBP MEIOTIC CHROMOSOME SEPARATION |
| setSize | 5 |
| pANOVA | 0.0108 |
| s.dist | -0.658 |
| p.adjustANOVA | 0.087 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| M1AP | -7006 |
| TTK | -6971 |
| NCAPH | -6950 |
| CHFR | -4234 |
| NCAPH2 | 1801 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| M1AP | -7006 |
| TTK | -6971 |
| NCAPH | -6950 |
| CHFR | -4234 |
| NCAPH2 | 1801 |
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.4.1 (2024-06-14)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 22.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.4.0 GGally_2.2.1
## [3] reshape2_1.4.4 gplots_3.1.3.1
## [5] gtools_3.9.5 tibble_3.2.1
## [7] dplyr_1.1.4 echarts4r_0.4.5
## [9] limma_3.60.0 SingleR_2.6.0
## [11] celldex_1.14.0 harmony_1.2.0
## [13] Rcpp_1.0.12 mitch_1.16.0
## [15] DESeq2_1.44.0 muscat_1.18.0
## [17] beeswarm_0.4.0 stringi_1.8.4
## [19] SingleCellExperiment_1.26.0 SummarizedExperiment_1.34.0
## [21] Biobase_2.64.0 GenomicRanges_1.56.0
## [23] GenomeInfoDb_1.40.0 IRanges_2.38.0
## [25] S4Vectors_0.42.0 BiocGenerics_0.50.0
## [27] MatrixGenerics_1.16.0 matrixStats_1.3.0
## [29] hdf5r_1.3.11 Seurat_5.1.0
## [31] SeuratObject_5.0.2 sp_2.1-4
## [33] plyr_1.8.9 ggplot2_3.5.1
## [35] kableExtra_1.4.0
##
## loaded via a namespace (and not attached):
## [1] progress_1.2.3 goftest_1.2-3
## [3] Biostrings_2.72.0 HDF5Array_1.32.0
## [5] vctrs_0.6.5 spatstat.random_3.2-3
## [7] digest_0.6.36 png_0.1-8
## [9] corpcor_1.6.10 shape_1.4.6.1
## [11] gypsum_1.0.1 ggrepel_0.9.5
## [13] deldir_2.0-4 parallelly_1.37.1
## [15] MASS_7.3-61 httpuv_1.6.15
## [17] foreach_1.5.2 withr_3.0.0
## [19] xfun_0.45 survival_3.7-0
## [21] memoise_2.0.1.9000 ggbeeswarm_0.7.2
## [23] systemfonts_1.1.0 zoo_1.8-12
## [25] GlobalOptions_0.1.2 pbapply_1.7-2
## [27] prettyunits_1.2.0 KEGGREST_1.44.0
## [29] promises_1.3.0 httr_1.4.7
## [31] globals_0.16.3 fitdistrplus_1.1-11
## [33] rhdf5filters_1.16.0 rhdf5_2.48.0
## [35] rstudioapi_0.16.0 UCSC.utils_1.0.0
## [37] miniUI_0.1.1.1 generics_0.1.3
## [39] curl_5.2.1 zlibbioc_1.50.0
## [41] ScaledMatrix_1.12.0 polyclip_1.10-6
## [43] GenomeInfoDbData_1.2.12 ExperimentHub_2.12.0
## [45] SparseArray_1.4.3 xtable_1.8-4
## [47] stringr_1.5.1 doParallel_1.0.17
## [49] evaluate_0.24.0 S4Arrays_1.4.0
## [51] BiocFileCache_2.12.0 hms_1.1.3
## [53] irlba_2.3.5.1 colorspace_2.1-0
## [55] filelock_1.0.3 ROCR_1.0-11
## [57] reticulate_1.38.0 spatstat.data_3.1-2
## [59] magrittr_2.0.3 lmtest_0.9-40
## [61] later_1.3.2 viridis_0.6.5
## [63] lattice_0.22-6 spatstat.geom_3.2-9
## [65] future.apply_1.11.2 scattermore_1.2
## [67] scuttle_1.14.0 cowplot_1.1.3
## [69] RcppAnnoy_0.0.22 pillar_1.9.0
## [71] nlme_3.1-165 iterators_1.0.14
## [73] caTools_1.18.2 compiler_4.4.1
## [75] beachmat_2.20.0 RSpectra_0.16-1
## [77] tensor_1.5 minqa_1.2.7
## [79] crayon_1.5.3 abind_1.4-5
## [81] scater_1.32.0 blme_1.0-5
## [83] locfit_1.5-9.10 bit_4.0.5
## [85] codetools_0.2-20 BiocSingular_1.20.0
## [87] bslib_0.7.0 alabaster.ranges_1.4.0
## [89] GetoptLong_1.0.5 plotly_4.10.4
## [91] remaCor_0.0.18 mime_0.12
## [93] splines_4.4.1 circlize_0.4.16
## [95] fastDummies_1.7.3 dbplyr_2.5.0
## [97] sparseMatrixStats_1.16.0 knitr_1.48
## [99] blob_1.2.4 utf8_1.2.4
## [101] clue_0.3-65 BiocVersion_3.19.1
## [103] lme4_1.1-35.3 listenv_0.9.1
## [105] DelayedMatrixStats_1.26.0 Rdpack_2.6
## [107] Matrix_1.7-0 statmod_1.5.0
## [109] svglite_2.1.3 fANCOVA_0.6-1
## [111] pkgconfig_2.0.3 tools_4.4.1
## [113] cachem_1.1.0 RhpcBLASctl_0.23-42
## [115] rbibutils_2.2.16 RSQLite_2.3.7
## [117] viridisLite_0.4.2 DBI_1.2.3
## [119] numDeriv_2016.8-1.1 fastmap_1.2.0
## [121] rmarkdown_2.27 scales_1.3.0
## [123] grid_4.4.1 ica_1.0-3
## [125] broom_1.0.6 AnnotationHub_3.12.0
## [127] sass_0.4.9 patchwork_1.2.0
## [129] BiocManager_1.30.23 ggstats_0.6.0
## [131] dotCall64_1.1-1 RANN_2.6.1
## [133] alabaster.schemas_1.4.0 farver_2.1.2
## [135] aod_1.3.3 mgcv_1.9-1
## [137] yaml_2.3.9 cli_3.6.3
## [139] purrr_1.0.2 leiden_0.4.3.1
## [141] lifecycle_1.0.4 uwot_0.2.2
## [143] glmmTMB_1.1.9 mvtnorm_1.2-5
## [145] backports_1.5.0 BiocParallel_1.38.0
## [147] gtable_0.3.5 rjson_0.2.21
## [149] ggridges_0.5.6 progressr_0.14.0
## [151] jsonlite_1.8.8 edgeR_4.2.0
## [153] RcppHNSW_0.6.0 bitops_1.0-7
## [155] bit64_4.0.5 Rtsne_0.17
## [157] alabaster.matrix_1.4.0 spatstat.utils_3.0-5
## [159] BiocNeighbors_1.22.0 highr_0.11
## [161] jquerylib_0.1.4 alabaster.se_1.4.0
## [163] pbkrtest_0.5.3 lazyeval_0.2.2
## [165] alabaster.base_1.4.1 shiny_1.8.1.1
## [167] htmltools_0.5.8.1 sctransform_0.4.1
## [169] rappdirs_0.3.3 glue_1.7.0
## [171] spam_2.10-0 httr2_1.0.1
## [173] XVector_0.44.0 gridExtra_2.3
## [175] EnvStats_2.8.1 boot_1.3-30
## [177] igraph_2.0.3 variancePartition_1.34.0
## [179] TMB_1.9.11 R6_2.5.1
## [181] tidyr_1.3.1 labeling_0.4.3
## [183] cluster_2.1.6 Rhdf5lib_1.26.0
## [185] nloptr_2.1.1 DelayedArray_0.30.1
## [187] tidyselect_1.2.1 vipor_0.4.7
## [189] xml2_1.3.6 AnnotationDbi_1.66.0
## [191] future_1.33.2 rsvd_1.0.5
## [193] munsell_0.5.1 KernSmooth_2.23-24
## [195] data.table_1.15.4 htmlwidgets_1.6.4
## [197] ComplexHeatmap_2.20.0 RColorBrewer_1.1-3
## [199] rlang_1.1.4 spatstat.sparse_3.1-0
## [201] spatstat.explore_3.2-7 lmerTest_3.1-3
## [203] fansi_1.0.6END of report